Citrus Sinensis ID: 011041
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 495 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZVM9 | 572 | Probable serine/threonine | yes | no | 0.961 | 0.832 | 0.691 | 0.0 | |
| F4I114 | 714 | Probable serine/threonine | no | no | 0.759 | 0.526 | 0.707 | 1e-162 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | no | no | 0.666 | 0.643 | 0.517 | 5e-98 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.666 | 0.635 | 0.517 | 2e-97 | |
| Q9LFT8 | 505 | Cyclin-dependent kinase C | no | no | 0.666 | 0.653 | 0.515 | 2e-97 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.666 | 0.643 | 0.504 | 9e-95 | |
| Q9NYV4 | 1490 | Cyclin-dependent kinase 1 | yes | no | 0.743 | 0.246 | 0.406 | 2e-76 | |
| D2H526 | 1491 | Cyclin-dependent kinase 1 | yes | no | 0.660 | 0.219 | 0.434 | 4e-76 | |
| Q3MJK5 | 1484 | Cyclin-dependent kinase 1 | no | no | 0.660 | 0.220 | 0.431 | 2e-75 | |
| Q14AX6 | 1484 | Cyclin-dependent kinase 1 | no | no | 0.660 | 0.220 | 0.431 | 2e-75 |
| >sp|Q9ZVM9|Y1461_ARATH Probable serine/threonine-protein kinase At1g54610 OS=Arabidopsis thaliana GN=At1g54610 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 701 bits (1810), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 331/479 (69%), Positives = 397/479 (82%), Gaps = 3/479 (0%)
Query: 1 MGCVFAREFSGKAVERRREEGSVRVDRKVSAAAAAEAVEIRNGNGGPNHRKESSNSNNEQ 60
MGCVF RE + ++ S + V + + +K++ +N ++
Sbjct: 1 MGCVFGREAATTTTAEAKQAKSSKASSGVVVVGESSVTKSNGVIADDVEKKKNEEANGDK 60
Query: 61 ETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTF 120
E + + G++RRS+KPNPRLSNP KH GEQVAAGWPSWLS GEA++GW PR+ADTF
Sbjct: 61 ERKSSK--GDRRRSTKPNPRLSNPSKHWRGEQVAAGWPSWLSDACGEALNGWVPRKADTF 118
Query: 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
EK+DKIGQGTYSNVYKA+D LTG+IVALKKVRFDNLEPESV+FMAREIL+LRRLDHPNVV
Sbjct: 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNVV 178
Query: 181 KLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
KLEGLVTSRMSCSLYLVF+YM+HDLAGLA+SP +KF++++VKC M QL+SGLEHCH++ V
Sbjct: 179 KLEGLVTSRMSCSLYLVFQYMDHDLAGLASSPVVKFSESEVKCLMRQLISGLEHCHSRGV 238
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGV 300
LHRDIKGSNLLID+ G+L IADFGLA+ FDPNHK+PMTSRVVTLWYR PELLLGATDYGV
Sbjct: 239 LHRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTSRVVTLWYRAPELLLGATDYGV 298
Query: 301 GVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQ 360
G+DLWSAGCILAELLA +PIMPGRTEVEQLHKI+KLCGSPSE+YWKK K H I+KP++
Sbjct: 299 GIDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLCGSPSEDYWKKGKFTHGAIYKPRE 358
Query: 361 SYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYP 420
YKR I ETFKDFPPSSLPLI+ LL+I+P +RQTA+AAL+SEFFT++PYAC+P+ LPKYP
Sbjct: 359 PYKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASAALKSEFFTSEPYACEPADLPKYP 418
Query: 421 PTKEMDAKLRDEEARRLRAAGKANAE-AKKARSRDRAARAMPAPEANAELQANLDVRLI 478
P+KE+DAK RDEE RR RAA KA + A+K R RDR+ RA+PAPEANAELQ+N+D R +
Sbjct: 419 PSKEIDAKRRDEETRRQRAASKAQGDGARKNRHRDRSNRALPAPEANAELQSNVDRRRL 477
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|F4I114|Y1960_ARATH Probable serine/threonine-protein kinase At1g09600 OS=Arabidopsis thaliana GN=At1g09600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 572 bits (1473), Expect = e-162, Method: Compositional matrix adjust.
Identities = 268/379 (70%), Positives = 319/379 (84%), Gaps = 3/379 (0%)
Query: 90 GEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALK 149
G QV AGWPSWL++VAGEAI+GW PR+AD+FEKL+KIGQGTYS+VYKARD T Q+VALK
Sbjct: 133 GAQVMAGWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARDLETNQLVALK 192
Query: 150 KVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLA 209
KVRF N++P+SVRFMAREI+ILRRLDHPNV+KLEGL+TSR+S S+YL+F+YMEHDLAGLA
Sbjct: 193 KVRFANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLA 252
Query: 210 ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269
++P I F++AQ+KCYM QLL GLEHCH++ VLHRDIKGSNLL+D+ L I DFGLA+F+
Sbjct: 253 STPGINFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFY 312
Query: 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ 329
+ KQP+TSRVVTLWYRPPELLLG+TDYGV VDLWS GCILAEL KPIMPGRTEVEQ
Sbjct: 313 QGHQKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQ 372
Query: 330 LHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDP 389
LHKIFKLCGSPSEEYWK SKLPHATIFKPQQ YKRC+AETFK P S+L L+E LLA++P
Sbjct: 373 LHKIFKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEP 432
Query: 390 AERQTATAALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEEARRLRAAGKANAEAKK 449
R T +AL SEFFTT P A DPSSLPKY P KE+D K ++EEA+R + ++K+
Sbjct: 433 DARGTTASALESEFFTTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRKKDTSSKQNDSKQ 492
Query: 450 ARSRDRAARAMPAPEANAE 468
R ++A+PAP++NAE
Sbjct: 493 V---SRESKAVPAPDSNAE 508
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 358 bits (919), Expect = 5e-98, Method: Compositional matrix adjust.
Identities = 180/348 (51%), Positives = 233/348 (66%), Gaps = 18/348 (5%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILI 170
W R D FEKL++IG+GTY VY A++T T +IVALKK+R DN E E A REI I
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMAKETETNEIVALKKIRMDN-EREGFPITAIREIKI 75
Query: 171 LRRLDHPNVVKLEGLVTS---------------RMSCSLYLVFKYMEHDLAGLAASPTIK 215
L++L H NV++L+ +VTS + S+Y+VF+YM+HDL GLA P ++
Sbjct: 76 LKKLHHQNVIQLKEIVTSPGPERDEQGKPIEGNKYKGSIYMVFEYMDHDLTGLADRPGMR 135
Query: 216 FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275
FT Q+KCYM QLL+GL +CH VLHRDIKGSNLLIDNEG L +ADFGLA F +H
Sbjct: 136 FTVPQIKCYMRQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSSDHNG 195
Query: 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
+T+RV+TLWYRPPELLLG+T YG VD+WS GCI AELL KPI+ G+ E EQL KIF+
Sbjct: 196 NLTNRVITLWYRPPELLLGSTRYGPAVDMWSVGCIFAELLNGKPILTGKNEPEQLSKIFE 255
Query: 336 LCGSPSEEYWKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT 394
LCG+P E W +K+P FKPQ+ KR + E+FK F +L L+E +L +DP++R +
Sbjct: 256 LCGTPDELIWPGVTKMPWYNNFKPQRPMKRRVKESFKHFDQHALDLLEKMLTLDPSQRIS 315
Query: 395 ATAALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEEARRLRAAGK 442
A AL +E+F T P CDP SLPKY + E K + ++ R+ A K
Sbjct: 316 AKDALDAEYFWTDPLPCDPKSLPKYEASHEFQTKKKRQQQRQAEEAAK 363
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 356 bits (914), Expect = 2e-97, Method: Compositional matrix adjust.
Identities = 180/348 (51%), Positives = 231/348 (66%), Gaps = 18/348 (5%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILI 170
W R D FEKL++IG+GTY VY AR+T T +IVALKK+R DN E E A REI I
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMARETETQEIVALKKIRMDN-EREGFPITAIREIKI 75
Query: 171 LRRLDHPNVVKLEGLVTS---------------RMSCSLYLVFKYMEHDLAGLAASPTIK 215
L++L H NV++L+ +VTS + S+Y+VF+YM+HDL GLA P ++
Sbjct: 76 LKKLHHQNVIQLKEIVTSPGPERDEQGKPIHGNKYKGSIYMVFEYMDHDLTGLADRPGMR 135
Query: 216 FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275
FT Q+KCYM QLL+GL +CH VLHRDIKGSNLLIDNEG L +ADFGLA F +H
Sbjct: 136 FTVPQIKCYMKQLLTGLHYCHINQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSNDHNG 195
Query: 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
+T+RV+TLWYRPPELLLG+T YG VD+WS GCI AELL KPI+PG+ E EQL KIF
Sbjct: 196 NLTNRVITLWYRPPELLLGSTKYGPAVDMWSVGCIFAELLNGKPILPGKNEPEQLSKIFD 255
Query: 336 LCGSPSEEYWKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT 394
+CG+P E W +K+P FKP + KR + E FK F +L L+E +L +DPA+R +
Sbjct: 256 VCGTPDESNWPGVTKMPWYNNFKPPRQLKRRVKEYFKHFDRLALDLLEKMLTLDPAQRIS 315
Query: 395 ATAALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEEARRLRAAGK 442
A AL +E+F + P CDP SLPKY + E K + ++ R+ A K
Sbjct: 316 AQDALDAEYFWSDPLPCDPKSLPKYESSHEFQTKKKRQQMRQADEAAK 363
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 356 bits (913), Expect = 2e-97, Method: Compositional matrix adjust.
Identities = 179/347 (51%), Positives = 232/347 (66%), Gaps = 17/347 (4%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILI 170
W R D FEKL++IG+GTY VY A++ TG+IVALKK+R DN E E A REI I
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDN-EREGFPITAIREIKI 76
Query: 171 LRRLDHPNVVKLEGLVTS--------------RMSCSLYLVFKYMEHDLAGLAASPTIKF 216
L++L H NV++L+ +VTS + +Y+VF+YM+HDL GLA P ++F
Sbjct: 77 LKKLHHENVIQLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRF 136
Query: 217 TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276
T Q+KCYM QLL+GL +CH VLHRDIKGSNLLIDNEG L +ADFGLA + +H
Sbjct: 137 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGN 196
Query: 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336
+T+RV+TLWYRPPELLLGAT YG +D+WS GCI AELL KPI+PG+ E EQL+KIF+L
Sbjct: 197 LTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFEL 256
Query: 337 CGSPSEEYWKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA 395
CGSP E+ W SK+P FKP + KR + E F+ F +L L+E +L +DPA+R +A
Sbjct: 257 CGSPDEKLWPGVSKMPWFNNFKPARPLKRRVREFFRHFDRHALELLEKMLVLDPAQRISA 316
Query: 396 TAALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEEARRLRAAGK 442
AL +E+F T P CDP SLP Y + E K + ++ R+ A K
Sbjct: 317 KDALDAEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQQRQNEEAAK 363
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 347 bits (891), Expect = 9e-95, Method: Compositional matrix adjust.
Identities = 175/347 (50%), Positives = 227/347 (65%), Gaps = 17/347 (4%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILI 170
W R D FEKL++IG+GTY VY A++ TG+IVALKK+R DN E E A REI I
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDN-EREGFPITAIREIKI 76
Query: 171 LRRLDHPNVVKLEGLVTS--------------RMSCSLYLVFKYMEHDLAGLAASPTIKF 216
L++L H NV+ L+ +VTS + +Y+VF+YM+HDL GLA P ++F
Sbjct: 77 LKKLHHENVIHLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRF 136
Query: 217 TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276
T Q+KCYM QLL+GL +CH VLHRDIKGSNLLIDNEG L +ADFGLA + +H
Sbjct: 137 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGN 196
Query: 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336
+T+RV+TLWYRPPELLLGAT YG +D+WS GCI AELL KPI+PG+TE EQL+KI++L
Sbjct: 197 LTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLNGKPILPGKTENEQLNKIYEL 256
Query: 337 CGSPSEEYWKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA 395
CGSP E W SK+P K + KR + E ++ F +L L+E +L +DP++R A
Sbjct: 257 CGSPDESNWPGVSKMPWYNQMKSSRPLKRRVREIYRHFDRHALELLEKMLVLDPSQRICA 316
Query: 396 TAALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEEARRLRAAGK 442
AL +E+F T P CDP SLP Y + E K + ++ R A K
Sbjct: 317 KDALDAEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQMRHNEEAAK 363
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9NYV4|CDK12_HUMAN Cyclin-dependent kinase 12 OS=Homo sapiens GN=CDK12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 286 bits (732), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 157/386 (40%), Positives = 224/386 (58%), Gaps = 18/386 (4%)
Query: 67 PRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKI 126
P G+ P P+ PP+ + ++ P + E S W R D F+ + I
Sbjct: 676 PGGDLSPPDSPEPKAITPPQQPYKKRPKICCPRYGERRQTE--SDWGKRCVDKFDIIGII 733
Query: 127 GQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHPNVVKLEGL 185
G+GTY VYKA+D TG++VALKKVR DN E E A REI ILR+L H +VV ++ +
Sbjct: 734 GEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKILRQLIHRSVVNMKEI 792
Query: 186 VTSRMSC--------SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
VT + + YLVF+YM+HDL GL S + F++ +K +M QL+ GLE+CH
Sbjct: 793 VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLEYCHK 852
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
++ LHRDIK SN+L++N G + +ADFGLA ++ +P T++V+TLWYRPPELLLG
Sbjct: 853 KNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEER 912
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS-KLPHATIF 356
Y +D+WS GCIL EL +KPI E+ QL I +LCGSP W KLP+
Sbjct: 913 YTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDVIKLPYFNTM 972
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA-CDPSS 415
KP++ Y+R + E F P ++L L++ +L +DP++R TA L+S+F + P
Sbjct: 973 KPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFLKDVELSKMAPPD 1032
Query: 416 LPKYPPTKEMDAKLRDEEARRLRAAG 441
LP + E+ +K R RR R +G
Sbjct: 1033 LPHWQDCHELWSKKR----RRQRQSG 1054
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|D2H526|CDK12_AILME Cyclin-dependent kinase 12 OS=Ailuropoda melanoleuca GN=CDK12 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (730), Expect = 4e-76, Method: Compositional matrix adjust.
Identities = 149/343 (43%), Positives = 210/343 (61%), Gaps = 16/343 (4%)
Query: 110 SGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REI 168
S W R D F+ + IG+GTY VYKA+D TG++VALKKVR DN E E A REI
Sbjct: 718 SDWGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREI 776
Query: 169 LILRRLDHPNVVKLEGLVTSRMSC--------SLYLVFKYMEHDLAGLAASPTIKFTQAQ 220
ILR+L H +VV ++ +VT + + YLVF+YM+HDL GL S + F++
Sbjct: 777 KILRQLIHRSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH 836
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280
+K +M QL+ GL++CH ++ LHRDIK SN+L++N G + +ADFGLA ++ +P T++
Sbjct: 837 IKSFMKQLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNK 896
Query: 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSP 340
V+TLWYRPPELLLG Y +D+WS GCIL EL +KPI E+ QL I +LCGSP
Sbjct: 897 VITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSP 956
Query: 341 SEEYWKKS-KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
W KLP+ KP++ Y+R + E F P ++L L++ +L +DP++R TA L
Sbjct: 957 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTL 1016
Query: 400 RSEFFTTKPYA-CDPSSLPKYPPTKEMDAKLRDEEARRLRAAG 441
+S+F + DP LP + E+ +K R RR R +G
Sbjct: 1017 QSDFLKDVELSKMDPPDLPHWQDCHELWSKKR----RRQRQSG 1055
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Ailuropoda melanoleuca (taxid: 9646) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q3MJK5|CDK12_RAT Cyclin-dependent kinase 12 OS=Rattus norvegicus GN=Cdk12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 283 bits (724), Expect = 2e-75, Method: Compositional matrix adjust.
Identities = 148/343 (43%), Positives = 209/343 (60%), Gaps = 16/343 (4%)
Query: 110 SGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REI 168
S W R D F+ + IG+GTY VYKA+D TG++VALKKVR DN E E A REI
Sbjct: 713 SDWGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREI 771
Query: 169 LILRRLDHPNVVKLEGLVTSRMSC--------SLYLVFKYMEHDLAGLAASPTIKFTQAQ 220
ILR+L H +VV ++ +VT + + YLVF+YM+HDL GL S + F++
Sbjct: 772 KILRQLVHQSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH 831
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280
+K +M QL+ GL++CH ++ LHRDIK SN+L++N G + +ADFGLA ++ +P T++
Sbjct: 832 IKSFMKQLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNK 891
Query: 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSP 340
V+TLWYRPPELLLG Y +D+WS GCIL EL +KPI E+ QL I +LCGSP
Sbjct: 892 VITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSP 951
Query: 341 SEEYWKKS-KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
W KLP+ KP++ Y+R + E F P ++L L++ +L +DP++R TA L
Sbjct: 952 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTL 1011
Query: 400 RSEFFTTKPYA-CDPSSLPKYPPTKEMDAKLRDEEARRLRAAG 441
+S+F + P LP + E+ +K R RR R +G
Sbjct: 1012 QSDFLKDVELSKMAPPDLPHWQDCHELWSKKR----RRQRQSG 1050
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors (By similarity). Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q14AX6|CDK12_MOUSE Cyclin-dependent kinase 12 OS=Mus musculus GN=Cdk12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 283 bits (724), Expect = 2e-75, Method: Compositional matrix adjust.
Identities = 148/343 (43%), Positives = 209/343 (60%), Gaps = 16/343 (4%)
Query: 110 SGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REI 168
S W R D F+ + IG+GTY VYKA+D TG++VALKKVR DN E E A REI
Sbjct: 713 SDWGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREI 771
Query: 169 LILRRLDHPNVVKLEGLVTSRMSC--------SLYLVFKYMEHDLAGLAASPTIKFTQAQ 220
ILR+L H +VV ++ +VT + + YLVF+YM+HDL GL S + F++
Sbjct: 772 KILRQLVHQSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH 831
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280
+K +M QL+ GL++CH ++ LHRDIK SN+L++N G + +ADFGLA ++ +P T++
Sbjct: 832 IKSFMKQLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNK 891
Query: 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSP 340
V+TLWYRPPELLLG Y +D+WS GCIL EL +KPI E+ QL I +LCGSP
Sbjct: 892 VITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSP 951
Query: 341 SEEYWKKS-KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
W KLP+ KP++ Y+R + E F P ++L L++ +L +DP++R TA L
Sbjct: 952 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTL 1011
Query: 400 RSEFFTTKPYA-CDPSSLPKYPPTKEMDAKLRDEEARRLRAAG 441
+S+F + P LP + E+ +K R RR R +G
Sbjct: 1012 QSDFLKDVELSKMAPPDLPHWQDCHELWSKKR----RRQRQSG 1050
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 495 | ||||||
| 225432386 | 575 | PREDICTED: probable serine/threonine-pro | 0.935 | 0.805 | 0.820 | 0.0 | |
| 297736913 | 563 | unnamed protein product [Vitis vinifera] | 0.935 | 0.822 | 0.820 | 0.0 | |
| 224102621 | 490 | predicted protein [Populus trichocarpa] | 0.830 | 0.838 | 0.922 | 0.0 | |
| 356519994 | 548 | PREDICTED: probable serine/threonine-pro | 0.905 | 0.817 | 0.793 | 0.0 | |
| 356564577 | 546 | PREDICTED: probable serine/threonine-pro | 0.905 | 0.820 | 0.790 | 0.0 | |
| 357447451 | 540 | hypothetical protein MTR_2g020210 [Medic | 0.923 | 0.846 | 0.788 | 0.0 | |
| 449432797 | 571 | PREDICTED: probable serine/threonine-pro | 0.937 | 0.812 | 0.794 | 0.0 | |
| 449495394 | 571 | PREDICTED: probable serine/threonine-pro | 0.941 | 0.816 | 0.787 | 0.0 | |
| 356549060 | 540 | PREDICTED: probable serine/threonine-pro | 0.814 | 0.746 | 0.888 | 0.0 | |
| 356555563 | 541 | PREDICTED: probable serine/threonine-pro | 0.814 | 0.744 | 0.881 | 0.0 |
| >gi|225432386|ref|XP_002276606.1| PREDICTED: probable serine/threonine-protein kinase At1g54610 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 791 bits (2042), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/480 (82%), Positives = 415/480 (86%), Gaps = 17/480 (3%)
Query: 1 MGCVFAREFSGKAVERRREE---GSVRVDRKVSAAAAAEAVEIRNGNGGPNHRKESSNSN 57
MGCVF RE S K V RRE+ + A E E+RNG KE S +
Sbjct: 1 MGCVFGREVSAKRVVERREDRDVAAAEAAAATVAVVRVEKEEVRNGGDRKEEEKEGSVRS 60
Query: 58 NEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRA 117
+ S +PNPRLSNPPK+VHGEQVAAGWPSWLSA AGEAI+GWTPRRA
Sbjct: 61 RRR-------------SGRPNPRLSNPPKNVHGEQVAAGWPSWLSAAAGEAINGWTPRRA 107
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
DTFEKLDKIGQGTYSNVYKARDTLTG+IVALKKVRFDNLEPESV+FMAREI ILRRLDHP
Sbjct: 108 DTFEKLDKIGQGTYSNVYKARDTLTGKIVALKKVRFDNLEPESVKFMAREIHILRRLDHP 167
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
NVVKLEGLVTSRMSCSLYLVF+YMEHDLAGLAASP IKFT+ QVKCYMHQLLSGLEHCHN
Sbjct: 168 NVVKLEGLVTSRMSCSLYLVFEYMEHDLAGLAASPGIKFTEPQVKCYMHQLLSGLEHCHN 227
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
++VLHRDIKGSNLL+DN G+L IADFGLAS FDPNHKQPMTSRVVTLWYRPPELLLGAT+
Sbjct: 228 RNVLHRDIKGSNLLLDNGGVLKIADFGLASTFDPNHKQPMTSRVVTLWYRPPELLLGATE 287
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357
YGVGVDLWSAGCILAELLA KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK
Sbjct: 288 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 347
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLP 417
PQQSYKRCIAETFKDFP SSLPLIETLLAIDPAERQTATAALRSEFFTTKPYAC+PSSLP
Sbjct: 348 PQQSYKRCIAETFKDFPASSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACEPSSLP 407
Query: 418 KYPPTKEMDAKLRDEEARRLRAAGKANAEA-KKARSRDRAARAMPAPEANAELQANLDVR 476
KYPP+KEMDAKLRDEEARRLRAAGKAN + KK R+RDRA RAMPAPEANAELQANLD R
Sbjct: 408 KYPPSKEMDAKLRDEEARRLRAAGKANVDGVKKTRTRDRAVRAMPAPEANAELQANLDRR 467
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297736913|emb|CBI26114.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2040), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/480 (82%), Positives = 415/480 (86%), Gaps = 17/480 (3%)
Query: 1 MGCVFAREFSGKAVERRREE---GSVRVDRKVSAAAAAEAVEIRNGNGGPNHRKESSNSN 57
MGCVF RE S K V RRE+ + A E E+RNG KE S +
Sbjct: 1 MGCVFGREVSAKRVVERREDRDVAAAEAAAATVAVVRVEKEEVRNGGDRKEEEKEGSVRS 60
Query: 58 NEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRA 117
+ S +PNPRLSNPPK+VHGEQVAAGWPSWLSA AGEAI+GWTPRRA
Sbjct: 61 RRR-------------SGRPNPRLSNPPKNVHGEQVAAGWPSWLSAAAGEAINGWTPRRA 107
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
DTFEKLDKIGQGTYSNVYKARDTLTG+IVALKKVRFDNLEPESV+FMAREI ILRRLDHP
Sbjct: 108 DTFEKLDKIGQGTYSNVYKARDTLTGKIVALKKVRFDNLEPESVKFMAREIHILRRLDHP 167
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
NVVKLEGLVTSRMSCSLYLVF+YMEHDLAGLAASP IKFT+ QVKCYMHQLLSGLEHCHN
Sbjct: 168 NVVKLEGLVTSRMSCSLYLVFEYMEHDLAGLAASPGIKFTEPQVKCYMHQLLSGLEHCHN 227
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
++VLHRDIKGSNLL+DN G+L IADFGLAS FDPNHKQPMTSRVVTLWYRPPELLLGAT+
Sbjct: 228 RNVLHRDIKGSNLLLDNGGVLKIADFGLASTFDPNHKQPMTSRVVTLWYRPPELLLGATE 287
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357
YGVGVDLWSAGCILAELLA KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK
Sbjct: 288 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 347
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLP 417
PQQSYKRCIAETFKDFP SSLPLIETLLAIDPAERQTATAALRSEFFTTKPYAC+PSSLP
Sbjct: 348 PQQSYKRCIAETFKDFPASSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACEPSSLP 407
Query: 418 KYPPTKEMDAKLRDEEARRLRAAGKANAEA-KKARSRDRAARAMPAPEANAELQANLDVR 476
KYPP+KEMDAKLRDEEARRLRAAGKAN + KK R+RDRA RAMPAPEANAELQANLD R
Sbjct: 408 KYPPSKEMDAKLRDEEARRLRAAGKANVDGVKKTRTRDRAVRAMPAPEANAELQANLDRR 467
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224102621|ref|XP_002312751.1| predicted protein [Populus trichocarpa] gi|222852571|gb|EEE90118.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 789 bits (2038), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/412 (92%), Positives = 395/412 (95%), Gaps = 1/412 (0%)
Query: 66 RPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDK 125
R R ++ RSSKPNPRL N PKH+HGEQVAAGWPSWLSAVAGEAI+GWTPRRADTFEKLDK
Sbjct: 1 RRREKRNRSSKPNPRLGNAPKHIHGEQVAAGWPSWLSAVAGEAINGWTPRRADTFEKLDK 60
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGL 185
IGQGTYSNVYKARDTLTG+IVALKKVRFDNLEPESV+FMAREILILRRLDHPNVVKLEGL
Sbjct: 61 IGQGTYSNVYKARDTLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVVKLEGL 120
Query: 186 VTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDI 245
VTSRMSCSLYLVF+YMEHDLAGLAASP IKFT+ QVKCYMHQLLSGLEHCHN+ VLHRDI
Sbjct: 121 VTSRMSCSLYLVFEYMEHDLAGLAASPNIKFTEPQVKCYMHQLLSGLEHCHNRCVLHRDI 180
Query: 246 KGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLW 305
KGSNLLI N+G+L IADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLW
Sbjct: 181 KGSNLLIGNDGVLKIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLW 240
Query: 306 SAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRC 365
SAGCILAELLA KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRC
Sbjct: 241 SAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRC 300
Query: 366 IAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYPPTKEM 425
IAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYPP+KEM
Sbjct: 301 IAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYPPSKEM 360
Query: 426 DAKLRDEEARRLRAAGKANAEA-KKARSRDRAARAMPAPEANAELQANLDVR 476
DAKLRDEE+RRLRA GKA+A+ KKARSRDR ARA PAPEANAELQANLD R
Sbjct: 361 DAKLRDEESRRLRAVGKASADGMKKARSRDRVARANPAPEANAELQANLDRR 412
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356519994|ref|XP_003528653.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 772 bits (1994), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/480 (79%), Positives = 413/480 (86%), Gaps = 32/480 (6%)
Query: 1 MGCVFAREFSGKAVERRREEGSVRVDRKVSAAAAAEAVEIRNGN---GGPNHRKESSNSN 57
MGCVF GK +R+EE V A A E V GN GG
Sbjct: 1 MGCVF-----GKEASKRKEE--------VEFARAEEGVVQNGGNVKEGG----------- 36
Query: 58 NEQETTTVRPRGEKRRSSK--PNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPR 115
+E + RP+GE+RRSSK PNPRLSNPP HVHGEQVAAGWPSWLS VAGEAI+G PR
Sbjct: 37 --EEEKSKRPKGERRRSSKLKPNPRLSNPPNHVHGEQVAAGWPSWLSKVAGEAINGLVPR 94
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
RADTFEKL+K+GQGTYSNVYKA+DTLTG+IVALKKVRFDNLEPESV+FMAREILILR LD
Sbjct: 95 RADTFEKLNKVGQGTYSNVYKAKDTLTGKIVALKKVRFDNLEPESVKFMAREILILRHLD 154
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
HPNVVKLEGLVTSRMSCSLYLVF+YM+HDLAGLA SPTIKFT++QVKCYMHQLLSGLEHC
Sbjct: 155 HPNVVKLEGLVTSRMSCSLYLVFEYMDHDLAGLATSPTIKFTESQVKCYMHQLLSGLEHC 214
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
HN+HVLHRDIKGSNLLID+EGIL IADFGLASFFDPNHK+PMTSRVVTLWYRPPELLLGA
Sbjct: 215 HNRHVLHRDIKGSNLLIDSEGILRIADFGLASFFDPNHKRPMTSRVVTLWYRPPELLLGA 274
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355
TDYGVGVDLWSAGCILAELLA KPIMPGRTEVEQLHKIFKLCGSPS+EYWKKSKLPHATI
Sbjct: 275 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSDEYWKKSKLPHATI 334
Query: 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSS 415
FKP+ SYKRCIAETFK+FP SSLPLIETLLAIDPAERQTA AAL SEFFT+KPYAC+PSS
Sbjct: 335 FKPRLSYKRCIAETFKNFPASSLPLIETLLAIDPAERQTAAAALHSEFFTSKPYACEPSS 394
Query: 416 LPKYPPTKEMDAKLRDEEARRLRAAGKANAEA-KKARSRDRAARAMPAPEANAELQANLD 474
LPKYPP+KEMD KLRDEEARR RAAGKANA KK+R RDR+ R +P P++NAE+QAN+D
Sbjct: 395 LPKYPPSKEMDTKLRDEEARRSRAAGKANAAGVKKSRPRDRSGRGIPVPDSNAEMQANID 454
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356564577|ref|XP_003550528.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 771 bits (1990), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/478 (79%), Positives = 411/478 (85%), Gaps = 30/478 (6%)
Query: 1 MGCVFAREFSGKAVERRREEGSVRVDRKVSAAAAAEAVEIRNGN---GGPNHRKESSNSN 57
MGCVF +E S +++EE V A A + V +GN GG
Sbjct: 1 MGCVFGKEAS-----KKKEE--------VEVARAEDGVAQNSGNVKVGG----------- 36
Query: 58 NEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRA 117
+E + RP+GE+RRSSKPNPRLSNPP HVHGEQVAAGWPSWLS VAGEAI+G PRRA
Sbjct: 37 --EEEKSKRPKGERRRSSKPNPRLSNPPNHVHGEQVAAGWPSWLSKVAGEAINGLVPRRA 94
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
DTFEKL+K+GQGTYSNVYKA+DTLTG+IVALKKVRFDNLEPESV+FMAREILILR LDHP
Sbjct: 95 DTFEKLNKVGQGTYSNVYKAKDTLTGKIVALKKVRFDNLEPESVKFMAREILILRHLDHP 154
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
NVVKLEGLVTSRMSCSLYLVF+YM+HDLAGLA SPTIKFT++QVKCYMHQLLSGLEHCHN
Sbjct: 155 NVVKLEGLVTSRMSCSLYLVFEYMDHDLAGLATSPTIKFTESQVKCYMHQLLSGLEHCHN 214
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
+HVLHRDIKGSNLLID+EGIL IADFGLASFFDPNHK PMTSRVVTLWYRPPELLLGATD
Sbjct: 215 RHVLHRDIKGSNLLIDSEGILRIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 274
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357
YGVGVDLWSAGCILAELLA KPIMPGRTEVEQLHKIFKLCGSPS+EYWKK KLPHATIFK
Sbjct: 275 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSDEYWKKLKLPHATIFK 334
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLP 417
P+ SYKRCIAETFK+FP SSLPLIE LLAIDPAERQTAT AL SEFFT+KPYAC+PSSLP
Sbjct: 335 PRISYKRCIAETFKNFPASSLPLIEILLAIDPAERQTATDALHSEFFTSKPYACEPSSLP 394
Query: 418 KYPPTKEMDAKLRDEEARRLRAAGKANAEA-KKARSRDRAARAMPAPEANAELQANLD 474
KYPP+KEMD KLRDEEARRLRAAGKANA KK+R RDR R + P++NAELQAN+D
Sbjct: 395 KYPPSKEMDTKLRDEEARRLRAAGKANAAGVKKSRPRDRGGRGISVPDSNAELQANID 452
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357447451|ref|XP_003594001.1| hypothetical protein MTR_2g020210 [Medicago truncatula] gi|355483049|gb|AES64252.1| hypothetical protein MTR_2g020210 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 768 bits (1983), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/478 (78%), Positives = 406/478 (84%), Gaps = 21/478 (4%)
Query: 1 MGCVFAREFSGKAVERRREEGSVRVDRKVSAAAAAEAVEIRNGNGGPNHRKESSNSNNEQ 60
MGCVF ++ S + E V V GG +E N
Sbjct: 1 MGCVFGKQSSVEERREEVREVKVDV-------------------GGGGSGREVENVKEGG 41
Query: 61 ETTTVRPRGEKRR-SSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADT 119
E VRP GE+RR SSK NPRLSNPP +VHGEQVAAGWPSWLS VAGEAI+G PRRADT
Sbjct: 42 EEKRVRPSGERRRRSSKANPRLSNPPNNVHGEQVAAGWPSWLSKVAGEAINGLVPRRADT 101
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
FEKLDKIGQGTYSNVYKARDTLTG++VALKKVRFDNLEPESV+FMAREILILRRLDHPNV
Sbjct: 102 FEKLDKIGQGTYSNVYKARDTLTGKVVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 161
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
VKLEGLVTSRMSCSLYLVF+YM HDLAGLA +P IKFT+ QVKCYMHQL SGLEHCHN+H
Sbjct: 162 VKLEGLVTSRMSCSLYLVFEYMAHDLAGLATNPAIKFTEPQVKCYMHQLFSGLEHCHNRH 221
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYG 299
VLHRDIKGSNLLIDN+G+L IADFGLASFFDP+HK PMTSRVVTLWYRPPELLLGAT+YG
Sbjct: 222 VLHRDIKGSNLLIDNDGVLKIADFGLASFFDPDHKHPMTSRVVTLWYRPPELLLGATEYG 281
Query: 300 VGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQ 359
VGVDLWSAGCILAELLA KPIMPGRTEVEQLHKIFKLCGSPSE+YWKKSKLPHATIFKPQ
Sbjct: 282 VGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWKKSKLPHATIFKPQ 341
Query: 360 QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKY 419
QSYKRCIAETFK+FPPSSLPLIETLLAIDP ER TATAAL SEFFTTKPYACDPSSLPKY
Sbjct: 342 QSYKRCIAETFKNFPPSSLPLIETLLAIDPDERLTATAALHSEFFTTKPYACDPSSLPKY 401
Query: 420 PPTKEMDAKLRDEEARRLRAAGKANAEA-KKARSRDRAARAMPAPEANAELQANLDVR 476
PP+KEMDAKLRDEEARRLRAAG++NA+ KK+R R+R R +P P+ANAELQAN+D R
Sbjct: 402 PPSKEMDAKLRDEEARRLRAAGRSNADGVKKSRPRERVRRGLPVPDANAELQANIDRR 459
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449432797|ref|XP_004134185.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 760 bits (1963), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/482 (79%), Positives = 416/482 (86%), Gaps = 18/482 (3%)
Query: 1 MGCVFAREFSGKAVER----RREEGSVRVDRKVSAAAAAEAVEIRNG-NGGPNHRKESSN 55
MGCVF RE S V++ RR+ G + +VS V++ N NGG RKE +
Sbjct: 1 MGCVFGREVSENPVQKEEEDRRQNGEEEI--RVSVKPEVVQVQVNNARNGG--SRKEVED 56
Query: 56 SNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPR 115
++ + R R R S+ P KHVHGEQVAAGWPSWLSAVAGEAI+GW PR
Sbjct: 57 DRGSRQRSERRRRPNPRSSNPP--------KHVHGEQVAAGWPSWLSAVAGEAINGWIPR 108
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
RAD+FEKLDKIGQGTYSNVYKARD+LTG+IVALKKVRFDNLEPESVRFMAREILILRRLD
Sbjct: 109 RADSFEKLDKIGQGTYSNVYKARDSLTGKIVALKKVRFDNLEPESVRFMAREILILRRLD 168
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
HPNVVKLEGLVTSRMSCSLYLVF+YMEHDLAGLAASPTIKFT+ QVKCYM+QLLSGLEHC
Sbjct: 169 HPNVVKLEGLVTSRMSCSLYLVFEYMEHDLAGLAASPTIKFTEPQVKCYMNQLLSGLEHC 228
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
HN++VLHRDIKGSNLLI N+GIL IADFGLAS FDPNHKQPMTSRVVTLWYRPPELLLGA
Sbjct: 229 HNRYVLHRDIKGSNLLIGNDGILKIADFGLASVFDPNHKQPMTSRVVTLWYRPPELLLGA 288
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355
TDYGVGVDLWSAGCILAELLA KPIMPGRTEVEQLHKIFKLCGSP++EYWKKS+LPHATI
Sbjct: 289 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPTDEYWKKSRLPHATI 348
Query: 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSS 415
FKPQ SYKRCI ETFKDFPPSSLPLIETLLAIDPAER TATAAL SEFFTTKPYAC+PSS
Sbjct: 349 FKPQHSYKRCITETFKDFPPSSLPLIETLLAIDPAERLTATAALNSEFFTTKPYACEPSS 408
Query: 416 LPKYPPTKEMDAKLRDEEARRLRAAGKANAEA-KKARSRDRAARAMPAPEANAELQANLD 474
LPKYPP+KEMDAKLRDEEARRLRAAG++N + KK+R+RDRA RA+PAPEANAELQANLD
Sbjct: 409 LPKYPPSKEMDAKLRDEEARRLRAAGRSNVDGVKKSRARDRAVRAIPAPEANAELQANLD 468
Query: 475 VR 476
R
Sbjct: 469 RR 470
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449495394|ref|XP_004159827.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 757 bits (1955), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/480 (78%), Positives = 414/480 (86%), Gaps = 14/480 (2%)
Query: 1 MGCVFAREFSGKAVERRREEGSVRVDRKVSAAAAAEAVEIRNGN---GGPNHRKESSNSN 57
MGCVF RE S V++ E+ + ++ + E V+++ N GG RKE +
Sbjct: 1 MGCVFGREVSENPVQKEEEDRRQNGEEEIRVSVKPEVVQVQVNNARNGG--SRKEVEDDR 58
Query: 58 NEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRA 117
++ + R R R S+ P KHVHGEQVAAGWPSWLSAVAGEAI+GW PRRA
Sbjct: 59 GSRQRSERRRRPNPRSSNPP--------KHVHGEQVAAGWPSWLSAVAGEAINGWIPRRA 110
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D+FEKLDKIGQGTYSNVYKARD+LTG+IVALKKVRFDNLEPESVRFMAREILILRRLDHP
Sbjct: 111 DSFEKLDKIGQGTYSNVYKARDSLTGKIVALKKVRFDNLEPESVRFMAREILILRRLDHP 170
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
NVVKLEGLVTSRMSCSLYLVF+YMEHDLAGLAASPTIKFT+ QVKCYM+QLLSGLEHCHN
Sbjct: 171 NVVKLEGLVTSRMSCSLYLVFEYMEHDLAGLAASPTIKFTEPQVKCYMNQLLSGLEHCHN 230
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
++VLHRDIKGSNLLI N+GIL IADFGLAS FDPNHKQPMTSRVVTLWYRPPELLLGATD
Sbjct: 231 RYVLHRDIKGSNLLIGNDGILKIADFGLASVFDPNHKQPMTSRVVTLWYRPPELLLGATD 290
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357
YGVGVDLWSAGCILAELLA KPIMPGRTEVEQLHKIFKLCGSP++EYWKKS+LPHATIFK
Sbjct: 291 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPTDEYWKKSRLPHATIFK 350
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLP 417
PQ SYKRCI ETFK FPPSSLPLIETLLAIDPAER TATAAL SEFFTTKPYAC+PSSLP
Sbjct: 351 PQHSYKRCITETFKGFPPSSLPLIETLLAIDPAERLTATAALNSEFFTTKPYACEPSSLP 410
Query: 418 KYPPTKEMDAKLRDEEARRLRAAGKANAEA-KKARSRDRAARAMPAPEANAELQANLDVR 476
KYPP+KEMDAKLRDEEARRLRAAG++N + KK+R+RDRA RA+PAPEANAELQANLD R
Sbjct: 411 KYPPSKEMDAKLRDEEARRLRAAGRSNVDGVKKSRARDRAVRAIPAPEANAELQANLDRR 470
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549060|ref|XP_003542916.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 757 bits (1954), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/404 (88%), Positives = 380/404 (94%), Gaps = 1/404 (0%)
Query: 74 SSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSN 133
SSKPNPRLSNPP HVHGEQVAAGWPSWLS VAGEAI+G TPRRADTFEK+DKIGQGTYSN
Sbjct: 56 SSKPNPRLSNPPNHVHGEQVAAGWPSWLSKVAGEAINGLTPRRADTFEKIDKIGQGTYSN 115
Query: 134 VYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193
VYKARDTLTG+IVALKKVRFDNLEPESV+FMAREILILRRLDHPNV+KLEGLVTSRMSCS
Sbjct: 116 VYKARDTLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 175
Query: 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID 253
LYLVF+YM HDLAGLA +P IKFT++QVKCYMHQL SGLEHCHN+HVLHRDIKGSNLLID
Sbjct: 176 LYLVFEYMVHDLAGLATNPAIKFTESQVKCYMHQLFSGLEHCHNRHVLHRDIKGSNLLID 235
Query: 254 NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAE 313
N+GIL I DFGLASFFDPNHK PMTSRVVTLWYRPPELLLGAT+Y VGVDLWSAGCILAE
Sbjct: 236 NDGILKIGDFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATEYSVGVDLWSAGCILAE 295
Query: 314 LLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDF 373
LLA KPIMPGRTEVEQLHKIFKLCGSPS+EYWKKSKLPHATIFKPQ SYKRCIAETFKDF
Sbjct: 296 LLAGKPIMPGRTEVEQLHKIFKLCGSPSDEYWKKSKLPHATIFKPQHSYKRCIAETFKDF 355
Query: 374 PPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEE 433
PPSSLPLI+TLLAIDP ER TATAAL SEFFTTKPYAC+PSSLPKYPP+KEMDAKLRDEE
Sbjct: 356 PPSSLPLIDTLLAIDPDERLTATAALHSEFFTTKPYACEPSSLPKYPPSKEMDAKLRDEE 415
Query: 434 ARRLRAAGKANAEA-KKARSRDRAARAMPAPEANAELQANLDVR 476
ARRLRAAGKANA+ KK+R R+R R +P PEANAELQAN+D R
Sbjct: 416 ARRLRAAGKANADGVKKSRPRERVGRGVPVPEANAELQANIDRR 459
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555563|ref|XP_003546100.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 752 bits (1942), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/404 (88%), Positives = 380/404 (94%), Gaps = 1/404 (0%)
Query: 74 SSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSN 133
SSKPNPRLSNPP HVHGEQVAAGWPSWLS VAGEAI+G TPRRADTFEK+DKIGQGTYSN
Sbjct: 57 SSKPNPRLSNPPNHVHGEQVAAGWPSWLSKVAGEAINGLTPRRADTFEKIDKIGQGTYSN 116
Query: 134 VYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193
VYKARDTLTG+IVALKKVRFDNLEPESV+FMAREILILRRLDHPNV+KLEGLVTSRMSCS
Sbjct: 117 VYKARDTLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 176
Query: 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID 253
LYLVF+YM HDLAGLA +P IKFT++QVKCYMHQL SGLEHCHN+HVLHRDIKGSNLLID
Sbjct: 177 LYLVFEYMVHDLAGLATNPAIKFTESQVKCYMHQLFSGLEHCHNRHVLHRDIKGSNLLID 236
Query: 254 NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAE 313
N+GIL I DFGLASFFDPNHK PMTSRVVTLWYRPPELLLGAT+Y VGVDLWSAGCILAE
Sbjct: 237 NDGILKIGDFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATEYSVGVDLWSAGCILAE 296
Query: 314 LLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDF 373
LLA KPIMPGRTEVEQLHKIFKLCGSPS+EYWKKSKLPHATIFKPQQSYKRCIAET+KDF
Sbjct: 297 LLAGKPIMPGRTEVEQLHKIFKLCGSPSDEYWKKSKLPHATIFKPQQSYKRCIAETYKDF 356
Query: 374 PPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEE 433
PPSSLPL++TLLAI+P ER TATAAL SEFFTTKPYAC+PSSLPKYPP+KEMDAKLRDEE
Sbjct: 357 PPSSLPLMDTLLAINPDERLTATAALHSEFFTTKPYACEPSSLPKYPPSKEMDAKLRDEE 416
Query: 434 ARRLRAAGKANAEA-KKARSRDRAARAMPAPEANAELQANLDVR 476
ARRLRAAGKANA+ KK+R R+R R + PEANAELQAN+D R
Sbjct: 417 ARRLRAAGKANADGVKKSRPRERVGRGIAVPEANAELQANIDRR 460
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 495 | ||||||
| TAIR|locus:2199491 | 573 | AT1G54610 [Arabidopsis thalian | 0.856 | 0.739 | 0.694 | 1.4e-165 | |
| TAIR|locus:2037042 | 694 | AT1G53050 [Arabidopsis thalian | 0.747 | 0.533 | 0.728 | 1.4e-149 | |
| TAIR|locus:2096199 | 593 | AT3G05050 [Arabidopsis thalian | 0.777 | 0.649 | 0.704 | 2.8e-146 | |
| TAIR|locus:2152740 | 580 | AT5G50860 [Arabidopsis thalian | 0.668 | 0.570 | 0.767 | 1.6e-141 | |
| TAIR|locus:2012290 | 714 | AT1G09600 [Arabidopsis thalian | 0.680 | 0.471 | 0.753 | 7e-141 | |
| TAIR|locus:2019115 | 699 | AT1G74330 [Arabidopsis thalian | 0.717 | 0.507 | 0.705 | 1e-139 | |
| TAIR|locus:2020708 | 740 | AT1G03740 [Arabidopsis thalian | 0.690 | 0.462 | 0.698 | 2.4e-136 | |
| TAIR|locus:2034944 | 709 | IBS1 "IMPAIRED IN BABA-INDUCED | 0.715 | 0.499 | 0.691 | 3.2e-136 | |
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.751 | 0.605 | 0.641 | 2.1e-132 | |
| TAIR|locus:2158715 | 644 | AT5G44290 [Arabidopsis thalian | 0.741 | 0.569 | 0.654 | 1e-130 |
| TAIR|locus:2199491 AT1G54610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1611 (572.2 bits), Expect = 1.4e-165, P = 1.4e-165
Identities = 296/426 (69%), Positives = 351/426 (82%)
Query: 1 MGCVFAREFSGKAXXXXXXXXXXXXXXKVSXXXXXXXVEIRNGNGGPNHRKESSNSNNEQ 60
MGCVF RE + V + +K++ +N ++
Sbjct: 1 MGCVFGREAATTTTAEAKQAKSSKASSGVVVVGESSVTKSNGVIADDVEKKKNEEANGDK 60
Query: 61 ETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTF 120
E + +G++RRS+KPNPRLSNP KH GEQVAAGWPSWLS GEA++GW PR+ADTF
Sbjct: 61 ERKS--SKGDRRRSTKPNPRLSNPSKHWRGEQVAAGWPSWLSDACGEALNGWVPRKADTF 118
Query: 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
EK+DKIGQGTYSNVYKA+D LTG+IVALKKVRFDNLEPESV+FMAREIL+LRRLDHPNVV
Sbjct: 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNVV 178
Query: 181 KLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
KLEGLVTSRMSCSLYLVF+YM+HDLAGLA+SP +KF++++VKC M QL+SGLEHCH++ V
Sbjct: 179 KLEGLVTSRMSCSLYLVFQYMDHDLAGLASSPVVKFSESEVKCLMRQLISGLEHCHSRGV 238
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGV 300
LHRDIKGSNLLID+ G+L IADFGLA+ FDPNHK+PMTSRVVTLWYR PELLLGATDYGV
Sbjct: 239 LHRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTSRVVTLWYRAPELLLGATDYGV 298
Query: 301 GVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQ 360
G+DLWSAGCILAELLA +PIMPGRTEVEQLHKI+KLCGSPSE+YWKK K H I+KP++
Sbjct: 299 GIDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLCGSPSEDYWKKGKFTHGAIYKPRE 358
Query: 361 SYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYP 420
YKR I ETFKDFPPSSLPLI+ LL+I+P +RQTA+AAL+SEFFT++PYAC+P+ LPKYP
Sbjct: 359 PYKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASAALKSEFFTSEPYACEPADLPKYP 418
Query: 421 PTKEMD 426
P+KE+D
Sbjct: 419 PSKEID 424
|
|
| TAIR|locus:2037042 AT1G53050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1460 (519.0 bits), Expect = 1.4e-149, P = 1.4e-149
Identities = 277/380 (72%), Positives = 318/380 (83%)
Query: 57 NNEQETTTVRPRGEK--RRSSK-PNPRLSNP-------PKHVHGEQVAAGWPSWLSAVAG 106
+N+Q ++ RGE RR + N ++P K GE VAAGWP WL++VAG
Sbjct: 61 SNKQSNVSLHLRGENLSRREKRIENVAATSPLAMSITIAKATEGEYVAAGWPPWLASVAG 120
Query: 107 EAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAR 166
EAI GW PRRAD+FEKLDKIGQGTYSNVY+ARD +IVALKKVRFDNLEPESVRFMAR
Sbjct: 121 EAIRGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR 180
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMH 226
EI ILRRLDHPN++KLEGLVTSRMSCSLYLVF+YMEHDLAGLA+ P IKF+++QVKCY+
Sbjct: 181 EIQILRRLDHPNIIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPAIKFSESQVKCYLQ 240
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWY 286
QLL GL+HCH++ VLHRDIKGSNLLIDN G+L IADFGLASFFDP QP+TSRVVTLWY
Sbjct: 241 QLLHGLDHCHSRGVLHRDIKGSNLLIDNSGVLKIADFGLASFFDPRQTQPLTSRVVTLWY 300
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346
RPPELLLGAT YG VDLWSAGCILAEL A KPIMPGRTEVEQLHKIFKLCGSP+E+YW
Sbjct: 301 RPPELLLGATRYGAAVDLWSAGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPTEDYWV 360
Query: 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406
KS+LPHATIFKP Q YKR + ETFK+FP +L L+ETLL+++P +R TATAAL+SEFF+T
Sbjct: 361 KSRLPHATIFKPTQPYKRLVGETFKEFPQPALALLETLLSVNPDDRGTATAALKSEFFST 420
Query: 407 KPYACDPSSLPKYPPTKEMD 426
+P CDPSSLPKYPP+KE+D
Sbjct: 421 RPLPCDPSSLPKYPPSKELD 440
|
|
| TAIR|locus:2096199 AT3G05050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1429 (508.1 bits), Expect = 2.8e-146, P = 2.8e-146
Identities = 276/392 (70%), Positives = 319/392 (81%)
Query: 39 EIRNGNGGPNHRKESSNSNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWP 98
E+RN + +KE N E + +GE++RS P+PR SNPPK++ GEQVAAGWP
Sbjct: 59 EVRNHEDVVDQKKE--NGFVVTEAKERKSKGERKRSKPPDPRRSNPPKNLLGEQVAAGWP 116
Query: 99 SWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP 158
SWLS V GEA+SGW PR+AD+FEK+DKIG GTYSNVYKA+D+LTG IVALKKVR D E
Sbjct: 117 SWLSEVCGEALSGWLPRKADSFEKIDKIGSGTYSNVYKAKDSLTGNIVALKKVRCDVNER 176
Query: 159 ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQ 218
ES++FMAREILILRRLDHPNV+KLEGLVTSRMS SLYLVF+YM+HDLAGLAASP IKFT+
Sbjct: 177 ESLKFMAREILILRRLDHPNVIKLEGLVTSRMSSSLYLVFRYMDHDLAGLAASPEIKFTE 236
Query: 219 AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278
QVKCYM QLLSGLEHCHN+ VLHRDIKGSNLLID+ G+L I DFGLA+FFD + +Q MT
Sbjct: 237 QQVKCYMKQLLSGLEHCHNRGVLHRDIKGSNLLIDDGGVLRIGDFGLATFFDASKRQEMT 296
Query: 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCG 338
+RVVTLWYR PELL G +Y VGVDLWSAGCILAELLA + IMPGR EVEQLH+I+KLCG
Sbjct: 297 NRVVTLWYRSPELLHGVVEYSVGVDLWSAGCILAELLAGRAIMPGRNEVEQLHRIYKLCG 356
Query: 339 SPSEEYWKKSKLP----HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT 394
SPSEEYWKK +LP HA KP YKR I E +KDF P +L L++TLLA+DPAERQT
Sbjct: 357 SPSEEYWKKIRLPSTHKHAH-HKPLPQYKRRIREVYKDFSPEALSLLDTLLALDPAERQT 415
Query: 395 ATAALRSEFFTTKPYACDPSSLPKYPPTKEMD 426
AT L S+FFTT+P AC PS LPKYPP+KE+D
Sbjct: 416 ATDVLMSDFFTTEPLACQPSDLPKYPPSKEID 447
|
|
| TAIR|locus:2152740 AT5G50860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1384 (492.3 bits), Expect = 1.6e-141, P = 1.6e-141
Identities = 254/331 (76%), Positives = 293/331 (88%)
Query: 96 GWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN 155
GWP WL A G++I TPRRA T+EKL+KIGQGTYSNVYKA+D L+G+IVALKKVRFDN
Sbjct: 90 GWPPWLIAACGDSIKDLTPRRATTYEKLEKIGQGTYSNVYKAKDLLSGKIVALKKVRFDN 149
Query: 156 LEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK 215
LE ESV+FMAREIL+LRRL+HPNV+KL+GLVTSR+SCSLYLVF+YMEHDL+GLAA+ +K
Sbjct: 150 LEAESVKFMAREILVLRRLNHPNVIKLQGLVTSRVSCSLYLVFEYMEHDLSGLAATQGLK 209
Query: 216 FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275
F QVKC+M QLLSGLEHCH++ VLHRDIKGSNLLIDN+GIL IADFGLA+F+DP KQ
Sbjct: 210 FDLPQVKCFMKQLLSGLEHCHSRGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPKQKQ 269
Query: 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
MTSRVVTLWYRPPELLLGAT YG GVDLWSAGCI+AELLA KP+MPGRTEVEQLHKIFK
Sbjct: 270 TMTSRVVTLWYRPPELLLGATSYGTGVDLWSAGCIMAELLAGKPVMPGRTEVEQLHKIFK 329
Query: 336 LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA 395
LCGSPS+ YWKK +LP+AT+FKPQ YKRC+AE F F PSS+ L+ETLL IDPA+R T+
Sbjct: 330 LCGSPSDSYWKKYRLPNATLFKPQHPYKRCVAEAFNGFTPSSVHLVETLLTIDPADRGTS 389
Query: 396 TAALRSEFFTTKPYACDPSSLPKYPPTKEMD 426
T+AL SEFFTT+P CDPSSLPKYPP+KE++
Sbjct: 390 TSALNSEFFTTEPLPCDPSSLPKYPPSKELN 420
|
|
| TAIR|locus:2012290 AT1G09600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1378 (490.1 bits), Expect = 7.0e-141, P = 7.0e-141
Identities = 254/337 (75%), Positives = 293/337 (86%)
Query: 90 GEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALK 149
G QV AGWPSWL++VAGEAI+GW PR+AD+FEKL+KIGQGTYS+VYKARD T Q+VALK
Sbjct: 133 GAQVMAGWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARDLETNQLVALK 192
Query: 150 KVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLA 209
KVRF N++P+SVRFMAREI+ILRRLDHPNV+KLEGL+TSR+S S+YL+F+YMEHDLAGLA
Sbjct: 193 KVRFANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLA 252
Query: 210 ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269
++P I F++AQ+KCYM QLL GLEHCH++ VLHRDIKGSNLL+D+ L I DFGLA+F+
Sbjct: 253 STPGINFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFY 312
Query: 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ 329
+ KQP+TSRVVTLWYRPPELLLG+TDYGV VDLWS GCILAEL KPIMPGRTEVEQ
Sbjct: 313 QGHQKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQ 372
Query: 330 LHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDP 389
LHKIFKLCGSPSEEYWK SKLPHATIFKPQQ YKRC+AETFK P S+L L+E LLA++P
Sbjct: 373 LHKIFKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEP 432
Query: 390 AERQTATAALRSEFFTTKPYACDPSSLPKYPPTKEMD 426
R T +AL SEFFTT P A DPSSLPKY P KE+D
Sbjct: 433 DARGTTASALESEFFTTSPLASDPSSLPKYQPRKEID 469
|
|
| TAIR|locus:2019115 AT1G74330 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1367 (486.3 bits), Expect = 1.0e-139, P = 1.0e-139
Identities = 252/357 (70%), Positives = 303/357 (84%)
Query: 72 RRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTY 131
R S + RL N +++ EQVAAGWP+WLS VAGEAI GW P R+D FEKL+KIGQGTY
Sbjct: 73 RASDSLSFRLGNVSRYLEAEQVAAGWPAWLSNVAGEAIHGWVPLRSDAFEKLEKIGQGTY 132
Query: 132 SNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191
SNV++A +T TG+IVALKKVRFDN EPESV+FMAREILILRRL+HPN++KLEGL+TS++S
Sbjct: 133 SNVFRAVETETGRIVALKKVRFDNFEPESVKFMAREILILRRLNHPNIIKLEGLITSKLS 192
Query: 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLL 251
C++ LVF+YMEHDL GL +SP IKFT Q+KCYM QLLSGL+HCH++ V+HRDIKGSNLL
Sbjct: 193 CNIQLVFEYMEHDLTGLLSSPDIKFTTPQIKCYMKQLLSGLDHCHSRGVMHRDIKGSNLL 252
Query: 252 IDNEGILTIADFGLASFFDPN-HKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGC 309
+ NEGIL +ADFGLA+F + + HK+ P+TSRVVTLWYRPPELLLGATDYG VDLWS GC
Sbjct: 253 LSNEGILKVADFGLANFSNSSGHKKKPLTSRVVTLWYRPPELLLGATDYGASVDLWSVGC 312
Query: 310 ILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAET 369
+ AELL KPI+ GRTEVEQLHKIFKLCGSP E+YWKKSKLPHA +FKPQQ+Y C+ ET
Sbjct: 313 VFAELLLGKPILRGRTEVEQLHKIFKLCGSPPEDYWKKSKLPHAMLFKPQQTYDSCLRET 372
Query: 370 FKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYPPTKEMD 426
KD + + LIETLL+IDP +R TA++AL S++FTTKP+ACDPSSLP YPP+KE+D
Sbjct: 373 LKDLSETEINLIETLLSIDPHKRGTASSALVSQYFTTKPFACDPSSLPIYPPSKEID 429
|
|
| TAIR|locus:2020708 AT1G03740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1296 (461.3 bits), Expect = 2.4e-136, Sum P(3) = 2.4e-136
Identities = 239/342 (69%), Positives = 287/342 (83%)
Query: 85 PKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQ 144
PK +QVAAGWPSWL +VAGE++ W PRRA+TFEKL+KIGQGTYS+VY+ARD L +
Sbjct: 178 PKDAERKQVAAGWPSWLVSVAGESLVDWAPRRANTFEKLEKIGQGTYSSVYRARDLLHNK 237
Query: 145 IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD 204
IVALKKVRFD + ESV+FMAREI+++RRLDHPNV+KLEGL+T+ +S SLYLVF+YM+HD
Sbjct: 238 IVALKKVRFDLNDMESVKFMAREIIVMRRLDHPNVLKLEGLITAPVSSSLYLVFEYMDHD 297
Query: 205 LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264
L GL++ P +KFT+ QVKCYM QLLSGLEHCH++ VLHRDIKGSNLLID++G+L IADFG
Sbjct: 298 LLGLSSLPGVKFTEPQVKCYMRQLLSGLEHCHSRGVLHRDIKGSNLLIDSKGVLKIADFG 357
Query: 265 LASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR 324
LA+FFDP +TS VVTLWYRPPELLLGA+ YGVGVDLWS GCIL EL A KPI+PG+
Sbjct: 358 LATFFDPAKSVSLTSHVVTLWYRPPELLLGASHYGVGVDLWSTGCILGELYAGKPILPGK 417
Query: 325 TEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETL 384
TEVEQLHKIFKLCGSP+E YW+K KLP + FK Y+R ++E FKDFP S L L+ETL
Sbjct: 418 TEVEQLHKIFKLCGSPTENYWRKQKLPSSAGFKTAIPYRRKVSEMFKDFPASVLSLLETL 477
Query: 385 LAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYPPTKEMD 426
L+IDP R +A AL SE+F TKP+ACDPS+LPKYPP+KE+D
Sbjct: 478 LSIDPDHRSSADRALESEYFKTKPFACDPSNLPKYPPSKEID 519
|
|
| TAIR|locus:2034944 IBS1 "IMPAIRED IN BABA-INDUCED STERILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1334 (474.7 bits), Expect = 3.2e-136, P = 3.2e-136
Identities = 247/357 (69%), Positives = 299/357 (83%)
Query: 73 RSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYS 132
RS + RL N K++ EQVAAGWP+WLS VAGEAI GW P R+D FEKL+KIGQGTYS
Sbjct: 84 RSESVSFRLGNLSKYLEAEQVAAGWPAWLSNVAGEAIHGWVPFRSDAFEKLEKIGQGTYS 143
Query: 133 NVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192
+V++AR+T TG+IVALKKVRFDN EPESVRFMAREILILR+L+HPN++KLEG+VTS++SC
Sbjct: 144 SVFRARETETGRIVALKKVRFDNFEPESVRFMAREILILRKLNHPNIIKLEGIVTSKLSC 203
Query: 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252
S++LVF+YMEHDL GL +SP I FT Q+KCYM QLLSGL+HCH + V+HRDIKGSNLL+
Sbjct: 204 SIHLVFEYMEHDLTGLLSSPDIDFTTPQIKCYMKQLLSGLDHCHARGVMHRDIKGSNLLV 263
Query: 253 DNEGILTIADFGLASFFDPN-HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCIL 311
+NEGIL +ADFGLA+F + + +KQP+TSRVVTLWYRPPELLLGAT+YG VDLWS GC+
Sbjct: 264 NNEGILKVADFGLANFCNASGNKQPLTSRVVTLWYRPPELLLGATEYGASVDLWSVGCVF 323
Query: 312 AELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFK 371
AELL KP++ GRTEVEQLHKIFKLCGSP E+YWKKSKLPHA +FKPQQ Y C+ ET K
Sbjct: 324 AELLIGKPVLQGRTEVEQLHKIFKLCGSPPEDYWKKSKLPHAMLFKPQQHYDGCLRETLK 383
Query: 372 --DFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYPPTKEMD 426
+ + LIETLL+I P +R TA+ AL S++FT+KP+ACDPSSLP Y P+KE+D
Sbjct: 384 LKGLSDADINLIETLLSIQPHKRGTASTALVSQYFTSKPFACDPSSLPVYSPSKEID 440
|
|
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1298 (462.0 bits), Expect = 2.1e-132, P = 2.1e-132
Identities = 243/379 (64%), Positives = 304/379 (80%)
Query: 55 NSNNEQETTTV-RP-RGEKRRSSKPNPR-----LSNPPKHVHGEQVAAGWPSWLSAVAGE 107
+ +++ +T V RP R ++ R N + +SN P+ E +AAGWP WL++VAGE
Sbjct: 69 DDSHDGKTVIVERPSRSQRGRRVSDNGKGGGLIISNVPRSAEAELIAAGWPYWLTSVAGE 128
Query: 108 AISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMARE 167
AI GW PRRAD+FEKLDKIGQGTYS VYKARD TG+IVA+KKVRF N++PESVRFMARE
Sbjct: 129 AIKGWVPRRADSFEKLDKIGQGTYSIVYKARDLETGKIVAMKKVRFANMDPESVRFMARE 188
Query: 168 ILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQ 227
I ILR+LDHPNV+KL+ LVTS++S SL+LVF+YMEHDL+GLA P +KFT+ Q+KC+M Q
Sbjct: 189 INILRKLDHPNVMKLQCLVTSKLSGSLHLVFEYMEHDLSGLALRPGVKFTEPQIKCFMKQ 248
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
LL GLEHCH++ +LHRDIKGSNLL++N+G+L I DFGLASF+ P+ QP+TSRVVTLWYR
Sbjct: 249 LLCGLEHCHSRGILHRDIKGSNLLVNNDGVLKIGDFGLASFYKPDQDQPLTSRVVTLWYR 308
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
PELLLG+T+YG +DLWS GCILAEL KPIMPGRTEVEQ+HKIFKLCGSPSEE+W
Sbjct: 309 APELLLGSTEYGPAIDLWSVGCILAELFVCKPIMPGRTEVEQMHKIFKLCGSPSEEFWNT 368
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407
+K P AT +KPQ YKR + ETFK+ SSL L++ LL+++P +R +A++ L SEFFTT+
Sbjct: 369 TKFPQATSYKPQHPYKRVLLETFKNLSSSSLDLLDKLLSVEPEKRCSASSTLLSEFFTTE 428
Query: 408 PYACDPSSLPKYPPTKEMD 426
P C SSLPKYPP+KE+D
Sbjct: 429 PLPCHISSLPKYPPSKELD 447
|
|
| TAIR|locus:2158715 AT5G44290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1282 (456.3 bits), Expect = 1.0e-130, P = 1.0e-130
Identities = 242/370 (65%), Positives = 296/370 (80%)
Query: 58 NEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGE-QVAAGWPSWLSAVAGEAISGWTPRR 116
+E E P E +R +P+ + P+ V E ++AAGWP+WL +VAGEA+ WTPRR
Sbjct: 76 DEDEDDDHHPPEELKR--EPSVVIPPSPETVSKEAELAAGWPAWLVSVAGEALVNWTPRR 133
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
A TFEKL+KIGQGTYS+VYKARD +IVALK+VRFD + ESV+FMAREI+++RRLDH
Sbjct: 134 ASTFEKLEKIGQGTYSSVYKARDLTNNKIVALKRVRFDLSDLESVKFMAREIIVMRRLDH 193
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
PNV+KLEGL+T+ +S SLYLVF+YM+HDL GLA+ P IKF++ QVKCYM QLLSGL HCH
Sbjct: 194 PNVLKLEGLITASVSSSLYLVFEYMDHDLVGLASIPGIKFSEPQVKCYMQQLLSGLHHCH 253
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
++ VLHRDIKGSNLLID+ G+L IADFGLA+FFDP + P+TSRVVTLWYRPPELLLGA
Sbjct: 254 SRGVLHRDIKGSNLLIDSNGVLKIADFGLATFFDPQNCVPLTSRVVTLWYRPPELLLGAC 313
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
YGVGVDLWS GCIL EL + KPI+ G+TEVEQLHKIFKLCGSP+E+YW+K KLP + F
Sbjct: 314 HYGVGVDLWSTGCILGELYSGKPILAGKTEVEQLHKIFKLCGSPTEDYWRKLKLPPSAAF 373
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSL 416
+P Y R +AE FKD P + L L+E LL+IDP R +A AL SE+F T+P+ACDPSSL
Sbjct: 374 RPALPYGRRVAEMFKDLPTNVLSLLEALLSIDPDRRGSAARALESEYFRTEPFACDPSSL 433
Query: 417 PKYPPTKEMD 426
PKYPP+KE+D
Sbjct: 434 PKYPPSKEID 443
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9ZVM9 | Y1461_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6910 | 0.9616 | 0.8321 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.VIII.1954.1 | hypothetical protein (490 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 495 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-158 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-120 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-115 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-111 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-106 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-106 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-105 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-98 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-94 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-90 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-89 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-86 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-85 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-83 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-82 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-81 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-80 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-78 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-78 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-77 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-77 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-75 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-75 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-72 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-71 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-70 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-69 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-65 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-65 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-64 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-63 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-63 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-62 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-59 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-58 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-58 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-58 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-58 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-58 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-57 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-57 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-56 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-55 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-54 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-52 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-52 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-49 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-48 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-47 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-47 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-47 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-46 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-46 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-46 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-45 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-45 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-45 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-40 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-40 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-39 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-38 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-37 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-36 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-36 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-36 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-36 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-34 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-33 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-32 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-31 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-31 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-30 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-30 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-30 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-29 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-27 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-27 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-26 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-26 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-26 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-26 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-25 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-24 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-23 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-23 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-22 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-22 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-21 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-21 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-20 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-19 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-19 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-19 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-16 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-16 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-16 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-15 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-14 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-14 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-13 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-13 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-13 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-13 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-13 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-13 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.002 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 449 bits (1158), Expect = e-158
Identities = 156/287 (54%), Positives = 211/287 (73%), Gaps = 2/287 (0%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+EK+ +IG+GTY VYKAR+ TG++VALKK+R +N + REI +L++L HPN+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
V+L+ +VTS+ S+Y+VF+YM+HDL GL SP +KFT++Q+KCYM QLL GL++ H+
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYG 299
+LHRDIKGSN+LI+N+G+L +ADFGLA + + T+RV+TLWYRPPELLLGAT YG
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYG 180
Query: 300 VGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHATIFKP 358
VD+WS GCILAEL KPI G TE+EQL KIF+LCGSP++E W SKLP KP
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240
Query: 359 QQSYKRCIAETFKDF-PPSSLPLIETLLAIDPAERQTATAALRSEFF 404
++ YKR + E FK PS+L L++ LL +DP +R +A AL+ E+F
Sbjct: 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 354 bits (910), Expect = e-120
Identities = 124/290 (42%), Positives = 178/290 (61%), Gaps = 13/290 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE----PESVRFMAREILILRRLD 175
+EKL+K+G+GTY VYKARD TG+IVALKK+R DN E ++R EI +L+ L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELK 56
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
HPN+VKL ++ + LYLVF+Y + DL + +K M+QLL GL +C
Sbjct: 57 HPNIVKLLDVIHTERK--LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H+ +LHRD+K N+LI+ +G+L +ADFGLA F + T VVTLWYR PE+LLG+
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP-LRTYTHEVVTLWYRAPEILLGS 173
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHAT 354
Y VD+WS GCI AE++ KP+ PG +E++QL KIF++ G+P+EE W +KLP
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
P+ K + + P + L+ +L +PA+R +A AL+ +F
Sbjct: 234 PTFPKFPPKD-LEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 341 bits (877), Expect = e-115
Identities = 134/303 (44%), Positives = 188/303 (62%), Gaps = 11/303 (3%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE--PESVRFMA-REILILRRLDH 176
+EK K+G+GTY+ VYKARD TG+IVA+KK++ + + + F A REI +L+ L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
PN++ L + + + + LVF++ME DL + +I T A +K YM L GLE+ H
Sbjct: 62 PNIIGLLDVFGHKSN--INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRPPELLLGA 295
+ +LHRD+K +NLLI ++G+L +ADFGLA F PN K MT +VVT WYR PELL GA
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGA 177
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHAT 354
YGVGVD+WS GCI AELL P +PG ++++QL KIF+ G+P+EE W + LP
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPS 414
FKP + + F +L L++ LL ++P +R TA AL +F+ P PS
Sbjct: 238 EFKPFPPTP--LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPS 295
Query: 415 SLP 417
LP
Sbjct: 296 QLP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 330 bits (849), Expect = e-111
Identities = 147/309 (47%), Positives = 200/309 (64%), Gaps = 6/309 (1%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRR 173
R FEKL++IG+GTY VY+ARDT +G+IVALKKVR DN E + + + REI +L
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLREITLLLN 62
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
L HPN+V+L+ +V + S++LV +Y E DLA L + F+++QVKC M QLL GL+
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ H ++HRD+K SNLL+ ++G L IADFGLA + +PMT +VVTLWYR PELLL
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL-PAKPMTPKVVTLWYRAPELLL 181
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPH 352
G T Y +D+W+ GCILAELLA KP++PG++E+EQL I +L G+P+E W S LP
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241
Query: 353 ATIFK-PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYAC 411
F P+Q Y + F + L L+ LL DP +R TA AL S +F KP C
Sbjct: 242 VGKFTLPKQPYNN-LKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPC 300
Query: 412 DPSSLPKYP 420
+P +P +P
Sbjct: 301 EPEMMPTFP 309
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 319 bits (820), Expect = e-106
Identities = 141/302 (46%), Positives = 194/302 (64%), Gaps = 11/302 (3%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILI 170
W R D F+ + +IG+GTY VYKARD TG++VALKKVR DN E E A REI I
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 59
Query: 171 LRRLDHPNVVKLEGLVTSRMSC--------SLYLVFKYMEHDLAGLAASPTIKFTQAQVK 222
LR+L+H N+V L+ +VT + + YLVF+YM+HDL GL S + F++ +K
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119
Query: 223 CYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282
+M QLL GL +CH ++ LHRDIK SN+L++N+G + +ADFGLA ++ +P T++V+
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342
TLWYRPPELLLG YG +D+WS GCIL EL +KPI E+ QL I +LCGSP
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
Query: 343 EYWKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401
W KLP+ KP++ Y+R + E F P +L L++ +L +DP++R TA AL S
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299
Query: 402 EF 403
+
Sbjct: 300 PW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 318 bits (818), Expect = e-106
Identities = 138/303 (45%), Positives = 188/303 (62%), Gaps = 19/303 (6%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHPN 178
+E L K+G+GT+ VYKAR TG++VALKK+ N E + A REI IL++L HPN
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN-EKDGFPITALREIKILKKLKHPN 68
Query: 179 VVKLEGLV------TSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
VV L + + R S+Y+V YM+HDL+GL +P++K T++Q+KCYM QLL G+
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGI 128
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM----------TSRVV 282
+ H H+LHRDIK +N+LIDN+GIL IADFGLA +D P T+ VV
Sbjct: 129 NYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV 188
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342
T WYRPPELLLG Y VD+W GC+ AE+ +PI+ G+++++QLH IFKLCG+P+E
Sbjct: 189 TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTE 248
Query: 343 EYWKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401
E W LP +Y R + E F P L L+ LL++DP +R TA+ AL
Sbjct: 249 ETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308
Query: 402 EFF 404
+F
Sbjct: 309 PYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 316 bits (811), Expect = e-105
Identities = 142/299 (47%), Positives = 191/299 (63%), Gaps = 16/299 (5%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRR 173
R D +EKL++I +GTY VY+ARD TG+IVALKK++ + E E + REI IL +
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSLREINILLK 60
Query: 174 LDHPNVVKL-EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
L HPN+V + E +V S + +Y+V +Y+EHDL L + F Q++VKC M QLLSG+
Sbjct: 61 LQHPNIVTVKEVVVGSNLD-KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGV 119
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRPPEL 291
H H+ +LHRD+K SNLL++N GIL I DFGLA + P +P T VVTLWYR PEL
Sbjct: 120 AHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP--LKPYTQLVVTLWYRAPEL 177
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKL 350
LLGA +Y +D+WS GCI AELL +KP+ PG++E++QL+KIFKL G+P+E+ W S+L
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSSLP-----LIETLLAIDPAERQTATAALRSEFF 404
P A Y K FP SL L+ LL DPA+R +A AL+ +F
Sbjct: 238 PGAKKKTF-TKYPYNQLR--KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 298 bits (766), Expect = 2e-98
Identities = 143/300 (47%), Positives = 184/300 (61%), Gaps = 14/300 (4%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDH 176
+EKL KIGQGT+ V+KAR T QIVALKKV +N E E A REI IL+ L H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN-EKEGFPITALREIKILQLLKH 70
Query: 177 PNVVKL------EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLS 230
NVV L + +R S YLVF++ EHDLAGL ++ +KFT +++K M LL+
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQP--MTSRVVTLWYR 287
GL + H +LHRD+K +N+LI +GIL +ADFGLA +F + +P T+RVVTLWYR
Sbjct: 131 GLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
PPELLLG DYG +D+W AGCI+AE+ PIM G TE QL I +LCGS + E W
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250
Query: 348 -SKLPHATIFKPQQSYKRCIAETFKDF--PPSSLPLIETLLAIDPAERQTATAALRSEFF 404
KL + Q KR + E K + P +L LI+ LL +DPA+R A AL +FF
Sbjct: 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 287 bits (736), Expect = 2e-94
Identities = 124/286 (43%), Positives = 174/286 (60%), Gaps = 4/286 (1%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
++KL KIG+GTY VYKARD LTG+IVA+KK++ + REI +L+ L+HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
+KL + + LYLVF++M+ DL L ++ +K Y++QLL GL CH+
Sbjct: 61 IKLLDVFRHKGD--LYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYG 299
+LHRD+K NLLI+ EG+L +ADFGLA F + P T VVT WYR PELLLG Y
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYTHYVVTRWYRAPELLLGDKGYS 177
Query: 300 VGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHATIFKP 358
VD+WS GCI AELL+ +P+ PG++E++QL KIF+ G+P E W K + L F
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237
Query: 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
+ + + F + P +L L+ +L DP +R TA AL +F
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 277 bits (711), Expect = 1e-90
Identities = 129/293 (44%), Positives = 187/293 (63%), Gaps = 18/293 (6%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHPN 178
++K++KIG+GTY VYKARD LTG+IVALKK+R + E E V A REI +L+ L+HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPN 59
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
+V+L +V S LYLVF++++ DL + +SP +K Y++QLL G+ +CH+
Sbjct: 60 IVRLLDVVHSENK--LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM---TSRVVTLWYRPPELLLG 294
VLHRD+K NLLID EG L +ADFGLA F P+ T VVTLWYR PE+LLG
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFG----VPVRTYTHEVVTLWYRAPEILLG 173
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHA 353
+ Y VD+WS GCI AE++ +P+ PG +E++QL +IF+ G+P E+ W + LP
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD- 232
Query: 354 TIFKPQ--QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
+KP + ++ +++ + L L+ +L DPA+R +A AAL+ +F
Sbjct: 233 --YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 274 bits (703), Expect = 3e-89
Identities = 121/294 (41%), Positives = 161/294 (54%), Gaps = 15/294 (5%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE---PESVRFMAREILILRRLD 175
++ L +IG+G + V+KA+D TG+ VALKKV LE P REI L+
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA---LREIKALQACQ 57
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
HP VVKL L LV +YM DL+ + +AQVK YM LL G+ +
Sbjct: 58 HPYVVKL--LDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H ++HRD+K +NLLI +G+L IADFGLA F + + +V T WYR PELL GA
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHAT 354
Y GVDLW+ GCI AELL P+ PG ++EQL +F+ G+P+EE W + LP
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235
Query: 355 --IFKPQQSYKRCIAET-FKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
F K E F D P +L L++ LL DP++R +A ALR +FT
Sbjct: 236 KITFPES---KPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 268 bits (686), Expect = 3e-86
Identities = 124/325 (38%), Positives = 185/325 (56%), Gaps = 32/325 (9%)
Query: 120 FEKLDK-IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES-----------VRFMA-R 166
+ + +G+GTY V KA DTLTG+IVA+KKV+ + + + F R
Sbjct: 10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMH 226
E+ I+ + H N++ L + + LV M DL + I+ T++QVKC +
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDF--INLVMDIMASDLKKVVDR-KIRLTESQVKCILL 126
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS------FFDPNHKQP---- 276
Q+L+GL H + +HRD+ +N+ I+++GI IADFGLA + D K
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 277 ---MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
MTS+VVTLWYR PELL+GA Y VD+WS GCI AELL KP+ PG E++QL +I
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246
Query: 334 FKLCGSPSEEYW-KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
F+L G+P+E+ W + KLP T F P++ + + F + ++ L+++LL ++P ER
Sbjct: 247 FELLGTPNEDNWPQAKKLPLYTEFTPRK--PKDLKTIFPNASDDAIDLLQSLLKLNPLER 304
Query: 393 QTATAALRSEFFTTKPYACDPSSLP 417
+A AL+ E+F + P CDPS LP
Sbjct: 305 ISAKEALKHEYFKSDPLPCDPSQLP 329
|
Length = 335 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 264 bits (677), Expect = 2e-85
Identities = 119/298 (39%), Positives = 174/298 (58%), Gaps = 24/298 (8%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE---PESVRFMAREILILRRLD- 175
+E+L +IG+G Y VYKARD TG+ VALKKVR E P S REI +L++L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS---TLREIALLKQLES 57
Query: 176 --HPNVVKL----EGLVTSRMSCSLYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQL 228
HPN+V+L G T R L LVF++++ DLA L+ P +K M QL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRP 288
L G++ H+ ++HRD+K N+L+ ++G + IADFGLA + +TS VVTLWYR
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MALTSVVVTLWYRA 174
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW-KK 347
PE+LL ++ Y VD+WS GCI AEL +P+ G +E +QL KIF + G PSEE W +
Sbjct: 175 PEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233
Query: 348 SKLPHATI-FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
LP ++ +S+K + E ++ L L++ +L +P +R +A AL+ +F
Sbjct: 234 VSLPRSSFPSYTPRSFKSFVPEICEE----GLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 257 bits (658), Expect = 5e-83
Identities = 107/291 (36%), Positives = 156/291 (53%), Gaps = 43/291 (14%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+E L+K+G+G++ VY ARD TG++VA+K ++ ++ + R + REI IL++L HPN+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERIL-REIKILKKLKHPNI 59
Query: 180 VKLEG-LVTSRMSCSLYLVFKYMEH-DLAGLAASPTIK----FTQAQVKCYMHQLLSGLE 233
V+L LYLV +Y E DL L +K ++ + + Y+ Q+LS LE
Sbjct: 60 VRLYDVFEDED---KLYLVMEYCEGGDLFDL-----LKKRGRLSEDEARFYLRQILSALE 111
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ H++ ++HRD+K N+L+D +G + +ADFGLA DP K +T+ V T Y PE+LL
Sbjct: 112 YLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLL 169
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
G YG VD+WS G IL ELL KP PG +QL ++FK G P +
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPPEWD--- 222
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
I+ KD I LL DP +R TA AL+ FF
Sbjct: 223 ------------ISPEAKDL-------IRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 256 bits (656), Expect = 2e-82
Identities = 129/295 (43%), Positives = 177/295 (60%), Gaps = 22/295 (7%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHPN 178
F+K++KIG+GTY VYKAR+ LTG++VALKK+R D E E V A REI +L+ L+HPN
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD-TETEGVPSTAIREISLLKELNHPN 60
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
+VKL ++ + LYLVF+++ DL + ASP +K Y+ QLL GL CH+
Sbjct: 61 IVKLLDVIHTENK--LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM---TSRVVTLWYRPPELLLG 294
VLHRD+K NLLI+ EG + +ADFGLA F P+ T VVTLWYR PE+LLG
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYTHEVVTLWYRAPEILLG 174
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHA 353
Y VD+WS GCI AE++ + + PG +E++QL +IF+ G+P E W + LP
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD- 233
Query: 354 TIFKPQQSYKRCIAETFKDFPP----SSLPLIETLLAIDPAERQTATAALRSEFF 404
+KP S+ + + F P L+ +L DP +R +A AAL FF
Sbjct: 234 --YKP--SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 253 bits (648), Expect = 3e-81
Identities = 122/288 (42%), Positives = 171/288 (59%), Gaps = 8/288 (2%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHPN 178
+EKL+KIG+GTY V+KA++ T +IVALK+VR D+ + E V A REI +L+ L H N
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKN 60
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
+V+L ++ S L LVF+Y + DL S VK +M QLL GL CH+
Sbjct: 61 IVRLYDVLHSDKK--LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH 118
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDY 298
+VLHRD+K NLLI+ G L +ADFGLA F + ++ VVTLWYRPP++L GA Y
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLY 177
Query: 299 GVGVDLWSAGCILAELL-AEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHATIF 356
+D+WSAGCI AEL A +P+ PG +QL +IF+L G+P+EE W SKLP +
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
+ + K + L++ LL +P +R +A AL+ +F
Sbjct: 238 PMYPATTSLVNVVPKLN-STGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 252 bits (647), Expect = 2e-80
Identities = 114/324 (35%), Positives = 176/324 (54%), Gaps = 17/324 (5%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLDHPNVVKLE 183
IG G Y V A D TG+ VA+KK+ FD+L + + REI +LR L H N++ L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI--DAKRILREIKLLRHLRHENIIGLL 65
Query: 184 GLVTSRMSCS---LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
++ +Y+V + ME DL + SP T ++ +++Q+L GL++ H+ +V
Sbjct: 66 DILRPPSPEDFNDVYIVTELMETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANV 124
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP--MTSRVVTLWYRPPELLLGATDY 298
+HRD+K SN+L+++ L I DFGLA DP+ + +T VVT WYR PELLL ++ Y
Sbjct: 125 IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRY 184
Query: 299 GVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT--IF 356
+D+WS GCI AELL KP+ PGR ++QL+ I ++ G+PSEE K A +
Sbjct: 185 TKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLK 244
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACD---P 413
+ K+ +++ F P ++ L+E +L DP +R TA AL + P
Sbjct: 245 SLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL--AQLHDPEDEP 302
Query: 414 SSLPKYPPTKEMDAKLRDEEARRL 437
+ P + D +L +EE + L
Sbjct: 303 VAKPPFDFDFFDDDELTEEELKEL 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 3e-78
Identities = 101/287 (35%), Positives = 145/287 (50%), Gaps = 29/287 (10%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+E L K+G G++ VYKA+ TG+IVA+K ++ + + + + REI ILRRL HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
V+L LYLV +Y E DL + ++ + K Q+L GLE+ H+
Sbjct: 61 VRLIDAFED--KDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLHSN 117
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDY 298
++HRD+K N+L+D G++ IADFGLA +T+ V T WY PE+LLG Y
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 299 GVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK-LCGSPSEEYWKKSKLPHATIFK 357
G VD+WS G IL ELL KP G ++QL I + L + K S
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWS--------- 227
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
+E KD I+ L DP++R TA L+ +F
Sbjct: 228 -------SGSEEAKDL-------IKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 244 bits (625), Expect = 8e-78
Identities = 125/294 (42%), Positives = 184/294 (62%), Gaps = 19/294 (6%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHPN 178
+ K++KIG+GTY VYK R+ TGQIVA+KK+R ++ E E V A REI +L+ L HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPN 60
Query: 179 VVKLEGLVT--SRMSCSLYLVFKYMEHDLAG-LAASPTIKFTQAQ-VKCYMHQLLSGLEH 234
+V L+ ++ SR LYL+F+++ DL L + P ++ A+ VK Y++Q+L G+
Sbjct: 61 IVCLQDVLMQESR----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM---TSRVVTLWYRPPEL 291
CH++ VLHRD+K NLLIDN+G++ +ADFGLA F P+ T VVTLWYR PE+
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG----IPVRVYTHEVVTLWYRAPEV 172
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKL 350
LLG+ Y VD+WS G I AE+ +KP+ G +E++QL +IF++ G+P+E+ W + L
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
P P+ K + K+ L L+E +L DPA+R +A AL +F
Sbjct: 233 PDYKNTFPKWK-KGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 243 bits (623), Expect = 2e-77
Identities = 129/301 (42%), Positives = 177/301 (58%), Gaps = 21/301 (6%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDH 176
D +EKL+KIG+GTY VYKARD TG++VALKK R + ++ E + A REI +L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE-MDEEGIPPTALREISLLQMLSE 59
Query: 177 -PNVVKL---EGLVTSRMSCSLYLVFKYMEHDLA----GLAASPTIKFTQAQVKCYMHQL 228
+V+L E + SLYLVF+Y++ DL P +K +M+QL
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
L G+ HCH V+HRD+K NLL+D + G+L IAD GL F K T +VTLWYR
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS-YTHEIVTLWYR 178
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
PE+LLG+T Y VD+WS GCI AE+ ++P+ PG +E++QL IFKL G+P+E+ W
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238
Query: 348 -SKLPHATIF---KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
SKL F KPQ ++ D P L L++ +L DPA+R +A AAL +
Sbjct: 239 VSKLRDWHEFPQWKPQD-----LSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
Query: 404 F 404
F
Sbjct: 294 F 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 242 bits (620), Expect = 6e-77
Identities = 127/299 (42%), Positives = 184/299 (61%), Gaps = 25/299 (8%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDH 176
D +EK++KIG+GTY VYKARD +T + +ALKK+R + E E V A REI +L+ + H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQH 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHC 235
N+V+L+ +V S LYLVF+Y++ DL + +SP +K Y++Q+L G+ +C
Sbjct: 61 GNIVRLQDVVHSEKR--LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 236 HNQHVLHRDIKGSNLLIDNE-GILTIADFGLASFFD-PNHKQPMTSRVVTLWYRPPELLL 293
H+ VLHRD+K NLLID L +ADFGLA F P + T VVTLWYR PE+LL
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--VRTFTHEVVTLWYRAPEILL 176
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK------- 346
G+ Y VD+WS GCI AE++ +KP+ PG +E+++L KIF++ G+P+EE W
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236
Query: 347 -KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
KS P + P+ +A P+ + L+ +L +DP++R TA AAL E+F
Sbjct: 237 YKSAFPK---WPPKD-----LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 238 bits (608), Expect = 3e-75
Identities = 112/291 (38%), Positives = 173/291 (59%), Gaps = 14/291 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE--PESVRFMAREILILRRLDHP 177
F++L+K+G+GTY+ VYK R+ TG+IVALK++ D E P + REI +++ L H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA---IREISLMKELKHE 58
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK--FTQAQVKCYMHQLLSGLEHC 235
N+V+L ++ + L LVF+YM+ DL + ++ VK + +QLL G+ C
Sbjct: 59 NIVRLHDVIHTE--NKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRPPELLLG 294
H VLHRD+K NLLI+ G L +ADFGLA +F P + ++ VVTLWYR P++LLG
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEVVTLWYRAPDVLLG 174
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHA 353
+ Y +D+WS GCI+AE++ +P+ PG +QL KIF++ G+P+E W S+LP
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
P+ + + + F P + L+ LL ++P R +A AL+ +F
Sbjct: 235 KPTFPRYP-PQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 238 bits (608), Expect = 4e-75
Identities = 118/300 (39%), Positives = 173/300 (57%), Gaps = 22/300 (7%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRL 174
+ +T++KLDK+G+G+Y+ VYK R LTGQ+VALK++R + E F A RE +L+ L
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLE--HEEGAPFTAIREASLLKDL 60
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
H N+V L ++ ++ + L LVF+Y++ DL + V+ ++ QLL GL +
Sbjct: 61 KHANIVTLHDIIHTKKT--LTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLA---SFFDPNHKQPMTSRVVTLWYRPPEL 291
CH + VLHRD+K NLLI G L +ADFGLA S P+ ++ VVTLWYRPP++
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV--PSKT--YSNEVVTLWYRPPDV 174
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSEEYWKK-SK 349
LLG+T+Y +D+W GCI E+ +P+ PG T+V +QLHKIF++ G+P+EE W S
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234
Query: 350 LPHATIFKPQQS--YKR---CIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
P FKP Y D P L L +P +R +A A++ +F
Sbjct: 235 NPE---FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 231 bits (590), Expect = 4e-72
Identities = 111/317 (35%), Positives = 159/317 (50%), Gaps = 32/317 (10%)
Query: 119 TFEKLDKIGQGTYSNVYKAR--DTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLD 175
+E IG+GTY VYKA+ + G+ A+KK + D + + A REI +LR L
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGL----AASPTIKFTQAQVKCYMHQLLSG 231
H NVV L + S+YL+F Y EHDL + + + + VK + Q+L+G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 232 LEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASFFDPNHKQPMTSR--VVTLW 285
+ + H+ VLHRD+K +N+L+ G++ I D GLA F+ K VVT+W
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---------VEQLHKIFKL 336
YR PELLLGA Y +D+W+ GCI AELL +PI GR +QL +IF++
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240
Query: 337 CGSPSEEYWKK-SKLPH----ATIFKPQQSYKRC----IAETFKDFPPSSLPLIETLLAI 387
G+P+E+ W K+P FK ++Y E K L+ LL
Sbjct: 241 LGTPTEKDWPDIKKMPEYDTLMKDFKT-KTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299
Query: 388 DPAERQTATAALRSEFF 404
DP +R TA AL +F
Sbjct: 300 DPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 226 bits (579), Expect = 7e-71
Identities = 108/290 (37%), Positives = 175/290 (60%), Gaps = 12/290 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKV--RFDNLEPESVRFMAREILILRRL-DH 176
++ + ++G GT+ +VY AR+ TG++VA+KK+ +F + E E + RE+ LR+L +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNL--REVKSLRKLNEH 57
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK-FTQAQVKCYMHQLLSGLEHC 235
PN+VKL+ + R + LY VF+YME +L L K F+++ ++ ++Q+L GL H
Sbjct: 58 PNIVKLKEVF--RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H HRD+K NLL+ ++ IADFGLA + + P T V T WYR PE+LL +
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS-KLPHAT 354
T Y VD+W+ GCI+AEL +P+ PG +E++QL+KI + G+P+++ W + KL
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
F+ Q + + + P ++ LI+ +L DP +R TA+ AL+ +F
Sbjct: 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 3e-70
Identities = 104/289 (35%), Positives = 154/289 (53%), Gaps = 7/289 (2%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+E L +G+G Y V K R+ TG+IVA+KK + + + + RE+ +LR+L H N+
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENI 62
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
V L R LYLVF+Y+E L L ASP V+ Y+ QLL + +CH+
Sbjct: 63 VNL--KEAFRRKGRLYLVFEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDY 298
+++HRDIK N+L+ G+L + DFG A P+T V T WYR PELL+G T+Y
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179
Query: 299 GVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS-PSEEYWKKSKLPHATIFK 357
G VD+W+ GCI+AELL +P+ PG ++++QL+ I K G P S P
Sbjct: 180 GKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239
Query: 358 -PQQSYKRCIAETF-KDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
P+ S + + +L ++ L +DP ER T L+ +F
Sbjct: 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 224 bits (574), Expect = 2e-69
Identities = 122/320 (38%), Positives = 175/320 (54%), Gaps = 36/320 (11%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFD---NLEPESVRFMAREILILRRL-D 175
+E L K+G+G Y V+KA D T ++VALKK+ FD N F REI+ L+ L D
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-FDAFRNATDAQRTF--REIMFLQELGD 65
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDL-----AGLAASPTIKFTQAQVKCY-MHQLL 229
HPN+VKL ++ + +YLVF+YME DL A + + K Y M+QLL
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANI--------LEDVHKRYIMYQLL 117
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA---SFFDPNHKQP-MTSRVVTLW 285
L++ H+ +V+HRD+K SN+L++++ + +ADFGLA S + N + P +T V T W
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
YR PE+LLG+T Y GVD+WS GCIL E+L KP+ PG + + QL KI ++ G PS E
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237
Query: 346 K--KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
+ KS + ++ + E +L L++ LL +P +R TA AL
Sbjct: 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH-- 295
Query: 404 FTTKPYACD---PSSLPKYP 420
PY PS P P
Sbjct: 296 ----PYVAQFHNPSDEPVLP 311
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 1e-65
Identities = 117/296 (39%), Positives = 175/296 (59%), Gaps = 17/296 (5%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
+ +T+ KLDK+G+GTY+ V+K R LT +VALK++R ++ E + RE+ +L+ L
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLK 61
Query: 176 HPNVVKLEGLV-TSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
H N+V L ++ T R L LVF+Y++ DL + + VK +M QLL GL +
Sbjct: 62 HANIVTLHDIIHTER---CLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
CH + +LHRD+K NLLI+ +G L +ADFGLA K ++ VVTLWYRPP++LLG
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT-YSNEVVTLWYRPPDVLLG 177
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
+T+Y +D+W GCIL E+ +P+ PG T E+LH IF+L G+P+EE W P T
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW-----PGIT 232
Query: 355 IFKPQQSY--KRCIAETFKDFPP----SSLPLIETLLAIDPAERQTATAALRSEFF 404
+ +SY + A+ + P + L+ +LL + R +A AALR +F
Sbjct: 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 6e-65
Identities = 110/286 (38%), Positives = 155/286 (54%), Gaps = 11/286 (3%)
Query: 123 LDKIGQGTYSNVYKARDTLTGQIVALK--KVRFDNLEPESVRFMAREILILRRL-DHPNV 179
L KIG+GT+S V KA+ TG+ A+K K F +LE + REI LRRL HPN+
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNL--REIQALRRLSPHPNI 60
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
++L ++ R + L LVF+ M+ +L L + +VK YM+QLL L+H H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYG 299
+ HRDIK N+LI ++ IL +ADFG S K P T + T WYR PE LL YG
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFG--SCRGIYSKPPYTEYISTRWYRAPECLLTDGYYG 177
Query: 300 VGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY-WKKSKLPHATIFKP 358
+D+W+ GC+ E+L+ P+ PG E++Q+ KI + G+P E K K H P
Sbjct: 178 PKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237
Query: 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
+ + + + L L++ LLA DP ER TA ALR +F
Sbjct: 238 SKK-GTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 208 bits (532), Expect = 6e-64
Identities = 101/297 (34%), Positives = 155/297 (52%), Gaps = 21/297 (7%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ +EKL KIG+G+Y V+K R+ TGQIVA+KK +P + REI +L++L HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N+V L + R L+LVF+Y +H L L +P + +K + Q L + CH
Sbjct: 61 NLVNL--IEVFRRKRKLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH 117
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ +HRD+K N+LI +G + + DFG A T V T WYR PELL+G T
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYVATRWYRAPELLVGDT 176
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS---------PSEEYWKK 347
YG VD+W+ GC+ AELL +P+ PG+++V+QL+ I K G + +++K
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
+P +P + F + +L ++ L +DP ER + L +F
Sbjct: 237 LSIPEPETREP-------LESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 208 bits (531), Expect = 4e-63
Identities = 109/318 (34%), Positives = 162/318 (50%), Gaps = 15/318 (4%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV--RFDNLEPESVRFMAREILILRRLD 175
++ ++ IG G Y V A DT +G+ VA+KK+ FD P + RE+ ILR
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV--PTLAKRTLRELKILRHFK 62
Query: 176 HPNVVKLEGLVTSRMS--CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
H N++ + ++ + +Y+V ME DL + S T+ ++ +++QLL GL+
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLK 121
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN---HKQPMTSRVVTLWYRPPE 290
+ H+ +V+HRD+K SNLL++ + L I DFG+A + HK MT V T WYR PE
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK--S 348
LLL +Y +D+WS GCI AE+L + + PG+ V QL I + GSPSEE + S
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241
Query: 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408
I + ++ F P +L L+ +L DP ER T AL+ F
Sbjct: 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301
Query: 409 YACDPSSLPKYPPTKEMD 426
DP P PP + D
Sbjct: 302 ---DPDDEPTCPPPFDFD 316
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 207 bits (527), Expect = 5e-63
Identities = 113/293 (38%), Positives = 168/293 (57%), Gaps = 11/293 (3%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
+ +T+ KLDK+G+GTY+ VYK R LT +VALK++R ++ E + RE+ +L+ L
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
H N+V L ++ + S L LVF+Y++ DL VK ++ QLL GL +C
Sbjct: 63 HANIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H + VLHRD+K NLLI+ G L +ADFGLA K ++ VVTLWYRPP++LLG+
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-YSNEVVTLWYRPPDILLGS 179
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355
TDY +D+W GCI E+ +P+ PG T EQLH IF++ G+P+EE W +
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW--PGILSNEE 237
Query: 356 FKPQQSYKRCIAETFKDFPP----SSLPLIETLLAIDPAERQTATAALRSEFF 404
FK +Y + A+ + P L+ LL + +R +A A++ +F
Sbjct: 238 FK-SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 8e-62
Identities = 119/298 (39%), Positives = 171/298 (57%), Gaps = 20/298 (6%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLD 175
A ++ L+K+G+G+Y+ VYK + GQ+VALK + E V F A RE +L+ L
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLK 61
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
H N+V L ++ ++ + L VF+YM DLA V+ +M QLL GL +
Sbjct: 62 HANIVLLHDIIHTKET--LTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRPPELLLG 294
H QH+LHRD+K NLLI G L +ADFGLA + P+ Q +S VVTLWYRPP++LLG
Sbjct: 120 HGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--QTYSSEVVTLWYRPPDVLLG 177
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSEEYWKK-SKLPH 352
ATDY +D+W AGCI E+L +P PG ++V EQL KI+ + G P+E+ W SKLP+
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237
Query: 353 ATIFKPQQSYKRCIAETFKDF------PPSSLPLIETLLAIDPAERQTATAALRSEFF 404
+KP+ + C + + PP + L +L + P +R +A AL +F
Sbjct: 238 ---YKPEW-FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 2e-59
Identities = 112/297 (37%), Positives = 166/297 (55%), Gaps = 31/297 (10%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLDHPNVVKLE 183
IG+G Y V A+++ T + VA+KK+ FDN ++ R + REI +LR LDH NV+ ++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI-DAKRTL-REIKLLRHLDHENVIAIK 70
Query: 184 GLV--TSRMSCS-LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
++ R + + +Y+V++ M+ DL + S + + +++QLL GL++ H+ +V
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQT-LSDDHCQYFLYQLLRGLKYIHSANV 129
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGV 300
LHRD+K SNLL++ L I DFGLA MT VVT WYR PELLL ++Y
Sbjct: 130 LHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTT 188
Query: 301 GVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE------------YWKKS 348
+D+WS GCI AELL KP+ PG+ V QL I +L GSPSEE Y +
Sbjct: 189 AIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIR-- 246
Query: 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
LP+ P+QS+ A F P ++ L+E +L DP++R T AL +
Sbjct: 247 SLPYT----PRQSF----ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 1e-58
Identities = 114/347 (32%), Positives = 172/347 (49%), Gaps = 47/347 (13%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA----REILILR 172
++ L IG+G Y V A TG VA+KK+ P + REI ILR
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-----SPFEHQTFCQRTLREIKILR 58
Query: 173 RLDHPNVVKLEGLVTSRMSCSL---YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLL 229
R H N++ + ++ S Y+V + ME DL L T + ++ +++Q+L
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQIL 116
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP--MTSRVVTLWYR 287
GL++ H+ +VLHRD+K SNLL++ L I DFGLA DP H +T V T WYR
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE--YW 345
PE++L + Y +D+WS GCILAE+L+ +P+ PG+ + QL+ I + G+PS+E
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236
Query: 346 KKSK--------LPHATIFKPQQSYKRCIAETFKDFP---PSSLPLIETLLAIDPAERQT 394
S LP FKP+ + + FP P +L L++ +L +P +R T
Sbjct: 237 IISLRARNYIKSLP----FKPKVPWNKL-------FPNADPKALDLLDKMLTFNPHKRIT 285
Query: 395 ATAALRSEFFTTKPYACDPSSLP----KYPPTKEMDAKLRDEEARRL 437
AL + + Y DPS P +P E+ L E+ + L
Sbjct: 286 VEEALAHPYL--EQYH-DPSDEPVAEEPFPFDFELFDDLPKEKLKEL 329
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 1e-58
Identities = 112/293 (38%), Positives = 159/293 (54%), Gaps = 14/293 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL---DH 176
+E + +IG G Y VYKARD +G VALK VR E RE+ +L+RL DH
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 177 PNVVKLEGL-VTSRM--SCSLYLVFKYMEHDL-AGLAASPTIKFTQAQVKCYMHQLLSGL 232
PN+V+L + TSR + LVF++++ DL L P +K M Q L GL
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL 292
+ H ++HRD+K N+L+ + G + +ADFGLA + + + +T VVTLWYR PE+L
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYRAPEVL 179
Query: 293 LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS-KLP 351
L +T Y VD+WS GCI AE+ KP+ G +E +QL KIF L G P E+ W + LP
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238
Query: 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
F P+ R + + S L+ +L +P +R +A AL+ FF
Sbjct: 239 RGA-FSPRG--PRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 1e-58
Identities = 103/291 (35%), Positives = 167/291 (57%), Gaps = 13/291 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHPN 178
+E L +G+G+Y V K + TGQIVA+KK ++ + + V+ +A REI +L++L H N
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
+V L + R LYLVF++++H L L P +++V+ Y+ Q+L G+E CH+
Sbjct: 62 LVNL--IEVFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHS 118
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFD-PNHKQPMTSRVVTLWYRPPELLLGAT 296
+++HRDIK N+L+ G++ + DFG A P + T V T WYR PELL+G T
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYTDYVATRWYRAPELLVGDT 176
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE---EYWKKSKLPHA 353
YG VD+W+ GC++ E+L +P+ PG ++++QL+ I K G+ E ++K+ L A
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL-FA 235
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
+ P+ + + F L L + L IDP +R +++ L EFF
Sbjct: 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 3e-58
Identities = 96/230 (41%), Positives = 147/230 (63%), Gaps = 4/230 (1%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
+ +T+ KL+K+G+GTY+ V+K R LT +VALK++R ++ E + RE+ +L+ L
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
H N+V L +V + S L LVF+Y++ DL + VK +++Q+L GL +C
Sbjct: 63 HANIVTLHDIVHTDKS--LTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H + VLHRD+K NLLI+ G L +ADFGLA K ++ VVTLWYRPP++LLG+
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT-YSNEVVTLWYRPPDVLLGS 179
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
++Y +D+W GCI E+ + +P+ PG T ++LH IF+L G+P+EE W
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 3e-58
Identities = 71/191 (37%), Positives = 109/191 (57%), Gaps = 6/191 (3%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGL 185
+G+G + VY ARD TG+ VA+K ++ ++ + REI IL++L+HPN+VKL G+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELL-REIEILKKLNHPNIVKLYGV 59
Query: 186 VTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRD 244
LYLV +Y E L L K ++ ++ + Q+L GLE+ H+ ++HRD
Sbjct: 60 FEDE--NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 245 IKGSNLLIDN-EGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVD 303
+K N+L+D+ G + +ADFGL+ + K + + V T Y PE+LLG Y D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 304 LWSAGCILAEL 314
+WS G IL EL
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 2e-57
Identities = 109/313 (34%), Positives = 160/313 (51%), Gaps = 21/313 (6%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLD 175
D ++ L +G G Y V A DT TG+ VA+KK+ F + + RE+ +L+ +D
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMD 72
Query: 176 HPNVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
H NV+ L + T S +YLV M DL + K + ++ ++Q+L G
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ--KLSDDHIQFLVYQILRG 130
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
L++ H+ ++HRD+K SN+ ++ + L I DFGLA D MT V T WYR PE+
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEI 186
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
+L Y VD+WS GCI+AELL K + PG ++QL +I L G+P EE +K
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246
Query: 352 HATIF---KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408
A + PQ K+ E F P ++ L+E +L +DP +R TA AL +
Sbjct: 247 SARNYIQSLPQMP-KKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL--AE 303
Query: 409 YACDPSSLPKYPP 421
Y DP P PP
Sbjct: 304 YH-DPEDEPVAPP 315
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 191 bits (485), Expect = 8e-57
Identities = 115/302 (38%), Positives = 173/302 (57%), Gaps = 18/302 (5%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRL 174
+AD++EKL+K+G+G+Y+ VYK + + G++VALK +R E E F A RE +L+ L
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ--EEEGTPFTAIREASLLKGL 60
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
H N+V L ++ ++ + L LVF+Y+ DL VK ++ QLL GL +
Sbjct: 61 KHANIVLLHDIIHTKET--LTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSY 118
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD-PNHKQPMTSRVVTLWYRPPELLL 293
H +++LHRD+K NLLI + G L +ADFGLA P+H ++ VVTLWYRPP++LL
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT--YSNEVVTLWYRPPDVLL 176
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE-QLHKIFKLCGSPSEEYWKK-SKLP 351
G+T+Y +D+W GCI E++ PG +++ QL +IF + G+P+E+ W LP
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236
Query: 352 HATIFKPQQ----SYKRCIAETFK-DFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406
H FKP++ S K K + + L LL P R +A AAL E+F+
Sbjct: 237 H---FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293
Query: 407 KP 408
P
Sbjct: 294 LP 295
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 3e-56
Identities = 106/300 (35%), Positives = 158/300 (52%), Gaps = 12/300 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+ L +G G + V ARD LTGQ VA+KK+ P + RE+ +L+ L H N+
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI 71
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
+ L + S + +Y V + + DL L S ++ Q +++Q+L GL++ H+
Sbjct: 72 ISLSDIFISPLE-DIYFVTELLGTDLHRLLTSRPLEKQFIQY--FLYQILRGLKYVHSAG 128
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYG 299
V+HRD+K SN+LI+ L I DFGLA DP MT V T +YR PE++L Y
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYD 184
Query: 300 VGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK--SKLPHATIFK 357
V VD+WSAGCI AE+L KP+ PG+ V Q I L G+P ++ S+ +
Sbjct: 185 VEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS 244
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLP 417
+ +E FK+ PS++ L+E +L DP +R +A AL + PY DP+ P
Sbjct: 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL--APYH-DPTDEP 301
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 7e-55
Identities = 108/330 (32%), Positives = 172/330 (52%), Gaps = 29/330 (8%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+ L +G G+ V+ A D+ + VA+KK+ +P+SV+ REI I+RRLDH N+
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNI 64
Query: 180 VKLEGLVTSRMS------------CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQ 227
VK+ ++ S S+Y+V +YME DLA + + ++ + +M+Q
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPL--SEEHARLFMYQ 122
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPN--HKQPMTSRVVTL 284
LL GL++ H+ +VLHRD+K +N+ I+ E +L I DFGLA DP+ HK ++ +VT
Sbjct: 123 LLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344
WYR P LLL +Y +D+W+AGCI AE+L KP+ G E+EQ+ I + EE
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242
Query: 345 WKK--SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
+ + +P + + +R + + P +L +E +L +P +R TA AL
Sbjct: 243 RNELLNVIP-SFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHP 301
Query: 403 FFTTKPYACDPSSLPKYPPTKEMDAKLRDE 432
+ Y+C P P + DE
Sbjct: 302 YM--SCYSC-----PFDEPVSLHPFHIEDE 324
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 3e-54
Identities = 106/298 (35%), Positives = 155/298 (52%), Gaps = 27/298 (9%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLT--GQIVALKKVR--FDNLEPESVRFMAREILILRRL- 174
+E + ++GQG Y V AR+ T + VA+KK+ F + RE+ +LR
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK--KILAKRALRELKLLRHFR 59
Query: 175 DHPNVVKLEGL--VTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
H N+ L + V LYL + ME DL + S T A + +++Q+L GL
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGL 118
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP---MTSRVVTLWYRPP 289
++ H+ +VLHRD+K NLL++ + L I DFGLA F N + MT V T WYR P
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349
E++L Y +D+WS GCILAELL KP+ G+ V+QL++I ++ G+P EE +
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238
Query: 350 LPHATIFKPQQSY--------KRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
P A Q+Y K+ F + P +L L+E LLA DP +R + AL
Sbjct: 239 SPKA------QNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 3e-52
Identities = 82/301 (27%), Positives = 137/301 (45%), Gaps = 56/301 (18%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN 178
+ + + +G+G++ +VY A D TG+++A+K V E + + REI IL L HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEH----DLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
+V+ G +L + ++E+ L+ L K + ++ Y Q+L GL +
Sbjct: 61 IVRYYGSERDEEKNTLNI---FLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAY 116
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLL 293
H+ ++HRDIKG+N+L+D++G++ +ADFG A T V T ++ PE++
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
G +YG D+WS GC + E+ KP W + P A
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKPP------------------------WSELGNPMA 211
Query: 354 TIFK----------PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
++K P+ ++E KDF + L DP +R TA L+ F
Sbjct: 212 ALYKIGSSGEPPEIPE-----HLSEEAKDF-------LRKCLRRDPKKRPTADELLQHPF 259
Query: 404 F 404
Sbjct: 260 L 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 177 bits (449), Expect = 9e-52
Identities = 112/297 (37%), Positives = 164/297 (55%), Gaps = 21/297 (7%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTG-QIVALKKVRFDNLEPESVRFMAREILILRRLD--- 175
+E + +IG+G Y V+KARD G + VALK+VR E RE+ +LR L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 176 HPNVVKLEGLVT-SRM--SCSLYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSG 231
HPNVV+L + T SR L LVF++++ DL L P +K M QLL G
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
L+ H+ V+HRD+K N+L+ + G + +ADFGLA + + + +TS VVTLWYR PE+
Sbjct: 123 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEV 180
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
LL ++ Y VDLWS GCI AE+ KP+ G ++V+QL KI + G P EE W +
Sbjct: 181 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD--- 236
Query: 352 HATIFKPQQSYKRCIAETFKDFPPS----SLPLIETLLAIDPAERQTATAALRSEFF 404
+ P+Q++ A+ + F L+ L +PA+R +A +AL +F
Sbjct: 237 ---VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 1e-49
Identities = 116/335 (34%), Positives = 179/335 (53%), Gaps = 25/335 (7%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLDHP 177
++ + IG+G+Y V A DT TG+ VA+KK+ F+++ ++ R + REI +LR L HP
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS-DATRIL-REIKLLRLLRHP 59
Query: 178 NVVKLEGLV---TSRMSCSLYLVFKYMEHDLAGLAASPTIK----FTQAQVKCYMHQLLS 230
++V+++ ++ + R +Y+VF+ ME DL IK T + +++QLL
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMESDL-----HQVIKANDDLTPEHHQFFLYQLLR 114
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA--SFFDPNHKQPMTSRVVTLWYRP 288
L++ H +V HRD+K N+L + + L I DFGLA +F D T V T WYR
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 289 PELLLGA--TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346
PEL G+ + Y +D+WS GCI AE+L KP+ PG+ V QL I L G+PS E
Sbjct: 175 PELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233
Query: 347 KSKLPHATIFKPQQSYKRCI--AETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
+ + A + K+ + ++ F + P +L L+E LLA DP +R TA AL +F
Sbjct: 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293
Query: 405 TTKPYAC-DPSSLPKYPPTKEMDA-KLRDEEARRL 437
+PS+ P E + +L E+ R L
Sbjct: 294 KGLAKVEREPSAQPITKLEFEFERRRLTKEDVREL 328
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 169 bits (428), Expect = 2e-48
Identities = 111/314 (35%), Positives = 167/314 (53%), Gaps = 38/314 (12%)
Query: 125 KIGQGTYSNVYKAR--DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
K+G+GTY +VYKA+ D + ALK++ + + REI +LR L HPNV+ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA----CREIALLRELKHPNVISL 63
Query: 183 EGLVTSRMSCSLYLVFKYMEHDL--------AGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
+ + S ++L+F Y EHDL A A ++ + VK ++Q+L G+ +
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 235 CHNQHVLHRDIKGSNLLIDNEGI----LTIADFGLASFFDPNHK--QPMTSRVVTLWYRP 288
H VLHRD+K +N+L+ EG + IAD G A F+ K + VVT WYR
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---------VEQLHKIFKLCGS 339
PELLLGA Y +D+W+ GCI AELL +PI R E +QL +IF + G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243
Query: 340 PSEEYWKK-SKLP-HATIFKP--QQSYKRC----IAETFKDFPPS-SLPLIETLLAIDPA 390
P+++ W+ K+P H+T+ K + +Y C E K P S + L++ LL +DP
Sbjct: 244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 303
Query: 391 ERQTATAALRSEFF 404
+R T+ A++ +F
Sbjct: 304 KRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 2e-47
Identities = 109/321 (33%), Positives = 162/321 (50%), Gaps = 26/321 (8%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
P R ++ L +G G Y +V A DT Q VA+KK+ R RE+ +L+
Sbjct: 14 PER---YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKH 70
Query: 174 LDHPNVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLL 229
+ H NV+ L + T S +YLV M DL + K + V+ ++QLL
Sbjct: 71 MKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQLL 128
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPP 289
GL++ H+ ++HRD+K SN+ ++ + L I DFGLA D MT V T WYR P
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD----DEMTGYVATRWYRAP 184
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349
E++L Y VD+WS GCI+AELL K + PG ++QL +I ++ G+PS E KK
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244
Query: 350 LPHATIF------KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
HA + PQQ K + F+ P ++ L+E +L +D +R +A+ AL +
Sbjct: 245 SEHARKYIQSLPHMPQQDLK----KIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300
Query: 404 FTTKPYACDPSSLPKYPPTKE 424
F+ DP P+ P E
Sbjct: 301 FSQYH---DPEDEPEAEPYDE 318
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 4e-47
Identities = 106/329 (32%), Positives = 171/329 (51%), Gaps = 22/329 (6%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA----REILILRRL 174
+ L ++G G Y +V A D TG+ VA+KK+ P A RE+ +L+ +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS----RPFQSEIFAKRAYRELTLLKHM 71
Query: 175 DHPNVVKLEGLVTSRMSC----SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLS 230
H NV+ L + TS +S YLV YM+ DL + P ++ +V+ ++Q+L
Sbjct: 72 QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYLVYQMLC 128
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPE 290
GL++ H+ ++HRD+K NL ++ + L I DFGLA D MT VVT WYR PE
Sbjct: 129 GLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPE 184
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK--S 348
++L Y VD+WS GCI+AE+L K + G+ ++QL +I K+ G P E+ +K
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244
Query: 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408
K + I + ++ + F P ++ L+E +L +D +R TAT AL +F +
Sbjct: 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304
Query: 409 YACDPSSLPKYPPTKEMDAKLRDEEARRL 437
A + + Y + E + KL +E ++
Sbjct: 305 DADEETEQQPYDDSLE-NEKLSVDEWKKH 332
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 7e-47
Identities = 82/285 (28%), Positives = 137/285 (48%), Gaps = 34/285 (11%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
FE L+KIG+G + VYKAR TG+ VA+K ++ + E + EI IL++ HPN+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNI 59
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
VK G + L++V ++ L L S T++Q+ +LL GLE+ H+
Sbjct: 60 VKYYGSYLKKDE--LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDY 298
++HRDIK +N+L+ ++G + + DFGL++ + + + V T ++ PE++ G Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVING-KPY 174
Query: 299 GVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358
D+WS G EL KP ++ L KI + + P
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKI--------------ATNGPPGLRNP 220
Query: 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
++ ++ FKDF ++ L +P +R TA L+ F
Sbjct: 221 EKW-----SDEFKDF-------LKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 164 bits (415), Expect = 8e-47
Identities = 103/293 (35%), Positives = 153/293 (52%), Gaps = 12/293 (4%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDH 176
+ FE L +G+G Y V K R T +IVA+KK + D+ E E V+ RE+ +LR L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK-DSEENEEVKETTLRELKMLRTLKQ 59
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N+V+L+ R LYLVF+Y+E ++ L +V+ Y++QL+ + CH
Sbjct: 60 ENIVELKEAFRRR--GKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
++HRDIK NLLI + +L + DFG A T V T WYR PELLLGA
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS-PSEE---YWKKSKLPH 352
YG VD+WS GCIL EL +P+ PG +E++QL I K+ G P+E+ ++ + H
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF-H 235
Query: 353 ATIFKPQQSYKRCIAETFKDFPPS-SLPLIETLLAIDPAERQTATAALRSEFF 404
F P ++ + + + L L++ LL ++P +R L F
Sbjct: 236 GLRF-PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 4e-46
Identities = 106/330 (32%), Positives = 166/330 (50%), Gaps = 21/330 (6%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA----REILILRR 173
D + L ++G G Y V A D TG VA+KK+ P A RE+ +L+
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLKH 70
Query: 174 LDHPNVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLL 229
+ H NV+ L + T +S YLV +M DL L K ++ +++ ++Q+L
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQML 128
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPP 289
GL++ H ++HRD+K NL ++ + L I DFGLA D MT VVT WYR P
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAP 184
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349
E++L Y VD+WS GCI+AE+L KP+ G ++QL +I K+ G+PS+E+ +K +
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244
Query: 350 LPHAT--IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407
A + K + K+ + P ++ ++E +L +D R TA AL +F
Sbjct: 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304
Query: 408 PYACDPSSLPKYPPTKEMDAKLRDEEARRL 437
D + P Y + + + EE +RL
Sbjct: 305 HDPEDETEAPPYDDSFD-EVDQSLEEWKRL 333
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 162 bits (410), Expect = 8e-46
Identities = 109/316 (34%), Positives = 164/316 (51%), Gaps = 42/316 (13%)
Query: 125 KIGQGTYSNVYKAR--DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
K+G+GTY +VYKA+ D + ALK++ + + REI +LR L HPNV+ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA----CREIALLRELKHPNVIAL 63
Query: 183 EGLVTSRMSCSLYLVFKYMEHDL--------AGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
+ + S ++L+F Y EHDL A A ++ ++ VK ++Q+L G+ +
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 235 CHNQHVLHRDIKGSNLLIDNEGI----LTIADFGLASFFDPNHK--QPMTSRVVTLWYRP 288
H VLHRD+K +N+L+ EG + IAD G A F+ K + VVT WYR
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---------VEQLHKIFKLCGS 339
PELLLGA Y +D+W+ GCI AELL +PI R E +QL +IF + G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243
Query: 340 PSEEYWKK-SKLPHATIFKPQQSYKRCI---------AETFKDFPPSSL-PLIETLLAID 388
P+++ W+ K+P Q+ ++R E K P S + L++ LL +D
Sbjct: 244 PADKDWEDIRKMPEYPTL--QKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMD 301
Query: 389 PAERQTATAALRSEFF 404
P +R T+ AL+ +F
Sbjct: 302 PTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 164 bits (414), Expect = 8e-46
Identities = 88/339 (25%), Positives = 137/339 (40%), Gaps = 40/339 (11%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFD-NLEPESVRFMAREILILRRLDHP- 177
+ L K+G+G++ VY ARD ++VALK + + + V REI IL L+HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYME-HDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEH 234
N+VKL SLYLV +Y++ L L ++++ + Q+LS LE+
Sbjct: 59 NIVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 235 CHNQHVLHRDIKGSNLLID-NEGILTIADFGLASFFDPN-----HKQPMTSRVVTLWYRP 288
H++ ++HRDIK N+L+D + ++ + DFGLA ++ V T Y
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 289 PELLLGATD--YGVGVDLWSAGCILAELLAEKPIMPGRTE---VEQLHKIFKLCGSPSEE 343
PE+LLG + D+WS G L ELL P G Q KI +PS
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
P ++ L++ LLA DP R ++++ L +
Sbjct: 237 SPLSPSNPE-------------------LISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277
Query: 404 FTTKPYACDPSSLPKYPPTKEMDAKLRDEEARRLRAAGK 442
S P L ++
Sbjct: 278 LAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLN 316
|
Length = 384 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 162 bits (410), Expect = 2e-45
Identities = 106/310 (34%), Positives = 153/310 (49%), Gaps = 15/310 (4%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ ++ L +G G Y +V A DT TG VA+KK+ + RE+ +L+ + H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 178 NVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
NV+ L + T S +YLV M DL + K T V+ ++Q+L GL+
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLK 134
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ H+ ++HRD+K SNL ++ + L I DFGLA D MT V T WYR PE++L
Sbjct: 135 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIML 190
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK--SKLP 351
Y VD+WS GCI+AELL + + PG ++QL I +L G+P E KK S+
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 250
Query: 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYAC 411
I Q K A F P ++ L+E +L +D +R TA AL +F
Sbjct: 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH--- 307
Query: 412 DPSSLPKYPP 421
DP P P
Sbjct: 308 DPDDEPVADP 317
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-45
Identities = 77/294 (26%), Positives = 127/294 (43%), Gaps = 46/294 (15%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+E + +IG+G++ VY R G++ LK++ N+ + E+ IL++L+HPN+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 180 VKL-EGLVTSRMSCSLYLVFKYMEH----DLAGL---AASPTIKFTQAQVKCYMHQLLSG 231
+K E L +V ME+ DL+ F + Q+ + QL
Sbjct: 62 IKYYESFEE---KGKLCIV---MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPE 290
L++ H++ +LHRDIK N+ + + G++ + DFG++ + + VV T +Y PE
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL--SSTVDLAKTVVGTPYYLSPE 173
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
L Y D+WS GC+L EL K G +E KI K + +
Sbjct: 174 LCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG---------QYPPI 223
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
P Y + L+ +LL DP ER + L+S F
Sbjct: 224 P--------SQYSSELRN-----------LVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 4e-45
Identities = 95/284 (33%), Positives = 150/284 (52%), Gaps = 13/284 (4%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLDHPNVVK-L 182
IG G + V+ D G+ VALKK+ F NL S + + RE+ +L H NV+ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV--SCKRVFRELKMLCFFKHDNVLSAL 65
Query: 183 EGLVTSRMSC--SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
+ L + +Y+V + M+ DL + SP + VK +++Q+L GL++ H+ +
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAGI 124
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGV 300
LHRDIK NLL+++ +L I DFGLA +P+ + MT VVT +YR PE+L+G+ Y
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTS 184
Query: 301 GVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS-EEYWKKSKLPHATIFKPQ 359
VD+WS GCI AELL + + ++ ++QL I L G+PS E + A I +
Sbjct: 185 AVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGP 244
Query: 360 QSYKRCIAETFKDFPPSS---LPLIETLLAIDPAERQTATAALR 400
+ + ++ + L+ +L DP +R +A AL
Sbjct: 245 HKPP-SLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 4e-45
Identities = 69/199 (34%), Positives = 117/199 (58%), Gaps = 10/199 (5%)
Query: 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLE 183
D IG+G + VYK + TG VA+K++ + ++ E+++ + +EI +L+ L HPN+VK
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 184 GLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLH 242
G + + S SLY++ +Y E+ L + F ++ V Y++Q+L GL + H Q V+H
Sbjct: 66 GSIET--SDSLYIILEYAENGSLRQII-KKFGPFPESLVAVYVYQVLQGLAYLHEQGVIH 122
Query: 243 RDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL--GATDYGV 300
RDIK +N+L +G++ +ADFG+A+ + K + V T ++ PE++ GA+
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-VGTPYWMAPEVIEMSGAS---T 178
Query: 301 GVDLWSAGCILAELLAEKP 319
D+WS GC + ELL P
Sbjct: 179 ASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 4e-40
Identities = 87/307 (28%), Positives = 137/307 (44%), Gaps = 43/307 (14%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
+ ++ L+KIG+G VYKA D TG+ VA+KK+R E + EILI++
Sbjct: 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCK 73
Query: 176 HPNVVKLEG--LVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
HPN+V LV L++V +YM+ L + ++ + Q+ ++L GL
Sbjct: 74 HPNIVDYYDSYLV---GDE-LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL 292
E+ H+Q+V+HRDIK N+L+ +G + +ADFG A+ + S V T ++ PE++
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK-RNSVVGTPYWMAPEVI 188
Query: 293 LGATDYGVGVDLWSAGCILAELL-AEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
DYG VD+WS G + E+ E P + L +F + +K
Sbjct: 189 KR-KDYGPKVDIWSLGIMCIEMAEGEPPYL----REPPLRALFLI----------TTKGI 233
Query: 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYAC 411
P + FKDF + L DP +R +A L+ F AC
Sbjct: 234 ------PPLKNPEKWSPEFKDF-------LNKCLVKDPEKRPSAEELLQHPFLKK---AC 277
Query: 412 DPSSLPK 418
Sbjct: 278 PKEEFAP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-40
Identities = 90/289 (31%), Positives = 132/289 (45%), Gaps = 38/289 (13%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
E++ +GQG+ VYK R TG+I ALKK+ D + E + + RE+ LR + P V
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG-DEEFRKQLLRELKTLRSCESPYV 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
VK G + +V +YM+ LA L K + + Q+L GL++ H +
Sbjct: 62 VKCYGAFYK--EGEISIVLEYMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 239 -HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
H++HRDIK SNLLI+++G + IADFG++ + Q T V T+ Y PE + G +
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQGES- 176
Query: 298 YGVGVDLWSAGCILAEL-LAEKPIMPGRTE--VEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
Y D+WS G L E L + P +P E + I C P LP
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---CDGPPPS------LPA-- 225
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
+ F+DF I L DP +R +A L+ F
Sbjct: 226 ---------EEFSPEFRDF-------ISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 90/318 (28%), Positives = 138/318 (43%), Gaps = 69/318 (21%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV--RFDNLEPESVRFMAREILILRRLD 175
D F+ IG+G++S V A++ T + A+K + R E + V+++ E +L RL+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-KKVKYVKIEKEVLTRLN 59
Query: 176 -HPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIK----FTQAQVKCYMHQLL 229
HP ++KL T + +LY V +Y + +L I+ + + Y ++L
Sbjct: 60 GHPGIIKLYY--TFQDEENLYFVLEYAPNGELLQY-----IRKYGSLDEKCTRFYAAEIL 112
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK--------------- 274
LE+ H++ ++HRD+K N+L+D + + I DFG A DPN
Sbjct: 113 LALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 275 QPMTSR----VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQL 330
+ R V T Y PELL G DLW+ GCI+ ++L KP G E
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF 231
Query: 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPA 390
KI KL EY P +FPP + LIE LL +DP
Sbjct: 232 QKILKL------EY----SFPP-------------------NFPPDAKDLIEKLLVLDPQ 262
Query: 391 ERQTA---TAALRS-EFF 404
+R L++ FF
Sbjct: 263 DRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 94/309 (30%), Positives = 158/309 (51%), Gaps = 38/309 (12%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLDHP 177
++ L IG G V A DT+TGQ VA+KK+ F N + RE+++++ ++H
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN--VTHAKRAYRELVLMKLVNHK 75
Query: 178 NVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
N++ L + T + S +YLV + M+ +L + + ++ ++Q+L G++
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---QMDLDHERMSYLLYQMLCGIK 132
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-----SFFDPNHKQPMTSRVVTLWYRP 288
H H+ ++HRD+K SN+++ ++ L I DFGLA SF MT VVT +YR
Sbjct: 133 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-------MTPYVVTRYYRA 185
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348
PE++LG Y VD+WS GCI+ E++ + PG ++Q +KI + G+PS+E+ +
Sbjct: 186 PEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244
Query: 349 KLPHATIFKPQQSYK-RCIAETFKD--FPPSS-----------LPLIETLLAIDPAERQT 394
+ + + Y E F D FPP S L+ +L IDP +R +
Sbjct: 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS 304
Query: 395 ATAALRSEF 403
AL+ +
Sbjct: 305 VDDALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 74/275 (26%), Positives = 121/275 (44%), Gaps = 48/275 (17%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDHPNVVKLEG 184
+G+G++ V R TG++ A+K ++ ++ + V E IL R++HP +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 185 LVTSRMSCS------LYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
+ LYLV +Y +L S +F++ + + Y +++ LE+ H+
Sbjct: 59 ------HYAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARFYAAEIVLALEYLHS 111
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
+++RD+K N+L+D +G + + DFGLA + + T Y PE+LLG
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKEL-SSEGSRTNTFCGTPEYLAPEVLLGK-G 169
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357
YG VD WS G +L E+L KP E KI K L
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI------------LKDPL------- 210
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
+ ++ +D LI LL DP +R
Sbjct: 211 ---RFPEFLSPEARD-------LISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 84/293 (28%), Positives = 139/293 (47%), Gaps = 58/293 (19%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDN---LEPESVRFMAREILILRRLDHPNVVKL 182
+G G++ +VY+ + G A+K+V + E+V+ + +EI +L +L HPN+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQLLSGLEHCHNQH 239
G T R +LY+ ++E G A K F + ++ Y Q+L GLE+ H+++
Sbjct: 68 LG--TEREEDNLYI---FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN 122
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT-----SRVVTLWYRPPELLLG 294
+HRDIKG+N+L+D G++ +ADFG+A KQ + S + ++ PE++
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMA-------KQVVEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
YG+ D+WS GC + E+ KP +++E + +FK+ S LP
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKE--------LPP-- 222
Query: 355 IFKPQQSYKRCIAETF----KDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
I + KDF I L DP+ R TA L F
Sbjct: 223 -----------IPDHLSDEAKDF-------ILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 101/332 (30%), Positives = 166/332 (50%), Gaps = 29/332 (8%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+++L IG G V A DT+ G VA+KK+ + RE+++L+ ++H N+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 180 VKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
+ L + T + S +YLV + M+ A L ++ ++ ++Q+L G++H
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMD---ANLCQVIHMELDHERMSYLLYQMLCGIKHL 139
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H+ ++HRD+K SN+++ ++ L I DFGLA N MT VVT +YR PE++LG
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVVTRYYRAPEVILG- 196
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK--SKLPHA 353
Y VD+WS GCI+ EL+ I G ++Q +K+ + G+PS E+ + + +
Sbjct: 197 MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256
Query: 354 TIFKPQQSYKRCIAETFKD--FPPSS----------LPLIETLLAIDPAERQTATAALRS 401
+PQ E F D FP S L+ +L IDP +R + ALR
Sbjct: 257 VENRPQY-PGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315
Query: 402 EFFTTKPYACDPSSLPKYPPTKEMDAKLRDEE 433
+ T DP+ + PP + DA+L + E
Sbjct: 316 PYITV---WYDPAE-AEAPPPQIYDAQLEERE 343
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 3e-36
Identities = 97/334 (29%), Positives = 169/334 (50%), Gaps = 33/334 (9%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
++ L IG G V A D + + VA+KK+ + RE+++++ ++H N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 180 VKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
+ L + T + S +YLV + M+ A L ++ ++ ++Q+L G++H
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMD---ANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H+ ++HRD+K SN+++ ++ L I DFGLA + MT VVT +YR PE++LG
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG- 192
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355
Y VD+WS GCI+ E++ K + PGR ++Q +K+ + G+P E+ KK + T+
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ---PTV 249
Query: 356 FKPQQSYKRCIAETF-KDFPPSSLP---------------LIETLLAIDPAERQTATAAL 399
++ + TF K FP S P L+ +L IDPA+R + AL
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309
Query: 400 RSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEE 433
+ + DP+ + + PP + D +L + E
Sbjct: 310 QHPYINV---WYDPAEV-EAPPPQIYDKQLDERE 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 5e-36
Identities = 83/297 (27%), Positives = 142/297 (47%), Gaps = 50/297 (16%)
Query: 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
++ +KIG GT+ VY A + TG+++A+K++R + +P++++ +A E+ +L L HPN+V
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 181 KLEGLVTSRMSCSLYLVFKYMEH----DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
K G+ R V+ +ME+ L L I + ++ Y QLL GL + H
Sbjct: 63 KYYGVEVHREK-----VYIFMEYCSGGTLEELLEHGRIL-DEHVIRVYTLQLLEGLAYLH 116
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL----WYRPPELL 292
+ ++HRDIK +N+ +D+ G++ + DFG A N+ M V +L Y PE++
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK-NNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 293 LGATDYGVG--VDLWSAGCILAELLAEKPIMPGRT---EVEQLHKI-FKLCGSPSEEYWK 346
G G G D+WS GC++ E+ G+ E++ +I F +
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEM------ATGKRPWSELDNEFQIMFHVGAGH------ 223
Query: 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
KP ++ KDF ++ L DP +R TA+ L+ F
Sbjct: 224 ----------KPPIPDSLQLSPEGKDF-------LDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 7e-36
Identities = 102/309 (33%), Positives = 150/309 (48%), Gaps = 30/309 (9%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGL 185
IG G++ VY+A T + VA+KKV D P+ + RE+LI++ L+H N++ L+
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQD---PQ---YKNRELLIMKNLNHINIIFLKDY 127
Query: 186 VTSR--------------MSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
+ M V KYM+H A P VK Y +QL
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF-----LVKLYSYQLCRA 182
Query: 232 LEHCHNQHVLHRDIKGSNLLID-NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPE 290
L + H++ + HRD+K NLLID N L + DFG A + S + + +YR PE
Sbjct: 183 LAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS--VSYICSRFYRAPE 240
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
L+LGAT+Y +DLWS GCI+AE++ PI G++ V+QL +I ++ G+P+E+ K+
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP 300
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410
+A I P K K P ++ I L +P +R AL FF
Sbjct: 301 NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360
Query: 411 CDPSSLPKY 419
C LPKY
Sbjct: 361 C--IKLPKY 367
|
Length = 440 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 3e-34
Identities = 95/336 (28%), Positives = 164/336 (48%), Gaps = 37/336 (11%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
++ L IG G V A D + + VA+KK+ + RE+++++ ++H N+
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 180 VKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
+ L + T + S +Y+V + M+ A L ++ ++ ++Q+L G++H
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMD---ANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLA-----SFFDPNHKQPMTSRVVTLWYRPPE 290
H+ ++HRD+K SN+++ ++ L I DFGLA SF MT VVT +YR PE
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-------MTPYVVTRYYRAPE 195
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
++LG Y VD+WS GCI+ E++ + PG ++Q +K+ + G+P E+ KK +
Sbjct: 196 VILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 351 PHATIFKPQQSYK-RCIAETFKD--FPPSS----------LPLIETLLAIDPAERQTATA 397
T + + Y + F D FP S L+ +L ID ++R +
Sbjct: 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314
Query: 398 ALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEE 433
AL+ + DPS + PP K D +L + E
Sbjct: 315 ALQHPYINV---WYDPSE-AEAPPPKIPDKQLDERE 346
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 70/223 (31%), Positives = 111/223 (49%), Gaps = 11/223 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+E L+ IG+G++ V K R G+I+ K++ + N+ + + + E+ ILR L HPN+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAGL---AASPTIKFTQAQVKCYMHQLLSGLEHC 235
V+ + R + +LY+V +Y E DLA L + + + QLL L C
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 236 HN-----QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPE 290
HN VLHRD+K +N+ +D + + DFGLA + + V T +Y PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG-HDSSFAKTYVGTPYYMSPE 180
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
L + Y D+WS GC++ EL A P R +++ KI
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 86/288 (29%), Positives = 140/288 (48%), Gaps = 35/288 (12%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKV--------RFDNLEPESVRFMAREILILRRLDHP 177
IG+GTY VY A + TG+++A+K+V R D+ + + V+ + EI L+ LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
N+V+ G T+ S++L +Y+ G +F + V+ + Q+L GL + H+
Sbjct: 69 NIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP--NHKQPMTSRVVTLWYRPPELLLGA 295
+ +LHRD+K NLL+D +GI I+DFG++ D ++ Q M+ + W P + +
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355
Y VD+WS GC++ E+ A + P E E + +FKL G+ K+S P
Sbjct: 187 QGYSAKVDIWSLGCVVLEMFAGR--RPWSDE-EAIAAMFKL-GN------KRSAPPIPPD 236
Query: 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
S P +L + I+P R TA L+ F
Sbjct: 237 VSMNLS-------------PVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 74/212 (34%), Positives = 113/212 (53%), Gaps = 25/212 (11%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDH 176
F+ KIG+G +S VYKA L G++VALKKV+ F+ ++ ++ + +EI +L++LDH
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 177 PNVVK-LEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKC--------YMH 226
PNV+K L + + L +V + + DL S IK + Q + Y
Sbjct: 62 PNVIKYLASFIENNE---LNIVLELADAGDL-----SRMIKHFKKQKRLIPERTIWKYFV 113
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT--SRVVTL 284
QL S LEH H++ ++HRDIK +N+ I G++ + D GL FF + S V T
Sbjct: 114 QLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS---SKTTAAHSLVGTP 170
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
+Y PE + Y D+WS GC+L E+ A
Sbjct: 171 YYMSPERIHE-NGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 79/304 (25%), Positives = 129/304 (42%), Gaps = 48/304 (15%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
F L+ IG+G++ VYKA D T Q+VA+K + + E E + + +EI L + P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQLLSGLEHCH 236
K G L+++ ME+ G + +K + + + ++L GLE+ H
Sbjct: 62 TKYYGSFLKG--SKLWII---MEY-CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH 115
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR---VVTLWYRPPELLL 293
+ +HRDIK +N+L+ EG + +ADFG++ M+ R V T ++ PE++
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVSG----QLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
+ Y D+WS G EL +P + + L I K
Sbjct: 172 Q-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN----------------- 213
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDP 413
P ++ FKDF + L DP ER +A L+ +F A
Sbjct: 214 ---NPPSLEGNKFSKPFKDF-------VSLCLNKDPKERPSAKELLKHKFIKK---AKKT 260
Query: 414 SSLP 417
S L
Sbjct: 261 SYLT 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 8e-31
Identities = 78/266 (29%), Positives = 122/266 (45%), Gaps = 22/266 (8%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKK-VRFDNLEPESVRFMAREILILRRLDHPN 178
FE L IG+G + V + T ++ A+K + +E SVR + E IL+ L+HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAG---LAASPTIKFTQAQVKCYMHQLLSGLEHC 235
+V L + + ++YLV + L G S +KF++ QVK ++ +++ LE+
Sbjct: 62 LVNLW--YSFQDEENMYLVVDLL---LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYL 116
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H++ ++HRDIK N+L+D +G + I DF +A+ P+ TS T Y PE+L
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEVLCRQ 174
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPG--RTEVEQLHKIFKLCGSPSEEYWKK---SKL 350
Y V VD WS G E L K G RT +Q+ + W +
Sbjct: 175 -GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAI 233
Query: 351 PHATIFKPQQSYKR--CIAETFKDFP 374
PQ KR + K+ P
Sbjct: 234 NKLLERDPQ---KRLGDNLKDLKNHP 256
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 78/258 (30%), Positives = 124/258 (48%), Gaps = 24/258 (9%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES---VRFMAREILILRRLDHPNVVKL 182
+GQG + VY D TG+ +A+K+V FD PE+ V + EI +L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK----FTQAQVKCYMHQLLSGLEHCHNQ 238
G + + S++ ME+ + G + +K T+ + Y Q+L G+E+ H+
Sbjct: 70 YGCLRDDETLSIF-----MEY-MPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPELLLGAT 296
++HRDIKG+N+L D+ G + + DFG + + V T ++ PE++ G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
YG D+WS GC + E+L EKP E E + IFK+ P+ P A F
Sbjct: 184 -YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239
Query: 357 KPQQSYKRCIAETFKDFP 374
+R E K P
Sbjct: 240 -----LRRTFVENAKKRP 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 73/239 (30%), Positives = 122/239 (51%), Gaps = 38/239 (15%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRF----DNLEPESVRFMAREILILRRLDHPNVVK 181
+G G +S+ Y+ARD TG ++A+K+V + + + E V + +EI ++ RL+HP++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 182 LEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK----FTQAQVKCYMHQLLSGLEHCHN 237
+ G +L++ + +AG + S + F +A + Y QLL GL + H
Sbjct: 68 MLGATCEDSHFNLFVEW------MAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 238 QHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNHKQPMTSRVV-----------TLW 285
++HRD+KG+NLLID+ G L IADFG A+ + ++ T+
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAA--------RLAAKGTGAGEFQGQLLGTIA 173
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLC---GSPS 341
+ PE+L G YG D+WS GC++ E+ KP L IFK+ +PS
Sbjct: 174 FMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 85/293 (29%), Positives = 143/293 (48%), Gaps = 45/293 (15%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ F+ L+K+G+G+Y +VYKA TGQ+VA+K V + E ++ + +EI IL++ D P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSP 58
Query: 178 NVVKLEGLVTSRMSCS-LYLVFKYMEHDLAG----LAASPTIKFTQAQVKCYMHQLLSGL 232
+VK G S + L++V ME+ AG + T+ ++ ++Q L GL
Sbjct: 59 YIVKYYG---SYFKNTDLWIV---MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGL 112
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS-FFDPNHKQPMTSRVVTLWYRPPEL 291
E+ H+ +HRDIK N+L++ EG +ADFG++ D K+ + + T ++ PE+
Sbjct: 113 EYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR--NTVIGTPFWMAPEV 170
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
+ Y D+WS G I A +AE P +++ + IF + P
Sbjct: 171 IQE-IGYNNKADIWSLG-ITAIEMAEG--KPPYSDIHPMRAIFMIPNKPPP--------- 217
Query: 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
T+ P++ + F DF ++ L DP ER +A L+ F
Sbjct: 218 --TLSDPEK-----WSPEFNDF-------VKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 79/286 (27%), Positives = 118/286 (41%), Gaps = 60/286 (20%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVR---FMAREILILRRLDHPNVVKL 182
I +G Y V+ A+ TG I A+K ++ ++ ++ R+IL + P VVKL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILS--QAQSPYVVKL 58
Query: 183 -EGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
+ +LYLV +Y+ DLA L + + + Y+ +++ LE+ H+ +
Sbjct: 59 YYSFQGKK---NLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLHSNGI 114
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM-------TSRVV-TLWYRPPELL 292
+HRD+K N+LID+ G L + DFGL S +Q R+V T Y PE++
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGL-SKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 293 LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI------FKLCGSPSEEYWK 346
LG + VD WS GCIL E L P G T E I + S+E
Sbjct: 174 LG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAID 232
Query: 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
LI LL DP +R
Sbjct: 233 ---------------------------------LISKLLVPDPEKR 245
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 80/301 (26%), Positives = 132/301 (43%), Gaps = 56/301 (18%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ +E + +IG GTY +VYKARD TG++VA+K ++ + + + +EI +L+ HP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHP 60
Query: 178 NVVKLEGLVTSR------MSC----SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQ 227
N+V G R M SL +++ L ++ Q+ +
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPL-----------SELQIAYVCRE 109
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
L GL + H +HRDIKG+N+L+ +G + +ADFG+++ S + T ++
Sbjct: 110 TLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT-ATIAKRKSFIGTPYWM 168
Query: 288 PPELLL--GATDYGVGVDLWSAG--CI-LAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342
PE+ Y D+W+ G I LAEL P ++ + +F + S+
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIELAELQ------PPMFDLHPMRALFLI----SK 218
Query: 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
+ KL + P F DF I+ L DP +R TAT L+
Sbjct: 219 SNFPPPKLKDKEKWSPV----------FHDF-------IKKCLTKDPKKRPTATKLLQHP 261
Query: 403 F 403
F
Sbjct: 262 F 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 81/294 (27%), Positives = 140/294 (47%), Gaps = 51/294 (17%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES-------VRFMAREILILRRLDHPN 178
IG G++ +VY + +G+++A+K+V ++ S + +AREI +L+ L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQLLSGLEHC 235
+V+ G S + + +L ++E+ G A+ F + V+ ++ Q+L GL +
Sbjct: 68 IVQYLG---SSLD-ADHLNI-FLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYL 122
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN------HKQPMTSRVVTLWYRPP 289
HN+ ++HRDIKG+N+L+DN+G + I+DFG++ + N + + + W P
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349
++ T Y D+WS GC++ E+L K P + QL IFK+ + S E
Sbjct: 183 --VVKQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKIGENASPEI----- 232
Query: 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
P I+ DF +E ID +R TA L+ F
Sbjct: 233 --------PSN-----ISSEAIDF-------LEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 112 bits (284), Expect = 2e-28
Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 19/227 (8%)
Query: 120 FEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
E K+G+G + VYK T VA+K ++ E E F+ E I+++L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFL-EEASIMKKLS 59
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
HPN+V+L G+ T LY+V +YM DL K T + Q+ G+E+
Sbjct: 60 HPNIVRLLGVCTQGEP--LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL----WYRPPE 290
+++ +HRD+ N L+ ++ I+DFGL+ D R W PE
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWM-APE 174
Query: 291 LLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKIFK 335
L + D+WS G +L E+ L E+P PG + E L +
Sbjct: 175 SLKDGK-FTSKSDVWSFGVLLWEIFTLGEQPY-PGMSNEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 77/301 (25%), Positives = 126/301 (41%), Gaps = 48/301 (15%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE--PESVRFMAREILILRRLD 175
D +E ++ IG G + VY A + VA+K++ +LE SV + +E+ + + +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCN 57
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYME----HDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
HPNVVK L+LV Y+ D+ ++ P +A + + ++L G
Sbjct: 58 HPNVVKYYTSFVVGDE--LWLVMPYLSGGSLLDIMK-SSYPRGGLDEAIIATVLKEVLKG 114
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGL-ASFFDPNHKQPMTSRVV--TLWYRP 288
LE+ H+ +HRDIK N+L+ +G + IADFG+ AS D + + T +
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK- 347
PE++ Y D+WS G EL P K P +
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAA--PY-------SKYP-----PMKVLMLTL 220
Query: 348 ----SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
L YK+ +++F+ I L DP++R TA L+ +F
Sbjct: 221 QNDPPSLETGA------DYKKY-SKSFRKM-------ISLCLQKDPSKRPTAEELLKHKF 266
Query: 404 F 404
F
Sbjct: 267 F 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 69/236 (29%), Positives = 108/236 (45%), Gaps = 29/236 (12%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-D 175
FE ++ IG+GTY VYKAR TGQ+VA+K + E E ++ E ILR+ +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIK---EEYNILRKYSN 61
Query: 176 HPNVVKLEGLVTSRMSCS----LYLVFKYMEH----DLAGLAASPTIKFTQAQVKCYMHQ 227
HPN+ G + L+LV + DL + + + + +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD-PNHKQPMTSRVVTLWY 286
L GL + H V+HRDIKG N+L+ + + DFG+++ D ++ + + T ++
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR--NTFIGTPYW 179
Query: 287 RPPELLLG----ATDYGVGVDLWSAGCILAELLAE-KP----IMPGRTEVEQLHKI 333
PE++ Y D+WS G I A LA+ KP + P R L KI
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLG-ITAIELADGKPPLCDMHPMRA----LFKI 230
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 121 EKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
K+G+G + VYK + VA+K ++ D E + F+ RE I+R+LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
PNVVKL G+ T LY+V +YME DL K + + + + Q+ G+E+
Sbjct: 61 PNVVKLLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL-WYRPPELLLG 294
+++ +HRD+ N L+ ++ I+DFGL+ + + + W PE L
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APESLKE 177
Query: 295 ATDYGVGVDLWSAGCILAEL--LAEKP 319
+ D+WS G +L E+ L E+P
Sbjct: 178 GK-FTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 89/299 (29%), Positives = 127/299 (42%), Gaps = 68/299 (22%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGL 185
+G+GTY VY ARD T +A+K++ + V+ + EI + L H N+V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLG- 72
Query: 186 VTSRMSCSLYLVFK-YMEH----DLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQ 238
S S FK +ME L+ L S +K + + Y Q+L GL++ H+
Sbjct: 73 -----SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127
Query: 239 HVLHRDIKGSNLLIDN-EGILTIADFG----LASFFDPNHKQPMTSRVV-TLWYRPPELL 292
++HRDIKG N+L++ G++ I+DFG LA P T TL Y PE++
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI------NPCTETFTGTLQYMAPEVI 181
Query: 293 -LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
G YG D+WS GC + E+ KP P F G P
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKP--P-----------FIELGE-----------P 217
Query: 352 HATIFKPQQSYKRCIAETFKDFP--PSSLPL-----IETLLAIDPAERQTATAALRSEF 403
A +FK FK P P SL I DP +R +A L+ F
Sbjct: 218 QAAMFK---------VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 121 EKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
K+G+G + VYK VA+K ++ D E + F+ RE I+R+LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLSGLEH 234
PN+VKL G+ T L +V +YM DL L + + + + + + Q+ G+E+
Sbjct: 61 PNIVKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL-WYRPPELLL 293
+++ +HRD+ N L+ ++ I+DFGL+ + + + + W PE L
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APESLK 177
Query: 294 GATDYGVGVDLWSAGCILAEL--LAEKP 319
+ D+WS G +L E+ L E+P
Sbjct: 178 EGK-FTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 94/315 (29%), Positives = 130/315 (41%), Gaps = 80/315 (25%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDH 176
D FE + IG+G + V+ RD TGQ+ A+K +R D ++ + + E IL D
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 177 PNVVKLEGLVTSRMSCS------LYLVFKYMEH-DLAGLAASPTIK---FTQAQVKCYMH 226
P +VKL S LYLV +YM DL L I+ F + + Y+
Sbjct: 61 PWIVKLY--------YSFQDEEHLYLVMEYMPGGDLMNL----LIRKDVFPEETARFYIA 108
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD---------------- 270
+L+ L+ H +HRDIK N+LID +G + +ADFGL +
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 271 ---------PNHKQPMT---SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEK 318
+HKQ S V T Y PE+L G T YG+ D WS G IL E+L
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGF 227
Query: 319 PIMPGRTEVEQLHKIFKLCGSPSEEYWKKS-KLPHATIFKPQQSYKRCIAETFKDFPPSS 377
P T E +KI WK+S + P P +
Sbjct: 228 PPFYSDTLQETYNKIIN---------WKESLRFPPD-----------------PPVSPEA 261
Query: 378 LPLIETLLAIDPAER 392
+ LI LL DP +R
Sbjct: 262 IDLICRLLC-DPEDR 275
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 69/221 (31%), Positives = 111/221 (50%), Gaps = 9/221 (4%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES---VRFMAREILILRRLDHPNVVKL 182
+GQG + VY D TG+ +A K+V+FD PE+ V + EI +L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLH 242
G + R +L + +YM T++ + Y Q+L G+ + H+ ++H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 243 RDIKGSNLLIDNEGILTIADFGLASFFDP--NHKQPMTSRVVTLWYRPPELLLGATDYGV 300
RDIKG+N+L D+ G + + DFG + + S T ++ PE++ G YG
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGR 188
Query: 301 GVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS 341
D+WS GC + E+L EKP E E + IFK+ P+
Sbjct: 189 KADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPT 226
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 8e-26
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 124 DKIGQGTYSNVYKAR---DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
K+G+G + VYK + VA+K ++ D E E F+ +E ++++L HPNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFL-KEARVMKKLGHPNVV 59
Query: 181 KLEGLVTSRMSCSLYLVFKYMEH-DL-------AGLAASPTIK-FTQAQVKCYMHQLLSG 231
+L G+ T LYLV +YME DL + SP + + + Q+ G
Sbjct: 60 RLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF-FDPNHKQPMTSRVVTL-WYRPP 289
+E+ ++ +HRD+ N L+ + ++ I+DFGL+ +D ++ + T + + W P
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-AP 176
Query: 290 ELLLGATDYGVGVDLWSAGCILAEL--LAEKP 319
E L + D+WS G +L E+ L P
Sbjct: 177 ESLKDGI-FTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-25
Identities = 76/226 (33%), Positives = 112/226 (49%), Gaps = 18/226 (7%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDHPNVVKLE 183
KIG+G +S VY+A L G VALKKV+ FD ++ ++ +EI +L++L+HPNV+K
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 184 GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKC--------YMHQLLSGLEHC 235
++ L D L S IK + Q + Y QL S LEH
Sbjct: 69 ASFIEDNELNIVLELA----DAGDL--SRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H++ V+HRDIK +N+ I G++ + D GL FF + S V T +Y PE +
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE-RIHE 180
Query: 296 TDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSP 340
Y D+WS GC+L E+ A + P + + L K + C P
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 226
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 69/221 (31%), Positives = 111/221 (50%), Gaps = 9/221 (4%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES---VRFMAREILILRRLDHPNVVKL 182
+GQG + VY D TG+ +A+K+V+FD PE+ V + EI +L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLH 242
G + M +L + ++M T+ + Y Q+L G+ + H+ ++H
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVH 129
Query: 243 RDIKGSNLLIDNEGILTIADFGLASFFDPN--HKQPMTSRVVTLWYRPPELLLGATDYGV 300
RDIKG+N+L D+ G + + DFG + M S T ++ PE++ G YG
Sbjct: 130 RDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGR 188
Query: 301 GVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS 341
D+WS GC + E+L EKP E E + IFK+ P+
Sbjct: 189 KADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPT 226
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREILILRRLDHPN 178
F L +IG G++ VY ARD T ++VA+KK+ + + E + + +E+ L++L HPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
++ +G + +LV +Y + + + ++ H L GL + H+
Sbjct: 77 TIEYKGCYLREHTA--WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD- 297
+HRDIK N+L+ G + +ADFG AS P + S V T ++ PE++L A D
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-----SFVGTPYWMAPEVIL-AMDE 188
Query: 298 --YGVGVDLWSAGCILAELLAEKP 319
Y VD+WS G EL KP
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 9e-25
Identities = 77/254 (30%), Positives = 124/254 (48%), Gaps = 43/254 (16%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDHPN 178
F+ KIG+G +S VY+A L + VALKKV+ F+ ++ ++ + +EI +L++L+HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 179 VVK-LEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKC--------YMHQL 228
V+K L+ + L +V + + DL S IK+ + Q + Y QL
Sbjct: 64 VIKYLDSFIEDN---ELNIVLELADAGDL-----SQMIKYFKKQKRLIPERTVWKYFVQL 115
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRP 288
S +EH H++ V+HRDIK +N+ I G++ + D GL FF + S V T +Y
Sbjct: 116 CSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMS 174
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLA----------------------EKPIMPGRTE 326
PE + Y D+WS GC+L E+ A + P +P
Sbjct: 175 PE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHY 233
Query: 327 VEQLHKIFKLCGSP 340
E+L ++ +C P
Sbjct: 234 SEKLRELVSMCIYP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 12/219 (5%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
F+ L K+G+G+Y +VYK + Q ALK+V ++ + EI IL ++HPN+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIK---FTQAQVKCYMHQLLSGLEHC 235
+ + L +V +Y DL+ + K + ++ QLL GL+
Sbjct: 62 ISYKE--AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLLG 294
H Q +LHRD+K +N+L+ ++ I D G++ K+ M + T Y PE+ G
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVWKG 175
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
Y D+WS GC+L E+ P R+ + +K+
Sbjct: 176 -RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 122 KLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ ++G+G + V R TG+ VA+K + E + REI ILR LDH
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG-EEQHRSDFEREIEILRTLDHE 66
Query: 178 NVVKLEGLVTSRMSCSLYLVFKY-----MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
N+VK +G+ SL L+ +Y + L + ++ + Q+ G+
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGM 122
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-----KQPMTSRVVTLWYR 287
++ +Q +HRD+ N+L+++E ++ I+DFGLA + K+P S + WY
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FWY- 179
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELL 315
PE L + D+WS G L EL
Sbjct: 180 APECLRTSKFSSAS-DVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 80/297 (26%), Positives = 135/297 (45%), Gaps = 44/297 (14%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVR-FMAREILILRRLDHPN 178
+ + +KIGQG VY A D TGQ VA+K++ NL+ + + + EIL++R HPN
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVMRENKHPN 77
Query: 179 VVKLEGLVTSRMSC-SLYLVFKYMEHDLAGLAASPTIKFTQ---AQVKCYMHQLLSGLEH 234
+V + S + L++V +Y LAG + + + T Q+ + L LE
Sbjct: 78 IVNY---LDSYLVGDELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQALEF 130
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
H+ V+HRDIK N+L+ +G + + DFG + P + ++ V T ++ PE++
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVT- 188
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
YG VD+WS G + E++ +P + L+ I AT
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------------AT 229
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT-TKPYA 410
P+ ++ F+DF + L +D +R +A L+ F KP +
Sbjct: 230 NGTPELQNPEKLSAIFRDF-------LNRCLEMDVEKRGSAKELLQHPFLKIAKPLS 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 85/252 (33%), Positives = 117/252 (46%), Gaps = 50/252 (19%)
Query: 98 PSWLSAVAGEAISGWTPRRADTFEKLDK---IGQGTYSNVYKARDTLTGQIVALKKVRFD 154
S S+ + + SG P A + +L++ IG G VYK TG++ ALK V +
Sbjct: 51 SSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK-VIYG 109
Query: 155 NLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYM------------E 202
N E R + REI ILR ++HPNVVK + + + ++ ++M E
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQVLLEFMDGGSLEGTHIADE 167
Query: 203 HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIAD 262
LA +A Q+LSG+ + H +H++HRDIK SNLLI++ + IAD
Sbjct: 168 QFLADVA----------------RQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIAD 211
Query: 263 FG----LASFFDPNHKQPMTSRVVTLWYRPPE-----LLLGATDYGVGVDLWSAG-CILA 312
FG LA D P S V T+ Y PE L GA D G D+WS G IL
Sbjct: 212 FGVSRILAQTMD-----PCNSSVGTIAYMSPERINTDLNHGAYD-GYAGDIWSLGVSILE 265
Query: 313 ELLAEKPIMPGR 324
L P GR
Sbjct: 266 FYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 3e-23
Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 10/217 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREILILRRLDHPN 178
F L +IG G++ VY ARD T ++VA+KK+ + + E + + +E+ L+R+ HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
++ +G + +LV +Y + L + ++ H L GL + H+
Sbjct: 87 SIEYKGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD- 297
+++HRDIK N+L+ G + +ADFG AS P S V T ++ PE++L +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASI-----ASPANSFVGTPYWMAPEVILAMDEG 199
Query: 298 -YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
Y VD+WS G EL KP + + L+ I
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 4e-23
Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 10/217 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREILILRRLDHPN 178
F L +IG G++ VY ARD ++VA+KK+ + + E + + +E+ L++L HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
++ G + +LV +Y + L + ++ H L GL + H+
Sbjct: 77 TIQYRGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD- 297
+++HRD+K N+L+ G++ + DFG AS P V T ++ PE++L +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPEVILAMDEG 189
Query: 298 -YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
Y VD+WS G EL KP + + L+ I
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 7e-23
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDH 176
D FE + +G G++ V R +G+ ALK + ++ + V + E IL+ + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYME-------HDLAGLAASPTIKFTQAQVKCYMHQLL 229
P +V L G + + +LYLV +Y+ +G P +F AQV +
Sbjct: 61 PFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV-------V 111
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW---- 285
LE+ H+ +++RD+K NLL+D++G + I DFG A R TL
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG--------RTYTLCGTPE 163
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLA 316
Y PE++L YG VD W+ G ++ E+LA
Sbjct: 164 YLAPEIILS-KGYGKAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 69/288 (23%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+E + KIG+G++ +Y A+ + +K++ + + +E+++L ++ HPN+
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
V + + + L++V +Y + DL + + F++ Q+ + Q+ GL+H H+
Sbjct: 62 VTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 238 QHVLHRDIKGSNLLIDNEGILT-IADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ +LHRDIK N+ + G++ + DFG+A + + + T V T +Y PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPEICQNRP 178
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
Y D+WS GC+L EL K G + QL + K+C +
Sbjct: 179 -YNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQL--VLKICQG------------YFAPI 222
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
P S LI L + P +R + T+ L+ F
Sbjct: 223 SPNFSRDL-------------RSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 2e-22
Identities = 75/288 (26%), Positives = 134/288 (46%), Gaps = 38/288 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ F KL++IG+G++ V+K D T Q+VA+K + + E E + + +EI +L + D P
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSP 62
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYME--HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
V K G + L+++ +Y+ L L A P F + Q+ + ++L GL++
Sbjct: 63 YVTKYYG--SYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYL 117
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H++ +HRDIK +N+L+ +G + +ADFG+A + T W P ++
Sbjct: 118 HSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE--VIQQ 175
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355
+ Y D+WS G EL +P +++ + +F + K T+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEP---PNSDMHPMRVLFLI-----------PKNNPPTL 221
Query: 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
++ FK+F I+ L DP+ R TA L+ +F
Sbjct: 222 TGE-------FSKPFKEF-------IDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 78/298 (26%), Positives = 125/298 (41%), Gaps = 44/298 (14%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
D +E + ++G G + VYKA+ TG A K ++ ++ E E FM EI IL H
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMV-EIDILSECKH 61
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK-----FTQAQVKCYMHQLLSG 231
PN+V L + + F G A + T+ Q++ Q+L
Sbjct: 62 PNIVGLYEAYFYENKLWILIEF------CDGGALDSIMLELERGLTEPQIRYVCRQMLEA 115
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
L H+ V+HRD+K N+L+ +G + +ADFG+ S + + Q + + T ++ PE+
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGV-SAKNKSTLQKRDTFIGTPYWMAPEV 174
Query: 292 LLGATD----YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
+ T Y D+WS G L E LA+ + P E+ + + K+ S
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIE-LAQ--MEPPHHELNPMRVLLKILKSEP------ 225
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
P + +F DF S L DP +R TA L+ F +
Sbjct: 226 ----------PTLDQPSKWSSSFNDFLKSC-------LVKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 4e-22
Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 30/221 (13%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQ-IVALKKVRFDNLE--------PESVRFMAREIL 169
+ L+ +G G + VYK R GQ ++ALK++ N +S+ + E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 170 ILR-RLDHPNVVK-----LEGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIK---FTQA 219
I++ +L HPN+V+ LE LY+V +E L S K FT+
Sbjct: 61 IIKEQLRHPNIVRYYKTFLEN-------DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE 113
Query: 220 QVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278
++ Q++ L + H + ++HRD+ +N+++ + +TI DFGLA P K +T
Sbjct: 114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LT 171
Query: 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKP 319
S V T+ Y PE++ YG D+W+ GCIL ++ +P
Sbjct: 172 SVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 4e-22
Identities = 67/245 (27%), Positives = 99/245 (40%), Gaps = 58/245 (23%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D E L ++G G V K TG+I+A+K +R + + + + RE+ IL + + P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSP 59
Query: 178 NVVKLEG---------LVTSRMSC-SLYLVFKYM-----EHDLAGLAASPTIKFTQAQVK 222
+V G + M SL + K + E L +A
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIA------------- 106
Query: 223 CYMHQLLSGLEHCHNQH-VLHRDIKGSNLLIDNEGILTIADFG--------LASFFDPNH 273
+L GL + H +H ++HRD+K SN+L+++ G + + DFG LA F
Sbjct: 107 ---VAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF---- 159
Query: 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL-LAEKPI----MPGRTEVE 328
V T Y PE + G DY V D+WS G L EL P P E
Sbjct: 160 -------VGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE 211
Query: 329 QLHKI 333
L I
Sbjct: 212 LLQYI 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-22
Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 19/232 (8%)
Query: 114 PRRADTFEK---------LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRF 163
P AD F K L +IG G++ VY A ++ T ++VA+KK+ + + E +
Sbjct: 8 PEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD 67
Query: 164 MAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKC 223
+ +E+ L++L HPN ++ +G + +LV +Y + L + ++
Sbjct: 68 IIKEVKFLQQLKHPNTIEYKGCYLKEHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAA 125
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVT 283
H L GL + H+ +++HRDIK N+L+ G + +ADFG AS P S V T
Sbjct: 126 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK-----SSPANSFVGT 180
Query: 284 LWYRPPELLLGATD--YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
++ PE++L + Y VD+WS G EL KP + + L+ I
Sbjct: 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 79/309 (25%), Positives = 140/309 (45%), Gaps = 51/309 (16%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH--- 176
+++L+ IG+G Y VY+ + TG++VALK + D + + V + RE+ +L +L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQP 61
Query: 177 PNVVKLEG--LVTSRMSCSLYLVFKYMEHDLAG-----LAASPTIKFTQAQVKCYMHQLL 229
PN+ K G L R L+++ ME+ G + A P I V + ++L
Sbjct: 62 PNITKYYGSYLKGPR----LWII---MEYAEGGSVRTLMKAGP-IAEKYISV--IIREVL 111
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPP 289
L++ H V+HRDIK +N+L+ N G + + DFG+A+ + N + T V T ++ P
Sbjct: 112 VALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF-VGTPYWMAP 170
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349
E++ Y D+WS G + E+ P + L
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPPYSD----VDAFRAMML------------- 213
Query: 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409
+P + KP + ++ ++F + L +P ER +A L+S++ K +
Sbjct: 214 IPKS---KPPRLEDNGYSKLLREF-------VAACLDEEPKERLSAEELLKSKWI--KAH 261
Query: 410 ACDPSSLPK 418
+ P S+ K
Sbjct: 262 SKTPVSILK 270
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 53/201 (26%), Positives = 101/201 (50%), Gaps = 6/201 (2%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+ K+ KIG+G++ + G+ +K++ + P+ +E+ +L + HPN+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DL-AGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
V+ + + + +LY+V Y E DL + A + F + Q+ + Q+ L+H H+
Sbjct: 62 VQYQE--SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
+ +LHRDIK N+ + +G + + DFG+A + + T + T +Y PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYYLSPEICENRP- 177
Query: 298 YGVGVDLWSAGCILAELLAEK 318
Y D+W+ GC+L E+ K
Sbjct: 178 YNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 81/279 (29%), Positives = 123/279 (44%), Gaps = 49/279 (17%)
Query: 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILILRRLDHPN 178
L I +G + +VY A+ TG A+K ++ ++ + +V+ R I++++ + P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVK-AERAIMMIQG-ESPY 58
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIK----FTQAQVKCYMHQLLSGLE 233
V KL S+ LYLV +Y+ D A L IK + K Y+ +++ G+E
Sbjct: 59 VAKLYYSFQSKDY--LYLVMEYLNGGDCASL-----IKTLGGLPEDWAKQYIAEVVLGVE 111
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H + ++HRDIK NLLID G L + DFGL+ N K V T Y PE +L
Sbjct: 112 DLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETIL 166
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
G D + D WS GC++ E L P E +F +
Sbjct: 167 GVGDDKMS-DWWSLGCVIFEFLFGYPPF----HAETPDAVFD-------------NILSR 208
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
I P E + P ++ LI LL +DPA+R
Sbjct: 209 RINWP--------EEVKEFCSPEAVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 82/311 (26%), Positives = 137/311 (44%), Gaps = 57/311 (18%)
Query: 118 DTFEKLD---KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVR-FMAREILILRR 173
D LD KIG+G+ V A D TG+ VA+KK+ +L + R + E++I+R
Sbjct: 16 DPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM---DLRKQQRRELLFNEVVIMRD 72
Query: 174 LDHPNVVKLEG--LVTSRMSCSLYLVFKYMEHDLAGLAASPTI---KFTQAQVKCYMHQL 228
HPN+V++ LV L++V +++E G A + + + + Q+ +
Sbjct: 73 YQHPNIVEMYSSYLVGDE----LWVVMEFLE----GGALTDIVTHTRMNEEQIATVCLAV 124
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD---PNHKQPMTSRVVTLW 285
L L H Q V+HRDIK ++L+ ++G + ++DFG + P K S V T +
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK----SLVGTPY 180
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
+ PE ++ YG VD+WS G ++ E++ +P ++ + +I +
Sbjct: 181 WMAPE-VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-------RDNLP 232
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
K K H P ++ +L DPA+R TA L F
Sbjct: 233 PKLKNLHKV-------------------SPRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273
Query: 406 TKPYACDPSSL 416
A PSS+
Sbjct: 274 K---AGPPSSI 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 3e-21
Identities = 63/204 (30%), Positives = 109/204 (53%), Gaps = 15/204 (7%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVR-FMAREILILRRLDHPN 178
+ + +KIGQG V+ A D TGQ VA+K++ NL+ + + + EIL+++ L +PN
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKELKNPN 77
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFT---QAQVKCYMHQLLSGLEHC 235
+V L + + L++V +Y LAG + + + T +AQ+ + L LE
Sbjct: 78 IVNF--LDSFLVGDELFVVMEY----LAGGSLTDVVTETCMDEAQIAAVCRECLQALEFL 131
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H V+HRDIK N+L+ +G + + DFG + P + ++ V T ++ PE++
Sbjct: 132 HANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRK 190
Query: 296 TDYGVGVDLWSAGCILAELLAEKP 319
YG VD+WS G + E++ +P
Sbjct: 191 A-YGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-21
Identities = 69/286 (24%), Positives = 111/286 (38%), Gaps = 42/286 (14%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+ + +G+G + R T +V K+V L + R EI+IL L HPN+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAG-----LAASPTIKFTQAQVKCYMHQLLSGLEH 234
+ + + ME+ G + F + V Y+ Q++S + +
Sbjct: 62 IAYYNHFMDDNT-----LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLL 293
H +LHRDIK N+ + G++ + DFG++ + M VV T +Y PEL
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSPELCQ 174
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
G Y D+W+ GC+L ELL L + F +P K + +
Sbjct: 175 GV-KYNFKSDIWALGCVLYELLT-------------LKRTFD-ATNPLNLVVKIVQGNYT 219
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
+ S L+ +LL DP +R TA L
Sbjct: 220 PVVSVYSSELI--------------SLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 3e-21
Identities = 73/287 (25%), Positives = 114/287 (39%), Gaps = 42/287 (14%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
FE L+KIG+G++ V+K ++ A+K++ + E +L +LD +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 180 VK-LEGLVTSRMSCSLYLVFKYME----HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
++ E + L +V +Y E H L L + QV + Q+L GL H
Sbjct: 62 IRYYESFLDKGK---LNIVMEYAENGDLHKL--LKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
H++ +LHRDIK NL +D + I D G+A N T V T +Y PE L
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPE-LCE 174
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
Y D+W+ G +L E K + + KI +
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR------------------G 216
Query: 355 IFKP-QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+F P Q Y + +A+ LI+ L D +R LR
Sbjct: 217 VFPPVSQMYSQQLAQ-----------LIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 4e-21
Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES---VRFMAREILILRRLDHPNVVKL 182
+G+G + VY D TG+ +A+K+V FD E+ V + EI +L+ L H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK----FTQAQVKCYMHQLLSGLEHCHNQ 238
G + L + +YM G + +K T+ + Y Q+L G+ + H+
Sbjct: 70 YGCLRDPEEKKLSIFVEYM----PGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPELLLGAT 296
++HRDIKG+N+L D+ G + + DFG + + V T ++ PE++ G
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG-E 184
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342
YG D+WS C + E+L EKP E E + IFK+ P++
Sbjct: 185 GYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTK 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 4e-21
Identities = 77/289 (26%), Positives = 129/289 (44%), Gaps = 40/289 (13%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
F KL++IG+G++ VYK D T ++VA+K + + E E + + +EI +L + D P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYI 64
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQLLSGLEHCH 236
+ G + L+++ +Y L G +A +K + + + ++L GL++ H
Sbjct: 65 TRYYG--SYLKGTKLWIIMEY----LGGGSALDLLKPGPLEETYIATILREILKGLDYLH 118
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
++ +HRDIK +N+L+ +G + +ADFG+A + T W P + A
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
D+ D+WS G EL +P + L I K SP + SK
Sbjct: 179 DF--KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK--NSPPTLEGQYSK------- 227
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
FK+F +E L DP R TA L+ +F T
Sbjct: 228 ------------PFKEF-------VEACLNKDPRFRPTAKELLKHKFIT 257
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 5e-21
Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 36/231 (15%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRF-----MAREILILR 172
D E++ +G GT+ V+ RD ++ ALK + PE +R + E +L+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAI----PEVIRLKQEQHVHNEKRVLK 56
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG------LAASPTIKFTQAQVKCYMH 226
+ HP +++L T LY++ +Y + G L S +F+ + Y
Sbjct: 57 EVSHPFIIRLF--WTEHDQRFLYMLMEY----VPGGELFSYLRNSG--RFSNSTGLFYAS 108
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW- 285
+++ LE+ H++ +++RD+K N+L+D EG + + DFG A + + R TL
Sbjct: 109 EIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFA--------KKLRDRTWTLCG 160
Query: 286 ---YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
Y PE ++ + + VD W+ G ++ E+L P KI
Sbjct: 161 TPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 6e-21
Identities = 72/277 (25%), Positives = 115/277 (41%), Gaps = 47/277 (16%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHPNVVKLEG 184
+G+G + V + TG++ A KK+ L+ MA E IL ++ +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 185 LVTSRMSCSLYLV--------FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
++ L + + G F +A+ Y Q++ GLEH H
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--------FPEARAIFYAAQIICGLEHLH 112
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ +++RD+K N+L+D+ G + I+D GLA + + R T Y PE+L G
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL--KGGKKIKGRAGTPGYMAPEVLQGEV 170
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
Y VD ++ GC L E++A GR+ Q K E +K +L T+
Sbjct: 171 -YDFSVDWFALGCTLYEMIA------GRSPFRQ-RK----------EKVEKEELKRRTLE 212
Query: 357 KPQQSYKRCIAETFKD-FPPSSLPLIETLLAIDPAER 392
+ D F P + L E LL DP +R
Sbjct: 213 MA---------VEYPDKFSPEAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 7e-21
Identities = 75/288 (26%), Positives = 132/288 (45%), Gaps = 39/288 (13%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+ + +KIGQG VY A D TGQ VA++++ +P+ + EIL++R +PN+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKK-ELIINEILVMRENKNPNI 79
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFT---QAQVKCYMHQLLSGLEHCH 236
V L + + L++V +Y LAG + + + T + Q+ + L LE H
Sbjct: 80 VNY--LDSYLVGDELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ V+HRDIK N+L+ +G + + DFG + P + ++ V T ++ PE++
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKA 192
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
YG VD+WS G + E++ +P + L+ I AT
Sbjct: 193 -YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------------------ATNG 232
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
P+ ++ F+DF + L +D +R +A L+ +F
Sbjct: 233 TPELQNPEKLSAIFRDF-------LNRCLDMDVEKRGSAKELLQHQFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 9e-21
Identities = 84/319 (26%), Positives = 129/319 (40%), Gaps = 41/319 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDH 176
F+ +G+G + V R+ TG I A+K ++ L E+V F E IL +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
P + +L + +LYLV +Y DL L +F + + Y+ +L+ +
Sbjct: 61 PWIPQL--QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL-- 293
H +HRDIK N+LID G + +ADFG A+ N V T Y PE+L
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178
Query: 294 ---GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
G YGV D WS G I E++ + T + + I
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM---------------- 222
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSS---LPLIETLLAIDPAERQTATAALRSEFFTTK 407
+++R + F + P S L LI++LL ER FF+
Sbjct: 223 ----------NFQRFL--KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269
Query: 408 PYACDPSSLPKYPPTKEMD 426
+ +SLP + PT + D
Sbjct: 270 DWNNIRNSLPPFVPTLKSD 288
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-20
Identities = 61/203 (30%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+ + +KIGQG VY A D TGQ VA+K++ +P+ + EIL++R +PN+
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKK-ELIINEILVMRENKNPNI 78
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFT---QAQVKCYMHQLLSGLEHCH 236
V L + + L++V +Y LAG + + + T + Q+ + L L+ H
Sbjct: 79 VNY--LDSYLVGDELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ V+HRDIK N+L+ +G + + DFG + P + ++ V T ++ PE++
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKA 191
Query: 297 DYGVGVDLWSAGCILAELLAEKP 319
YG VD+WS G + E++ +P
Sbjct: 192 -YGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 9/207 (4%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREILILRRLDH 176
+ FE + +IG GTY +VYKAR+ TG++ A+K ++ LEP E + +EI++++ H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKH 65
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N+V G R L++ ++ T +++Q+ + L GL + H
Sbjct: 66 SNIVAYFGSYLRRDK--LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL--LLG 294
++ +HRDIKG+N+L+ + G + +ADFG+++ + S + T ++ PE+ +
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK-RKSFIGTPYWMAPEVAAVER 182
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIM 321
Y D+W+ G EL +P M
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 73/234 (31%), Positives = 102/234 (43%), Gaps = 27/234 (11%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREILILRRLDHPN 178
F+ L ++GQG Y V+ A+ TG+IVALK+++ L VR + E IL
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAG-----LAASPTIKFTQAQVKCYMHQLLSGLE 233
+VKL L + LYL ME+ G L + A + YM ++ ++
Sbjct: 63 LVKL--LYAFQDDEYLYLA---MEYVPGGDFRTLLNNLGVLSEDHA--RFYMAEMFEAVD 115
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H +HRD+K N LID G + + DFGL+ S V + Y PE+L
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLR 171
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
G Y VD WS GC+L E L P G T E + YWK+
Sbjct: 172 G-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK---------YWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 75/263 (28%), Positives = 110/263 (41%), Gaps = 59/263 (22%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDH 176
D FE + IG+G + V + TG I A+KK+R + LE E V + E IL D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 177 PNVVKLEGLVTSRMSCS------LYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQ 227
P VVK + S LYL+ ME+ G + +K FT+ + + Y+ +
Sbjct: 61 PWVVK--------LYYSFQDENYLYLI---MEYLPGGDMMTLLMKKDTFTEEETRFYIAE 109
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-------------- 273
+ ++ H +HRDIK NLL+D +G + ++DFGL + +H
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 274 ------KQPMTS-RVVTLW----------------YRPPELLLGATDYGVGVDLWSAGCI 310
+PM+S R W Y PE+ L T Y D WS G I
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVI 228
Query: 311 LAELLAEKPIMPGRTEVEQLHKI 333
+ E+L P E KI
Sbjct: 229 MYEMLVGYPPFCSDNPQETYRKI 251
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 82/295 (27%), Positives = 132/295 (44%), Gaps = 52/295 (17%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREIL---- 169
DT+E ++ IG+GTY VYK + G + A+K L+P + + EI
Sbjct: 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKI-----LDP--ISDVDEEIEAEYN 70
Query: 170 ILRRL-DHPNVVKLEGLVTSRMSCS---LYLVFKYMEHDLAGLAASPTIK--------FT 217
IL+ L +HPNVVK G+ L+LV + G + + +K
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCN----GGSVTELVKGLLICGQRLD 126
Query: 218 QAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277
+A + ++ L GL+H HN ++HRD+KG+N+L+ EG + + DFG+++ +
Sbjct: 127 EAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186
Query: 278 TSRVVTLWYRPPELLLGATDYGVG----VDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
TS V T ++ PE++ Y D+WS G EL P + V+ L KI
Sbjct: 187 TS-VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
Query: 334 FKLCGSPSEEYWKKSKLPHATIFKPQQ---SYKRCIAETF-KDFP--PSSLPLIE 382
+ P T+ P++ S+ I++ KDF PS L+E
Sbjct: 246 --------------PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 120 FEKLDKIGQGTYSNV----YKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
+K+ +G+G + V Y + TG++VA+K ++ + ++ +EI IL+ L
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLY 64
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEH 234
H N+VK +G + + L L+ +Y+ L L P K AQ+ + Q+ G+ +
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAY 122
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR---VVTLWYRPPEL 291
H+QH +HRD+ N+L+DN+ ++ I DFGLA H+ WY
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE-- 180
Query: 292 LLGATDYGVGVDLWSAGCILAELL 315
L + D+WS G L ELL
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ +L ++G+G +V K R TG I ALK + D P+ + + RE+ I + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSP 59
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQL-------LS 230
+VK G S S+ + +Y E G S K + + L L
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCE---GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPE 290
GL + H++ ++HRDIK SN+L+ +G + + DFG++ + T T +Y PE
Sbjct: 117 GLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL--VNSLAGTF-TGTSFYMAPE 173
Query: 291 LLLGATDYGVGVDLWSAGCILAEL 314
+ G Y + D+WS G L E+
Sbjct: 174 RIQGKP-YSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 21/240 (8%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILR 172
P +DT+E ++ IG+GTY V+K + G A+K + +++ E + E IL+
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEAEYNILK 69
Query: 173 RL-DHPNVVKLEGLVTSRMSCS---LYLVFKYME----HDLAGLAASPTIKFTQAQVKCY 224
L DHPNVVK G+ + + L+LV + DL + + +
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL 284
+H+ L GL+H H +HRD+KG+N+L+ EG + + DFG+++ + TS
Sbjct: 130 LHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF 189
Query: 285 WYRPP----ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSP 340
W P E L +T Y D+WS G EL P + ++ + +FK+ +P
Sbjct: 190 WMAPEVIACEQQLDST-YDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPRNP 245
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 123 LDKIGQGTYSNVYKAR-DTL---TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN 178
+ ++G+G + +V R D L TG++VA+KK++ E +R REI IL+ L H N
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDN 66
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
+VK +G+ S +L LV +Y+ + L + ++ Y Q+ G+E+ +
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-----KQPMTSRVVTLWYRPPELL 292
+ +HRD+ N+L+++E + I DFGL + ++P S + WY P
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI--FWYAPES-- 182
Query: 293 LGATDYGVGVDLWSAGCILAEL 314
L + + V D+WS G +L EL
Sbjct: 183 LTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 60/203 (29%), Positives = 107/203 (52%), Gaps = 8/203 (3%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ F KL+KIG+G++ V+K D T ++VA+K + + E E + + +EI +L + D P
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSP 62
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
V K G + L+++ +Y+ A P + Q+ + ++L GL++ H+
Sbjct: 63 YVTKYYG--SYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHS 119
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ +HRDIK +N+L+ G + +ADFG+A D K+ + V T ++ PE ++ +
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPE-VIKQS 176
Query: 297 DYGVGVDLWSAGCILAELLAEKP 319
Y D+WS G EL +P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 4e-19
Identities = 63/259 (24%), Positives = 107/259 (41%), Gaps = 30/259 (11%)
Query: 167 EILILRRLDHPNVVKL-EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYM 225
E ++L+ ++HP+V+++ + LV+ ++C +V + DL + Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITC---MVLPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TL 284
Q+L GL + H Q ++HRD+K N+ I++ + I D G A F P + T+
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLAGTV 220
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLA----------EKPIMPGRTEVEQLHKIF 334
PE+L Y D+WSAG +L E+LA P ++ L KI
Sbjct: 221 ETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279
Query: 335 KLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSS---LP-----LIETLLA 386
EE+ + P + + + Y + + +P LP L+ +L
Sbjct: 280 STLKVHPEEF---PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLT 336
Query: 387 IDPAERQTATAALRSEFFT 405
D A R +A L F
Sbjct: 337 FDAAMRPSAEEILNYPMFA 355
|
Length = 357 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 5e-19
Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 28/206 (13%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVR----FDNLEPESVRFMAREILILRRLDHPNVVK 181
+G G + V + + ALK V+ + + E + E IL +HP +VK
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF---SEKEILEECNHPFIVK 57
Query: 182 LEGLVTSRMSCSLYLVFKYME--------HDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
L T + +Y++ +Y D GL T +F A V + E
Sbjct: 58 L--YRTFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACV-------VLAFE 107
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ HN+ +++RD+K NLL+D+ G + + DFG A Q + T Y PE++L
Sbjct: 108 YLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS--GQKTWTFCGTPEYVAPEIIL 165
Query: 294 GATDYGVGVDLWSAGCILAELLAEKP 319
Y VD WS G +L ELL +P
Sbjct: 166 N-KGYDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 9/205 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREILILRRLDHPN 178
+E + ++G GTY +VYKAR+ TG++ A+K ++ LEP + + +EI +++ H N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHCN 67
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
+V G SR L++ +Y T ++ Q+ + L GL + H++
Sbjct: 68 IVAYFGSYLSREK--LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDY 298
+HRDIKG+N+L+ + G + +ADFG+A+ + S + T ++ PE+ +
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK-RKSFIGTPYWMAPEVAAVEKNG 184
Query: 299 GVG--VDLWSAGCILAELLAEKPIM 321
G D+W+ G EL +P M
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 58/236 (24%), Positives = 105/236 (44%), Gaps = 16/236 (6%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHP 177
TF +G+G + V + TG++ A KK+ ++ MA E IL +++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 178 NVVKLEGLVTSRMSCSLYLV------FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
VV L ++ + L L K+ +++ F + + Y ++ G
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG------FDEERAVFYAAEITCG 114
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
LE H + +++RD+K N+L+D+ G + I+D GLA + + RV T+ Y PE
Sbjct: 115 LEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ETIRGRVGTVGYMAPE- 171
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
++ Y D W GC++ E++ K R E + ++ + EEY +K
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 6e-18
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESV----RFMAREILILRRLDHPNVVK 181
+G+G Y VY T GQ++A+K+V D + + E+ +L+ L H N+V+
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 182 LEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK----FTQAQVKCYMHQLLSGLEHCHN 237
G + S+++ F + G + S + + Y Q+L G+ + HN
Sbjct: 67 YLGTCLDDNTISIFMEF------VPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFF-----DPNHKQPMTSRVVTLWYRPPELL 292
V+HRDIKG+N+++ GI+ + DFG A H + S T ++ PE +
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE-V 179
Query: 293 LGATDYGVGVDLWSAGCILAELLAEKP 319
+ + YG D+WS GC + E+ KP
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 7e-18
Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 24/227 (10%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES---VRFMAREILILRRLDH 176
+ L +G+G++ + + Q A+K++R P+S V +E ++L ++ H
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRL----PKSSSAVEDSRKEAVLLAKMKH 57
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIK-FTQAQVKCYMHQLLSGLEH 234
PN+V + + LY+V +Y + DL K F + + + Q+ G++H
Sbjct: 58 PNIVAFKE--SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT---SRVVTLWYRPPEL 291
H + VLHRDIK N+ + G + + DFG A P + V T +Y PPE+
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL----TSPGAYACTYVGTPYYVPPEI 171
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEK-PIMPGRTEVEQLHKIFKLC 337
Y D+WS GCIL EL K P + + I K+C
Sbjct: 172 WENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWK----NLILKVC 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 120 FEKLDKIGQGTYSNV----YKARDTLTGQIVALKKVRFDNLEPES----VRFMAREILIL 171
+++ +G+G + V Y TG+ VA+K +L+PES + + +EI IL
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK-----SLKPESGGNHIADLKKEIEIL 60
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLS 230
R L H N+VK +G+ T + L+ +++ L K Q Y Q+
Sbjct: 61 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICK 120
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-----KQPMTSRVVTLW 285
G+++ ++ +HRD+ N+L+++E + I DFGL + + K + S V W
Sbjct: 121 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV--FW 178
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELL 315
Y PE L+ + Y + D+WS G L ELL
Sbjct: 179 Y-APECLIQSKFY-IASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 60/193 (31%), Positives = 93/193 (48%), Gaps = 7/193 (3%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKV-RFDNLEPESVRFMAREILILRRLDHPNVVKLEG 184
IG+GT+ VY+ R T +I A+K + + + + + V E IL R + G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 185 LVTSRMSCS-LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHR 243
L S + S LYLV YM +F++ + K Y+ +L+ LEH H +++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 244 DIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPELLLGATDYGVG 301
D+K N+L+D G + + DFGL+ N T+ T Y PE+LL Y
Sbjct: 121 DLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177
Query: 302 VDLWSAGCILAEL 314
VD WS G ++ E+
Sbjct: 178 VDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 64/233 (27%), Positives = 111/233 (47%), Gaps = 25/233 (10%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ +E + ++G G + VYKA++ TG + A K + + E E +M EI IL +HP
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMV-EIEILATCNHP 69
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTI-----KFTQAQVKCYMHQLLSGL 232
+VKL G + + F G A + T+ Q++ Q+L L
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEF------CPGGAVDAIMLELDRGLTEPQIQVICRQMLEAL 123
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK--QPMTSRVVTLWYRPPE 290
++ H+ ++HRD+K N+L+ +G + +ADFG+++ N K Q S + T ++ PE
Sbjct: 124 QYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA---KNVKTLQRRDSFIGTPYWMAPE 180
Query: 291 LLLGAT----DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS 339
+++ T Y D+WS G L E+ I P E+ + + K+ S
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEM---AQIEPPHHELNPMRVLLKIAKS 230
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 63/195 (32%), Positives = 98/195 (50%), Gaps = 11/195 (5%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILRRL-DHPNVVK 181
IG+G + VY R TG++ A+K K R + E++ R +L L D P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 182 LE-GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
+ T C + M S F++ +++ Y +++ GLEH HN+ V
Sbjct: 62 MTYAFHTPDKLC---FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFV 118
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGV 300
++RD+K +N+L+D G + I+D GLA F + K+P S V T Y PE+L T Y
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHAS-VGTHGYMAPEVLQKGTAYDS 175
Query: 301 GVDLWSAGCILAELL 315
D +S GC+L +LL
Sbjct: 176 SADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 21/231 (9%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ +E + ++G G + VYKA++ TG + A K + D E + EI IL DHP
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI--DTKSEEELEDYMVEIDILASCDHP 62
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTI-----KFTQAQVKCYMHQLLSGL 232
N+VKL L +L+++ ++ AG A + T+ Q++ Q L L
Sbjct: 63 NIVKL--LDAFYYENNLWILIEF----CAGGAVDAVMLELERPLTEPQIRVVCKQTLEAL 116
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL 292
+ H ++HRD+K N+L +G + +ADFG+++ + Q S + T ++ PE++
Sbjct: 117 NYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 293 LGATD----YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS 339
+ T Y D+WS G L E+ I P E+ + + K+ S
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEM---AQIEPPHHELNPMRVLLKIAKS 223
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 69/285 (24%), Positives = 116/285 (40%), Gaps = 43/285 (15%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGL 185
+G+G+Y V R G+ +KK+ N + +E +L +L HPN+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV----- 62
Query: 186 VTSRMS-----CSLYLVFKYMEH-DL-AGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
R S LY+V + E DL L + QV + Q+ L++ H +
Sbjct: 63 -AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDY 298
H+LHRD+K N+ + I+ + D G+A + N ++ + T +Y PE L Y
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPE-LFSNKPY 179
Query: 299 GVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358
D+W+ GC + E+ K + +++I + KLP
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII------------EGKLPPMP---- 223
Query: 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
KD+ P LI T+L+ P +R + + LR +
Sbjct: 224 ------------KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 83/305 (27%), Positives = 125/305 (40%), Gaps = 42/305 (13%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILRRL-DHPNVVK 181
IG+G + VY R TG++ A+K K R + E++ R +L L D P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 182 LEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
+ L + M S F++A+++ Y +++ GLEH HN+ V+
Sbjct: 62 MS--YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVG 301
+RD+K +N+L+D G + I+D GLA D + K+P S V T Y PE+L Y
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSS 176
Query: 302 VDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361
D +S GC+L +LL SP ++ K K +
Sbjct: 177 ADWFSLGCMLFKLLRGH--------------------SPFRQHKTKDKHEIDRMTLTMA- 215
Query: 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAER-----QTATAALRSEFFTTKPYACDPSSL 416
E F P L+E LL D R + A FF + + L
Sbjct: 216 -----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW--QMVFL 268
Query: 417 PKYPP 421
KYPP
Sbjct: 269 QKYPP 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 9/197 (4%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES-VRFMAREILILRRLDHPNVVKLEG 184
IG+G++ V + R T +I ALK +R ++ S V E +L +++ P +V L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 185 LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRD 244
S LYLV ++ +F ++ + Y +LL LE+ H +V++RD
Sbjct: 61 SFQSPEK--LYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 245 IKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPELLLGATDYGVGV 302
+K N+L+D +G + + DFGL N K + T Y PELLLG Y V
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKL---NMKDDDKTNTFCGTPEYLAPELLLG-HGYTKAV 174
Query: 303 DLWSAGCILAELLAEKP 319
D W+ G +L E+L P
Sbjct: 175 DWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 4e-16
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
A FE ++ +G GTY VYK R TGQ+ A+K + E E ++ +EI +L++ H
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSH 61
Query: 177 -PNVVKLEGLVTSR----MSCSLYLVFKYMEH----DLAGLAASPTIKFTQAQVKCYMHQ 227
N+ G + M L+LV ++ DL T+K C +
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC--RE 119
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
+L GL H H V+HRDIKG N+L+ + + DFG+++ D + T + T ++
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWM 178
Query: 288 PPELLLGATD------YGVGVDLWSAGCILAELLAEKP 319
PE++ A D Y DLWS G E+ P
Sbjct: 179 APEVI--ACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 104 VAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVR 162
S W + FE + +G G++ V A+ TG+ A+K ++ L+ + V+
Sbjct: 7 FTKPDTSSW---KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQ 63
Query: 163 FMAREILILRRLDHPNVVKLEGLVTSRMSCS------LYLVFKYMEHDLAGLAASPTIKF 216
+A+E IL L HP +V M CS +Y + +++ +F
Sbjct: 64 HVAQEKSILMELSHPFIVN--------MMCSFQDENRVYFLLEFVVGGELFTHLRKAGRF 115
Query: 217 TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276
K Y +L+ E+ H++ +++RD+K NLL+DN+G + + DFG A +
Sbjct: 116 PNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA--------KK 167
Query: 277 MTSRVVTLW----YRPPELLLGATDYGVGVDLWSAGCILAELLAEKP 319
+ R TL Y PE ++ + +G VD W+ G +L E +A P
Sbjct: 168 VPDRTFTLCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 7e-16
Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 126 IGQGTYSNVYKARDTLTG---QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
IG G + V + R L G VA+K ++ E + F++ E I+ + DHPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS-EASIMGQFDHPNIIHL 70
Query: 183 EGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
EG+VT S + ++ ++ME+ L +FT Q+ + + +G+++ + +
Sbjct: 71 EGVVTK--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFF-----DPNHKQPMTSRVVTLWYRPPELLLGAT 296
HRD+ N+L+++ + ++DFGL+ F DP + + ++ W P +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY--R 186
Query: 297 DYGVGVDLWSAGCILAELLA--EKP 319
+ D+WS G ++ E+++ E+P
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 7e-16
Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D E LD++G+G Y +VYK TG +A+K++R + L+ + E+ IL + P
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSP 59
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH---DLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
+V G + ++Y+ +YM+ D T + ++ + ++ GL+
Sbjct: 60 YIVDFYGAFF--IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 235 CHNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL- 292
+H ++HRD+K +N+L++ G + + DFG++ + + Y PE +
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTNIGCQSYMAPERIK 174
Query: 293 -LGATD---YGVGVDLWSAGCILAEL 314
G Y V D+WS G + E+
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 120 FEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNL-----EPESVRFMAREILIL 171
FE L +G G Y V+ R TG++ A+K ++ L E R R +L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR-TERNVLEH 60
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
R P +V L + L+L+ Y+ F++ +V+ Y +++
Sbjct: 61 VR-QSPFLVTLH--YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA 117
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
LEH H +++RDIK N+L+D+EG + + DFGL+ F K+ S T+ Y PE+
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 292 LLGATDYGVGVDLWSAGCILAELL 315
+ G +G VD WS G ++ ELL
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 58/227 (25%), Positives = 104/227 (45%), Gaps = 20/227 (8%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILR 172
PR + E+ K+G G + V+ T G VA+K ++ + PE+ +E I++
Sbjct: 4 PRESLKLER--KLGAGQFGEVWMG--TWNGTTKVAVKTLKPGTMSPEA---FLQEAQIMK 56
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMH-QLLS 230
+L H +V+L + + +Y+V +YM L S K + M Q+
Sbjct: 57 KLRHDKLVQLYAVCSEEEP--IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAE 114
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPE 290
G+ + +++ +HRD+ N+L+ + IADFGLA + + + + PE
Sbjct: 115 GMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE 174
Query: 291 LLLGATDYG---VGVDLWSAGCILAELLAEKPI-MPGRTEVEQLHKI 333
A +YG + D+WS G +L E++ + PG T E L ++
Sbjct: 175 ----AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 53/219 (24%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 116 RADTFEKLDKIGQGTYSNVYKA--RDTLTGQ---IVALKKVRFDNLEPESVRFMAREILI 170
+ DT ++G+G + V+ +VA+K ++ + ++ + RE +
Sbjct: 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAEL 61
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH------------DLAGLAA--SPTIKF 216
L H N+VK G+ T +VF+YMEH D A L + SP +
Sbjct: 62 LTNFQHENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 217 TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQ 275
T +Q+ Q+ SG+ + +QH +HRD+ N L+ + ++ I DFG++ + ++ +
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179
Query: 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 314
++ + + PPE ++ + D+WS G +L E+
Sbjct: 180 VGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+EK+ +G+G + V+ R ++V +K++ + + + E +L+ L HPN+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK-----FTQAQVKCYMHQLLSGLEH 234
+ E +L +V +Y G A K + + + Q+L L H
Sbjct: 62 I--EYYENFLEDKALMIVMEYAP---GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHH 116
Query: 235 CHNQHVLHRDIKGSNLLID-NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H + +LHRD+K N+L+D ++ ++ I DFG++ + K + V T Y PEL
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELCE 174
Query: 294 GATDYGVGVDLWSAGCILAELLAEK 318
G Y D+W+ GC+L EL + K
Sbjct: 175 GKP-YNQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 51/202 (25%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 126 IGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
IG G + V + R L G+ VA+K ++ + + + + F+ E I+ + DHPN+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASIMGQFDHPNIIRL 70
Query: 183 EGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
EG+VT + ++ +YME+ L KFT Q+ + + SG+++ + +
Sbjct: 71 EGVVTKSR--PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV 128
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS--RVVTLWYRPPELLLGATDYG 299
HRD+ N+L+++ + ++DFGL+ + + T ++ W P + +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK--FT 186
Query: 300 VGVDLWSAGCILAELLA--EKP 319
D+WS G ++ E+++ E+P
Sbjct: 187 SASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 11/206 (5%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILIL 171
W R D K K+G G Y VY+ VA+K ++ D +E E F+ +E ++
Sbjct: 1 WEMERTDITMK-HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FL-KEAAVM 56
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYM-HQLL 229
+ + HPN+V+L G+ T Y++ ++M + +L + A V YM Q+
Sbjct: 57 KEIKHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRP 288
S +E+ ++ +HRD+ N L+ ++ +ADFGL+ + ++ W P
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 174
Query: 289 PELLLGATDYGVGVDLWSAGCILAEL 314
L + + D+W+ G +L E+
Sbjct: 175 ES--LAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 11/218 (5%)
Query: 123 LDKIGQGTYSNVY---KARDTLTGQIVALKKVRFDNLE-PESVRF-MAREILILRRLDHP 177
L +GQG++ V+ K GQ+ A+K ++ L+ + VR M R+IL ++HP
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILA--EVNHP 58
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
+VKL + LYL+ ++ S + FT+ VK Y+ +L L+H H+
Sbjct: 59 FIVKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 116
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
+++RD+K N+L+D EG + + DFGL S +H++ S T+ Y PE ++
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGL-SKESIDHEKKAYSFCGTVEYMAPE-VVNRRG 174
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
+ D WS G ++ E+L G+ E + I K
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 71/283 (25%), Positives = 118/283 (41%), Gaps = 45/283 (15%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHP 177
TF + +G+G + V + TG++ A KK+ ++ MA E IL +++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 178 NVVKLEGLVTSRMSCSLYLV--------FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLL 229
VV L ++ + L L F AG F + + Y ++
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG--------FEEGRAVFYAAEIC 112
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPP 289
GLE H + +++RD+K N+L+D+ G + I+D GLA Q + RV T+ Y P
Sbjct: 113 CGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRVGTVGYMAP 170
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349
E++ Y D W+ GC+L E++A + R + + ++ +L EEY +K
Sbjct: 171 EVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEK-- 227
Query: 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
F P + L + LL DP ER
Sbjct: 228 -----------------------FSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 74/291 (25%), Positives = 132/291 (45%), Gaps = 40/291 (13%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEG 184
KIG+G+ V A +G++VA+KK+ + + F E++I+R H NVV++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF--NEVVIMRDYQHENVVEMYN 84
Query: 185 LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFT---QAQVKCYMHQLLSGLEHCHNQHVL 241
+ + L++V +++E G A + + T + Q+ +L L H Q V+
Sbjct: 85 --SYLVGDELWVVMEFLE----GGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVI 138
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVG 301
HRDIK ++L+ ++G + ++DFG + S V T ++ PE L+ YG
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPE-LISRLPYGPE 196
Query: 302 VDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361
VD+WS G ++ E++ +P ++ + I + LP P+
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------------RDNLP------PKLK 237
Query: 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK-PYAC 411
++ + K F ++ LL DPA+R TA L+ F P +C
Sbjct: 238 NLHKVSPSLKGF-------LDRLLVRDPAQRATAAELLKHPFLAKAGPPSC 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 72/288 (25%), Positives = 134/288 (46%), Gaps = 39/288 (13%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
E KIG+G+ V AR+ +G+ VA+K + + + F E++I+R H NV
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF--NEVVIMRDYQHQNV 80
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
V++ + + L+++ ++++ S + + Q+ +L L + H+Q
Sbjct: 81 VEM--YKSYLVGEELWVLMEFLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQG 137
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFD---PNHKQPMTSRVVTLWYRPPELLLGAT 296
V+HRDIK ++L+ +G + ++DFG + P K S V T ++ PE ++ T
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK----SLVGTPYWMAPE-VISRT 192
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
YG VD+WS G ++ E++ +P + V+ + ++ + S P
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL------------RDSPPP----- 235
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
K + ++K I+ +DF +E +L +P ER TA L F
Sbjct: 236 KLKNAHK--ISPVLRDF-------LERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 77/269 (28%), Positives = 122/269 (45%), Gaps = 26/269 (9%)
Query: 165 AREILILRRLDHPNVVKLEGLVT-SRMSCSLYLVFKYMEHDL-AGLAASPTIKFTQAQVK 222
A E ILR ++HP++++L+G T ++ +C L+ + DL LAA I +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTC---LILPRYKTDLYCYLAAKRNIAI--CDIL 185
Query: 223 CYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282
+L +++ H ++HRDIK N+ I++ G + + DFG A F +
Sbjct: 186 AIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245
Query: 283 TLWYRPPELLLGATD-YGVGVDLWSAGCILAEL------LAEKPIMPGRTEVE-QLHKIF 334
T+ PELL A D YG VD+WSAG +L E+ L EK + G + + Q+ I
Sbjct: 246 TIATNAPELL--ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII 303
Query: 335 KLCGSPSEEYW--KKSKLPHATIFKPQQSYK----RCIAETFKDFPPSSLPLIETLLAID 388
+ G+ E+ ++ L I ++S + R + + P LI +LA D
Sbjct: 304 RRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFD 363
Query: 389 PAERQTATAALRSEFFTTKPYACDPSSLP 417
R +A A L F P DP P
Sbjct: 364 AHHRPSAEALLDFAAFQDIP---DPYPNP 389
|
Length = 391 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 20/201 (9%)
Query: 125 KIGQGTYSNVYKARDTLTG---QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVK 181
++G+G++ VY +D ++ LK++ L P +E +L +LDHP +VK
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 182 LEGLVTSRMSCSLY--------LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
R + + L K E G ++ QV + QLL G+
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK------TLSENQVCEWFIQLLLGVH 120
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ H + +LHRD+K N+ + N +L I DFG++ T+ T +Y PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPE-AL 177
Query: 294 GATDYGVGVDLWSAGCILAEL 314
Y D+WS GCIL E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 35/102 (34%), Positives = 61/102 (59%), Gaps = 1/102 (0%)
Query: 215 KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274
FT+++V+ Y+ +++ L+H H +++RDIK N+L+D+EG + + DFGL+ F +
Sbjct: 101 HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160
Query: 275 QPMTSRVVTLWYRPPELLLGATD-YGVGVDLWSAGCILAELL 315
+ S T+ Y PE++ G + + VD WS G + ELL
Sbjct: 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 27/220 (12%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
A FE ++ +G GTY VYK R TGQ+ A+K + E E ++ EI +L++ H
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSH 71
Query: 177 -PNVVKLEGLVTSRMSC----SLYLVFKYMEHDLAGLAASPTIKFTQAQ------VKCYM 225
N+ G + L+LV ME AG + + +K T+ +
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLV---MEFCGAG-SVTDLVKNTKGNALKEDWIAYIC 127
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW 285
++L GL H H V+HRDIKG N+L+ + + DFG+++ D + T + T +
Sbjct: 128 REILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPY 186
Query: 286 YRPPELLLGATD------YGVGVDLWSAGCILAELLAEKP 319
+ PE++ A D Y D+WS G E+ P
Sbjct: 187 WMAPEVI--ACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 73/294 (24%), Positives = 135/294 (45%), Gaps = 46/294 (15%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEG 184
KIG+G+ V A + TG+ VA+KK+ + + F E++I+R H NVV +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF--NEVVIMRDYHHENVVDMYN 86
Query: 185 LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFT---QAQVKCYMHQLLSGLEHCHNQHVL 241
+ + L++V +++E G A + + T + Q+ +L L + HNQ V+
Sbjct: 87 --SYLVGDELWVVMEFLE----GGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVI 140
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFD---PNHKQPMTSRVVTLWYRPPELLLGATDY 298
HRDIK ++L+ ++G + ++DFG + P K S V T ++ PE ++ Y
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK----SLVGTPYWMAPE-VISRLPY 195
Query: 299 GVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358
G VD+WS G ++ E++ +P ++ + +I + LP P
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-------------RDNLP------P 236
Query: 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT-TKPYAC 411
+ ++ + F ++ +L +P++R TA L+ F P +C
Sbjct: 237 RVKDSHKVSSVLRGF-------LDLMLVREPSQRATAQELLQHPFLKLAGPPSC 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV-RFDNLEPESVRFMAREILILRRL 174
+A+ F+ + IG+G + V R + Q+ A+K + +F+ ++ F E I+
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 175 DHPNVVKLEGLVTSRMSCS------LYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQ 227
+ +V+L + LY+V +YM DL L ++ I A+ Y +
Sbjct: 101 NSEWIVQLH--------YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARF--YTAE 150
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
++ L+ H+ +HRD+K N+L+D G L +ADFG D N + V T Y
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYI 210
Query: 288 PPELLL---GATDYGVGVDLWSAGCILAELL 315
PE+L G YG D WS G L E+L
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 30/222 (13%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREI---LILRRL-----DHP 177
+G+G++ V+ A T Q A+K ++ D V M ++ ++ +R+ +HP
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKD------VVLMDDDVECTMVEKRVLSLAWEHP 56
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
+ L T + +L+ V +Y+ KF + Y +++ GL+ H+
Sbjct: 57 FLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS 114
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW------YRPPEL 291
+ +++RD+K N+L+D +G + IADFG+ K+ M T Y PE+
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMC-------KENMLGDAKTCTFCGTPDYIAPEI 167
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
LLG Y VD WS G +L E+L + G E E I
Sbjct: 168 LLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 58/231 (25%), Positives = 109/231 (47%), Gaps = 20/231 (8%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILR 172
PR ++ + + K+G G + V+ T G VA+K ++ + PES E I++
Sbjct: 4 PR--ESLQLIKKLGNGQFGEVW--MGTWNGNTKVAVKTLKPGTMSPES---FLEEAQIMK 56
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD--LAGLAASPTIKFTQAQVKCYMHQLLS 230
+L H +V+L +V+ +Y+V +YM L L + Q+ +
Sbjct: 57 KLRHDKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 113
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN-HKQPMTSRVVTLWYRPP 289
G+ + + +HRD++ +N+L+ + + IADFGLA + N + ++ W P
Sbjct: 114 GMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEK----PIMPGRTEVEQLHKIFKL 336
L G + + D+WS G +L EL+ + P M R +EQ+ + +++
Sbjct: 174 AALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 76/319 (23%), Positives = 123/319 (38%), Gaps = 85/319 (26%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH- 176
D E ++++G+G Y V K R TG I+A+K++R + + + + ++ I R
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRA-TVNSQEQKRLLMDLDISMRSVDC 59
Query: 177 PNVVKLEGLVTSR---------MSCSLYLVFKYM--------EHDLAGLAASPTIKFTQA 219
P V G + M SL +K + E L +A S
Sbjct: 60 PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVS-------- 111
Query: 220 QVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFG--------LASFFD 270
++ LE+ H++ V+HRD+K SN+LI+ G + + DFG +A D
Sbjct: 112 --------IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID 163
Query: 271 PNHKQPMTSRVVTLWYRPPELLLGATD---YGVGVDLWSAGCILAELLAEK-PIMPGRTE 326
K Y PE + + Y V D+WS G + EL + P +T
Sbjct: 164 AGCKP----------YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP 213
Query: 327 VEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLA 386
+QL ++ + PS +LP F P+ F+DF + L
Sbjct: 214 FQQLKQVVE---EPS------PQLPAEK-FSPE----------FQDF-------VNKCLK 246
Query: 387 IDPAERQTATAALRSEFFT 405
+ ER L+ FF
Sbjct: 247 KNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 42/228 (18%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMARE--ILILRRLDHPNVVKL 182
+G+G++ V A T ++ A+K ++ D L+ + V E +L L HP + +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQL 61
Query: 183 EGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
SC L+ V +Y M H + +F + + + Y +++ G
Sbjct: 62 -------HSCFQTKDRLFFVMEYVNGGDLMFHIQR------SGRFDEPRARFYAAEIVLG 108
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW------ 285
L+ H + +++RD+K N+L+D+EG + IADFG+ K+ + V T
Sbjct: 109 LQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMC-------KEGILGGVTTSTFCGTPD 161
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
Y PE+L YG VD W+ G +L E+LA + G E E I
Sbjct: 162 YIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 18/225 (8%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDHP 177
F L +G+G++ V A T ++ A+K ++ D ++ + V E +L D P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 178 NVVKLEGLVTSRMSC-----SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
+T SC LY V +Y+ KF + Q Y ++ GL
Sbjct: 61 P------FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGL 114
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPE 290
H + +++RD+K N+++D+EG + IADFG+ + +T+R T Y PE
Sbjct: 115 FFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPE 171
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
++ YG VD W+ G +L E+LA +P G E E I +
Sbjct: 172 -IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 56/192 (29%), Positives = 93/192 (48%), Gaps = 7/192 (3%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLE- 183
+G+GT+ V R+ TG+ A+K +R + + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 184 GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHR 243
T C V +Y S FT+ + + Y +++S LE+ H++ V++R
Sbjct: 63 AFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 244 DIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVD 303
DIK NL++D +G + I DFGL + M + T Y PE +L DYG VD
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPE-VLEDNDYGRAVD 177
Query: 304 LWSAGCILAELL 315
W G ++ E++
Sbjct: 178 WWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 9/203 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNL--EPESVRFMAREILILRRL 174
FE L +G G Y V+ R +G++ A+K ++ + + ++ E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 175 DH-PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
P +V L + L+L+ Y+ S +F + +V+ Y +++ LE
Sbjct: 62 RQSPFLVTLH--YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE 119
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H H +++RDIK N+L+D+ G + + DFGL+ F + + S T+ Y P+++
Sbjct: 120 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 294 GA-TDYGVGVDLWSAGCILAELL 315
G + VD WS G ++ ELL
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 31/202 (15%)
Query: 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
+ +G G VYKA LT +I+A+K + D + E + + E+ IL + D P ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 183 EG--LVTSRMS-CSLYL------VFKYM-EHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
G V +R+S C+ ++ V++ + EH L +A + ++ GL
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA----------------VVKGL 108
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL 292
+ + +LHRD+K SN+L++ G + + DFG+++ + V T Y PE +
Sbjct: 109 TYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERI 165
Query: 293 LGATDYGVGVDLWSAGCILAEL 314
G YG+ D+WS G EL
Sbjct: 166 SG-EQYGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 33/225 (14%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR----FDNLEPESVRFMAREILILRRLD 175
F L +G+G + V A TG++ A+K ++ E ES+ R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKY------MEHDLAGLAASPTIKFTQAQVKCYMHQLL 229
HP +V L + + V +Y M H + F++ + Y ++
Sbjct: 61 HPFLVNLFACFQT--EDHVCFVMEYAAGGDLMMHIHTDV-------FSEPRAVFYAACVV 111
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM--TSRVVTLWYR 287
GL++ H +++RD+K NLL+D EG + IADFGL K+ M R T
Sbjct: 112 LGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLC-------KEGMGFGDRTSTFCGT 164
Query: 288 P----PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE 328
P PE+L T Y VD W G ++ E+L + PG E E
Sbjct: 165 PEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 56/225 (24%), Positives = 106/225 (47%), Gaps = 17/225 (7%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEG 184
K+GQG + V+ T + VA+K ++ + PE+ +E ++++L H +V+L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYA 68
Query: 185 LVTSRMSCSLYLVFKYMEHD--LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLH 242
+V+ +Y+V +YM L L Q+ Q+ SG+ + + +H
Sbjct: 69 VVSEE---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 125
Query: 243 RDIKGSNLLIDNEGILTIADFGLASFFDPN-HKQPMTSRVVTLWYRPPELLLGATDYGVG 301
RD++ +N+L+ + +ADFGLA + N + ++ W P L G + +
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIK 183
Query: 302 VDLWSAGCILAELLAEK----PIMPGRTEVEQLHKIFKLCGSPSE 342
D+WS G +L EL + P M R ++Q+ + +++ P E
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PCPPE 227
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 68/222 (30%), Positives = 102/222 (45%), Gaps = 36/222 (16%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILILRR 173
+ FE + I G Y VY R T Q A+KK+ NL + + V F+ R+IL
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQV-FVERDILTFA- 58
Query: 174 LDHPNVVKLEG-LVTSRMSCSLYLVFKYMEH-DLAGL----AASPTIKFTQAQVKCYMHQ 227
++P VV + T R C +V +Y+E D A L A P + Y +
Sbjct: 59 -ENPFVVSMFCSFETKRHLC---MVMEYVEGGDCATLLKNIGALPV-----DMARMYFAE 109
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS-------------FFDPNHK 274
+ LE+ HN ++HRD+K NLLI + G + + DFGL+ + + +
Sbjct: 110 TVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 275 QPMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
+ + +V T Y PE++L YG VD W+ G IL E L
Sbjct: 170 EFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 58/236 (24%), Positives = 107/236 (45%), Gaps = 16/236 (6%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHP 177
TF + +G+G + V + TG++ A K++ ++ MA E IL +++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 178 NVVKLEGLVTSRMSCSLYLV------FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
VV L ++ + L L K+ +++ F + + Y ++L G
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG------FEEERALFYAAEILCG 114
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
LE H ++ ++RD+K N+L+D+ G + I+D GLA + + RV T+ Y PE
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPE- 171
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
+L Y + D W GC++ E++ + GR E + ++ + E Y K
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-14
Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 27/225 (12%)
Query: 114 PRRADTFEKLDKIGQGTYSNV----YKARDTLTGQIVALKKVRFDNLEPESVRFMAREIL 169
PR +T + + K+G G + V Y VA+K ++ ++ PE+ F+A E
Sbjct: 4 PR--ETLKLVKKLGAGQFGEVWMGYYNGH-----TKVAIKSLKQGSMSPEA--FLA-EAN 53
Query: 170 ILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD--LAGLAASPTIKFTQAQVKCYMHQ 227
++++L HP +V+L +VT +Y++ +YME+ + L IK T ++ Q
Sbjct: 54 LMKQLQHPRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ 110
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
+ G+ ++ +HRD++ +N+L+ IADFGLA + N + +
Sbjct: 111 IAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT 170
Query: 288 PPELLLGATDYG---VGVDLWSAGCILAELLAEKPI-MPGRTEVE 328
PE A +YG + D+WS G +L E++ I PG T E
Sbjct: 171 APE----AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 13/207 (6%)
Query: 122 KLDK-IGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
K++K IG G + V R L G+ VA+K ++ E + F++ E I+ + DHP
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS-EASIMGQFDHP 65
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N++ LEG+VT S + +V +YME+ L +FT Q+ + + SG+++
Sbjct: 66 NIIHLEGVVTK--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFF--DPNHKQPMTSRVVTLWYRPPELLLG 294
+ +HRD+ N+L+++ + ++DFGL+ DP + + + PE +
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIA 182
Query: 295 ATDYGVGVDLWSAGCILAELLA--EKP 319
+ D+WS G ++ E+++ E+P
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 5e-14
Identities = 55/190 (28%), Positives = 91/190 (47%), Gaps = 12/190 (6%)
Query: 163 FMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQA--- 219
+ EIL L RL+H N++K+E ++ R + Y++ + + DL +
Sbjct: 209 QLENEILALGRLNHENILKIEEIL--RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 220 -QVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278
Q + M QLL +E+ H++ ++HRDIK N+ ++ +G + + DFG A F+ +
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP----GRTEVEQLHKIF 334
V T+ PE+L G Y D+WS G IL ++L+ P G +QL KI
Sbjct: 327 GWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLS-HDFCPIGDGGGKPGKQLLKII 384
Query: 335 KLCGSPSEEY 344
EE+
Sbjct: 385 DSLSVCDEEF 394
|
Length = 501 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 54/229 (23%), Positives = 96/229 (41%), Gaps = 34/229 (14%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV-RFDNLEPESVRFMAREILILRRLDH 176
F+K+ +G+G V+ R TG++ ALK + + + ++ V+ + E IL LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKY-MEHDL-AGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
P + L + + L LV Y +L L P ++ + Y ++L LE+
Sbjct: 61 PFLPTLYA--SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLA----------------SFFDPNHKQPMT 278
H +++RD+K N+L+ G + ++DF L+ + +
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 279 SRVV------------TLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
T Y PE++ G +G VD W+ G +L E+L
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 71/299 (23%), Positives = 118/299 (39%), Gaps = 42/299 (14%)
Query: 133 NVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192
V+ A+ T +VA+KK+ D+ E ++ + +EI+ R+L HPN++ VTS +
Sbjct: 15 IVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP---YVTSFIVD 71
Query: 193 S-LYLVFKYMEH----DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKG 247
S LY+V M + DL L + + + +L+ L++ H++ +HR +K
Sbjct: 72 SELYVVSPLMAYGSCEDL--LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKA 129
Query: 248 SNLLIDNEGILTIADFGLA-SFFDPNHKQ-----PMTSRVVTLWYRPPELL----LGATD 297
S++L+ +G + ++ + S +Q S V L + PE+L G
Sbjct: 130 SHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG--- 186
Query: 298 YGVGVDLWSAGCILAEL------LAEKPIMPGRTE-----VEQLHKIFKLCGSPSEEYWK 346
Y D++S G EL + P E V L
Sbjct: 187 YNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQS 246
Query: 347 KSKLPHATIFKPQQS-YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
+S H Y R +E F F +E L DP R +A+ L FF
Sbjct: 247 RSSNEHPNNRDSVDHPYTRTFSEHFHQF-------VELCLQRDPESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 56/231 (24%), Positives = 102/231 (44%), Gaps = 32/231 (13%)
Query: 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLE 183
+ IG+G + V + TGQ VA+K ++ D + + E ++ +L H N+V+L
Sbjct: 12 EIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLL 65
Query: 184 GLVTSRMSCSLYLVFKYMEHD-------LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
G++ + LY+V + M G A I+ Q + + G+E+
Sbjct: 66 GVI---LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQ-----FSLDVAEGMEYLE 117
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
++ ++HRD+ N+L+ +G+ ++DFGLA S++ W P L
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLPVKWTAPEALKHK-- 172
Query: 297 DYGVGVDLWSAGCILAELL----AEKPIMPGRTEVEQLHKIFKLCGSPSEE 343
+ D+WS G +L E+ A P M + E + K +++ P E
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM--EPPEG 221
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 69/252 (27%), Positives = 105/252 (41%), Gaps = 40/252 (15%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDH 176
D FE L IG+G + V + TG I A+K +R D LE E V + E IL D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
VVK+ + + +LYL+ +++ D+ L ++ + Y+ + + ++
Sbjct: 61 AWVVKM--FYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAI 117
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGL------------------------------ 265
H +HRDIK NLL+D +G + ++DFGL
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 266 ----ASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIM 321
A + N +Q S V T Y PE+ + T Y D WS G I+ E+L P
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 322 PGRTEVEQLHKI 333
T E K+
Sbjct: 237 CSETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 50/195 (25%), Positives = 91/195 (46%), Gaps = 10/195 (5%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEG 184
+IG G + V+ L + VA+K +R + E E ++ +L HP +V+L G
Sbjct: 11 EIGSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEEDFI---EEAQVMMKLSHPKLVQLYG 66
Query: 185 LVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHR 243
+ T R + LVF++MEH L+ + KF+Q + + G+ + + +V+HR
Sbjct: 67 VCTER--SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 244 DIKGSNLLIDNEGILTIADFGLASF-FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGV 302
D+ N L+ ++ ++DFG+ F D + ++ W P Y
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS--KYSSKS 182
Query: 303 DLWSAGCILAELLAE 317
D+WS G ++ E+ +E
Sbjct: 183 DVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV-RFDNLEPESVRFMAREILILRRL 174
+A+ ++ + IG+G + V R + ++ A+K + +F+ ++ F E I+
Sbjct: 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
+ P VV+L + LY+V +YM DL L ++ + + K Y +++ L+
Sbjct: 101 NSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVP--EKWAKFYTAEVVLALD 156
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H+ ++HRD+K N+L+D G L +ADFG D + V T Y PE+L
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216
Query: 294 ---GATDYGVGVDLWSAGCILAELL 315
G YG D WS G L E+L
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 54/194 (27%), Positives = 91/194 (46%), Gaps = 11/194 (5%)
Query: 124 DKIGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
+KIG+G + +VYK L G VA+K R L P+ R +E IL++ DHPN+VKL
Sbjct: 1 EKIGKGNFGDVYKGV--LKGNTEVAVKTCRST-LPPDLKRKFLQEAEILKQYDHPNIVKL 57
Query: 183 EGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
G+ + +Y+V + + L + T ++ +G+E+ +++ +
Sbjct: 58 IGVCVQKQP--IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCI 115
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFDPN--HKQPMTSRVVTLWYRPPELLLGATDYG 299
HRD+ N L+ +L I+DFG++ + ++ W P L G Y
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR--YT 173
Query: 300 VGVDLWSAGCILAE 313
D+WS G +L E
Sbjct: 174 SESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 71/258 (27%), Positives = 100/258 (38%), Gaps = 48/258 (18%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDHPN 178
F K+ IG G + V R T + A+K +R D L + E IL D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
VVKL + + +LY V Y+ D+ L I F + + Y+ +L +E H
Sbjct: 63 VVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVHK 119
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH------------------------ 273
+HRDIK N+LID +G + + DFGL + F H
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 274 --KQPMT----------------SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
+ + S V T Y PE+LL T Y D WS G IL E+L
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEML 238
Query: 316 AEKPIMPGRTEVEQLHKI 333
+P T E K+
Sbjct: 239 VGQPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 58/218 (26%), Positives = 112/218 (51%), Gaps = 34/218 (15%)
Query: 123 LDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
L+++G+G + VYK + L+ VA+K ++ +N EP+ + +E ++ L HP
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQHP 68
Query: 178 NVVKLEGLVT-SRMSCSLYLVFKYMEH-DL----------AGLAASPTIKFTQAQVKC-- 223
N+V L G+ T + +C L F+Y+ H DL + + A + ++ + C
Sbjct: 69 NIVCLLGVCTKEQPTCML---FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 224 YMH---QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTS 279
++H Q+ +G+E+ + H +HRD+ N L+ + I+DFGL+ + ++ + +
Sbjct: 126 FLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 280 RVVTLWYRPPELLLGATDYG---VGVDLWSAGCILAEL 314
++ + + PPE +L YG D+WS G +L E+
Sbjct: 186 SLLPVRWMPPEAIL----YGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 72/264 (27%), Positives = 105/264 (39%), Gaps = 52/264 (19%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRF-DNLEPESVRFMAREILILRRLDHPN 178
F K+ +G G + V AR T + A+K +R D L V + E IL D+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
VV+L + + +LY V Y+ D+ L I F + + Y+ +L +E H
Sbjct: 63 VVRL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVHK 119
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK----------------------- 274
+HRDIK N+LID +G + + DFGL + F H
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 275 ----------QPMTSR-------------VVTLWYRPPELLLGATDYGVGVDLWSAGCIL 311
+P+ R V T Y PE+LL T Y D WS G IL
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVIL 238
Query: 312 AELLAEKPIMPGRTEVEQLHKIFK 335
E+L +P +T +E K+
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 79/339 (23%), Positives = 139/339 (41%), Gaps = 57/339 (16%)
Query: 125 KIGQG--TYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
+IG+G ++VY AR T TG +V ++ +N E ++ + E+++ HPN++
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK------FTQAQVKCYMHQLLSGLEHCH 236
+ T+ L+++ +M + +A+ +K ++A + + L GL + H
Sbjct: 65 WTVFTT--GSWLWVISPFMAYG----SANSLLKTYFPEGMSEALIGNILFGALRGLNYLH 118
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD-PNHKQ--------PMTSRVVTLWYR 287
+HR+IK S++LI +G+++++ GL+ + + Q P S V W
Sbjct: 119 QNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS 176
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHK----IFKLCGSPSEE 343
P L Y V D++S G EL GR + + + + KL G P
Sbjct: 177 PELLRQDLYGYNVKSDIYSVGITACELAT------GRVPFQDMLRTQMLLQKLKGPPYSP 230
Query: 344 YWKKSKLPHA-TIFKPQQS--------------------YKRCIAETFKDFPPSSLPLIE 382
+ P + K QS +R + K F P+ L+E
Sbjct: 231 -LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVE 289
Query: 383 TLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYPP 421
L DP +R +A++ L FF S L PP
Sbjct: 290 LCLQQDPEKRPSASSLLSHAFFKQVKEQTQGSILSLLPP 328
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 9/205 (4%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV-RFDNLEPESVRFMAREILILRRL 174
+A+ +E + IG+G + V R T ++ A+K + +F+ ++ F E I+
Sbjct: 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
+ P VV+L + LY+V +YM DL L ++ + A+ Y +++ L+
Sbjct: 101 NSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF--YTAEVVLALD 156
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H+ +HRD+K N+L+D G L +ADFG + + V T Y PE+L
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 216
Query: 294 ---GATDYGVGVDLWSAGCILAELL 315
G YG D WS G L E+L
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 76/318 (23%), Positives = 136/318 (42%), Gaps = 43/318 (13%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEG 184
+G+GT+ V R+ +G+ A+K ++ + + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK- 61
Query: 185 LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRD 244
+ + L V +Y+ S F++ + + Y +++S L++ H+ +++RD
Sbjct: 62 -YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 245 IKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDL 304
+K NL++D +G + I DFGL M + T Y PE +L DYG VD
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPE-VLEDNDYGRAVDW 178
Query: 305 WSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKR 364
W G ++ E++ + +P + + K+F+L I + R
Sbjct: 179 WGLGVVMYEMMCGR--LPFYNQDHE--KLFEL------------------ILMEDIKFPR 216
Query: 365 CIAETFKDFPPSSLPLIETLLAIDPAER-----QTATAALRSEFFTTKPY--ACDPSSLP 417
++ K L+ LL DP +R A +R FFT + D +P
Sbjct: 217 TLSADAKS-------LLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVP 269
Query: 418 KYPP--TKEMDAKLRDEE 433
+ P T E D + DEE
Sbjct: 270 PFKPQVTSETDTRYFDEE 287
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 80/321 (24%), Positives = 132/321 (41%), Gaps = 49/321 (15%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLE- 183
+G+GT+ V R+ TG+ A+K ++ + + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 184 GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHR 243
T C V +Y S F++ + + Y +++S L + H+ V++R
Sbjct: 63 SFQTHDRLC---FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 244 DIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVD 303
D+K NL++D +G + I DFGL + M + T Y PE +L DYG VD
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVD 177
Query: 304 LWSAGCILAELLAEKPIMPGRTEV-EQLH-KIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361
W G ++ E+ M GR Q H K+F+L I +
Sbjct: 178 WWGLGVVMYEM------MCGRLPFYNQDHEKLFEL------------------ILMEEIR 213
Query: 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAER-----QTATAALRSEFFTTKPY--ACDPS 414
+ R ++ K L+ LL DP +R + A + FF + +
Sbjct: 214 FPRTLSPEAKS-------LLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKK 266
Query: 415 SLPKYPP--TKEMDAKLRDEE 433
P + P T E D + DEE
Sbjct: 267 LEPPFKPQVTSETDTRYFDEE 287
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
+ IG+G + +V GQ VA+K ++ D+ ++ F+A E ++ L HPN+V
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQA--FLA-EASVMTTLRHPNLV 63
Query: 181 KLEGLVTSRMSCSLYLVFKYMEH----DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
+L G+V LY+V +YM D L + T AQ + + G+E+
Sbjct: 64 QLLGVVLQ--GNPLYIVTEYMAKGSLVDY--LRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
++ +HRD+ N+L+ + + ++DFGLA + + Q + ++ W P L
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQD-SGKLPVKWTAPEALREK-- 174
Query: 297 DYGVGVDLWSAGCILAELLA 316
+ D+WS G +L E+ +
Sbjct: 175 KFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 50/217 (23%), Positives = 92/217 (42%), Gaps = 10/217 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
F K+G G + V++ VA+K ++ D+L + +E+ L+RL H ++
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLL--KQQDFQKEVQALKRLRHKHL 64
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMH-QLLSGLEHCHN 237
+ L + + +Y++ + ME L SP + M Q+ G+ +
Sbjct: 65 ISLFAVCSV--GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
Q+ +HRD+ N+L+ + + +ADFGLA + ++ W P G
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT-- 180
Query: 298 YGVGVDLWSAGCILAELLAEKPI-MPGRTEVEQLHKI 333
+ D+WS G +L E+ + PG E +I
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 54/226 (23%), Positives = 106/226 (46%), Gaps = 24/226 (10%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ + L K+G G + V++ T VA+K ++ ++P+ F+ E I+++L HP
Sbjct: 6 TSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKD--FL-AEAQIMKKLRHP 61
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQ--AQVKCYMHQLL------ 229
+++L + T + +Y+V + M++ +++ Q A + QL+
Sbjct: 62 KLIQLYAVCT--LEEPIYIVTELMKY-------GSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 230 -SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRP 288
SG+ + Q+ +HRD+ N+L+ I +ADFGLA + + + +
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTA 172
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPI-MPGRTEVEQLHKI 333
PE L + + D+WS G +L E++ + PG T E L ++
Sbjct: 173 PEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 68/252 (26%), Positives = 107/252 (42%), Gaps = 40/252 (15%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDH 176
+ FE L IG+G + V + TG + A+K +R D LE E V + E IL D
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
VVK+ +++ LYL+ +++ D+ L T+ + + Y+ + + ++
Sbjct: 61 LWVVKMFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSI 117
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-----------------QPMT 278
H +HRDIK NLL+D++G + ++DFGL + H+ Q M
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 279 S-RVVTLWYR----------------PPELLLGATDYGVGVDLWSAGCILAELLAEKPIM 321
S R W R PE+ + T Y D WS G I+ E+L P
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 322 PGRTEVEQLHKI 333
T E K+
Sbjct: 237 CSETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-13
Identities = 49/149 (32%), Positives = 73/149 (48%), Gaps = 6/149 (4%)
Query: 167 EILILRRLDHPNVVKLEGL-VTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYM 225
E +LRRL HP V+ L + V ++C LV DL + AQV
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTC---LVLPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TL 284
QLLS +++ H + ++HRDIK N+L++ + + DFG A F + P + T+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAE 313
PE+L G Y VD+WSAG ++ E
Sbjct: 327 DTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 9e-13
Identities = 78/313 (24%), Positives = 129/313 (41%), Gaps = 60/313 (19%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESV--RFMAREILILRRLDHP 177
++ + IG+G VY A D + + VALKK+R D E + RF+ RE I L HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFL-REAKIAADLIHP 62
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYME-HDLAGLAAS-------PTIKFTQAQVKCYM---H 226
+V + + + +Y Y+E + L L S + V ++ H
Sbjct: 63 GIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA----------SFFDPNHKQP 276
++ + +E+ H++ VLHRD+K N+L+ G + I D+G A D + +
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 277 MTSR-------VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ 329
S V T Y PE LLG D+++ G IL ++L P R
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLS--FPYR----- 232
Query: 330 LHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDP 389
+ +K I P + +A +++ PP + LA+DP
Sbjct: 233 ------------RKKGRKISYRD-VILSPIE-----VA-PYREIPPFLSQIAMKALAVDP 273
Query: 390 AERQTATAALRSE 402
AER ++ L+ +
Sbjct: 274 AERYSSVQELKQD 286
|
Length = 932 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 126 IGQGTYSNVYKARDTL---TGQIVA---LKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+G+G Y V++ R TG+I A LKK + ++ A E IL + HP +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA-ERNILEAVKHPFI 62
Query: 180 VKLEGLVTSRMSCSLYLVFKY-------MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
V L + + LYL+ +Y M + G+ T F Y+ ++ L
Sbjct: 63 VDL--IYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF-------YLSEISLAL 113
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPEL 291
EH H Q +++RD+K N+L+D +G + + DFGL + H+ +T T+ Y PE+
Sbjct: 114 EHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEI 171
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
L+ + +G VD WS G ++ ++L P + + KI K
Sbjct: 172 LM-RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 41/177 (23%), Positives = 82/177 (46%), Gaps = 12/177 (6%)
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD--LAGLAASPTIKFTQAQVKCY 224
E ++ +L HPN+V+L G+ T + +++V +YM + L L K +
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRP--IFIVTEYMANGCLLNYLRERKG-KLGTEWLLDM 105
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF-FDPNHKQPMTSRVVT 283
+ +E+ + +HRD+ N L+ + ++ ++DFGLA + D + ++
Sbjct: 106 CSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV 165
Query: 284 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTE---VEQLHKIFKL 336
W PPE+ + + D+WS G ++ E+ +E K + VE + ++L
Sbjct: 166 KW-APPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 48/192 (25%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLE 183
++IG+G + V+ R VA+K R + L P+ +E IL++ HPN+V+L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 184 GLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLH 242
G+ T + +Y+V + ++ D + + ++ + +G+E+ ++H +H
Sbjct: 60 GVCTQKQP--IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 243 RDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVG 301
RD+ N L+ + +L I+DFG++ D + + + + + PE L Y
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE-ALNYGRYSSE 176
Query: 302 VDLWSAGCILAE 313
D+WS G +L E
Sbjct: 177 SDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 29/214 (13%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
A+ + L +IG+G + V K +G I+A+K++R E E R + +++R D
Sbjct: 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 177 PNVVKLEGLVTSR---------MSCSLYLVFKYM-EHDLAGLAASPTIKFTQAQVKCYMH 226
P +VK G + M SL +KY+ E + + K A VK
Sbjct: 63 PYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVK---- 118
Query: 227 QLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW 285
L + + ++HRD+K SN+L+D G + + DFG++ ++
Sbjct: 119 ----ALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG-----QLVDSIAKTRDAG 169
Query: 286 YRP---PELLL--GATDYGVGVDLWSAGCILAEL 314
RP PE + Y V D+WS G L E+
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 72/235 (30%), Positives = 102/235 (43%), Gaps = 37/235 (15%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKK-VRFDNLEPESVRFMAREILILRRLDH 176
+ E L +IG GT VYK R TG ++A+K+ R N E M ++ +L+ D
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV-VLKSHDC 73
Query: 177 PNVVKLEGLVTSR---------MSCSLYLVFKYMEH----DLAGLAASPTIKFTQAQVKC 223
P +VK G + MS L + K ++ D+ G K T A VK
Sbjct: 74 PYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-------KMTVAIVKA 126
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVV 282
L L+ H V+HRD+K SN+L+D G + + DFG++ D K T
Sbjct: 127 -----LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAG 176
Query: 283 TLWYRPPELLLGAT---DYGVGVDLWSAGCILAELL-AEKPIMPGRTEVEQLHKI 333
Y PE + Y + D+WS G L EL + P +TE E L KI
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 56/218 (25%), Positives = 103/218 (47%), Gaps = 14/218 (6%)
Query: 126 IGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEG 184
+G+G + V+K TL + VA+K + D + ++F++ E IL++ DHPN+VKL G
Sbjct: 3 LGKGNFGEVFKG--TLKDKTPVAVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLIG 59
Query: 185 LVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHR 243
+ T R +Y+V + + D + Q+ + +G+ + +++ +HR
Sbjct: 60 VCTQRQP--IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 244 DIKGSNLLIDNEGILTIADFGLASFFDPN-HKQPMTSRVVTLWYRPPELLLGATDYGVGV 302
D+ N L+ +L I+DFG++ D + ++ W P L G Y
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR--YSSES 175
Query: 303 DLWSAGCILAELLA----EKPIMPGRTEVEQLHKIFKL 336
D+WS G +L E + P M + EQ+ K +++
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM 213
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 14/224 (6%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL--EPESVRFMAREILILRRLDHPNVVKLE 183
IG+G++ V A+ G A+K ++ + + E MA ++L+ L HP +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 184 GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHR 243
+ + + LY V Y+ F + + + Y ++ S + + H+ ++++R
Sbjct: 63 --YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 244 DIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLLGATDYGVGV 302
D+K N+L+D++G + + DFGL + + TS T Y PE +L Y V
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPE-VLRKEPYDRTV 177
Query: 303 DLWSAGCILAELLAEKPIMPGRTEVEQ-----LHKIFKLCGSPS 341
D W G +L E+L P R +V Q LHK +L G +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILHKPLQLPGGKT 220
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 77/300 (25%), Positives = 131/300 (43%), Gaps = 35/300 (11%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
+ D FEK+ ++G G V+K +G I+A K + + ++P + RE+ +L +
Sbjct: 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECN 61
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
P +V G S S+ + ++M+ + + + ++ GL +
Sbjct: 62 SPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 119
Query: 236 HNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
+H ++HRD+K SN+L+++ G + + DFG++ + S V T Y PE L G
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQG 176
Query: 295 ATDYGVGVDLWSAGCILAEL-LAEKPIMPGRTEVEQLHKIF--KLCGSPSEEYWKKSKLP 351
T Y V D+WS G L E+ + PI P + ++L +F + G P+E P
Sbjct: 177 -THYSVQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFGCPVEGDPAESETSPRPRP 233
Query: 352 HATIFKPQQSY---KRCIAETFK--DF----PPSSLP----------LIETLLAIDPAER 392
+P SY R F+ D+ PP LP + L +PAER
Sbjct: 234 PG---RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAER 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVR--FMAREILILRRLDHPNVVKL 182
+G+G++ V A T + A+K ++ D LE + V + R +L L +HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTHL 61
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLH 242
T + L+ V +Y+ + +F +A+ + Y +++ GL+ H + +++
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 243 RDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV------TLWYRPPELLLGAT 296
RD+K N+L+D +G + IADFG+ K+ M T Y PE+L G
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMC-------KENMNGEGKASTFCGTPDYIAPEILKGQK 172
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
Y VD WS G +L E+L + G E E I
Sbjct: 173 -YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-12
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 29/170 (17%)
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV- 282
Y Q++SGLEH H + +++RD+K N+L+DN+G + I+D GLA + Q T
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAG 159
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342
T + PELL G +Y VD ++ G L E++A + P R E++
Sbjct: 160 TPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARG--PFRARGEKV------------ 204
Query: 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
+ +L + + F P+S E LLA DP +R
Sbjct: 205 ---ENKELKQRILNDSVTYPDK--------FSPASKSFCEALLAKDPEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 16/215 (7%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVR-------FMAREILILRRLDHPN 178
IG+G++ V A+ G+ A+K L+ +++ MA ++L+ + HP
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKV-----LQKKAILKKKEQKHIMAERNVLLKNVKHPF 57
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
+V L + + + LY V Y+ F + + + Y ++ S L + H+
Sbjct: 58 LVGLH--YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDY 298
++++RD+K N+L+D++G + + DFGL H + ++ T Y PE+L Y
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLR-KQPY 173
Query: 299 GVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
VD W G +L E+L P R E I
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 18/222 (8%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDHPN 178
F L +G+G++ V A T ++ A+K ++ D ++ + V E +L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 179 VVKLEGLVTSRMSC-----SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
+T SC LY V +Y+ KF + Y ++ GL
Sbjct: 62 ------FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLF 115
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPEL 291
H++ +++RD+K N+++D EG + IADFG+ N T+R T Y PE+
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFCGTPDYIAPEI 172
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
+ YG VD W+ G +L E+LA +P G E E I
Sbjct: 173 IA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 22/216 (10%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAR-EILILRRLDHPNVVKLEG 184
+G+G + V + TG++ A KK+ L+ +S MA E IL +++ P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 185 LVTSRMSCSLYLVF------KYMEHDLA--GLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
S+ L + KY +++ GL I ++ AQ+ C G+ H H
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYS-AQITC-------GILHLH 112
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ +++RD+K N+L+D++G ++D GLA + + +T R T Y PE+L
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEP 170
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHK 332
Y VD ++ GC + E++A + P + E++ K
Sbjct: 171 -YSYPVDWFAMGCSIYEMVAGR--TPFKDHKEKVAK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 7e-12
Identities = 55/219 (25%), Positives = 104/219 (47%), Gaps = 16/219 (7%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEG 184
K+GQG + V+ T + VA+K ++ + PE+ +E I+++L H +V L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPLYA 68
Query: 185 LVTSRMSCSLYLVFKYMEHD--LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLH 242
+V+ +Y+V ++M L L Q+ Q+ G+ + + +H
Sbjct: 69 VVSEE---PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125
Query: 243 RDIKGSNLLIDNEGILTIADFGLASFFDPN-HKQPMTSRVVTLWYRPPELLLGATDYGVG 301
RD++ +N+L+ + + IADFGLA + N + ++ W P L G + +
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIK 183
Query: 302 VDLWSAGCILAELLAEK----PIMPGRTEVEQLHKIFKL 336
D+WS G +L EL+ + P M R +EQ+ + +++
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (164), Expect = 8e-12
Identities = 62/235 (26%), Positives = 102/235 (43%), Gaps = 37/235 (15%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
R + +E + KIG G + V+ + T + K + + L+ + E+ ++R L
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMH-------QL 228
H N+V+ ++ + LY++ ++ + AG + K + K H QL
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCD---AGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127
Query: 229 LSGLEHCHN-------QHVLHRDIKGSNLL-----------------IDNEGILTIADFG 264
L L +CHN + VLHRD+K N+ ++ I I DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 265 LASFFDPNHKQPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAEK 318
L+ + + S V T +Y PELLL T Y D+W+ GCI+ EL + K
Sbjct: 188 LSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 64/225 (28%), Positives = 109/225 (48%), Gaps = 19/225 (8%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
+ D FE++ ++G G V K + +G I+A K + + ++P + RE+ +L +
Sbjct: 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECN 61
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQL----LSG 231
P +V G S S+ MEH + G + +K + + + ++ L G
Sbjct: 62 SPYIVGFYGAFYSDGEISIC-----MEH-MDGGSLDQVLKEAKRIPEEILGKVSIAVLRG 115
Query: 232 LEHCHNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPE 290
L + +H ++HRD+K SN+L+++ G + + DFG++ + S V T Y PE
Sbjct: 116 LAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPE 172
Query: 291 LLLGATDYGVGVDLWSAGCILAEL-LAEKPIMPGRTEVEQLHKIF 334
L G T Y V D+WS G L EL + PI P + ++L IF
Sbjct: 173 RLQG-THYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 8e-12
Identities = 61/235 (25%), Positives = 101/235 (42%), Gaps = 33/235 (14%)
Query: 126 IGQGTYSNV----YKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVK 181
+G G + +V Y + + VA+K ++ + RE ++ +LDHP +V+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVE-VAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 182 LEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQ-------AQVKCYMHQLLSGLEH 234
L G+ LV ME LA L P +K+ + + +K HQ+ G+ +
Sbjct: 61 LIGVCKGEPLM---LV---ME--LAPLG--PLLKYLKKRREIPVSDLKELAHQVAMGMAY 110
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGL--ASFFDPNHKQPMTS-RVVTLWYRPPEL 291
++H +HRD+ N+L+ N I+DFG+ A ++ + T+ R WY P +
Sbjct: 111 LESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 292 LLGATDYGVGVDLWSAGCILAELLA--EKPI--MPGRTEVEQLHKIFKLCGSPSE 342
G D+WS G L E + KP M G + L +L P E
Sbjct: 171 NYGKFSS--KSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL-PRPEE 222
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 9e-12
Identities = 51/194 (26%), Positives = 95/194 (48%), Gaps = 8/194 (4%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLE 183
IG+G+Y+ V R T +I A+K V+ + + + E + ++ E + + +HP +V L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 184 GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHR 243
+ L+ V +Y+ K + + Y ++ L + H + +++R
Sbjct: 63 SCFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 244 DIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLLGATDYGVGV 302
D+K N+L+D+EG + + D+G+ + TS T Y PE+L G DYG V
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSV 177
Query: 303 DLWSAGCILAELLA 316
D W+ G ++ E++A
Sbjct: 178 DWWALGVLMFEMMA 191
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 18/161 (11%)
Query: 122 KLDKI-GQGTYSNVYKAR---DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
KL KI G+G + +V + + D + VA+K ++ D + E ++ DHP
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 178 NVVKLEGLVTSRMSC-----SLYLVFKYMEH-DL------AGLAASPTIKFTQAQVKCYM 225
NV+KL G V S ++ +M+H DL + L P Q +K +M
Sbjct: 62 NVMKLIG-VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK-FM 119
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ G+E+ N++ +HRD+ N ++ + + +ADFGL+
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 26/220 (11%)
Query: 119 TFEKLDKIGQGTYSNVYKAR--DTLTG---QIVALKKVRFDNLEPESVRFMAREILILRR 173
T ++++G+ + VYK T G Q VA+K ++ D E E ++ R
Sbjct: 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRSR 64
Query: 174 LDHPNVVKLEGLVTSRMSCSL------------YLVFKYMEHDLAGLAASPTIKFTQAQV 221
L HPN+V L G+VT S+ +LV + D+ T+K T
Sbjct: 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124
Query: 222 KCYMH---QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGL-ASFFDPNHKQPM 277
++H Q+ +G+E + HV+H+D+ N+L+ ++ + I+D GL + ++ + M
Sbjct: 125 D-FVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 278 TSRVVTL-WYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
+ ++ + W P ++ G + + D+WS G +L E+ +
Sbjct: 184 GNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 46/202 (22%), Positives = 100/202 (49%), Gaps = 12/202 (5%)
Query: 126 IGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
IG G + V++ + G+ VA+K ++ E + F++ E I+ + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-EASIMGQFSHHNIIRL 71
Query: 183 EGLVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
EG+VT ++ +YME+ L +F+ Q+ + + +G+++ + + +
Sbjct: 72 EGVVTKFKP--AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFF--DPNHKQPMTSRVVTLWYRPPELLLGATDYG 299
HRD+ N+L+++ ++DFGL+ DP + + + + PE + +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIAYRKFT 188
Query: 300 VGVDLWSAGCILAELLA--EKP 319
D+WS G ++ E+++ E+P
Sbjct: 189 SASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 14/228 (6%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALK----KVRFDNLEPESVRFMAREILILRRLDHPNVVK 181
IG+G++ V A+ L G+ A+K K+ + E + + MA ++L+ + HP +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHI--MAERNVLLKNVKHPFLVG 60
Query: 182 LEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
L + + + LY V ++ F + + + Y ++ S L + H+ +++
Sbjct: 61 LH--YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVG 301
+RD+K N+L+D++G + + DFGL T+ T Y PE++ Y
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIR-KQPYDNT 176
Query: 302 VDLWSAGCILAELLAEKPIMPGRTEVEQ----LHKIFKLCGSPSEEYW 345
VD W G +L E+L P R E LHK L S W
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAW 224
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 30/208 (14%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVR--FMAREILILRRLDHPNVVKL 182
+G+G++ V A T ++ A+K ++ D L+ + V + IL L HP
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHP----- 56
Query: 183 EGLVTSRMSC-----SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
+T+ C L+ V +Y+ + KF + + + Y ++ L H
Sbjct: 57 --FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW------YRPPEL 291
V++RD+K N+L+D EG +ADFG+ K+ + + V T Y PE
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMC-------KEGILNGVTTTTFCGTPDYIAPE- 166
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKP 319
+L +YG VD W+ G ++ E++A +P
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 56/232 (24%), Positives = 104/232 (44%), Gaps = 36/232 (15%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR--DTLTGQ---IVALKKVRFDNLEPESVRFMAREI 168
PR + E + IGQG + V++AR L + +VA+K ++ + F RE
Sbjct: 3 PR--NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REA 59
Query: 169 LILRRLDHPNVVKLEGL-VTSRMSCSLYLVFKYMEH-DL--------------------- 205
++ DHPN+VKL G+ + C L+F+YM + DL
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMC---LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116
Query: 206 AGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGL 265
A + + + C Q+ +G+ + + +HRD+ N L+ ++ IADFGL
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 176
Query: 266 A-SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
+ + + ++ + + + + + PPE + Y D+W+ G +L E+ +
Sbjct: 177 SRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMARE--ILILRRLDHPNVVKL 182
+G+G++ V AR +G++ A+K ++ D L+ + V E IL L R +HP + +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLH 242
+ L+ V +++ + +F +A+ + Y ++ S L H++ +++
Sbjct: 62 --YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 243 RDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLLGATDYGVG 301
RD+K N+L+D+EG +ADFG+ + TS T Y PE +L YG
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPE-ILQEMLYGPS 176
Query: 302 VDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
VD W+ G +L E+L E + I
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 57/236 (24%), Positives = 104/236 (44%), Gaps = 16/236 (6%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHP 177
TF +G+G + V + TG++ A KK+ ++ MA E IL +++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 178 NVVKLEGLVTSRMSCSLYLV------FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
VV L ++ + L L K+ +++ F + + Y +L G
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG------FDEQRAIFYAAELCCG 114
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
LE + +++RD+K N+L+D+ G + I+D GLA + + RV T+ Y PE+
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAV--QIPEGETVRGRVGTVGYMAPEV 172
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
+ Y D W GC++ E++ + R E + ++ + EEY +K
Sbjct: 173 INNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-11
Identities = 38/150 (25%), Positives = 78/150 (52%), Gaps = 6/150 (4%)
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYM 225
E ++ +L H +V+L G+ T + +Y+V +YM + L +F +Q+
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRP--IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC 106
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF-FDPNHKQPMTSRVVTL 284
+ G+ + ++ +HRD+ N L+D++G + ++DFGL+ + D + + S+
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR 166
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAEL 314
W PPE+LL + + D+W+ G ++ E+
Sbjct: 167 W-SPPEVLL-YSKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 12/224 (5%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV-RFDNLEPESVRFMAREILILRRLDH 176
D FE + IG+G + V + T +I A+K + +++ L+ E +L D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKY-MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
+ L + LYLV Y + DL L + + + + Y+ +++ +
Sbjct: 61 QWITTLH--YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPELLL 293
H H +HRDIK N+L+D G + +ADFG S N + S V T Y PE+L
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 294 GATD----YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
D YG D WS G + E+L + + VE KI
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 5e-11
Identities = 53/213 (24%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 125 KIGQGTYSNVYKA--------RDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
++G+G + V+ A +D + + LK DN + RE +L L H
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKD----FHREAELLTNLQH 66
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DL----------AGLAA--SPTIKFTQAQVKC 223
++VK G+ L +VF+YM+H DL A L A + + TQ+Q+
Sbjct: 67 EHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVV 282
Q+ +G+ + +QH +HRD+ N L+ ++ I DFG++ + ++ + ++
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
+ + PPE ++ + D+WS G +L E+
Sbjct: 185 PIRWMPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 6/211 (2%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL--EPESVRFMAREILILRRLDHPNVVKLE 183
IG+G++ V AR + A+K ++ + + E M+ ++L+ + HP +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 184 GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHR 243
+ + + LY V Y+ F + + + Y ++ S L + H+ ++++R
Sbjct: 63 --FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 244 DIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVD 303
D+K N+L+D++G + + DFGL + H ++ T Y PE +L Y VD
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPE-VLHKQPYDRTVD 178
Query: 304 LWSAGCILAELLAEKPIMPGRTEVEQLHKIF 334
W G +L E+L P R E I
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 11/202 (5%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILRRLDH 176
EK+ +G G + VYK G+ V + KV + P++ + + E ++ +DH
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
P+VV+L G+ +S + L+ + M L + + + Q+ G+ +
Sbjct: 69 PHVVRLLGIC---LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS--RVVTLWYRPPELLL 293
+ ++HRD+ N+L+ + I DFGLA D + K+ +V W +L
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 294 GATDYGVGVDLWSAGCILAELL 315
Y D+WS G + EL+
Sbjct: 186 R--IYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 45/224 (20%)
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA--SFFDPNHKQPMTSRV 281
Y +++ GL+ H++ +++RD+K N+++D +G + IADFG+ + F N ++
Sbjct: 101 YAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFC 157
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS 341
T Y PE+L G Y VD WS G +L E+L + G E E I
Sbjct: 158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI-------- 208
Query: 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401
+ PH Y R I + KD ++E L DP R +R
Sbjct: 209 -----RVDTPH---------YPRWITKESKD-------ILEKLFERDPTRRLGVVGNIRG 247
Query: 402 E-FFTTKPYAC------DPSSLPKYPPTKE---MDAKLRDEEAR 435
FF T + DP PK + D + E+ R
Sbjct: 248 HPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPR 291
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 74/284 (26%), Positives = 127/284 (44%), Gaps = 43/284 (15%)
Query: 124 DKIGQGTYSNVY------------KARDTLTGQ--IVALKKVRFDNLEPESVRFMAREIL 169
+K+G+G + V+ + GQ +VA+K +R D + F+ +EI
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL-KEIK 69
Query: 170 ILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTI--KFTQAQ-VKC-- 223
I+ RL +PN+++L G+ S L ++ +YME+ DL + I FT A +
Sbjct: 70 IMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 224 -----YMH-QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277
YM Q+ SG+++ + + +HRD+ N L+ N + IADFG++ +
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187
Query: 278 TSRVV--TLWYRPPELLLGATDYGVGVDLWSAGCILAE---LLAEKP--IMPGRTEVEQL 330
R V W +LLG + D+W+ G L E L E+P ++ +E
Sbjct: 188 QGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENT 245
Query: 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFP 374
+ F+ G + Y ++ L + +FK RC + KD P
Sbjct: 246 GEFFRNQG--RQIYLSQTPLCPSPVFKLMM---RCWSRDIKDRP 284
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 15/219 (6%)
Query: 124 DKIGQGTYSNVYKAR-DTLTGQI--VALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
K+G G++ V + T G++ VA+K ++ D L F+ +E I+ LDH N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLI 59
Query: 181 KLEGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVKC-YMHQLLSGLEHCHNQ 238
+L G+V ++ L +V + L + C Y Q+ +G+ + ++
Sbjct: 60 RLYGVV---LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS--RVVTLWYRPPELLLGAT 296
+HRD+ N+L+ ++ + I DFGL N + V + PE L T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 297 DYGVGVDLWSAGCILAELLA--EKPIMPGRTEVEQLHKI 333
+ D+W G L E+ E+P G + + L KI
Sbjct: 177 -FSHASDVWMFGVTLWEMFTYGEEPWA-GLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 51/206 (24%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 126 IGQGTYSNVYKAR---DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
+G+G + +V +A+ + + Q VA+K ++ D + RE ++ DHPNV+KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 183 EGL-VTSRMSCSL---YLVFKYMEH-DL------AGLAASPTIKFTQAQVKCYMHQLLSG 231
G+ + SR L ++ +M+H DL + + P Q V+ +M + SG
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR-FMIDIASG 125
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFDPNHKQPMTSRVVTLWYRPP 289
+E+ +++ +HRD+ N +++ + +ADFGL+ + ++Q S++ W
Sbjct: 126 MEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALE 185
Query: 290 ELLLGATDYGVGVDLWSAGCILAELL 315
L Y D+W+ G + E++
Sbjct: 186 S--LADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 78/321 (24%), Positives = 138/321 (42%), Gaps = 48/321 (14%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEG 184
+G+GT+ V ++ TG+ A+K ++ + + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 61
Query: 185 LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHR 243
+ + L V +Y S F++ + + Y +++S L++ H++ +V++R
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 244 DIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVD 303
D+K NL++D +G + I DFGL M + T Y PE +L DYG VD
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVD 178
Query: 304 LWSAGCILAELLAEKPIMPGRTEV-EQLH-KIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361
W G ++ E+ M GR Q H K+F+L I +
Sbjct: 179 WWGLGVVMYEM------MCGRLPFYNQDHEKLFEL------------------ILMEEIR 214
Query: 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAER-----QTATAALRSEFFTTKPY--ACDPS 414
+ R ++ P + L+ LL DP +R A ++ +FF + +
Sbjct: 215 FPRTLS-------PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKK 267
Query: 415 SLPKYPP--TKEMDAKLRDEE 433
+P + P T E D + DEE
Sbjct: 268 LVPPFKPQVTSETDTRYFDEE 288
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
PR + EK K+G G + V+ A + VA+K ++ ++ SV E +++
Sbjct: 4 PRESLKLEK--KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSM---SVEAFLAEANVMKT 57
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD--LAGLAASPTIKFTQAQVKCYMHQLLSG 231
L H +VKL +VT +Y++ ++M L L + K ++ + Q+ G
Sbjct: 58 LQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 114
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
+ ++ +HRD++ +N+L+ + IADFGLA + N + + PE
Sbjct: 115 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE- 173
Query: 292 LLGATDYG---VGVDLWSAGCILAELLAEKPI-MPGRTEVE 328
A ++G + D+WS G +L E++ I PG + E
Sbjct: 174 ---AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 119 TFEKLDKIGQGTYSNVY--KARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
TF K ++G G + V+ K R + VA+K + + E F+ E ++ +L H
Sbjct: 7 TFMK--ELGSGQFGVVHLGKWRAQIK---VAIKAINEGAMSEED--FI-EEAKVMMKLSH 58
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
P +V+L G+ T + LY+V ++ME+ L K ++ + + G+E+
Sbjct: 59 PKLVQLYGVCTQQKP--LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL 116
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASF-FDPNHKQPMTSRVVTLWYRPPELLLG 294
+HRD+ N L+ + G++ ++DFG+ + D + ++ W PPE+
Sbjct: 117 ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW-SPPEVFN- 174
Query: 295 ATDYGVGVDLWSAGCILAELLAE 317
+ Y D+WS G ++ E+ E
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 72/302 (23%), Positives = 115/302 (38%), Gaps = 68/302 (22%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
R + E + +G G +V K + TG ++A KKV + + + RE+ I+
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECR 61
Query: 176 HPNVVKLEG---------LVTSRMSC----SLYLVFKYMEHDLAGLAASPTIKFTQAQVK 222
P +V G + M C +Y + ++ G A ++
Sbjct: 62 SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVE------- 114
Query: 223 CYMHQLLSGLEHCHNQH-VLHRDIKGSNLLIDNEGILTIADFGLA-----SFFDPNHKQP 276
GL + +N H ++HRDIK SN+L+++ G + + DFG++ S D
Sbjct: 115 --------GLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD------ 160
Query: 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL-LAEKPI-MPGRTEVEQLHK-- 332
+ V T Y PE + G Y V D+WS G + EL L + P + Q
Sbjct: 161 --TFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG 217
Query: 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
I L +E +LP + DFP ++ L DP ER
Sbjct: 218 ILDLLQQIVQE--PPPRLPSS------------------DFPEDLRDFVDACLLKDPTER 257
Query: 393 QT 394
T
Sbjct: 258 PT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 49/192 (25%), Positives = 85/192 (44%), Gaps = 30/192 (15%)
Query: 214 IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPN 272
+ F + +V +Q++ L+ H++ ++HRD+K +N+ + GI+ + DFG + + D
Sbjct: 164 LPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223
Query: 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHK 332
+S T +Y PE L Y D+WS G IL ELL LH+
Sbjct: 224 SLDVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLT-------------LHR 269
Query: 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
FK PS+ ++ ++ + ++ K L++ LL+ +PA R
Sbjct: 270 PFK---GPSQR-----EIMQQVLYGKYDPFPCPVSSGMK-------ALLDPLLSKNPALR 314
Query: 393 QTATAALRSEFF 404
T L +EF
Sbjct: 315 PTTQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 48/218 (22%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 123 LDKIGQGTYSNVYKARDTLTG----QIVALKKVRFDNLEPESVRFMAREILILRRLDHPN 178
++++G+ + +YK L G Q+VA+K ++ D P+ +E ++ L HPN
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPN 68
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKC--------------- 223
+V L G+VT + ++F+Y+ L ++ + V C
Sbjct: 69 IVCLLGVVTQEQP--VCMLFEYLNQ--GDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 224 -YMH---QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMT 278
++H Q+ +G+E+ + +H+D+ N+LI + + I+D GL+ + ++ +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
++ + + PPE ++ + D+WS G +L E+ +
Sbjct: 185 KSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 66/228 (28%), Positives = 102/228 (44%), Gaps = 32/228 (14%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D FEKL ++G G V K +G I+A K + + ++P + RE+ +L + P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSP 59
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH------DL----AGLAASPTI-KFTQAQVKCYMH 226
+V G S S+ MEH D AG + K + A ++
Sbjct: 60 YIVGFYGAFYSDGEISIC-----MEHMDGGSLDQVLKKAGRIPENILGKISIAVLR---- 110
Query: 227 QLLSGLEHCHNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW 285
GL + +H ++HRD+K SN+L+++ G + + DFG++ S V T
Sbjct: 111 ----GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRS 163
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEK-PI-MPGRTEVEQLH 331
Y PE L G T Y V D+WS G L E+ + PI P E+E +
Sbjct: 164 YMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 18/224 (8%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDHPN 178
F L +G+G++ V A T ++ A+K ++ D ++ + V E +L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 179 VVKLEGLVTSRMSC-----SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
+T SC LY V +Y+ +F + Y ++ GL
Sbjct: 62 ------FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF 115
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPEL 291
H++ +++RD+K N+++D+EG + IADFG+ N +T++ T Y PE
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPE- 171
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
++ YG VD W+ G +L E+LA + G E E I +
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 64/266 (24%), Positives = 102/266 (38%), Gaps = 56/266 (21%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDH 176
+ F + IG+G + V + TG+I A+K + + + + + + E +L D
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQLLSGLE 233
P VV L + + + LYL+ ME G + IK F++ + YM + + +E
Sbjct: 61 PWVVSL--YYSFQDAQYLYLI---MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIE 115
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-----KQPMTSRVVT----- 283
H +HRDIK N+LID G + ++DFGL++ F H ++ + +
Sbjct: 116 AVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175
Query: 284 --------------------LW----------------YRPPELLLGATDYGVGVDLWSA 307
W Y PE+ L YG D WS
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSL 234
Query: 308 GCILAELLAEKPIMPGRTEVEQLHKI 333
G I+ E L P E KI
Sbjct: 235 GAIMFECLIGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 16/200 (8%)
Query: 126 IGQGTYSNVYKARDTLTGQI---VALKKV-RFDNLEPESVRFMAREILILRRLDHPNVVK 181
IG+G + VY + A+K + R +LE V +E +I++ HPNV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE--EVEQFLKEGIIMKDFSHPNVLS 60
Query: 182 LEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
L G+ L +V YM+H DL S T T + + Q+ G+E+ ++
Sbjct: 61 LLGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF 119
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRPPELL----LGA 295
+HRD+ N ++D + +ADFGLA +D + L P + + L
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL---PVKWMALESLQT 176
Query: 296 TDYGVGVDLWSAGCILAELL 315
+ D+WS G +L EL+
Sbjct: 177 QKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 6e-10
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 8/223 (3%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV-RFDNLEPESVRFMAREILILRRLDH 176
+ FE L IG+G + V + ++ A+K + +++ L+ E +L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKY-MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
+ L + +LYLV Y + DL L + + + + Y+ +++ ++
Sbjct: 61 QWITTLH--YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H H +HRDIK N+L+D G + +ADFG + + V T Y PE+L
Sbjct: 119 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 296 TD----YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIF 334
D YG D WS G + E+L + + VE KI
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 62/223 (27%), Positives = 95/223 (42%), Gaps = 10/223 (4%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV-RFDNLEPESVRFMAREILILRRLDH 176
D FE L IG+G + V + TGQ+ A+K + +++ L+ E +L D
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKY-MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
+ L + LYLV Y + DL L + + + + Y+ +++ ++
Sbjct: 61 RWITNLHYAFQDENN--LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H +HRDIK N+L+D G + +ADFG + V T Y PE+L
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 296 TD----YGVGVDLWSAGCILAELL-AEKPIMPGRTEVEQLHKI 333
D YG D WS G + E+L E P VE KI
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 51/196 (26%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLD-HPNVVKLE 183
IG+G+Y+ V R QI A+K V+ + + + E + ++ E + + +P +V L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 184 GL--VTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
TSR L+LV +Y+ K + + Y ++ L H + ++
Sbjct: 63 SCFQTTSR----LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGII 118
Query: 242 HRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGV 300
+RD+K N+L+D +G + + D+G+ P ++ T Y PE+L G +YG
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRG-EEYGF 175
Query: 301 GVDLWSAGCILAELLA 316
VD W+ G ++ E++A
Sbjct: 176 SVDWWALGVLMFEMMA 191
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 68/259 (26%), Positives = 100/259 (38%), Gaps = 54/259 (20%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRF-DNLEPESVRFMAREILILRRLDHPN 178
F K+ +G G + V A T + A+K +R D L V + E IL D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
VVKL + + LY V Y+ D+ L + F + + Y+ +L +E H
Sbjct: 63 VVKLYYSFQDKDN--LYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHK 119
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFF----------DPNHKQPMTSRVVTLW-- 285
+HRDIK N+LID +G + + DFGL + F +H + + LW
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 286 ----------------------------------YRPPELLLGATDYGVGVDLWSAGCIL 311
Y PE+LL Y D WS G IL
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVIL 238
Query: 312 AELLAEKP--IMPGRTEVE 328
E+L +P + P TE +
Sbjct: 239 FEMLVGQPPFLAPTPTETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-10
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 142 TGQIVALKKVRFDNLEPESVRF-MAREILILRRLDHPNVVKL--EGLVTSRMSCSLYLVF 198
TG VA+K +R D E E R RE + RL HPN+V L G + L+ VF
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL---LFAVF 58
Query: 199 KYME-HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI 257
+Y+ L + A+ + M Q+L L HNQ ++HRD+K N+++ G+
Sbjct: 59 EYVPGRTLREVLAADGA-LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 258 LTIA---DFGLASFFDPNHKQ-----PMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAG 308
A DFG+ + T+ V+ T Y PE L G DL++ G
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP-VTPNSDLYAWG 176
Query: 309 CILAELLAEKPIMPGRTEVEQLHK 332
I E L + ++ G + E L++
Sbjct: 177 LIFLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 125 KIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
++G+G + V+ A T +VA+K ++ L + RE +L L H ++
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHI 69
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAGL--AASPTIKF------TQAQVKCYMHQLL- 229
VK G+ L +VF+YM+H DL A P QA+ + + Q+L
Sbjct: 70 VKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 230 ------SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVV 282
SG+ + +QH +HRD+ N L+ ++ I DFG++ + ++ + ++
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
+ + PPE ++ + D+WS G IL E+
Sbjct: 188 PIRWMPPESIM-YRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 9e-10
Identities = 52/219 (23%), Positives = 99/219 (45%), Gaps = 20/219 (9%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP--ESVRFMAREILILRRLD 175
++ + + K+G G + V+ G KV L+P SV+ E +++ L
Sbjct: 6 ESIKLVKKLGAGQFGEVW------MGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQ 59
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHD--LAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
H +V+L +VT +Y++ +YM L L + K ++ + Q+ G+
Sbjct: 60 HDKLVRLYAVVTKEEP--IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ ++ +HRD++ +N+L+ + IADFGLA + N + + PE
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE--- 174
Query: 294 GATDYG---VGVDLWSAGCILAELLAEKPI-MPGRTEVE 328
A ++G + D+WS G +L E++ I PG + +
Sbjct: 175 -AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 38/157 (24%), Positives = 71/157 (45%), Gaps = 22/157 (14%)
Query: 125 KIGQGTYSNVYKARDTLTGQI-----VALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
IG+G + +VY+ VA+K + +F+ E I+R+ DHP++
Sbjct: 13 CIGEGQFGDVYQG--VYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-EAYIMRQFDHPHI 69
Query: 180 VKLEGLVTSRMS------CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
VKL G++T L + Y++ + L + I + Y QL + L
Sbjct: 70 VKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILY------SY--QLSTALA 121
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270
+ ++ +HRDI N+L+ + + + DFGL+ + +
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 50/196 (25%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLE 183
IG+G+Y+ V T +I A+K ++ + + + E + ++ E + +HP +V L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 184 GL--VTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
SR L+ V +++ K + + Y ++ L H + ++
Sbjct: 63 SCFQTESR----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGII 118
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLLGATDYGV 300
+RD+K N+L+D EG + + D+G+ + TS T Y PE+L G DYG
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRG-EDYGF 175
Query: 301 GVDLWSAGCILAELLA 316
VD W+ G ++ E++A
Sbjct: 176 SVDWWALGVLMFEMMA 191
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 26/229 (11%)
Query: 126 IGQGTYSNVYK--ARDTL---TGQI-VALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+G G + VY+ A D L +G I VA+K +R + E F+ E ++ +HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK-EAHLMSNFNHPNI 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DL------AGLAASPTIKFTQAQVKCYMHQLLSGL 232
VKL G+ ++ Y++ + ME DL A + T ++ + G
Sbjct: 62 VKLLGVCL--LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEG-----ILTIADFGLA-SFFDPNHKQPMTSRVVTLWY 286
+ H +HRD+ N L+ +G ++ I DFGLA + ++ + ++ + +
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAELL--AEKPIMPGRTEVEQLHKI 333
PE LL + D+WS G ++ E+L ++P P E L +
Sbjct: 180 MAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQP-YPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 39/238 (16%)
Query: 114 PRRADTFEKLDKIGQGTYSNV----------YKARDTLTGQI------VALKKVRFDNLE 157
PR+ TF+ +K+G+G + V + +D VA+K +R D +
Sbjct: 3 PRKRLTFK--EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 158 PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME----------HDLAG 207
F+ +EI I+ RL PN+++L L S L ++ +YME H+
Sbjct: 61 NARNDFL-KEIKIMSRLKDPNIIRL--LAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117
Query: 208 LAASPTIKFTQAQVKCYMH-QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
A + +M Q+ SG+++ + + +HRD+ N L+ + IADFG++
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 267 SFFDPNHKQPMTSRVV--TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA---EKP 319
+ R V W +LLG + D+W+ G L E+L E+P
Sbjct: 178 RNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTLCKEQP 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 52/231 (22%), Positives = 102/231 (44%), Gaps = 33/231 (14%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYK--ARDTLTGQI---VALKKVRFDNLEPESVRFMAR 166
W R + + ++GQG++ VY+ A+ + G+ VA+K V + E + F+
Sbjct: 1 WELPR-EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN- 58
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLA--------------GLAAS 211
E +++ + +VV+L G+V+ +V + M DL GL
Sbjct: 59 EASVMKEFNCHHVVRLLGVVS--TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP 116
Query: 212 PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFD 270
KF Q ++ G+ + + +HRD+ N ++ + + I DFG+ ++
Sbjct: 117 TLQKFIQ-----MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE 171
Query: 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKP 319
++ + ++ + + PE L + D+WS G +L E+ LAE+P
Sbjct: 172 TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 25/212 (11%)
Query: 124 DKIGQGTYSNVYKARDTLTG--QIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVV 180
D IG+G + V KAR G A+K+++ + + R A E+ +L +L HPN++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 181 KLEGLVTSRMSCSLYLVFKYMEH---------------DLA-GLAASPTIKFTQAQVKCY 224
L G R LYL +Y H D A +A S + Q+ +
Sbjct: 72 NLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL 284
+ G+++ + +HRD+ N+L+ + IADFGL+ + K+ M R+
Sbjct: 130 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVR 188
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
W L + Y D+WS G +L E+++
Sbjct: 189 WMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 69/268 (25%), Positives = 105/268 (39%), Gaps = 45/268 (16%)
Query: 166 REILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDL-AGLAASPTIKFTQAQVKCY 224
REI IL+ + H ++ L + R ++ +V + DL + S + QA
Sbjct: 135 REIDILKTISHRAIINL--IHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAIT--I 190
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT-SRVVT 283
+LL L + H + ++HRD+K N+ +D + DFG A D + P T
Sbjct: 191 QRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250
Query: 284 LWYRPPELLLGATD-YGVGVDLWSAGCILAELLAEKPIMPGR---TEVEQLHKIFKLCGS 339
L PELL A D Y D+WSAG +L E+ + + G+ + QL I +
Sbjct: 251 LETNSPELL--ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQV 308
Query: 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDF-----PPSSLP--------------L 380
H F S C + FK + PP ++P L
Sbjct: 309 ------------HPLEFPQNGSTNLC--KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYL 354
Query: 381 IETLLAIDPAERQTATAALRSEFFTTKP 408
I +L D R +A L FT +P
Sbjct: 355 IAKMLTFDQEFRPSAQDILSLPLFTKEP 382
|
Length = 392 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 125 KIGQGTYSNVYKA--------RDTLTGQIVALKKVRFDNLEPESVRF-MAREILILRRLD 175
++G+G + V+ A +D + + ALK+ ES R RE +L L
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS------ESARQDFQREAELLTVLQ 65
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHD---------------LAGLAASPTIKFTQAQ 220
H ++V+ G+ T L +VF+YM H LAG + T Q
Sbjct: 66 HQHIVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQ 123
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTS 279
+ Q+ SG+ + + H +HRD+ N L+ ++ I DFG++ + ++ +
Sbjct: 124 MLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 183
Query: 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
++ + + PPE +L + D+WS G +L E+
Sbjct: 184 TMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 116 RADTFEKLDKIGQGTYSNV----YKARDTLTGQIVALKKVRFDNLEPESVRFMAREILIL 171
+ + F + +G G++ V YK D I +K + ++ + V + E IL
Sbjct: 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI--IKQKQVDHVFSERKIL 85
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKC-YMHQLLS 230
++HP V L G + + LYLV +++ +F V C Y Q++
Sbjct: 86 NYINHPFCVNLYG--SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN-DVGCFYAAQIVL 142
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRP-- 288
E+ + ++++RD+K NLL+D +G + + DFG A D +R TL P
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD--------TRTYTLCGTPEY 194
Query: 289 --PELLLGATDYGVGVDLWSAGCILAELLAEKP 319
PE+LL +G D W+ G + E+L P
Sbjct: 195 IAPEILLN-VGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 8e-09
Identities = 61/232 (26%), Positives = 110/232 (47%), Gaps = 29/232 (12%)
Query: 125 KIGQGTYSNVYKA--RDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
++G G + V K + + + VA+K ++ DN +P + RE ++++LD+P +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKF-------TQAQVKCYMHQLLSGLEHC 235
G+ + S LV ME LA L P KF T+ + +HQ+ G+++
Sbjct: 62 IGICEAE---SWMLV---ME--LAELG--PLNKFLQKNKHVTEKNITELVHQVSMGMKYL 111
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF--DPNHKQPMTSRVVTL-WYRPPELL 292
+ +HRD+ N+L+ + I+DFGL+ D N+ + T + WY P
Sbjct: 112 EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE--C 169
Query: 293 LGATDYGVGVDLWSAGCILAELLA--EKPI--MPGRTEVEQLHKIFKLCGSP 340
+ + D+WS G ++ E + +KP M G EV Q+ + + P
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEVTQMIESGERMECP 220
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 30/200 (15%)
Query: 134 VYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192
VYK R QI VA+K ++ +N E M RE I+ +LD+P +V++ G+ +
Sbjct: 15 VYKMRKK---QIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE--- 67
Query: 193 SLYLVFKYMEHDLAGLAASPTIKF--------TQAQVKCYMHQLLSGLEHCHNQHVLHRD 244
+L LV ME G P KF T + V MHQ+ G+++ ++ +HRD
Sbjct: 68 ALMLV---MEMASGG----PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRD 120
Query: 245 IKGSNLLIDNEGILTIADFGLASFF---DPNHKQPMTSRVVTLWYRPPELLLGATDYGVG 301
+ N+L+ N+ I+DFGL+ D +K + WY P + +
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF--RKFSSR 178
Query: 302 VDLWSAGCILAELLA--EKP 319
D+WS G + E + +KP
Sbjct: 179 SDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 48/204 (23%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 126 IGQGTYSNVYKARDTLTGQI--VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLE 183
+G+G + +V + + I VA+K ++ + E + ++ DHPNV++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 184 GLVTSRMSCSLY----LVFKYMEH-DL------AGLAASPTIKFTQAQVKCYMHQLLSGL 232
G+ + Y ++ +M+H DL + L P TQ VK +M + SG+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIASGM 125
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFDPNHKQPMTSRVVTLWYRPPE 290
E+ ++ +HRD+ N +++ + +ADFGL+ + ++Q +++ W
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES 185
Query: 291 LLLGATDYGVGVDLWSAGCILAEL 314
L Y D+WS G + E+
Sbjct: 186 --LADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 34/276 (12%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-----ESVRFMAREI 168
PR +F K +G G + V +A + A+ KV L+P E M+ E+
Sbjct: 33 PRNNLSFGKT--LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS-EL 89
Query: 169 LILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKF-TQAQVKCYM 225
I+ L +H N+V L G T + + ++ +Y + DL F T + +
Sbjct: 90 KIMSHLGNHENIVNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS 147
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFDPNHKQPMTSRVVT 283
+Q+ G+ +++ +HRD+ N+L+ + I+ I DFGLA D N+ +R+
Sbjct: 148 YQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207
Query: 284 LWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKIFKLCGSPS 341
W P + Y D+WS G +L E+ L P PG + +K+ K
Sbjct: 208 KWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSNP-YPGMPVDSKFYKLIK------ 258
Query: 342 EEYWKKSKLPHATIFKPQQSY---KRCIAETFKDFP 374
E ++ ++ HA P + Y K C P
Sbjct: 259 -EGYRMAQPEHA----PAEIYDIMKTCWDADPLKRP 289
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 50/208 (24%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 126 IGQGTYSNVYKAR-----DTLTGQIV---ALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+G+G + V+ A+ + +V AL+K + +NL+ E RE+ + R+L H
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE----FRRELDMFRKLSHK 68
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYME-HDL-----AGLAASPTIK---FTQAQVKCYMHQL 228
NVV+L GL R + Y++ +Y + DL A + +K + Q Q+
Sbjct: 69 NVVRLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ--PMTSRVVTLWY 286
G++H N +HRD+ N L+ ++ + ++ L+ D + + + + ++ L +
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIPLRW 184
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAEL 314
PE + D+ D+WS G ++ E+
Sbjct: 185 LAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 50/193 (25%), Positives = 80/193 (41%), Gaps = 20/193 (10%)
Query: 129 GTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTS 188
G V DT T Q LK +R + R +I + PN+V L + S
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRE-----RLTIIPHCV--PNMVCLHKYIVS 56
Query: 189 RMSCSLYLVFKYMEHDLAGLAASPTIKFT---QAQVKCYMHQLLSGLEHCHNQHVLHRDI 245
S VF ++H G S KF + VK + +++ L+ H + ++ RD+
Sbjct: 57 EDS-----VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDL 111
Query: 246 KGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLW 305
+N+L+D+ G + + F S + + + Y PE + G ++ D W
Sbjct: 112 NPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPE-VGGISEETEACDWW 166
Query: 306 SAGCILAELLAEK 318
S G IL ELL K
Sbjct: 167 SLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 49/225 (21%), Positives = 97/225 (43%), Gaps = 37/225 (16%)
Query: 123 LDK-IGQGTYSNVYKARDT-LTGQ----IVALKKVRFDNLEPESVRFMAREILILRRLDH 176
L K +G+G + V KA L G+ VA+K ++ +N +R + E +L++++H
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQVNH 62
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH------------------------DLAGLAASP 212
P+V+KL G + L L+ +Y ++ + + L
Sbjct: 63 PHVIKLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 213 TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFD 270
T + + Q+ G+++ ++HRD+ N+L+ + I+DFGL+ + +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
++ + R+ W L Y D+WS G +L E++
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 34/214 (15%)
Query: 146 VALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKY---- 200
VA+K ++ D+ + + + E+ +++ + H N++ L G T LY++ +Y
Sbjct: 50 VAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKG 106
Query: 201 -------------MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKG 247
ME+ +A P + T + +Q+ G+E+ +Q +HRD+
Sbjct: 107 NLREYLRARRPPGMEYSY-DIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165
Query: 248 SNLLIDNEGILTIADFGLASFFDPN----HKQPMTSRVVTLWYRPPELLLGATDYGVGVD 303
N+L+ ++ IADFGLA D N +K+ R+ W P L Y D
Sbjct: 166 RNVLVTENNVMKIADFGLAR--DVNNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSD 221
Query: 304 LWSAGCILAEL--LAEKPIMPGRTEVEQLHKIFK 335
+WS G ++ E+ L P PG VE+L K+ K
Sbjct: 222 VWSFGVLMWEIFTLGGSP-YPG-IPVEELFKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 38/130 (29%), Positives = 61/130 (46%), Gaps = 14/130 (10%)
Query: 146 VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-D 204
VA+K +R D + F+ +E+ IL RL PN+ +L G+ T L ++ +YME+ D
Sbjct: 49 VAVKVLRPDASDNAREDFL-KEVKILSRLSDPNIARLLGVCTV--DPPLCMIMEYMENGD 105
Query: 205 L---------AGLAASPTIKFTQAQVKCYMH-QLLSGLEHCHNQHVLHRDIKGSNLLIDN 254
L + K YM Q+ SG+ + + + +HRD+ N L+
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165
Query: 255 EGILTIADFG 264
+ IADFG
Sbjct: 166 NYTIKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 4/103 (3%)
Query: 216 FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFDPNH 273
T + CY Q+ G+E ++ +HRD+ N+L+ ++ I DFGLA + DP++
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235
Query: 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
+ +R+ W P + Y + D+WS G +L E+ +
Sbjct: 236 VRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 41/161 (25%), Positives = 78/161 (48%), Gaps = 9/161 (5%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPES-VRFMAREILILRRLD 175
+++ +G G + VYK G+ V + K+ + P++ V FM E LI+ +D
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFM-DEALIMASMD 67
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
HP++V+L G+ +S ++ LV + M H L + + Q+ G+ +
Sbjct: 68 HPHLVRLLGVC---LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMY 124
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275
+ ++HRD+ N+L+ + + I DFGLA + + K+
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 67/242 (27%), Positives = 110/242 (45%), Gaps = 45/242 (18%)
Query: 126 IGQGTYSNVYKARDTLTG-------QIVALKKVRFDNLEPESVRFMAREILILRRL-DHP 177
+G+G + V KA G VA+K ++ D E + ++ E+ +++ + H
Sbjct: 20 LGEGAFGQVVKA--EAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS-EMEMMKMIGKHK 76
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------AGLAASPTI------KFTQAQV 221
N++ L G+ T LY+V +Y H +L G ASP TQ +
Sbjct: 77 NIINLLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 222 KCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH----KQPM 277
+ +Q+ G+E ++ +HRD+ N+L+ + ++ IADFGLA D +H ++
Sbjct: 135 VSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTT 192
Query: 278 TSRVVTLWYRPPELLLGATD--YGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
R+ W P L D Y D+WS G +L E+ L P PG VE+L K+
Sbjct: 193 NGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLLWEIFTLGGSP-YPG-IPVEELFKL 246
Query: 334 FK 335
K
Sbjct: 247 LK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 35/117 (29%), Positives = 55/117 (47%), Gaps = 5/117 (4%)
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD--PNHKQPMT 278
V C +Q+ G+E+ +Q +HRD+ N+L+ + ++ IADFGLA +K+
Sbjct: 137 VSC-AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
R+ W P L Y D+WS G +L E+ VE+L K+ K
Sbjct: 196 GRLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 53/232 (22%), Positives = 90/232 (38%), Gaps = 40/232 (17%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL-EG 184
+G G V A+ G+ A+K V + + E+ L D ++VK E
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99
Query: 185 LVTS-----RMSCSLYLVFKY-----MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
+ LV Y + ++ A + F + + Q+L + H
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNR-TFREHEAGLLFIQVLLAVHH 158
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF--------------DPNHKQPMTSR 280
H++H++HRDIK +N+L+ + G++ + DFG + + P + P
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP---- 214
Query: 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHK 332
+W R P Y D++S G +L ELL K G E +HK
Sbjct: 215 --EIWRRKP--------YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 4/103 (3%)
Query: 216 FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFDPNH 273
T + CY Q+ G+E ++ +HRD+ N+L+ ++ I DFGLA + DP++
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230
Query: 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
+ ++R+ W P + Y D+WS G +L E+ +
Sbjct: 231 VRKGSARLPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 51/224 (22%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGL 185
IG+G + +V G VA+K ++ D + F+A E ++ +L H N+V+L G+
Sbjct: 14 IGKGEFGDVMLG--DYRGNKVAVKCIKND---ATAQAFLA-EASVMTQLRHSNLVQLLGV 67
Query: 186 VTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVK------CYMH---QLLSGLEHCH 236
+ LY+V +YM A + + +++ + C + + +E+
Sbjct: 68 IVEEKG-GLYIVTEYM-------AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 119
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ +HRD+ N+L+ + + ++DFGL + + Q T ++ W P L
Sbjct: 120 ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD-TGKLPVKWTAPEALR--EK 174
Query: 297 DYGVGVDLWSAGCILAELLA----EKPIMPGRTEVEQLHKIFKL 336
+ D+WS G +L E+ + P +P + V ++ K +K+
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 218
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 44/201 (21%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 146 VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD- 204
VA+ +R + + F+A E L L + DH N+V+LEG++T ++ +V +YM +
Sbjct: 36 VAIHTLRAGCSDKQRRGFLA-EALTLGQFDHSNIVRLEGVITR--GNTMMIVTEYMSNGA 92
Query: 205 LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264
L + Q+ + L SG+++ +H+ + +L++++ + I+ F
Sbjct: 93 LDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
Query: 265 LASFFDPNHK-----QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA--E 317
K M+ + LW P + + D+WS G ++ E+++ E
Sbjct: 153 RL----QEDKSEAIYTTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWEVMSYGE 206
Query: 318 KPI--MPGRTEVEQLHKIFKL 336
+P M G+ ++ + F+L
Sbjct: 207 RPYWDMSGQDVIKAVEDGFRL 227
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 40/121 (33%), Positives = 61/121 (50%), Gaps = 13/121 (10%)
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH----KQP 276
V C +Q+ G+E+ ++ +HRD+ N+L+ + ++ IADFGLA D +H K+
Sbjct: 143 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDYYKKT 199
Query: 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKIF 334
R+ W P L Y D+WS G +L E+ L P PG VE+L K+
Sbjct: 200 TNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG-VPVEELFKLL 255
Query: 335 K 335
K
Sbjct: 256 K 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 13/203 (6%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQ----IVALKKVRFDNLEPESVRFMAREILILRRLD 175
F+K+ +G G + VYK G+ VA+K++R + P++ + + E ++ +D
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 67
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
+P+V +L G+ ++ ++ L+ + M L + + Q+ G+ +
Sbjct: 68 NPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 124
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK--QPMTSRVVTLWYRPPELL 292
+ ++HRD+ N+L+ + I DFGLA + K +V W +L
Sbjct: 125 LEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 293 LGATDYGVGVDLWSAGCILAELL 315
Y D+WS G + EL+
Sbjct: 185 --HRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 11/207 (5%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILR 172
+ KL +G G + V+K G + + K D ++ + + +L +
Sbjct: 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMG 64
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSG 231
LDH +V+L G+ SL LV + L ++ + Q+ G
Sbjct: 65 SLDHAYIVRLLGICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVT--LWYRPP 289
+ + ++HR++ N+L+ ++ I+ IADFG+A P+ K+ S T W
Sbjct: 122 MYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLA 316
+L G Y D+WS G + E+++
Sbjct: 182 SILFGR--YTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 41/224 (18%)
Query: 119 TFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
FE D IG+G + V +A + I LK+ +N R A E+ +L +
Sbjct: 5 KFE--DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEN----DHRDFAGELEVLCK 58
Query: 174 L-DHPNVVKLEGLVTSRMSCSLYLVFKY---------------MEHDLA-----GLAASP 212
L HPN++ L G +R LY+ +Y +E D A G A++
Sbjct: 59 LGHHPNIINLLGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST- 115
Query: 213 TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272
T Q+ + + +G+++ + +HRD+ N+L+ IADFGL+ +
Sbjct: 116 ---LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY 172
Query: 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
K+ M R+ W L + Y D+WS G +L E+++
Sbjct: 173 VKKTM-GRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 58/237 (24%), Positives = 99/237 (41%), Gaps = 35/237 (14%)
Query: 118 DTFEKLDKIGQGTYSNVYKA-----RDTLTGQIVALKKVRFDNLEPESVRFMAREILILR 172
D+ L +G G + VY+ VA+K + E + F+ E LI+
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-MEALIMS 64
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYME-HDLAGL-------AASPTIKFTQAQVKCY 224
+ +H N+V+L G+ R+ +++ + M DL P+ + + C
Sbjct: 65 KFNHQNIVRLIGVSFERL--PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLA------SFFDPNHKQ 275
+ G ++ H +HRDI N L+ +G + IADFG+A S++ +
Sbjct: 123 R-DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181
Query: 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQL 330
+ + + PPE L + D+WS G +L E+ L P PGRT E +
Sbjct: 182 MLPIK-----WMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMP-YPGRTNQEVM 231
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 82/359 (22%), Positives = 135/359 (37%), Gaps = 69/359 (19%)
Query: 18 REEGSVRVDRKVSAAAAAEAVEIRNGNGGPNHRKESSNSNNEQETTTVR--PRGEKRRSS 75
+ R S A +G + ++ TT V P +K++ +
Sbjct: 44 TSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPPPKKKKVT 103
Query: 76 KPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVY 135
P S H + V GE I T R F+ L +G+GT+ V
Sbjct: 104 YALPNQSREEGHFY-------------VVLGEDIDVSTQR----FKILSLLGEGTFGKVV 146
Query: 136 KARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL------DHPNVVKLEGLVTSR 189
+A D + A+K VR N+ P+ R EI + ++ D ++K++ +
Sbjct: 147 EAWDRKRKEYCAVKIVR--NV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203
Query: 190 MSCSLYLVFKY--------MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HV 240
++ KY M+H F+ + + Q L++ H + H+
Sbjct: 204 TGHMCIVMPKYGPCLLDWIMKHG----------PFSHRHLAQIIFQTGVALDYFHTELHL 253
Query: 241 LHRDIKGSNLLIDNEGI----------------LTIADFGLASFFDPNHKQPMTSRVVTL 284
+H D+K N+L++ + I D G D H + T+ V T
Sbjct: 254 MHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCC--DERHSR--TAIVSTR 309
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK-LCGSPSE 342
YR PE++LG + D+WS GCI+ EL K + +E LH + K L PSE
Sbjct: 310 HYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSE 367
|
Length = 467 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 50/226 (22%), Positives = 91/226 (40%), Gaps = 32/226 (14%)
Query: 118 DTFEKLDKIGQGTYSNVYKA--RDTLTG--QIVALKKVRFDNLEPESVRFMAREILILRR 173
D D + +GT+ ++ D G + V +K V+ D+ V + +E +L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCLLYG 64
Query: 174 LDHPNVVKLEGLVTSR----MSCSLYLVF----KYMEHDLAGLAASPTIKFTQAQVKCYM 225
L H N++ + + Y+ + +++ G A +P + Q+
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ-ALSTQQLVHMA 123
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP--------NHKQPM 277
Q+ G+ + H + V+H+DI N +ID E + I D L+ P N +P+
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKPIM 321
W L+ +Y D+WS G +L EL L + P +
Sbjct: 184 K------WMALESLV--NKEYSSASDVWSFGVLLWELMTLGQTPYV 221
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 37/148 (25%), Positives = 61/148 (41%), Gaps = 32/148 (21%)
Query: 223 CYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFDPNHKQPMTSR 280
Y Q+ G+E ++ +HRD+ N+L+ ++ I DFGLA + DP++ + +R
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSP 340
+ W P + Y D+WS G +L E IF L SP
Sbjct: 237 LPLKWMAPESIF--DKVYTTQSDVWSFGVLLWE-------------------IFSLGASP 275
Query: 341 ------SEEYWKKSKLPHAT-IFKPQQS 361
EE+ +L T + P+ +
Sbjct: 276 YPGVQIDEEFC--RRLKEGTRMRAPEYA 301
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 51/213 (23%), Positives = 99/213 (46%), Gaps = 32/213 (15%)
Query: 146 VALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYLVFKYM--- 201
VA+K ++ DN + + + E+ +++ + H N++ L G+ T LY++ +Y
Sbjct: 47 VAVKMLK-DNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ--EGPLYVIVEYAAKG 103
Query: 202 ---EHDLAGLAASPTIKFT-----------QAQVKCYMHQLLSGLEHCHNQHVLHRDIKG 247
E A P F + V C +Q+ G+E+ ++ +HRD+
Sbjct: 104 NLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC-AYQVARGMEYLESRRCIHRDLAA 162
Query: 248 SNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWS 306
N+L+ + ++ IADFGLA D ++ + ++ + + + PE L Y D+WS
Sbjct: 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWS 221
Query: 307 AGCILAELL----AEKPIMPGRTEVEQLHKIFK 335
G ++ E+ + P +P VE+L K+ +
Sbjct: 222 FGILMWEIFTLGGSPYPGIP----VEELFKLLR 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 21/213 (9%)
Query: 124 DKIGQGTYSNVYKA---RDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
D+IG G + V R ++V +K++R E + F+ +E+ R L+HPNV+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVV-VKELRASATPDEQLLFL-QEVQPYRELNHPNVL 58
Query: 181 KLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYM----HQLLSGLEHC 235
+ G S LV ++ DL S Q K + ++ SGL
Sbjct: 59 QCLGQCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRPPELL-- 292
H +H D+ N + + + I D+GLA + ++ V L + PEL+
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 293 ----LGATDYGVGVDLWSAGCILAEL--LAEKP 319
L D ++WS G + EL A++P
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 30/204 (14%)
Query: 133 NVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192
NV K R L VA+K +R D + F+ +E+ IL RL PN+++L G+
Sbjct: 40 NVRKGRPLL----VAVKILRPDANKNARNDFL-KEVKILSRLKDPNIIRLLGVCVD--ED 92
Query: 193 SLYLVFKYMEH-------------DLAGLAASPTIKFTQAQVKCY---MH---QLLSGLE 233
L ++ +YME+ D Y +H Q+ SG++
Sbjct: 93 PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPEL 291
+ + + +HRD+ N L+ + IADFG++ + R V W +
Sbjct: 153 YLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI 212
Query: 292 LLGATDYGVGVDLWSAGCILAELL 315
L+G + D+W+ G L E+L
Sbjct: 213 LMG--KFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 8e-06
Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 17/207 (8%)
Query: 121 EKLDKIGQG--TYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN 178
E L IG+G V AR TG+ V ++++ + E V F+ E+ + + +HPN
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAG--LAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
+V + L++V +M + A + ++ + + +L L++ H
Sbjct: 61 IVPYRATFIA--DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH 118
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP-NHKQ--------PMTSRVVTLWYR 287
+ +HR +K S++LI +G + ++ GL S NH Q P S V W
Sbjct: 119 HMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLS 176
Query: 288 PPELLLGATDYGVGVDLWSAGCILAEL 314
P L Y D++S G EL
Sbjct: 177 PEVLQQNLQGYDAKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 49/217 (22%)
Query: 122 KLDK-IGQGTYSNVY----KARDTLTGQIVALKKVRFDNLEPESVRFMAREILI------ 170
K+DK IG G + VY + + Q VA + +NLE E+ + E L+
Sbjct: 15 KIDKLIGCGGFGCVYETQCASDHCINNQAVA----KIENLENET---IVMETLVYNNIYD 67
Query: 171 ---------LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQV 221
+ +DH + K G S C +Y F +E L + F + +
Sbjct: 68 IDKIALWKNIHNIDHLGIPKYYG-CGSFKRCRMYYRFILLEK----LVENTKEIFKR--I 120
Query: 222 KCY--------MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273
KC M +L+ LE+ H + H DIK N+++D I D+G+AS F +
Sbjct: 121 KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHG 180
Query: 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCI 310
K S+ +R T Y G+D + C+
Sbjct: 181 KHIEYSKEQKDLHR-------GTLYYAGLDAHNGACV 210
|
Length = 294 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 4e-05
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 31/215 (14%)
Query: 124 DKIGQGTYSNVYKA---RDTL--TGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHP 177
D IG+G + V KA +D L I +K+ + R A E+ +L +L HP
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD----DHRDFAGELEVLCKLGHHP 56
Query: 178 NVVKLEGLVTSRMSCSLYLVFKY---------------MEHDLAGLAASPTIK-FTQAQV 221
N++ L G R LYL +Y +E D A A+ T + Q+
Sbjct: 57 NIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 222 KCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281
+ + G+++ + +HRD+ N+L+ + IADFGL+ + K+ M R+
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRL 173
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
W L + Y D+WS G +L E+++
Sbjct: 174 PVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 11/146 (7%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFM--AREILILRRLDHPNVVKL 182
I +G + VY R ++ A+K V+ D + V + R+ L L + P +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK--SPFIVHL 69
Query: 183 EGLVTSRMSCS-LYLVFKYM-EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
S S + +YLV +Y+ D+ L F + Y+ ++ L++ H +
Sbjct: 70 ---YYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHRHGI 125
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLA 266
+HRD+K N+LI NEG + + DFGL+
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 44/202 (21%), Positives = 86/202 (42%), Gaps = 11/202 (5%)
Query: 120 FEKLDKIGQGTYSNVYK---ARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
+K+ +G G + VYK D +I KV +N P++ + + E ++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
P V +L G+ ++ ++ LV + M + L + + + Q+ G+ +
Sbjct: 69 PYVCRLLGIC---LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL 125
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS--RVVTLWYRPPELLL 293
++HRD+ N+L+ + + I DFGLA D + + +V W +L
Sbjct: 126 EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL- 184
Query: 294 GATDYGVGVDLWSAGCILAELL 315
+ D+WS G + EL+
Sbjct: 185 -HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 5e-05
Identities = 38/131 (29%), Positives = 59/131 (45%), Gaps = 27/131 (20%)
Query: 215 KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID-NEGILTIADFGLASFFDPNH 273
K ++A+VK + QL+ L H +++H DIK N+L D + + + D+GL
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL-------- 156
Query: 274 KQPMTSRVV--------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEK-PIMPGR 324
+++ TL Y PE + G +Y V D W+ G + ELL K P
Sbjct: 157 -----CKIIGTPSCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
Query: 325 TE---VEQLHK 332
E +E L K
Sbjct: 211 DEELDLESLLK 221
|
Length = 267 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 19/160 (11%)
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFDPNHKQPMTSRV 281
+ +Q+ +G+E +++ +HRD+ N+LI ++ I DFGLA D N+ ++ +
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKIFKLCGS 339
W P + Y D+WS G +L E+ L P P EQ + +
Sbjct: 304 PLKWMAPESIF--NNLYTTLSDVWSFGILLWEIFTLGGTP-YPELPMNEQFY-------N 353
Query: 340 PSEEYWKKSKLPHAT--IFKPQQSYKRCIAETFKDFPPSS 377
+ ++ +K HA+ I++ Q +C E F+ P S
Sbjct: 354 AIKRGYRMAKPAHASDEIYEIMQ---KCWEEKFEIRPDFS 390
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 21/46 (45%), Positives = 29/46 (63%)
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+K M Q+L+GL H ++HRDIK NLL+ +G + I DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 54/219 (24%), Positives = 106/219 (48%), Gaps = 30/219 (13%)
Query: 123 LDKIGQGTYSNVYK--ARDTLTGQI---VALKKVRFDNLEPESVRFMAREILILRRLDHP 177
L ++GQG++ VY+ ARD + G+ VA+K V E + F+ E +++
Sbjct: 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCH 69
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAAS-------------PTIKFTQAQVKC 223
+VV+L G+V S+ +L +V + M H DL S PT++ ++
Sbjct: 70 HVVRLLGVV-SKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ----EMIQ 123
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVV 282
++ G+ + + + +HRD+ N ++ ++ + I DFG+ ++ ++ + ++
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKP 319
+ + PE L + D+WS G +L E+ LAE+P
Sbjct: 184 PVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFDPNHKQPMTSRV 281
+ +Q+ G+E +++ +HRD+ N+L+ I+ I DFGLA D N+ ++ +
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
W P + Y D+WS G +L E+ +
Sbjct: 302 PVKWMAPESIF--DNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFDPNHKQPMTSRV 281
+ Q+ G++ +++ +HRD+ N+L+ + + I DFGLA D N+ +R+
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
W P + Y V D+WS G +L E+ +
Sbjct: 277 PVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 43/183 (23%), Positives = 79/183 (43%), Gaps = 28/183 (15%)
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQV------KCY 224
R L HPN+++ G + LVF+Y E DL + +Q+ C
Sbjct: 50 RILQHPNILQCLGQCVE--AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMAC- 106
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVT 283
++ +G+ H H + LH D+ N + ++ + + D+G+ S + ++ + + V
Sbjct: 107 --EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164
Query: 284 LWYRPPEL-------LLGA--TDYGVGVDLWSAGCILAELL--AEKPIMPGRTEVEQLHK 332
L + PEL L+ A T ++W+ G L EL A +P ++ E L+
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPS---NVWALGVTLWELFENAAQP-YSHLSDREVLNH 220
Query: 333 IFK 335
+ K
Sbjct: 221 VIK 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 32/116 (27%), Positives = 54/116 (46%), Gaps = 7/116 (6%)
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF--DPNHKQPMTSRV 281
+ +Q+ G+ +++ +HRD+ N+L+ + I I DFGLA D N+ +R+
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKIFK 335
W P + Y D+WS G +L E+ L P PG + +K+ K
Sbjct: 279 PVKWMAPESIF--NCVYTFESDVWSYGILLWEIFSLGSSP-YPGMPVDSKFYKMIK 331
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 46/216 (21%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 125 KIGQGTYSNVYK--ARDTLTGQI---VALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
++GQG++ VY+ A+ + + VA+K V E + F+ E +++ + +V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNCHHV 71
Query: 180 VKLEGLVT------------SRMSCSLYL-VFKYMEHDLAGLAASPTIKFTQAQVKCYMH 226
V+L G+V+ +R YL + + A K Q
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA-----G 126
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLW 285
++ G+ + + +HRD+ N ++ + + I DFG+ ++ ++ + ++ +
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKP 319
+ PE L + D+WS G +L E+ LAE+P
Sbjct: 187 WMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 46/232 (19%), Positives = 85/232 (36%), Gaps = 41/232 (17%)
Query: 126 IGQGTYSNVYKAR------DTLTGQIVALKKVRFDNLEPESVRFMA--REILILRRLDHP 177
+GQGT++N+YK + G + V L + +A ++ +L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKV-LGSDHRDSLAFFETASLMSQLSHK 61
Query: 178 NVVKLEGLVTSRMSCSLY-LVFKYMEHDLAGLAASPTIKFTQAQVKC--------YMHQL 228
++VKL G+ +V +Y++ P F + QL
Sbjct: 62 HLVKLYGV----CVRDENIMVEEYVKF-------GPLDVFLHREKNNVSLHWKLDVAKQL 110
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF---DPNHKQPMTSRVVTL- 284
S L + ++ ++H ++ G N+L+ G+ + G F DP + SR +
Sbjct: 111 ASALHYLEDKKLVHGNVCGKNILVARYGL----NEGYVPFIKLSDPGIPITVLSREERVE 166
Query: 285 ---WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPI-MPGRTEVEQLHK 332
W P + G + D WS G L E+ + + + E+
Sbjct: 167 RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 495 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.71 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.54 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.48 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.42 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.25 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.24 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.24 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.15 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.13 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.12 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.02 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.95 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.95 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.84 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.74 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.67 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.65 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.65 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.56 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.54 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.5 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.38 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.31 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.29 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.25 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.23 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.11 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.05 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.97 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.89 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.88 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.88 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.8 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.7 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.63 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.61 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.59 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.56 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.55 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.53 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.53 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.51 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.36 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.24 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.14 | |
| PLN02236 | 344 | choline kinase | 97.07 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.99 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.92 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.88 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.62 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.46 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.43 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.38 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.29 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.25 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.25 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.06 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.05 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.44 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.19 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.48 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-86 Score=657.61 Aligned_cols=393 Identities=66% Similarity=1.100 Sum_probs=367.2
Q ss_pred CCCCCCCCCCcccccCCCcchhhhhcccccCCCCCCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHH
Q 011041 81 LSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES 160 (495)
Q Consensus 81 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~ 160 (495)
..+.++....++..++||.|...++++.+.+|.++..+.|+.+++||+|+||.||+|++..||+.||+|+++++......
T Consensus 80 ~~~~~~~~e~~~~~a~~p~~l~~~~ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~ 159 (560)
T KOG0600|consen 80 PSSVPKSTEAEQVAAGWPAWLSSVAGEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF 159 (560)
T ss_pred CCCCCCcchhhhhhccCccccccccccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc
Confidence 34445555667889999999999999999999999999999999999999999999999999999999999999888888
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 011041 161 VRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240 (495)
Q Consensus 161 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~gi 240 (495)
...+.|||.||++|+||||++|.+++.+...+.+|||||||++||.+++.....+|++.++++||+||+.||+|||++||
T Consensus 160 ~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gv 239 (560)
T KOG0600|consen 160 PITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGV 239 (560)
T ss_pred hHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCe
Confidence 89999999999999999999999999987778999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 011041 241 LHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPI 320 (495)
Q Consensus 241 vHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~p 320 (495)
+|||||..|||||.+|.+||+|||||+++.......+++.|.|+||+|||+|+|...|+.++|+||+||||.||+.|+|+
T Consensus 240 lHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI 319 (560)
T KOG0600|consen 240 LHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPI 319 (560)
T ss_pred eeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCC
Confidence 99999999999999999999999999999988888899999999999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 321 MPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 321 f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
|.|.++.+|+++|+++||.|.+++|+..++|....++++.+|++++.+.++.+++.+.+|+..||.+||.+|.||.++|+
T Consensus 320 ~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 320 LQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCCCCCCCChhHhhhcCHHHHHHHHHhccchHHHHHHhhhhhhhhcCCCcchhHHHhhhhhhh
Q 011041 401 SEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEEARRLRAAGKANAEAKKARSRDRAARAMPAPEANAELQANLDVR 476 (495)
Q Consensus 401 hp~f~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 476 (495)
|+||+..|.+|+++.+|.+++.++++.+.++++.++......... ......+..++.|+++++++.++..+.+
T Consensus 400 seyF~t~p~~~~p~~Lp~y~~s~E~~~K~r~e~~r~~~~~~~~~~---~~~~~~~~~r~~p~~~~~~~~~~~~~~~ 472 (560)
T KOG0600|consen 400 SEYFTTEPLPCDPSSLPKYPPSHELDAKRRREQKRRNKGGASKRR---IRERGDRGSRAIPAQPANAESQASPQRR 472 (560)
T ss_pred CcccccCCCCCCcccCCCCCcchhHHHHHHHHHhhcccccccccc---cccccccccCCCCCCCCCHHHhcccccc
Confidence 999999999999999999999999999999988876652221111 1122256678999999999999988866
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-64 Score=480.01 Aligned_cols=308 Identities=43% Similarity=0.760 Sum_probs=272.4
Q ss_pred CCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 115 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
+..++|+.++.|++|+||+||+|+|+.|++.||+|.++.+.-.....-.-.|||.+|.+++|||||.+.+++....-..+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 44689999999999999999999999999999999998765322222345689999999999999999999987667789
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|||||||++|+..++......|...++++++.|++.||+|||.+.|+||||||+|+|+++.|.+||+|||+|+.++.. .
T Consensus 153 y~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~ 231 (419)
T KOG0663|consen 153 YIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-L 231 (419)
T ss_pred eeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-c
Confidence 999999999999999888889999999999999999999999999999999999999999999999999999998755 3
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC-C
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH-A 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~-~ 353 (495)
.+++..+.|.||+|||+++|...|+.++|+||+|||+.||++++|+|+|..+.+++.+|++.+|.|.+..|+...... .
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 568889999999999999999999999999999999999999999999999999999999999999999999865433 3
Q ss_pred c-cCCCCcccccccccccCC--CCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCCCCCCCCCCCCCChh
Q 011041 354 T-IFKPQQSYKRCIAETFKD--FPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYPPTKE 424 (495)
Q Consensus 354 ~-~~~~~~~~~~~~~~~~~~--~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~~~~~~~p~~~~~~~ 424 (495)
. ...+..+|. .+...|.. +++...+|+..+|.+||.+|.||.|+|+|.||...|.+++|..+|.+|...+
T Consensus 312 k~~~f~~~pyn-~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~ 384 (419)
T KOG0663|consen 312 KKMTFSEHPYN-NLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSE 384 (419)
T ss_pred hccccCCCCch-hhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccccc
Confidence 2 223333333 34444444 4589999999999999999999999999999999999999999999986544
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-63 Score=458.46 Aligned_cols=295 Identities=42% Similarity=0.783 Sum_probs=265.7
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|..+++||+|.||.||+|++..||+.||||+|+..+..........|||+.|+.++|+||+.|+++|.+ ...+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~--~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH--KSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC--CCceEEE
Confidence 57899999999999999999999999999999999876654445567799999999999999999999988 4579999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
+|||+.+|...+......|+..+++.|+.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+.+... ..
T Consensus 80 fEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~-~~ 158 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR-IQ 158 (318)
T ss_pred EEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc-cc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999876553 33
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC-CCCCCccC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS-KLPHATIF 356 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~-~~~~~~~~ 356 (495)
+..+.|.||+|||++.|...|+..+||||.|||+.||+-|.|.|+|.++.+|+..|++.+|+|.++.|+.. .+|....+
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 44589999999999999999999999999999999999999999999999999999999999999999974 45554433
Q ss_pred C--CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCCCCCCCCCCC
Q 011041 357 K--PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKY 419 (495)
Q Consensus 357 ~--~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~~~~~~~p~~ 419 (495)
. |..+ ....|...++++.||+.+||.+||.+|+|+.|+|+|+||++.|.++++..+|..
T Consensus 239 ~~~P~~~----~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p 299 (318)
T KOG0659|consen 239 QQFPKPP----LNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIP 299 (318)
T ss_pred hcCCCCc----cccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCC
Confidence 2 2222 333778888999999999999999999999999999999999999988887754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-62 Score=454.72 Aligned_cols=287 Identities=34% Similarity=0.578 Sum_probs=250.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++.|+.+.++|+|+||+||+|++++||+.||||++.-..-++...+-..|||++|++|+|+|+|.|+++|.. ...+++
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklhL 78 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLHL 78 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeEE
Confidence 367999999999999999999999999999999987655556666677899999999999999999999977 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
|||||++..+..+......+++..++.|++|++.|+.|||++++||||||||||||+.+|.+||||||+|+.+.. ....
T Consensus 79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~ 157 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDN 157 (396)
T ss_pred EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccch
Confidence 999999999888877666799999999999999999999999999999999999999999999999999998864 3356
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh--CCCCCCc
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK--SKLPHAT 354 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~--~~~~~~~ 354 (495)
++.++.|.||+|||++.|...||..+|||++||++.||++|.|+|+|.++.+++..|.+.+|...+..... ...-...
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 78899999999999999999999999999999999999999999999999999999999999987653321 1111112
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
...|...-...+...++.++.-+.||+++||..||++|++.+|+|.|+||.+
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 2223333334466777888889999999999999999999999999999943
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-62 Score=482.65 Aligned_cols=288 Identities=36% Similarity=0.650 Sum_probs=256.7
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|.++++||.|+||.||+|+.+.+|..||||.+++....-+++-. .||++.|++|+ |||||+|.+++.+.. ..+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~-~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDND-RIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccC-ceE
Confidence 357899999999999999999999999999999999876655554443 47999999998 999999999998853 389
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+|||||+..|..++..++..|+|..++.|+.||+.||+|+|.+|++|||||||||||.....|||+|||+|+.+.. .
T Consensus 86 ~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S--k 163 (538)
T KOG0661|consen 86 YFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS--K 163 (538)
T ss_pred eeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc--C
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998754 4
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh-CCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~-~~~~~~ 353 (495)
.+++.+|.|.||+|||+|+....|+.++|||++|||++|+++-+|+|+|.++.+++.+|..++|+|..+.|.. ..+...
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 6789999999999999999999999999999999999999999999999999999999999999999999987 344444
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
..|.-...-...+...+...++++.+||..||.|||.+||||.|+|+||||+..
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 334333333333556666788999999999999999999999999999999853
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-61 Score=469.27 Aligned_cols=264 Identities=29% Similarity=0.424 Sum_probs=230.6
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh-----HHHHHHHHHHHHHHhCCCCCeeeeeceeeccC
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-----ESVRFMAREILILRRLDHPNVVKLEGLVTSRM 190 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 190 (495)
..+.|.+.+.||+|+||.|-+|.++.||+.||||++.+..... .....+++|++||++|+|||||+++++|+.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-- 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-- 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--
Confidence 3578889999999999999999999999999999998765422 233456799999999999999999999998
Q ss_pred CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC---CcEEEeeccccc
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE---GILTIADFGLAS 267 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~---~~vkL~DFG~a~ 267 (495)
..+.||||||++||.+....-..+.+.|...+.+++||+.||.|||++||+||||||||||+..+ ..+||+|||+|+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 56789999999998777777777789999999999999999999999999999999999999776 689999999999
Q ss_pred ccCCCCCCCCccccccCCCCCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChhh
Q 011041 268 FFDPNHKQPMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE-QLHKIFKLCGSPSEEY 344 (495)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~g~~~~~~ 344 (495)
+.+ ....+.+.||||.|.|||++.+. ..|..++||||||||||.+|+|.|||.+..... ..++|.+.-..+.+..
T Consensus 328 ~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 328 VSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred ccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 876 33567889999999999999653 335568999999999999999999999876554 7777877666666666
Q ss_pred hhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
|. .+++++++||.+||.+||++|||+.|+|+||||+..|
T Consensus 406 w~-------------------------~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 406 WD-------------------------RISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hh-------------------------hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 64 4889999999999999999999999999999999754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-58 Score=466.86 Aligned_cols=257 Identities=28% Similarity=0.441 Sum_probs=232.8
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.+|...+.||+|+|+.||++++..+|+.||+|+|.+..+ .....+++.+||+|.+.|+|||||+++++|++ ..++||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED--s~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED--SNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec--CCceEE
Confidence 679999999999999999999999999999999988655 56677889999999999999999999999999 678999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
|+|+|..+.+..+....+.++|.+++.|++||+.||.|||+++|||||||..||||+++.+|||+|||||..+.... +.
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-Er 174 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-ER 174 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc-cc
Confidence 99999988777777788899999999999999999999999999999999999999999999999999999887543 33
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
-.+.||||.|+|||++.. ..++..+||||+|||||.||+|+|||...+-.+.+.+|...-...
T Consensus 175 k~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~---------------- 237 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSM---------------- 237 (592)
T ss_pred cceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccc----------------
Confidence 467899999999999985 678999999999999999999999999999999999986532221
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
...++.++.+||..||..||.+|||++++|.|+||+..
T Consensus 238 -------------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 238 -------------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred -------------ccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 23588999999999999999999999999999999653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-57 Score=438.99 Aligned_cols=262 Identities=29% Similarity=0.444 Sum_probs=234.6
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|++++.||+|+||+||+++.++|++.||+|++++... .....+.+..|..||..++||+||.++..|++ ...+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt--~~kL 100 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT--EEKL 100 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc--CCeE
Confidence 35899999999999999999999999999999999998766 44577889999999999999999999988887 6789
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|||+||+.||.+...+++.+.|+|..++.|+.+|+.||.|||++|||||||||||||||.+|+++|+|||+++..... .
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~ 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-G 179 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC-C
Confidence 999999999999888888889999999999999999999999999999999999999999999999999999854322 2
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
....+.|||+.|||||++.+ ..|+..+|+|||||++|||++|.+||.+.+.....++|.+.....
T Consensus 180 ~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~-------------- 244 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL-------------- 244 (357)
T ss_pred CccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC--------------
Confidence 34456899999999999987 579999999999999999999999999999999999997643111
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc----CHHHHHhCCCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ----TATAALRSEFFTTKPY 409 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~----ta~elL~hp~f~~~~~ 409 (495)
...-++.++++||+++|..||++|. .+.++-+||||....|
T Consensus 245 --------------~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 245 --------------PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred --------------CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 1123678999999999999999995 6999999999998777
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-57 Score=435.84 Aligned_cols=290 Identities=37% Similarity=0.601 Sum_probs=249.4
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeec---cCCcee
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTS---RMSCSL 194 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---~~~~~~ 194 (495)
..|..++.||.|+||.|..|.++.+|+.||||+|..........+...||+++|+.++|+||+.+.+++.. ..-..+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 56777899999999999999999999999999998544456677888899999999999999999999865 234679
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC-C
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN-H 273 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~-~ 273 (495)
|+|+|+|+.+|...+... ..+++.++..+++||+.||.|+|+.||+||||||.|||++.+..+||+|||+|+..+.. .
T Consensus 102 YiV~elMetDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 102 YLVFELMETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred EEehhHHhhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 999999998888776654 35999999999999999999999999999999999999999999999999999987542 2
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
...++..+.|.||+|||++.....|+.++||||+||||.||++|+|.|+|.+..+++..|+..+|+|+++.+.......+
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 34568889999999999998888999999999999999999999999999999999999999999999887765442222
Q ss_pred ccCC--CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 354 TIFK--PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 354 ~~~~--~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
..+. -...-+......++..++.++|||++||..||.+|+|++|+|+||||....
T Consensus 261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 2111 011112335677888999999999999999999999999999999998643
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-57 Score=433.96 Aligned_cols=292 Identities=40% Similarity=0.729 Sum_probs=252.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCC-eeeeeceeeccC----C
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN-VVKLEGLVTSRM----S 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~----~ 191 (495)
...|+.+++||+|+||+||+|+++.+|+.||+|+++.+...........+|+.+|+.|+|+| ||+|++++.... .
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 46788999999999999999999999999999999876543223455679999999999999 999999997632 2
Q ss_pred ceeEEEEeeccCChhhhhhCCC---CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccc
Q 011041 192 CSLYLVFKYMEHDLAGLAASPT---IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~---~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~ 268 (495)
..+|+||||++.++...+.... ..++...++.+++||+.||+|||+++|+||||||.||||+.+|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 3799999999999988877654 4578899999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
+.-.. ..+++.++|.||+|||+++|...|+..+||||+|||++||++++++|+|.++.+++.+|++.+|.|.++.|+..
T Consensus 170 ~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 170 FSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred hcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 75332 34678899999999999999989999999999999999999999999999999999999999999999999874
Q ss_pred -CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 349 -KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 349 -~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
.++......+...-.+.+....+...+++.+|+.+||++||.+|.||+.+|.||||...+.
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 3444443323222234456666777789999999999999999999999999999997644
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-56 Score=443.23 Aligned_cols=263 Identities=32% Similarity=0.485 Sum_probs=235.1
Q ss_pred CCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCc
Q 011041 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 115 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 192 (495)
+...+|.+++.||+|+|++||+|+++.+++.||||++.+..+ ....+..+.+|-.+|.+| +||.|++|+-.|.+ ..
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~ 147 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EE 147 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--cc
Confidence 456899999999999999999999999999999999987765 344466788999999999 89999999888887 66
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|+|+||+++|.+..++...+.|+|..++.|+.||+.||+|||++|||||||||||||||.|+++||+|||.|..+.+.
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 89999999998777667777789999999999999999999999999999999999999999999999999999988643
Q ss_pred CCC------------CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 011041 273 HKQ------------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSP 340 (495)
Q Consensus 273 ~~~------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~ 340 (495)
... ...++|||..|++||+|.. ...++.+|||+||||||.|+.|.|||.+.++.-++++|+.+...+
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~f 306 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEF 306 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccC
Confidence 221 1256899999999998876 567999999999999999999999999999999999999875444
Q ss_pred ChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 341 SEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
+ ++||+.+.|||+++|..||.+|+|+.||.+||||.+..|
T Consensus 307 p-----------------------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 307 P-----------------------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred C-----------------------------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 3 468899999999999999999999999999999998766
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-58 Score=419.38 Aligned_cols=286 Identities=26% Similarity=0.395 Sum_probs=246.1
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
..+.|++.+.||+|.|+.||+|.+..||+.+|+|+|....+.....+.+.+|+.|.+.|+|||||+|++.+.+ ..+.|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~~y 86 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHY 86 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc--cceeE
Confidence 3578999999999999999999999999999999999888877788999999999999999999999999877 67899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC---CCcEEEeecccccccCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASFFDPN 272 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~---~~~vkL~DFG~a~~~~~~ 272 (495)
||||+|.|+.+..-+-.+..++|..+..+++||+++|.|||.+||||||+||+|+|+.. ..-|||+|||+|....
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 99999998765544433467899999999999999999999999999999999999954 3469999999998876
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.......++|||.|||||++.. .+|+..+|||+.|||||.||.|.+||++.+...+++.|.......+..+|+
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~------ 237 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWD------ 237 (355)
T ss_pred CccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccC------
Confidence 4456778899999999998875 679999999999999999999999999999999999999877777766664
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCCCCCCCCCCCCCChhHhhhcCHH
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDE 432 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 432 (495)
.+++++++||++||..||++|+|+.|+|+|||+.+.... .......+.-..+++-
T Consensus 238 -------------------~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~------As~~H~~dtvd~lrkf 292 (355)
T KOG0033|consen 238 -------------------TVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERV------ASAIHRQDTVDCLKKF 292 (355)
T ss_pred -------------------cCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHH------HHHhhhHHHHHHHHHh
Confidence 588999999999999999999999999999999864221 1112233444555655
Q ss_pred HHHHH
Q 011041 433 EARRL 437 (495)
Q Consensus 433 ~~~~~ 437 (495)
.++|.
T Consensus 293 NarRK 297 (355)
T KOG0033|consen 293 NARRK 297 (355)
T ss_pred hHHHH
Confidence 55543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-55 Score=440.81 Aligned_cols=275 Identities=32% Similarity=0.442 Sum_probs=235.7
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|++++.||+|+||.||+|+.+.||..||+|++++..+ ..++++.+..|-.||...++|+||+|+..|.+ ..++
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD--~~~L 216 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD--KEYL 216 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC--CCee
Confidence 46999999999999999999999999999999999998876 67778899999999999999999999999988 6789
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC--
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN-- 272 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~-- 272 (495)
||||||++||...-++.....|+|..++.|+.+++.|++.||+.|||||||||+|+|||..|++||+||||+.-+...
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 999999999877777777779999999999999999999999999999999999999999999999999998543210
Q ss_pred --------------------CC------------------------CCCccccccCCCCCcccccCCCCCCchhhHHHHH
Q 011041 273 --------------------HK------------------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAG 308 (495)
Q Consensus 273 --------------------~~------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlG 308 (495)
.. ....+.+|||.|+|||++++ ..|+..+|+||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHHH
Confidence 00 01125699999999999998 4699999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCC
Q 011041 309 CILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAID 388 (495)
Q Consensus 309 vil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~d 388 (495)
||+||||.|.|||.+.++.+++.+|+..... ...| .-..+++++.|||.+||+ |
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--------l~fP-----------------~~~~~s~eA~DLI~rll~-d 429 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRET--------LKFP-----------------EEVDLSDEAKDLITRLLC-D 429 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--------ccCC-----------------CcCcccHHHHHHHHHHhc-C
Confidence 9999999999999999999999999763211 0111 113467899999999999 9
Q ss_pred CCCccC---HHHHHhCCCCCCCCCCCCCCCCCCC
Q 011041 389 PAERQT---ATAALRSEFFTTKPYACDPSSLPKY 419 (495)
Q Consensus 389 P~~R~t---a~elL~hp~f~~~~~~~~~~~~p~~ 419 (495)
|.+|+. ++||.+||||++..|.--....|.+
T Consensus 430 ~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apf 463 (550)
T KOG0605|consen 430 PENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPF 463 (550)
T ss_pred HHHhcCcccHHHHhcCCccccCCcchhhcCCCCC
Confidence 999975 9999999999998885433333333
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-55 Score=412.06 Aligned_cols=260 Identities=24% Similarity=0.408 Sum_probs=236.3
Q ss_pred CCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 115 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
...++|++++.||.|+||.|.+++++.+|..||+|++.+... ...+++...+|..+|+.+.||+++++++.+.+ ...
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d--~~~ 118 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD--NSN 118 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc--CCe
Confidence 346899999999999999999999999999999999988765 56677889999999999999999999988877 678
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+||||||++|+.+..++...++|+|..++.|+.||+.||+|||+++|++|||||||||||.+|.+||+|||+|+.....
T Consensus 119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 9999999999999888888889999999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
..+.||||.|+|||++.. ++|+.++|+|+|||++|||++|.+||...+...+.++|+...-.++
T Consensus 198 ---T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP------------ 261 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP------------ 261 (355)
T ss_pred ---EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC------------
Confidence 467899999999998876 6899999999999999999999999999999999999987433222
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCc-----cCHHHHHhCCCCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER-----QTATAALRSEFFTTKPYA 410 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R-----~ta~elL~hp~f~~~~~~ 410 (495)
.-+++++++||+++|+.|-.+| ....++..||||++..|.
T Consensus 262 -----------------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 262 -----------------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred -----------------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence 3578999999999999999999 357899999999987773
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-55 Score=424.57 Aligned_cols=260 Identities=28% Similarity=0.433 Sum_probs=225.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++.+.++.||+|..|+||+|+|+.|++.+|+|+|. ...+....+++.+|++|++..+|||||.+||.|.+... .++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI 155 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISI 155 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEe
Confidence 467888999999999999999999999999999994 34567778899999999999999999999999998433 6999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+||||+++.+..+....+.++|.....++.+|+.||.|||+ ++||||||||+||||+..|+|||||||.+..+...
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999888888777889999999999999999999995 99999999999999999999999999999877543
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR--TEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~--~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
...+.+||..|||||.+.+ ..|+.++||||||++++|+++|+-||... +....+..+..++..+++.
T Consensus 233 ~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~---------- 301 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR---------- 301 (364)
T ss_pred hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC----------
Confidence 4578899999999999988 57999999999999999999999999874 2223333333333333321
Q ss_pred ccCCCCcccccccccccC-CCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFK-DFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~-~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
... .+|+++.+||..||++||.+|+|+.|+|+|||++..
T Consensus 302 ---------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 302 ---------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred ---------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 112 489999999999999999999999999999999864
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-55 Score=422.24 Aligned_cols=281 Identities=37% Similarity=0.630 Sum_probs=241.6
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc---ee
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC---SL 194 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~---~~ 194 (495)
-.|...+++|.|+||.||+|+...+++.||||++..+.. .-.+|+.||+.++|||||+|.-+|....+. ++
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 458888999999999999999999999999999876542 233799999999999999999888664444 56
Q ss_pred EEEEeeccCChhhhhhC---CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC-CcEEEeecccccccC
Q 011041 195 YLVFKYMEHDLAGLAAS---PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFGLASFFD 270 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~---~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~-~~vkL~DFG~a~~~~ 270 (495)
.+|||||+..+...+.. .+..++.-.++-|+.||++||.|||+.||+||||||.|||||.+ |.+||||||.|+...
T Consensus 98 nlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 98 NLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 78999999988876653 46689999999999999999999999999999999999999986 999999999999886
Q ss_pred CCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
.+ ++..++..|..|+|||++.|...|+.+.||||.||++.||+-|+|.|.|.+..+++..|.+.+|.|+.+....++.
T Consensus 178 ~~--epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 178 KG--EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred cC--CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 55 4457788999999999999999999999999999999999999999999999999999999999999988776654
Q ss_pred CCCccCCCCccccccccc-ccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 351 PHATIFKPQQSYKRCIAE-TFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.....-.++ -....+.+ .....++++.+|+.++|.++|.+|.++.|+|.||||...
T Consensus 256 ~y~~~~~p~-ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 256 NYTEFKFPQ-IKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred ccccccCcc-cccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 433222222 11222223 567789999999999999999999999999999999853
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-54 Score=418.85 Aligned_cols=265 Identities=29% Similarity=0.465 Sum_probs=234.6
Q ss_pred CCCCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 113 TPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 113 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
.....++|.+.+.||.|+||+||+|+++.++..||||.|.+..+.....+.+..||.||+.|+|||||+++++++. ++
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~--~~ 82 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED--DD 82 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--CC
Confidence 3445789999999999999999999999999999999999998888899999999999999999999999999988 56
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC------CcEEEeecccc
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE------GILTIADFGLA 266 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~------~~vkL~DFG~a 266 (495)
++|||||||.|+.+..++...+.++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 899999999988888888888899999999999999999999999999999999999999875 45899999999
Q ss_pred cccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 011041 267 SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (495)
Q Consensus 267 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (495)
+.+.+. .-..+.||+|.|||||++.. ..|+.++|+||+|+|||+|++|++||...+..+.+..+.+.-...
T Consensus 163 R~L~~~--~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~------ 233 (429)
T KOG0595|consen 163 RFLQPG--SMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV------ 233 (429)
T ss_pred hhCCch--hHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc------
Confidence 998754 34567899999999999864 679999999999999999999999999999999988664422111
Q ss_pred hCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
......++....+|+..+|+.||..|.+..+.+.|+++...|
T Consensus 234 --------------------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 234 --------------------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred --------------------CchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 111223567778999999999999999999999999998765
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-54 Score=437.42 Aligned_cols=262 Identities=27% Similarity=0.400 Sum_probs=235.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecC-CCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFD-NLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.+-|++++.||.|+.|.|.+|++..||+.+|||+|.+. .........+.+||.||+.|.||||+++|++|++ ..++|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~~~ly 88 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--KQHLY 88 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc--CceEE
Confidence 46689999999999999999999999999999999877 4555666789999999999999999999999998 56899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+|.||+.+|.+++++-..+.|+|.+++++++||+.||.|||..+|+||||||||+|||..+++||+|||+|....++ .
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--k 166 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--K 166 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC--c
Confidence 99999999888888877889999999999999999999999999999999999999999999999999999876544 4
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
...+.||+|.|.+||++.|..+.|.++||||+|||||.||+|+.||.+.|-...+.++.+...
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f----------------- 229 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF----------------- 229 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-----------------
Confidence 567789999999999999988889999999999999999999999998888888888765322
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYAC 411 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~~ 411 (495)
+....+|+++++||.+||.+||++|+|.+|+++|||+....-..
T Consensus 230 ------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 230 ------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred ------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence 22346899999999999999999999999999999998754433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=425.57 Aligned_cols=259 Identities=28% Similarity=0.439 Sum_probs=224.9
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC---hHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCC
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE---PESVRFMAREILILRRLD-HPNVVKLEGLVTSRMS 191 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 191 (495)
..+.|.+.+.||+|+||.|+.|++..+|..||+|++.+.... ....+.+.+|+.+++.++ ||||+++++++...
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-- 92 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-- 92 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC--
Confidence 457899999999999999999999999999999988765221 134567779999999998 99999999999884
Q ss_pred ceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC-CcEEEeecccccccC
Q 011041 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFGLASFFD 270 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~-~~vkL~DFG~a~~~~ 270 (495)
..+|+||||+.++.+...+...+++.|.+++.+|+||+.||+|||++||+||||||||||++.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 4599999999985444444447899999999999999999999999999999999999999999 999999999999874
Q ss_pred CCCCCCCccccccCCCCCcccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 271 PNHKQPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
.......+.+||+.|+|||++.+.. +-+.++|||||||+||.|++|..||...+....+.+|.+.....
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~--------- 242 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKI--------- 242 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccC---------
Confidence 3335668889999999999998866 44689999999999999999999999988888888875532211
Q ss_pred CCCCccCCCCcccccccccccCCC-CCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDF-PPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
...+ ++++.+||.+||..||.+|+|+.+++.||||+.
T Consensus 243 --------------------p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 243 --------------------PSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred --------------------CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 1234 889999999999999999999999999999997
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-53 Score=371.18 Aligned_cols=286 Identities=40% Similarity=0.710 Sum_probs=251.3
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
.+|...++||+|.||+||+|+++++++.||+|.++.+.-+........+||-+|+.|+|.|||+++++... +..+-+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlv 79 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEe
Confidence 46888899999999999999999999999999999876555555567799999999999999999999877 5679999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
||||..++......-++.++.+.++.++.|++.||.|||++++.||||||.|+||+.+|.+||+|||+++.++-.- ..+
T Consensus 80 fe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv-rcy 158 (292)
T KOG0662|consen 80 FEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCY 158 (292)
T ss_pred HHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-Eee
Confidence 9999999999888888899999999999999999999999999999999999999999999999999999876443 344
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhC-CCCCCcc
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS-KLPHATI 355 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~-~~~~~~~ 355 (495)
+..+.|.||++|.++.|.+-|+...|+||.|||+.|+.. |.|+|+|.+..+++.+|++.+|.|.++.|+.. ++|....
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 566889999999999999999999999999999999985 99999999999999999999999999999873 4443322
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
+..- +....++.+.+.+.....||+.++|..+|..|++|+++|+||||+..
T Consensus 239 yp~y-pattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 239 YPIY-PATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cCCc-cccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 2111 11123556677788889999999999999999999999999999863
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-54 Score=400.43 Aligned_cols=250 Identities=29% Similarity=0.491 Sum_probs=217.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
..+|+++++||+|+||.||++++..+|..||+|.|..+..+....+.+..|+.+|++|+|||||++++.-..+....++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 46899999999999999999999999999999999988888888899999999999999999999998433333556999
Q ss_pred EEeeccCChhhhhh----CCCCCCCHHHHHHHHHHHHHHHHHhhh--CC--ceeccCCCCCeeeCCCCcEEEeecccccc
Q 011041 197 VFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHN--QH--VLHRDIKGSNLLIDNEGILTIADFGLASF 268 (495)
Q Consensus 197 v~e~~~~~l~~~~~----~~~~~l~e~~~~~i~~qil~~L~~LH~--~g--ivHrDlKp~NILl~~~~~vkL~DFG~a~~ 268 (495)
|||||+++.+..++ .....++|..++.++.|++.||.+||+ .. |+||||||.||||+.+|.|||+|||++++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999976655443 456679999999999999999999998 55 99999999999999999999999999998
Q ss_pred cCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
+.... ....+.+|||+||+||++.+ .+|+.++|||||||++|||+.-.+||.|.+-.+...+|.+.-..|-++
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~----- 250 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD----- 250 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH-----
Confidence 87543 44567899999999999887 679999999999999999999999999998888888886542221110
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCH
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA 395 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta 395 (495)
..+|.++..||..|+..||..||+.
T Consensus 251 ----------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 ----------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ----------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 2367788999999999999999986
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-53 Score=415.30 Aligned_cols=265 Identities=30% Similarity=0.448 Sum_probs=228.4
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh------------HHHHHHHHHHHHHHhCCCCCeeeee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP------------ESVRFMAREILILRRLDHPNVVKLE 183 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~------------~~~~~~~~Ei~il~~l~HpnIv~l~ 183 (495)
..++|++++.||+|.||.|.+|++..+++.||||++.+..+.. ...+.+.+||.||++|+|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4689999999999999999999999999999999997653221 1246889999999999999999999
Q ss_pred ceeeccCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeec
Q 011041 184 GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADF 263 (495)
Q Consensus 184 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DF 263 (495)
++..+.....+|||+|||..+-....-.....+++.+++.|++.++.||+|||.+|||||||||+|+||+++|+|||+||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence 99999888999999999998766555544444999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC----CCCCccccccCCCCCcccccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 011041 264 GLASFFDPNH----KQPMTSRVVTLWYRPPELLLG---ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336 (495)
Q Consensus 264 G~a~~~~~~~----~~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 336 (495)
|.+..+.... ...+...+|||.|+|||.+.+ ....+.+.|||||||+||.|+.|+.||.+....+.+.+|...
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~ 334 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND 334 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence 9998763221 123345799999999999876 234578899999999999999999999999999999999764
Q ss_pred cCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 337 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.-.++ ..+++.+.++|||.+||.+||.+|++..++..|||.+..
T Consensus 335 pL~fP---------------------------~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 335 PLEFP---------------------------ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cccCC---------------------------CcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 32222 123567889999999999999999999999999999864
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-51 Score=406.02 Aligned_cols=283 Identities=39% Similarity=0.711 Sum_probs=236.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||.|+||.||+|++..++..||+|++...... .....+.+|+.+++.++||||+++++++.. ....|+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCLTL 80 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEE
Confidence 57899999999999999999999999999999999754322 223456789999999999999999999877 457999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||+.+++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~ 159 (288)
T cd07871 81 VFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KT 159 (288)
T ss_pred EEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-cc
Confidence 99999998877766555568999999999999999999999999999999999999999999999999997654322 22
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC--c
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA--T 354 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~--~ 354 (495)
.....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+..+.|+....... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 34557899999999987766789999999999999999999999999999999999999999999998876332111 1
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
...+... ..........+++++++||.+||++||.+|+|++|+|+||||
T Consensus 240 ~~~~~~~-~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 240 YLFPQYR-AQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccCccC-CCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 1111110 111222345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-52 Score=425.05 Aligned_cols=281 Identities=30% Similarity=0.537 Sum_probs=230.3
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-C-----CCeeeeeceeeccCC
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-H-----PNVVKLEGLVTSRMS 191 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~~~~~~~~~ 191 (495)
.+|.+++.||+|+||+|.+|.|..|++.||||+|+.. .........|+.||..|+ | -|||+++++|.. .
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r 260 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--R 260 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--c
Confidence 4789999999999999999999999999999999754 455566778999999996 3 499999999998 5
Q ss_pred ceeEEEEeeccCChhhhhhCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC--cEEEeecccccc
Q 011041 192 CSLYLVFKYMEHDLAGLAASPT-IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG--ILTIADFGLASF 268 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~-~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~--~vkL~DFG~a~~ 268 (495)
+++|||+|.++.+|..++.... ..|+...++.++.||+.||.+||+.||||+|||||||||.+.+ .|||+|||.++.
T Consensus 261 ~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 261 NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 6899999999999998887643 4599999999999999999999999999999999999997644 799999999987
Q ss_pred cCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
... ...+++.+..|+|||+++| .+|+.+.||||||||++||++|.|+|+|.++.+++..|+..+|.|+..+++..
T Consensus 341 ~~q----~vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 341 ESQ----RVYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cCC----cceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 642 2337788999999999998 67999999999999999999999999999999999999999999998766543
Q ss_pred CCCCCccCCCCccccc-c---------------------------------cccccC-CCCCCcHHHHHHhccCCCCCcc
Q 011041 349 KLPHATIFKPQQSYKR-C---------------------------------IAETFK-DFPPSSLPLIETLLAIDPAERQ 393 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~-~---------------------------------~~~~~~-~~s~~~~~Li~~~L~~dP~~R~ 393 (495)
.-... +|.....+.+ + +...+. .-...+.|||.+||.+||.+|+
T Consensus 416 ~~~~k-ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 416 KKAHK-FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred cccce-ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 21110 0100000000 0 000000 0113468999999999999999
Q ss_pred CHHHHHhCCCCCCCCC
Q 011041 394 TATAALRSEFFTTKPY 409 (495)
Q Consensus 394 ta~elL~hp~f~~~~~ 409 (495)
|+.++|+||||+....
T Consensus 495 tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 495 TPAQALNHPFLTGTSL 510 (586)
T ss_pred CHHHHhcCcccccccc
Confidence 9999999999996433
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=400.13 Aligned_cols=275 Identities=25% Similarity=0.325 Sum_probs=235.6
Q ss_pred CCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 115 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
...+.|++++.||.|.-|+||+|..+.++..+|+|++.+..+ ......+.+.|.+||+.++||.+++||..|+. +.+
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~~~ 151 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET--DKY 151 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec--cce
Confidence 346889999999999999999999999999999999998876 35566778889999999999999999999988 678
Q ss_pred eEEEEeeccCChhhhhh--CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 194 LYLVFKYMEHDLAGLAA--SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~--~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
.|++||||.|+.+..+. +....|++..++.|+.+++.||+|||.+|||+||||||||||.++|+|.|+||.|+.....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999987666544 4567899999999999999999999999999999999999999999999999999844311
Q ss_pred ---------------------------------C-C---------------------CCCCccccccCCCCCcccccCCC
Q 011041 272 ---------------------------------N-H---------------------KQPMTSRVVTLWYRPPELLLGAT 296 (495)
Q Consensus 272 ---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~l~~~~ 296 (495)
. . .....+.|||-.|+|||++.|.
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~- 310 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE- 310 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC-
Confidence 0 0 0112356899999999999984
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCC
Q 011041 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPS 376 (495)
Q Consensus 297 ~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 376 (495)
..+.++|||+|||+|||||.|..||.|.+..+.+.+|+...-.++. ...++..
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~---------------------------~~~vs~~ 363 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE---------------------------EPEVSSA 363 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC---------------------------CCcchhH
Confidence 5699999999999999999999999999999999998753222221 1246788
Q ss_pred cHHHHHHhccCCCCCccC----HHHHHhCCCCCCCCCCCCCCCCCCC
Q 011041 377 SLPLIETLLAIDPAERQT----ATAALRSEFFTTKPYACDPSSLPKY 419 (495)
Q Consensus 377 ~~~Li~~~L~~dP~~R~t----a~elL~hp~f~~~~~~~~~~~~p~~ 419 (495)
++|||+++|.+||.+|+. |.||-+||||.+..|+.-....|.+
T Consensus 364 akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~ 410 (459)
T KOG0610|consen 364 AKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPE 410 (459)
T ss_pred HHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCc
Confidence 999999999999999999 9999999999999998665555544
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=423.41 Aligned_cols=262 Identities=25% Similarity=0.386 Sum_probs=232.6
Q ss_pred CCCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCC
Q 011041 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMS 191 (495)
Q Consensus 114 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 191 (495)
....++|.++++||+|+||+|+++..+.+++.||||+++++.. ..+.++....|.+|+.... ||.++.|+..|.. .
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT--K 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc--C
Confidence 4457999999999999999999999999999999999999876 6778889999999999885 9999999999988 5
Q ss_pred ceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
.++|+||||+.|+. ...++....|+|..++.|+..|+.||+|||++||||||||.+|||||.+|++||+|||+++..-.
T Consensus 442 ~~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred CeEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 78999999999988 34445556899999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
. ....++.||||.|||||++.+ ..|+.++|+|+|||+|||||.|.+||.|+++++++..|+..--
T Consensus 521 ~-g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~------------- 585 (694)
T KOG0694|consen 521 Q-GDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV------------- 585 (694)
T ss_pred C-CCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-------------
Confidence 2 234578899999999999987 6799999999999999999999999999999999999975211
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-----HHHHHhCCCCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEFFTTKPY 409 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----a~elL~hp~f~~~~~ 409 (495)
.....+|.++.+++++||+.||++|+. +.++.+||||....|
T Consensus 586 ----------------~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 586 ----------------RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred ----------------CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 112347889999999999999999976 588999999998776
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-51 Score=413.16 Aligned_cols=264 Identities=33% Similarity=0.481 Sum_probs=234.1
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCce
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 193 (495)
....|++.+.||+|.||+||+|+++.||+.||+|+|.+... .......+.+|+.||++|. |||||.++++|++ ...
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~~ 110 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED--PDS 110 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc--CCe
Confidence 35789999999999999999999999999999999988765 3335678899999999998 9999999999998 558
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC----CcEEEeeccccccc
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE----GILTIADFGLASFF 269 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~----~~vkL~DFG~a~~~ 269 (495)
+|+|||++.|+.+.+.+... .++|..+..+++||+.++.|||+.||+||||||||||+... +.+|++|||++...
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999987766655444 49999999999999999999999999999999999999643 57999999999988
Q ss_pred CCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
.. .......+||+.|+|||++.+ ..|+..+||||+||++|.|++|.+||.+.++.+.+.+|...-..+..++|
T Consensus 190 ~~--~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w---- 262 (382)
T KOG0032|consen 190 KP--GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPW---- 262 (382)
T ss_pred cC--CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCc----
Confidence 76 355678899999999999875 57999999999999999999999999999999999988876665665555
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~ 410 (495)
.+++..+.+||+.||..||.+|+|+.++|+|||++.....
T Consensus 263 ---------------------~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~ 302 (382)
T KOG0032|consen 263 ---------------------DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA 302 (382)
T ss_pred ---------------------cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence 4588999999999999999999999999999999875443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-52 Score=416.92 Aligned_cols=257 Identities=33% Similarity=0.494 Sum_probs=229.8
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+........+.+.+|++|++.|+|||||.++++|+. ...+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET--SAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--cceEEEE
Confidence 67999999999999999999999999999999999988888888999999999999999999999999998 6789999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
.||+.|+|...+ ...+.++|+.++.++.+++.||.|||+++|+|||+||.|||++..|.+|+||||+|+.+..+. ...
T Consensus 80 te~a~g~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~vl 157 (808)
T KOG0597|consen 80 TEYAVGDLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-SVL 157 (808)
T ss_pred ehhhhhhHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc-eee
Confidence 999999666554 445689999999999999999999999999999999999999999999999999999876543 456
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (495)
+...|||.|||||++.+ ..|+..+|+||||||+|||++|+|||....-......|....-.+
T Consensus 158 tsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~----------------- 219 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP----------------- 219 (808)
T ss_pred eeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC-----------------
Confidence 77889999999998875 789999999999999999999999999888777777775422111
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
....+..+.+||+.+|.+||.+|+|-.++|.|||++.+-
T Consensus 220 ------------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 220 ------------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred ------------cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 124678899999999999999999999999999998753
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=398.28 Aligned_cols=284 Identities=34% Similarity=0.567 Sum_probs=234.0
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|++.+.||+|+||.||+|+++.+++.||+|++............+.+|+.+++.++||||+++++++.. +..+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEEEE
Confidence 47999999999999999999999999999999998665444556678899999999999999999999977 5689999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
|||+.++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99999998887766566799999999999999999999999999999999999999999999999999987654333334
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC---c
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA---T 354 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~---~ 354 (495)
....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+..+...+........ .
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 45678999999999876 4589999999999999999999999999998888888888888777665542111000 0
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.+................+|+++.+||.+||++||.+|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00000000111122234578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-52 Score=390.10 Aligned_cols=293 Identities=38% Similarity=0.648 Sum_probs=239.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCe----EEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ----IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
...|+++..||+|+||.||+|..++++. .||||++.-..-.........||+.+++.|+||||+.|..+|... +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cc
Confidence 4679999999999999999997665543 789999976522112223455899999999999999999998764 67
Q ss_pred eeEEEEeeccCChhhhhhC----CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC----CcEEEeecc
Q 011041 193 SLYLVFKYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE----GILTIADFG 264 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~----~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~----~~vkL~DFG 264 (495)
.++|++||.+++|+..+.. ....++...++.++.||+.|+.|||++-|+||||||.||||..+ |.|||+|||
T Consensus 102 ~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 102 KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 8999999999999886542 33578999999999999999999999999999999999999888 899999999
Q ss_pred cccccCCCCCC--CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHH
Q 011041 265 LASFFDPNHKQ--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT---------EVEQLHKI 333 (495)
Q Consensus 265 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~---------~~~~~~~i 333 (495)
+++.+...-.. .....+.|.||+|||+++|...|+.++|||++|||+.||++-.|+|.+.. ..+++.+|
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 99988644321 23456889999999999999999999999999999999999999998753 46889999
Q ss_pred HHhcCCCChhhhhhC-CCCCCccCC---CCcccccc----cccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 334 FKLCGSPSEEYWKKS-KLPHATIFK---PQQSYKRC----IAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 334 ~~~~g~~~~~~~~~~-~~~~~~~~~---~~~~~~~~----~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
++++|.|.++.|+.. ++|+..... ....+..+ .-...+.-++.+.+|+.+||++||.+|+|++++|+|+||+
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~ 341 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT 341 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence 999999999999874 455542110 00111111 1122334567799999999999999999999999999999
Q ss_pred CCCCC
Q 011041 406 TKPYA 410 (495)
Q Consensus 406 ~~~~~ 410 (495)
..+.+
T Consensus 342 ~d~lp 346 (438)
T KOG0666|consen 342 EDPLP 346 (438)
T ss_pred cCCCC
Confidence 98665
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-52 Score=383.72 Aligned_cols=260 Identities=28% Similarity=0.438 Sum_probs=232.3
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC------ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL------EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 190 (495)
+.|.--+.||.|..++|.+|.++.+|..+|+|+|..... ..+..+...+|+.||+++ .||+|++++++|+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes-- 94 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES-- 94 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--
Confidence 567777889999999999999999999999999975422 122344566899999998 79999999999998
Q ss_pred CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
+..+++|||.|..+.+.+++.....++|.+.+.+|+||++|++|||.++||||||||||||++++.++||+|||+++.+.
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 67899999999999888888888899999999999999999999999999999999999999999999999999999887
Q ss_pred CCCCCCCccccccCCCCCccccc-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 011041 271 PNHKQPMTSRVVTLWYRPPELLL-----GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345 (495)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (495)
++ ......||||+|+|||.+. +...|+..+|+|++|||+|-||.|.|||+.....-.+..|+.....+..+.|
T Consensus 175 ~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 175 PG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred Cc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 65 4567889999999999984 3456899999999999999999999999999888888999887777766666
Q ss_pred hhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.+++...+|||.+||+.||.+|.|++|+|+||||..
T Consensus 253 -------------------------adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 253 -------------------------ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred -------------------------hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 458899999999999999999999999999999964
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-50 Score=399.99 Aligned_cols=286 Identities=36% Similarity=0.662 Sum_probs=232.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|+++.+|+.||||++...... .....+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEE
Confidence 57899999999999999999999999999999999754322 223456789999999999999999999987 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 159 (303)
T cd07869 81 VFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HT 159 (303)
T ss_pred EEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-cc
Confidence 99999999888777666679999999999999999999999999999999999999999999999999987543222 23
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT-EVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
.....+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.. ..+.+..+....+.+....|....... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 237 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP--H 237 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc--c
Confidence 3456789999999998776678999999999999999999999999854 457778888888888887776532110 0
Q ss_pred CCCCcc---ccccccccc--CCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 356 FKPQQS---YKRCIAETF--KDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 356 ~~~~~~---~~~~~~~~~--~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
+.+... ....+...+ ..+++++.+||.+||++||.+|+|+.|+|+||||+..+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 100000 000011111 12467899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-52 Score=382.75 Aligned_cols=294 Identities=45% Similarity=0.773 Sum_probs=248.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeec------cC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTS------RM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~ 190 (495)
.+.|+.+.+||+|.||.||+|+.+.+|+.||+|++..++-....-....+|+++|+.|.|+|++.+++++.. ..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 477889999999999999999999999999999887654333333456689999999999999999988743 22
Q ss_pred CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
...+|+||.+|+++|.+++.....+|+..+++.++.+++.||.|+|.+.|+|||+|++|+||+.+|.+||+|||+++.+.
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 34699999999999999998888899999999999999999999999999999999999999999999999999997664
Q ss_pred CCC---CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 011041 271 PNH---KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 271 ~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (495)
... ...+++++.|.||++||.++|...|+++.|||..|||+.||+++.|.|.+.++..++..|-.+||+...+.|+.
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 332 23367789999999999999999999999999999999999999999999999999999999999999999987
Q ss_pred C-CCCCCccC--CC-CcccccccccccCCC--CCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCC
Q 011041 348 S-KLPHATIF--KP-QQSYKRCIAETFKDF--PPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 348 ~-~~~~~~~~--~~-~~~~~~~~~~~~~~~--s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~ 410 (495)
. ++|-.... .| ...-++.+....+-+ .+++.||++.||.+||.+|+++.++|.|.||..+|.+
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 3 34433222 11 111122233333322 5789999999999999999999999999999987655
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=416.12 Aligned_cols=284 Identities=31% Similarity=0.495 Sum_probs=228.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc------C
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR------M 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 190 (495)
..+|++++.||+|+||.||+|++..+++.||||++.... ....+|+.+|+.++|||||++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 467999999999999999999999999999999986432 2345799999999999999999877431 1
Q ss_pred CceeEEEEeeccCChhhhhh---CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC-cEEEeecccc
Q 011041 191 SCSLYLVFKYMEHDLAGLAA---SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLA 266 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~---~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~-~vkL~DFG~a 266 (495)
...+++||||+++++...+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 23578999999988765443 3456799999999999999999999999999999999999999765 7999999999
Q ss_pred cccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 011041 267 SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (495)
Q Consensus 267 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (495)
..+.... .....+||+.|+|||++.+...|+.++|||||||+||||++|.+||.+.+..+.+.++...++.+..+.+.
T Consensus 219 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 219 KNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 8764332 23456789999999998876679999999999999999999999999999999999999999999877665
Q ss_pred hCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
...........+...............|+++.+||.+||++||.+|+|+.|+|+||||....
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 43221111111111111111112234678899999999999999999999999999998643
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=394.05 Aligned_cols=304 Identities=46% Similarity=0.803 Sum_probs=251.7
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
..++|++.+.||+|+||.||+|++..+|+.||+|++............+.+|+.+++.++|+||+++++++.......+|
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 35789999999999999999999999999999999976543333333456799999999999999999998765456789
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+||||+++++...+......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... .
T Consensus 85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~ 163 (309)
T cd07845 85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-K 163 (309)
T ss_pred EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-C
Confidence 999999998777766555679999999999999999999999999999999999999999999999999998765332 2
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC-CCCCc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPHAT 354 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~-~~~~~ 354 (495)
......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|+... ++...
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 23344568899999998776678999999999999999999999999999999999999999998888876532 22222
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCCCCCCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYP 420 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~~~~~~~p~~~ 420 (495)
.+.........+...+..+++++.+||.+||++||.+|||+.++|+||||...+.++.+..+|.+|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~~~ 309 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTFP 309 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCCCC
Confidence 221111111123334455688999999999999999999999999999999999999888777654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=396.28 Aligned_cols=261 Identities=29% Similarity=0.440 Sum_probs=213.8
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
.+|..++.||+|+||.||++.+..+|..+|+|.+...... ..+.+.+|+.+|.+|+|||||+++|.........++|+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 5688889999999999999999999999999999876322 26778999999999999999999997554322379999
Q ss_pred EeeccCChhhhhhCCCC-CCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC-CCcEEEeecccccccCC--CC
Q 011041 198 FKYMEHDLAGLAASPTI-KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADFGLASFFDP--NH 273 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~-~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~-~~~vkL~DFG~a~~~~~--~~ 273 (495)
|||+.++.+..+....+ .|+|..++.+.+||+.||.|||++|||||||||+||||+. ++.+||+|||++..... ..
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999887776665444 7999999999999999999999999999999999999999 79999999999987763 22
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR-TEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
........||+.|||||++......+.++|||||||++.||+||++||... ...+.+..|.... .
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~---~----------- 240 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED---S----------- 240 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC---C-----------
Confidence 223446789999999999985222345999999999999999999999873 3333333332111 0
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.......+|+++.+||.+||..||.+||||.++|.|||.+..
T Consensus 241 -------------~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 241 -------------LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred -------------CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 112334588899999999999999999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=408.04 Aligned_cols=257 Identities=27% Similarity=0.491 Sum_probs=225.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
...|....+||+|+.|.||.|+...+++.||||.+.+.... ..+.+.+|+.+|+.++|+|||.+++.|.- ...+|+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv--~deLWV 347 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLV--GDELWV 347 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhcc--cceeEE
Confidence 36788889999999999999999999999999999876543 33568899999999999999999998876 357999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
|||||+|+.+.++.... .++|.+++.|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus 348 VMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred EEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 99999998887776654 599999999999999999999999999999999999999999999999999998876543 4
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
..+.+|||+|||||++.. ..|++++||||||+++.||+-|+|||-.+++...+..|.. -|.|.-
T Consensus 426 R~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~l-------------- 489 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKL-------------- 489 (550)
T ss_pred cccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCc--------------
Confidence 577899999999999876 6799999999999999999999999999888887777754 233321
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.....+|+.+++||.+||+.|+.+|++|.|||+||||+.
T Consensus 490 -----------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 490 -----------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred -----------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 223458899999999999999999999999999999954
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-51 Score=369.85 Aligned_cols=255 Identities=31% Similarity=0.455 Sum_probs=226.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|-||.||+|+.+.++-.||+|++.+..+ .....+.+.+|++|...|+||||+++|++|.+ ...+|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd--~~riy 98 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD--SKRIY 98 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec--cceeE
Confidence 6899999999999999999999999999999999988765 33445678999999999999999999999998 67899
Q ss_pred EEEeeccCChhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 196 LVFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~--~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+++||...+.+...+. ...+|+|..++.|+.|++.||.|||.++||||||||+|+|++.+|.+||+|||++.....
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~-- 176 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 176 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC--
Confidence 9999998765554443 667899999999999999999999999999999999999999999999999999976542
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
....+.|||..|.+||+..+ ..++..+|+|++|++.||++.|.+||...+..+...+|.+.-...+
T Consensus 177 -~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p------------ 242 (281)
T KOG0580|consen 177 -NKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP------------ 242 (281)
T ss_pred -CCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC------------
Confidence 33477899999999999877 5689999999999999999999999999999999999977532221
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
..++.++.|||.+||.++|.+|.+..|++.|||+..
T Consensus 243 -----------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 243 -----------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred -----------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 458899999999999999999999999999999864
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-49 Score=392.48 Aligned_cols=289 Identities=35% Similarity=0.663 Sum_probs=238.8
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
..++|.+++.||+|+||.||+|+++.++..||+|.+...... .....+.+|+.+++.++||||+++++++.. +...|
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 80 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSLT 80 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeEE
Confidence 357899999999999999999999999999999999765432 223456689999999999999999999987 56799
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+||||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 159 (309)
T cd07872 81 LVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-K 159 (309)
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-c
Confidence 999999998887776666678999999999999999999999999999999999999999999999999997653322 2
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+++..+.+..+.|+.........
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 23345789999999998776678999999999999999999999999999999999999999999988887643211100
Q ss_pred -CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 356 -FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 356 -~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
+................+++++.+||.+||..||.+|+|+.|+|+||||+..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00000000111223456788999999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-49 Score=397.17 Aligned_cols=290 Identities=34% Similarity=0.536 Sum_probs=231.4
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC---CceeE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM---SCSLY 195 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---~~~~~ 195 (495)
+|++.+.||+|+||.||+|++..+|..||||++............+.+|+.+|+.++||||+++++++.... ...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999999999999999998754333344456789999999999999999999875432 23589
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC--
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-- 273 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~-- 273 (495)
+||||+++++...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 9999999877665543 4469999999999999999999999999999999999999999999999999997543221
Q ss_pred CCCCccccccCCCCCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+...++..+....+.+....+.......
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 1222456799999999987642 468899999999999999999999999999988888888888888776554321110
Q ss_pred CccC--CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 353 ATIF--KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 353 ~~~~--~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
...+ .-...........++.+++.+.+||.+||+.||.+|||+.++|+||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0000 00000011123345567888999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=390.14 Aligned_cols=255 Identities=25% Similarity=0.435 Sum_probs=230.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
..+|++.+.||+|.||.|-+|++...|+.||||.|+++.. +....-.+++||+||..|+||||+.+|++|++ ...+.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN--kdKIv 129 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN--KDKIV 129 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC--CceEE
Confidence 3679999999999999999999999999999999999887 55567789999999999999999999999998 46799
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
|||||..++.+.+++...+.|+|.+++.||+||+.|+.|||.++|+|||||.||||+|.++++||+|||++..+... .
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--k 207 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--K 207 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc--c
Confidence 99999999999999988889999999999999999999999999999999999999999999999999999988543 5
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
..+++||+|-|.+||++.|..+-++.+|-|||||+||.|+.|..||.|.+......+|-+.-..
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr---------------- 271 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR---------------- 271 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc----------------
Confidence 5788999999999999998777789999999999999999999999999988888887543211
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
-+.-|.++.-||+.||.+||++|.|++++-.|=|++
T Consensus 272 --------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 272 --------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred --------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 123467788899999999999999999999987765
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-49 Score=387.87 Aligned_cols=282 Identities=38% Similarity=0.641 Sum_probs=227.2
Q ss_pred CCeeeeeeecccCceEEEEEEECC-CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC---CCCCeeeeeceeec---cC
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTL-TGQIVALKKVRFDNLEPESVRFMAREILILRRL---DHPNVVKLEGLVTS---RM 190 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~---~~ 190 (495)
++|++++.||+|+||.||+|++.. +|..||+|++............+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 369999999999999999999854 578899999876544333334556788877766 69999999998752 22
Q ss_pred CceeEEEEeeccCChhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccccccc
Q 011041 191 SCSLYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~ 269 (495)
...+++||||+.+++...+... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 4568999999998877766542 345899999999999999999999999999999999999999999999999999866
Q ss_pred CCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.++.+.+.+|....+.+....|+...
T Consensus 161 ~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 161 SFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred cCC--cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 433 23345678999999999876 568999999999999999999999999999999999999998888877775432
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
......+... -...+.....++++.+.+||.+||+.||++|||+.++|+||||
T Consensus 238 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 238 ALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cccchhccCC--CCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 1111111110 0112333445678889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=403.29 Aligned_cols=289 Identities=31% Similarity=0.481 Sum_probs=234.2
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC---CceeE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM---SCSLY 195 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---~~~~~ 195 (495)
+|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++|+||+++++++.... ...+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999999999999998754334445567889999999999999999999987632 12689
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+||||+.+++...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 81 lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9999999887766544 447999999999999999999999999999999999999999999999999999876544333
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc-
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT- 354 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~- 354 (495)
.....++|+.|+|||++.+...|+.++||||||||+|||++|++||.+.+..+++..|...+|.+....+.........
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 4455678999999999987667899999999999999999999999999999999999999998886654321100000
Q ss_pred c--CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 355 I--FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 355 ~--~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
. ..........+.......++++.+||.+||++||.+|||+.|+|+||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 0 00000000111122345678899999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-49 Score=384.43 Aligned_cols=271 Identities=24% Similarity=0.379 Sum_probs=224.5
Q ss_pred CCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 115 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
...++|++.+.||.|..++||+|+...+++.||||++..+....+ ...+++|+..|+.++||||++++..|.. +..+
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv--~~~L 99 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVV--DSEL 99 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEe--ccee
Confidence 346899999999999999999999999999999999998876544 7889999999999999999999999987 5689
Q ss_pred EEEEeeccCChhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 195 YLVFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~--~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
|+||.||.+|....++.. ...|+|..++.|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+-..
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999998765554432 224899999999999999999999999999999999999999999999999988655332
Q ss_pred CCC---CCccccccCCCCCccccc-CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 273 HKQ---PMTSRVVTLWYRPPELLL-GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 273 ~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
... .+.+.+||++|||||+++ ....|+.++||||||++..||.+|..||..-.+...+..-+ -+.|+... .
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL--qn~pp~~~--t- 254 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL--QNDPPTLL--T- 254 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh--cCCCCCcc--c-
Confidence 211 125669999999999954 34679999999999999999999999999888777664433 34443111 0
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.. .-.+..+.++..++.+|..||++||.+||||+++|+|+||+..
T Consensus 255 ------~~--------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 255 ------SG--------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred ------cc--------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 00 0112334577789999999999999999999999999999864
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=395.90 Aligned_cols=285 Identities=31% Similarity=0.514 Sum_probs=229.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC----c
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS----C 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----~ 192 (495)
.++|++++.||+|+||.||+|++..+|..||+|++............+.+|+.+++.++||||+++++++..... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 578999999999999999999999999999999997654445556677899999999999999999998865321 3
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|+||||+++++...+.. .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 100 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 100 DVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 5799999999987766532 4889999999999999999999999999999999999999999999999999765332
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC--
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL-- 350 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-- 350 (495)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+...++.....
T Consensus 177 --~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 177 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred --ccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 22345678999999999876 5689999999999999999999999999999999999999888887665443110
Q ss_pred -------CCCccCCCCcccccc----cccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 351 -------PHATIFKPQQSYKRC----IAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 351 -------~~~~~~~~~~~~~~~----~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
+..........+..+ ........++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 000000000000000 011122346788999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=404.95 Aligned_cols=281 Identities=23% Similarity=0.327 Sum_probs=219.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCC------CCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH------PNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~~~~~~ 190 (495)
.++|++++.||+|+||+||+|++..+++.||||+++... ........|+.+++.+.| .+|+++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~- 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE- 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-
Confidence 578999999999999999999999999999999996432 223445668888877754 4588999988764
Q ss_pred CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCeeeCCCC-------------
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEG------------- 256 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NILl~~~~------------- 256 (495)
...+|+|||+++++++..+... ..+++..++.|+.||+.||+|||+ .|||||||||+||||+.++
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 4579999999988887766543 479999999999999999999997 6999999999999998765
Q ss_pred ---cEEEeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 011041 257 ---ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333 (495)
Q Consensus 257 ---~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i 333 (495)
.+||+|||++.... ......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+..|
T Consensus 283 ~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCceEEECCCCccccCc----cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 49999999886432 22345689999999999987 56899999999999999999999999999999999999
Q ss_pred HHhcCCCChhhhhhCCCCCCc-cC------CCC---cccccccc-cccC--CCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 334 FKLCGSPSEEYWKKSKLPHAT-IF------KPQ---QSYKRCIA-ETFK--DFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 334 ~~~~g~~~~~~~~~~~~~~~~-~~------~~~---~~~~~~~~-~~~~--~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.+.+|.++..++......... .+ .+. ..+..... ..+. ...+.+.|||.+||++||.+|||+.|+|+
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 999998877654322111100 00 000 00000000 0000 01355789999999999999999999999
Q ss_pred CCCCCCC
Q 011041 401 SEFFTTK 407 (495)
Q Consensus 401 hp~f~~~ 407 (495)
||||...
T Consensus 438 Hp~~~~~ 444 (467)
T PTZ00284 438 HPYVLKY 444 (467)
T ss_pred Ccccccc
Confidence 9999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=388.32 Aligned_cols=256 Identities=23% Similarity=0.359 Sum_probs=219.0
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|++.+.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEE
Confidence 479999999999999999999999999999999976433 23445678899999999999999999998877 568999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||+.++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 9999998766665555667999999999999999999999999999999999999999999999999999865432
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....-
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~------------------ 215 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL------------------ 215 (291)
T ss_pred cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc------------------
Confidence 234578999999998876 5689999999999999999999999999888777777654210
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-----HHHHHhCCCCCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEFFTTKPY 409 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----a~elL~hp~f~~~~~ 409 (495)
.....+++.+.+||.+||..||.+|++ +.++++||||+...|
T Consensus 216 -----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 216 -----------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred -----------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 111235678899999999999999995 999999999987555
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=395.36 Aligned_cols=285 Identities=27% Similarity=0.487 Sum_probs=230.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC----Cc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~ 192 (495)
.++|++++.||+|+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 57899999999999999999999999999999999765444455567789999999999999999999875421 24
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|+||||+++++...+.. .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 103 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 6899999999987766542 5889999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.++....+.+....+.......
T Consensus 180 --~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 180 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred --CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 22345678999999999876 568999999999999999999999999999999999999999988876655432110
Q ss_pred CccCCCCcc-------------cccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 353 ATIFKPQQS-------------YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 353 ~~~~~~~~~-------------~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......... ............+..+.+||.+||+.||.+|||+.++|+||||...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 000000000 0000111122235678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=402.24 Aligned_cols=282 Identities=24% Similarity=0.346 Sum_probs=220.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
...|++++.||+|+||.||+|++..+++.||||.... ..+.+|+.+|+.|+|||||++++++.. ....++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTY--NKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEE--CCeeEE
Confidence 4689999999999999999999999999999997532 345689999999999999999999987 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
|||++.+++...+.. ...+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++..........
T Consensus 161 v~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 161 ILPRYKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 999999887766544 3468999999999999999999999999999999999999999999999999997543332233
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR-------TEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~-------~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+. ....++..+....|.++.+++....
T Consensus 240 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 240 YYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred cccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 445689999999999876 56899999999999999999999877543 2346677777777776544321100
Q ss_pred CCCCccC------CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCC
Q 011041 350 LPHATIF------KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 350 ~~~~~~~------~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~ 410 (495)
......+ .......+........++.++.+||.+||++||.+|||+.|+|+||||+..+.+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 0000000 000000000111223467789999999999999999999999999999875433
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=381.60 Aligned_cols=281 Identities=37% Similarity=0.658 Sum_probs=227.5
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC---CCCCeeeeeceeecc---CCc
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL---DHPNVVKLEGLVTSR---MSC 192 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~---~~~ 192 (495)
+|++++.||+|+||+||+|+++.+|+.||+|.+............+.+|+.+++.+ +||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 48999999999999999999999999999999876533322233455677777665 799999999987642 235
Q ss_pred eeEEEEeeccCChhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 193 SLYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
.++++|||+.+++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 68999999998877665442 34589999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+.++....+.+....|+.....
T Consensus 161 ~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 161 Q--MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred c--ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 2 22345578999999999876 46899999999999999999999999999999999999998888887777642211
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
....+.+. ....+....+.++..+.+||.+||++||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSPR--GPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCCC--CCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11111111 1122344455678889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=392.16 Aligned_cols=258 Identities=26% Similarity=0.482 Sum_probs=233.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.+-|.+.+.||+|.|++|-+|++.-||..||||+|++..++.-....+.+|++.|+.+.|||||+||+++.. ...+||
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT--QTKlyL 94 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--QTKLYL 94 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc--cceEEE
Confidence 467999999999999999999999999999999999998877777888899999999999999999999987 457999
Q ss_pred EEeeccC-ChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC-CCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~-~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~-~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+|+-++ ++..+++.....+.|..+++||+||+.|+.|||+..|||||||||||.+.+ -|.|||+|||++..+.++
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-- 172 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-- 172 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc--
Confidence 9999987 566666666778999999999999999999999999999999999988755 689999999999999876
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
...++.||++.|-|||+++|..+..+++||||||||||.|+||++||...++.+.+..|+......+
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP------------- 239 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP------------- 239 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc-------------
Confidence 4568889999999999999987777899999999999999999999999999999999987544332
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
..++.+++|||..||..||.+|.+.++|..|+|++..
T Consensus 240 ----------------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 240 ----------------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred ----------------hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 3578899999999999999999999999999999864
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-48 Score=383.28 Aligned_cols=287 Identities=38% Similarity=0.695 Sum_probs=237.0
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
..++|++++.||.|+||.||+|++..++..||+|.+...... .....+.+|+.+++.++|+||+++++++.. ...+|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~ 80 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLT 80 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEec--CCeEE
Confidence 467899999999999999999999999999999998754322 223456789999999999999999999987 56799
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+||||+.+++...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .
T Consensus 81 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 159 (301)
T cd07873 81 LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 159 (301)
T ss_pred EEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-C
Confidence 999999998887776666679999999999999999999999999999999999999999999999999997653322 2
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC-c
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA-T 354 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~-~ 354 (495)
......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+....+.+....|+....... .
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 223456789999999987766788999999999999999999999999999999999999999988888865311100 0
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.+........++......+++.+.+||.+||+.||.+|||+.|+|+||||..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0011111112223334567888999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=394.70 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=220.5
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|++.+.||+|+||.||+|+++.+|+.||||++..... .......+.+|+.+|+.++||||+++++++.+ ...+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 93 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRV 93 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEE
Confidence 35889999999999999999999999999999999976532 23445678899999999999999999999987 5689
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 999999988766665555668999999999999999999999999999999999999999999999999999866432
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.... +
T Consensus 172 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~-------------- 232 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--L-------------- 232 (329)
T ss_pred --cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--c--------------
Confidence 234579999999999876 567899999999999999999999999888777776664311 0
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-----HHHHHhCCCCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEFFTTKPYA 410 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----a~elL~hp~f~~~~~~ 410 (495)
.....++..+.+||.+||+.||.+|++ +.+++.||||....|.
T Consensus 233 -------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 233 -------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred -------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 001235677899999999999999997 7999999999875543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=396.85 Aligned_cols=264 Identities=26% Similarity=0.362 Sum_probs=218.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|++++.||+|+||+||+|++..+++.||||++.+... .......+.+|+.++..++|+||+++++.+.+ ...+|+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEE
Confidence 479999999999999999999999999999999976433 33445678899999999999999999999987 568999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC--
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-- 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~-- 274 (495)
||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999876666665566899999999999999999999999999999999999999999999999999875432110
Q ss_pred --------------------------------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 011041 275 --------------------------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP 322 (495)
Q Consensus 275 --------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~ 322 (495)
......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 01124589999999999876 568999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCC---ccCHHHHH
Q 011041 323 GRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE---RQTATAAL 399 (495)
Q Consensus 323 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~---R~ta~elL 399 (495)
+.+..+.+.++........ + .....+++++.+||.+|+. +|.+ ||+++|++
T Consensus 238 ~~~~~~~~~~i~~~~~~~~--------------~-----------p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~ 291 (363)
T cd05628 238 SETPQETYKKVMNWKETLI--------------F-----------PPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK 291 (363)
T ss_pred CCCHHHHHHHHHcCcCccc--------------C-----------CCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 9988888877764221110 0 0012367889999999876 5554 58999999
Q ss_pred hCCCCCCCCCC
Q 011041 400 RSEFFTTKPYA 410 (495)
Q Consensus 400 ~hp~f~~~~~~ 410 (495)
+||||+...|.
T Consensus 292 ~hp~f~~~~~~ 302 (363)
T cd05628 292 TNPFFEGVDWE 302 (363)
T ss_pred CCCCCCCCCHH
Confidence 99999987664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=392.48 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=214.2
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeecc
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME 202 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~ 202 (495)
+.||+|+||.||+|++..+|+.||||++.+... .......+.+|+.+|+.++||||+++++++.. ...+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCC
Confidence 369999999999999999999999999986533 33445667889999999999999999999887 568999999999
Q ss_pred CChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccccc
Q 011041 203 HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282 (495)
Q Consensus 203 ~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 282 (495)
++.+.........+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...... .......+|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~g 157 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccceec
Confidence 8777666666668999999999999999999999999999999999999999999999999998754222 122345679
Q ss_pred cCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCccc
Q 011041 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSY 362 (495)
Q Consensus 283 t~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 362 (495)
|+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+.......+.....
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~------------------------ 212 (323)
T cd05571 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI------------------------ 212 (323)
T ss_pred CccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC------------------------
Confidence 999999999876 5689999999999999999999999998877766665532110
Q ss_pred ccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCC
Q 011041 363 KRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPY 409 (495)
Q Consensus 363 ~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~ 409 (495)
.....+++++.+||.+||..||.+|| ++.++++||||....|
T Consensus 213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 213 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 11134678899999999999999999 8999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=383.98 Aligned_cols=278 Identities=36% Similarity=0.652 Sum_probs=217.7
Q ss_pred eeeecccCceEEEEEEEC--CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEee
Q 011041 123 LDKIGQGTYSNVYKARDT--LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (495)
Q Consensus 123 ~~~LG~G~~g~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~ 200 (495)
.++||+|+||+||+|+++ .++..||+|.+...... ..+.+|+.+|+.++||||+++++++....+..+|++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999965 46789999998754322 346689999999999999999999876656789999999
Q ss_pred ccCChhhhhhC--------CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee----CCCCcEEEeecccccc
Q 011041 201 MEHDLAGLAAS--------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASF 268 (495)
Q Consensus 201 ~~~~l~~~~~~--------~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl----~~~~~vkL~DFG~a~~ 268 (495)
+++++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 99987665432 12358999999999999999999999999999999999999 4567899999999987
Q ss_pred cCCCCC--CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhc
Q 011041 269 FDPNHK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---------VEQLHKIFKLC 337 (495)
Q Consensus 269 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~---------~~~~~~i~~~~ 337 (495)
+..... ......+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+..+ .+++..++...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 653321 1234567899999999998766789999999999999999999999986543 46788899999
Q ss_pred CCCChhhhhhCC-CCCCccCC--------CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 338 GSPSEEYWKKSK-LPHATIFK--------PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 338 g~~~~~~~~~~~-~~~~~~~~--------~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
+.+....|.... .+...... ........+.......+.++.+||.+||++||.+|+|++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 998888776532 11111000 00000111111112335678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=378.80 Aligned_cols=282 Identities=41% Similarity=0.710 Sum_probs=232.4
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+|++.+.||+|+||.||+|++..+|+.||+|.+............+.+|+.+++.++|+||+++++++.+ ...+|+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS--DKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CCceEEEE
Confidence 4889999999999999999999999999999997654433344567789999999999999999999987 56799999
Q ss_pred eeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCc
Q 011041 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278 (495)
Q Consensus 199 e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 278 (495)
||+++++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (284)
T cd07839 79 EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYS 157 (284)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCcC
Confidence 999998887776656679999999999999999999999999999999999999999999999999998654332 2234
Q ss_pred cccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCChhhhhhCC-CCCCccC
Q 011041 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPI-MPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPHATIF 356 (495)
Q Consensus 279 ~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~-~~~~~~~ 356 (495)
...+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+.++.+....|.... .+....+
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 456789999999987766689999999999999999998766 66777788889999999888887776422 1111111
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
+.......+......+++++.+||.+||..||.+|||++++|.||||
T Consensus 238 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 238 -PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred -CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 11111111233445688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=390.28 Aligned_cols=285 Identities=29% Similarity=0.504 Sum_probs=230.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC----Cc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~ 192 (495)
.++|++++.||+|+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 57899999999999999999999999999999999765545555667889999999999999999999886432 23
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|+||||+++++...+.. .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 96 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 96 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred eeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 5799999999987766532 5889999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+..+.+.......
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 173 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred --cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 22345678999999999876 568999999999999999999999999999999999999888888776654422100
Q ss_pred CccCCCCcc-------------cccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 353 ATIFKPQQS-------------YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 353 ~~~~~~~~~-------------~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......... ............+.++.+||.+||..||.+|||+.|+|+||||...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 000000000 0000111122345678999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=397.37 Aligned_cols=264 Identities=29% Similarity=0.420 Sum_probs=219.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|++++.||+|+||.||+|++..+|+.||||++.+... .......+.+|+.+|..++||||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEE
Confidence 479999999999999999999999999999999986533 33455678899999999999999999999987 568999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC-
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ- 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~- 275 (495)
||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999998766666555567999999999999999999999999999999999999999999999999998754321100
Q ss_pred ------------------------------------CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 011041 276 ------------------------------------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKP 319 (495)
Q Consensus 276 ------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~ 319 (495)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCC
Confidence 1123479999999998875 568999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC---HH
Q 011041 320 IMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT---AT 396 (495)
Q Consensus 320 pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t---a~ 396 (495)
||.+.+..+....+........ ......+++++.+||.+||. ||.+|++ +.
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQ-------------------------FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccC-------------------------CCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 9999888777766653211100 00011467889999999997 9999998 99
Q ss_pred HHHhCCCCCCCCCC
Q 011041 397 AALRSEFFTTKPYA 410 (495)
Q Consensus 397 elL~hp~f~~~~~~ 410 (495)
++|+||||+...|.
T Consensus 292 ~ll~h~~~~~~~~~ 305 (364)
T cd05599 292 EIKSHPFFKGVDWE 305 (364)
T ss_pred HHhcCCCcCCCCHH
Confidence 99999999986653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=376.28 Aligned_cols=283 Identities=40% Similarity=0.713 Sum_probs=231.6
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+|++++.||+|+||.||+|++..+|..||||++............+.+|+.+++.++||||+++++++.+ +..+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence 5889999999999999999999999999999997654444444667889999999999999999999987 56799999
Q ss_pred eeccCChhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 199 KYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 199 e~~~~~l~~~~~~--~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||+.+++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (285)
T cd07861 79 EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RV 157 (285)
T ss_pred ecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-cc
Confidence 9999877665543 23578999999999999999999999999999999999999999999999999997654332 22
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....++...+.+....|+..........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 23446789999999987766688999999999999999999999999998888888888888887777754221110000
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.........+......+++++.+||.+||..||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000001112233445688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=388.50 Aligned_cols=285 Identities=34% Similarity=0.564 Sum_probs=230.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC----Cc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~ 192 (495)
.++|++++.||+|+||.||+|.+..++..||||++............+.+|+.+|+.++|+||+++++++.... ..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 47899999999999999999999999999999998765433344556778999999999999999999875421 24
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
..|++++++++++..... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 94 ~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 94 EVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred cEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 579999999877765443 346999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..+.+.......
T Consensus 172 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred ----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 3456789999999998776678999999999999999999999999999999999998888888766554321111
Q ss_pred CccCCCC--cccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 353 ATIFKPQ--QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 353 ~~~~~~~--~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
...+... ......+...+...++.+.+||.+||..||.+|||+.|+|+||||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0000000 000011222334566778999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-48 Score=390.04 Aligned_cols=265 Identities=26% Similarity=0.379 Sum_probs=223.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|++++.||+|+||.||+|++..+|+.||||++.+... .......+.+|+.++..++||||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEEE
Confidence 479999999999999999999999999999999986533 23345678889999999999999999999987 568999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... .
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 999999877776666666899999999999999999999999999999999999999999999999999976543 2
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+..+...........
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------ 221 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPV------------ 221 (333)
T ss_pred cCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCC------------
Confidence 345679999999999876 4789999999999999999999999999888877776654221111000
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~ 410 (495)
.......+++++.+||.+||..+|.+|+++.++++||||....|.
T Consensus 222 ---------~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~ 266 (333)
T cd05600 222 ---------YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN 266 (333)
T ss_pred ---------CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence 000013468889999999999999999999999999999986653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-48 Score=396.61 Aligned_cols=263 Identities=28% Similarity=0.368 Sum_probs=215.2
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
.|++++.||+|+||+||+|++..+++.||||++.+... .......+.+|+.+|+.++|+||+++++++.+ ...+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence 68999999999999999999999999999999986543 34456778899999999999999999999987 5689999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC---
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK--- 274 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~--- 274 (495)
|||+.++.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99998876665555556799999999999999999999999999999999999999999999999999754311000
Q ss_pred -------------------------------------------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHH
Q 011041 275 -------------------------------------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCIL 311 (495)
Q Consensus 275 -------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil 311 (495)
......+||+.|+|||++.+ ..|+.++||||||||+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il 238 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVIL 238 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhHH
Confidence 00124579999999999876 5689999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCC--C
Q 011041 312 AELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAID--P 389 (495)
Q Consensus 312 ~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~d--P 389 (495)
|||++|.+||...+..+...++........ ......+++++.+||.+||..+ |
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLH-------------------------IPPQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccC-------------------------CCCCCCCCHHHHHHHHHHccCcccc
Confidence 999999999998887766665543211110 0011246789999999977654 4
Q ss_pred CCccCHHHHHhCCCCCCCCC
Q 011041 390 AERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 390 ~~R~ta~elL~hp~f~~~~~ 409 (495)
..|+++.++++||||+...|
T Consensus 294 ~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 294 LGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred cCCCCHHHHhcCcccCCCCh
Confidence 45999999999999987554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=379.40 Aligned_cols=261 Identities=23% Similarity=0.382 Sum_probs=213.9
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
.|++.+.||+|+||.||+|.+..+|+.||+|++.+.... ......+.+|+.+++.++|+||+++++++.+ ...+|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CCeEEEE
Confidence 388899999999999999999999999999999765432 2334467789999999999999999999877 5679999
Q ss_pred EeeccCChhhhhh--CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 198 FKYMEHDLAGLAA--SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 198 ~e~~~~~l~~~~~--~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
|||+.++.+.... .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--E 156 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--C
Confidence 9999976554333 23346899999999999999999999999999999999999999999999999999875432 2
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+........
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ-------------- 221 (285)
T ss_pred eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc--------------
Confidence 2345578999999999876 5689999999999999999999999998765443333332221111
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-----HHHHHhCCCCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEFFTTKPY 409 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----a~elL~hp~f~~~~~ 409 (495)
......+++++.+||.+||+.||.+|++ ++++++||||....|
T Consensus 222 -----------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 222 -----------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred -----------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 1122457888999999999999999997 999999999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-48 Score=391.04 Aligned_cols=259 Identities=24% Similarity=0.330 Sum_probs=219.9
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCC-eEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTG-QIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g-~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
..++|++.+.||+|+||.||+|++..++ ..||+|++.+... .......+.+|+.+++.++||||+++++++.+ ...
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~ 105 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD--ESY 105 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe--CCE
Confidence 3578999999999999999999876655 7899999975433 33445678899999999999999999999987 568
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|+||||+.++.+..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 9999999988766666666668999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.....
T Consensus 185 ---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~--------------- 245 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII--------------- 245 (340)
T ss_pred ---cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---------------
Confidence 235679999999999876 5678999999999999999999999999888777777653211
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPYA 410 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~~ 410 (495)
.....+++.+.+||++||+.||.+|+ |++++++||||.+..|.
T Consensus 246 --------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 246 --------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred --------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 11134667889999999999999995 89999999999976553
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=395.43 Aligned_cols=262 Identities=29% Similarity=0.394 Sum_probs=215.6
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
.|++++.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.+++.++|+|||++++++.+ ...+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEE
Confidence 58999999999999999999999999999999976432 34456678899999999999999999999987 5689999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC----
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH---- 273 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~---- 273 (495)
|||+.++.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 9999886655555555679999999999999999999999999999999999999999999999999975321000
Q ss_pred ------------------------------------------CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHH
Q 011041 274 ------------------------------------------KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCIL 311 (495)
Q Consensus 274 ------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil 311 (495)
.......+||+.|+|||++.+ ..|+.++|||||||+|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil 238 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVIL 238 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHHH
Confidence 000123579999999999876 5689999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCC
Q 011041 312 AELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE 391 (495)
Q Consensus 312 ~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~ 391 (495)
|||++|++||.+.+..+...++........ ......+++++.+||.+|+ .||.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~p~~~~~s~~~~~li~~l~-~~p~~ 292 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLH-------------------------IPPQAKLSPEASDLIIKLC-RGPED 292 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcC-------------------------CCCcccCCHHHHHHHHHHc-cCHhH
Confidence 999999999999887777666643211110 0011347889999999986 59999
Q ss_pred ccC---HHHHHhCCCCCCCCC
Q 011041 392 RQT---ATAALRSEFFTTKPY 409 (495)
Q Consensus 392 R~t---a~elL~hp~f~~~~~ 409 (495)
|++ +.++++||||....|
T Consensus 293 R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 293 RLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred cCCCCCHHHHhcCCCcCCcCh
Confidence 997 999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-48 Score=395.47 Aligned_cols=263 Identities=26% Similarity=0.379 Sum_probs=215.6
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|.+++.||+|+||.||+|++..+|+.||||++.+... .......+.+|+.+++.++|||||++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeEE
Confidence 479999999999999999999999999999999876432 33455678899999999999999999999987 568999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC-
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ- 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~- 275 (495)
||||+.++.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999987666555555667999999999999999999999999999999999999999999999999998643210000
Q ss_pred ---------------------------------------------CCccccccCCCCCcccccCCCCCCchhhHHHHHHH
Q 011041 276 ---------------------------------------------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCI 310 (495)
Q Consensus 276 ---------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvi 310 (495)
.....+||+.|+|||++.+ ..|+.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchh
Confidence 0012479999999999876 568999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCC
Q 011041 311 LAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPA 390 (495)
Q Consensus 311 l~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~ 390 (495)
+|||++|.+||.+.+..+.+..+........ + .....++.++.+||.+||. +|.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------~-----------------p~~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLY--------F-----------------PDDIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccC--------C-----------------CCCCCCCHHHHHHHHHHhc-CHh
Confidence 9999999999999888777777654211100 0 0012367789999999998 777
Q ss_pred Cc---cCHHHHHhCCCCCCCCC
Q 011041 391 ER---QTATAALRSEFFTTKPY 409 (495)
Q Consensus 391 ~R---~ta~elL~hp~f~~~~~ 409 (495)
+| +|+.++|.||||+...|
T Consensus 292 ~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 292 NRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred hcCCCCCHHHHhcCCCcCCCCH
Confidence 65 59999999999987554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=393.35 Aligned_cols=267 Identities=24% Similarity=0.341 Sum_probs=222.5
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|++.+.||+|+||.||+|++..++..||+|++.+... .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~~~ 118 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DKYL 118 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCEE
Confidence 46899999999999999999999999999999999975432 23344567889999999999999999999887 5689
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+||||+.++.+..+... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999987766555443 3689999999999999999999999999999999999999999999999999987654332
Q ss_pred CCCccccccCCCCCcccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGA---TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
......+||+.|+|||++.+. ..++.++|||||||++|||++|.+||.+.+....+.+|........ +
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---~------ 268 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT---F------ 268 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC---C------
Confidence 233456799999999998653 2478999999999999999999999999888877777754211110 0
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCC--ccCHHHHHhCCCCCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE--RQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--R~ta~elL~hp~f~~~~~~ 410 (495)
.....+|.++.+||.+||..+|.+ |+|++++++||||+...|.
T Consensus 269 ----------------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 269 ----------------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred ----------------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 011246788999999999999998 9999999999999987664
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-48 Score=395.86 Aligned_cols=263 Identities=28% Similarity=0.362 Sum_probs=215.5
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|++++.||+|+||.||+|++..+++.||||++.+... .......+.+|+.+|+.++|+||+++++.+.+ ...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEE
Confidence 479999999999999999999999999999999875432 22345668899999999999999999999987 568999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC---
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH--- 273 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~--- 273 (495)
||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 99999887666665556679999999999999999999999999999999999999999999999999975331100
Q ss_pred ---------------------------------------CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHH
Q 011041 274 ---------------------------------------KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 314 (495)
Q Consensus 274 ---------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~el 314 (495)
.......+||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeeh
Confidence 001123579999999999876 5689999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-
Q 011041 315 LAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ- 393 (495)
Q Consensus 315 ltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~- 393 (495)
++|++||.+.+..+....+........ ......+++++.+||.+|+ .||.+|+
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLH-------------------------IPSQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCcccc-------------------------CCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 999999999887776666543111100 0011346788999999977 5999999
Q ss_pred --CHHHHHhCCCCCCCCC
Q 011041 394 --TATAALRSEFFTTKPY 409 (495)
Q Consensus 394 --ta~elL~hp~f~~~~~ 409 (495)
|+.++++||||....+
T Consensus 292 ~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 292 KNGADEIKAHPFFKGIDF 309 (376)
T ss_pred CCCHHHHhCCCCcCCCCH
Confidence 9999999999987544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=384.96 Aligned_cols=253 Identities=24% Similarity=0.391 Sum_probs=213.5
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeecc
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME 202 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~ 202 (495)
+.||+|+||.||+|++..+|+.||+|++.+... .......+.+|+.+|+.++||||+++++++.. ...+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEEeCCC
Confidence 369999999999999999999999999986533 33455678899999999999999999999887 568999999999
Q ss_pred CChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccccc
Q 011041 203 HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282 (495)
Q Consensus 203 ~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 282 (495)
++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+|
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~g 157 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCG 157 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccC
Confidence 8777666666668999999999999999999999999999999999999999999999999998754322 122345679
Q ss_pred cCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCccc
Q 011041 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSY 362 (495)
Q Consensus 283 t~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 362 (495)
|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+....
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~------------------------- 211 (328)
T cd05593 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED------------------------- 211 (328)
T ss_pred CcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-------------------------
Confidence 999999999876 568999999999999999999999999887766665553210
Q ss_pred ccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCC
Q 011041 363 KRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPY 409 (495)
Q Consensus 363 ~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~ 409 (495)
......+++++.+||.+||..||.+|+ ++.++++||||....|
T Consensus 212 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 212 ----IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred ----ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 011234678899999999999999997 8999999999987554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=369.41 Aligned_cols=284 Identities=41% Similarity=0.689 Sum_probs=237.0
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+|++.+.||+|+||.||+|++..+|..||+|++............+.+|+.+++.++|+||+++++++.. ....|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 5899999999999999999999999999999998765545556778899999999999999999999987 56899999
Q ss_pred eeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCc
Q 011041 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278 (495)
Q Consensus 199 e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 278 (495)
||+.+++...+......+++.+++.++.||+.+|.|||++||+|+||||+||+++.++.++|+|||++............
T Consensus 79 e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 79 EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99966666665555567999999999999999999999999999999999999999999999999999876544323344
Q ss_pred cccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC-CCcc-C
Q 011041 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP-HATI-F 356 (495)
Q Consensus 279 ~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~-~~~~-~ 356 (495)
...++.+|+|||++.+...++.++|||||||++|+|++|.++|.+.++.+.+..+....+.+....|+..... .... .
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 5678999999999877666789999999999999999999999999999999999999998888777653211 1100 0
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
.+... ...+...+.+.+.++.+||.+||..||.+|||+.++|+||||.
T Consensus 239 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 239 FPESK-PIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCC-cchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 11111 1112344556778899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=383.41 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=214.1
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeecc
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME 202 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~ 202 (495)
+.||+|+||.||++++..+|..||+|++..... .......+.+|+.+++.++||||+++++++.. ...+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCCC
Confidence 369999999999999999999999999986532 33455677789999999999999999999987 568999999999
Q ss_pred CChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccccc
Q 011041 203 HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282 (495)
Q Consensus 203 ~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 282 (495)
++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g 157 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-CccccccC
Confidence 87776666556679999999999999999999999999999999999999999999999999987532221 22345679
Q ss_pred cCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCccc
Q 011041 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSY 362 (495)
Q Consensus 283 t~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 362 (495)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~------------------------ 212 (323)
T cd05595 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------------------------ 212 (323)
T ss_pred CcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC------------------------
Confidence 999999999876 5689999999999999999999999998887776666542110
Q ss_pred ccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCC
Q 011041 363 KRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPY 409 (495)
Q Consensus 363 ~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~ 409 (495)
.....+++++.+||.+||..||.+|+ ++.++++|+||....|
T Consensus 213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 213 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 11234678899999999999999998 8999999999997655
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=389.60 Aligned_cols=264 Identities=32% Similarity=0.452 Sum_probs=221.4
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|.+++.||+|+||.||+|++..+|+.||||++.+... .......+.+|+.++..++|+||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEEE
Confidence 479999999999999999999999999999999986543 22455678899999999999999999999987 568999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC---
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH--- 273 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~--- 273 (495)
||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 99999876555555445689999999999999999999999999999999999999999999999999998664432
Q ss_pred -------------------------CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 011041 274 -------------------------KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE 328 (495)
Q Consensus 274 -------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~ 328 (495)
.......+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 112344578999999999876 478999999999999999999999999988777
Q ss_pred HHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-HHHHHhCCCCCCC
Q 011041 329 QLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-ATAALRSEFFTTK 407 (495)
Q Consensus 329 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-a~elL~hp~f~~~ 407 (495)
...++........ ......+++++.+||..||. ||.+|++ +.++|+||||...
T Consensus 238 ~~~~i~~~~~~~~-------------------------~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 238 TYNKIINWKESLR-------------------------FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHhccCCccc-------------------------CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 7777654211110 00112368889999999997 9999999 9999999999986
Q ss_pred CCC
Q 011041 408 PYA 410 (495)
Q Consensus 408 ~~~ 410 (495)
.|.
T Consensus 292 ~~~ 294 (350)
T cd05573 292 DWE 294 (350)
T ss_pred CHH
Confidence 653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=381.43 Aligned_cols=251 Identities=28% Similarity=0.418 Sum_probs=212.0
Q ss_pred ecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeeccCC
Q 011041 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD 204 (495)
Q Consensus 126 LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~ 204 (495)
||+|+||.||+|++..+++.||+|++..... .......+.+|+.+|..++||||+++++++.. ...+|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCCC
Confidence 7999999999999999999999999975432 34455677889999999999999999999887 56899999999987
Q ss_pred hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccccccC
Q 011041 205 LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL 284 (495)
Q Consensus 205 l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 284 (495)
.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~ 157 (312)
T cd05585 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTP 157 (312)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCc
Confidence 776666556679999999999999999999999999999999999999999999999999987543222 2234567999
Q ss_pred CCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCccccc
Q 011041 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKR 364 (495)
Q Consensus 285 ~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (495)
.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 158 ~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~-------------------------- 210 (312)
T cd05585 158 EYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL-------------------------- 210 (312)
T ss_pred ccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC--------------------------
Confidence 9999999876 5689999999999999999999999998887776666543110
Q ss_pred ccccccCCCCCCcHHHHHHhccCCCCCcc---CHHHHHhCCCCCCCCC
Q 011041 365 CIAETFKDFPPSSLPLIETLLAIDPAERQ---TATAALRSEFFTTKPY 409 (495)
Q Consensus 365 ~~~~~~~~~s~~~~~Li~~~L~~dP~~R~---ta~elL~hp~f~~~~~ 409 (495)
.....+++++.+||.+||..||.+|+ ++.++|.||||....+
T Consensus 211 ---~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~ 255 (312)
T cd05585 211 ---RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW 255 (312)
T ss_pred ---CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence 11234678899999999999999997 5899999999987533
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=385.10 Aligned_cols=260 Identities=28% Similarity=0.416 Sum_probs=211.8
Q ss_pred CeeeeeeecccCceEEEEEEEC---CCCeEEEeEEEecCCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCc
Q 011041 119 TFEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNL--EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~---~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 192 (495)
+|++++.||+|+||.||++++. .+|..||+|++.+... .....+.+.+|+.+++.+ +|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 4899999999999999999864 5789999999975432 223455678899999999 59999999998877 56
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 79999999998766655555567999999999999999999999999999999999999999999999999999866443
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHhcCCCChhhhhhC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV----EQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~----~~~~~i~~~~g~~~~~~~~~~ 348 (495)
........+||+.|+|||++.+...++.++|||||||++|+|++|..||...... .....+....
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~----------- 227 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD----------- 227 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC-----------
Confidence 3333345689999999999877556889999999999999999999999754322 2222221100
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPY 409 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~ 409 (495)
......+++.+.+||.+||..||.+|+ +++++++||||+...|
T Consensus 228 ------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 228 ------------------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 011234677889999999999999999 8999999999997554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-49 Score=386.13 Aligned_cols=256 Identities=26% Similarity=0.439 Sum_probs=222.2
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
..|..++.||+|+||.||+|.+..+++.||||+++.+.. ...++.+++|+.+|..++++||.++|+.|.. +..++++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~--g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHHHH
Confidence 468888999999999999999999999999999998754 4556889999999999999999999999987 6689999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
||||.|+.....+..+..+.|.++..++++++.||.|||..+.+|||||+.||||..+|.|||+|||.+..........
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 9999998888777777777999999999999999999999999999999999999999999999999998776544333
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (495)
.+++|||.||||||+.+ ..|+.++||||||++.+||++|.||+....+...+..|-+ .+++
T Consensus 169 ~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk---~~PP--------------- 229 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK---SAPP--------------- 229 (467)
T ss_pred ccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC---CCCC---------------
Confidence 78899999999999985 6799999999999999999999999987766333222211 0000
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
..-.++++.+++||..||.+||+.||+|.++|+|+|++.
T Consensus 230 ----------~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 230 ----------RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ----------ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 111268899999999999999999999999999999986
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=359.57 Aligned_cols=258 Identities=22% Similarity=0.288 Sum_probs=218.1
Q ss_pred CCCeeee-eeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC--Cc
Q 011041 117 ADTFEKL-DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM--SC 192 (495)
Q Consensus 117 ~~~y~~~-~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~--~~ 192 (495)
.++|.+- ++||-|-.|.|..|.++.||+.+|+|++.- ....++|+++.-.. .|||||.++++|++.. ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 4778776 569999999999999999999999999752 24567888887766 6999999999997632 34
Q ss_pred eeEEEEeeccCChhhhhhCCCC--CCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC---CCcEEEeeccccc
Q 011041 193 SLYLVFKYMEHDLAGLAASPTI--KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLAS 267 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~--~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~---~~~vkL~DFG~a~ 267 (495)
.+.+|||+|+|+.+...++..+ .|+|.++..|++||..|+.|||+++|.||||||||+|+.. +..+||+|||+|+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 6889999999987776665444 4999999999999999999999999999999999999975 4579999999998
Q ss_pred ccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCChh
Q 011041 268 FFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE----VEQLHKIFKLCGSPSEE 343 (495)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~----~~~~~~i~~~~g~~~~~ 343 (495)
.-.. ...+.+.+-||+|.|||++. ...|+...|+||||||+|.||||+|||+.... .+.-.+|......++.+
T Consensus 213 ~t~~--~~~L~TPc~TPyYvaPevlg-~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 213 ETQE--PGDLMTPCFTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred ccCC--CccccCCcccccccCHHHhC-chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 7553 24467778999999999875 46799999999999999999999999986543 34556777777777777
Q ss_pred hhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
.|.. +|++++|||+.||..+|.+|+|+.+++.|||+++.+.
T Consensus 290 EWs~-------------------------VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 290 EWSC-------------------------VSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred hHhH-------------------------HHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 7754 7888999999999999999999999999999997543
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=378.40 Aligned_cols=261 Identities=28% Similarity=0.388 Sum_probs=209.4
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
..++|++++.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+|+.++|+||+++++++.. ...+|
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 148 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQ 148 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEE
Confidence 3578999999999999999999999999999999986543 33445678899999999999999999999977 56799
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+||||+.++.+.. ...+.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... .
T Consensus 149 lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~ 223 (353)
T PLN00034 149 VLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-D 223 (353)
T ss_pred EEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-c
Confidence 9999999876532 2346788889999999999999999999999999999999999999999999998764322 2
Q ss_pred CCccccccCCCCCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 276 PMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
.....+||..|+|||++.. ...++.++|||||||++|||++|+.||......+....+.......
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------- 292 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ----------- 292 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-----------
Confidence 2345689999999998743 1234578999999999999999999998543322222221111000
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
.......++.++.+||.+||..||++|||+.|+|+||||.....
T Consensus 293 --------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 293 --------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred --------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence 01112356788999999999999999999999999999997543
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=386.56 Aligned_cols=265 Identities=26% Similarity=0.362 Sum_probs=220.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|.+.+.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+++.++|+||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEE
Confidence 469999999999999999999999999999999986543 33455678899999999999999999999887 567999
Q ss_pred EEeeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999876555444 33367999999999999999999999999999999999999999999999999999876543332
Q ss_pred CCccccccCCCCCcccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 276 PMTSRVVTLWYRPPELLLG-----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+....+.++........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--------- 229 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK--------- 229 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC---------
Confidence 2234578999999999863 34578999999999999999999999999888777777654211000
Q ss_pred CCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCC
Q 011041 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~ 410 (495)
......+++++.+||..||. ||.+|+|+.+++.||||....|.
T Consensus 230 ----------------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~ 272 (330)
T cd05601 230 ----------------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN 272 (330)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence 00112467889999999998 99999999999999999976554
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=388.82 Aligned_cols=267 Identities=24% Similarity=0.336 Sum_probs=219.8
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|++.+.||+|+||.||++++..+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+ +..+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~ 118 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKYL 118 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEE
Confidence 35789999999999999999999999999999999975432 33345567889999999999999999999987 5689
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+||||+.++.+..+... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++........
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 999999987655555443 3689999999999999999999999999999999999999999999999999987654332
Q ss_pred CCCccccccCCCCCcccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGA---TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
......+||+.|+|||++.+. ..++.++|||||||+||+|++|.+||.+.+....+.+|........ |
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~------ 268 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN---F------ 268 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC---C------
Confidence 233456899999999998653 2378899999999999999999999999888887777754321111 0
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCC--ccCHHHHHhCCCCCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE--RQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--R~ta~elL~hp~f~~~~~~ 410 (495)
.....++..+.+||..||..++.+ |+|+.++++||||+...|.
T Consensus 269 ----------------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~ 313 (370)
T cd05621 269 ----------------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWN 313 (370)
T ss_pred ----------------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcC
Confidence 001246788999999999865544 8999999999999986553
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=388.98 Aligned_cols=264 Identities=27% Similarity=0.375 Sum_probs=218.5
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.++..++|+||+++++.+.+ ...+|+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 479999999999999999999999999999999975432 34455678899999999999999999999887 568999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC--
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-- 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~-- 274 (495)
||||+.++.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++........
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999876666665566799999999999999999999999999999999999999999999999999875432110
Q ss_pred --------------------------------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 011041 275 --------------------------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP 322 (495)
Q Consensus 275 --------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~ 322 (495)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCC
Confidence 01124579999999999876 568999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc---CHHHHH
Q 011041 323 GRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ---TATAAL 399 (495)
Q Consensus 323 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~---ta~elL 399 (495)
+.+..+.+.++........ + .....+++++.+||.+|+ .||.+|+ ++.+++
T Consensus 238 ~~~~~~~~~~i~~~~~~~~--------------~-----------p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 291 (360)
T cd05627 238 SETPQETYRKVMNWKETLV--------------F-----------PPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIK 291 (360)
T ss_pred CCCHHHHHHHHHcCCCcee--------------c-----------CCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence 9888887777653211000 0 001136778999999987 4999998 489999
Q ss_pred hCCCCCCCCCC
Q 011041 400 RSEFFTTKPYA 410 (495)
Q Consensus 400 ~hp~f~~~~~~ 410 (495)
+||||.+..|.
T Consensus 292 ~hp~f~~~~~~ 302 (360)
T cd05627 292 SHPFFEGVDWG 302 (360)
T ss_pred cCCCCCCCCHH
Confidence 99999987664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=372.78 Aligned_cols=278 Identities=36% Similarity=0.652 Sum_probs=215.3
Q ss_pred eeeecccCceEEEEEEECC--CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEee
Q 011041 123 LDKIGQGTYSNVYKARDTL--TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (495)
Q Consensus 123 ~~~LG~G~~g~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~ 200 (495)
..+||+|+||.||+|+++. ++..||+|.+...... ..+.+|+.+|+.++||||+++++++....+..+|+||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 3579999999999999654 6688999998754322 346789999999999999999999876556789999999
Q ss_pred ccCChhhhhhC--------CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee----CCCCcEEEeecccccc
Q 011041 201 MEHDLAGLAAS--------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASF 268 (495)
Q Consensus 201 ~~~~l~~~~~~--------~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl----~~~~~vkL~DFG~a~~ 268 (495)
+++++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 82 AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred eCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 99987765431 12358999999999999999999999999999999999999 4567999999999987
Q ss_pred cCCCCC--CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhc
Q 011041 269 FDPNHK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---------VEQLHKIFKLC 337 (495)
Q Consensus 269 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~---------~~~~~~i~~~~ 337 (495)
+..... ......+||+.|+|||++.+...++.++|||||||++|||++|.+||....+ ..++..++..+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 643321 1234557899999999987766789999999999999999999999986442 45677888888
Q ss_pred CCCChhhhhhCC-CCCCcc----C----CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 338 GSPSEEYWKKSK-LPHATI----F----KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 338 g~~~~~~~~~~~-~~~~~~----~----~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
+.+....|.... .+.... + .................+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 888887776532 111000 0 000011111111112234568899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=380.29 Aligned_cols=268 Identities=23% Similarity=0.304 Sum_probs=217.9
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|++++.||+|+||.||++++..+++.||+|++.+... .......+.+|+.++..++|+||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD--ENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--CCeEEE
Confidence 479999999999999999999999999999999975322 33445668889999999999999999999987 568999
Q ss_pred EEeeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||||+.++.+..+. .....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 99999875554443 33557999999999999999999999999999999999999999999999999998766443322
Q ss_pred CCccccccCCCCCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 276 PMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
.....+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+.+..+........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 228 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ---------- 228 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc----------
Confidence 2233579999999999863 24578899999999999999999999998887777776643211110
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCC--ccCHHHHHhCCCCCCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE--RQTATAALRSEFFTTKPYAC 411 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--R~ta~elL~hp~f~~~~~~~ 411 (495)
+......+++++.+||.+||..++.+ |+++.++|+||||....|..
T Consensus 229 --------------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~ 276 (331)
T cd05597 229 --------------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN 276 (331)
T ss_pred --------------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence 11112347888999999999765554 78999999999998866543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=362.37 Aligned_cols=262 Identities=24% Similarity=0.394 Sum_probs=233.4
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
.+++|+.+++||+|.||.|-+|+.+.+|+.||||+++++-. ..+.+.....|-++|+..+||.+..|...|.. ...+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt--~drl 243 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT--QDRL 243 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc--CceE
Confidence 46899999999999999999999999999999999988765 66677778889999999999999998777766 5689
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+||||..|+.+...+.....|+|..++.|-..|+.||.|||+++||+||||.+|+|+|.||++||+|||+++.-- ...
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g 322 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYG 322 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc-ccc
Confidence 9999999999988888888899999999999999999999999999999999999999999999999999997532 233
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
....+.||||.|+|||++.. ..|+.++|+|.+||++|||+||+.||+..+....+..|+-.--
T Consensus 323 ~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~---------------- 385 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL---------------- 385 (516)
T ss_pred ceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc----------------
Confidence 45678899999999999875 6899999999999999999999999999999888888764321
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-----HHHHHhCCCCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEFFTTKPYA 410 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----a~elL~hp~f~~~~~~ 410 (495)
.....++++++.||..+|.+||.+|+. |.|+.+|+||.+..|.
T Consensus 386 -------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 386 -------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred -------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence 223468899999999999999999964 8999999999988774
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=378.03 Aligned_cols=258 Identities=25% Similarity=0.366 Sum_probs=216.0
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCC-CeeeeeceeeccCCceeEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHP-NVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~~~l 196 (495)
+|++++.||+|+||.||+|++..+++.||||++.+... .....+.+..|+.++..++|+ +|+.+++++.. ...+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 58999999999999999999999999999999986532 334456778899999999765 58889888877 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 157 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KT 157 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cc
Confidence 99999987666666556679999999999999999999999999999999999999999999999999986532221 22
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~------------------ 218 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV------------------ 218 (324)
T ss_pred eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 345579999999999876 5689999999999999999999999999888877777653211
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCH-----HHHHhCCCCCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA-----TAALRSEFFTTKPY 409 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta-----~elL~hp~f~~~~~ 409 (495)
.....+++++.+||.+||..||.+|++. .++++||||....|
T Consensus 219 -----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 219 -----------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred -----------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 1113467788999999999999999986 89999999987544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=366.90 Aligned_cols=288 Identities=43% Similarity=0.746 Sum_probs=235.0
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC---hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE---PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
+|++.+.||+|+||.||+|.+..+|+.||||.+...... ......+..|+.+++.++|+||+++++++.+ ...+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 488999999999999999999999999999999865443 3334567789999999999999999999987 56899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+||||+.+++...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... .
T Consensus 79 lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 157 (298)
T cd07841 79 LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-R 157 (298)
T ss_pred EEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-c
Confidence 999999666665554443479999999999999999999999999999999999999999999999999998765432 2
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC-CCCCc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPHAT 354 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~-~~~~~ 354 (495)
......+++.|+|||.+.+...++.++|||||||++|+|++|.++|.+.++.+.+.++...++.+....|.... ++...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 22344668899999988765678899999999999999999999999999989999998888888877775422 11111
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYAC 411 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~~ 411 (495)
.. .......+...+..++..+.+||.+||.+||.+|||+.++|+|+||++.+.+.
T Consensus 238 ~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 238 EF--KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred cc--cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 11 00011112334456678899999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=377.08 Aligned_cols=256 Identities=25% Similarity=0.368 Sum_probs=213.6
Q ss_pred eeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHH---HhCCCCCeeeeeceeeccCCceeE
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILIL---RRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
|++++.||+|+||.||+|.+..+|+.||||++.+... .....+.+.+|+.++ +.++||||+++++++.+ ...+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence 7889999999999999999999999999999986432 233455677777665 45689999999999987 56899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+||||+.++.+...... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .
T Consensus 79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-D 156 (324)
T ss_pred EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-C
Confidence 99999998766655543 469999999999999999999999999999999999999999999999999987543222 2
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~----------------- 218 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV----------------- 218 (324)
T ss_pred cccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------------
Confidence 2345679999999998876 5689999999999999999999999999888877777654211
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPY 409 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~ 409 (495)
.....+++.+.+||.+||+.||.+|| ++.++++||||....|
T Consensus 219 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 219 ------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 01134678889999999999999999 7999999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=383.22 Aligned_cols=258 Identities=26% Similarity=0.448 Sum_probs=231.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.+.|..++.+|+|+||.+++++++..+..|++|.|..........+...+|+.+++++.|||||.+.+.|+.. ++.++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-GQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-CceEEE
Confidence 5789999999999999999999999999999999999887666667888999999999999999999999874 566999
Q ss_pred EEeeccCChhhhhh-C-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAGLAA-S-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~-~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||+|++|+.+...+ . ++..|+|+.+..|+.||+.||.|||+++|+|||||+.|||++.++.|||+|||+|+...+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 99999987666544 3 34689999999999999999999999999999999999999999999999999999987654
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
....+.+||+.|++||++.+ .+|+.++|||||||++|||++-++.|.+.+-.....+|++....|-+
T Consensus 161 ~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp------------ 227 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP------------ 227 (426)
T ss_pred hhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC------------
Confidence 34567899999999998876 78999999999999999999999999999999999999887654433
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
..++.++..||+.||..+|..||++.++|.+|.+.
T Consensus 228 ----------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 228 ----------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred ----------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 34677889999999999999999999999998876
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=368.25 Aligned_cols=287 Identities=45% Similarity=0.788 Sum_probs=236.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||.|+||.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++........|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 46899999999999999999999999999999999865544333445678999999999999999999987754478999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||+.+++...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+.... ..
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 162 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KP 162 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-cc
Confidence 99999987777666555579999999999999999999999999999999999999999999999999998765432 22
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC-CCCCcc
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPHATI 355 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~-~~~~~~ 355 (495)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.++...++.+....|.... ++....
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 3445678999999998765567899999999999999999999999999999999999999999888887532 222211
Q ss_pred CCCCcccccccccccCC--CCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 356 FKPQQSYKRCIAETFKD--FPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~--~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
..........+...+.. +++.+.+||.+||+.||++|||+.|+|.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 11111111122333444 47889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=378.88 Aligned_cols=253 Identities=24% Similarity=0.372 Sum_probs=212.6
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeEEEEeec
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
+.||+|+||.||+|+++.+++.||||++.+... .......+..|+.++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999976432 234456677888888877 69999999999987 56799999999
Q ss_pred cCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcccc
Q 011041 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (495)
Q Consensus 202 ~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 281 (495)
.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTFC 157 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccccc
Confidence 987766666556689999999999999999999999999999999999999999999999999987543221 2234567
Q ss_pred ccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcc
Q 011041 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (495)
Q Consensus 282 gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 361 (495)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~---------------------- 214 (320)
T cd05590 158 GTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV---------------------- 214 (320)
T ss_pred cCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC----------------------
Confidence 9999999998875 56899999999999999999999999999888877776532110
Q ss_pred cccccccccCCCCCCcHHHHHHhccCCCCCccCH------HHHHhCCCCCCCCC
Q 011041 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA------TAALRSEFFTTKPY 409 (495)
Q Consensus 362 ~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta------~elL~hp~f~~~~~ 409 (495)
....+++++.+||.+||+.||.+|+++ +++++||||....|
T Consensus 215 -------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 215 -------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred -------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 112367788999999999999999998 99999999987554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-47 Score=381.14 Aligned_cols=253 Identities=24% Similarity=0.382 Sum_probs=212.7
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeecc
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME 202 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~ 202 (495)
+.||+|+||.||+|++..+|..||+|++.+... .......+.+|+.+++.++||||+++++++.. ...+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCCC
Confidence 369999999999999999999999999986533 23445667789999999999999999999887 568999999999
Q ss_pred CChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcccc
Q 011041 203 HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (495)
Q Consensus 203 ~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 281 (495)
++.+.........+++..++.++.||+.||.|||+ +||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 157 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFC 157 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccccc
Confidence 88776666666689999999999999999999997 899999999999999999999999999987543221 2234567
Q ss_pred ccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcc
Q 011041 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (495)
Q Consensus 282 gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 361 (495)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~----------------------- 213 (325)
T cd05594 158 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI----------------------- 213 (325)
T ss_pred CCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC-----------------------
Confidence 9999999999876 5689999999999999999999999998887766665532110
Q ss_pred cccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCC
Q 011041 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPY 409 (495)
Q Consensus 362 ~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~ 409 (495)
.....+++++.+||.+||..||.+|+ ++.++|+||||....|
T Consensus 214 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 214 ------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 01134678899999999999999997 9999999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=413.40 Aligned_cols=265 Identities=26% Similarity=0.325 Sum_probs=231.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|.+++.||+|+||.|.+++++.|++.||+|++.+-.. .......|..|-.||..-+.+-|+.++-.|.+ +.++|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD--~~~LY 151 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD--ERYLY 151 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC--ccceE
Confidence 5899999999999999999999999999999999987443 34556788899999999999999999999988 67899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+|||||.||.+-.+.....+++|.-++.|+..|+.||+-||+.|+|||||||+|||||..|+|||+|||.+-.++..+.-
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 99999987654444444448999999999999999999999999999999999999999999999999999888766655
Q ss_pred CCccccccCCCCCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc--CCCChhhhhhCC
Q 011041 276 PMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLC--GSPSEEYWKKSK 349 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~--g~~~~~~~~~~~ 349 (495)
.....||||.|++||+|.. ...||+.+|+|||||++|||++|..||+..+-.+.+.+|+... ..+|+
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~------- 304 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD------- 304 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc-------
Confidence 5667899999999999842 2569999999999999999999999999999999999998762 22221
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC---HHHHHhCCCCCCCCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT---ATAALRSEFFTTKPYAC 411 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t---a~elL~hp~f~~~~~~~ 411 (495)
..++|+++++||.++|+ +|..|+. ++++-.||||.+.+|..
T Consensus 305 --------------------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~ 348 (1317)
T KOG0612|consen 305 --------------------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDN 348 (1317)
T ss_pred --------------------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhh
Confidence 13489999999999886 8999988 99999999999999843
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=374.32 Aligned_cols=283 Identities=23% Similarity=0.332 Sum_probs=216.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||++++..+|..||+|++.... .......+.+|+.+|+.++||||+++++++.. +..+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEE
Confidence 478999999999999999999999999999999997642 34455678999999999999999999999887 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~-givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||||+.++.+..+......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 999999877766666566799999999999999999999986 6999999999999999999999999998765332
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC-CCCCC-
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS-KLPHA- 353 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~-~~~~~- 353 (495)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+...........+... ..+..
T Consensus 158 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2244578999999999876 46899999999999999999999999877665443322111110001100000 00000
Q ss_pred -c-------cCCCCcccc---c-ccccc-----cCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 354 -T-------IFKPQQSYK---R-CIAET-----FKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 354 -~-------~~~~~~~~~---~-~~~~~-----~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
. ...+..... . .+... ...+++++.+||.+||.+||++|||+.++|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 0 000000000 0 00000 1235678999999999999999999999999999986
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=367.56 Aligned_cols=289 Identities=47% Similarity=0.864 Sum_probs=239.7
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC-----
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----- 190 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 190 (495)
..++|++.+.||+|+||.||+|.++.+|+.||+|+++...........+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 457899999999999999999999999999999999765433334456778999999999999999999886632
Q ss_pred ---CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 191 ---SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 191 ---~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
...+|+||||+++++...+......+++..+..++.||+.||.|||++||+|+||||+||++++++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 23789999999998887776665679999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 011041 268 FFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (495)
..............++..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+.+.++.+....|+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 76544333334446688899999887655678999999999999999999999999999999999999999888777764
Q ss_pred CC-CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 348 SK-LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 348 ~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.. .+............+.+...+..+|..+.+||..||..||.+|||+.++|.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 32 1111111222222233445556688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=368.30 Aligned_cols=288 Identities=47% Similarity=0.846 Sum_probs=235.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC------
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM------ 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 190 (495)
.++|++.+.||+|+||.||+|++..+++.||||++............+.+|+.+++.++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 58999999999999999999999999999999998765433333345678999999999999999999875432
Q ss_pred CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
...+|+||||+.+++...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 23589999999998888777666789999999999999999999999999999999999999999999999999997654
Q ss_pred CCCC----------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 011041 271 PNHK----------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSP 340 (495)
Q Consensus 271 ~~~~----------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~ 340 (495)
.... ...+...+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+...++.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 3221 112344678999999988765668999999999999999999999999999999999999999888
Q ss_pred ChhhhhhCC-CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 341 SEEYWKKSK-LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 341 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.+..|.... ++..............+...+..+++.+.+||.+||..||.+|||+.++|.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 877665432 1211111111112222334455677889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=365.92 Aligned_cols=282 Identities=41% Similarity=0.756 Sum_probs=229.5
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+|++++.||.|+||.||+|++..+|..||||.+............+.+|+.++++++||||+++++++.+ ....|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEEe
Confidence 4889999999999999999999999999999987654444444578889999999999999999999876 56799999
Q ss_pred eeccCChhhhhhC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 199 KYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 199 e~~~~~l~~~~~~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
||+.+++...+.. ....+++..+..++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++....... ...
T Consensus 79 e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (284)
T cd07860 79 EFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTY 157 (284)
T ss_pred eccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-ccc
Confidence 9998876665543 34578999999999999999999999999999999999999999999999999987654332 223
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC-CCCccC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL-PHATIF 356 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~~~ 356 (495)
....+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.++.+.+.++....+.+....|+.... +.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 3446788999999987755678899999999999999999999999999899999998888888776653211 100000
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.+. ............+++++.+||.+||+.||.+|||+.++|.||||
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 238 FPK-WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ccc-ccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 000 00111222334577889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=377.16 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=212.9
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeEEEEeec
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
+.||+|+||.||+|++..+++.||||++.+... .......+..|+.++..+ +||||+++++++.+ ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence 369999999999999999999999999986533 334455677899999876 79999999999987 56799999999
Q ss_pred cCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcccc
Q 011041 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (495)
Q Consensus 202 ~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 281 (495)
+++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 157 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTFC 157 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccccc
Confidence 987666655556679999999999999999999999999999999999999999999999999987543222 2234567
Q ss_pred ccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcc
Q 011041 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (495)
Q Consensus 282 gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 361 (495)
||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~---------------------- 214 (321)
T cd05591 158 GTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL---------------------- 214 (321)
T ss_pred cCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------------------
Confidence 8999999998875 56899999999999999999999999999988888777542100
Q ss_pred cccccccccCCCCCCcHHHHHHhccCCCCCcc-------CHHHHHhCCCCCCCCC
Q 011041 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-------TATAALRSEFFTTKPY 409 (495)
Q Consensus 362 ~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-------ta~elL~hp~f~~~~~ 409 (495)
....++.++.+||.+||+.||.+|+ ++.++++||||....|
T Consensus 215 -------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 215 -------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred -------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence 0123567889999999999999999 9999999999987554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=375.09 Aligned_cols=258 Identities=23% Similarity=0.348 Sum_probs=216.2
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~l 196 (495)
+|.+++.||+|+||.||+|++..+++.||||++.+... .......+..|+.++..+ .|++|+++++++.+ ...+|+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 58899999999999999999999999999999986533 233445567788888887 58999999999877 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~ 157 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VT 157 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Cc
Confidence 99999877666555555679999999999999999999999999999999999999999999999999987543221 22
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~----------------- 219 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA----------------- 219 (323)
T ss_pred cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------------
Confidence 345678999999999876 56899999999999999999999999998888877776542111
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-----HHHHHhCCCCCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEFFTTKPY 409 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----a~elL~hp~f~~~~~ 409 (495)
....+++++.+||.+||+.||.+|++ ..++++||||....|
T Consensus 220 ------------~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 220 ------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred ------------CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 11346788999999999999999998 489999999987655
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=383.44 Aligned_cols=266 Identities=25% Similarity=0.340 Sum_probs=219.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++.+.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+ ...+|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~~ 119 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYLY 119 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEEE
Confidence 5899999999999999999999999999999999975332 33345567889999999999999999999987 57899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+||||+.++.+..+... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 120 lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 99999987665555443 35899999999999999999999999999999999999999999999999999876543322
Q ss_pred CCccccccCCCCCcccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 276 PMTSRVVTLWYRPPELLLGA---TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+....+.+|........ +
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~------- 268 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT---F------- 268 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc---C-------
Confidence 33456799999999998653 2378999999999999999999999999888877777754221110 0
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCC--ccCHHHHHhCCCCCCCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE--RQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--R~ta~elL~hp~f~~~~~~ 410 (495)
....+++..+.+||..||..++.+ |+++.++++|+||++..|.
T Consensus 269 ---------------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~~ 313 (371)
T cd05622 269 ---------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 313 (371)
T ss_pred ---------------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCChh
Confidence 012357888999999999844443 7899999999999986653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=361.20 Aligned_cols=281 Identities=37% Similarity=0.602 Sum_probs=227.4
Q ss_pred eeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCceeEEEE
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
|++++.||+|+||.||+|.+..++..||+|++.......... ...+|+.++.++. |+||+++++++.+.....+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 678899999999999999999999999999987643332322 3447899999885 99999999999875447899999
Q ss_pred eeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCc
Q 011041 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278 (495)
Q Consensus 199 e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 278 (495)
||++++++..+......+++..+..++.||+.||.|||++||+||||||+||+++. +.+||+|||++...... ....
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--~~~~ 156 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK--PPYT 156 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC--CCcC
Confidence 99999888877665567999999999999999999999999999999999999999 99999999999866432 2223
Q ss_pred cccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCC
Q 011041 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (495)
Q Consensus 279 ~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 358 (495)
...+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+....+.+....+..........+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 45689999999987655567899999999999999999999999999999999998888887765533222111111111
Q ss_pred CcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 359 ~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.......+......++.++.+||.+||..||.+|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111111223334678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=360.33 Aligned_cols=283 Identities=34% Similarity=0.622 Sum_probs=227.4
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|++.+.||+|+||.||+|+++.+|+.||+|++..........+.+.+|+.+++.++|+||+++++++.. ...+|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEE
Confidence 47999999999999999999999999999999987554333334567889999999999999999999987 5679999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
|||++++++..+......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY 157 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence 99999998887776666799999999999999999999999999999999999999999999999999987654321 22
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh---hhhCCCCCCc
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY---WKKSKLPHAT 354 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~---~~~~~~~~~~ 354 (495)
....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+...... |........
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG- 236 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc-
Confidence 3456789999999987766688999999999999999999999999888888777766655443321 111000000
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
...+.......+...+.+++..+.+||.+||..||++|||+.|+|.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00011000111223345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=362.88 Aligned_cols=284 Identities=38% Similarity=0.693 Sum_probs=227.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||+|+++.+++.||||.+...... .....+.+|+.+++.++|+||+++++++.+ ....|+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEE
Confidence 57899999999999999999999999999999998754322 122345689999999999999999999987 568999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~ 159 (291)
T cd07844 81 VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KT 159 (291)
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC-cc
Confidence 99999988877666555578999999999999999999999999999999999999999999999999987543221 11
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCChhhhhhCCCCCC-c
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT-EVEQLHKIFKLCGSPSEEYWKKSKLPHA-T 354 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~~~-~ 354 (495)
.....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+ ..+.+..+.+..+.+....|........ .
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 2333568899999998765668899999999999999999999998766 6677888888888888887765321110 0
Q ss_pred cCCCCcccccccccccCCCC--CCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFP--PSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s--~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
...........+......++ .++.+||.+||+.||.+|||+.++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00000000111222333444 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=375.09 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=211.8
Q ss_pred eeeecccCceEEEEEEEC---CCCeEEEeEEEecCCC--ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 123 LDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNL--EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 123 ~~~LG~G~~g~Vy~a~~~---~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++.||+|+||.||+|++. .+++.||+|++..... .......+.+|+.+|+.++||||+++++++.. +..+|+|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv 78 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLI 78 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEE
Confidence 367999999999999864 5789999999976432 22334567789999999999999999999987 5679999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
|||+.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVT 157 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Ccc
Confidence 9999987776666666678999999999999999999999999999999999999999999999999987543222 223
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (495)
...+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+....+..+.....
T Consensus 158 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~------------------- 217 (323)
T cd05584 158 HTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL------------------- 217 (323)
T ss_pred cccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence 44579999999999876 4678999999999999999999999999887777666643210
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPY 409 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~ 409 (495)
.....+++++.+||.+||..||.+|+ ++.++++||||....|
T Consensus 218 ----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 218 ----------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred ----------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 11234677889999999999999999 8999999999987544
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=373.21 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=208.5
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeEEEEeec
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
+.||+|+||.||+|++..+++.||||++..... .......+..|..++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999986432 223344555677777654 89999999999877 56899999999
Q ss_pred cCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcccc
Q 011041 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (495)
Q Consensus 202 ~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 281 (495)
.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~ 157 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccccc
Confidence 887766666556679999999999999999999999999999999999999999999999999997643222 2334567
Q ss_pred ccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcc
Q 011041 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (495)
Q Consensus 282 gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 361 (495)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~----------------------- 213 (316)
T cd05592 158 GTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP----------------------- 213 (316)
T ss_pred CCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 9999999999876 4689999999999999999999999999888777766643110
Q ss_pred cccccccccCCCCCCcHHHHHHhccCCCCCccCH-HHHHhCCCCCCCCC
Q 011041 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA-TAALRSEFFTTKPY 409 (495)
Q Consensus 362 ~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta-~elL~hp~f~~~~~ 409 (495)
.....++.++.+||.+||..||.+|+++ .++++||||....|
T Consensus 214 ------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 214 ------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 0112366788999999999999999986 58889999987554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=360.88 Aligned_cols=285 Identities=54% Similarity=0.964 Sum_probs=239.4
Q ss_pred eeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEe
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFK 199 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e 199 (495)
|++.+.||.|+||.||+|++..+|+.||+|++............+.+|+.+++.++|+||+++++++........|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 67899999999999999999999999999999876433344566788999999999999999999998743368999999
Q ss_pred eccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcc
Q 011041 200 YMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS 279 (495)
Q Consensus 200 ~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 279 (495)
|+++++...+......+++..+..++.||+.||.|||+.|++|+||||+|||+++++.+||+|||++.............
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence 99988877776665689999999999999999999999999999999999999999999999999998775543323445
Q ss_pred ccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC-CCCCccCCC
Q 011041 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPHATIFKP 358 (495)
Q Consensus 280 ~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~-~~~~~~~~~ 358 (495)
..++..|+|||.+.+...++.++|||||||++|+|++|++||...+....+..+...++.+....|.... +.....+.+
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07840 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240 (287)
T ss_pred cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence 5678899999988765668999999999999999999999999999999999999999988887776532 222222333
Q ss_pred CcccccccccccCCC-CCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 359 QQSYKRCIAETFKDF-PPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 359 ~~~~~~~~~~~~~~~-s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.......+...+... ++.+.++|.+||..||.+||++.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 333333344445554 8899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=356.67 Aligned_cols=261 Identities=24% Similarity=0.341 Sum_probs=223.0
Q ss_pred CCeeee-eeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeE
Q 011041 118 DTFEKL-DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 118 ~~y~~~-~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~ 195 (495)
+-|++. +.||+|+|+.|-.|+...+|..||||+|.+.. ......+.||++++.+. .|+||+.|+++|++ +...|
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FY 152 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFY 152 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEE
Confidence 334443 57999999999999999999999999998763 44556788999999998 69999999999998 56799
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC---cEEEeecccccccCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPN 272 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~---~vkL~DFG~a~~~~~~ 272 (495)
||||-|.|+-+-..+.....|+|.++..++++|+.||+|||.+||.||||||||||..... -||||||.+..-+...
T Consensus 153 LVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~ 232 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN 232 (463)
T ss_pred EEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence 9999999987767777778999999999999999999999999999999999999997654 4899999998654322
Q ss_pred ------CCCCCccccccCCCCCccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------------hH
Q 011041 273 ------HKQPMTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAEKPIMPGRT---------------EV 327 (495)
Q Consensus 273 ------~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DvwSlGvil~elltG~~pf~~~~---------------~~ 327 (495)
......+.+|+..|||||+.. ....|+.+.|+||||||||.||+|++||.|.- ..
T Consensus 233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~ 312 (463)
T KOG0607|consen 233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN 312 (463)
T ss_pred CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence 122345678999999999862 24569999999999999999999999998642 35
Q ss_pred HHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 328 EQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 328 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
..++.|......+++..|. ++|.+++|||..+|..|+..|.++.++|+|||++.-
T Consensus 313 ~LFesIQEGkYeFPdkdWa-------------------------hIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 313 KLFESIQEGKYEFPDKDWA-------------------------HISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHHHHhccCCcCChhhhH-------------------------HhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 6678888888888887774 488999999999999999999999999999999863
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=375.33 Aligned_cols=266 Identities=22% Similarity=0.306 Sum_probs=216.7
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|++++.||+|+||.||+++++.+++.||+|++.+... .......+.+|+.++..++|+||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEEE
Confidence 479999999999999999999999999999999875322 23344567889999999999999999999987 567999
Q ss_pred EEeeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 99999876554444 43567999999999999999999999999999999999999999999999999998765433322
Q ss_pred CCccccccCCCCCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 276 PMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
.....+||+.|+|||++.+ ...++.++|||||||++|||++|++||.+.+..+.+.++........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 228 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---------- 228 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc----------
Confidence 2334579999999999862 34588999999999999999999999999888777777653211100
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCC--ccCHHHHHhCCCCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE--RQTATAALRSEFFTTKPY 409 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--R~ta~elL~hp~f~~~~~ 409 (495)
+......+++++.+||.+||..++.+ |+++.++++||||....|
T Consensus 229 --------------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 229 --------------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred --------------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 11122457888999999999776555 689999999999997655
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=364.79 Aligned_cols=256 Identities=26% Similarity=0.374 Sum_probs=206.6
Q ss_pred ecccCceEEEEEEECCCCeEEEeEEEecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeeccCC
Q 011041 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD 204 (495)
Q Consensus 126 LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~ 204 (495)
||+|+||+||+|.+..+|+.||+|++...... ......+..|+.+|+.++|+||+++++++.. ...+|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCCC
Confidence 79999999999999999999999999765432 2334567789999999999999999998877 46799999999987
Q ss_pred hhhhhh----CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccc
Q 011041 205 LAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280 (495)
Q Consensus 205 l~~~~~----~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 280 (495)
.+.... .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... .....
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccccc
Confidence 655433 2345699999999999999999999999999999999999999999999999999976643322 23345
Q ss_pred cccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCc
Q 011041 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQ 360 (495)
Q Consensus 281 ~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 360 (495)
.||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+........
T Consensus 158 ~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------- 217 (280)
T cd05608 158 AGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS------------------- 217 (280)
T ss_pred CCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC-------------------
Confidence 78999999999876 5688999999999999999999999987544322222211110000
Q ss_pred ccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCCC
Q 011041 361 SYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPYA 410 (495)
Q Consensus 361 ~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~~ 410 (495)
......+++.+.+||.+||+.||.+|+ |++++++||||+...|.
T Consensus 218 ------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 218 ------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred ------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 011235778899999999999999999 89999999999986554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=359.65 Aligned_cols=282 Identities=38% Similarity=0.704 Sum_probs=230.9
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+|++++.||.|++|.||+|++..+|..||||++...... .....+.+|+.+++.++|+||+++++++.+ ....|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEE
Confidence 589999999999999999999999999999999765432 233556789999999999999999999987 46789999
Q ss_pred eeccCChhhhhhCCC--CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 199 KYMEHDLAGLAASPT--IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 199 e~~~~~l~~~~~~~~--~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||+.+++...+.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ..
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~~ 156 (284)
T cd07836 78 EYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-NT 156 (284)
T ss_pred ecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-cc
Confidence 999998777655433 468999999999999999999999999999999999999999999999999997654322 22
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
.....+++.|++||++.+...++.++|||||||++|+|++|++||.+.+..+.+.++......+....|...........
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 23456789999999987766678999999999999999999999999999999999999988888887765331111000
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
..............+.+++.+.++|.+||+.||.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 000000111222334568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=364.66 Aligned_cols=262 Identities=24% Similarity=0.392 Sum_probs=214.2
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
.|++.+.||+|+||.||++.+..+++.||||++...... ......+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEE
Confidence 488999999999999999999999999999999764432 2233556789999999999999999999877 4579999
Q ss_pred EeeccCChhhhhh-C-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 198 FKYMEHDLAGLAA-S-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 198 ~e~~~~~l~~~~~-~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
|||+.++.+.... . ....+++..+..++.||+.||.|||++||+||||||+|||+++++.++|+|||++...... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~ 156 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--E 156 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC--C
Confidence 9999876555433 2 2346999999999999999999999999999999999999999999999999999865432 2
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
.....+|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ-------------- 221 (285)
T ss_pred ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc--------------
Confidence 2244578999999999876 5689999999999999999999999998766554444432211100
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPYA 410 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~~ 410 (495)
......+++.+.+||.+||..||.+|| ++.++++||||....|.
T Consensus 222 -----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 222 -----------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred -----------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 011234678889999999999999999 99999999999876553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=371.87 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=208.3
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeEEEEeec
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
+.||+|+||.||+|+++.+|..||+|++.+... .......+..|+.++..+ +||||+++++++.+ ...+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 469999999999999999999999999986432 123345566788888765 89999999999987 56899999999
Q ss_pred cCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcccc
Q 011041 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (495)
Q Consensus 202 ~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 281 (495)
.++.+.........+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-CceeccC
Confidence 987666555555679999999999999999999999999999999999999999999999999987432221 2234567
Q ss_pred ccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcc
Q 011041 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (495)
Q Consensus 282 gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 361 (495)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.... +
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~--~--------------------- 213 (316)
T cd05620 158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--P--------------------- 213 (316)
T ss_pred CCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C---------------------
Confidence 9999999999876 568999999999999999999999999888777666553211 0
Q ss_pred cccccccccCCCCCCcHHHHHHhccCCCCCccCH-HHHHhCCCCCCCCC
Q 011041 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA-TAALRSEFFTTKPY 409 (495)
Q Consensus 362 ~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta-~elL~hp~f~~~~~ 409 (495)
.....++.++.+||.+||..||.+|+++ +++++||||....|
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 214 ------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence 0112356788999999999999999997 58889999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=374.32 Aligned_cols=253 Identities=24% Similarity=0.374 Sum_probs=209.1
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHH-HHHhCCCCCeeeeeceeeccCCceeEEEEeec
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREIL-ILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
+.||+|+||+||+|++..+|+.||||++.+... .......+..|.. +++.++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcCC
Confidence 369999999999999999999999999976432 2223334445544 5678999999999999877 56899999999
Q ss_pred cCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcccc
Q 011041 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (495)
Q Consensus 202 ~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 281 (495)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFC 157 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccccc
Confidence 98777666666668999999999999999999999999999999999999999999999999998753222 12234557
Q ss_pred ccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcc
Q 011041 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (495)
Q Consensus 282 gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 361 (495)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------------------ 212 (323)
T cd05575 158 GTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP------------------------ 212 (323)
T ss_pred CChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC------------------------
Confidence 9999999999876 568999999999999999999999999988777776664321
Q ss_pred cccccccccCCCCCCcHHHHHHhccCCCCCccCH----HHHHhCCCCCCCCC
Q 011041 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA----TAALRSEFFTTKPY 409 (495)
Q Consensus 362 ~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta----~elL~hp~f~~~~~ 409 (495)
......+++.+.+||.+||+.||.+|+++ .+++.||||....|
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 213 -----LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 01123467889999999999999999997 69999999987554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=363.45 Aligned_cols=288 Identities=47% Similarity=0.746 Sum_probs=228.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC------
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM------ 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 190 (495)
.++|++.+.||+|+||.||+|++..+++.||||.+............+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 57899999999999999999999999999999998765433333345668999999999999999999876532
Q ss_pred CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
....|+||||+.+++...+......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+.
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS 170 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence 24579999999998887776666679999999999999999999999999999999999999999999999999998664
Q ss_pred CCCC---CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 011041 271 PNHK---QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 271 ~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (495)
.... .......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+...++..+.+.|+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (310)
T cd07865 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250 (310)
T ss_pred CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 3322 1223456788999999887755678999999999999999999999999998888888888888887776654
Q ss_pred CCCCC-CccCCCCccccccccccc--CCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 348 SKLPH-ATIFKPQQSYKRCIAETF--KDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 348 ~~~~~-~~~~~~~~~~~~~~~~~~--~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
..... .............+.... ...++.+.+||.+||..||.+|||++++|+||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 31110 000000011111111111 1135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=373.26 Aligned_cols=253 Identities=21% Similarity=0.370 Sum_probs=205.7
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeEEEEeec
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
+.||+|+||.||+|++..+++.||||++.+... .......+.+|+.++..+ +||||+++++++.+ ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 369999999999999999999999999986543 334456788999999998 79999999999987 56899999999
Q ss_pred cCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcccc
Q 011041 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (495)
Q Consensus 202 ~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 281 (495)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCcccccc
Confidence 98766655555568999999999999999999999999999999999999999999999999998743221 12234568
Q ss_pred ccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------HHH-HHHHHHhcCCCChhhhhhCCCCC
Q 011041 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE--------VEQ-LHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 282 gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~--------~~~-~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+. ...+...
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---------------- 220 (329)
T cd05588 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK---------------- 220 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC----------------
Confidence 9999999999876 5689999999999999999999999963211 111 1111110
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC------HHHHHhCCCCCCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT------ATAALRSEFFTTKPY 409 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t------a~elL~hp~f~~~~~ 409 (495)
.......++.++.+||.+||+.||.+|+| +.++++||||....|
T Consensus 221 -------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 221 -------------QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 00112346778899999999999999987 799999999987554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=371.87 Aligned_cols=285 Identities=29% Similarity=0.521 Sum_probs=228.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC----Cc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~ 192 (495)
.++|++++.||+|+||.||+|++..+|+.||||++.+..........+.+|+.+++.++|+||+++++++.... ..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 47899999999999999999999999999999998765444455566778999999999999999999886432 23
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
..|+||||+.+++...+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 95 DVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 5799999999877766543 2899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
. ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.++...++.+..+++.......
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 172 F--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred C--CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 2 2344568999999999876 568999999999999999999999999999999999999999998876654321110
Q ss_pred CccCCCC-----cccccc---------cccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 353 ATIFKPQ-----QSYKRC---------IAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 353 ~~~~~~~-----~~~~~~---------~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
....... ..+... ........++.+.+||.+||+.||.+|||+.|+|.||||...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 0000000 000000 001112345678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=373.92 Aligned_cols=267 Identities=22% Similarity=0.306 Sum_probs=217.5
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|++++.||+|+||.||++++..+++.||+|++.+... .......+.+|+.++..++|+||+++++++.+ ...+|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 579999999999999999999999999999999975322 33345567889999999999999999999987 568999
Q ss_pred EEeeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||||+.++.+..+. .....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 99999876555444 33567999999999999999999999999999999999999999999999999999776543322
Q ss_pred CCccccccCCCCCcccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 276 PMTSRVVTLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
.....+||+.|+|||++.+. ..++.++|||||||+||+|++|+.||.+.+..+.+.++......+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 228 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---------- 228 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc----------
Confidence 22345799999999988642 3578899999999999999999999998887777776653211110
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCC--ccCHHHHHhCCCCCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE--RQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--R~ta~elL~hp~f~~~~~~ 410 (495)
+.....+++.++.+||.+||..++.+ |++++++++|+||....|.
T Consensus 229 --------------~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 229 --------------FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred --------------CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 11122457888999999999976655 5799999999999875553
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=360.66 Aligned_cols=286 Identities=42% Similarity=0.762 Sum_probs=232.3
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|++.+.||+|++|.||+|.++.+|+.||+|.+............+.+|+.+++.++|+||+++++++.+ ....|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeEEEE
Confidence 67999999999999999999999999999999987654433444667889999999999999999999987 5689999
Q ss_pred EeeccCChhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC-CCcEEEeecccccccCCCCCC
Q 011041 198 FKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~-~~~vkL~DFG~a~~~~~~~~~ 275 (495)
|||+++++....... ...+++..++.++.||+.||.|||++||+|+||||+||+++. ++.+||+|||++....... .
T Consensus 80 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~ 158 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-R 158 (294)
T ss_pred EecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-c
Confidence 999998877665443 334688999999999999999999999999999999999985 5679999999997654321 2
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC-CCCCc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPHAT 354 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~-~~~~~ 354 (495)
......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.+++...+.+....|.... ++...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 23445678999999998765568899999999999999999999999999889999999988988888876421 11111
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
...+.. .........+.+++++.++|.+||..||.+||++.++|+||||...
T Consensus 239 ~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 239 SAFPKW-PPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhcccC-CCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 111100 0011222345678899999999999999999999999999999863
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=370.01 Aligned_cols=253 Identities=29% Similarity=0.403 Sum_probs=212.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeE-EEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~-vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++..+.+.||.|+||+||++.++ |.. ||+|++............|.+|+.+|.+|+|||||+++|++.+.. ..+.
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~-~~~~ 116 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP-GSLC 116 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-CceE
Confidence 345566677999999999999766 555 999999877665555789999999999999999999999998742 2689
Q ss_pred EEEeeccCChhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhCC-ceeccCCCCCeeeCCCC-cEEEeecccccccCC
Q 011041 196 LVFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQH-VLHRDIKGSNLLIDNEG-ILTIADFGLASFFDP 271 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~--~~~l~e~~~~~i~~qil~~L~~LH~~g-ivHrDlKp~NILl~~~~-~vkL~DFG~a~~~~~ 271 (495)
|||||+.++.+..+... ...++...+..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999998877776654 678999999999999999999999999 99999999999999998 999999999987653
Q ss_pred CCCCCCccccccCCCCCcccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 272 NHKQPMTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
.. ...+...||+.|||||++.+ ...|+.++||||||++||||+||..||.+.........+......|.
T Consensus 197 ~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~--------- 266 (362)
T KOG0192|consen 197 SK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP--------- 266 (362)
T ss_pred cc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC---------
Confidence 32 33455789999999999985 36799999999999999999999999999888666665543222211
Q ss_pred CCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....++.+..||..|+..||.+||+..+++.
T Consensus 267 ------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 ------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 12237788999999999999999999999875
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=370.80 Aligned_cols=253 Identities=23% Similarity=0.370 Sum_probs=212.3
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeEEEEeec
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
+.||+|+||.||+|++..+++.||||++.+... .......+.+|+.++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999986532 234456677899999988 79999999999987 56799999999
Q ss_pred cCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcccc
Q 011041 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (495)
Q Consensus 202 ~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 281 (495)
.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFC 157 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccccee
Confidence 987776666666689999999999999999999999999999999999999999999999999986532221 2233457
Q ss_pred ccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcc
Q 011041 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (495)
Q Consensus 282 gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 361 (495)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 158 g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~----------------------- 213 (318)
T cd05570 158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV----------------------- 213 (318)
T ss_pred cCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 8999999999876 5689999999999999999999999998887776666543110
Q ss_pred cccccccccCCCCCCcHHHHHHhccCCCCCccCH-----HHHHhCCCCCCCCC
Q 011041 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA-----TAALRSEFFTTKPY 409 (495)
Q Consensus 362 ~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta-----~elL~hp~f~~~~~ 409 (495)
.....+++++.+||.+||..||.+|||+ .++++||||....|
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 214 ------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred ------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 0113467788999999999999999999 99999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=373.97 Aligned_cols=281 Identities=23% Similarity=0.305 Sum_probs=218.4
Q ss_pred CCCeeeeeeecccCceEEEEEEEC--CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT--LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
..+|.+++.||+|+||.||+|... .++..||+|.+... ....+|+.+|+.|+|||||++++++.. ...+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRW--KSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEee--CCEE
Confidence 467999999999999999999754 45678999987643 234579999999999999999999876 5679
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+|||++.+++...+ .....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 162 ~lv~e~~~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKYKCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhcCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 999999998887766 4455799999999999999999999999999999999999999999999999999976643322
Q ss_pred C-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 275 Q-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT---EVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 275 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~---~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.. ....+..+.+.++..+.++......
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred cccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 1 2234579999999998876 568999999999999999999999998754 4566777777666544332211000
Q ss_pred C-------CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCC
Q 011041 351 P-------HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 351 ~-------~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~ 410 (495)
. ......+.......+. -..++.++.+||.+||+.||.+|||+.++|.||||...|+.
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~ 384 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIR--KYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN 384 (392)
T ss_pred hHHHHHHhhcccccCCccccchhh--ccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence 0 0000000000000010 12456788999999999999999999999999999986653
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=357.58 Aligned_cols=285 Identities=34% Similarity=0.632 Sum_probs=233.9
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++.. ....|++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEE
Confidence 46999999999999999999999999999999987654444555778899999999999999999999987 5679999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
|||++++++..+......+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++...........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99999988887766666799999999999999999999999999999999999999999999999999987765443344
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC--cc
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA--TI 355 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~--~~ 355 (495)
...+++.+|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++......+........ ..
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 5567899999999998754788999999999999999999999999888888888888777776654433211000 00
Q ss_pred CCCCccccccccccc-CCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 356 FKPQQSYKRCIAETF-KDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~-~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
..+.......+...+ ..++.++.+||.+||..||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 000100011111122 2348899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=374.49 Aligned_cols=253 Identities=27% Similarity=0.407 Sum_probs=212.1
Q ss_pred eeecccCceEEEEEEE---CCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEee
Q 011041 124 DKIGQGTYSNVYKARD---TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~---~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~ 200 (495)
+.||+|+||.||++++ ..+|+.||+|++.+..........+.+|+.+|++++||||+++++++.+ ...+|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEEcC
Confidence 5799999999999986 4678999999998654433444567789999999999999999999987 5689999999
Q ss_pred ccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccc
Q 011041 201 MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280 (495)
Q Consensus 201 ~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 280 (495)
+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 158 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSF 158 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceecc
Confidence 9876665555555679999999999999999999999999999999999999999999999999987654332 223456
Q ss_pred cccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCc
Q 011041 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQ 360 (495)
Q Consensus 281 ~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 360 (495)
.||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 159 ~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~---------------------- 215 (318)
T cd05582 159 CGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL---------------------- 215 (318)
T ss_pred cCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC----------------------
Confidence 78999999998876 5678999999999999999999999999888777776643211
Q ss_pred ccccccccccCCCCCCcHHHHHHhccCCCCCccC-----HHHHHhCCCCCCCCC
Q 011041 361 SYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEFFTTKPY 409 (495)
Q Consensus 361 ~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----a~elL~hp~f~~~~~ 409 (495)
.....+++++.+||.+||+.||.+||| +.+++.||||....|
T Consensus 216 -------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 216 -------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 111346778899999999999999999 788999999987554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=368.89 Aligned_cols=258 Identities=25% Similarity=0.375 Sum_probs=215.2
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCceeEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~l 196 (495)
+|++.+.||+|+||.||+|+++.+|+.||||++.+... .......+..|+.++..+. |++|+++++++.. ...+|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 47889999999999999999999999999999986532 2334556778999998886 5778889988877 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||+.++.+.........+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~ 157 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT 157 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-cc
Confidence 99999987666666556679999999999999999999999999999999999999999999999999987543222 12
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.....
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~------------------ 218 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV------------------ 218 (323)
T ss_pred ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence 234578999999998876 5689999999999999999999999999888777777654211
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-----HHHHHhCCCCCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEFFTTKPY 409 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----a~elL~hp~f~~~~~ 409 (495)
.....++.++.+||.+||..||.+|++ ..++++||||....|
T Consensus 219 -----------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 219 -----------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred -----------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 111346778899999999999999997 589999999997655
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=381.48 Aligned_cols=277 Identities=25% Similarity=0.311 Sum_probs=210.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
...|.+.+.||+|+||.||+|++..+++.||||.... ..+.+|+.+|++|+|+|||++++++.. ....|+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVV--GGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEE
Confidence 4579999999999999999999999999999996432 234689999999999999999999876 567899
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC-
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ- 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~- 275 (495)
|||++.+++...+......+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++........
T Consensus 238 v~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 238 VLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 9999998888777665567999999999999999999999999999999999999999999999999999866433221
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCC------hHHHHHHHHHhcCCCChhhhh--
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPI-MPGRT------EVEQLHKIFKLCGSPSEEYWK-- 346 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~p-f~~~~------~~~~~~~i~~~~g~~~~~~~~-- 346 (495)
.....+||+.|+|||++.+ ..++.++||||||||||||++|..+ |.... ...++.+++...+....++-.
T Consensus 318 ~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 1234579999999999876 5689999999999999999998754 43321 133444454443322111100
Q ss_pred ------hCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 347 ------KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 347 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
...........+. ........+..++.++.+||.+||++||.+|||+.|+|+||||++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPA--YTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCc--cCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0000000000000 000001112346778999999999999999999999999999975
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=360.02 Aligned_cols=286 Identities=42% Similarity=0.721 Sum_probs=228.7
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCC---ce
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMS---CS 193 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~---~~ 193 (495)
++|++.+.||+|+||.||+|++..+|+.||||++............+.+|+.+++.+. |+||+++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4699999999999999999999999999999998765433333456778999999995 6999999998865321 24
Q ss_pred eEEEEeeccCChhhhhhCC----CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC-CCcEEEeecccccc
Q 011041 194 LYLVFKYMEHDLAGLAASP----TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADFGLASF 268 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~----~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~-~~~vkL~DFG~a~~ 268 (495)
.|+||||+++++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999999877765432 345899999999999999999999999999999999999998 88999999999976
Q ss_pred cCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
+.... .......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.++.+.+.+++...+.+....|...
T Consensus 161 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 161 FSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred cCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 54322 22233467899999998876566889999999999999999999999999999999999888888877766532
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
.........++. ....+....+.+++++.+||.+||..||.+|||+.++|.||||.
T Consensus 240 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQW-KPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcc-cchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 111000000000 00112333456889999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=356.81 Aligned_cols=284 Identities=39% Similarity=0.645 Sum_probs=223.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|.+++.||+|+||.||+|.+..+|..||||++...... .....+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEE
Confidence 46899999999999999999999999999999998755322 223356689999999999999999999887 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||+.++++..+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 159 (291)
T cd07870 81 VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QT 159 (291)
T ss_pred EEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-CC
Confidence 99999988887766655578899999999999999999999999999999999999999999999999987543222 22
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCChhhhhhCC-CCCCc
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT-EVEQLHKIFKLCGSPSEEYWKKSK-LPHAT 354 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~-~~~~~ 354 (495)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+ ..+.+.++....+.|....|.... ++...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 2344679999999998765567889999999999999999999998754 457777777777777766654321 11100
Q ss_pred cCCCCcccccccccccC--CCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 355 IFKPQQSYKRCIAETFK--DFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~--~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
...........+..... ..++++.+||.+||..||.+|||+.|+|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000000000111111 125688999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=358.56 Aligned_cols=284 Identities=33% Similarity=0.609 Sum_probs=228.8
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEEE
Confidence 46999999999999999999999999999999987654433445667889999999999999999999976 5689999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
|||+.++++..+......+++..+..++.||+.||.|||+.||+|+||+|+||++++++.++|+|||++....... ...
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY 157 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-ccc
Confidence 9999998887766555569999999999999999999999999999999999999999999999999998764433 233
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC--Ccc
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH--ATI 355 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~--~~~ 355 (495)
....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.............. ...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 455789999999998765667889999999999999999999999988888888887766665432211100000 000
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
..+............+.++..+.+||.+||..||.+|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0001111111223345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=371.39 Aligned_cols=253 Identities=23% Similarity=0.390 Sum_probs=205.5
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeEEEEeec
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
+.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 369999999999999999999999999986533 334556678899998877 89999999999987 56899999999
Q ss_pred cCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcccc
Q 011041 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (495)
Q Consensus 202 ~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 281 (495)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccccc
Confidence 987766666556689999999999999999999999999999999999999999999999999987532221 2234567
Q ss_pred ccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------hHH-HHHHHHHhcCCCChhhhhhCCCCC
Q 011041 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT--------EVE-QLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 282 gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~--------~~~-~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.... ..+ ....+...
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---------------- 220 (329)
T cd05618 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---------------- 220 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC----------------
Confidence 9999999999876 568999999999999999999999995311 111 11111110
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC------HHHHHhCCCCCCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT------ATAALRSEFFTTKPY 409 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t------a~elL~hp~f~~~~~ 409 (495)
.......++..+.+||.+||+.||.+|+| ..++++||||....|
T Consensus 221 -------------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 221 -------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 00112346777899999999999999998 589999999987655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=356.86 Aligned_cols=281 Identities=43% Similarity=0.789 Sum_probs=229.1
Q ss_pred eeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEe
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFK 199 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e 199 (495)
|++.+.||.|++|.||+|+++.+|..||+|++............+.+|+.+++.++|+||+++++++.+ ....|++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc--CCeEEEEEe
Confidence 678899999999999999999999999999998665444444567789999999999999999999877 578999999
Q ss_pred eccCChhhhhhCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCc
Q 011041 200 YMEHDLAGLAASPT-IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278 (495)
Q Consensus 200 ~~~~~l~~~~~~~~-~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 278 (495)
|+++.+...+.... ..+++..+..++.||+.||.|||+++++||||+|+|||++.++.++|+|||++....... ....
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~ 157 (283)
T cd07835 79 FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYT 157 (283)
T ss_pred ccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-cccC
Confidence 99877666554432 468999999999999999999999999999999999999999999999999997654322 2223
Q ss_pred cccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC-CCCccCC
Q 011041 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL-PHATIFK 357 (495)
Q Consensus 279 ~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~~~~ 357 (495)
...+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+.++.+..+.+....|..... +......
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 346789999999887655678999999999999999999999999999888888988888888877754321 1110000
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
+.. ...........++.++.+||.+||+.||.+|||+.++++||||
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 238 PKW-ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccc-cccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 000 0111223345678889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=374.91 Aligned_cols=253 Identities=26% Similarity=0.366 Sum_probs=207.8
Q ss_pred ecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC---CCCCeeeeeceeeccCCceeEEEEeec
Q 011041 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL---DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 126 LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
||+|+||+||+|++..+|+.||||++.+... .......+..|..++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 7999999999999999999999999975432 223334455677777765 79999999999987 56799999999
Q ss_pred cCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcccc
Q 011041 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (495)
Q Consensus 202 ~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 281 (495)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFC 157 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCcc
Confidence 987666555566689999999999999999999999999999999999999999999999999987543222 2234567
Q ss_pred ccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcc
Q 011041 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (495)
Q Consensus 282 gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 361 (495)
||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------------------- 216 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF--------------------- 216 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCC---------------------
Confidence 99999999998765668999999999999999999999999988777666653211000
Q ss_pred cccccccccCCCCCCcHHHHHHhccCCCCCcc----CHHHHHhCCCCCCCCC
Q 011041 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQ----TATAALRSEFFTTKPY 409 (495)
Q Consensus 362 ~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~----ta~elL~hp~f~~~~~ 409 (495)
....+++++.+||.+||..||.+|| ++.++++||||....|
T Consensus 217 -------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~ 261 (330)
T cd05586 217 -------PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW 261 (330)
T ss_pred -------CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence 0123678889999999999999998 7999999999987543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=370.79 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=208.3
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHH-HHHHhCCCCCeeeeeceeeccCCceeEEEEeec
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREI-LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei-~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
+.||+|+||.||+|++..+++.||+|++.+... .......+..|. .+++.++|+||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeCC
Confidence 369999999999999999999999999975432 112223333444 45788999999999999887 56799999999
Q ss_pred cCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcccc
Q 011041 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (495)
Q Consensus 202 ~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 281 (495)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~~ 157 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTFC 157 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccccc
Confidence 987776666666679999999999999999999999999999999999999999999999999987543221 2234567
Q ss_pred ccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcc
Q 011041 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (495)
Q Consensus 282 gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 361 (495)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~----------------------- 213 (325)
T cd05602 158 GTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL----------------------- 213 (325)
T ss_pred CCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc-----------------------
Confidence 9999999999876 5689999999999999999999999999888877776654210
Q ss_pred cccccccccCCCCCCcHHHHHHhccCCCCCccCHH----HHHhCCCCCCCCC
Q 011041 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT----AALRSEFFTTKPY 409 (495)
Q Consensus 362 ~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~----elL~hp~f~~~~~ 409 (495)
.....+++.+.+||.+||+.||.+|+++. ++++|+||....|
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 214 ------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 11235778899999999999999999876 8999999986544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=372.13 Aligned_cols=276 Identities=24% Similarity=0.330 Sum_probs=210.7
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
..|++++.||+|+||.||+|++..++..||+|+..... ...|+.+++.++|+||+++++++.. ....|+|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVS--GAITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEe--CCeeEEE
Confidence 57999999999999999999999999999999854322 2468999999999999999999987 5678999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
|||+.+++...+......+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||++...... ...
T Consensus 136 ~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~ 213 (357)
T PHA03209 136 LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAF 213 (357)
T ss_pred EEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--ccc
Confidence 999999888887776678999999999999999999999999999999999999999999999999999753321 222
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCh---------HHHHHHHHHhcCCCChhhhhh
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTE---------VEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~---------~~~~~~i~~~~g~~~~~~~~~ 347 (495)
....||+.|+|||++.+ ..|+.++|||||||++|||+++ .++|..... ...+..+....+..+..+...
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 292 (357)
T PHA03209 214 LGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292 (357)
T ss_pred ccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence 44578999999999876 5689999999999999999985 555554221 233444444444433322100
Q ss_pred CCCCCCccC-----CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 348 SKLPHATIF-----KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 348 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
........+ ....++..........++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 000000000 00000000001112356788999999999999999999999999999985
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=367.43 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=208.0
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeEEEEeec
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
+.||+|+||.||+|++..+++.||||++..... ..........|+.++..+ +||||+++++++.+ ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence 369999999999999999999999999986432 123344566788888764 99999999999987 56799999999
Q ss_pred cCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcccc
Q 011041 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (495)
Q Consensus 202 ~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 281 (495)
.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeeec
Confidence 887666665555679999999999999999999999999999999999999999999999999987532221 2234557
Q ss_pred ccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcc
Q 011041 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (495)
Q Consensus 282 gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 361 (495)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.... +.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~-------------------- 214 (316)
T cd05619 158 GTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PC-------------------- 214 (316)
T ss_pred CCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CC--------------------
Confidence 8999999999876 568999999999999999999999999888777666653210 00
Q ss_pred cccccccccCCCCCCcHHHHHHhccCCCCCccCHH-HHHhCCCCCCCCC
Q 011041 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT-AALRSEFFTTKPY 409 (495)
Q Consensus 362 ~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~-elL~hp~f~~~~~ 409 (495)
....++.++.+||.+||+.||.+|+++. ++++||||....|
T Consensus 215 -------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 215 -------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred -------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence 0123567789999999999999999996 8999999988655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=371.41 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=207.9
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHH-HHHhCCCCCeeeeeceeeccCCceeEEEEeec
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREIL-ILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
+.||+|+||+||+|++..+|+.||+|++.+... .......+..|.. +++.++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcCC
Confidence 369999999999999999999999999976432 2233344455554 5677999999999999887 56899999999
Q ss_pred cCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcccc
Q 011041 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (495)
Q Consensus 202 ~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 281 (495)
.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTFC 157 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCccccc
Confidence 987776666666689999999999999999999999999999999999999999999999999987532221 2234567
Q ss_pred ccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcc
Q 011041 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (495)
Q Consensus 282 gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 361 (495)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~------------------------ 212 (325)
T cd05604 158 GTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP------------------------ 212 (325)
T ss_pred CChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC------------------------
Confidence 9999999999876 568899999999999999999999999988777766664311
Q ss_pred cccccccccCCCCCCcHHHHHHhccCCCCCccCH----HHHHhCCCCCCCCC
Q 011041 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA----TAALRSEFFTTKPY 409 (495)
Q Consensus 362 ~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta----~elL~hp~f~~~~~ 409 (495)
......++..+.+||.+||..||.+||++ .+++.||||....|
T Consensus 213 -----~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 213 -----LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred -----ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 00112466778899999999999999976 59999999987554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=364.47 Aligned_cols=296 Identities=41% Similarity=0.751 Sum_probs=237.9
Q ss_pred CCCeee-eeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHH------------HHHHHHHHHHHHhCCCCCeeeee
Q 011041 117 ADTFEK-LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES------------VRFMAREILILRRLDHPNVVKLE 183 (495)
Q Consensus 117 ~~~y~~-~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~------------~~~~~~Ei~il~~l~HpnIv~l~ 183 (495)
.++|.. .+.||.|+||+||+|++..+++.||||++......... ...+.+|+.+++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 356765 46799999999999999999999999998754332100 12467899999999999999999
Q ss_pred ceeeccCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeec
Q 011041 184 GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADF 263 (495)
Q Consensus 184 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DF 263 (495)
+++.. ....|+||||+.+++...+. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+||
T Consensus 87 ~~~~~--~~~~~lv~e~~~~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 87 DVYVE--GDFINLVMDIMASDLKKVVD-RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEEec--CCcEEEEEeccccCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 99887 56899999999987766654 3456999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-------------CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 011041 264 GLASFFDPN-------------HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQL 330 (495)
Q Consensus 264 G~a~~~~~~-------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~ 330 (495)
|++...... .........+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.++.+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999765411 1112233457889999999877666799999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhhhhCC-CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 331 HKIFKLCGSPSEEYWKKSK-LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
..++..++.+....|+... .+....+... ............+.++.+||.+||..||.+|||++++|.||||+..+.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPR--KPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcC--CcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 9999999988887776432 1111111110 111223344567888999999999999999999999999999999888
Q ss_pred CCCCCCCC
Q 011041 410 ACDPSSLP 417 (495)
Q Consensus 410 ~~~~~~~p 417 (495)
.+.+..+|
T Consensus 322 ~~~~~~~~ 329 (335)
T PTZ00024 322 PCDPSQLP 329 (335)
T ss_pred CCCcccCC
Confidence 77766554
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=364.58 Aligned_cols=291 Identities=35% Similarity=0.587 Sum_probs=232.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC---Cce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM---SCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---~~~ 193 (495)
.++|.+++.||+|+||+||+|++..+|..||||.+............+.+|+.+++.++|+||+++++++.... ...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35799999999999999999999999999999998764333344456778999999999999999999886532 145
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|+||||+.+++...+.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 899999999877665544 4579999999999999999999999999999999999999999999999999998664322
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......++..|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+....+.+..+.|........
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 163 -DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred -ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 2234457899999999887545688999999999999999999999999988888888888888877665532111110
Q ss_pred ccC---CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCC
Q 011041 354 TIF---KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 354 ~~~---~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~ 410 (495)
..+ .+... ........+++++++.+||.+||+.||.+|||+.++|+||||....-+
T Consensus 242 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 242 RRYIRSLPYTP-RQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred hHHHHhcCccc-ccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 000 00000 001122345688999999999999999999999999999999875433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=362.63 Aligned_cols=288 Identities=33% Similarity=0.563 Sum_probs=229.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC---Cce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM---SCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---~~~ 193 (495)
.++|++.+.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+++.++|+||+++++++.... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 478999999999999999999999999999999986432 2234456778999999999999999999875421 245
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|+++||+.+++...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 899999999877765543 469999999999999999999999999999999999999999999999999997654322
Q ss_pred C--CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 274 K--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 274 ~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
. ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....+.+..+.|......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 1 11234578999999998766566899999999999999999999999999888888888888888776665432211
Q ss_pred CCccCC--CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 352 HATIFK--PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 352 ~~~~~~--~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
....+. ...............+++++.+||.+||+.||.+|||+.++|+||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 110000 00000111122334568899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=383.91 Aligned_cols=261 Identities=22% Similarity=0.331 Sum_probs=218.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC-----
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS----- 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----- 191 (495)
.++|.+.+.||+|+||+||+|++..+|+.||||++............+.+|+.+|..++|+||+++++.+.....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 479999999999999999999999999999999998877666777788899999999999999999887753211
Q ss_pred -ceeEEEEeeccCChhhhhhC----CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccc
Q 011041 192 -CSLYLVFKYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266 (495)
Q Consensus 192 -~~~~lv~e~~~~~l~~~~~~----~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a 266 (495)
..+++||||+.++.+...+. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 24789999999765544332 2346999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC-CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 011041 267 SFFDPNH-KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345 (495)
Q Consensus 267 ~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (495)
..+.... .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..+.....
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~------- 262 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY------- 262 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-------
Confidence 8664321 122345679999999999876 5689999999999999999999999999887777666543211
Q ss_pred hhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
......+++++.+||..||..||.+||++.++|+|||++.
T Consensus 263 ---------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 263 ---------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 0112356788999999999999999999999999999874
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=368.37 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=205.8
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHH-HHHHhCCCCCeeeeeceeeccCCceeEEEEeec
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREI-LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei-~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
+.||+|+||.||+|++..+|+.||+|++.+... .......+.+|+ .+++.++||||+++++++.+ ...+|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999976432 222233444554 46788999999999999877 56899999999
Q ss_pred cCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcccc
Q 011041 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (495)
Q Consensus 202 ~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 281 (495)
+++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFC 157 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccccc
Confidence 987766666556679999999999999999999999999999999999999999999999999987532221 2234557
Q ss_pred ccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcc
Q 011041 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (495)
Q Consensus 282 gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 361 (495)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------------------------ 212 (321)
T cd05603 158 GTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP------------------------ 212 (321)
T ss_pred CCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC------------------------
Confidence 8999999999876 568999999999999999999999999987766666554210
Q ss_pred cccccccccCCCCCCcHHHHHHhccCCCCCccCH----HHHHhCCCCCCCCC
Q 011041 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA----TAALRSEFFTTKPY 409 (495)
Q Consensus 362 ~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta----~elL~hp~f~~~~~ 409 (495)
.......+.++.+||.+||+.||.+|+++ .++++|+||....|
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 213 -----LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 01112356678999999999999999875 59999999986443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=365.74 Aligned_cols=282 Identities=24% Similarity=0.357 Sum_probs=213.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.++||+|+||.||++++..++..||+|++.... .......+.+|+++|+.++|+||+++++++.+ +..+|+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEEEE
Confidence 478999999999999999999999999999999987642 34455678899999999999999999999987 568999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~-givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||||+.++.+..+......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 999998876666555556789999999999999999999975 7999999999999999999999999999765322
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh--cCCCChhhhhhCCCC--
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL--CGSPSEEYWKKSKLP-- 351 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~--~g~~~~~~~~~~~~~-- 351 (495)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+.. .++.. .+.+...........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCcccCCcc
Confidence 1234578999999999876 56899999999999999999999999876553332 22211 111110000000000
Q ss_pred -----CCccCCCCccc----cccccccc-----CCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 352 -----HATIFKPQQSY----KRCIAETF-----KDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 352 -----~~~~~~~~~~~----~~~~~~~~-----~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
......+.... ...+.... ..++.++.+||.+||++||.+|||+.|+|.||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 00000000000 00001111 124667899999999999999999999999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=374.36 Aligned_cols=261 Identities=26% Similarity=0.443 Sum_probs=232.1
Q ss_pred CCCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 114 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
......|.+.++||+|.|+.|.++++..+|..||||.|++..++......+.+|+++|..|+|||||+++.+++. ...
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--~~~ 129 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--EAT 129 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee--cce
Confidence 345688999999999999999999999999999999999998888887889999999999999999999999987 567
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|+||||+.++.+..++...+++.+..++.+|.|++.+++|||+++|||||||++||||+.+.++||+|||++.+++..
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~- 208 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG- 208 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc-
Confidence 9999999999888888888888999999999999999999999999999999999999999999999999999999754
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
....+.+|++.|.|||++.|..+.++.+|+||||++||-|++|..||.|.+-.+.-.+.+...
T Consensus 209 -~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk---------------- 271 (596)
T KOG0586|consen 209 -LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK---------------- 271 (596)
T ss_pred -ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee----------------
Confidence 456788999999999999998888999999999999999999999999987555443332211
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
..+.--++.++.+||+++|.++|.+|++.++++.|.|....
T Consensus 272 -------------~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 272 -------------YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred -------------ecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 01112256789999999999999999999999999998753
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=366.45 Aligned_cols=290 Identities=34% Similarity=0.576 Sum_probs=234.0
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc--CCceeE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR--MSCSLY 195 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~~~ 195 (495)
++|++.+.||+|+||.||+|++..+|..||+|++............+.+|+.+|+.++||||+++++++... ....+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 689999999999999999999999999999999976543344556777899999999999999999987542 245789
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC-
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK- 274 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~- 274 (495)
+||||+.+++...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 9999998876665543 45699999999999999999999999999999999999999999999999999976543221
Q ss_pred --CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 275 --QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 275 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
......+|+.+|+|||++.+...++.++|||||||++|+|++|++||.+.+...++..+....|.++...+....-..
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 112345789999999998665568999999999999999999999999999999999999988988776554311000
Q ss_pred Cc----cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCC
Q 011041 353 AT----IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 353 ~~----~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~ 410 (495)
.. .+..... .........+++++.+||.+||+.||.+|||+.++|.||||...+.+
T Consensus 244 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 244 VRKYIQNLPRKQP--VPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred HHHHHhhcccCCC--CCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 00 0000000 01223345678899999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=353.64 Aligned_cols=260 Identities=30% Similarity=0.450 Sum_probs=211.9
Q ss_pred eeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEe
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFK 199 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e 199 (495)
|++++.||+|+||+||++++..+++.||+|++..............+|+.+++.++|+||+++++++.+ ....++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 889999999999999999999999999999999776544444445669999999999999999999987 678999999
Q ss_pred eccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcc
Q 011041 200 YMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS 279 (495)
Q Consensus 200 ~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 279 (495)
|+.++.+..+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.... ........
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~~ 157 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFNP 157 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 99995444444345578999999999999999999999999999999999999999999999999997642 22233455
Q ss_pred ccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCC
Q 011041 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQ 359 (495)
Q Consensus 280 ~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 359 (495)
..+|..|+|||++.....++.++||||||+++|+|++|..||...+..+....+.+.........+..
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------------ 225 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ------------ 225 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc------------
Confidence 67899999999987346789999999999999999999999998854444444443332211111100
Q ss_pred cccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 360 QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 360 ~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
....+..+.+||..||+.||++|||+.++++||||
T Consensus 226 ----------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 226 ----------SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ----------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ----------cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 01112678899999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=376.60 Aligned_cols=259 Identities=25% Similarity=0.389 Sum_probs=222.0
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
+.|.|+..||.|+||.||+|.++.++-..|.|+|... ..+..+.+.-||.||..++||+||+|++.|.. .+.+||+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~--enkLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYF--ENKLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc--cCceEEE
Confidence 6789999999999999999999999999999998643 46777888899999999999999999998876 5679999
Q ss_pred EeeccCChhhhh-hCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 198 FKYMEHDLAGLA-ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 198 ~e~~~~~l~~~~-~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
.|||+||-.+.+ ..-+..|+|.++..+++|+|.||.|||+++|||||||..|||++.+|.|+|+|||.+.... .....
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qk 186 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQK 186 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch-hHHhh
Confidence 999999865543 3446679999999999999999999999999999999999999999999999999886432 22345
Q ss_pred CccccccCCCCCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 277 MTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
..+++|||+|||||+++. ..+|++++||||||++|.||..+.||-...++..++-+|.+. .|+ .
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--ePP-T--------- 254 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP-T--------- 254 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc--CCC-c---------
Confidence 578899999999999843 467999999999999999999999999999988888887652 111 0
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.-.....+..+.|||++||.+||..||++.++|+||||++.
T Consensus 255 --------------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 255 --------------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred --------------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 01123456778899999999999999999999999999974
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=358.42 Aligned_cols=286 Identities=38% Similarity=0.649 Sum_probs=224.2
Q ss_pred CeeeeeeecccCceEEEEEEECC--CCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTL--TGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~--~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
+|++.+.||+|+||.||+|++.. ++..||||.+..... .......+.+|+.+++.++||||+++++++.+.....+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 899999999986431 122235567899999999999999999999885457899
Q ss_pred EEEeeccCChhhhhhC----CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC----CCcEEEeeccccc
Q 011041 196 LVFKYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN----EGILTIADFGLAS 267 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~----~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~----~~~vkL~DFG~a~ 267 (495)
+||||+++++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9999999887765532 1236899999999999999999999999999999999999999 8999999999998
Q ss_pred ccCCCCC--CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHHHh
Q 011041 268 FFDPNHK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV---------EQLHKIFKL 336 (495)
Q Consensus 268 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~---------~~~~~i~~~ 336 (495)
....... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.. ..+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 7643322 12234567999999999877667899999999999999999999999876542 466777888
Q ss_pred cCCCChhhhhhCC-CCCCccC---CCCcccc----cccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 337 CGSPSEEYWKKSK-LPHATIF---KPQQSYK----RCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 337 ~g~~~~~~~~~~~-~~~~~~~---~~~~~~~----~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
++.+....|.... ++..... .....+. ....+.....+..+.+||.+||+.||.+|||+.|+++||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 8877776664321 1111110 0000000 00111113567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=364.90 Aligned_cols=254 Identities=22% Similarity=0.373 Sum_probs=206.3
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeEEEEeec
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
+.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.++.++ +||||+.+++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence 369999999999999999999999999986543 334566788999999988 69999999999987 56799999999
Q ss_pred cCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcccc
Q 011041 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (495)
Q Consensus 202 ~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 281 (495)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTFC 157 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceeccc
Confidence 987666655555679999999999999999999999999999999999999999999999999987532211 2234567
Q ss_pred ccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT------EVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 282 gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~------~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.... ..+.+.++... .
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~---------------- 218 (327)
T cd05617 158 GTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K---------------- 218 (327)
T ss_pred CCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C----------------
Confidence 9999999999876 568999999999999999999999996432 11222221110 0
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC------HHHHHhCCCCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT------ATAALRSEFFTTKPY 409 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t------a~elL~hp~f~~~~~ 409 (495)
.......++..+.+||.+||..||.+|++ ..+++.||||....|
T Consensus 219 ----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 219 ----------PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 00112346778899999999999999998 579999999998655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=347.75 Aligned_cols=257 Identities=27% Similarity=0.447 Sum_probs=212.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC---hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE---PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
+.|++.+.||+|+||.||.|.+..+++.||+|.+...... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeE
Confidence 4689999999999999999999999999999998765432 2234578899999999999999999999987 4589
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+||||+.++.+.........+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999998876655555555789999999999999999999999999999999999999999999999999976543221
Q ss_pred CCC--ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 275 QPM--TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 275 ~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
... ....++..|+|||++.+ ..++.++|||||||++|+|++|++||...+..+...++......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------------- 225 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN------------- 225 (263)
T ss_pred ccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC-------------
Confidence 111 33467889999999876 45899999999999999999999999876655554443221100
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
......++..+.+||.+||..||.+|||+.++|+|+||
T Consensus 226 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 226 --------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred --------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 01123467788999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=361.24 Aligned_cols=267 Identities=27% Similarity=0.417 Sum_probs=224.1
Q ss_pred CCCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 114 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
+...+.|...+.||+|+||.||-|+.+.||+.||+|.+.+..+ .........+|-.||.+++.+.||.+-..|+. ..
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT--kd 258 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET--KD 258 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC--CC
Confidence 4456889999999999999999999999999999999877654 22334456789999999999999999888877 45
Q ss_pred eeEEEEeeccCChhhhhhCCCC--CCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTI--KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~--~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
.+++||..|+|+.+...+.+.+ .|+|..+..|+.+|+.||++||+.+||+|||||+|||+|+.|+|+|+|+|+|..+.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 7999999999988877665544 79999999999999999999999999999999999999999999999999998875
Q ss_pred CCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
.+ .+....+||.+|||||++... .|+..+|+|||||+||||+.|+.||....+......+-+..-.-+.
T Consensus 339 ~g--~~~~~rvGT~GYMAPEvl~ne-~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~-------- 407 (591)
T KOG0986|consen 339 EG--KPIRGRVGTVGYMAPEVLQNE-VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPE-------- 407 (591)
T ss_pred CC--CccccccCcccccCHHHHcCC-cccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchh--------
Confidence 44 556777999999999999874 5999999999999999999999999876544333333221111111
Q ss_pred CCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCCC
Q 011041 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPYA 410 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~~ 410 (495)
+....||+++++|.+.+|++||.+|+ .+.++.+||||++..|.
T Consensus 408 -----------------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 408 -----------------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred -----------------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 12246899999999999999999995 47899999999997774
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=355.40 Aligned_cols=261 Identities=25% Similarity=0.419 Sum_probs=209.4
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++|+||+.+++.+.+ ...+|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEE
Confidence 478889999999999999999999999999998765432 2334556789999999999999999999877 4679999
Q ss_pred EeeccCChhhhhh--CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 198 FKYMEHDLAGLAA--SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 198 ~e~~~~~l~~~~~--~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
|||+.++.+.... .....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 9999876554433 233468999999999999999999999999999999999999999999999999987654322
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+..................
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-------------- 221 (285)
T ss_pred cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh--------------
Confidence 2234578999999999876 5689999999999999999999999987543221111111110000
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-----HHHHHhCCCCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEFFTTKPY 409 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----a~elL~hp~f~~~~~ 409 (495)
......+++++.+||..||+.||.+|+| +.|+++||||....+
T Consensus 222 -----------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 222 -----------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred -----------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 0112346788999999999999999999 999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=377.49 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=214.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCC-CeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLT-GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+|+.++|||||++++++.. ...+|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~ 141 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLL 141 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCEEE
Confidence 45699999999999999999998877 7889999875432 3445677889999999999999999999987 56899
Q ss_pred EEEeeccCChhhhhh----CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 196 LVFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 196 lv~e~~~~~l~~~~~----~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
|||||+.++.+...+ .....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 999999876554322 2345689999999999999999999999999999999999999999999999999987643
Q ss_pred CCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 272 NHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 272 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----------- 289 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD----------- 289 (478)
T ss_pred ccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence 322 12345579999999998876 56899999999999999999999999988887777766532111
Q ss_pred CCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.....+++++.+||.+||..||.+||++.++|.|+|++.
T Consensus 290 -----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 290 -----------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred -----------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 011246778999999999999999999999999999864
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=359.76 Aligned_cols=288 Identities=36% Similarity=0.598 Sum_probs=235.8
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC---CceeE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM---SCSLY 195 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---~~~~~ 195 (495)
+|++.+.||.|+||.||+|++..+|+.||||++............+.+|+.+++.++|+||+++++++.... ...+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 589999999999999999999999999999998765433455677889999999999999999999987632 23689
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC-
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK- 274 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~- 274 (495)
++|||+++++...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 81 lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 9999999876655544 34899999999999999999999999999999999999999999999999999987654321
Q ss_pred -CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 -QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......++++|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..+.|........
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 2234557899999999988754789999999999999999999999999999999999999999888776653221111
Q ss_pred ccCCC--CcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 354 TIFKP--QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 354 ~~~~~--~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
..+.. .......+......+++++.+||.+||++||.+|||+.++|+||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 11100 0001111233445578899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=393.40 Aligned_cols=263 Identities=27% Similarity=0.421 Sum_probs=215.6
Q ss_pred CCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 115 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
...++|++++.||+|+||.||+|++..++..||+|++............+.+|+.+|+.|+|||||+++++|.+.....+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34689999999999999999999999999999999998776666667788899999999999999999999876556789
Q ss_pred EEEEeeccCChhhhhhC----CCCCCCHHHHHHHHHHHHHHHHHhhhC-------CceeccCCCCCeeeCC---------
Q 011041 195 YLVFKYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQ-------HVLHRDIKGSNLLIDN--------- 254 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~----~~~~l~e~~~~~i~~qil~~L~~LH~~-------givHrDlKp~NILl~~--------- 254 (495)
||||||+.++.+..++. ....+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999755544332 235799999999999999999999984 4999999999999964
Q ss_pred --------CCcEEEeecccccccCCCCCCCCccccccCCCCCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 011041 255 --------EGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRT 325 (495)
Q Consensus 255 --------~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~ 325 (495)
.+.+||+|||++..+.... .....+||+.|+|||++.+. ..++.++||||||||||+|++|.+||...+
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 2359999999998664322 22455799999999998643 457899999999999999999999998776
Q ss_pred hHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 326 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
....+..++... +. .....++.++.+||..||..||.+||++.|+|.|+||.
T Consensus 248 ~~~qli~~lk~~--p~--------------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 248 NFSQLISELKRG--PD--------------------------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred cHHHHHHHHhcC--CC--------------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 655544433211 00 01123567899999999999999999999999999997
Q ss_pred CC
Q 011041 406 TK 407 (495)
Q Consensus 406 ~~ 407 (495)
..
T Consensus 300 ~i 301 (1021)
T PTZ00266 300 NV 301 (1021)
T ss_pred hc
Confidence 43
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=360.02 Aligned_cols=259 Identities=28% Similarity=0.456 Sum_probs=211.9
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 194 (495)
+...|+++++||.||.+.||++... ..+.||+|.+.....+...+.-+.+||..|.+| .|.+||+|++|-.. ++++
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~l 435 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYL 435 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceE
Confidence 4578999999999999999999744 456788888877777788888999999999999 59999999999776 7899
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||||-+.||-..+.+....++.-.++.|..|||.++.++|++||||.||||.|+|+-. |.+||+|||+|..+.....
T Consensus 436 YmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred EEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 999999999999888877766776799999999999999999999999999999999865 8999999999998765443
Q ss_pred C-CCccccccCCCCCcccccCCC----------CCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCh
Q 011041 275 Q-PMTSRVVTLWYRPPELLLGAT----------DYGVGVDLWSAGCILAELLAEKPIMPGRT-EVEQLHKIFKLCGSPSE 342 (495)
Q Consensus 275 ~-~~~~~~gt~~y~aPE~l~~~~----------~~~~~~DvwSlGvil~elltG~~pf~~~~-~~~~~~~i~~~~g~~~~ 342 (495)
. ...+.+||+.||+||.+.... ..++++||||||||||+|+.|++||..-. ...-+..| ..|..
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI----~~P~~ 590 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAI----TDPNH 590 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhh----cCCCc
Confidence 2 334679999999999985421 25688999999999999999999996432 22222222 12211
Q ss_pred hhhhhCCCCCCccCCCCcccccccccccCCCCC--CcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPP--SSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.-.|+++|+ +++++++.||.+||.+|||..++|+|||++.
T Consensus 591 ------------------------~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 591 ------------------------EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ------------------------cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 112333432 3899999999999999999999999999875
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=352.72 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=201.6
Q ss_pred ecccCceEEEEEEECCCCeEEEeEEEecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeeccCC
Q 011041 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD 204 (495)
Q Consensus 126 LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~ 204 (495)
||+|+||.||+++++.+|+.||+|.+...... ......+..|+.+++.++||||+++++++.. ...+|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCCC
Confidence 79999999999999999999999999754332 2223445679999999999999999999887 56799999999876
Q ss_pred hhhhhh--CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccccc
Q 011041 205 LAGLAA--SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282 (495)
Q Consensus 205 l~~~~~--~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 282 (495)
.+.... .....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... ......|
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~ 156 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAG 156 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCC
Confidence 554333 233458999999999999999999999999999999999999999999999999998764322 2234578
Q ss_pred cCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCccc
Q 011041 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSY 362 (495)
Q Consensus 283 t~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 362 (495)
|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+........
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------- 214 (277)
T cd05607 157 TNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE--------------------- 214 (277)
T ss_pred CCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc---------------------
Confidence 999999999876 4589999999999999999999999986543221111111100000
Q ss_pred ccccccccCCCCCCcHHHHHHhccCCCCCccCH----HHHHhCCCCCCCCC
Q 011041 363 KRCIAETFKDFPPSSLPLIETLLAIDPAERQTA----TAALRSEFFTTKPY 409 (495)
Q Consensus 363 ~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta----~elL~hp~f~~~~~ 409 (495)
+......+++++.+||.+||+.||.+||++ ++++.|+||....|
T Consensus 215 ---~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 215 ---VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred ---cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 001123577889999999999999999999 77889999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=353.27 Aligned_cols=282 Identities=25% Similarity=0.420 Sum_probs=221.5
Q ss_pred CCCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCC--C----Ceeeeeceee
Q 011041 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH--P----NVVKLEGLVT 187 (495)
Q Consensus 114 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H--p----nIv~l~~~~~ 187 (495)
+....+|.++++||+|+||.|-+|.|..++..||||+|+.-. ...+...-|+.+|+++.+ | -+|.+.++|+
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 334688999999999999999999999999999999987322 223344568999999932 1 3677888887
Q ss_pred ccCCceeEEEEeeccCChhhhhhC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC------------
Q 011041 188 SRMSCSLYLVFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN------------ 254 (495)
Q Consensus 188 ~~~~~~~~lv~e~~~~~l~~~~~~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~------------ 254 (495)
. .++++||||.++-++.+.+.. ....|+..+++.+.+||+.++.|||+++++|-||||||||+..
T Consensus 162 y--rghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 162 Y--RGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred c--cCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 7 578999999999777776655 4567999999999999999999999999999999999999932
Q ss_pred --------CCcEEEeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 011041 255 --------EGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE 326 (495)
Q Consensus 255 --------~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~ 326 (495)
+..|+|+|||.|++.... -+..+.|..|+|||+++| -+++.++||||+||||+||.+|..+|++.++
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 234899999999875433 267788999999999998 5689999999999999999999999999999
Q ss_pred HHHHHHHHHhcCCCChhhhhh---------CCCCCCccCC---------CCcccccccccccCCCCCCcHHHHHHhccCC
Q 011041 327 VEQLHKIFKLCGSPSEEYWKK---------SKLPHATIFK---------PQQSYKRCIAETFKDFPPSSLPLIETLLAID 388 (495)
Q Consensus 327 ~~~~~~i~~~~g~~~~~~~~~---------~~~~~~~~~~---------~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~d 388 (495)
.+.+.-+...+|.++.....+ .++....... +..+........ ..--.++.|||++||.+|
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~-d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQD-DLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccC-cHHHhHHHHHHHHHHccC
Confidence 999999999999877554332 2222211111 111111111000 001134789999999999
Q ss_pred CCCccCHHHHHhCCCCCC
Q 011041 389 PAERQTATAALRSEFFTT 406 (495)
Q Consensus 389 P~~R~ta~elL~hp~f~~ 406 (495)
|.+|+|+.|+|.||||+.
T Consensus 394 P~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 394 PARRITLREALSHPFFAR 411 (415)
T ss_pred ccccccHHHHhcCHHhhc
Confidence 999999999999999986
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=352.78 Aligned_cols=261 Identities=25% Similarity=0.407 Sum_probs=214.0
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
.|+..+.||+|+||+||+|.+..+++.||+|.+...... ......+.+|+.+|+.++|+||+.+++++.. +..+|++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEE
Confidence 378889999999999999999999999999999765432 2334567789999999999999999998877 5679999
Q ss_pred EeeccCChhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 198 FKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 198 ~e~~~~~l~~~~~~--~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
|||+.++.+..... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--E 156 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--C
Confidence 99999765544332 2346999999999999999999999999999999999999999999999999998765322 2
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
......|++.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+..+......+.........
T Consensus 157 ~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~------------- 222 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE------------- 222 (285)
T ss_pred cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc-------------
Confidence 2345578999999999876 56899999999999999999999999987765554444332211110
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-----HHHHHhCCCCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEFFTTKPY 409 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----a~elL~hp~f~~~~~ 409 (495)
.....+++++.+||..||..||.+||| +.+++.|+||....+
T Consensus 223 ------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 223 ------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred ------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 112346778899999999999999999 899999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=358.41 Aligned_cols=285 Identities=34% Similarity=0.571 Sum_probs=228.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC----c
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS----C 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----~ 192 (495)
.++|++++.||+|+||.||+|.+..+|..||||++............+.+|+.+|+.++|+||+++++++..... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 478999999999999999999999999999999986543334445567899999999999999999998865322 2
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|+||||+++++...... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 4699999997766554432 46899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.....+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+....+.++++..+.++..++.......
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07880 172 ----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247 (343)
T ss_pred ----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence 2344678999999998764568899999999999999999999999998888888888877777666554422111
Q ss_pred CccCCC--CcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 353 ATIFKP--QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 353 ~~~~~~--~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
...+.. .......+......+++.+.+||.+||+.||.+|||+.+++.||||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 100000 0000001222345678889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=342.76 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=212.2
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
.|++++.||.|++|.||++++..+++.||+|.+............+.+|+.++++++|+||+++++.+... +..+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence 48999999999999999999999999999999987655555667788999999999999999999887643 45789999
Q ss_pred eeccCChhhhhh-C-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 199 KYMEHDLAGLAA-S-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 199 e~~~~~l~~~~~-~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||+.++.+.... . ....+++.++..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ..
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~ 158 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DM 158 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-Cc
Confidence 999876554433 2 23468999999999999999999999999999999999999999999999999998764332 22
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~------------------ 219 (257)
T cd08223 159 ASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL------------------ 219 (257)
T ss_pred cccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC------------------
Confidence 344578999999998876 5678999999999999999999999988776555544432110
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
......+++.+.+||.+||..||.+|||+.++++||||
T Consensus 220 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 ----------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ----------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01113467789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=360.74 Aligned_cols=289 Identities=37% Similarity=0.616 Sum_probs=232.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++.+.||+|+||.||+|.+..+|..||+|++............+.+|+.+++.+ +|+||+++++++........|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 5789999999999999999999999999999999865433344455677899999999 999999999998765456789
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC-
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK- 274 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~- 274 (495)
+||||+.+++...+... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 86 lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 86 LVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 99999998776555443 788999999999999999999999999999999999999999999999999986643322
Q ss_pred ---CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 275 ---QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 275 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+....+...++....+.+....|.....+
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 12334578999999998876667889999999999999999999999999988888888888887776554432111
Q ss_pred CCccCC--CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 352 HATIFK--PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 352 ~~~~~~--~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
....+. .............+.++.++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 000000 00001111233445578899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=354.82 Aligned_cols=267 Identities=27% Similarity=0.342 Sum_probs=220.4
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.++|+||+++++++.+ ....|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEE
Confidence 4799999999999999999999999999999999876543 2456678899999999999999999999877 568999
Q ss_pred EEeeccCChhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~~--~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||+.++.+..+.. ....+++..+..++.||+.||.|||+.||+|+||||+||||+.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999998765554443 235799999999999999999999999999999999999999999999999999875532211
Q ss_pred C----------------------------CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 011041 275 Q----------------------------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE 326 (495)
Q Consensus 275 ~----------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~ 326 (495)
. .....+||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 0 1123468899999999876 4678999999999999999999999998887
Q ss_pred HHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC----HHHHHhCC
Q 011041 327 VEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT----ATAALRSE 402 (495)
Q Consensus 327 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t----a~elL~hp 402 (495)
...+.++....... .....+++.+.+||.+||..||.+||| ++++|+||
T Consensus 238 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~ 290 (316)
T cd05574 238 DETFSNILKKEVTF---------------------------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290 (316)
T ss_pred HHHHHHHhcCCccC---------------------------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence 77666654211000 001226788999999999999999999 99999999
Q ss_pred CCCCCCCCCCCC
Q 011041 403 FFTTKPYACDPS 414 (495)
Q Consensus 403 ~f~~~~~~~~~~ 414 (495)
||++..|+....
T Consensus 291 ~~~~~~~~~~~~ 302 (316)
T cd05574 291 FFRGVNWALIRH 302 (316)
T ss_pred hhhcCChhhccc
Confidence 999987765444
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=358.53 Aligned_cols=285 Identities=33% Similarity=0.568 Sum_probs=228.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC----Cc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~ 192 (495)
.++|.+.+.||+|+||.||+|++..+|+.||||++.+..........+.+|+.+++.++|+||+++++++.... ..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36899999999999999999999999999999998765433334456778999999999999999999986532 13
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|+|+||+...+.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~- 169 (342)
T cd07879 94 DFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA- 169 (342)
T ss_pred eEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence 56999999987655433 23689999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
......+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+....+.......
T Consensus 170 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 170 ---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred ---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence 22345778999999998765568899999999999999999999999998888999999888877776655432111
Q ss_pred CccCCC--CcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 353 ATIFKP--QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 353 ~~~~~~--~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
...+.. .......+...++.+++.+.+||.+||+.||.+|||+.++|.||||....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 110000 00001112223345778899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=349.01 Aligned_cols=282 Identities=42% Similarity=0.751 Sum_probs=233.6
Q ss_pred eeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEe
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFK 199 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e 199 (495)
|++.+.||+|.||.||+|++..+++.||+|++............+.+|+.+++.++|+||+++++++.+ ....|+|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEec
Confidence 667889999999999999999999999999998654334445667789999999999999999999987 468999999
Q ss_pred eccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcc
Q 011041 200 YMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS 279 (495)
Q Consensus 200 ~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 279 (495)
|+++++...+......+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....... .....
T Consensus 79 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~~~ 157 (282)
T cd07829 79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-RTYTH 157 (282)
T ss_pred CcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-cccCc
Confidence 99988776666554579999999999999999999999999999999999999999999999999998764332 22334
Q ss_pred ccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCC
Q 011041 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQ 359 (495)
Q Consensus 280 ~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 359 (495)
..++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+.++...++.+.+..|.....-........
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 45688899999987655789999999999999999999999999999999999999999999888865322111111111
Q ss_pred cccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 360 QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 360 ~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
..........++.++..+.++|.+||..||.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 111112234455668889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=367.78 Aligned_cols=255 Identities=29% Similarity=0.492 Sum_probs=221.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
..|.-++.||.|+||.||-|+|..+.+.||||++..... ..+...++..|+..|++|+|||++.+.|+|.. +...||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e~TaWL 103 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--EHTAWL 103 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec--cchHHH
Confidence 457788999999999999999999999999999988765 45567789999999999999999999999987 567899
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
|||||-|+-.+++.-..+.+-|.++..|+.+.+.||.|||+++.||||||..|||+++.|.|||+|||.|....+
T Consensus 104 VMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----- 178 (948)
T KOG0577|consen 104 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----- 178 (948)
T ss_pred HHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence 999999977666666667899999999999999999999999999999999999999999999999999988754
Q ss_pred CccccccCCCCCccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 277 MTSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~--~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
..+++|||+||||||++ ..+.|+-++||||||++..||.-.+||+..-+....+..|...- .|.
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-sPt------------- 244 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPT------------- 244 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-CCC-------------
Confidence 46789999999999985 34679999999999999999999999988888777776664321 110
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
+. -.+.+..+.+||..||++-|.+|||.+++|+|+|+..
T Consensus 245 -----------Lq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 245 -----------LQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred -----------CC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 00 1234567888999999999999999999999999874
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=349.57 Aligned_cols=281 Identities=44% Similarity=0.778 Sum_probs=233.0
Q ss_pred eeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEe
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFK 199 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e 199 (495)
|++.+.||+|++|.||+|.+..+|+.+++|.+............+.+|+.+|+.++|+||+++++++.+ ...+|+|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCCEEEEEe
Confidence 667889999999999999999999999999987665554556778899999999999999999999887 467999999
Q ss_pred eccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcc
Q 011041 200 YMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS 279 (495)
Q Consensus 200 ~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 279 (495)
|+++++...+......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+....... .....
T Consensus 79 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~ 157 (283)
T cd05118 79 FMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH 157 (283)
T ss_pred ccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence 99998887776655689999999999999999999999999999999999999999999999999998775443 22344
Q ss_pred ccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC--CCCccCC
Q 011041 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL--PHATIFK 357 (495)
Q Consensus 280 ~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~--~~~~~~~ 357 (495)
..++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+.++....+.+....|..... .......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 56888999999987754789999999999999999999999999999999999988888887776655321 0000000
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
+. ............++.++.+||.+||..||.+||++.+++.||||
T Consensus 238 ~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 PK-KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cc-ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00 00000122334578889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=329.84 Aligned_cols=281 Identities=31% Similarity=0.590 Sum_probs=235.0
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|++.+++|+|-|+.||.|.+..+++.++||+++ +.....+.||++||+.|. ||||++|++++.+..+...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 3589999999999999999999999999999999976 345678999999999996 9999999999999888889
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC-CcEEEeecccccccCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFGLASFFDPNH 273 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~-~~vkL~DFG~a~~~~~~~ 273 (495)
.++|||++......+.. .|+.-.++.++.||+.||.|||++||+|||+||.|++||.. -.++|+|+|+|-++.++
T Consensus 111 aLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~- 186 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG- 186 (338)
T ss_pred hhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC-
Confidence 99999999755444332 57889999999999999999999999999999999999985 46999999999998765
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCCh-hhhhhCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEK-PIMPGRTEVEQLHKIFKLCGSPSE-EYWKKSKLP 351 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~-~pf~~~~~~~~~~~i~~~~g~~~~-~~~~~~~~~ 351 (495)
......+.+..|--||++..-..|+..-|+|||||+|..|+..+ |.|.|.++.+++-+|.+.+|+..- .+..+.++.
T Consensus 187 -~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 187 -KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred -ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 34566788999999999988888999999999999999999876 556789999999999999998653 333443332
Q ss_pred CCccC------CCCcccccccccccCCC-CCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 352 HATIF------KPQQSYKRCIAETFKDF-PPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 352 ~~~~~------~~~~~~~~~~~~~~~~~-s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
-...+ .....+.+++...-..+ ++++.|||.++|.+|-.+|+||.|++.||||..
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 22222 22334444454444443 699999999999999999999999999999974
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=375.01 Aligned_cols=284 Identities=24% Similarity=0.343 Sum_probs=207.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCC-eEEEeEEE--------------ecC-CCChHHHHHHHHHHHHHHhCCCCCee
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTG-QIVALKKV--------------RFD-NLEPESVRFMAREILILRRLDHPNVV 180 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g-~~vAiK~i--------------~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv 180 (495)
.++|++++.||+|+||.||+|..+... ..+++|.+ .+. .........+.+|+.+|+.++|+|||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 578999999999999999999765332 22222211 111 11223455688999999999999999
Q ss_pred eeeceeeccCCceeEEEEeeccCChhhhhhCC----CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC
Q 011041 181 KLEGLVTSRMSCSLYLVFKYMEHDLAGLAASP----TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG 256 (495)
Q Consensus 181 ~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~----~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~ 256 (495)
++++++.+ ....|+|++++.++++..+... ........++.|+.||+.||.|||++|||||||||+||||+.++
T Consensus 227 ~l~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 227 KIEEILRS--EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred cEeEEEEE--CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999987 4678999999998887765432 22345677889999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC-C--CChHHHHHHH
Q 011041 257 ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP-G--RTEVEQLHKI 333 (495)
Q Consensus 257 ~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~-~--~~~~~~~~~i 333 (495)
.+||+|||++..+...........+||+.|+|||++.+ ..|+.++|||||||+||||++|..++. + .+...++.++
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 99999999998775443333345689999999999876 568999999999999999999875443 2 3445666666
Q ss_pred HHhcCCCChhh-------hhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 334 FKLCGSPSEEY-------WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 334 ~~~~g~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
...++....++ |..... .............+.. ..++.++.++|.+||++||.+|||+.|+|.||||..
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~--~~~~~~~~~~~~~~~~--~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDS--AEIDHAGHSVPPLIRN--LGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhh--hhcccCccchhhHHHh--cCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 66555433221 111000 0000000111111111 235778899999999999999999999999999986
Q ss_pred C
Q 011041 407 K 407 (495)
Q Consensus 407 ~ 407 (495)
.
T Consensus 460 ~ 460 (501)
T PHA03210 460 E 460 (501)
T ss_pred C
Confidence 4
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=357.13 Aligned_cols=281 Identities=21% Similarity=0.304 Sum_probs=208.1
Q ss_pred eeeeeccc--CceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEe
Q 011041 122 KLDKIGQG--TYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFK 199 (495)
Q Consensus 122 ~~~~LG~G--~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e 199 (495)
++++||+| +|++||+++++.+|+.||+|++............+.+|+.+++.++||||+++++++.. +...|+|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEEEe
Confidence 56789999 78999999999999999999998765555666788899999999999999999999987 567999999
Q ss_pred eccCChhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC--
Q 011041 200 YMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ-- 275 (495)
Q Consensus 200 ~~~~~l~~~~~~~--~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-- 275 (495)
|+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||...........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9998766554432 345899999999999999999999999999999999999999999999999875433211100
Q ss_pred ----CCccccccCCCCCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC---------
Q 011041 276 ----PMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS--------- 341 (495)
Q Consensus 276 ----~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~--------- 341 (495)
......++..|+|||++.+. ..|+.++|||||||++|+|++|++||.............. +..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 237 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccccchh
Confidence 01123567889999998753 3589999999999999999999999987655443333322 1111
Q ss_pred hhhhhh--C------CCCCCccC--CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 342 EEYWKK--S------KLPHATIF--KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 342 ~~~~~~--~------~~~~~~~~--~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.+.+.. . ........ ................+++.+.+||.+||++||.+|||+.++|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 000000 0 00000000 00000000111222345778999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=358.58 Aligned_cols=285 Identities=35% Similarity=0.596 Sum_probs=231.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC----c
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS----C 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----~ 192 (495)
.++|++.+.||+|+||.||+|++..+++.||+|++............+.+|+.+++.++|+||+++++++..... .
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 578999999999999999999999999999999987654344455667789999999999999999988765321 3
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
..|+|+||+++++...+.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 94 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred cEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 4899999998877665543 36999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.....++..|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+.+..|.......
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred ----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 3445788999999988664567899999999999999999999999999999999999988888877665433211
Q ss_pred CccCCCC--cccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 353 ATIFKPQ--QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 353 ~~~~~~~--~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
...+... ..........+..+++++.+||.+||..||.+|||+.++|+||||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 1111000 000001122334568899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=364.99 Aligned_cols=257 Identities=23% Similarity=0.388 Sum_probs=224.7
Q ss_pred Ceeee--eeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 119 TFEKL--DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 119 ~y~~~--~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
-|++. +.||+|.||+||-|+++.+|+.||||+|++..+.......+++|+.||+.++||.||.+.-.|+. ...+|+
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET--~ervFV 640 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET--PERVFV 640 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC--CceEEE
Confidence 35554 68999999999999999999999999999988877777889999999999999999999988887 567999
Q ss_pred EEeeccCChhhhhhC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC---CcEEEeecccccccCCC
Q 011041 197 VFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE---GILTIADFGLASFFDPN 272 (495)
Q Consensus 197 v~e~~~~~l~~~~~~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~---~~vkL~DFG~a~~~~~~ 272 (495)
|||-+.|+.+..++. ..++|+|...+.++.||+.||.|||-+||+|+||||||||+... -++||||||+|++++..
T Consensus 641 VMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 641 VMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred EehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 999999999887764 56789999999999999999999999999999999999999654 37999999999998654
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
....+.+|||.|+|||++.. +.|+..-|+||.|||+|.-|+|.-||... +++-.+|.+.-...+...|
T Consensus 721 --sFRrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW------- 788 (888)
T KOG4236|consen 721 --SFRRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPW------- 788 (888)
T ss_pred --hhhhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCch-------
Confidence 44577899999999999976 67999999999999999999999888643 4455556554444444444
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
+.+++.++|||..+|++.-.+|.+.+..|.|||+++.
T Consensus 789 ------------------~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 789 ------------------SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred ------------------hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 4588999999999999999999999999999999874
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=349.27 Aligned_cols=257 Identities=27% Similarity=0.433 Sum_probs=217.0
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|++.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+++|++++||||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEE
Confidence 479999999999999999999999999999999875433 33455678899999999999999999999987 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||+.++.+.........+++..+..++.||+.||.|||++||+|+||+|.||||+.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999976655555555568999999999999999999999999999999999999999999999999999876433
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+......++... .+
T Consensus 155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~---------------- 215 (290)
T cd05580 155 TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--KV---------------- 215 (290)
T ss_pred CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--Cc----------------
Confidence 234468999999998865 46788999999999999999999999887766555555321 10
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPYA 410 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~~ 410 (495)
.....+++.+.++|.+||..||.+|+ +++++++||||....|.
T Consensus 216 -----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 216 -----------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred -----------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 11123567889999999999999999 99999999999886653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=356.97 Aligned_cols=286 Identities=34% Similarity=0.593 Sum_probs=221.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC-----
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS----- 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----- 191 (495)
.++|.+.+.||.|+||.||+|++..+|..||+|++..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 4789999999999999999999999999999999876543 344667889999999999999999987765321
Q ss_pred -------ceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC-CCcEEEeec
Q 011041 192 -------CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADF 263 (495)
Q Consensus 192 -------~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~-~~~vkL~DF 263 (495)
...|+||||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 35799999999876655533 36899999999999999999999999999999999999975 567899999
Q ss_pred ccccccCCCCC--CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 011041 264 GLASFFDPNHK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS 341 (495)
Q Consensus 264 G~a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~ 341 (495)
|++........ .......++..|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99976543211 1122346788999999876656688999999999999999999999999988888777766544433
Q ss_pred hhhhhhC--CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 342 EEYWKKS--KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 342 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
...+... ..+.. ..................++.++.+||.+||+.||.+|||+.++|.||||+..
T Consensus 240 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 240 EEDRNELLNVIPSF-VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hHHhhhhhhhhhhh-hhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 3222110 00000 00000111111223345678889999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=354.61 Aligned_cols=285 Identities=35% Similarity=0.563 Sum_probs=226.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC----Cc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~ 192 (495)
.++|++++.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++|+||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 37899999999999999999999999999999999765433444566788999999999999999999885421 24
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
..|++++++++++...... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~- 172 (345)
T cd07877 96 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 172 (345)
T ss_pred cEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc-
Confidence 5789999987766554432 3689999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+....+.+....+.......
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (345)
T cd07877 173 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249 (345)
T ss_pred ---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence 22345789999999988765568899999999999999999999999988888888888888777766554321110
Q ss_pred CccCCC--CcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 353 ATIFKP--QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 353 ~~~~~~--~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
...+.. ...............++++.+||.+||+.||.+|+|+.++|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 000000 0000000112223467889999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=346.60 Aligned_cols=256 Identities=22% Similarity=0.338 Sum_probs=207.0
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|++++.||+|+||.||+|++..+++.||+|++.... .......+.+|+.++++++||||+++++++.. ....++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEE
Confidence 36889999999999999999999999999999997653 34455678899999999999999999999987 5678999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
|||++++.+... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...... ..
T Consensus 78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~ 150 (279)
T cd06619 78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IA 150 (279)
T ss_pred EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cc
Confidence 999998876543 35789999999999999999999999999999999999999999999999999765432 22
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE---QLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~---~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
...+||..|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+.........
T Consensus 151 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------ 217 (279)
T cd06619 151 KTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP------------ 217 (279)
T ss_pred cCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC------------
Confidence 34578999999999876 468999999999999999999999997532111 00111111100000
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.......+++++.+||.+||..||.+||++.++++||||...
T Consensus 218 -----------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 218 -----------PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred -----------CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 000112356788999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=338.68 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=214.3
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+|.+.+.||+|+||.||+|++..++..|++|.+............+.+|+.+++.++||||+++++++.. ....|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEEE
Confidence 4888999999999999999999999999999998766666667788899999999999999999999887 56899999
Q ss_pred eeccCChhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 199 KYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 199 e~~~~~l~~~~~~~--~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||+.++.+..+... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+.... ..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~~ 157 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-NF 157 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc-ch
Confidence 99987555444322 4578999999999999999999999999999999999999999999999999988765432 22
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
.....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------ 218 (256)
T cd08529 158 ANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF------------------ 218 (256)
T ss_pred hhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 234578899999998876 4578999999999999999999999998887666655533110
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
......++.++.++|.+||+.||++||++.++++|||+
T Consensus 219 ----------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 219 ----------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ----------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 01112466788999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=357.63 Aligned_cols=254 Identities=23% Similarity=0.364 Sum_probs=198.7
Q ss_pred CCCeeeeeeecccCceEEEEEEE-----CCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 190 (495)
.++|++.+.||+|+||.||+|.+ ..++..||+|++.... .......+.+|+.+|..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 36899999999999999999975 3456789999987442 334456788999999999 899999999988653
Q ss_pred CceeEEEEeeccCChhhhhhCC----------------------------------------------------------
Q 011041 191 SCSLYLVFKYMEHDLAGLAASP---------------------------------------------------------- 212 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~---------------------------------------------------------- 212 (495)
...+|+||||+.++.+..++..
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4568999999997655433321
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC-CCCccccccCCCC
Q 011041 213 ----TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYR 287 (495)
Q Consensus 213 ----~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~ 287 (495)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 12478889999999999999999999999999999999999999999999999976532211 1112334577899
Q ss_pred CcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCccccccc
Q 011041 288 PPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCI 366 (495)
Q Consensus 288 aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (495)
|||++.+ ..++.++|||||||+||||++ |.+||.+....+.+...+.. +..
T Consensus 244 aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~-------------------------- 295 (338)
T cd05102 244 APESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GTR-------------------------- 295 (338)
T ss_pred CcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CCC--------------------------
Confidence 9999876 568999999999999999997 99999886544433332221 000
Q ss_pred ccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 367 AETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 367 ~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......+++++.+||.+||..||.+|||+.++++
T Consensus 296 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 296 MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0011345678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=350.30 Aligned_cols=279 Identities=24% Similarity=0.335 Sum_probs=212.3
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|++.+.||+|+||.||++.+..++..||+|.+.... .......+.+|++++++++||||+++++++.. +..+|+|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEE
Confidence 46999999999999999999999999999999987542 34455678899999999999999999999987 5689999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
|||+.++.+..+......+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...... .
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~ 154 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 154 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---c
Confidence 9999987766666555679999999999999999999997 69999999999999999999999999998755322 1
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
....+|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..... .++........ +...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~ 230 (308)
T cd06615 155 ANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGE--AKESHRPVSGHP 230 (308)
T ss_pred cccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCcccccc--ccCCcccccCCC
Confidence 234578999999998866 46889999999999999999999999876643332 22211110000 000000000000
Q ss_pred CCCcc-------ccccccc-----ccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 357 KPQQS-------YKRCIAE-----TFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 357 ~~~~~-------~~~~~~~-----~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
..... ....... ....++.++.+||.+||..||++|||+.++++||||..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 00000 0000000 01125677999999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=343.39 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=208.8
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|.+.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDKLWIC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEEE
Confidence 58999999999999999999999999999999987553 2334567889999999999999999999877 5679999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
|||++++.+..+......+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ...
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 163 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKR 163 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccc
Confidence 9999987666655555679999999999999999999999999999999999999999999999999987654322 222
Q ss_pred ccccccCCCCCccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 278 TSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~--~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
....|++.|+|||++. ....++.++|||||||++|+|++|.+||...........+... ......
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~--~~~~~~----------- 230 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--NFQPPK----------- 230 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc--CCCCCc-----------
Confidence 4457899999999874 2345788999999999999999999999766544433332211 000000
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~ 403 (495)
......++..+.+||.+||..||.+|||+.++|+|||
T Consensus 231 -----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 231 -----------LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -----------ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0011235677899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=340.84 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=208.2
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC---ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL---EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
.+|+..+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++.......+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 368899999999999999999999999999999876532 23445678899999999999999999999876545788
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC-
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH- 273 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~- 273 (495)
+++|||+.++.+.........+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 9999999876665555555578999999999999999999999999999999999999999999999999987653211
Q ss_pred -CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 274 -KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 274 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
........++..|+|||++.+ ..++.++|||||||++|+|++|++||...........+......+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 228 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP------------ 228 (266)
T ss_pred cCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCC------------
Confidence 111223457899999998876 567899999999999999999999998765544443332111000
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
.....+++.+.+|| .||..||.+|||++|+++||||+
T Consensus 229 ---------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 229 ---------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ---------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 01123456678888 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=340.42 Aligned_cols=261 Identities=26% Similarity=0.403 Sum_probs=215.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|++++.||.|+||+||+|.+..++..||+|++....... ....+.+|+.+|+.++|+||+++++.+.. ....|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEE
Confidence 47999999999999999999999999999999987655433 56788999999999999999999998877 5689999
Q ss_pred EeeccCChhhhhhCC---CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 198 FKYMEHDLAGLAASP---TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~---~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|||+.++.+...... ...+++..+..++.||+.||.|||++||+||||||+||++++++.++|+|||++..+.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999987665554432 24689999999999999999999999999999999999999999999999999976654322
Q ss_pred C---CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 275 Q---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 275 ~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
. .....+|+..|++||++.....++.++|+|||||++|+|++|+.||...+....+.++.... +. . +.
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-~-~~----- 228 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND--PP-S-LE----- 228 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC--CC-C-cC-----
Confidence 2 12334689999999998765468899999999999999999999998877666555543320 00 0 00
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.......+++.+.+||.+||..||.+|||+.++++||||
T Consensus 229 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 229 --------------TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred --------------CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 001124577889999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=340.66 Aligned_cols=255 Identities=28% Similarity=0.514 Sum_probs=210.0
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC-------hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-------PESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
+|.+...||+|+||.||+|.+..++..||+|.+...... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--A 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Confidence 477888999999999999999999999999998755332 1234578899999999999999999999877 5
Q ss_pred ceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
...+++|||+.++.+..+......+++..+..++.||+.||.|||++||+||||+|+|||++.++.++|+|||++.....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 67899999998876666665556789999999999999999999999999999999999999999999999999987642
Q ss_pred CCC-----CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 011041 272 NHK-----QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (495)
Q Consensus 272 ~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (495)
... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+......++....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 228 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA--------- 228 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---------
Confidence 211 11123457889999998876 467889999999999999999999998876655444432210
Q ss_pred hCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.......++..+.+||.+||+.||.+||++.++++||||
T Consensus 229 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 229 -------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 011123467788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=326.55 Aligned_cols=261 Identities=23% Similarity=0.371 Sum_probs=220.0
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++.+++..||.|+.|+|++++.+.+|...|||.+.... +.+...++.+.+.++..- ++|+||+++|+|.. +..+
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~--n~dV 166 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT--NTDV 166 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee--CchH
Confidence 3567788899999999999999999999999999998764 445556677777776655 59999999999987 4568
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|-||.|......++..-.+.++|..+-++...++.||.||.+ +||||||+||+|||||+.|++||||||++-++....
T Consensus 167 ~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 167 FICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 9999999987777777767789999999999999999999985 689999999999999999999999999998775432
Q ss_pred CCCCccccccCCCCCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPG-RTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwSlGvil~elltG~~pf~~-~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
..+...|-+.|||||.+.- ...|+..+||||||++|+||.||..||.+ .++.+.+.+|++.. |+
T Consensus 247 --AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e--PP--------- 313 (391)
T KOG0983|consen 247 --AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE--PP--------- 313 (391)
T ss_pred --ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC--CC---------
Confidence 2345578999999999843 35689999999999999999999999998 56778888887621 11
Q ss_pred CCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.......||+.+.+|+..||++|+.+||...++|+|||+...
T Consensus 314 ---------------~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 314 ---------------LLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred ---------------CCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 111223489999999999999999999999999999999864
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=342.52 Aligned_cols=258 Identities=25% Similarity=0.397 Sum_probs=207.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLS--REKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEE
Confidence 3679999999999999999999999999999999875432 334567889999999999999999999877 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||++++.+..+......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AK 162 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-cc
Confidence 99999987666555555678999999999999999999999999999999999999999999999999998664322 12
Q ss_pred CccccccCCCCCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 277 MTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
.....|++.|+|||.+.+ ...++.++|||||||++|+|++|.+||...+..+....+......+
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 228 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP-------------- 228 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCC--------------
Confidence 234568899999998742 3447789999999999999999999997654433222221100000
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~ 403 (495)
. .......++..+.+||.+||..||++|||++++|+|+|
T Consensus 229 ----~------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 229 ----P------KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ----C------CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 0 00112346778999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=344.67 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=212.8
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
+.|++++.||.|+||.||+|++..++..|++|++... .......+.+|+.+++.++|+||+++++++.. +...|+|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYW--DGKLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--CCeEEEE
Confidence 6799999999999999999999999999999998754 34556778889999999999999999999876 5679999
Q ss_pred EeeccCChhhhh-hCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 198 FKYMEHDLAGLA-ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 198 ~e~~~~~l~~~~-~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
|||+.++.+..+ ......+++..+..++.||+.+|.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 999998766544 3445578999999999999999999999999999999999999999999999999987543221 22
Q ss_pred CccccccCCCCCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 277 MTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+......++.... ++
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~----------- 233 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PP----------- 233 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC--Cc-----------
Confidence 234568899999998853 2447889999999999999999999998877655544443210 00
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.......++.++.+||.+||..||.+||++.++|+||||...
T Consensus 234 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 234 -------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred -------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 001123456778999999999999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=341.45 Aligned_cols=280 Identities=39% Similarity=0.672 Sum_probs=223.9
Q ss_pred eeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC---CCCCeeeeeceeeccCC---ce
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL---DHPNVVKLEGLVTSRMS---CS 193 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~---~~ 193 (495)
|++.+.||+|+||.||+|+++.++..||+|++............+.+|+.+++++ +|+||+++++++..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6789999999999999999998999999999976543333344566788887776 59999999999876321 24
Q ss_pred eEEEEeeccCChhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
++++|||+.+++...+... ...+++..+..++.||+.||.|||++||+|+||+|+|||++.++.+||+|||++..+...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 8999999998776655432 236899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+.+++...+.+....|.......
T Consensus 161 ~--~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 161 M--ALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred c--ccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 2 2234467889999999876 467899999999999999999999999999999999998887777666654322111
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
...+. .............+++.+.+||.+||..||.+||++.++|+||||
T Consensus 238 ~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFP--SYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhcc--cccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 11111 111112233445667889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=347.19 Aligned_cols=265 Identities=28% Similarity=0.337 Sum_probs=217.3
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|++++.||+|+||.||++.+..+++.|++|.+..... .......+.+|+.+++.++||||+++++.+.. ...+|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEE
Confidence 479999999999999999999999999999999876543 23445678899999999999999999999877 568999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC--
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-- 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~-- 274 (495)
||||++++.+..+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999876666665556799999999999999999999999999999999999999999999999999864211100
Q ss_pred ------------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 011041 275 ------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342 (495)
Q Consensus 275 ------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (495)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~- 236 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP- 236 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC-
Confidence 01112457889999998876 5689999999999999999999999998877776666543211100
Q ss_pred hhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC---HHHHHhCCCCCCCCCCC
Q 011041 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT---ATAALRSEFFTTKPYAC 411 (495)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t---a~elL~hp~f~~~~~~~ 411 (495)
.....+++++.+||.+||..||.+||+ +.++|+||||....|..
T Consensus 237 -------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 237 -------------------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred -------------------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 001246778899999999999999998 89999999998866643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=348.04 Aligned_cols=257 Identities=25% Similarity=0.452 Sum_probs=214.5
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
+-|.++++||+|+||.||+|.++.+|+.+|||.+..+ ...+.+..||.||++++.|++|++||.|.. ...+|||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK--~sDLWIV 106 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFK--HSDLWIV 106 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhcc--CCceEee
Confidence 4588999999999999999999999999999998754 345677889999999999999999998766 4569999
Q ss_pred EeeccCChhhh-hhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 198 FKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 198 ~e~~~~~l~~~-~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||+-+...+ +..+++.|+|.++..+++..+.||+|||...-||||||..|||++.+|..||+|||.|..+... -..
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAK 185 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAK 185 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh-HHh
Confidence 99999665554 4456778999999999999999999999999999999999999999999999999999765432 234
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
..+.+|||.|||||++.. -.|+..+||||||++..||.-|+|||.+-.+. ..|+-....|++.+
T Consensus 186 RNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMIPT~PPPTF------------ 249 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMIPTKPPPTF------------ 249 (502)
T ss_pred hCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCccccccc---ceeEeccCCCCCCC------------
Confidence 567899999999999865 56899999999999999999999999765543 23332222222211
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
......+.++-|||+.||.++|++|-||.++++|||+++.+
T Consensus 250 -----------~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 250 -----------KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred -----------CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 11223567888999999999999999999999999998753
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=349.52 Aligned_cols=286 Identities=36% Similarity=0.580 Sum_probs=227.3
Q ss_pred CeeeeeeecccCceEEEEEEECCC--CeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeec--cCCce
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLT--GQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS--RMSCS 193 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~--g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~--~~~~~ 193 (495)
+|++.+.||+|+||.||++++..+ +..||+|++............+.+|+.+++++ +||||++++++... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488999999999999999999888 89999999875433333455677899999999 59999999986532 12356
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|++++|+++++...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 899999999877666543 4579999999999999999999999999999999999999999999999999998654322
Q ss_pred C---CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 274 K---QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 274 ~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
. ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..++...+.++.+.+.....
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 1 1123457899999999887656689999999999999999999999999999999999999999888766544322
Q ss_pred CCCccC---CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 351 PHATIF---KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 351 ~~~~~~---~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
+....+ ..... ...+.......+..+.+||.+||+.||.+|||+.++|.||||..
T Consensus 240 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 240 PKAQNYIRSLPNIP-KKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred hhHHHHHHhccccC-CcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 111000 00000 00112223445778999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=342.89 Aligned_cols=258 Identities=25% Similarity=0.371 Sum_probs=213.1
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
.|++++.||+|+||.||++.+..++..+++|.+... .......+.+|+.+++.++|+||+++++++.. ....|+||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v~ 81 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILI 81 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEEE
Confidence 478889999999999999999999999999998643 24455678889999999999999999999877 56799999
Q ss_pred eeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 199 KYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 199 e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
||+.++.+.... .....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ...
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 160 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence 999987665543 345579999999999999999999999999999999999999999999999999987653221 223
Q ss_pred ccccccCCCCCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 278 TSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
....+++.|+|||++.. ...++.++|||||||++|+|++|.+||...+..+....+.......
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 227 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT------------- 227 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-------------
Confidence 34578999999998742 2457789999999999999999999999887766665554321100
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......++.++.+||.+||..||.+|||+.++++||||+..
T Consensus 228 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 228 -------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred -------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 00113467789999999999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=345.29 Aligned_cols=259 Identities=21% Similarity=0.383 Sum_probs=211.7
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|++++.||+|+||.||++++..+|..||+|.+... ........+.+|+.++++++|+||+++++++.. ...+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEE
Confidence 4789999999999999999999999999999998754 234445678899999999999999999999887 5689999
Q ss_pred EeeccCChhhhhhCC---CCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 198 FKYMEHDLAGLAASP---TIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~---~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
|||+.++.+..+... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++..+....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999998766555443 2378999999999999999999996 699999999999999999999999999987653221
Q ss_pred CCCCccccccCCCCCcccccCC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGA-----TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
.....+++.|+|||++.+. ..++.++|||||||++|+|++|..||...+.......+........
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 227 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------- 227 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-------
Confidence 2344678899999988542 2357899999999999999999999987655544444332221111
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......+++++.+||.+||..||.+||++.+++.||||...
T Consensus 228 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 228 ------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred ------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 01123467888999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=343.84 Aligned_cols=259 Identities=26% Similarity=0.425 Sum_probs=214.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||.|+||.||++.+..++..||+|++... .......+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFY--ENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--CCeEEE
Confidence 36799999999999999999999989999999998754 34455678899999999999999999999987 567999
Q ss_pred EEeeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||||++++.+..+. .....+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... .
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q 158 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence 99999987665554 334579999999999999999999999999999999999999999999999999987653322 2
Q ss_pred CCccccccCCCCCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 276 PMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
......+++.|++||++.. ...++.++|||||||++|+|++|.+||.+.+....+.++.... ++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~---------- 226 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE--PP---------- 226 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC--CC----------
Confidence 2234578999999998752 2346789999999999999999999998877666555543211 00
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.......++.++.+||..||..||.+||++.++|+||||..
T Consensus 227 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 227 --------------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred --------------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence 00111246778899999999999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=341.55 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=205.0
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHH-HHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILI-LRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|++.+.||+|+||.||++++..+|+.||||++.......... .+..|+.+ ++.++||||+++++++.. +..+|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHH-HHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEE
Confidence 47999999999999999999999999999999998654333333 44456554 666799999999999976 567999
Q ss_pred EEeeccCChhhhhh---CCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 197 VFKYMEHDLAGLAA---SPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 197 v~e~~~~~l~~~~~---~~~~~l~e~~~~~i~~qil~~L~~LH~~-givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
+|||+++++...+. .....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++..+...
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred EhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999987655443 2345799999999999999999999997 9999999999999999999999999999765422
Q ss_pred CCCCCccccccCCCCCcccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChhhhhhC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGA---TDYGVGVDLWSAGCILAELLAEKPIMPGR-TEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
. ......++..|+|||++.+. ..++.++|+|||||++|+|++|..||... +..+.+..+.... ..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~------- 226 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP--SP------- 226 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC--CC-------
Confidence 1 12335688999999988542 34688999999999999999999999653 3333333332210 00
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......+|.++.+||.+||..||.+|||+.+++.||||...
T Consensus 227 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 227 ------------------QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred ------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 00012367789999999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=340.22 Aligned_cols=257 Identities=26% Similarity=0.449 Sum_probs=213.6
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|++.+.||.|+||.||+|++..+++.||+|++.... .......+.+|+.+++.++|+||+++++++.+ +..+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEEEE
Confidence 46889999999999999999999999999999997654 23445667899999999999999999999887 5689999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
+||+.++.+..+.... .+++..++.++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++....... ...
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 155 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKR 155 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-ccc
Confidence 9999987665555443 78999999999999999999999999999999999999999999999999998775432 223
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (495)
....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+.... ++.
T Consensus 156 ~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~--------------- 217 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--PPS--------------- 217 (274)
T ss_pred ccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--CCC---------------
Confidence 34578899999999876 458999999999999999999999998776555444332210 000
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
+. ...+++++.++|.+||..||.+|||+.++++||||+..
T Consensus 218 --------~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 218 --------LE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred --------Cc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 00 01267789999999999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=340.33 Aligned_cols=280 Identities=36% Similarity=0.663 Sum_probs=226.3
Q ss_pred eeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCceeEEEE
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
|++.+.||+|+||.||+|++..+++.|+||.+....... ......+|+..+..++ |+||+++++++.+ +...|+||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEE
Confidence 678899999999999999999999999999987543322 2234457999999998 9999999999987 56899999
Q ss_pred eeccCChhhhhhCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 199 KYMEHDLAGLAASPT-IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 199 e~~~~~l~~~~~~~~-~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
||+.+++...+.... ..+++..+..++.||+.+|.|||++||+|+||+|+||+++.++.++|+|||++...... ...
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--~~~ 155 (283)
T cd07830 78 EYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--PPY 155 (283)
T ss_pred ecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC--CCc
Confidence 999877776665543 47899999999999999999999999999999999999999999999999999866432 223
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc-cC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT-IF 356 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~-~~ 356 (495)
....++..|+|||++.+...++.++|+|||||++++|++|.+||.+.+..+.+.++....+.+..+.|......... ..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 44578899999998876566889999999999999999999999999999999999999998887777543211100 00
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.........+...+...+..+.+||.+||..||.+|||+.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 000000011222233446789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=347.25 Aligned_cols=285 Identities=35% Similarity=0.582 Sum_probs=229.6
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
..++|++++.||.|+||.||+|++..+|..||||++.+..........+.+|+.+++.++||||+++++++... ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CCcEE
Confidence 35789999999999999999999999999999999876544444456777899999999999999999988653 34689
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
++|||+++++...+.. ..+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++......
T Consensus 87 lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--- 161 (328)
T cd07856 87 FVTELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--- 161 (328)
T ss_pred EEeehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC---
Confidence 9999998876655433 35889999999999999999999999999999999999999999999999998755322
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
....++++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+.+.++.++.+.+..........
T Consensus 162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 2345678899999988665568999999999999999999999999998888888888888888776654321110000
Q ss_pred CCC--CcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 356 FKP--QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 356 ~~~--~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
+.. ............+.+++.+.++|.+||+.||.+|||+.++|.||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 000 0000111223445678899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=335.67 Aligned_cols=256 Identities=28% Similarity=0.483 Sum_probs=214.0
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+|++++.||.|+||.||++.+..+|..||+|++............+.+|+.+++.++|+||+++++++.......+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58899999999999999999999999999999987666666677888999999999999999999988765567789999
Q ss_pred eeccCChhhhhhC----CCCCCCHHHHHHHHHHHHHHHHHhh-----hCCceeccCCCCCeeeCCCCcEEEeeccccccc
Q 011041 199 KYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCH-----NQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (495)
Q Consensus 199 e~~~~~l~~~~~~----~~~~l~e~~~~~i~~qil~~L~~LH-----~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~ 269 (495)
||+.++.+..+.. ....+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9998765443332 2457899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
..... ......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 226 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK------------ 226 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC------------
Confidence 54321 1334578999999999876 457899999999999999999999999877555444432210
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.......++..+.+||.+||..||.+|||+.++|+|||+
T Consensus 227 ----------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 227 ----------------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ----------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 001123467788999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=336.46 Aligned_cols=259 Identities=27% Similarity=0.436 Sum_probs=209.9
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC---ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL---EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
.+|++.+.||+|+||.||.+++..+|..||||.+..... .......+.+|+.+++.++||||+++++++.+.....+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 479999999999999999999999999999999875432 23456788899999999999999999999876545678
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|++|||+.++.+.........+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 99999998876655554545689999999999999999999999999999999999999999999999999876532111
Q ss_pred --CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 275 --QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 275 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.......++..|+|||++.+ ..++.++|||||||++|+|++|++||...+......++.. .+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~---------- 227 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPTN---------- 227 (265)
T ss_pred cccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCCC----------
Confidence 11233468899999999876 5678999999999999999999999987655544433321 1110
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
......++..+.++|.+||. +|.+||+++++++|||+.
T Consensus 228 --------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 228 --------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred --------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 00112355678899999994 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=333.40 Aligned_cols=254 Identities=25% Similarity=0.437 Sum_probs=215.7
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+|+.++.||.|+||.||.+++..+++.|++|.+............+.+|+.++++++|+||+++++++.+ ...++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence 5899999999999999999999999999999998776666667778899999999999999999999987 56899999
Q ss_pred eeccCChhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 199 KYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 199 e~~~~~l~~~~~~~--~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||+.++.+...... ...+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~-~~ 157 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY-SM 157 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc-cc
Confidence 99987555444332 3568999999999999999999999999999999999999999999999999998764333 12
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+... .+.
T Consensus 158 ~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~--------------- 219 (256)
T cd08221 158 AETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT--------------- 219 (256)
T ss_pred ccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC---------------
Confidence 345678999999998876 45788999999999999999999999988877776666431 111
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.....++.++.++|.+||..||.+||++.++|+|+|+
T Consensus 220 -----------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 -----------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -----------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0113467788999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=339.56 Aligned_cols=256 Identities=25% Similarity=0.422 Sum_probs=205.4
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC----Cc
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM----SC 192 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~----~~ 192 (495)
+.|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.+ +|+||+++++++.... ..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 56889999999999999999999999999999987543 2234677899999998 7999999999986532 24
Q ss_pred eeEEEEeeccCChhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 193 SLYLVFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~--~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
.+|++|||+.++.+..+... ...+++..+..++.||+.||.|||++||+|+||||+||++++++.+||+|||++....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 68999999987655544332 3468999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCCCccccccCCCCCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 011041 271 PNHKQPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (495)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (495)
... .......|++.|+|||++.+ ...|+.++|||||||++|+|++|.+||...........+... +.
T Consensus 163 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~~----- 233 (272)
T cd06637 163 RTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PA----- 233 (272)
T ss_pred ccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---CC-----
Confidence 322 22345678999999999853 235788999999999999999999999765544333222110 00
Q ss_pred hCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.......++.++.+||.+||..||.+|||+.++++||||
T Consensus 234 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 234 -------------------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -------------------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 000112466788999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=343.48 Aligned_cols=257 Identities=25% Similarity=0.463 Sum_probs=212.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
..+|++++.||+|+||.||++++..+++.||+|.+...... ....+.+|+.+++.++|+||+++++.+.. ....|+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~l 94 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 94 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEE
Confidence 36899999999999999999999999999999999765432 34668899999999999999999999887 568999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||+.++.+..+... ..+++.++..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ..
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~ 172 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (296)
T ss_pred eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc-cc
Confidence 9999998766555543 358999999999999999999999999999999999999999999999999987654332 12
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+....+..+... +.+.
T Consensus 173 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~--------------- 235 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE--------------- 235 (296)
T ss_pred cCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC---------------
Confidence 234578999999998865 55789999999999999999999999887765544333211 0000
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
......+++.+.+||.+||..||.+|||+.++++||||..
T Consensus 236 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 236 ----------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred ----------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 0112346677899999999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=335.78 Aligned_cols=256 Identities=25% Similarity=0.441 Sum_probs=209.3
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC----ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
+|++.+.||+|+||.||+|.+ .+|+.+|+|.+..... .......+.+|+.+++.++|+||+++++++.+ ....
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeE
Confidence 478889999999999999986 4788999999875432 23345678899999999999999999999987 5789
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC--
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN-- 272 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~-- 272 (495)
|++|||+.++.+..+......+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999998777666655567899999999999999999999999999999999999999999999999998764321
Q ss_pred ---CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 273 ---HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 273 ---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
.........|+..|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------- 226 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL---------- 226 (265)
T ss_pred cccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC----------
Confidence 1112234568999999998875 56789999999999999999999999876655544333221111
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.......++.++.+||.+||..||.+|||+.++|.||||
T Consensus 227 ----------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 227 ----------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ----------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 011123467788999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=334.33 Aligned_cols=257 Identities=28% Similarity=0.447 Sum_probs=211.3
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|++.+.||.|+||.||+|.+..++..+++|++..... .....+.+|+.+++.++||||+++++++.+ ...+|++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEEE
Confidence 689999999999999999999999999999999976542 245778899999999999999999999877 5679999
Q ss_pred EeeccCChhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 198 FKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
|||++++.+..+... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 157 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK 157 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence 999998766655543 3689999999999999999999999999999999999999999999999999997664322 12
Q ss_pred CccccccCCCCCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 277 MTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
.....++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+.......+......+.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~------------- 224 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP------------- 224 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc-------------
Confidence 2345788999999988653 2678899999999999999999999988776555444322110000
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~ 403 (495)
.......++.++.+||.+||..||.+|||+.+++.|+|
T Consensus 225 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 225 -----------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred -----------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00011234567899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=342.06 Aligned_cols=257 Identities=26% Similarity=0.479 Sum_probs=214.8
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
.+|++++.||.|+||.||+|++..+|+.|+||.+..... .....+.+|+.+++.++|+||+++++++.. ...+|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLV--GDELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEEE
Confidence 579999999999999999999999999999999875432 234667899999999999999999999977 5679999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
|||+.++.+..+.... .+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ..
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (296)
T cd06655 95 MEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR 172 (296)
T ss_pred EEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence 9999987776655433 689999999999999999999999999999999999999999999999999876543322 22
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (495)
....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+....+..+... ..+.
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~---------------- 234 (296)
T cd06655 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE---------------- 234 (296)
T ss_pred CCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc----------------
Confidence 34568899999998865 56789999999999999999999999988776665544321 1100
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......+++.+.+||.+||..||.+|||+.+++.||||...
T Consensus 235 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 235 ---------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred ---------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 01123467789999999999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=334.06 Aligned_cols=254 Identities=22% Similarity=0.457 Sum_probs=212.0
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+|++++.||+|+||.||.+++..+|+.||+|.+............+.+|+.+++.++|+||+++++++.. ....|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEEEE
Confidence 5899999999999999999999999999999998665555556678899999999999999999999877 56899999
Q ss_pred eeccCChhh-hhhC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 199 KYMEHDLAG-LAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 199 e~~~~~l~~-~~~~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||+.++.+. .+.. ....+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++....... ..
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 157 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-EL 157 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-hh
Confidence 999875444 3333 23368999999999999999999999999999999999999999999999999997664322 11
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
.....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+.... ..
T Consensus 158 ~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~--~~--------------- 219 (256)
T cd08218 158 ARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS--YP--------------- 219 (256)
T ss_pred hhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC--CC---------------
Confidence 223467889999998866 457889999999999999999999998877766666554311 10
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.....++.++.+||.+||+.||.+||++.++|+||||
T Consensus 220 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 220 -----------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 1123467788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=336.74 Aligned_cols=261 Identities=28% Similarity=0.505 Sum_probs=209.3
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC--------ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL--------EPESVRFMAREILILRRLDHPNVVKLEGLVTSRM 190 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 190 (495)
+|.+.+.||+|+||.||+|.+..+|+.||+|.+..... .....+.+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 58888999999999999999999999999999864321 11234567889999999999999999999877
Q ss_pred CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
...+++||||+.++.+.........+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 56799999999887666665555689999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCC-CCccccccCCCCCcccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 271 PNHKQ-PMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 271 ~~~~~-~~~~~~gt~~y~aPE~l~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
..... ......|+..|+|||++.... .++.++|+|||||++|+|++|..||...+..+.+..+......+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 232 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP------- 232 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCc-------
Confidence 22111 123346788999999886543 478899999999999999999999976555444333221100000
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
........++.++.+||.+||..||.+|||+.++|+||||
T Consensus 233 ----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 233 ----------------IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ----------------CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0112234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=336.98 Aligned_cols=260 Identities=30% Similarity=0.531 Sum_probs=209.4
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC----hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE----PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
+|+..+.||+|+||.||++.+..+++.||+|++...... ......+.+|+.+++.++|+||+++++++.+ ....
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CCeE
Confidence 478889999999999999999999999999999754321 2245678899999999999999999999987 5679
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC-cEEEeecccccccCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNH 273 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~-~vkL~DFG~a~~~~~~~ 273 (495)
++||||+.++.+..+......+++..+..++.||+.||.|||++||+|+||||+||+++.++ .+||+|||++.......
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999877766665556799999999999999999999999999999999999998876 59999999997764321
Q ss_pred C---CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 274 K---QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 274 ~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 228 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT--------- 228 (268)
T ss_pred ccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC---------
Confidence 1 11123467899999999876 5678999999999999999999999976554333333322110000
Q ss_pred CCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
.......+++++.++|.+||..||.+|||+.++|+||||.
T Consensus 229 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 229 ---------------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ---------------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0111234677889999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=331.76 Aligned_cols=253 Identities=24% Similarity=0.414 Sum_probs=212.3
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+|+.++||||+++++.+.. ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence 5899999999999999999999999999999998776666667788999999999999999999998876 56799999
Q ss_pred eeccCChhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC-CcEEEeecccccccCCCCCC
Q 011041 199 KYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 199 e~~~~~l~~~~~~~--~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~-~~vkL~DFG~a~~~~~~~~~ 275 (495)
||+.++.+..+... ...+++..+..++.||+.+|.|||++||+|+||||+||+++.+ +.+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-- 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-- 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--
Confidence 99987655544432 3458999999999999999999999999999999999999865 468999999998764332
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~----------------- 218 (256)
T cd08220 157 KAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF----------------- 218 (256)
T ss_pred cccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-----------------
Confidence 2234578999999998876 4578899999999999999999999988776666555533110
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
......+++++.+||..||..||.+|||+.++|+||||
T Consensus 219 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 219 -----------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -----------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 01112467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=343.73 Aligned_cols=258 Identities=25% Similarity=0.454 Sum_probs=212.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
..+|++++.||+|+||.||++++..+++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEE
Confidence 3789999999999999999999999999999999976443 234567899999999999999999999987 568999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||++++.+..+... ..+++.++..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....... ..
T Consensus 94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~~ 171 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 171 (297)
T ss_pred eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc-cC
Confidence 9999998766665543 358999999999999999999999999999999999999999999999999987654332 22
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+....+..+.. .+.+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~--------------- 234 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------------- 234 (297)
T ss_pred cCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC---------------
Confidence 234578999999998876 5678999999999999999999999987665443322211 01110
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 235 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 235 ----------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred ----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 01123456778899999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=338.25 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=205.9
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeecc----CCc
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSR----MSC 192 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~----~~~ 192 (495)
+.|++.+.||.|+||.||+|++..+++.||+|++.... .....+..|+.+++++ +|+||+++++++... ...
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 67999999999999999999999999999999986542 3345678899999998 799999999988532 245
Q ss_pred eeEEEEeeccCChhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 193 SLYLVFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~--~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
.+|++|||+.++.+..+.. ....+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 7899999998755544332 23458899999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCCCccccccCCCCCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 011041 271 PNHKQPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (495)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (495)
... .......|++.|+|||++.. ...++.++|||||||++|+|++|.+||...........+.... .
T Consensus 173 ~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~----- 243 (282)
T cd06636 173 RTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---P----- 243 (282)
T ss_pred ccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC---C-----
Confidence 222 12344578999999998753 2457889999999999999999999998765544433321110 0
Q ss_pred hCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.......++.++.+||.+||..||.+|||+.|+|+||||
T Consensus 244 -------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 -------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred -------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 001123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=338.77 Aligned_cols=244 Identities=18% Similarity=0.184 Sum_probs=203.3
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeec--cCCceeEEEEee
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTS--RMSCSLYLVFKY 200 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~~~lv~e~ 200 (495)
..||+|++|.||+|.. +|+.||||++..... .....+.+.+|+.+|++++|||||++++++.+ .....+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999976 689999999976543 23335778899999999999999999999866 434578999999
Q ss_pred ccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcc
Q 011041 201 MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS 279 (495)
Q Consensus 201 ~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 279 (495)
+.++.+..+......+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++...... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----PFK 179 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc----ccc
Confidence 9998777666666689999999999999999999998 49999999999999999999999999999865432 134
Q ss_pred ccccCCCCCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCC
Q 011041 280 RVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (495)
Q Consensus 280 ~~gt~~y~aPE~l~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 358 (495)
.+||+.|+|||++.+. ..|+.++|||||||++|||++|..||.+.+..+.+..+......+.
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------- 242 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK----------------- 242 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-----------------
Confidence 5788999999998652 4689999999999999999999999998887777666643221111
Q ss_pred CcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 359 ~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....++.+.+||.+||+.||.+|||+.++++
T Consensus 243 ----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 243 ----------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred ----------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 01246778999999999999999999999986
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=341.42 Aligned_cols=255 Identities=27% Similarity=0.471 Sum_probs=213.0
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
..|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--EHTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--CCeEEE
Confidence 459999999999999999999999999999999875433 34455678899999999999999999999987 567899
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||+.+++..........+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++......
T Consensus 93 v~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 93 VMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred EHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 9999999887776655567999999999999999999999999999999999999999999999999998765432
Q ss_pred CccccccCCCCCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 277 MTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+.......+... .++
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~------------- 232 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSP------------- 232 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCC-------------
Confidence 34467889999998753 345788999999999999999999999887765544433210 000
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
......++..+.+||.+||..||.+||++.+++.||||..
T Consensus 233 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 233 ------------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred ------------CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0001125667899999999999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=333.00 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=209.3
Q ss_pred ecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeeccCC
Q 011041 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD 204 (495)
Q Consensus 126 LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~ 204 (495)
||.|+||.||+|++..++..||+|++.+... .......+.+|+.+++.++||||+++++++.+ ...+|++|||+.++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCCC
Confidence 6999999999999999999999999986544 33455778999999999999999999999877 56799999999877
Q ss_pred hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccccccC
Q 011041 205 LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL 284 (495)
Q Consensus 205 l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 284 (495)
.+.........+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ......+++
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~ 156 (262)
T cd05572 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTP 156 (262)
T ss_pred cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCc
Confidence 666665555678999999999999999999999999999999999999999999999999998764432 123347889
Q ss_pred CCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCccc
Q 011041 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT--EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSY 362 (495)
Q Consensus 285 ~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~--~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 362 (495)
.|++||++.+ ..++.++|+|||||++|+|++|.+||...+ ..+.+.++......+
T Consensus 157 ~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------- 213 (262)
T cd05572 157 EYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL---------------------- 213 (262)
T ss_pred CccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCC----------------------
Confidence 9999998765 467899999999999999999999998876 444554443211000
Q ss_pred ccccccccCCCCCCcHHHHHHhccCCCCCccC-----HHHHHhCCCCCCCCC
Q 011041 363 KRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEFFTTKPY 409 (495)
Q Consensus 363 ~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----a~elL~hp~f~~~~~ 409 (495)
......++++.+||.+||..||.+|+| +.|+++||||++..|
T Consensus 214 -----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 214 -----EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred -----CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 011224678999999999999999999 999999999987544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=338.10 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=199.0
Q ss_pred eecccCceEEEEEEECCCCeEEEeEEEecCCCCh-HHHHHHHHHHHHHHh---CCCCCeeeeeceeeccCCceeEEEEee
Q 011041 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREILILRR---LDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (495)
Q Consensus 125 ~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~---l~HpnIv~l~~~~~~~~~~~~~lv~e~ 200 (495)
.||+|+||.||++.+..+++.||+|.+.+..... .......+|..+++. .+|+||+.+++++.. ....|+||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence 4899999999999999999999999997654322 222233445444443 479999999998876 4579999999
Q ss_pred ccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccc
Q 011041 201 MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280 (495)
Q Consensus 201 ~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 280 (495)
+.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... ....
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 155 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS 155 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCc
Confidence 9987776666556679999999999999999999999999999999999999999999999999987554322 1334
Q ss_pred cccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCChhhhhhCCCCCCccCCC
Q 011041 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV--EQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (495)
Q Consensus 281 ~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 358 (495)
.||+.|+|||++.+...++.++|||||||++|+|++|..||.+.... ..+..+.. ..
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~~------------------ 214 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TV------------------ 214 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---cC------------------
Confidence 78999999998865456889999999999999999999999764321 11111110 00
Q ss_pred CcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCC
Q 011041 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPY 409 (495)
Q Consensus 359 ~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~ 409 (495)
.......+++++.+||.+||..||.+|+ |+.++++||||+...|
T Consensus 215 -------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 215 -------NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred -------CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 0011234678899999999999999999 6999999999998554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=342.03 Aligned_cols=258 Identities=24% Similarity=0.410 Sum_probs=212.4
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++|+||+++++.+.. ....|+|
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv 97 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVV 97 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEE
Confidence 45666778999999999999999999999999986533 3445668899999999999999999999877 5679999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
|||+.++.+..+... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ...
T Consensus 98 ~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 175 (292)
T cd06658 98 MEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKR 175 (292)
T ss_pred EeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccC
Confidence 999998776665543 368999999999999999999999999999999999999999999999999987653322 222
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (495)
....|++.|+|||++.+ ..++.++|||||||++|||++|..||.+.+....+..+.......
T Consensus 176 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 237 (292)
T cd06658 176 KSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR----------------- 237 (292)
T ss_pred ceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc-----------------
Confidence 34578999999998865 567899999999999999999999999877766655543211000
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
......++..+.+||.+||..||.+|||+.++|+||||...+
T Consensus 238 ---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 238 ---------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred ---------cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 001123567788999999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=330.54 Aligned_cols=258 Identities=27% Similarity=0.490 Sum_probs=212.2
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+|++.+.||+|+||.||++.+..+++.|++|.+............+.+|+.+++.++|+||+++++++.. ...+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEEEEE
Confidence 5889999999999999999999999999999998776555677889999999999999999999998876 56799999
Q ss_pred eeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC--
Q 011041 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP-- 276 (495)
Q Consensus 199 e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~-- 276 (495)
||+.++.+..+......+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++..........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 999988777776666678999999999999999999999999999999999999999999999999998765433221
Q ss_pred -CccccccCCCCCcccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 277 -MTSRVVTLWYRPPELLLGAT--DYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 277 -~~~~~gt~~y~aPE~l~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.....+++.|++||++.+.. .++.++|||||||++|+|++|..||...... .....+.. +....
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~---------- 226 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--GHKPP---------- 226 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--CCCCC----------
Confidence 12346788999999987532 3788999999999999999999999765432 22222211 11000
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
......+++.+.+||.+||+.||.+|||+.+++.|||+
T Consensus 227 --------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 227 --------------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred --------------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00112357788999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=342.95 Aligned_cols=262 Identities=25% Similarity=0.365 Sum_probs=227.4
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCce
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 193 (495)
+..+|.++.+||+|+||.|.+|..+.+.+.||||+++++-. ..+.++--..|-++|... +-|.+++++.+|.. -..
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mDR 424 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDR 424 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hhh
Confidence 46789999999999999999999999999999999988765 444555556677787776 56789999999987 467
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|+||||+.|+.+-+.+++-+.|.|..+..|+.+|+-||-|||++|||+||||.+||||+.+|+|||+|||+++.--..
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~- 503 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD- 503 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC-
Confidence 9999999999888888888889999999999999999999999999999999999999999999999999999743222
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.....+.+|||.|+|||++.- .+|+..+|+||+||+||||+.|++||.|.++.+.+..|...--.
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs-------------- 568 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS-------------- 568 (683)
T ss_pred CcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc--------------
Confidence 233467899999999998865 68999999999999999999999999999999999999764322
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-----HHHHHhCCCCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEFFTTKPYA 410 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----a~elL~hp~f~~~~~~ 410 (495)
..+.+|.++.++++.+|.+.|.+|+. -.++-.||||....|.
T Consensus 569 ---------------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWe 615 (683)
T KOG0696|consen 569 ---------------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWE 615 (683)
T ss_pred ---------------CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHH
Confidence 23568889999999999999999965 3678899999987763
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=330.17 Aligned_cols=255 Identities=27% Similarity=0.468 Sum_probs=211.0
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC---ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL---EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
+|+..+.||+|+||+||+|.+..++..|++|.+..... ..+....+.+|+.+++.++|+||+++++++.+ ...+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--EDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--CCeEE
Confidence 47778899999999999999998999999999876432 24456778899999999999999999999876 56799
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+++||++++.+..+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 999999987666665555578999999999999999999999999999999999999999999999999987654332
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
......|+..|++||.+.....++.++|+|||||++|+|++|.+||......+...++.....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----------------- 219 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE----------------- 219 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-----------------
Confidence 234557899999999886543488999999999999999999999987665444443322100
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.......+++++.+||.+||..||.+|||+.++|.|||+
T Consensus 220 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 220 ----------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ----------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 011123467788999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=334.47 Aligned_cols=253 Identities=29% Similarity=0.414 Sum_probs=211.9
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
.|++.+.||.|+||.||+|.+..++..||+|++.+... .....+.+.+|+.++++++||||+++++++.. ....|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CCeEEEE
Confidence 48999999999999999999999999999999986544 33556788999999999999999999999876 5679999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
+||+.++.+.........+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++....... ..
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 156 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT 156 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence 9999987766666555689999999999999999999999999999999999999999999999999998664332 22
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE--VEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
....|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...+. .+.+...... .
T Consensus 157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~--------------- 217 (258)
T cd05578 157 TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---A--------------- 217 (258)
T ss_pred cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---c---------------
Confidence 44568889999998866 4588999999999999999999999987764 2222222110 0
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCH--HHHHhCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA--TAALRSEFF 404 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta--~elL~hp~f 404 (495)
.......++..+.++|.+||..||.+|+++ .|+++||||
T Consensus 218 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 218 ----------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ----------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 011123466889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=334.05 Aligned_cols=252 Identities=16% Similarity=0.221 Sum_probs=204.3
Q ss_pred CCCeeeeeeecccCceEEEEEEEC---CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
..+|++.+.||+|+||.||+|.++ ..+..||+|+++... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CCC
Confidence 357999999999999999999765 456789999987543 33445678899999999999999999999876 567
Q ss_pred eEEEEeeccCChhhhhhC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.|+||||++++.+..+.. ....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 999999999876665543 3457899999999999999999999999999999999999999999999999987654322
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
.........++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------------ 227 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL------------ 227 (266)
T ss_pred chhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC------------
Confidence 1111112234678999998876 578999999999999999775 99999988877766665322110
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....++..+.+++..||..||.+|||+.++++
T Consensus 228 ----------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 228 ----------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ----------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 112346778899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=335.58 Aligned_cols=259 Identities=27% Similarity=0.409 Sum_probs=207.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC---Cc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM---SC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~---~~ 192 (495)
.++|.+.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++.... ..
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 578999999999999999999999999999999986532 2235567899999999 8999999999986532 24
Q ss_pred eeEEEEeeccCChhhhhh----CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccc
Q 011041 193 SLYLVFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~----~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~ 268 (495)
..|+||||+.++.+..+. .....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 689999999876554433 2345789999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCccccccCCCCCcccccCCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh
Q 011041 269 FDPNHKQPMTSRVVTLWYRPPELLLGAT----DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344 (495)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (495)
...... ......|+..|+|||++.... .++.++|||||||++|+|++|++||...+....+..+.+.. ...
T Consensus 178 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~---~~~- 252 (291)
T cd06639 178 LTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP---PPT- 252 (291)
T ss_pred cccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC---CCC-
Confidence 543221 123346889999999875422 36789999999999999999999998876655554442210 000
Q ss_pred hhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
+ .....++..+.+||.+||..||.+||++.++|+||||+
T Consensus 253 ---------------------~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 253 ---------------------L-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ---------------------C-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 0 00123456789999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=334.11 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=209.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC----C
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM----S 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~----~ 191 (495)
.++|++.+.||+|+||.||+|.+..+++.|++|++.... .....+.+|+.+++.+ +|+||+++++++.... .
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 478999999999999999999999999999999987543 2345688999999999 7999999999987532 4
Q ss_pred ceeEEEEeeccCChhhhhhC----CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 192 CSLYLVFKYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~----~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
..+|+||||+.++.+..+.. ....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 56899999999865544432 24578999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCccccccCCCCCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 011041 268 FFDPNHKQPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE 343 (495)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (495)
...... .......|++.|+|||++.. ...++.++|||||||+||+|++|.+||...+....+..+.... +. .
T Consensus 162 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-~ 237 (275)
T cd06608 162 QLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP--PP-T 237 (275)
T ss_pred ecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC--CC-C
Confidence 654322 22344578999999998753 2346788999999999999999999998766555554443210 00 0
Q ss_pred hhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
+ .....++.++.+||.+||..||.+|||+.++++|||+
T Consensus 238 ----------------------~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 ----------------------L-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ----------------------C-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0 0012356788999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=339.31 Aligned_cols=261 Identities=21% Similarity=0.333 Sum_probs=207.4
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|+..+.||+|+||.||++++..+|+.||||.+...... .....+.+|+.++.++. |+||+++++++.. ....++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEE
Confidence 5677888999999999999999999999999998765433 44567889999999996 9999999998876 457899
Q ss_pred EEeeccCChhhhh----hCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 197 VFKYMEHDLAGLA----ASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 197 v~e~~~~~l~~~~----~~~~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
+|||+...+..+. ......+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9999987654432 1234579999999999999999999997 5999999999999999999999999999976543
Q ss_pred CCCCCCccccccCCCCCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 272 NHKQPMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
.. ......|++.|+|||++.+. ..++.++|||||||++|+|++|++||..... ....+...........
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~----- 231 (288)
T cd06616 161 SI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPIL----- 231 (288)
T ss_pred CC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcC-----
Confidence 22 12334688999999998764 3689999999999999999999999976542 2222222211110000
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.......++.++.+||.+||..||.+|||+.+++.||||..
T Consensus 232 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 232 ----------------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred ----------------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 01111347788999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=337.07 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=204.6
Q ss_pred ecccCceEEEEEEECCCCeEEEeEEEecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeeccCC
Q 011041 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD 204 (495)
Q Consensus 126 LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~ 204 (495)
||+|+||+||+|.+..+|+.||+|++.+.... ......+.+|+.+|+.++||||+++++++.. ....|+||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCCC
Confidence 69999999999999999999999999764332 2234556789999999999999999999877 56799999999976
Q ss_pred hhhhhhCCC--CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccccc
Q 011041 205 LAGLAASPT--IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282 (495)
Q Consensus 205 l~~~~~~~~--~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 282 (495)
.+....... ..+++..+..++.||+.||.|||++||+||||+|+|||++.++.+||+|||++...... .......+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 156 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAG 156 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--CccccccC
Confidence 555444332 36999999999999999999999999999999999999999999999999998765432 22334567
Q ss_pred cCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCccc
Q 011041 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSY 362 (495)
Q Consensus 283 t~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 362 (495)
+..|++||++.+ ..++.++|||||||++|+|++|+.||...........+.......
T Consensus 157 ~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------- 213 (277)
T cd05577 157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM---------------------- 213 (277)
T ss_pred CCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc----------------------
Confidence 889999999876 448899999999999999999999998765422222221110000
Q ss_pred ccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCCC
Q 011041 363 KRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPYA 410 (495)
Q Consensus 363 ~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~~ 410 (495)
.......+++.+.+||.+||+.||.+|| ++.+++.||||....|.
T Consensus 214 ---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 214 ---AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred ---cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence 0112234688899999999999999999 99999999999876663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=335.35 Aligned_cols=252 Identities=27% Similarity=0.389 Sum_probs=200.7
Q ss_pred eecccCceEEEEEEECCCCeEEEeEEEecCCCCh-HHHHHHHHHH---HHHHhCCCCCeeeeeceeeccCCceeEEEEee
Q 011041 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREI---LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (495)
Q Consensus 125 ~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~~~Ei---~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~ 200 (495)
.||+|+||.||+|++..+++.||+|.+.+..... .....+..|. .+++..+||||+.+++++.. ...+|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 4899999999999999999999999998654321 1112233333 44555689999999999987 4679999999
Q ss_pred ccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccc
Q 011041 201 MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280 (495)
Q Consensus 201 ~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 280 (495)
+.++.+.........+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..+.... ....
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~ 155 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS 155 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcCc
Confidence 9987776666666689999999999999999999999999999999999999999999999999987654322 2345
Q ss_pred cccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCChhhhhhCCCCCCccCC
Q 011041 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV---EQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (495)
Q Consensus 281 ~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~---~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (495)
.|+..|+|||++.+...++.++|||||||++|+|++|..||.+.... .....+.. .
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----~----------------- 214 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----M----------------- 214 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc----c-----------------
Confidence 78999999999875456889999999999999999999999876322 21111110 0
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPYA 410 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~~ 410 (495)
.......+++++.+||.+||..||.+|+ ++.++++||||....|.
T Consensus 215 --------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 215 --------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred --------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 0011234578899999999999999999 99999999999986553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=331.61 Aligned_cols=282 Identities=30% Similarity=0.540 Sum_probs=235.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC----Cc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~ 192 (495)
..+|.-+..+|.|.- .|..|.|..+++.||+|++..........+...+|..++..+.|+||++++.+|.... -.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357889999999999 8889999999999999998766444555677889999999999999999999996532 24
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|+|||||...+..... ..++-..+..++.|++.|+.|||+.||+||||||+||++..++.+||.|||+|+..+..
T Consensus 95 e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 589999999998877665 35677889999999999999999999999999999999999999999999999876544
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
-.++.++.|..|+|||++.+.+ |...+||||+|||+.||++|.-+|+|.+..+++.+|...+|+|++.+..+...-.
T Consensus 172 --~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred --cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 4567889999999999999855 9999999999999999999999999999999999999999999998877643322
Q ss_pred CccCCCCcccc-cccccccCC------------CCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 353 ATIFKPQQSYK-RCIAETFKD------------FPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 353 ~~~~~~~~~~~-~~~~~~~~~------------~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
.........+. ....+.+++ -+..+.+|+.+||..||++|.++.++|+||||+
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 22222222211 112222222 124578999999999999999999999999998
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=333.28 Aligned_cols=261 Identities=27% Similarity=0.422 Sum_probs=207.0
Q ss_pred CCCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeec---c
Q 011041 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS---R 189 (495)
Q Consensus 114 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~---~ 189 (495)
....++|++++.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.+ +|+||+++++++.. .
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 344689999999999999999999999999999999876432 2234577899999999 79999999998743 2
Q ss_pred CCceeEEEEeeccCChhhhhh----CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccc
Q 011041 190 MSCSLYLVFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGL 265 (495)
Q Consensus 190 ~~~~~~lv~e~~~~~l~~~~~----~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~ 265 (495)
.+...|+||||++++.+..+. .....+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 246799999999876554432 2345689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccccCCCCCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 011041 266 ASFFDPNHKQPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS 341 (495)
Q Consensus 266 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~ 341 (495)
+....... .......|++.|+|||++.. ...++.++|||||||++|+|++|.+||...+....+.++.... +.
T Consensus 171 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~--~~ 247 (286)
T cd06638 171 SAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP--PP 247 (286)
T ss_pred eeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC--CC
Confidence 87664322 22234578999999998753 2347889999999999999999999998766544433321100 00
Q ss_pred hhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.......++..+.+||.+||+.||.+|||+.++|+|+||
T Consensus 248 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 248 ------------------------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ------------------------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 000012245678999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=337.18 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=214.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
+.|...+.||+|+||.||+|++..+|..|++|++..... .......+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 98 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHTAWL 98 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEE
Confidence 457778899999999999999999999999999976543 34445678889999999999999999999987 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||+.+++...+......+++..+..++.||+.+|.|||++||+|+||||+||+++.++.+||+|||++.... .
T Consensus 99 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----~ 173 (313)
T cd06633 99 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----P 173 (313)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-----C
Confidence 99999988887776666679999999999999999999999999999999999999999999999999986432 2
Q ss_pred CccccccCCCCCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 277 MTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
.....|+..|+|||++.. ...++.++|||||||++|+|++|.+||...+.......+.... .+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~------------- 238 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SP------------- 238 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CC-------------
Confidence 234578899999998742 3457889999999999999999999998877666665553210 00
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......++..+.+||.+||+.||.+||++.++|+||||...
T Consensus 239 ------------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 239 ------------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred ------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 00112355678999999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=355.94 Aligned_cols=253 Identities=27% Similarity=0.466 Sum_probs=206.1
Q ss_pred eecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeeccCC
Q 011041 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD 204 (495)
Q Consensus 125 ~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~ 204 (495)
+||+|.||+||-|+|+.|....|||.|.-. .....+-+..||.+.++|+|.|||+++|.+.. ++++-|.||-++|+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEEeecCCCC
Confidence 599999999999999999999999998643 34455678899999999999999999999876 67889999999987
Q ss_pred hhhhh-hCCCCCC--CHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC-CCcEEEeecccccccCCCCCCCCccc
Q 011041 205 LAGLA-ASPTIKF--TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADFGLASFFDPNHKQPMTSR 280 (495)
Q Consensus 205 l~~~~-~~~~~~l--~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~-~~~vkL~DFG~a~~~~~~~~~~~~~~ 280 (495)
.+..+ ...-+++ .|..+..|.+||++||.|||++.|||||||-+|+||+. .|.+||.|||.++....- +....++
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETF 736 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETF 736 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC-Ccccccc
Confidence 66554 4455566 88999999999999999999999999999999999976 799999999999876432 2334567
Q ss_pred cccCCCCCccccc-CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCC
Q 011041 281 VVTLWYRPPELLL-GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQ 359 (495)
Q Consensus 281 ~gt~~y~aPE~l~-~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 359 (495)
.||..|||||++. |...|+.++|||||||++.||.||+|||.... .|..-+|... .|+..
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg-------------spqAAMFkVG------myKvH 797 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG-------------SPQAAMFKVG------MYKVH 797 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC-------------ChhHhhhhhc------ceecC
Confidence 8999999999984 44679999999999999999999999997532 2222222111 11111
Q ss_pred cccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 360 QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 360 ~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
..+...++.++++||.+|+..||.+||+|.++|+.||++..+
T Consensus 798 -------P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 798 -------PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred -------CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence 122334667889999999999999999999999999998753
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=329.67 Aligned_cols=253 Identities=28% Similarity=0.478 Sum_probs=209.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|++.+.||+|+||.||+|++..++..|++|.+.... ....+.+|+.+++.++|+||+++++++.. ....|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFK--NTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCcEEEE
Confidence 67999999999999999999999989999999986432 25678899999999999999999999987 4679999
Q ss_pred EeeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 198 FKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 198 ~e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
+||+.++.+..+. .....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........ .
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 9999986665544 3455789999999999999999999999999999999999999999999999999987654321 2
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
.....++..|+|||++.+ ..++.++||||||||+|+|++|.+||...+.......+... ...
T Consensus 156 ~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~-------------- 217 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PPP-------------- 217 (256)
T ss_pred cccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CCC--------------
Confidence 234457889999998876 46889999999999999999999999876654433322110 000
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.......++..+.+||.+||..||.+|||+.++|.||||
T Consensus 218 ---------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 218 ---------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ---------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 001112356778999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=328.64 Aligned_cols=254 Identities=25% Similarity=0.494 Sum_probs=209.5
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+|.+.+.||+|+||.||++.++.+|..||+|.+............+.+|+.+++.++|+||+++++.+.. ....|+|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEEE
Confidence 4889999999999999999999999999999998765444455678899999999999999999999877 56899999
Q ss_pred eeccCChhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC-cEEEeecccccccCCCCCC
Q 011041 199 KYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 199 e~~~~~l~~~~~~--~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~-~vkL~DFG~a~~~~~~~~~ 275 (495)
||+.+..+..... ....+++..+..++.||+.||.|||+++|+|+||||+||++++++ .+||+|||.+....... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-E 157 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-c
Confidence 9998755544432 233589999999999999999999999999999999999999886 46999999998765332 2
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+....
T Consensus 158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------ 218 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY------------------ 218 (257)
T ss_pred cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc------------------
Confidence 2233468999999998765 457899999999999999999999998776655554433210
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.......++.++.++|.+||..||++|||+.++++||||
T Consensus 219 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 ----------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 111123467789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=335.32 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=205.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCC-----eEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTG-----QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
.++|++++.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.++..++||||+++++++.+ .
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~ 80 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--E 80 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC--C
Confidence 357999999999999999999876555 789999986443 34455678899999999999999999999876 4
Q ss_pred ceeEEEEeeccCChhhhhhCCC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC
Q 011041 192 CSLYLVFKYMEHDLAGLAASPT----------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE 255 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~----------------~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~ 255 (495)
...|++|||+.++.+..++... ..+++..+..++.||+.||.|||++||+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 6789999999876554433211 458899999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 011041 256 GILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKI 333 (495)
Q Consensus 256 ~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i 333 (495)
+.+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999976532221 12234466889999998875 468999999999999999998 99999988877766655
Q ss_pred HHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 334 FKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 334 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.... .......+|+++.+|+..||+.||.+|||+.+++++
T Consensus 240 ~~~~----------------------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSRQ----------------------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCC----------------------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3311 011123578889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=333.70 Aligned_cols=256 Identities=27% Similarity=0.463 Sum_probs=212.2
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
..|+.++.||.|+||.||+|.+..++..||||++..... ......+.+|+.+++.++|+||+++++++.+ +...|+|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEE
Confidence 468888999999999999999999999999999875432 3445778899999999999999999999987 5689999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
|||++++.+..+... ..+++.++..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-ccc
Confidence 999998766655543 468999999999999999999999999999999999999999999999999997664332 222
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (495)
....++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+.......+... .+
T Consensus 159 ~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~~----------------- 218 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN--NP----------------- 218 (277)
T ss_pred ccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC--CC-----------------
Confidence 34467889999998875 45789999999999999999999999877655444332110 00
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......++..+.+||.+||..||.+||++.++++|+||...
T Consensus 219 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 219 ---------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ---------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 01122456778899999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=333.64 Aligned_cols=255 Identities=32% Similarity=0.504 Sum_probs=213.2
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCceeE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~ 195 (495)
++|.+.+.||+|+||.||+|++..+|+.||+|++.+... .......+.+|+.+++.+. |+||+++++++.+ ...+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence 479999999999999999999999999999999876433 3344567889999999998 9999999999877 56799
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC-
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK- 274 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~- 274 (495)
+||||+.++.+.........+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999997655555555555799999999999999999999999999999999999999999999999999986643321
Q ss_pred ------------------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 011041 275 ------------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336 (495)
Q Consensus 275 ------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 336 (495)
.......++..|++||++.+ ..++.++|||||||++++|++|..||...+....+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 12233467899999998765 45788999999999999999999999988766665555421
Q ss_pred cCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCH----HHHHhCCCC
Q 011041 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA----TAALRSEFF 404 (495)
Q Consensus 337 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta----~elL~hp~f 404 (495)
.. .....+++.+.+||.+||+.||.+|||+ .++|+||||
T Consensus 238 ~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 EY-----------------------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CC-----------------------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 11 1123457788999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=333.76 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=207.6
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|++.+.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+.+++.++||||+++++++.. ....|++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEE
Confidence 468889999999999999999999999999999876543 3455678899999999999999999999887 4789999
Q ss_pred EeeccCChhhhhhC-CCCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 198 FKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 198 ~e~~~~~l~~~~~~-~~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+||+.+..+..+.. ....+++..+..++.||+.+|.|||+ .|++|+||||+||+++.++.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 99999654444443 33689999999999999999999999 9999999999999999999999999999876543221
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT-----EVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~-----~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+ ..+.+..+.. ....
T Consensus 157 --~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~-------- 222 (265)
T cd06605 157 --KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPPP-------- 222 (265)
T ss_pred --hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCCC--------
Confidence 12578889999998876 478999999999999999999999997642 2222222211 0000
Q ss_pred CCCccCCCCcccccccccccC-CCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 351 PHATIFKPQQSYKRCIAETFK-DFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.... .+++++.+||..||..||.+|||+.+++.||||+.
T Consensus 223 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 223 -----------------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred -----------------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 0011 16778999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=333.84 Aligned_cols=257 Identities=25% Similarity=0.473 Sum_probs=210.6
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC---CCCeeeeeceeeccCCceeE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD---HPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~~~ 195 (495)
.|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.+. ||||+++++++.. ....|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEE
Confidence 5888899999999999999999999999999987543 3344567889999999996 9999999999876 56799
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+||||+.++.+..+.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .
T Consensus 79 lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-S 156 (277)
T ss_pred EEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-c
Confidence 999999887665555443 78999999999999999999999999999999999999999999999999998765443 2
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
......|+..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+.......+... .++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~-------------- 220 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPP-------------- 220 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCC--------------
Confidence 2344578999999998876556789999999999999999999999876544332221110 000
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
. +. ...++.++.+||.+||..||.+|||+.+++.|+||+..
T Consensus 221 -----~----~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 221 -----R----LE--DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred -----C----CC--cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 0 00 01267789999999999999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=354.77 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=210.0
Q ss_pred CCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCce
Q 011041 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 115 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 193 (495)
...+.|.+...+|.|+|+.|-.|.+..+++.+++|++.+.. ....+|+.++... +||||+++++.+.+ ...
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~ 390 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYED--GKE 390 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecC--Cce
Confidence 35688999999999999999999999999999999998652 2234577666655 79999999999988 678
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee-CCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI-DNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl-~~~~~vkL~DFG~a~~~~~~ 272 (495)
+|+|||++.++.+...+.....+. .++..|+++|+.++.|||++|||||||||+|||+ +..|+++|+|||.++.....
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999999987776665554555 8888999999999999999999999999999999 58999999999999866433
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCChhhhhhCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
..+.+-|..|.|||++.. ..|+.++||||||++||+||+|+.||...... +++.+| +.+...
T Consensus 470 ----~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s-------- 532 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFS-------- 532 (612)
T ss_pred ----hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccc--------
Confidence 344567899999999874 78999999999999999999999999876655 443333 222111
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
..+|+++++||..||+.||.+|+++.+++.||||.+++.
T Consensus 533 -------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~t 571 (612)
T KOG0603|consen 533 -------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHPT 571 (612)
T ss_pred -------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcCCC
Confidence 357899999999999999999999999999999966554
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=336.34 Aligned_cols=259 Identities=20% Similarity=0.255 Sum_probs=199.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECC----------------CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCee
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTL----------------TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~----------------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 180 (495)
.++|.+.+.||+|+||.||+|++.. ++..||+|++.... .......+.+|+.+|..++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4689999999999999999997532 34579999987543 344556788999999999999999
Q ss_pred eeeceeeccCCceeEEEEeeccCChhhhhhCC-------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCce
Q 011041 181 KLEGLVTSRMSCSLYLVFKYMEHDLAGLAASP-------------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241 (495)
Q Consensus 181 ~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-------------------~~~l~e~~~~~i~~qil~~L~~LH~~giv 241 (495)
++++++.+ ....|+||||+.++.+..+... ...+++..+..++.||+.||.|||++||+
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 83 RLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred EEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 99999987 4568999999987554433221 12467888999999999999999999999
Q ss_pred eccCCCCCeeeCCCCcEEEeecccccccCCCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh--CC
Q 011041 242 HRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA--EK 318 (495)
Q Consensus 242 HrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt--G~ 318 (495)
||||||+||||+.++.+||+|||++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999765432211 1123345788999998875 568999999999999999986 66
Q ss_pred CCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHH
Q 011041 319 PIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAA 398 (495)
Q Consensus 319 ~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~el 398 (495)
.||.+.+..+.+..+........... .......+|..+.+||.+||..||.+|||+.++
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i 298 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQV---------------------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccc---------------------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 78887776666555433211100000 001123467789999999999999999999999
Q ss_pred Hh
Q 011041 399 LR 400 (495)
Q Consensus 399 L~ 400 (495)
.+
T Consensus 299 ~~ 300 (304)
T cd05096 299 HA 300 (304)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=335.80 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=210.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||+||++.+..+|..||+|++.... .......+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLN--ENNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEec--CCEEEE
Confidence 478999999999999999999999999999999987543 23445678899999999999999999999987 468999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||||+.++.+..+......+++..+..++.||+.+|.|||+ +||+||||||+||+++.++.++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999988777666656679999999999999999999996 699999999999999999999999999986543221
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHHhcCCCChhhhhh
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE--------QLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~--------~~~~i~~~~g~~~~~~~~~ 347 (495)
....+|+..|+|||++.+ ..++.++|||||||++|+|++|..||......+ ....+.........
T Consensus 159 -~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 231 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP----- 231 (284)
T ss_pred -cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC-----
Confidence 124578999999998876 468899999999999999999999998655421 11111000000000
Q ss_pred CCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......++.++.+||.+||..||.+|||+.|+++|+||...
T Consensus 232 -------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 232 -------------------RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred -------------------CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00001266778999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=329.67 Aligned_cols=253 Identities=28% Similarity=0.390 Sum_probs=204.0
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCCC-hHHHHHHHHHHHHH-HhCCCCCeeeeeceeeccCCceeEEEEeec
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILIL-RRLDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
+.||+|+||.||+|.+..+|+.||+|++.+.... ......+..|..++ ..++|+||+++++++.. ...+|+||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 5699999999999999999999999998765432 22233344555544 44589999999999987 56899999999
Q ss_pred cCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcccc
Q 011041 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (495)
Q Consensus 202 ~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 281 (495)
.++.+..+......+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||++..... .....
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~ 154 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFV 154 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCC
Confidence 9877666665556799999999999999999999999999999999999999999999999999875432 13346
Q ss_pred ccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcc
Q 011041 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (495)
Q Consensus 282 gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 361 (495)
+++.|++||.+.+. .++.++|||||||++|+|++|.+||...+.......+........
T Consensus 155 ~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------- 213 (260)
T cd05611 155 GTPDYLAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWP-------------------- 213 (260)
T ss_pred CCcCccChhhhcCC-CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCC--------------------
Confidence 78899999998764 478999999999999999999999998877666655533111100
Q ss_pred cccccccccCCCCCCcHHHHHHhccCCCCCccC---HHHHHhCCCCCCCCC
Q 011041 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQT---ATAALRSEFFTTKPY 409 (495)
Q Consensus 362 ~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t---a~elL~hp~f~~~~~ 409 (495)
......+++++.++|.+||+.||.+||| ++|+|.||||....|
T Consensus 214 -----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 214 -----EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred -----CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 0112346888999999999999999995 579999999987544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=327.69 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=210.6
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCC---CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN---LEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
.+|++.+.||+|+||.||+|++..++..||+|.+.... ........+.+|+.+++.++|+||+++++++.+.....+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999986432 133455688899999999999999999999877555678
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC-
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH- 273 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~- 273 (495)
+++|||+.++.+.........+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 9999999876665555444568999999999999999999999999999999999999999999999999997653211
Q ss_pred -CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 274 -KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 274 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
........++..|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+...++.. .+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~---------- 227 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTK---------- 227 (264)
T ss_pred cCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCCC----------
Confidence 111234568999999998876 4578999999999999999999999987765555444321 1110
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
......+++.+.++|.+||. +|.+|||+.++|.|||.
T Consensus 228 --------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 228 --------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred --------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 01123467789999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=332.03 Aligned_cols=262 Identities=26% Similarity=0.379 Sum_probs=207.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|+..+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+++++.++||||+++++++.......+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 468999999999999999999999999999999875432 2445678899999999999999999999876556679999
Q ss_pred EeeccCChhhhh----hCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 198 FKYMEHDLAGLA----ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 198 ~e~~~~~l~~~~----~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
|||++++.+..+ ......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999987544332 2334568999999999999999999999999999999999999999999999999987553222
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHhcCCCChhhhhhC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE-----VEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~-----~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
.....++..|++||.+.+ ..++.++|||||||++|+|++|..||..... .+....+... ... ....
T Consensus 160 ---~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~- 230 (287)
T cd06621 160 ---AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---PNP-ELKD- 230 (287)
T ss_pred ---cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---Cch-hhcc-
Confidence 123457889999998865 5688999999999999999999999986522 2222222110 000 0000
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.......+++.+.+||.+||..||.+|||+.|+++||||+.
T Consensus 231 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 231 -----------------EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred -----------------CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 00000124567889999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=337.70 Aligned_cols=259 Identities=25% Similarity=0.425 Sum_probs=212.7
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
..|.....||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.. ....|++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv 96 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVL 96 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEE
Confidence 456666789999999999999999999999999875432 234567899999999999999999999877 5679999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
|||+.++.+..+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... ...
T Consensus 97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 174 (297)
T cd06659 97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 174 (297)
T ss_pred EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence 999998766655443 468999999999999999999999999999999999999999999999999987654322 222
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (495)
....|++.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+.+..+... +. .
T Consensus 175 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~-~-------------- 235 (297)
T cd06659 175 KSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PP-P-------------- 235 (297)
T ss_pred cceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CC-C--------------
Confidence 34578999999998876 46899999999999999999999999887776665544221 00 0
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
.......++..+.++|.+||+.||.+||++.++++||||.....
T Consensus 236 --------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 236 --------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred --------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 00112346678899999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=345.95 Aligned_cols=247 Identities=23% Similarity=0.410 Sum_probs=205.7
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
+.+.+++.||+|.||.||+|....+ ..||+|.+....... +.|.+|+++|++|+|+|||++++++... ..+|||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~--~piyIV 279 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQ--EPIYIV 279 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecC--CceEEE
Confidence 5667789999999999999987643 379999998654433 4566999999999999999999999873 469999
Q ss_pred EeeccCC-hhhhhhC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 198 FKYMEHD-LAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 198 ~e~~~~~-l~~~~~~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||||..+ |+..+.. .+..+...+...++.||++|++||+++++|||||-..||||++++.+||+|||+|+....+...
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 9999976 4444443 4668999999999999999999999999999999999999999999999999999965443332
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
.....--..-|.|||.+.. ..++.++|||||||+|+||+| |+.|+.+.+..+.+..+.+..--|
T Consensus 360 ~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp-------------- 424 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP-------------- 424 (468)
T ss_pred ecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC--------------
Confidence 2222222556999999875 568999999999999999998 999999999999999986643222
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHH
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL 399 (495)
....+|+++.+|+..|+..+|++|||.+.+.
T Consensus 425 --------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 425 --------------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred --------------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 2346889999999999999999999998765
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=326.78 Aligned_cols=289 Identities=34% Similarity=0.540 Sum_probs=234.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC---ce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS---CS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---~~ 193 (495)
-.+.+--+.||.|+||+||.++|..+|+.||+|++..-...-...+.+-+|+++|.-++|.|++..+++.....- ..
T Consensus 52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 344555678999999999999999999999999986443344456678899999999999999988776654221 23
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|+++|+|..+|...+.... .++..+++-+++||++||+|||+.||+||||||.|+|++.+..+||||||+++..+...
T Consensus 132 iYV~TELmQSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 132 LYVLTELMQSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHHHhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 78899999998887766654 79999999999999999999999999999999999999999999999999999988877
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC-CC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL-PH 352 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~ 352 (495)
...++..+.|.+|+|||+++|...|+.++||||.|||+.||+..+-+|...++.+++..|..++|+|..+.+....- ..
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 77888889999999999999999999999999999999999999999999999999999999999999876543210 00
Q ss_pred CccC--CCCccccccccc--ccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 353 ATIF--KPQQSYKRCIAE--TFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 353 ~~~~--~~~~~~~~~~~~--~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.-.. ....+....+-. ...+-..+..+++..||..||.+|.+..+++.|+|+..
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 0000 000000000000 00122346788999999999999999999999999864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=368.95 Aligned_cols=149 Identities=26% Similarity=0.394 Sum_probs=133.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|.+++.||+|+||.||+|++..+++.||||++..... .......+.+|+.++..++|+||+++++++.. ...+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEE
Confidence 5789999999999999999999999999999999986543 44556778899999999999999999988876 56899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
|||||+.++.+..++.....+++..++.|+.||+.||.|||.+|||||||||+||||+.++.+||+|||++.
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999876665555555578999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=326.80 Aligned_cols=256 Identities=31% Similarity=0.464 Sum_probs=213.3
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|++.+.||+|++|.||+|++..+++.|++|++...... .....+.+|+.++..++|+||+++++++.. ...+|+|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEE
Confidence 4689999999999999999999999999999998765432 456778899999999999999999999887 5789999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
|||+.++.+..+......+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~ 156 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-Q 156 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-c
Confidence 9999977666665555679999999999999999999999 9999999999999999999999999999987653322 2
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT---EVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~---~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+ ..+....+.. ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~------------- 219 (264)
T cd06623 157 CNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GP------------- 219 (264)
T ss_pred ccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CC-------------
Confidence 234568899999998865 468899999999999999999999998764 2233333221 00
Q ss_pred ccCCCCcccccccccccCC-CCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKD-FPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~-~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
....... ++..+.++|..||..+|.+|||+.++|+||||+.
T Consensus 220 ------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 220 ------------PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred ------------CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 0011123 6788999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=351.94 Aligned_cols=263 Identities=28% Similarity=0.382 Sum_probs=217.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.-|..++.||-|+||.|.+++..+|...||+|.+++... ....+..+..|-.||..-+.+-||+||..|.+ ...+|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD--kdnLYF 706 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYF 706 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc--CCceEE
Confidence 568889999999999999999999999999999987654 66777888899999999999999999988887 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC--
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-- 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~-- 274 (495)
||+|+.|+.+-.++-+.+.|.|..++.|+.++..|+++.|.+|+|||||||+|||||.+|+|||+||||++-+....+
T Consensus 707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 999999765444444455799999999999999999999999999999999999999999999999999965421110
Q ss_pred ---------------------------------------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHH
Q 011041 275 ---------------------------------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315 (495)
Q Consensus 275 ---------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ell 315 (495)
......+||+.|+|||+|.. ..|+.-+|+||.|||||||+
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHHh
Confidence 01134689999999999986 57899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-
Q 011041 316 AEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT- 394 (495)
Q Consensus 316 tG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t- 394 (495)
.|.+||...+..+.-.+|.+ |...- .......+++++.+||.++. .++++|+.
T Consensus 866 ~g~~pf~~~tp~~tq~kv~n---------w~~~l----------------~~~~~~~ls~e~~~li~kLc-~sad~RLGk 919 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVIN---------WRNFL----------------HIPYQGNLSKEALDLIQKLC-CSADSRLGK 919 (1034)
T ss_pred hCCCCccCCCCCcceeeeee---------hhhcc----------------ccccccccCHHHHHHHHHHh-cChhhhhcc
Confidence 99999999888776665543 22200 00112457899999999965 58888865
Q ss_pred --HHHHHhCCCCCCCCC
Q 011041 395 --ATAALRSEFFTTKPY 409 (495)
Q Consensus 395 --a~elL~hp~f~~~~~ 409 (495)
++|+-.||||+...|
T Consensus 920 ng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 920 NGADQVKAHPFFKGIDF 936 (1034)
T ss_pred cchhhhhcCccccccch
Confidence 788999999997655
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=336.29 Aligned_cols=255 Identities=28% Similarity=0.463 Sum_probs=213.4
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
..|...+.||+|+||.||++++..++..||+|++..... ..+....+.+|+.+++.++|+||+++++++.+ +...|+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--EHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCeEEE
Confidence 448889999999999999999999999999999976543 33455678899999999999999999999887 567899
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||+.+++..........+++.++..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus 103 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 103 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred EEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 999999988777665566799999999999999999999999999999999999999999999999999875432
Q ss_pred CccccccCCCCCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 277 MTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
.....|++.|+|||++.. ...++.++|||||||++|+|++|.+||...+.......+.......
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 243 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT-------------- 243 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC--------------
Confidence 234468899999998742 2457889999999999999999999998877666655554321100
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.....+++.+.+||.+||+.||.+|||+.++++|+|+..
T Consensus 244 -------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 244 -------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 001235567899999999999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=335.46 Aligned_cols=255 Identities=26% Similarity=0.448 Sum_probs=209.3
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
+.|+..+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++|+||+++++++.. ....|+|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEE
Confidence 468888999999999999999999999999999875532 3345678899999999999999999999987 5679999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
|||++++.+...... ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhh
Confidence 999998766555543 468999999999999999999999999999999999999999999999999997664322 122
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (495)
....++..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+... .
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~------------------ 217 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--S------------------ 217 (277)
T ss_pred hcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--C------------------
Confidence 33467889999998876 46789999999999999999999999765544433222110 0
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.......++.++.+||.+||..||.+|||+.++|+||||..
T Consensus 218 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 218 --------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred --------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 00111245677899999999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=327.65 Aligned_cols=249 Identities=20% Similarity=0.340 Sum_probs=203.6
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
.+|.+.+.||+|+||.||+|.+..++..||+|++.... .....+.+|+.+++.++|+||+++++++.. +..++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcC--CCCcEEE
Confidence 56999999999999999999999999999999987442 234567889999999999999999999876 5678999
Q ss_pred EeeccCChhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 198 FKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 198 ~e~~~~~l~~~~~~--~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
|||+.++.+..... ....+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 99998765544432 2346899999999999999999999999999999999999999999999999999876533222
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---------------- 223 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---------------- 223 (263)
T ss_pred ccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC----------------
Confidence 1122234667999998865 568899999999999999998 9999998776666555432110
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......+|.++.+||.+||..||++|||+.++++
T Consensus 224 ------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 224 ------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0112356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=349.04 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=198.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCC-----eEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTG-----QIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 190 (495)
.++|++.+.||+|+||.||+|++..+| ..||+|++.... .......+.+|+.+|+.+ +|+|||++++++..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-- 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTH-- 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence 468999999999999999999865443 579999997543 234456788999999999 89999999999877
Q ss_pred CceeEEEEeeccCChhhhhhCC----------------------------------------------------------
Q 011041 191 SCSLYLVFKYMEHDLAGLAASP---------------------------------------------------------- 212 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~---------------------------------------------------------- 212 (495)
...+|+||||+.++.+..+...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 5679999999987654433211
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC-Ccc
Q 011041 213 ------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP-MTS 279 (495)
Q Consensus 213 ------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~-~~~ 279 (495)
...+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||++.......... ...
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1247889999999999999999999999999999999999999999999999997654322111 112
Q ss_pred ccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCC
Q 011041 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (495)
Q Consensus 280 ~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 358 (495)
..+++.|+|||++.+ ..++.++|||||||++|+|++ |++||........+.++......+.
T Consensus 274 ~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~----------------- 335 (374)
T cd05106 274 ARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS----------------- 335 (374)
T ss_pred CCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc-----------------
Confidence 234667999998865 568999999999999999997 9999987655444444332110000
Q ss_pred CcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 359 ~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
....+++++.+||.+||+.||.+|||+.++++
T Consensus 336 ----------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 336 ----------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01235788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=325.39 Aligned_cols=250 Identities=25% Similarity=0.429 Sum_probs=206.2
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+|++.+.||+|+||.||++++..++..||+|.++.... ....+.+.+|+.+++.++|+||+++++++.+ ...+|++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 58899999999999999999999999999999875532 3455678899999999999999999999987 56899999
Q ss_pred eeccCC-hhhhhhC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 199 KYMEHD-LAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 199 e~~~~~-l~~~~~~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||+.++ +...+.. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... ..
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 999875 4444332 34468999999999999999999999999999999999999999999999999997664322 22
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
.....|++.|+|||++.+ ..++.++|+|||||++|+|++|.+||...+.......+......
T Consensus 157 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 218 (255)
T cd08219 157 ACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK----------------- 218 (255)
T ss_pred cccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-----------------
Confidence 234578999999998865 46889999999999999999999999887766555544321100
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.....++..+.+||.+||..||.+|||+.++|.-
T Consensus 219 -----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 -----------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0112356678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=347.51 Aligned_cols=266 Identities=21% Similarity=0.305 Sum_probs=235.6
Q ss_pred CCCCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 113 TPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 113 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
......+++++..||-|+||.|-++........+|+|++++... +....+.+..|-.||...+.|.||+||..|.+ +
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd--~ 492 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD--S 492 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc--c
Confidence 33456788899999999999999998776666799999987655 66777889999999999999999999999877 6
Q ss_pred ceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
.++||.||-|-|+.+..++..++.|.+..++.|+..+++|++|||.+|||+|||||||++++.+|-+||.|||+|+.+..
T Consensus 493 kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 79999999999888878888888999999999999999999999999999999999999999999999999999998875
Q ss_pred CCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
+ ....++||||.|+|||+++. +..+.++|.||||+++||||+|.|||.+.++...+..|++.+.. |
T Consensus 573 g--~KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~-----i------ 638 (732)
T KOG0614|consen 573 G--RKTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK-----I------ 638 (732)
T ss_pred C--CceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh-----h------
Confidence 5 44578899999999999987 45789999999999999999999999999999999999886522 1
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-----HHHHHhCCCCCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEFFTTKPYA 410 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----a~elL~hp~f~~~~~~ 410 (495)
+....++..+.+||+++...+|.+|+. +.++-+|-||.+-.|.
T Consensus 639 ----------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 639 ----------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred ----------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 223457888999999999999999976 8999999999987663
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=372.38 Aligned_cols=263 Identities=30% Similarity=0.480 Sum_probs=207.1
Q ss_pred CCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc-----
Q 011041 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR----- 189 (495)
Q Consensus 115 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 189 (495)
+...+|+.++.||+|+||.||+++++-+|+.||||+|.... .......+.+|+..|.+|+|||||+++..|...
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 45789999999999999999999999999999999998765 566677899999999999999999987622110
Q ss_pred --------------------------------------------------------------------------------
Q 011041 190 -------------------------------------------------------------------------------- 189 (495)
Q Consensus 190 -------------------------------------------------------------------------------- 189 (495)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ------------------------CC--------ceeEEEEeeccCChhhhhhCCCCCC-CHHHHHHHHHHHHHHHHHhh
Q 011041 190 ------------------------MS--------CSLYLVFKYMEHDLAGLAASPTIKF-TQAQVKCYMHQLLSGLEHCH 236 (495)
Q Consensus 190 ------------------------~~--------~~~~lv~e~~~~~l~~~~~~~~~~l-~e~~~~~i~~qil~~L~~LH 236 (495)
.. ..+||-||||+..++..++..+... ....++.+|+||++||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 00 3579999999999999888877554 47788999999999999999
Q ss_pred hCCceeccCCCCCeeeCCCCcEEEeecccccccC-----------------CCCCCCCccccccCCCCCcccccCCC--C
Q 011041 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD-----------------PNHKQPMTSRVVTLWYRPPELLLGAT--D 297 (495)
Q Consensus 237 ~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~-----------------~~~~~~~~~~~gt~~y~aPE~l~~~~--~ 297 (495)
++|||||||||.||||++++.|||+|||+|+... .......++.+||.-|+|||++.+.. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999998721 01112457789999999999997765 6
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCc
Q 011041 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSS 377 (495)
Q Consensus 298 ~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 377 (495)
|+.++|+||||||||||+. ||.. ..+-...+..+- .+ .+|... ..+..--+.-
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~LR-~g--------~iP~~~-------------~f~~~~~~~e 847 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGT--SMERASILTNLR-KG--------SIPEPA-------------DFFDPEHPEE 847 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHhcc-cC--------CCCCCc-------------ccccccchHH
Confidence 9999999999999999995 4543 333333332211 11 111100 0011112445
Q ss_pred HHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 378 LPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 378 ~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
..+|..||+.||.+||||.|+|++.||-
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 6799999999999999999999999874
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=322.03 Aligned_cols=254 Identities=30% Similarity=0.505 Sum_probs=214.9
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+|++.+.||+|++|.||++++..+++.|++|.+............+.+|++++++++|+||+++++++.+ ....|++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEE
Confidence 5889999999999999999999999999999998776555667789999999999999999999999877 56899999
Q ss_pred eeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCc
Q 011041 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278 (495)
Q Consensus 199 e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 278 (495)
||+++..+..+......+++..+..++.||+.+|.|||++||+||||||+||+++.++.++|+|||++........ ...
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 157 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DDA 157 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-ccc
Confidence 9999876666665556899999999999999999999999999999999999999999999999999987754332 223
Q ss_pred cccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCC
Q 011041 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (495)
Q Consensus 279 ~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 358 (495)
...++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...+......++... .
T Consensus 158 ~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~------------------- 215 (254)
T cd06627 158 SVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--D------------------- 215 (254)
T ss_pred ccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--C-------------------
Confidence 4567899999998866 34789999999999999999999999877655544443210 0
Q ss_pred CcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 359 ~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.......+++.+.++|.+||..||++|||+.+++.||||
T Consensus 216 -------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 216 -------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred -------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 001123457788999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=323.20 Aligned_cols=254 Identities=28% Similarity=0.478 Sum_probs=213.5
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+|.+.+.||.|+||.||++.+..++..|++|++............+.+|+++++.++|+|++++++.+.. ....++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEEE
Confidence 5889999999999999999999999999999998766655667788899999999999999999999877 47899999
Q ss_pred eeccCChhhhhh-CC---CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 199 KYMEHDLAGLAA-SP---TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 199 e~~~~~l~~~~~-~~---~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||++++.+.... .. ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 999975444433 32 3679999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
.......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+.....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 220 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY---------------- 220 (258)
T ss_pred ceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC----------------
Confidence 22334578999999998765 4578999999999999999999999988775555544432110
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
......++..+.++|..||..||.+|||+.++|+||||
T Consensus 221 ------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 221 ------------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 01112467788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=330.23 Aligned_cols=257 Identities=25% Similarity=0.457 Sum_probs=211.7
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
..|...+.||+|++|.||++.+..+++.|++|++.... ......+.+|+.+++.++|+||+++++++.. ....|++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v 94 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVV 94 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEE
Confidence 34666689999999999999999999999999986433 2334567899999999999999999999876 5678999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
+||+.++.+...... ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....... ...
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~ 172 (285)
T cd06648 95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRR 172 (285)
T ss_pred EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-ccc
Confidence 999988766655544 468999999999999999999999999999999999999999999999999887553322 122
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (495)
....|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+....+..+.... +.
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~--~~---------------- 233 (285)
T cd06648 173 KSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL--PP---------------- 233 (285)
T ss_pred ccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC--CC----------------
Confidence 34568999999998876 458899999999999999999999998877766666554321 00
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.......++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 234 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 234 --------KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred --------CCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence 001112366789999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=327.06 Aligned_cols=254 Identities=30% Similarity=0.446 Sum_probs=208.6
Q ss_pred ecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeeccCC
Q 011041 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD 204 (495)
Q Consensus 126 LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~ 204 (495)
||.|+||.||++++..+|+.|++|++..... .......+.+|+.+++.++|+||+++++.+.. ....|++|||+.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCC
Confidence 6899999999999999999999999976543 23456678899999999999999999999876 56799999999876
Q ss_pred hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC-------CCC
Q 011041 205 LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-------QPM 277 (495)
Q Consensus 205 l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~-------~~~ 277 (495)
.+..+......+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++........ ...
T Consensus 79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 5555554444799999999999999999999999999999999999999999999999999876533211 122
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (495)
....++..|++||++.+ ..++.++|||||||++|+|++|..||...+..+....+.... .. |..
T Consensus 159 ~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~---~~~---------- 222 (265)
T cd05579 159 KRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK--IE---WPE---------- 222 (265)
T ss_pred cCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--cC---CCc----------
Confidence 34567889999998876 447889999999999999999999998888777666654311 10 000
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCH---HHHHhCCCCCCCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA---TAALRSEFFTTKPY 409 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta---~elL~hp~f~~~~~ 409 (495)
...+++.+.+||.+||+.||.+|||+ .++|+||||+...|
T Consensus 223 ------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 223 ------------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred ------------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 01257888999999999999999999 99999999986543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=341.44 Aligned_cols=278 Identities=23% Similarity=0.352 Sum_probs=204.2
Q ss_pred eeeccc--CceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeec
Q 011041 124 DKIGQG--TYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 124 ~~LG~G--~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
..||+| +||+||+|++..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.. ....|+||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEecc
Confidence 346666 99999999999999999999998766555666889999999999999999999999987 56799999999
Q ss_pred cCChhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC---
Q 011041 202 EHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP--- 276 (495)
Q Consensus 202 ~~~l~~~~~~~--~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~--- 276 (495)
.++.+..+... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 97655544432 2358999999999999999999999999999999999999999999999998654332111000
Q ss_pred ---CccccccCCCCCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 277 ---MTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 277 ---~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.....++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+......+..+....... .|.....+.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 238 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYS---PLDITTFPC 238 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCC---Cccccccch
Confidence 0112346679999998653 347899999999999999999999998876655544443321110 010000000
Q ss_pred Cc-----------------cCCC----CcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 353 AT-----------------IFKP----QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 353 ~~-----------------~~~~----~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.. .... ..............+++.+.+||.+||+.||.+|||+.++|+||||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 00 0000 000000011112345677899999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=350.75 Aligned_cols=254 Identities=24% Similarity=0.391 Sum_probs=216.4
Q ss_pred eeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC--ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL--EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 121 ~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+....||+|+|-+||+|.|..+|-.||.-.++...+ .+...+.|..|+.+|+.|+|||||++|++|.+.....+.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 344679999999999999999999999877665544 566678999999999999999999999999987777899999
Q ss_pred eeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--ceeccCCCCCeeeCC-CCcEEEeecccccccCCCCCC
Q 011041 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLIDN-EGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 199 e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~g--ivHrDlKp~NILl~~-~~~vkL~DFG~a~~~~~~~~~ 275 (495)
|+|..|.+..+....+.++...++.|++||+.||.|||++. |||||||.+||||+. .|.|||+|+|||+.....
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--- 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--- 199 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc---
Confidence 99999999888888889999999999999999999999874 999999999999987 589999999999987543
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE-VEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
...+.+|||.|||||++. ..|+..+||||||.+++||+|+..||...+. ..+++++.. |..+.-+ .
T Consensus 200 ~aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S--GiKP~sl-~-------- 266 (632)
T KOG0584|consen 200 HAKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS--GIKPAAL-S-------- 266 (632)
T ss_pred ccceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc--CCCHHHh-h--------
Confidence 235579999999999885 5799999999999999999999999987554 455555543 2222211 0
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
+--.+++++||.+||.. ..+|+|+.|+|.||||...
T Consensus 267 ----------------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 267 ----------------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ----------------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 11247899999999999 9999999999999999975
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=345.10 Aligned_cols=254 Identities=20% Similarity=0.317 Sum_probs=208.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++..++..||+|.||+||+|++.. .||||++..+...++..+.|++|+.+|++-+|.||+-+.|++... . +.|
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p--~-~AI 464 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP--P-LAI 464 (678)
T ss_pred HHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC--c-eee
Confidence 4667888999999999999998764 599999999988889999999999999999999999999999873 2 499
Q ss_pred EEeeccCChhhh-hhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC-CCC
Q 011041 197 VFKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP-NHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~-~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~-~~~ 274 (495)
|+-+|+|..+.. +......|.....+.|++||+.|+.|||.++|||||||..||||.+++.|||+|||++..-.- ...
T Consensus 465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 999999976654 444566799999999999999999999999999999999999999999999999999975321 122
Q ss_pred CCCccccccCCCCCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.......|...|||||++.. ..+|++.+|||||||++|||++|..||...+...++..+=+..+.+.
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd----------- 613 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD----------- 613 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc-----------
Confidence 33344567888999999853 45799999999999999999999999985554444333222111111
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......+.+.++++|+..|+.+++++||+..+||.
T Consensus 614 -------------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 614 -------------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -------------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 23334556779999999999999999999999986
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=328.32 Aligned_cols=255 Identities=27% Similarity=0.462 Sum_probs=211.0
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
+-|++++.||.|+||.||+|.+..++..||||++..... ......+.+|+.++..++||||+++++++.. +...|+|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEEEE
Confidence 457888999999999999999999999999999865432 3445678899999999999999999999987 5679999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
|||+.++.+..+... ..+++..+..++.||+.+|.|||++|++|+||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence 999998766655543 368999999999999999999999999999999999999999999999999987654322 122
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (495)
....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...+.......+... .+
T Consensus 159 ~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~----------------- 218 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--NP----------------- 218 (277)
T ss_pred ccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--CC-----------------
Confidence 34467889999998865 46788999999999999999999999876655544443211 00
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
......++.++.++|.+||..||.+||++.++++||||..
T Consensus 219 ---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 219 ---------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred ---------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 0112346778899999999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=328.13 Aligned_cols=248 Identities=23% Similarity=0.348 Sum_probs=195.6
Q ss_pred CCeeeeeee--cccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCcee
Q 011041 118 DTFEKLDKI--GQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 118 ~~y~~~~~L--G~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 194 (495)
+.|++.+.+ |+|+||.||+++++.++..+|+|.+....... .|+.+...+ +|+||+++++.+.. ...+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~--~~~~ 84 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTT--LKGH 84 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEec--CCee
Confidence 466676665 99999999999999999999999987543221 123233322 79999999999987 4579
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC-cEEEeecccccccCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNH 273 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~-~vkL~DFG~a~~~~~~~ 273 (495)
|+||||+.++.+..+......+++..+..++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++......
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 99999998765555544445899999999999999999999999999999999999999998 9999999998765422
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCChhhhhhCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ-LHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||......+. ...+.... ..
T Consensus 164 ----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~------------ 225 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QK------------ 225 (267)
T ss_pred ----ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cc------------
Confidence 23467899999999876 5688999999999999999999999986544332 11111110 00
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-HHHHHhCCCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-ATAALRSEFFTT 406 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-a~elL~hp~f~~ 406 (495)
.....+.+++.+.+||.+||+.||.+|++ .+++|+||||.+
T Consensus 226 -------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 226 -------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred -------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 01122357888999999999999999997 599999999963
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=328.92 Aligned_cols=261 Identities=18% Similarity=0.258 Sum_probs=204.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECC-----CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTL-----TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
.++|++.+.||+|+||.||+|.++. .+..||+|.+..... ......+.+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSK--G 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--C
Confidence 4789999999999999999997652 355899998865432 2334457789999999999999999999876 4
Q ss_pred ceeEEEEeeccCChhhhhhCC----------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEe
Q 011041 192 CSLYLVFKYMEHDLAGLAASP----------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIA 261 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~----------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~ 261 (495)
...|+||||+.++.+...... ...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 578999999987655544321 1235677889999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 011041 262 DFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGS 339 (495)
Q Consensus 262 DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~ 339 (495)
|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+....+.... .
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-~ 239 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG-Y 239 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C
Confidence 9999875532211 11122345678999998875 468999999999999999998 789998877766555443210 0
Q ss_pred CChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh------CCCCCCCCC
Q 011041 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR------SEFFTTKPY 409 (495)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~------hp~f~~~~~ 409 (495)
......+++.+.+||.+||+.||.+|||+.++++ ||||....|
T Consensus 240 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 240 ---------------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred ---------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 0011235678999999999999999999999987 999987544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=360.74 Aligned_cols=252 Identities=23% Similarity=0.384 Sum_probs=201.3
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeec-eeecc---C-C
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEG-LVTSR---M-S 191 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~-~~~~~---~-~ 191 (495)
.++++.+.|.+|||+.||+|++...|..||||++-.. +....+.+.+||.+|+.|. |+|||.+++ ..... . .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 5688899999999999999999998899999998754 5778889999999999996 999999999 33221 1 2
Q ss_pred ceeEEEEeecc-CChhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCC--ceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 192 CSLYLVFKYME-HDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 192 ~~~~lv~e~~~-~~l~~~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~g--ivHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
..++|.||||. |+|.+.+..+ ...|+|.++..||+|+++||.+||... |||||||-|||||+.+|+.||||||.|+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 45789999999 5777766532 234999999999999999999999887 9999999999999999999999999997
Q ss_pred ccCCCCCCCC--------ccccccCCCCCcccc--cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 011041 268 FFDPNHKQPM--------TSRVVTLWYRPPELL--LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLC 337 (495)
Q Consensus 268 ~~~~~~~~~~--------~~~~gt~~y~aPE~l--~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 337 (495)
..-..-.... -...-|+.|+|||++ .+....+.++|||+|||+||.|++...||.+.....++.--+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y--- 271 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNY--- 271 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccc---
Confidence 4321110000 012349999999997 234678999999999999999999999998765443322211
Q ss_pred CCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCC
Q 011041 338 GSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402 (495)
Q Consensus 338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp 402 (495)
.++ .++.++..+.+||+.||+.||.+||++.|++.+-
T Consensus 272 -~~P---------------------------~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 272 -SFP---------------------------PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred -cCC---------------------------CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 111 1234677899999999999999999999999743
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=331.62 Aligned_cols=264 Identities=24% Similarity=0.397 Sum_probs=209.8
Q ss_pred CeeeeeeecccCceEEEEEEEC---CCCeEEEeEEEecCCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCc
Q 011041 119 TFEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNL--EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~---~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 192 (495)
.|++.+.||.|+||.||+|++. .+|..||+|++..... .....+.+.+|+.+++.+ +|+||+.+++++.. +.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 4889999999999999999875 4789999999875432 223345678899999999 69999999999877 56
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|+||||+.++.+...+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 79999999998766655555567899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCccccccCCCCCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
.........|+..|+|||.+.+. ..++.++|||||||++|+|++|..||...+.......+...+....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 228 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE---------- 228 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC----------
Confidence 33333455789999999988643 3467899999999999999999999975443322222222110000
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPY 409 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~ 409 (495)
......+++.+.+||.+||..||.+|+ ++.+++.||||+...|
T Consensus 229 ---------------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 229 ---------------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred ---------------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 001134667789999999999999997 8999999999987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=319.04 Aligned_cols=258 Identities=29% Similarity=0.496 Sum_probs=212.7
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+|.+.+.||+|++|.||+|.+..++..|++|++............+.+|+.++++++|+||+++++.+.......+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 48889999999999999999999999999999987665556678899999999999999999999998874236899999
Q ss_pred eeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC-CC
Q 011041 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ-PM 277 (495)
Q Consensus 199 e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~ 277 (495)
||+.++.+..+......+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 99977666655555558999999999999999999999999999999999999999999999999999877544321 12
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE-VEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
....++..|++||.+.+ ..++.++|||||||++|+|++|..||..... ......+.. ...
T Consensus 161 ~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~----------------- 221 (260)
T cd06606 161 GSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-SGE----------------- 221 (260)
T ss_pred cCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-cCC-----------------
Confidence 34568899999998865 4478999999999999999999999987662 222211110 000
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.......++..+.+||.+||..||.+||++.++|+||||
T Consensus 222 ---------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 222 ---------PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ---------CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 111223457889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=324.02 Aligned_cols=254 Identities=25% Similarity=0.397 Sum_probs=199.8
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
.+.....||+|+||.||+|++..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++.. ....|+||
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 84 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGFFKIFM 84 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCEEEEEE
Confidence 3344468999999999999999999999999887543 3445678899999999999999999999877 56899999
Q ss_pred eeccCChhhhhhC-CCCCC--CHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC-CCcEEEeecccccccCCCCC
Q 011041 199 KYMEHDLAGLAAS-PTIKF--TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 199 e~~~~~l~~~~~~-~~~~l--~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~-~~~vkL~DFG~a~~~~~~~~ 274 (495)
||+.++.+..... ....+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~- 163 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN- 163 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC-
Confidence 9998765554443 33345 88899999999999999999999999999999999986 6799999999987654322
Q ss_pred CCCccccccCCCCCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCChhhhhhCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ-LHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.......|++.|+|||++.+. ..++.++|||||||++|+|++|.+||........ ...+ .....
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~-~~~~~------------- 229 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-GMFKI------------- 229 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-hhhcc-------------
Confidence 222344678999999987543 3478999999999999999999999975432211 1111 00000
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.......+++++.+||.+||..||.+|||+.+++.||||
T Consensus 230 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 230 -------------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -------------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 011123466788999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=322.75 Aligned_cols=248 Identities=20% Similarity=0.314 Sum_probs=200.7
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|++.+.||+|+||.||++..+. +..+|+|.+...... ...+.+|+.+|+.++||||+++++++.. ...+|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEE
Confidence 579999999999999999998754 567999988654332 3457789999999999999999999877 5679999
Q ss_pred EeeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 198 FKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 198 ~e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
|||+.++.+.... .....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999866544443 334568999999999999999999999999999999999999999999999999987653322222
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+.+..+.......
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~--------------- 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY--------------- 221 (256)
T ss_pred cCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC---------------
Confidence 222344668999998865 468899999999999999999 999999888777777664321000
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+.++.+||.+||..||.+|||+.++++
T Consensus 222 -------------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 222 -------------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred -------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01124567899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=341.12 Aligned_cols=254 Identities=21% Similarity=0.326 Sum_probs=199.6
Q ss_pred CCeeeeeeecccCceEEEEEEEC-----CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCC
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 191 (495)
++|++.+.||+|+||.||+|++. .+++.||+|+++... .......+.+|+.++.++ +|+||+++++++... +
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence 57999999999999999999754 345789999987543 334456677899999999 899999999987653 4
Q ss_pred ceeEEEEeeccCChhhhhhCC-----------------------------------------------------------
Q 011041 192 CSLYLVFKYMEHDLAGLAASP----------------------------------------------------------- 212 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~----------------------------------------------------------- 212 (495)
..++++|||+.++.+..++..
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 578999999998655443321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC-CCccccccCCCCCc
Q 011041 213 --TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPP 289 (495)
Q Consensus 213 --~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aP 289 (495)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...... ......++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 125789999999999999999999999999999999999999999999999999875432211 12233557789999
Q ss_pred ccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCccccccccc
Q 011041 290 ELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAE 368 (495)
Q Consensus 290 E~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (495)
|++.+ ..++.++|||||||+||+|++ |.+||.+....+.+.......-.+ .
T Consensus 245 E~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~ 296 (337)
T cd05054 245 ESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM---------------------------R 296 (337)
T ss_pred HHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC---------------------------C
Confidence 98876 568999999999999999998 999998765444443332211000 0
Q ss_pred ccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 369 TFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 369 ~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
....+++++.+++.+||+.+|++||++.++++|
T Consensus 297 ~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112356778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=381.56 Aligned_cols=259 Identities=27% Similarity=0.457 Sum_probs=219.7
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
-+|+...+||.|.||.||.|.+..+|...|+|.|............+.+|..+|..|+|||||+++|+-.++ ..+||.
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR--ekv~IF 1312 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR--EKVYIF 1312 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH--HHHHHH
Confidence 467778899999999999999999999999999987655556667788999999999999999999998774 468999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC---
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK--- 274 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~--- 274 (495)
||||+++.+..+...+...+|...+.|..|++.||.|||++|||||||||+||||+.+|.+|++|||.|..+.....
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 99999999988888887889999999999999999999999999999999999999999999999999987765421
Q ss_pred CCCccccccCCCCCcccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGAT--DYGVGVDLWSAGCILAELLAEKPIMPGRT-EVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
......+||+.|||||++.+.. ..+.+.|||||||++.||+||+.||..-+ +..++.++-- |..+
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~--gh~P---------- 1460 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA--GHKP---------- 1460 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc--cCCC----------
Confidence 2234678999999999997743 45678999999999999999999998644 4444444321 1111
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.....++++..|||..||..||.+|+++.|+|+|.|-+.
T Consensus 1461 ----------------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1461 ----------------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred ----------------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 112348899999999999999999999999999998764
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=325.40 Aligned_cols=253 Identities=19% Similarity=0.256 Sum_probs=201.7
Q ss_pred eeeeeeecccCceEEEEEEECC---CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC----Cc
Q 011041 120 FEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~ 192 (495)
|++++.||+|+||.||+|.+.. ++..||+|.+............+.+|+.+++.++|+||+++++++.... ..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5778999999999999998764 3478999999876555566678899999999999999999999875522 13
Q ss_pred eeEEEEeeccCChhhhhh------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccc
Q 011041 193 SLYLVFKYMEHDLAGLAA------SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~------~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a 266 (495)
..+++|||+.++.+.... .....+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 479999999976554333 12246899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhh
Q 011041 267 SFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEY 344 (495)
Q Consensus 267 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (495)
......... ......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+.... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~---- 233 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--R---- 233 (273)
T ss_pred eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--C----
Confidence 865433211 1112234678999998765 568999999999999999999 999998877766655543211 0
Q ss_pred hhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
......++.++.+||.+||+.||.+|||+.+++++
T Consensus 234 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 234 ----------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ----------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123467789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=333.71 Aligned_cols=256 Identities=27% Similarity=0.473 Sum_probs=212.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
...|+..+.||+|+||.||+|+++.++..||+|.+..... .......+.+|+.+++.++|+||+++++++.. ....|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 91 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAW 91 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCeeE
Confidence 3568888999999999999999999999999999875433 33445667789999999999999999999887 46789
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+||||+.+++...+......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 92 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 99999998877766655667899999999999999999999999999999999999999999999999998765432
Q ss_pred CCccccccCCCCCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 276 PMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
....+++.|+|||++.+ ...++.++|||||||++|+|++|..||...+..+....+..... +
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~------------- 232 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-P------------- 232 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-C-------------
Confidence 34467889999998753 24578899999999999999999999987665554444322100 0
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
......++..+.+||.+||..+|.+||++.+++.||||..
T Consensus 233 -------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 233 -------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred -------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 0001246677899999999999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=344.81 Aligned_cols=254 Identities=19% Similarity=0.278 Sum_probs=197.9
Q ss_pred CCCeeeeeeecccCceEEEEEEE-----CCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 190 (495)
.++|++.+.||+|+||.||+|++ ..++..||||++.... .....+.+.+|+.+|..+ +||||+++++++..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-- 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTV-- 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--
Confidence 35799999999999999999974 3567789999986543 233446788999999999 89999999999977
Q ss_pred CceeEEEEeeccCChhhhhh-CC---------------------------------------------------------
Q 011041 191 SCSLYLVFKYMEHDLAGLAA-SP--------------------------------------------------------- 212 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~-~~--------------------------------------------------------- 212 (495)
....|+||||+.++.+.... ..
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 56799999999875443322 11
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 213 -----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 213 -----------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788899999999999999999999999999999999999999999999999866433221
Q ss_pred C-CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 276 P-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 276 ~-~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
. .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+.++......+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------- 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM------------- 336 (375)
T ss_pred cccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC-------------
Confidence 1 112334667999999876 568999999999999999998 899998765544443332211000
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
......+.++.+||..||..||.+|||+.++++.
T Consensus 337 --------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 337 --------------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0012245678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=328.87 Aligned_cols=252 Identities=22% Similarity=0.327 Sum_probs=204.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECC-----CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTL-----TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
.++|.+.+.||+|+||.||+|++.. ++..||+|.+.... ..+....+.+|+++|+.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTE--G 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEec--C
Confidence 4679999999999999999998753 46789999987543 33345788899999999999999999999987 4
Q ss_pred ceeEEEEeeccCChhhhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCc
Q 011041 192 CSLYLVFKYMEHDLAGLAASP--------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI 257 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~--------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~ 257 (495)
...|+||||+.++.+..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 679999999987665544322 235889999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 011041 258 LTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFK 335 (495)
Q Consensus 258 vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~ 335 (495)
+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999975432211 11223355788999998876 568999999999999999998 9999988877766655542
Q ss_pred hcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 336 LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 336 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.. . ......++..+.+||.+||..||.+|||+.|+++
T Consensus 240 ~~--~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GR--L--------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CC--c--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 11 0 0112346778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=335.07 Aligned_cols=272 Identities=21% Similarity=0.298 Sum_probs=199.8
Q ss_pred CceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeeccCChhhhh
Q 011041 130 TYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLA 209 (495)
Q Consensus 130 ~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~ 209 (495)
++|.||.+++..+++.||||++............+.+|+.+++.++|+||+++++++.. ....|++|||+.++.+..+
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEeccCCCCHHHH
Confidence 44556666667799999999998765566677889999999999999999999999987 5678999999997766554
Q ss_pred hCC--CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC------CCCcccc
Q 011041 210 ASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK------QPMTSRV 281 (495)
Q Consensus 210 ~~~--~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~------~~~~~~~ 281 (495)
... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||.+........ .......
T Consensus 90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccc
Confidence 432 34689999999999999999999999999999999999999999999999999875532211 1123345
Q ss_pred ccCCCCCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc-----
Q 011041 282 VTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI----- 355 (495)
Q Consensus 282 gt~~y~aPE~l~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~----- 355 (495)
++..|+|||++.+. ..|+.++|||||||++|+|++|.+||........+..... +.... .+.....+....
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~ 246 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPC-LLDKSTYPLYEDSMSQS 246 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCcc-ccccCchhhhcCCcCcc
Confidence 67889999998653 3588999999999999999999999987665443322222 11110 000000000000
Q ss_pred ---CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 356 ---FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 356 ---~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.................++.++.+||..||.+||++|||+.++|+||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 000000000111112234567889999999999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=323.73 Aligned_cols=252 Identities=29% Similarity=0.465 Sum_probs=203.8
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|++.+.||+|+||.||+|++..+++.||||.+..... .......+.+|+.+++.++||||+++++++.. ....|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeEEE
Confidence 579999999999999999999999999999998875432 45556678899999999999999999999887 467999
Q ss_pred EEeeccCChhhhhh----CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 197 VFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 197 v~e~~~~~l~~~~~----~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
+|||+.++.+..+. .....+++..+..++.||+.||.|||++||+|+||||+||||+.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999976554333 23445899999999999999999999999999999999999999999999999998876432
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCChhhhhhCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE--VEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
. .......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||..... .+....+ ...+.++.
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~-------- 228 (267)
T cd08228 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQCDYPPL-------- 228 (267)
T ss_pred h-HHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-hcCCCCCC--------
Confidence 2 12234568899999998876 4578999999999999999999999975432 2222222 21111110
Q ss_pred CCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
....++..+.+||.+||..||.+||++.++|+
T Consensus 229 ------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 229 ------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred ------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 01235677899999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=325.65 Aligned_cols=284 Identities=26% Similarity=0.393 Sum_probs=224.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-----C---CCeeeeeceeec
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-----H---PNVVKLEGLVTS 188 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-----H---pnIv~l~~~~~~ 188 (495)
.++|.+.++||.|.|++||+|.|..+.+.||+|+++.. ....+....||++|++++ | .+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 37899999999999999999999999999999998743 344556678999999982 2 479999999965
Q ss_pred --cCCceeEEEEeeccCChhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHhh-hCCceeccCCCCCeeeC-----------
Q 011041 189 --RMSCSLYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCH-NQHVLHRDIKGSNLLID----------- 253 (495)
Q Consensus 189 --~~~~~~~lv~e~~~~~l~~~~~~~-~~~l~e~~~~~i~~qil~~L~~LH-~~givHrDlKp~NILl~----------- 253 (495)
..+.+++||||+++..|+.++... ...++...++.|++|||.||.||| +.||||-||||||||+.
T Consensus 154 sGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred cCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhh
Confidence 345789999999999999988754 456999999999999999999999 57999999999999982
Q ss_pred --------------------------------------------------------------------------------
Q 011041 254 -------------------------------------------------------------------------------- 253 (495)
Q Consensus 254 -------------------------------------------------------------------------------- 253 (495)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred -----------------------CC----------------------------------------------------CcE
Q 011041 254 -----------------------NE----------------------------------------------------GIL 258 (495)
Q Consensus 254 -----------------------~~----------------------------------------------------~~v 258 (495)
.. -.|
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 00 016
Q ss_pred EEeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC------CChHHHHHH
Q 011041 259 TIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG------RTEVEQLHK 332 (495)
Q Consensus 259 kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~------~~~~~~~~~ 332 (495)
||+|||-|+.+. ..++.-+.|..|+||||++| ..|+..+||||++|++|||+||-.+|.. ..+++.+..
T Consensus 394 KIaDlGNACW~~----khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~ 468 (590)
T KOG1290|consen 394 KIADLGNACWVH----KHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL 468 (590)
T ss_pred EEeeccchhhhh----hhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence 788888887654 34566678999999999998 4699999999999999999999999974 347889999
Q ss_pred HHHhcCCCChhhhhhCC-----------CCCCccCCCCcccccccccccCCCC----CCcHHHHHHhccCCCCCccCHHH
Q 011041 333 IFKLCGSPSEEYWKKSK-----------LPHATIFKPQQSYKRCIAETFKDFP----PSSLPLIETLLAIDPAERQTATA 397 (495)
Q Consensus 333 i~~~~g~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~s----~~~~~Li~~~L~~dP~~R~ta~e 397 (495)
|+.++|..+.......+ |.+....++-.-+. .+.+ -..+| .++.+||.-||+.+|++|+||.+
T Consensus 469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~-VL~e-KY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYE-VLIE-KYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHH-HHHH-HhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 99999988765433222 22222222222111 1111 12233 35778999999999999999999
Q ss_pred HHhCCCCCCCCCC
Q 011041 398 ALRSEFFTTKPYA 410 (495)
Q Consensus 398 lL~hp~f~~~~~~ 410 (495)
+|+|||+...+.+
T Consensus 547 cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 547 CLKHPWLNPVAGP 559 (590)
T ss_pred HhcCccccCCCCC
Confidence 9999999976554
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=324.34 Aligned_cols=253 Identities=18% Similarity=0.252 Sum_probs=199.5
Q ss_pred eeeeeeecccCceEEEEEEECCCCe--EEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc----CCce
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTGQ--IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR----MSCS 193 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----~~~~ 193 (495)
|.+.+.||+|+||.||+|++..++. .||+|.+............+.+|+.+++.++|+||+++++++... ....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999999887775 689999876655566677888999999999999999999876431 1235
Q ss_pred eEEEEeeccCChhhhhh------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 194 LYLVFKYMEHDLAGLAA------SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~------~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
.+++|||+.++.+.... .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 78999999875444322 123358999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 011041 268 FFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345 (495)
Q Consensus 268 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (495)
.+...... ......+++.|++||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~----- 232 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN--R----- 232 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--C-----
Confidence 76432211 1122245678999998875 568999999999999999999 899998877666555443210 0
Q ss_pred hhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
......++..+.+||.+||..||.+|||+.+++++
T Consensus 233 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 ---------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00113466778999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=323.00 Aligned_cols=249 Identities=21% Similarity=0.340 Sum_probs=202.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|+++++||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCcEE
Confidence 478999999999999999999865 55679999876433 234678899999999999999999998876 567899
Q ss_pred EEeeccCChhhhhh-C-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAGLAA-S-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~-~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
+|||+.++.+..+. . ....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999865444333 2 345689999999999999999999999999999999999999999999999999987653322
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-------------- 223 (261)
T ss_pred eccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 22233345778999998865 567899999999999999998 99999988777766665432110
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....++.++.+||.+||..||++|||++++++
T Consensus 224 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 224 --------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 112346778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=320.93 Aligned_cols=252 Identities=26% Similarity=0.428 Sum_probs=210.9
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+|++.+.||+|+||.||++++..+++.|++|.+............+.+|+.+++.++|+||+++++++.+ ....|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEEe
Confidence 4889999999999999999999999999999998765555566777889999999999999999999887 47899999
Q ss_pred eeccCChhhhhhC----CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 199 KYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 199 e~~~~~l~~~~~~----~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||+.+..+..... ....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 9998765544332 2356899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
......+++.|++||.+.+ ..++.++|+||||+++|+|++|++||...+..+....+.....
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 218 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY---------------- 218 (256)
T ss_pred -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----------------
Confidence 2233568899999999876 5678899999999999999999999988876655444422110
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
......++.++.++|.+||..||.+|||+.++|+||++
T Consensus 219 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 219 ------------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred ------------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 01112456778999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=331.77 Aligned_cols=258 Identities=26% Similarity=0.465 Sum_probs=211.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|.+++.||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLV--GDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeee--CCcEEE
Confidence 478999999999999999999999899999999986443 2234667889999999999999999999877 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
|+||+.++.+..+... ..+++.++..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++........ .
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred EEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 9999988766655543 3588999999999999999999999999999999999999999999999999876644322 2
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
.....+++.|++||.+.+ ..++.++|||||||++|+|++|.+||...+..+.+..+... +.+.
T Consensus 172 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~--------------- 234 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE--------------- 234 (293)
T ss_pred cccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CCCC---------------
Confidence 234568899999998865 46789999999999999999999999877655443322110 0000
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......++..+.+||.+||..||.+||++.+++.|+||...
T Consensus 235 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 235 ----------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred ----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 00112356678899999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=326.68 Aligned_cols=253 Identities=20% Similarity=0.334 Sum_probs=202.9
Q ss_pred CCCeeeeeeecccCceEEEEEEEC----CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
.++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 80 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ--EQ 80 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CC
Confidence 468999999999999999999853 456789999987543 33445678899999999999999999999877 45
Q ss_pred eeEEEEeeccCChhhhhhC-C----------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC
Q 011041 193 SLYLVFKYMEHDLAGLAAS-P----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE 255 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~-~----------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~ 255 (495)
..|+||||+.++.+..+.. . ...+++.++..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 7899999998754443331 1 2247889999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 011041 256 GILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKI 333 (495)
Q Consensus 256 ~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i 333 (495)
+.+||+|||++........ .......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999976543221 11233345778999998876 468999999999999999998 99999887776665555
Q ss_pred HHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 334 FKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 334 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.... . ......+++.+.+||..||+.||.+||++.+++++
T Consensus 240 ~~~~-~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 RKRQ-L---------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcCC-c---------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 3211 0 01123467788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=320.84 Aligned_cols=245 Identities=22% Similarity=0.343 Sum_probs=195.9
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeeccC
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH 203 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~ 203 (495)
+.||+|+||.||+|++..+++.||+|.+... ...+....+.+|+.+++.++||||+++++++.. ...+|+||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccC
Confidence 3699999999999999999999999987643 344556778899999999999999999999877 4679999999987
Q ss_pred Chhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC-cccc
Q 011041 204 DLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM-TSRV 281 (495)
Q Consensus 204 ~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~-~~~~ 281 (495)
+.+..+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........... ....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 6555444 3445689999999999999999999999999999999999999999999999999876542211110 1112
Q ss_pred ccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCc
Q 011041 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQ 360 (495)
Q Consensus 282 gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 360 (495)
.+..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+.......+......
T Consensus 158 ~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~--------------------- 215 (252)
T cd05084 158 IPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL--------------------- 215 (252)
T ss_pred CceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---------------------
Confidence 2456999998865 458899999999999999997 89999876665544444321000
Q ss_pred ccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 361 SYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 361 ~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....++..+.+||.+||..||.+|||+.++++
T Consensus 216 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 216 -------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011235678899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=321.88 Aligned_cols=250 Identities=20% Similarity=0.300 Sum_probs=200.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|.+++.||+|+||.||++.+.. +..||+|.+...... ...+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 76 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYI 76 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEE
Confidence 3579999999999999999998654 446999998754432 3457889999999999999999999876 456899
Q ss_pred EEeeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+|||+.++.+..+. .....+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.........
T Consensus 77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999876554443 33447899999999999999999999999999999999999999999999999998765432211
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
......++..|++||++.+ ..++.++|||||||++|+|++ |..||...+..+....+......+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 221 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY-------------- 221 (256)
T ss_pred ecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC--------------
Confidence 1122335677999998865 458899999999999999998 999998877766666554321100
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.....+..+.+||.+||..||.+|||+.+++.+
T Consensus 222 --------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 222 --------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred --------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 012246788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=316.07 Aligned_cols=252 Identities=30% Similarity=0.492 Sum_probs=208.3
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+|.+.+.||+|++|.||++.+..++..|++|++..... .....+.+|+.+++.++|+||+++++++.. ....++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEE
Confidence 58889999999999999999998999999999976543 355678899999999999999999999887 46799999
Q ss_pred eeccCChhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 199 KYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 199 e~~~~~l~~~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
||+++..+...... ...+++..+..++.||+.+|.|||++|++||||+|+||+++.++.++|+|||++........ .
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 99996655554433 35799999999999999999999999999999999999999999999999999987654321 3
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (495)
....++..|++||.+.+ ..++.++|||||||++|+|++|.+||...+.......+... .....
T Consensus 155 ~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~-------------- 217 (253)
T cd05122 155 NTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN--GPPGL-------------- 217 (253)
T ss_pred cceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc--CCCCc--------------
Confidence 45578899999998876 45788999999999999999999999887655544443221 00000
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~ 403 (495)
.....++..+.++|.+||..||.+|||+.++|+|||
T Consensus 218 ----------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 218 ----------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ----------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 000113677899999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=327.02 Aligned_cols=251 Identities=21% Similarity=0.315 Sum_probs=202.4
Q ss_pred CCCeeeeeeecccCceEEEEEEEC-----CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
.++|.+.+.||+|+||.||++.+. .++..||+|.+... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--G 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence 367999999999999999999853 35567999988643 24455678899999999999999999999876 5
Q ss_pred ceeEEEEeeccCChhhhhhCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcE
Q 011041 192 CSLYLVFKYMEHDLAGLAASP-------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGIL 258 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~-------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~v 258 (495)
..+|+||||+.++.+..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 679999999987655443321 1248999999999999999999999999999999999999999999
Q ss_pred EEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 011041 259 TIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKL 336 (495)
Q Consensus 259 kL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~ 336 (495)
||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+...
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~ 238 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999976533221 11123345778999998875 568999999999999999998 99999888777766665431
Q ss_pred cCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 337 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
. . ......++.++.+||.+||+.||.+|||+.+++.
T Consensus 239 ~--~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 239 R--V--------------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred C--c--------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1 0 0011246678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=362.51 Aligned_cols=255 Identities=27% Similarity=0.366 Sum_probs=201.0
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|+++++||+|+||.||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEEEE
Confidence 689999999999999999999999999999999975433 23445678899999999999999999999887 567999
Q ss_pred EEeeccCChhhhhhCC-----------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccc
Q 011041 197 VFKYMEHDLAGLAASP-----------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGL 265 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~-----------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~ 265 (495)
||||++++.+..+... ...++...+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 9999998655443321 12356678889999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC-----------------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 011041 266 ASFFDPNHK-----------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE 328 (495)
Q Consensus 266 a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~ 328 (495)
+........ ......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+...
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 986521100 01123579999999999876 568999999999999999999999998755433
Q ss_pred HHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 329 QLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 329 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
..... ....+.. ......+|+.+.+++.+||..||.+|++..+.|.+
T Consensus 239 i~~~~--~i~~P~~------------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 239 ISYRD--VILSPIE------------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhh--hccChhh------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32211 0000000 01123577889999999999999999887666643
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=324.70 Aligned_cols=253 Identities=16% Similarity=0.237 Sum_probs=199.6
Q ss_pred CCCeeeeeeecccCceEEEEEEEC-----CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
.++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~ 81 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 81 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--C
Confidence 468999999999999999999864 345789999986433 22334567899999999999999999999876 5
Q ss_pred ceeEEEEeeccCChhhhhhCC----------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEe
Q 011041 192 CSLYLVFKYMEHDLAGLAASP----------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIA 261 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~----------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~ 261 (495)
...++||||+.++.+..+... ...+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 679999999987655544322 1235778899999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 011041 262 DFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGS 339 (495)
Q Consensus 262 DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~ 339 (495)
|||++......... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-- 238 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG-- 238 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--
Confidence 99998755322111 1122345778999998875 568999999999999999998 789998887766555443211
Q ss_pred CChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
. .......++.+.+||.+||+.||.+|||+.+++++
T Consensus 239 ~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 L--------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred c--------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 00112356778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=331.92 Aligned_cols=252 Identities=20% Similarity=0.311 Sum_probs=199.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeE----EEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQI----VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
..+|++++.||+|+||.||+|++..+|.. ||+|++... ......+.+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---
Confidence 46899999999999999999998766654 899998643 2344556788999999999999999999998752
Q ss_pred eeEEEEeeccCChh-hhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 193 SLYLVFKYMEHDLA-GLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 193 ~~~lv~e~~~~~l~-~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
..++++||+.++.+ ..+......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 47899999987644 44444455689999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCC-CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 272 NHKQP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 272 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
..... .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.. .+......++
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~-------- 231 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLP-------- 231 (316)
T ss_pred CCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCC--------
Confidence 32211 122234678999998875 568999999999999999997 99999887655443 3322111100
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
....++.++.+||..||..||.+|||+.+++.+
T Consensus 232 -------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 232 -------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 012345678899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=327.81 Aligned_cols=256 Identities=26% Similarity=0.441 Sum_probs=209.7
Q ss_pred eeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEe
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFK 199 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e 199 (495)
|+...+||+|+||.||++.+..+|+.||||++.... ......+.+|+.+++.++|+||+++++++.. ....|+|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 97 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVME 97 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEe
Confidence 444578999999999999999999999999986432 3345678899999999999999999999987 568999999
Q ss_pred eccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcc
Q 011041 200 YMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS 279 (495)
Q Consensus 200 ~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 279 (495)
|+.++.+..+... ..+++..+..++.||+.+|.|||++||+||||||+||+++.++.++|+|||++....... .....
T Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~ 175 (292)
T cd06657 98 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS 175 (292)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccc
Confidence 9998766665543 368999999999999999999999999999999999999999999999999987654322 12234
Q ss_pred ccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCC
Q 011041 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQ 359 (495)
Q Consensus 280 ~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 359 (495)
..|++.|++||.+.+ ..++.++|+|||||++|+|++|.+||.+.+..+....+.... +.
T Consensus 176 ~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~--~~------------------ 234 (292)
T cd06657 176 LVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL--PP------------------ 234 (292)
T ss_pred cccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC--Cc------------------
Confidence 568999999998765 567899999999999999999999998877665554442211 00
Q ss_pred cccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 360 QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 360 ~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
.......+++.+.++|.+||..||.+||++.++|.||||....
T Consensus 235 ------~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 235 ------KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ------ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 0011234677889999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=324.18 Aligned_cols=253 Identities=21% Similarity=0.313 Sum_probs=200.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECC-----CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTL-----TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
.+.|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.+ .
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--R 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--C
Confidence 4679999999999999999999887 77899999886443 23344567889999999999999999998876 4
Q ss_pred ceeEEEEeeccCChhhhhhC-CC------CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC---cEEEe
Q 011041 192 CSLYLVFKYMEHDLAGLAAS-PT------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIA 261 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~-~~------~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~---~vkL~ 261 (495)
...|+||||+.++.+..+.. .. ..+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 56899999998755544332 21 2589999999999999999999999999999999999998765 59999
Q ss_pred ecccccccCCCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 011041 262 DFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGS 339 (495)
Q Consensus 262 DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~ 339 (495)
|||++......... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~ 239 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG-R 239 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-c
Confidence 99999865322110 1112233567999999875 468999999999999999997 999999887766655443210 0
Q ss_pred CChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
+ .....++..+.+||.+||..||++|||+.++|+|
T Consensus 240 ~---------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 L---------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0123467788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=320.32 Aligned_cols=244 Identities=21% Similarity=0.297 Sum_probs=198.6
Q ss_pred eecccCceEEEEEEE--CCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeecc
Q 011041 125 KIGQGTYSNVYKARD--TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME 202 (495)
Q Consensus 125 ~LG~G~~g~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~ 202 (495)
.||+|+||.||+|.+ ..++..||+|++..........+.+.+|+.+++.++|+||+++++++.. ...++||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCC
Confidence 589999999999964 4678899999987665555566788899999999999999999998754 35799999999
Q ss_pred CChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC--CCccc
Q 011041 203 HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ--PMTSR 280 (495)
Q Consensus 203 ~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~--~~~~~ 280 (495)
++.+..+......+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++......... .....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 7766555555567999999999999999999999999999999999999999999999999999866433211 11222
Q ss_pred cccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCC
Q 011041 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQ 359 (495)
Q Consensus 281 ~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 359 (495)
.+++.|+|||.+.. ..++.++|||||||++|||++ |.+||.+.+..+....+.+... +
T Consensus 159 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~------------------- 217 (257)
T cd05116 159 KWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-M------------------- 217 (257)
T ss_pred CCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-C-------------------
Confidence 34578999998764 568889999999999999998 9999988777766665532110 0
Q ss_pred cccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 360 QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 360 ~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+++++.+||..||+.||.+||++.++..
T Consensus 218 --------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 218 --------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred --------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 112346788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=319.01 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=200.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||+|.+. ++..||+|.+...... ...+.+|+.++++++|+||+++++++.. ....|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEec--CCCeee
Confidence 367999999999999999999865 4568999998754432 3457789999999999999999999877 567899
Q ss_pred EEeeccCChhhhhh-CC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAGLAA-SP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~-~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
+|||+.++.+..+. .. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999665444443 32 34689999999999999999999999999999999999999999999999999987653221
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
........+..|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+....+..+......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM-------------- 223 (261)
T ss_pred cccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 11112223457999998865 568899999999999999999 99999988777666655331100
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....++..+.+||.+||+.||.+||++.++++
T Consensus 224 --------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 224 --------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred --------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 011245678899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=327.04 Aligned_cols=260 Identities=23% Similarity=0.359 Sum_probs=207.5
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|++.+.||+|+||.||+|.+..+++.||||.+....... ....+.+|+.++..+ +|+||+++++++.+ ...+
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~ 89 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDV 89 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeec--CCeE
Confidence 4588999999999999999999999999999999997654332 334455677766666 59999999999987 5679
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
|++|||+.+.+..+.......+++..+..++.||+.||.|||+ +||+||||+|+||+++.++.+||+|||++..+....
T Consensus 90 ~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 90 FICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred EEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9999999887766665545579999999999999999999997 699999999999999999999999999987654322
Q ss_pred CCCCccccccCCCCCcccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChhhhhhCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGA---TDYGVGVDLWSAGCILAELLAEKPIMPGRTE-VEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
......+++.|+|||.+.+. ..++.++|||||||++|+|++|+.||..... .+.+..+.... .. .+
T Consensus 170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~--~~---- 239 (296)
T cd06618 170 --AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE--PP--SL---- 239 (296)
T ss_pred --cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC--CC--CC----
Confidence 12334578899999998653 2478899999999999999999999976332 33344332211 00 00
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.....++.++.+||.+||..||.+|||+.++++|+||..
T Consensus 240 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 240 ------------------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred ------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 001146678899999999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=321.01 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=199.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.++||+|+||.||+|++..++ .||+|++...... ...+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEE
Confidence 367999999999999999999887654 5999998754332 2467889999999999999999988753 45799
Q ss_pred EEeeccCChhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~~--~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999998755444433 234589999999999999999999999999999999999999999999999999987654332
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------------- 222 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------------- 222 (262)
T ss_pred ccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC--------------
Confidence 22223456778999998765 568999999999999999999 89999887776666555321100
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....++..+.+||.+||+.||.+|||+.++++
T Consensus 223 --------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 --------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred --------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 011346778899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=320.31 Aligned_cols=253 Identities=21% Similarity=0.342 Sum_probs=204.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCC---CeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLT---GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.++|++.+.||+|+||.||+|++..+ ...||+|++.... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCc
Confidence 36799999999999999999988654 4579999886543 34445678889999999999999999999876 567
Q ss_pred eEEEEeeccCChhhhh-hCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDLAGLA-ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~-~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.|++|||+.++.+..+ ......+++..+..++.||+.||.|||++||+||||||+||||+.++.++|+|||++..+...
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 8999999987655544 344457999999999999999999999999999999999999999999999999999877522
Q ss_pred CCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 273 HKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 273 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+......+
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP---------- 228 (266)
T ss_pred ccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence 111 1112234678999998865 568899999999999999998 999998877666665553311000
Q ss_pred CCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
...+.++.+.+|+..||+.||.+||++.+++++
T Consensus 229 ------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 229 ------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 112457788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=327.01 Aligned_cols=253 Identities=22% Similarity=0.303 Sum_probs=203.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECC-----CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTL-----TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
..+|++.+.||+|+||.||+|.+.. .+..||||++.... .......+.+|+.++..++||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~ 80 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK--E 80 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--C
Confidence 4578899999999999999998754 35789999987543 33445678899999999999999999999887 4
Q ss_pred ceeEEEEeeccCChhhhhhC----------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC
Q 011041 192 CSLYLVFKYMEHDLAGLAAS----------------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE 255 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~----------------~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~ 255 (495)
...++++||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 56899999998765443321 12358889999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 011041 256 GILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKI 333 (495)
Q Consensus 256 ~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i 333 (495)
+.+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999876533221 11223455788999999875 458899999999999999998 89999988877776666
Q ss_pred HHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 334 FKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 334 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
...... ....+++..+.+|+..||+.||.+||++.++++.
T Consensus 240 ~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 240 RNRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 432110 1123567788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=329.64 Aligned_cols=252 Identities=24% Similarity=0.307 Sum_probs=198.1
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeE--EEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCc
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQI--VALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 192 (495)
..++|++.+.||+|+||.||+|.++.++.. +++|.+... ........+.+|+.++.++ +|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~ 81 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RG 81 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CC
Confidence 457899999999999999999999887765 466665432 2345556788999999999 89999999999877 56
Q ss_pred eeEEEEeeccCChhhhhhC-C---------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC
Q 011041 193 SLYLVFKYMEHDLAGLAAS-P---------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG 256 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~-~---------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~ 256 (495)
.+|+||||+.++.+..+.. . ...+++..+..++.||+.||+|||++||+||||||+||||+.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 7999999998654443332 1 23588999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 011041 257 ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFK 335 (495)
Q Consensus 257 ~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~ 335 (495)
.+||+|||++....... ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 162 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 162 VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred cEEeCccccCcccchhh--hcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 99999999986432111 1111233567999998765 568899999999999999998 9999988776655544321
Q ss_pred hcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 336 LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 336 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.. . ......+++++.+||.+||..||.+||++.++|++
T Consensus 239 ~~---~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 GY---R-------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CC---c-------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 0 00112356788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=319.83 Aligned_cols=249 Identities=19% Similarity=0.287 Sum_probs=199.6
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
.+|++.+.||+|+||.||++.+. ++..+|+|++...... ...+.+|+.+++.++|+||+++++++.. ....|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTK--QRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCceEEE
Confidence 46889999999999999999876 4668999998754332 2356789999999999999999999876 4678999
Q ss_pred EeeccCChhh-hhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 198 FKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 198 ~e~~~~~l~~-~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
|||++++.+. .+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999876444 443434578999999999999999999999999999999999999999999999999987654322111
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL---------------- 220 (256)
T ss_pred cCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC----------------
Confidence 112233457999998875 568999999999999999998 89999887776666554321100
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
......|.++.+|+.+||..+|.+|||+.++++.
T Consensus 221 ------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 221 ------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 1112367789999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=319.92 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=199.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|.+. .+..||+|.+...... ...+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEE
Confidence 367999999999999999999866 5567999998765443 2457899999999999999999998753 45899
Q ss_pred EEeeccCChhhhhh-C-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAGLAA-S-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~-~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
+|||+.++.+..+. . ....+++..+..++.||+.||.|||++||+||||||+|||+++++.++|+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999875554443 2 234589999999999999999999999999999999999999999999999999987643322
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..... +
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~------------- 222 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR-M------------- 222 (260)
T ss_pred ccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C-------------
Confidence 22223345678999998765 568899999999999999999 9999998877776665532110 0
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
....+.+..+.+||.+||..||.+|||+.+++.
T Consensus 223 --------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 223 --------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred --------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 112346778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=317.09 Aligned_cols=246 Identities=25% Similarity=0.379 Sum_probs=203.3
Q ss_pred eeecccCceEEEEEEECCC---CeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEee
Q 011041 124 DKIGQGTYSNVYKARDTLT---GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~ 200 (495)
+.||+|+||.||+|.+... +..|++|++....... ....+.+|+.+++.++|+||+++++++.. ...++++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEe
Confidence 3699999999999998866 8899999997654333 46788899999999999999999999987 6789999999
Q ss_pred ccCChhhhhhCC---------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 201 MEHDLAGLAASP---------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 201 ~~~~l~~~~~~~---------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
+.++.+...... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 966555444433 36799999999999999999999999999999999999999999999999999987654
Q ss_pred CCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 272 NHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 272 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
... .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+... .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~---------- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--Y---------- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--C----------
Confidence 321 11234457889999998876 468999999999999999999 69999988776666655431 0
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.......+|+++.++|.+||..||.+|||+.+++++
T Consensus 225 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 ----------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ----------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 001123457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=321.46 Aligned_cols=252 Identities=30% Similarity=0.455 Sum_probs=202.6
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|++.+.||+|+||.||+|++..+|..||||.+..... .......+.+|+.+++.++|+||+++++++.. ....++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEEE
Confidence 578999999999999999999999999999998875433 34455678899999999999999999999887 567999
Q ss_pred EEeeccCChhhhhhC----CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 197 VFKYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 197 v~e~~~~~l~~~~~~----~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
+|||+.++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999765444322 3456899999999999999999999999999999999999999999999999998766433
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCChhhhhhCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV--EQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
. .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.... +....+... ..++
T Consensus 160 ~-~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~--------- 227 (267)
T cd08229 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYPP--------- 227 (267)
T ss_pred C-cccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC-CCCC---------
Confidence 2 22234578999999998865 45788999999999999999999999765432 222222110 0000
Q ss_pred CCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 228 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 228 -----------------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -----------------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 011246678999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=325.57 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=202.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCC-----CeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLT-----GQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 190 (495)
.++|++.+.||+|+||.||++.+... ...||+|.+.... .......+.+|+.+++.+ +|+||+++++++..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-- 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence 46899999999999999999987644 3789999987543 334456688999999999 89999999999876
Q ss_pred CceeEEEEeeccCChhhhhh----------------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC
Q 011041 191 SCSLYLVFKYMEHDLAGLAA----------------SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN 254 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~----------------~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~ 254 (495)
...+|++|||+.++.+..+. .....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 56799999999876554433 22446899999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 011041 255 EGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHK 332 (495)
Q Consensus 255 ~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~ 332 (495)
++.+||+|||++..+...... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 999999999999866432211 1122234677999998765 568899999999999999997 9999988776666554
Q ss_pred HHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 333 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
+..... ......++..+.+||.+||..||.+|||+.+++++
T Consensus 247 ~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 247 LKEGYR----------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 432110 00112356788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=326.08 Aligned_cols=250 Identities=22% Similarity=0.260 Sum_probs=197.6
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCe--EEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCcee
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQ--IVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 194 (495)
++|++.+.||+|+||.||+|++..++. .+++|.+... ......+.+.+|+.++.++ +||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcc
Confidence 579999999999999999999887765 4688877632 2334456788999999999 79999999999876 4579
Q ss_pred EEEEeeccCChhhhhhCC----------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcE
Q 011041 195 YLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGIL 258 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~----------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~v 258 (495)
|++|||+.++.+..+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 999999986544433321 1258899999999999999999999999999999999999999999
Q ss_pred EEeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 011041 259 TIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLC 337 (495)
Q Consensus 259 kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~ 337 (495)
||+|||++....... .......+..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+.++....
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999986432111 1111123457999998865 568999999999999999997 999999887766665543211
Q ss_pred CCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 338 GSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
. ......++.++.+||.+||..||.+|||++++++.
T Consensus 236 ~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 R----------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred C----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 01113467789999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=325.51 Aligned_cols=259 Identities=19% Similarity=0.280 Sum_probs=204.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCC----------------eEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCee
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTG----------------QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g----------------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 180 (495)
.++|++++.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.+++.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 468999999999999999999876544 568999987543 335567788999999999999999
Q ss_pred eeeceeeccCCceeEEEEeeccCChhhhhhCCCC-----------CCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCC
Q 011041 181 KLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTI-----------KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSN 249 (495)
Q Consensus 181 ~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~-----------~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~N 249 (495)
++++++.. +...+++|||+.++.+..+..... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 99999877 467999999998765554433322 68999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCh
Q 011041 250 LLIDNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA--EKPIMPGRTE 326 (495)
Q Consensus 250 ILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt--G~~pf~~~~~ 326 (495)
||++.++.++|+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999876533221 11223456788999998875 468999999999999999998 7788887776
Q ss_pred HHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 327 VEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 327 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.+.+..+.......... ........+|.++.+||.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQ---------------------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhcccccccc---------------------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 66665554321111000 000112345678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=324.61 Aligned_cols=264 Identities=25% Similarity=0.385 Sum_probs=206.6
Q ss_pred CeeeeeeecccCceEEEEEEEC---CCCeEEEeEEEecCCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCc
Q 011041 119 TFEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNL--EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~---~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 192 (495)
+|++.+.||+|+||.||++++. .++..||||++.+... .......+.+|+.++.++ +|+||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence 4889999999999999999864 4678999999875432 223345678899999999 69999999998876 56
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|+||||+.++.+.........+++..++.++.||+.+|.|||+.|++||||||.|||++.++.++|+|||++..+...
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 79999999998666555555567999999999999999999999999999999999999999999999999998765443
Q ss_pred CCCCCccccccCCCCCcccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
.........|+..|++||.+.+.. .++.++||||||+++|+|++|..||...+.......+.+.....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------- 227 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS----------- 227 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-----------
Confidence 322223456899999999886532 36789999999999999999999997543222212221110000
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC---HHHHHhCCCCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT---ATAALRSEFFTTKPY 409 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t---a~elL~hp~f~~~~~ 409 (495)
.......+++.+.+||.+||+.||++||| +.++|+||||+...|
T Consensus 228 --------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 228 --------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred --------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 00112346778899999999999999998 577899999988655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=324.51 Aligned_cols=258 Identities=29% Similarity=0.511 Sum_probs=212.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.+.|++.+.||+|+||.||++.+..++..|++|++..... ....+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 92 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLV--GDELWV 92 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--CCEEEE
Confidence 4679999999999999999999998999999999975432 45667889999999999999999999887 468999
Q ss_pred EEeeccCChhhhhhCCCC-CCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTI-KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~-~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
++||++++.+..+..... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~ 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-S 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-h
Confidence 999999655555444333 79999999999999999999999999999999999999999999999999987654322 1
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
......++..|++||++.+ ..++.++|+|||||++|+|++|..||...+.......+.... .+.
T Consensus 172 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~-------------- 235 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG-IPP-------------- 235 (286)
T ss_pred hhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCC--------------
Confidence 2233457889999998875 468899999999999999999999998877665555443210 000
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......++..+.+||.+||+.||.+|||+.++|.|+||+..
T Consensus 236 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 236 -----------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred -----------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 01112366788999999999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=320.39 Aligned_cols=249 Identities=20% Similarity=0.301 Sum_probs=204.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
..+|++++.||.|+||.||+|++.. +..+|+|++.... ......+.+|+.+++.++|+||+++++++.+ ....|+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSV--GEPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEec--CCCeEE
Confidence 4679999999999999999999887 8899999987543 2234568899999999999999999999877 467899
Q ss_pred EEeeccCChhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~~--~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999998755544433 344689999999999999999999999999999999999999999999999999976643221
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......++..|++||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+......
T Consensus 160 -~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM-------------- 223 (261)
T ss_pred -cccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC--------------
Confidence 1223345678999998865 568899999999999999998 89999988877777666432110
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+++++.++|.+||+.||.+|||+.++++
T Consensus 224 --------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 --------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred --------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 011346778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=319.79 Aligned_cols=252 Identities=18% Similarity=0.262 Sum_probs=201.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCC-----CeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLT-----GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
.++|++.+.||+|+||.||+|.++.. +..||+|.+.... .......+.+|+.+|+.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST--G 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC--C
Confidence 47899999999999999999987644 4889999986443 23344567789999999999999999999887 4
Q ss_pred ceeEEEEeeccCChhhhhhCC----------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEe
Q 011041 192 CSLYLVFKYMEHDLAGLAASP----------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIA 261 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~----------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~ 261 (495)
...|+||||+.++.+..+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 679999999986555443321 2247888999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 011041 262 DFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGS 339 (495)
Q Consensus 262 DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~ 339 (495)
|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~ 239 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG-GH 239 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-CC
Confidence 9999876543221 12233456788999998865 458899999999999999998 99999887776665544311 00
Q ss_pred CChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
+ .....++.++.+||.+||+.||.+|||+.+++.
T Consensus 240 ~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 240 L---------------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred C---------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 011234678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=315.79 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=202.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|.+.+.||+|+||.||+|.+. .+..||||.+...... ...+.+|+.+++.++|+||+++++++.. ....++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeec--CCceEE
Confidence 578999999999999999999876 4577999998755432 3567889999999999999999999876 467999
Q ss_pred EEeeccCChhhhhh-CC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAGLAA-SP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~-~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
+|||+.++.+..+. .. ...+++..+..++.||+.||.|||++||+|+||||+||+|+.++.+||+|||++..+.....
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999876554443 32 24689999999999999999999999999999999999999999999999999987643221
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+.++......+
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------------- 224 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP------------- 224 (261)
T ss_pred hhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 11222334678999998875 568999999999999999998 999999888777777664321110
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
....++.++.++|.+||..||.+||++.++++
T Consensus 225 ---------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 225 ---------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ---------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 11234678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=312.50 Aligned_cols=262 Identities=22% Similarity=0.383 Sum_probs=219.8
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCce
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 193 (495)
..++|.+++.||+|+|+.|.+++.+.|.+.||+|+++++-. +.+.+..++.|-.+..+- +||.+|-|+.+|.. ...
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--esr 325 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESR 325 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cce
Confidence 46899999999999999999999999999999999988755 455667788888888876 79999999999987 568
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+++|.||+.|+.+-...++..+++|++++.|-..|+.||.|||+.|||+||||.+|+|||..|++||+|+|+++.--. .
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~-~ 404 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG-P 404 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC-C
Confidence 999999999987777777778999999999999999999999999999999999999999999999999999875322 2
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CChHH-HHHHHHHhcCCCChhhh
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG-------RTEVE-QLHKIFKLCGSPSEEYW 345 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~-------~~~~~-~~~~i~~~~g~~~~~~~ 345 (495)
....++.+|||.|+|||++.| ..|+..+|+|+|||++|||+.|+.||.- .+.++ .++-|+..
T Consensus 405 gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek--------- 474 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK--------- 474 (593)
T ss_pred CcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh---------
Confidence 234567899999999999887 6799999999999999999999999962 12222 22223221
Q ss_pred hhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC------HHHHHhCCCCCCCCCC
Q 011041 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT------ATAALRSEFFTTKPYA 410 (495)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t------a~elL~hp~f~~~~~~ 410 (495)
-..+...+|-.+..+++..|.+||.+|.. ..++-.|+||....|.
T Consensus 475 --------------------qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 475 --------------------QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred --------------------cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence 11223345666778999999999999954 6899999999987774
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=315.07 Aligned_cols=252 Identities=30% Similarity=0.467 Sum_probs=202.6
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.... .......+.+|+.++++++|+||+++++++.. ....++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEE
Confidence 579999999999999999999999999999999875433 34446778899999999999999999999987 567899
Q ss_pred EEeeccCChhhhhh----CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 197 VFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 197 v~e~~~~~l~~~~~----~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
||||+.++.+..+. .....+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999875444332 23456899999999999999999999999999999999999999999999999998765433
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCChhhhhhCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE--VEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
. .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||..... .+....+.... ..
T Consensus 160 ~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~--------- 226 (267)
T cd08224 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD--YP--------- 226 (267)
T ss_pred C-cccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC--CC---------
Confidence 2 22234568899999998875 5688999999999999999999999965432 12222221100 00
Q ss_pred CCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
+ .....++..+.++|.+||..||.+|||+.++++
T Consensus 227 -------~---------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 227 -------P---------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -------C---------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0 001245678899999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=334.89 Aligned_cols=280 Identities=30% Similarity=0.512 Sum_probs=227.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC------CCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD------HPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~~~~~~~~ 190 (495)
.++|.+....|+|-|++|..|.|..-|..||||+|+.... -...=..|++||++|+ --|+++|+..|..
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h-- 505 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH-- 505 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh--
Confidence 4789999999999999999999999999999999986542 2233457999999994 3478999888877
Q ss_pred CceeEEEEeeccCChhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC-CcEEEeeccccc
Q 011041 191 SCSLYLVFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFGLAS 267 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~--~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~-~~vkL~DFG~a~ 267 (495)
.+++|||||.+.-.|...+.. .+..|....++.|+.||+.||..|-.+||+|.||||+||||++. ..+||||||.|.
T Consensus 506 knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 506 KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence 578999999998887776654 34457889999999999999999999999999999999999985 578999999998
Q ss_pred ccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 011041 268 FFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (495)
....+. .+.+..+..|+|||+++| ..|+...|+||+||+||||.||+-+|+|.++...+.-.+.+.|.++..+..+
T Consensus 586 ~~~ene---itPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 586 FASENE---ITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred cccccc---ccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 876543 466778889999999998 5799999999999999999999999999999999999999999998876654
Q ss_pred CCCCCC-----c--------------------cCCCCcccccccccccCCCC-------CCcHHHHHHhccCCCCCccCH
Q 011041 348 SKLPHA-----T--------------------IFKPQQSYKRCIAETFKDFP-------PSSLPLIETLLAIDPAERQTA 395 (495)
Q Consensus 348 ~~~~~~-----~--------------------~~~~~~~~~~~~~~~~~~~s-------~~~~~Li~~~L~~dP~~R~ta 395 (495)
..+-.. - +.+|...+..-+.. ...+| ..+.+||.+||..||++|.|.
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~-~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIA-VQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhc-cCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 332111 0 11111111111110 01122 357899999999999999999
Q ss_pred HHHHhCCCCCC
Q 011041 396 TAALRSEFFTT 406 (495)
Q Consensus 396 ~elL~hp~f~~ 406 (495)
.|+|+||||+.
T Consensus 741 nqAL~HpFi~~ 751 (752)
T KOG0670|consen 741 NQALKHPFITE 751 (752)
T ss_pred HHHhcCCcccC
Confidence 99999999975
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=319.69 Aligned_cols=251 Identities=20% Similarity=0.284 Sum_probs=199.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCe----EEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ----IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
.++|++++.||+|+||+||+|++..+|. .||+|++.... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT---S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---C
Confidence 4789999999999999999999877776 48999986543 34445678899999999999999999998865 3
Q ss_pred eeEEEEeeccCCh-hhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 193 SLYLVFKYMEHDL-AGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 193 ~~~lv~e~~~~~l-~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
..+++|||+.++. ...+......+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||++.....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 4789999998654 444444455799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 272 NHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 272 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
.... ......+++.|+|||.+.+ ..++.++|||||||++|||++ |.+||...........+.. ...+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~--------- 230 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERL--------- 230 (279)
T ss_pred ccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcC---------
Confidence 2211 1122234678999998865 468999999999999999998 9999987665554433321 1110
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....++.++.++|..||..||.+||++.+++.
T Consensus 231 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 231 ------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011235677889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=322.74 Aligned_cols=251 Identities=21% Similarity=0.303 Sum_probs=200.8
Q ss_pred CCCeeeeeeecccCceEEEEEEEC-----CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
..+|.+.+.||+|+||.||+|.+. .++..+++|.+.... ......+.+|+.+++.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 79 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGD--G 79 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--C
Confidence 457999999999999999999854 345678999876432 3344668899999999999999999999976 5
Q ss_pred ceeEEEEeeccCChhhhhhCC----------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC
Q 011041 192 CSLYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE 255 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~----------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~ 255 (495)
...++||||+.++.+..+... ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 679999999987655544321 2358999999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 011041 256 GILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKI 333 (495)
Q Consensus 256 ~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i 333 (495)
+.+||+|||++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999976543221 11233456888999998876 568899999999999999998 99999887776655544
Q ss_pred HHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 334 FKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 334 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.... . ......+|..+.+||.+||..||.+|||+.++++
T Consensus 239 ~~~~--~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQGR--V--------------------------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCC--C--------------------------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 2210 0 0111235678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=315.53 Aligned_cols=247 Identities=23% Similarity=0.356 Sum_probs=198.8
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|.+.+.||+|+||.||+|.+..++ .||+|.+..... ..+.+.+|+.+++.++|+||+++++++.. ...|++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEEE
Confidence 57999999999999999999876654 599998865432 23457789999999999999999988753 458999
Q ss_pred EeeccCC-hhhhhhC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 198 FKYMEHD-LAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 198 ~e~~~~~-l~~~~~~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
|||+.++ +...+.. ....+++..+..++.||+.||.|||++||+|+||||+|||+++++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 9999875 4444433 2335889999999999999999999999999999999999999999999999999866433222
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..... +
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~-------------- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR-M-------------- 222 (260)
T ss_pred ccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C--------------
Confidence 2223345778999998765 468899999999999999999 9999998877766665533110 0
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
....+++..+.+||.+||..||.+||++.++++
T Consensus 223 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 -------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011346778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=313.85 Aligned_cols=246 Identities=30% Similarity=0.467 Sum_probs=205.0
Q ss_pred ecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeeccCC
Q 011041 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD 204 (495)
Q Consensus 126 LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~ 204 (495)
||+|+||.||++.+..+++.||+|++..... .......+.+|+.+++.++|+||+++++.+.. +..+|++|||+.++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCCC
Confidence 6999999999999998999999999987644 33456678899999999999999999999877 56899999999665
Q ss_pred hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccccccC
Q 011041 205 LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL 284 (495)
Q Consensus 205 l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 284 (495)
.+.........+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .......++.
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 157 (250)
T cd05123 79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTP 157 (250)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCc
Confidence 555555445578999999999999999999999999999999999999999999999999998764332 1234456788
Q ss_pred CCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCccccc
Q 011041 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKR 364 (495)
Q Consensus 285 ~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (495)
.|++||.+.+ ..++.++|+|||||++|+|++|..||...+.......+... .+
T Consensus 158 ~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~------------------------ 210 (250)
T cd05123 158 EYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD--PL------------------------ 210 (250)
T ss_pred cccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--CC------------------------
Confidence 9999998876 45788999999999999999999999877765555554321 00
Q ss_pred ccccccCCCCCCcHHHHHHhccCCCCCccCH---HHHHhCCCC
Q 011041 365 CIAETFKDFPPSSLPLIETLLAIDPAERQTA---TAALRSEFF 404 (495)
Q Consensus 365 ~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta---~elL~hp~f 404 (495)
.....++..+.++|.+||..||.+|||+ .+++.||||
T Consensus 211 ---~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 211 ---RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 1112347788999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=316.00 Aligned_cols=248 Identities=23% Similarity=0.388 Sum_probs=200.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|+++++||+|+||.||+|.+. +++.||+|.+...... ...+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEE
Confidence 478999999999999999999865 5678999998755433 3467889999999999999999998754 45899
Q ss_pred EEeeccCChh-hhhhC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLA-GLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~-~~~~~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
+|||+.++.+ ..+.. ....+++.++..++.||+.||+|||++||+||||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999986544 43332 345789999999999999999999999999999999999999999999999999977653222
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+..+....+......
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 222 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-------------- 222 (260)
T ss_pred ccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--------------
Confidence 22233345678999998865 467899999999999999998 99999987766655554221100
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....++.++.+||.+||..||++|||+++++.
T Consensus 223 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 --------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111345678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.15 Aligned_cols=253 Identities=20% Similarity=0.251 Sum_probs=197.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCC-----CeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLT-----GQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 190 (495)
.++|++++.||+|+||.||+|++... +..||||++.... .....+.+.+|+.+|..++ |||||++++++..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-- 112 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-- 112 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence 47899999999999999999987433 4579999986543 3344567889999999996 9999999999976
Q ss_pred CceeEEEEeeccCChhhhhhCC----------------------------------------------------------
Q 011041 191 SCSLYLVFKYMEHDLAGLAASP---------------------------------------------------------- 212 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~---------------------------------------------------------- 212 (495)
...+||||||+.++.+..++..
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 5679999999987644332210
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC
Q 011041 213 --------------------------------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN 254 (495)
Q Consensus 213 --------------------------------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~ 254 (495)
...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 124788889999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 011041 255 EGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHK 332 (495)
Q Consensus 255 ~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~ 332 (495)
++.+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 99999999999976533221 11223456788999998876 568999999999999999997 9999987554333332
Q ss_pred HHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 333 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.......+ .....++.++.+||.+||..||.+|||+.++.+
T Consensus 352 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 352 KIKSGYRM---------------------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHhcCCCC---------------------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 22211000 011246778899999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=315.10 Aligned_cols=244 Identities=20% Similarity=0.279 Sum_probs=195.9
Q ss_pred eeecccCceEEEEEEECCCC---eEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEee
Q 011041 124 DKIGQGTYSNVYKARDTLTG---QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~ 200 (495)
++||+|+||.||+|+...++ ..||+|.+...... .....+.+|+.+++.++|+||+++++++.. ...++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEe
Confidence 46999999999999876554 78999998765543 455678899999999999999999998764 358999999
Q ss_pred ccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCc--
Q 011041 201 MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT-- 278 (495)
Q Consensus 201 ~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~-- 278 (495)
+.++.+...+.....+++..+..++.||+.+|.|||+.||+|+||||+|||++.++.+||+|||++............
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 987655555555557999999999999999999999999999999999999999999999999999876443321111
Q ss_pred cccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCC
Q 011041 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (495)
Q Consensus 279 ~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (495)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+.... +
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~--~----------------- 216 (257)
T cd05060 157 AGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE--R----------------- 216 (257)
T ss_pred CccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--c-----------------
Confidence 1123467999998865 568999999999999999998 999998877665554443210 0
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......++..+.+||.+||..||.+|||+.++++
T Consensus 217 ---------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 ---------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112346778899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=307.06 Aligned_cols=259 Identities=25% Similarity=0.364 Sum_probs=200.5
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc---CCc
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR---MSC 192 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---~~~ 192 (495)
...+|.+.+.||+|+|+-||+++...++..||+|+|.... .+..+...+||...++++||||++++++.... ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3578999999999999999999999999999999998765 56677888999999999999999998876431 245
Q ss_pred eeEEEEeeccCC-hhhhh---hCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--ceeccCCCCCeeeCCCCcEEEeecccc
Q 011041 193 SLYLVFKYMEHD-LAGLA---ASPTIKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLIDNEGILTIADFGLA 266 (495)
Q Consensus 193 ~~~lv~e~~~~~-l~~~~---~~~~~~l~e~~~~~i~~qil~~L~~LH~~g--ivHrDlKp~NILl~~~~~vkL~DFG~a 266 (495)
..||+++|...+ ++..+ ...+..++|.++..|+.+|++||++||+.. +.||||||.|||+.+++.++|.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 699999998866 44433 234557999999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCC--------CCCccccccCCCCCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 011041 267 SFFDPNHK--------QPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336 (495)
Q Consensus 267 ~~~~~~~~--------~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 336 (495)
+...-.-. +.......|..|+|||++.- ....+.++|||||||+||.|+.|..||... +..
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~~ 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQQ 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hhc
Confidence 75431110 11123346899999998732 234688999999999999999999999431 211
Q ss_pred cCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 337 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
-|+..- .....+-.+ .+ -..+|..+.+||+.||+.||.+||++.++|.+
T Consensus 248 GgSlaL-----------Av~n~q~s~----P~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 248 GGSLAL-----------AVQNAQISI----PN-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CCeEEE-----------eeecccccc----CC-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 111000 000000000 00 12378899999999999999999999999864
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=320.23 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=200.9
Q ss_pred CCCeeeeeeecccCceEEEEEEEC-----CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
..+|.+.++||+|+||.||++... .++..||+|.+... .......+.+|+.+++.++|+||+++++++.+ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTE--G 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec--C
Confidence 357888999999999999999743 35678999987643 34556688999999999999999999999877 4
Q ss_pred ceeEEEEeeccCChhhhhhCCC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC
Q 011041 192 CSLYLVFKYMEHDLAGLAASPT---------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG 256 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~---------------~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~ 256 (495)
...|++|||+.++.+..+.... ..+++..+..++.||+.||.|||++||+||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 6789999999876555443221 3588999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011041 257 ILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIF 334 (495)
Q Consensus 257 ~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~ 334 (495)
.+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+.
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 999999999975532211 11122345788999998876 468999999999999999998 999998877766665553
Q ss_pred HhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 335 KLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 335 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
..... .....+|+.+.+||.+||+.||.+||++.++++
T Consensus 239 ~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 239 QGREL----------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCccC----------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 21100 111346778899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=324.51 Aligned_cols=253 Identities=20% Similarity=0.295 Sum_probs=198.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECC-------CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeec
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTL-------TGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS 188 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 188 (495)
.++|.+.+.||+|+||.||++++.. ++..||+|.+.... .......+.+|+.+++.+ +|+||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3789999999999999999998643 33579999987543 234456688899999999 79999999999877
Q ss_pred cCCceeEEEEeeccCChhhhhhCC----------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee
Q 011041 189 RMSCSLYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (495)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~~~----------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl 252 (495)
...+|+||||+.++.+..++.. ...+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 96 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 96 --DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 4579999999987544433321 1248889999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCCC-CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011041 253 DNEGILTIADFGLASFFDPNHKQP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (495)
Q Consensus 253 ~~~~~vkL~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~ 330 (495)
+.++.+||+|||++.......... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~ 252 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 999999999999987653221111 112234568999998876 468999999999999999998 89999877665554
Q ss_pred HHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
..+.... .......++.++.+||.+||..||.+|||+.+++++
T Consensus 253 ~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 253 KLLKEGH----------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHcCC----------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4432110 001123467788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=322.55 Aligned_cols=253 Identities=20% Similarity=0.284 Sum_probs=200.5
Q ss_pred CCCeeeeeeecccCceEEEEEEE-----CCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 190 (495)
.++|.+.+.||+|+||.||++.+ ..++..||+|++.... .....+.+.+|+.+++++ +|+||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTI-- 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--
Confidence 46899999999999999999975 3456689999987543 234456788999999999 79999999999877
Q ss_pred CceeEEEEeeccCChhhhhh-CC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccc
Q 011041 191 SCSLYLVFKYMEHDLAGLAA-SP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~-~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~ 268 (495)
...+|++|||+.++.+..+. .. ...+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 46799999999866554443 32 23489999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 011041 269 FDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (495)
Q Consensus 269 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (495)
....... ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+.++......+
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------ 263 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM------ 263 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC------
Confidence 5432211 1122345778999998876 457899999999999999998 999998877655554443211000
Q ss_pred hCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+++.+.+||.+||..||++|||+.++++
T Consensus 264 ---------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 264 ---------------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ---------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 011235678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=322.56 Aligned_cols=259 Identities=20% Similarity=0.284 Sum_probs=201.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCC--------------CeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeee
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLT--------------GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~--------------g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 182 (495)
.++|++.+.||+|+||.||+|++..+ ...||+|++... ........+.+|+++|+.++|+||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 36899999999999999999987543 235899998754 334455678899999999999999999
Q ss_pred eceeeccCCceeEEEEeeccCChhhhhhCCC------------CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCe
Q 011041 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPT------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNL 250 (495)
Q Consensus 183 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~------------~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NI 250 (495)
++++.. ....|+||||+.++.+..+.... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 83 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 83 LGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred EEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 999976 56799999999876554433211 2368889999999999999999999999999999999
Q ss_pred eeCCCCcEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCChH
Q 011041 251 LIDNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA--EKPIMPGRTEV 327 (495)
Q Consensus 251 Ll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt--G~~pf~~~~~~ 327 (495)
|++.++.+||+|||++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 999999999999999976533221 11122345678999998875 468999999999999999988 67889887776
Q ss_pred HHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 328 EQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 328 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
+....+........... .......+|+.+.+||.+||..||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 240 QVIENTGEFFRNQGRQI---------------------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHhhhhccccc---------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 66655433211100000 01112346778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=315.86 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=203.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCC---eEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTG---QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.++|++.+.||+|+||.||+|+++.++ ..||+|.+.... .......+.+|+.+++.++||||+++++++.. +..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 79 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKP 79 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCc
Confidence 357999999999999999999886544 379999886543 33445678899999999999999999999876 567
Q ss_pred eEEEEeeccCChhh-hhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l~~-~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.|+||||+.++.+. .+......+++.++..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999876544 44444457899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCc--cccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 273 HKQPMT--SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 273 ~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
...... ...++..|++||++.+ ..++.++|+|||||++|++++ |..||.+.+..+....+......
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~---------- 228 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL---------- 228 (267)
T ss_pred cceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC----------
Confidence 221111 1223567999998875 468999999999999999886 99999887776666555432110
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+++.+.+|+.+||+.||.+||++.++++
T Consensus 229 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 229 ------------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 011246778899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=318.57 Aligned_cols=266 Identities=23% Similarity=0.333 Sum_probs=198.0
Q ss_pred CCe-eeeeeecccCceEEEEEE----ECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 118 DTF-EKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 118 ~~y-~~~~~LG~G~~g~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
++| ++++.||+|+||+||++. ...++..||+|++.... .......+.+|+.+|+.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 345 899999999999998864 34578899999987543 223446678899999999999999999988765456
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|++|||+.++.+....... .+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 789999999987666555433 5999999999999999999999999999999999999999999999999999866432
Q ss_pred CCC--CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc-CCCChhhhhhCC
Q 011041 273 HKQ--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLC-GSPSEEYWKKSK 349 (495)
Q Consensus 273 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~-g~~~~~~~~~~~ 349 (495)
... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... +..+.... +......+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~- 236 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIEL- 236 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhh-
Confidence 211 1122245667999998865 56889999999999999999999998654321 11111100 00000000000
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
. ... ........++.++.+|+..||..||.+|||+.++++
T Consensus 237 ~------~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 237 L------ERG-----MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred h------hcC-----CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 000 000112356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=314.99 Aligned_cols=252 Identities=20% Similarity=0.338 Sum_probs=203.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCe---EEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.++|+..+.||+|+||.||+|+++.++. .||+|.+.... .......+.+|+.+++.++|+||+++++++.+ ...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK--FKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc--CCC
Confidence 3578899999999999999999876654 79999886543 33445678899999999999999999999977 467
Q ss_pred eEEEEeeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.|+||||+.++.+..+. .....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 89999999986665544 34457899999999999999999999999999999999999999999999999999766432
Q ss_pred CCCCCcc--ccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 273 HKQPMTS--RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 273 ~~~~~~~--~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
....... ...++.|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+......+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~--------- 230 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP--------- 230 (268)
T ss_pred cccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---------
Confidence 2221111 123457999998875 567899999999999999997 999998887777666664321111
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
...+.+.++.+|+.+||..||.+||++.++++
T Consensus 231 -------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 -------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11245678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=312.80 Aligned_cols=244 Identities=24% Similarity=0.368 Sum_probs=199.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||.|+||.||+|.+. |+.||+|.+..... ....+.+|+.+++.++|+||+++++++.+ ....|+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEE
Confidence 468999999999999999999754 78999999875432 45678899999999999999999999887 567999
Q ss_pred EEeeccCChhhhhhCCC--CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAGLAASPT--IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~--~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||+.++.+....... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 99999975544444322 268999999999999999999999999999999999999999999999999998663221
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+.... .
T Consensus 157 ---~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~-------------- 217 (256)
T cd05039 157 ---DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-R-------------- 217 (256)
T ss_pred ---ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-C--------------
Confidence 12334667999998865 468899999999999999997 999998877665544442210 0
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......+|+.+.+||.+||..||.+|||+.+++.
T Consensus 218 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 218 -------------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred -------------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0112346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=329.88 Aligned_cols=255 Identities=22% Similarity=0.341 Sum_probs=196.7
Q ss_pred CCCeeeeeeecccCceEEEEEEE-----CCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 190 (495)
.++|++.+.||+|+||.||+|++ ..+++.||||+++... .......+.+|+.+|..+ +|+||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 36899999999999999999985 3567899999997543 234456788899999999 689999999988654
Q ss_pred CceeEEEEeeccCChhhhhhCC----------------------------------------------------------
Q 011041 191 SCSLYLVFKYMEHDLAGLAASP---------------------------------------------------------- 212 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~---------------------------------------------------------- 212 (495)
...++++|||++++.+..++..
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4568999999997655443321
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC-CCCccccc
Q 011041 213 ---------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-QPMTSRVV 282 (495)
Q Consensus 213 ---------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~g 282 (495)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 12367888899999999999999999999999999999999999999999999976532211 11122345
Q ss_pred cCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcc
Q 011041 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (495)
Q Consensus 283 t~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 361 (495)
++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+.........+
T Consensus 244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------- 301 (343)
T cd05103 244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--------------------- 301 (343)
T ss_pred CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC---------------------
Confidence 677999998876 568999999999999999997 999998755433332222110000
Q ss_pred cccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 362 ~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
......++++.+++..||..||.+|||+.++++|
T Consensus 302 ------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 302 ------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0011245678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=322.92 Aligned_cols=252 Identities=19% Similarity=0.296 Sum_probs=199.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECC-------CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeec
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTL-------TGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS 188 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 188 (495)
.++|.+.+.||+|+||.||+|++.. ....||+|.+.... .......+.+|+.+++.+ +||||+++++++.+
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3689999999999999999998632 34579999887543 344566788999999999 69999999999876
Q ss_pred cCCceeEEEEeeccCChhhhhhCC----------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee
Q 011041 189 RMSCSLYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (495)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~~~----------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl 252 (495)
...+|++|||+.++.+..+... ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 90 --~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 90 --EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 4679999999987655443321 2358899999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011041 253 DNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (495)
Q Consensus 253 ~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~ 330 (495)
+.++.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999765432111 1112234567999998876 568999999999999999999 89999887776666
Q ss_pred HHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
..+.... .......++.++.+||.+||..||.+|||+.++++
T Consensus 247 ~~~~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 247 KLLREGH----------------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 6553210 00112345678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=322.15 Aligned_cols=253 Identities=20% Similarity=0.301 Sum_probs=201.8
Q ss_pred CCCeeeeeeecccCceEEEEEEEC-------CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeec
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT-------LTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS 188 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 188 (495)
.++|.+.+.||+|+||.||+|++. .++..||+|.+... ........+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 578999999999999999999753 24467999988643 2344556788999999999 89999999999987
Q ss_pred cCCceeEEEEeeccCChhhhhhCC----------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee
Q 011041 189 RMSCSLYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (495)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~~~----------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl 252 (495)
...+|++|||+.++.+..++.. ...++...+..++.||+.||.|||++||+||||||+|||+
T Consensus 93 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 93 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 5678999999987554433321 2357888999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011041 253 DNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (495)
Q Consensus 253 ~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~ 330 (495)
+.++.+||+|||++......... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 99999999999999876432221 1122345678999998876 568899999999999999998 88999888776666
Q ss_pred HHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
..+..... ......++..+.+||.+||..+|.+|||+.++++.
T Consensus 250 ~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 250 KLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 55532110 01123467789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=315.30 Aligned_cols=253 Identities=25% Similarity=0.426 Sum_probs=202.9
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecC---CCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFD---NLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~---~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
+|.+.+.||+|+||.||++++..++..+++|++... .........+.+|+.+++.++||||+++++++.+ ....+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CCceE
Confidence 588999999999999999999888777777766532 2233344557789999999999999999999876 45689
Q ss_pred EEEeeccCChhhhhh----CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 196 LVFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 196 lv~e~~~~~l~~~~~----~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
+||||+.++.+.... .....+++..+..++.||+.||.|||++|++|+||||+||+++. +.+||+|||++.....
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999876555433 23457999999999999999999999999999999999999975 6799999999876643
Q ss_pred CCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
... ......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+... .++
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~~---------- 223 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PTP---------- 223 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CCC----------
Confidence 321 2234467889999998765 45788999999999999999999999877666555554321 100
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
.....++.++.+||.+||..||.+||++.++++||||
T Consensus 224 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 224 ----------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ----------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 1113466788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=317.14 Aligned_cols=251 Identities=21% Similarity=0.286 Sum_probs=196.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeE----EEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQI----VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
.++|++++.||+|+||+||+|++..+|+. |++|.+... ........+..|+.++..++||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~ 81 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---A 81 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---C
Confidence 46899999999999999999998877764 677776432 223344667788999999999999999998754 3
Q ss_pred eeEEEEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 193 SLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 193 ~~~lv~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
..++++||+.++ +...+......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 578899999865 4444444456799999999999999999999999999999999999999999999999999986643
Q ss_pred CCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 272 NHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 272 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
.... ......++..|++||++.+ ..++.++|||||||++|||++ |..||.+.........+.+ ...+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~-------- 231 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK-GERLA-------- 231 (279)
T ss_pred CCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcCC--------
Confidence 3221 1223456778999998875 468999999999999999998 9999988765544333211 10000
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+.++.+++.+|+..||.+|||+.++++
T Consensus 232 -------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 232 -------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01123456788999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=315.33 Aligned_cols=252 Identities=22% Similarity=0.383 Sum_probs=203.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCe---EEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.++|++.+.||+|+||.||+|.+..++. .||||++... ........+..|+.+++.++||||+++++++.. +..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~ 79 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SRP 79 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--CCc
Confidence 3579999999999999999999887664 6999998654 244556778999999999999999999999876 567
Q ss_pred eEEEEeeccCChhhhh-hCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDLAGLA-ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~-~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.++||||+.++.+..+ ......+++.++..++.|++.||.|||++|++|+||||+|||++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 8999999987655544 344557899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCC-Ccccc---ccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 011041 273 HKQP-MTSRV---VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 273 ~~~~-~~~~~---gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (495)
.... ..... .+..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~-------- 230 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL-------- 230 (269)
T ss_pred ccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC--------
Confidence 2111 11111 2457999998865 568999999999999999886 99999988777666665321100
Q ss_pred CCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
....++|..+.+|+..||..||.+||++.+++.
T Consensus 231 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 231 --------------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred --------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011346678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=311.63 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=200.9
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
.+|++.+.||+|+||.||++.+. .+..+|+|.+...... ...+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTE--RSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEcc--CCceEEE
Confidence 57999999999999999999875 4678999988754433 2457789999999999999999999877 4578999
Q ss_pred EeeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 198 FKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 198 ~e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
|||+.++.+..+. .....+++..+..++.||+.+|.|||++|++|+||||+||+++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999987665544 334568999999999999999999999999999999999999999999999999987654322211
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+......
T Consensus 158 ~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd05112 158 STGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL---------------- 220 (256)
T ss_pred cCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC----------------
Confidence 222345678999998875 568899999999999999998 99999887776666555321100
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
......+..+.+|+.+||..||.+|||+.+++++
T Consensus 221 ------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 221 ------------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 0012246778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=318.92 Aligned_cols=250 Identities=20% Similarity=0.293 Sum_probs=197.7
Q ss_pred CeeeeeeecccCceEEEEEEECC-----CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTL-----TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
+|++.+.||+|+||.||+|++.. ....+++|.+.... .......+.+|+.+++.++||||+++++.+.. ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCC
Confidence 47888999999999999998753 23578888886443 33445678899999999999999999999876 456
Q ss_pred eEEEEeeccCChhhhhhCC------------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASP------------------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSN 249 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~------------------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~N 249 (495)
.|++|||+.++.+..++.. ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 8999999997655543321 2357899999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 011041 250 LLIDNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEV 327 (495)
Q Consensus 250 ILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~ 327 (495)
|||++++.+||+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999765322211 1122345678999998865 568999999999999999998 99999887766
Q ss_pred HHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 328 EQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 328 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
+.+..+..... ......++.++.+||..||+.||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 237 RLFNLLKTGYR----------------------------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHhCCCC----------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 65544322110 0011346678899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=311.89 Aligned_cols=249 Identities=26% Similarity=0.397 Sum_probs=201.5
Q ss_pred eeeeeeecccCceEEEEEEECCCC----eEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTG----QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
+++.+.||.|+||.||+|++..++ ..||+|++.... .......+..|+.+++.++|+||+++++++.+ ....|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCeeE
Confidence 356789999999999999998766 899999986543 22256678899999999999999999999887 46799
Q ss_pred EEEeeccCChhhhhhC-CCCC-CCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 196 LVFKYMEHDLAGLAAS-PTIK-FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~-~~~~-l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
++|||+.++.+..... .... +++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999998765554443 2323 8999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
........+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+.....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------------- 222 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR-------------- 222 (258)
T ss_pred ccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------------
Confidence 111112236789999998854 568999999999999999998 8999988777666665533110
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......++.++.++|.+||..||.+|||+.++++
T Consensus 223 --------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 --------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred --------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0111236778999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=318.96 Aligned_cols=252 Identities=22% Similarity=0.361 Sum_probs=200.6
Q ss_pred CCCeeeeeeecccCceEEEEEEEC-----CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
.++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++.+ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAV--G 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC--C
Confidence 468999999999999999999875 367899999987543 34455678899999999999999999999876 4
Q ss_pred ceeEEEEeeccCChhhhhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCC
Q 011041 192 CSLYLVFKYMEHDLAGLAASP----------------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSN 249 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~----------------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~N 249 (495)
...|++|||+.++.+...... ...+++..+..++.||+.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 578999999987544433321 1247889999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 011041 250 LLIDNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEV 327 (495)
Q Consensus 250 ILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~ 327 (495)
||++.++.++|+|||++........ ........+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999875432211 11122334667999998875 568999999999999999997 88899887776
Q ss_pred HHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 328 EQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 328 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
+....+..... ......++.++.+||.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNV----------------------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 66555432110 0111346778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=309.04 Aligned_cols=244 Identities=22% Similarity=0.322 Sum_probs=195.1
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeeccC
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH 203 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~ 203 (495)
+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.++||||+++++++.. ....++||||+.+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECCCC
Confidence 36899999999999854 68899999886543 34444568899999999999999999999877 4579999999987
Q ss_pred Chhhhh-hCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccccc
Q 011041 204 DLAGLA-ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282 (495)
Q Consensus 204 ~l~~~~-~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 282 (495)
+.+... ......+++..+..++.||+.+|.|||++|++||||||+||+++.++.+||+|||++...............+
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 655444 3344568999999999999999999999999999999999999999999999999987543322111122234
Q ss_pred cCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcc
Q 011041 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (495)
Q Consensus 283 t~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 361 (495)
++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+.....
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~----------------------- 212 (250)
T cd05085 157 PIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR----------------------- 212 (250)
T ss_pred cccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 667999998865 567899999999999999998 9999988776665555432110
Q ss_pred cccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 362 ~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......++..+.+|+.+||..||.+||++.++++
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 213 -----MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0112346778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=315.56 Aligned_cols=253 Identities=19% Similarity=0.337 Sum_probs=201.8
Q ss_pred CCeeeeeeecccCceEEEEEEECC-----CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTL-----TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
++|++++.||+|+||.||+|+.+. +.+.|++|.+.... .......+.+|+.++++++|+||+++++++.+ ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--AE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECC--CC
Confidence 679999999999999999999754 34679999876432 23345678899999999999999999999876 46
Q ss_pred eeEEEEeeccCChhhhhhCCCC---------CCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeec
Q 011041 193 SLYLVFKYMEHDLAGLAASPTI---------KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADF 263 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~---------~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DF 263 (495)
..|+||||++++.+..+..... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 7899999999765554443322 6899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCh
Q 011041 264 GLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSE 342 (495)
Q Consensus 264 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (495)
|++...............+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+....+..+.... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~--~-- 236 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK--L-- 236 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC--c--
Confidence 9987543322223344566888999998865 457889999999999999998 889998766655544442110 0
Q ss_pred hhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.| .....++..+.++|.+||..||.+|||+.+++..
T Consensus 237 -~~----------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 237 -EL----------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -CC----------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 00 0113467788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=312.00 Aligned_cols=244 Identities=20% Similarity=0.346 Sum_probs=196.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
..+|++.+.||+|+||.||++... |..||+|.+.... ....+.+|+.+++.++|+||+++++++... ....|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEE
Confidence 468999999999999999999654 7889999986432 245678999999999999999999976543 456899
Q ss_pred EEeeccCChhh-hhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAG-LAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~-~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
+|||++++.+. .+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 99999875444 43332 2348899999999999999999999999999999999999999999999999987653321
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+.+.. .
T Consensus 157 ---~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--~------------- 217 (256)
T cd05082 157 ---DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--K------------- 217 (256)
T ss_pred ---CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--C-------------
Confidence 22344668999998765 568899999999999999997 999998776655554443210 0
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......+++.+.+||.+||..||.+|||+.++++
T Consensus 218 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 218 -------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred -------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=346.48 Aligned_cols=279 Identities=21% Similarity=0.272 Sum_probs=188.8
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCC----CeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceee----
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLT----GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVT---- 187 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~----g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~---- 187 (495)
..++|++.+.||+|+||.||+|++..+ +..||+|++..... .+....| .++...+.+++.++..+.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 468999999999999999999999988 99999998764321 1111111 122222333333322211
Q ss_pred ccCCceeEEEEeeccCChhhhhhCCCC--------------------CCCHHHHHHHHHHHHHHHHHhhhCCceeccCCC
Q 011041 188 SRMSCSLYLVFKYMEHDLAGLAASPTI--------------------KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKG 247 (495)
Q Consensus 188 ~~~~~~~~lv~e~~~~~l~~~~~~~~~--------------------~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp 247 (495)
......+++||||+.++.+..+..... ...+..+..++.||+.||.|||++||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 123567999999999875544332211 122445778999999999999999999999999
Q ss_pred CCeeeCC-CCcEEEeecccccccCCCCCCCCccccccCCCCCcccccCCC---------------------CCCchhhHH
Q 011041 248 SNLLIDN-EGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT---------------------DYGVGVDLW 305 (495)
Q Consensus 248 ~NILl~~-~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---------------------~~~~~~Dvw 305 (495)
+||||+. ++.+||+|||++..+...........++|+.|+|||.+.... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999986 589999999999866444333345668899999999764321 234567999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhc
Q 011041 306 SAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLL 385 (495)
Q Consensus 306 SlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L 385 (495)
|||||||||+++. |...+....+.+++..++... ..|.....+. .. ..... ..+.+......+.+||.+||
T Consensus 364 SlGviL~el~~~~--~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~---~~--~~~~~-~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 364 SAGLIFLQMAFPN--LRSDSNLIQFNRQLKRNDYDL-VAWRKLVEPR---AS--PDLRR-GFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred HHHHHHHHHHhCc--CCCchHHHHHHHHHHhcCCcH-HHHHHhhccc---cc--hhhhh-hhhhccccchHHHHHHHHHc
Confidence 9999999999854 455556666666666555433 3343211111 00 00000 01111222345679999999
Q ss_pred cCCCCCccCHHHHHhCCCCCCCCC
Q 011041 386 AIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 386 ~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
++||.+|||+.++|+||||+...+
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred cCCcccCCCHHHHhCCcCcCCCCc
Confidence 999999999999999999987554
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=311.82 Aligned_cols=243 Identities=21% Similarity=0.274 Sum_probs=194.0
Q ss_pred eecccCceEEEEEEEC--CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeecc
Q 011041 125 KIGQGTYSNVYKARDT--LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME 202 (495)
Q Consensus 125 ~LG~G~~g~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~ 202 (495)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++|+||+++++++.. ...++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence 3899999999999765 456679999986543 34455678899999999999999999998754 36899999998
Q ss_pred CChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC--Ccc
Q 011041 203 HDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP--MTS 279 (495)
Q Consensus 203 ~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~--~~~ 279 (495)
++.+..+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......... ...
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 76555444 345579999999999999999999999999999999999999999999999999997654332211 112
Q ss_pred ccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCC
Q 011041 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (495)
Q Consensus 280 ~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 358 (495)
..+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+....+.... .
T Consensus 158 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~------------------ 216 (257)
T cd05115 158 GKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK--R------------------ 216 (257)
T ss_pred CCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--C------------------
Confidence 223578999998765 468899999999999999996 999998887766655543211 0
Q ss_pred CcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 359 ~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.......++++.+||..||..||.+||++.++++
T Consensus 217 --------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 --------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0111345788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=313.45 Aligned_cols=251 Identities=21% Similarity=0.326 Sum_probs=200.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCC---CeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLT---GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.++|.+.+.||+|+||.||+|.+... ...|+||.+.... .....+.+.+|+.+++.++|+||+++++++.+ ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CC
Confidence 35789999999999999999987644 3568999876432 34455678899999999999999999998875 35
Q ss_pred eEEEEeeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.|+||||+.++.+..+. .....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 78999999876554444 33446899999999999999999999999999999999999999999999999999766433
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
.........++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~------------- 226 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER------------- 226 (270)
T ss_pred cceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc-------------
Confidence 2111122234567999998765 568899999999999999986 9999998877766655432110
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......+|..+.+||.+||..||.+|||+.+++.
T Consensus 227 ---------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 227 ---------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=314.62 Aligned_cols=267 Identities=23% Similarity=0.342 Sum_probs=196.8
Q ss_pred CCeeeeeeecccCceEEEEEE----ECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 118 DTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.+|++++.||+|+||.||+|. +..++..||+|.+... .......+.+|+.+++.++||||+++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 579999999999999999997 4567889999998644 3445567889999999999999999999876544567
Q ss_pred eEEEEeeccCChhhh-hhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~-~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
+|+||||+.++.+.. +......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 899999998655544 4344456899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCC--CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCChhhhhhCC
Q 011041 273 HKQP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCG-SPSEEYWKKSK 349 (495)
Q Consensus 273 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g-~~~~~~~~~~~ 349 (495)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|..++..... .....+..... ......+.. .
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~ 238 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHLIE-L 238 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchHHHHH-H
Confidence 2111 111223456999998875 4689999999999999999998876644321 11111100000 000000000 0
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
+ ... .......+++.++.+||.+||..||++|||+.++++
T Consensus 239 ~------~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 239 L------KNN-----GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred H------hcC-----CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 000 000112456778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=309.13 Aligned_cols=244 Identities=23% Similarity=0.330 Sum_probs=195.9
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeeccC
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH 203 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~ 203 (495)
++||+|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++.++|+||+++++++.+ ....|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEEcCCC
Confidence 369999999999999887 999999998765433 455678899999999999999999999877 5679999999987
Q ss_pred Chhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC-cccc
Q 011041 204 DLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM-TSRV 281 (495)
Q Consensus 204 ~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~-~~~~ 281 (495)
+.+..+. .....+++..+..++.|++.+|.|||++||+||||||+||||+.++.+||+|||++........... ....
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 6554433 4445689999999999999999999999999999999999999999999999999976542211111 1123
Q ss_pred ccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCc
Q 011041 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQ 360 (495)
Q Consensus 282 gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 360 (495)
++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+......
T Consensus 157 ~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~--------------------- 214 (251)
T cd05041 157 IPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM--------------------- 214 (251)
T ss_pred ceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC---------------------
Confidence 3567999998865 468999999999999999998 89999887765554444221000
Q ss_pred ccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 361 SYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 361 ~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....++..+.+||.+||..||.+|||+.++|+
T Consensus 215 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 215 -------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 011345778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=317.08 Aligned_cols=269 Identities=21% Similarity=0.345 Sum_probs=199.7
Q ss_pred CCeeeeeeecccCceEEEEEEE----CCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 118 DTFEKLDKIGQGTYSNVYKARD----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
..|++++.||+|+||.||+|+. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3578999999999999999974 4678899999986543 3444567889999999999999999999987754567
Q ss_pred eEEEEeeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.|+||||+.++.+..+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 89999999876655544 33346899999999999999999999999999999999999999999999999999876433
Q ss_pred CCC--CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 273 HKQ--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 273 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
... ......++..|+|||++.+ ..++.++|||||||++|+|+++..|+..... .+ .+..+.......... .
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~---~~~~~~~~~~~~~~~-~ 235 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT--LF---LKMIGPTHGQMTVTR-L 235 (284)
T ss_pred ccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc--hh---hhhcccccccccHHH-H
Confidence 211 1123456778999998876 4688999999999999999998776543211 11 111111110000000 0
Q ss_pred CCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
. ..... .........++..+.+||.+||+.||.+|||+.+++++
T Consensus 236 ~--~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 236 V--RVLEE-----GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred H--HHHHc-----CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0 00000 00011224577889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=310.51 Aligned_cols=245 Identities=24% Similarity=0.326 Sum_probs=198.2
Q ss_pred eeecccCceEEEEEEECC-CC--eEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEee
Q 011041 124 DKIGQGTYSNVYKARDTL-TG--QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~-~g--~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~ 200 (495)
+.||+|+||.||+|.+.. .+ ..||||.+...... .....+.+|+.++++++|+||+++++++.. ...++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEe
Confidence 368999999999998865 33 36999999876544 566788899999999999999999999876 578999999
Q ss_pred ccCChhhh-hhCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC--C
Q 011041 201 MEHDLAGL-AASPT-IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ--P 276 (495)
Q Consensus 201 ~~~~l~~~-~~~~~-~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~--~ 276 (495)
+.++.+.. +.... ..+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..+...... .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 98654444 33333 46899999999999999999999999999999999999999999999999999876442211 1
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
.....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+.......
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL--------------- 220 (257)
T ss_pred ccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC---------------
Confidence 112356788999998765 568999999999999999998 999998888777766664311000
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+|..+.+||..||..||.+|||+.++++
T Consensus 221 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 221 ------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 011245778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=314.61 Aligned_cols=253 Identities=19% Similarity=0.256 Sum_probs=201.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECC----CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTL----TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+... ........+.+|+.+++.++|+||+++++++... ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence 4789999999999999999999876 3578999987633 3455667788999999999999999999987653 45
Q ss_pred eeEEEEeeccCChhhhhhCC--------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecc
Q 011041 193 SLYLVFKYMEHDLAGLAASP--------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~--------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG 264 (495)
..+++++|+.++.+..+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 78999999986554443321 1468999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCh
Q 011041 265 LASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSE 342 (495)
Q Consensus 265 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (495)
+++.+...... ......++..|+|||++.+ ..++.++|||||||++|++++ |++||...+..+....+.... .+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~-- 238 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-RL-- 238 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-CC--
Confidence 99765332211 1122345677999998876 468999999999999999998 999998877665444332210 00
Q ss_pred hhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+|+++.++|.+||..||++|||+.++++
T Consensus 239 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 239 -------------------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -------------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 001235678899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=310.03 Aligned_cols=248 Identities=22% Similarity=0.363 Sum_probs=199.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||++.+. .+..||+|.+.... .....+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEE
Confidence 478999999999999999999855 45579999886432 334678889999999999999999998875 45899
Q ss_pred EEeeccCC-hhhhhhC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHD-LAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~-l~~~~~~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
+|||+.++ +...+.. ....+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999865 4444433 344678899999999999999999999999999999999999999999999999976643322
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......++..|+|||++.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+.....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------------- 221 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR--------------- 221 (260)
T ss_pred ccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC---------------
Confidence 22223345677999998865 568889999999999999998 9999998776665554432110
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......++.++.+++.+||+.||.+||++.+++.
T Consensus 222 -------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 222 -------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred -------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0112346778999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=313.19 Aligned_cols=239 Identities=19% Similarity=0.251 Sum_probs=186.6
Q ss_pred eeecccCceEEEEEEECC------------CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 124 DKIGQGTYSNVYKARDTL------------TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~------------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
+.||+|+||.||+|+... ....|++|++.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~--~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVR--D 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec--C
Confidence 368999999999997432 22358888875432 3344567789999999999999999999876 4
Q ss_pred ceeEEEEeeccCChhhhhhC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCc-------EEEeec
Q 011041 192 CSLYLVFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI-------LTIADF 263 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~-------vkL~DF 263 (495)
...++||||++++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++. +|++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 56899999999877665554 3456999999999999999999999999999999999999987664 899999
Q ss_pred ccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCCh
Q 011041 264 GLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL-AEKPIMPGRTEVEQLHKIFKLCGSPSE 342 (495)
Q Consensus 264 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ell-tG~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (495)
|++...... ....++..|+|||++.....++.++|||||||++|+|+ .|..||......+.. .+....
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~----- 225 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQ----- 225 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcC-----
Confidence 998755322 33467889999998865567899999999999999998 588888765543322 111100
Q ss_pred hhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.......++++.+||.+||+.||.+||++.++|++
T Consensus 226 ------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 ------------------------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ------------------------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 00011234567899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=315.33 Aligned_cols=239 Identities=17% Similarity=0.213 Sum_probs=188.0
Q ss_pred eeecccCceEEEEEEECCCCeE-------EEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 124 DKIGQGTYSNVYKARDTLTGQI-------VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~-------vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
+.||+|+||.||+|.+..++.. |++|.+.... ....+.+..|+.+++.++||||+++++++.. ....++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCcEE
Confidence 3699999999999998765544 8888875432 3344567789999999999999999999887 456899
Q ss_pred EEeeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCc--------EEEeeccccc
Q 011041 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI--------LTIADFGLAS 267 (495)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~--------vkL~DFG~a~ 267 (495)
||||+.++.+..+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999987655544 44456899999999999999999999999999999999999987764 6999999987
Q ss_pred ccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 011041 268 FFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (495)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (495)
.... .....+++.|+|||++.+...++.++|||||||++|+|++| .+||...+........ ....
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~~-------- 222 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-EDRH-------- 222 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-Hccc--------
Confidence 5532 23346788999999987656689999999999999999998 4666655544332211 1000
Q ss_pred hCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
......+.++.+||.+||+.||.+|||+.++++.
T Consensus 223 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 223 ---------------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ---------------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0111234568899999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=323.92 Aligned_cols=253 Identities=20% Similarity=0.291 Sum_probs=200.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECC-------CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeec
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTL-------TGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS 188 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 188 (495)
..+|++++.||+|+||.||+|++.. .+..||+|.+... ........+.+|+.+++++ +|+||+++++++..
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3579999999999999999998643 2347899987643 3344567788999999999 89999999999877
Q ss_pred cCCceeEEEEeeccCChhhhhhCC----------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee
Q 011041 189 RMSCSLYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (495)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~~~----------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl 252 (495)
...+|++|||+.++.+..++.. ...++...+..++.||+.||.|||++||+||||||+|||+
T Consensus 90 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 90 --DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 4579999999987655443321 2247788899999999999999999999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011041 253 DNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (495)
Q Consensus 253 ~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~ 330 (495)
+.++.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999765432211 1122234567999998876 568899999999999999998 89999988777666
Q ss_pred HHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
..+.... .......++..+.+||.+||..+|.+|||+.+++++
T Consensus 247 ~~~~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 247 KLLKEGH----------------------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHcCC----------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 5553210 001123456778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=317.10 Aligned_cols=258 Identities=19% Similarity=0.279 Sum_probs=197.2
Q ss_pred CCeeeeeeecccCceEEEEEEECC----------------CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeee
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTL----------------TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVK 181 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~----------------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 181 (495)
++|++.+.||+|+||.||++.+.. ++..||+|++.... .......+.+|+.+|+.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 579999999999999999986432 34579999987542 3344567889999999999999999
Q ss_pred eeceeeccCCceeEEEEeeccCChhhhhhCC-----------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCe
Q 011041 182 LEGLVTSRMSCSLYLVFKYMEHDLAGLAASP-----------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNL 250 (495)
Q Consensus 182 l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-----------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NI 250 (495)
+++++.. ....|++|||+.++.+..+... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 84 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 9999877 4578999999987544433321 12477889999999999999999999999999999999
Q ss_pred eeCCCCcEEEeecccccccCCCCCCC-CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCChH
Q 011041 251 LIDNEGILTIADFGLASFFDPNHKQP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA--EKPIMPGRTEV 327 (495)
Q Consensus 251 Ll~~~~~vkL~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt--G~~pf~~~~~~ 327 (495)
|++.++.++|+|||++..+....... .....+++.|++||++.+ ..++.++|||||||++|||++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999997654322111 122334678999998765 468999999999999999998 77899877766
Q ss_pred HHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 328 EQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 328 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
+......... ..... .. .......+++.+.+||..||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~--------~~~~~---~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFF--------RDQGR---QV----------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHH--------hhccc---cc----------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6554432211 00000 00 00111235677899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=314.96 Aligned_cols=248 Identities=27% Similarity=0.403 Sum_probs=194.4
Q ss_pred eeeeeecccCceEEEEEEEC----CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 121 EKLDKIGQGTYSNVYKARDT----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 121 ~~~~~LG~G~~g~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.+.+.||.|.||.||+|... ..+..|+||++.. ....+..+.+.+|++++++++||||+++++++.. ....++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~--~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE--NEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--SSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccc--cccccc
Confidence 46789999999999999887 4567899999954 3345557888999999999999999999999985 455999
Q ss_pred EEeeccCChhh-hhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAG-LAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~-~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||+.++.+. .+... ...+++..+..++.||+.||.|||+++|+|+||++.||||+.++.+||+|||++........
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999865444 44433 46799999999999999999999999999999999999999999999999999987622111
Q ss_pred -CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 275 -QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 275 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
...........|+|||.+.+ ..++.++||||||+++|||++ |..||...+..+...++.+..-
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-------------- 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-------------- 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------------
T ss_pred ccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccc--------------
Confidence 11123346778999998876 348999999999999999999 7899988888777777633211
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......++..+.+||..||..||.+|||+.++++
T Consensus 224 --------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 --------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp --------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred --------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1112346777899999999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=314.25 Aligned_cols=238 Identities=20% Similarity=0.264 Sum_probs=186.4
Q ss_pred eecccCceEEEEEEECCC------------------------CeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCee
Q 011041 125 KIGQGTYSNVYKARDTLT------------------------GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180 (495)
Q Consensus 125 ~LG~G~~g~Vy~a~~~~~------------------------g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 180 (495)
.||+|+||.||+|....+ ...|++|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 599999999999974321 2358888876432 23345677899999999999999
Q ss_pred eeeceeeccCCceeEEEEeeccCChhhhhhC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC---
Q 011041 181 KLEGLVTSRMSCSLYLVFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG--- 256 (495)
Q Consensus 181 ~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~--- 256 (495)
++++++.. ....|+||||++++.+..+.. ....+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999887 567899999999887665553 456789999999999999999999999999999999999997644
Q ss_pred ----cEEEeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHH
Q 011041 257 ----ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL-AEKPIMPGRTEVEQLH 331 (495)
Q Consensus 257 ----~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ell-tG~~pf~~~~~~~~~~ 331 (495)
.+||+|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|.+||.+.+..+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 4899999988644221 23457888999998876566899999999999999995 6999998766544322
Q ss_pred HHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 332 KIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 332 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.+ .... ......++.+.+||.+||..||.+|||+.++|++
T Consensus 233 ~~-~~~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 FY-EKKH-----------------------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HH-Hhcc-----------------------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 11 1000 0011234568899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=312.23 Aligned_cols=242 Identities=24% Similarity=0.308 Sum_probs=189.6
Q ss_pred eecccCceEEEEEEECCCCe--EEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeEEEEeec
Q 011041 125 KIGQGTYSNVYKARDTLTGQ--IVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 125 ~LG~G~~g~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
.||+|+||.||+|++..++. .+++|.+... ........+.+|+.++.++ +||||+++++++.. ...+|+||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYA 78 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeC
Confidence 58999999999999988775 4688877632 2345556788999999999 89999999999987 45789999999
Q ss_pred cCChhhhhhCC----------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccc
Q 011041 202 EHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGL 265 (495)
Q Consensus 202 ~~~l~~~~~~~----------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~ 265 (495)
.++.+..+... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 86544433321 12478999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhh
Q 011041 266 ASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEY 344 (495)
Q Consensus 266 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (495)
+....... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+....
T Consensus 159 ~~~~~~~~--~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~------- 228 (270)
T cd05047 159 SRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY------- 228 (270)
T ss_pred ccccchhh--hccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-------
Confidence 86332111 1111223567999998765 568999999999999999997 999998876665555442110
Q ss_pred hhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.......++.++.+||.+||..||.+|||+.+++.
T Consensus 229 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 229 ---------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ---------------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 00011235677899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=329.38 Aligned_cols=254 Identities=20% Similarity=0.249 Sum_probs=199.1
Q ss_pred CCCeeeeeeecccCceEEEEEEEC-----CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 190 (495)
.++|.++++||+|+||.||+|++. .++..||+|++..... ....+.+.+|+.+|..+. |||||++++++..
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-- 112 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTK-- 112 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence 357889999999999999999864 3557899999976432 333456889999999997 9999999999877
Q ss_pred CceeEEEEeeccCChhhhhhCC----------------------------------------------------------
Q 011041 191 SCSLYLVFKYMEHDLAGLAASP---------------------------------------------------------- 212 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~---------------------------------------------------------- 212 (495)
...+|+||||+.++.+..++..
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 4579999999997654433311
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee
Q 011041 213 ----------------------------------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (495)
Q Consensus 213 ----------------------------------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl 252 (495)
...+++..+..|+.||+.||.|||++||+||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 1236778889999999999999999999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011041 253 DNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (495)
Q Consensus 253 ~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~ 330 (495)
+.++.+||+|||++..+..... .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||......+.+
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 9999999999999986532211 11223456888999998875 568999999999999999998 89999876655544
Q ss_pred HHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.........+ .....++.++.+||.+||..||.+||++.++++.
T Consensus 352 ~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRGYRM---------------------------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4332210000 0113457789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=310.49 Aligned_cols=249 Identities=20% Similarity=0.282 Sum_probs=188.7
Q ss_pred eecccCceEEEEEEEC--CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeecc
Q 011041 125 KIGQGTYSNVYKARDT--LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME 202 (495)
Q Consensus 125 ~LG~G~~g~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~ 202 (495)
.||+|+||.||+|... .....+++|.+.... .......+.+|+.+++.++|+||+++++.+.. ....|+||||+.
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEeCC
Confidence 5899999999999643 244678888776432 33445667889999999999999999999876 567999999999
Q ss_pred CChhhhhhCC-----CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC-CC
Q 011041 203 HDLAGLAASP-----TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-QP 276 (495)
Q Consensus 203 ~~l~~~~~~~-----~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~ 276 (495)
++.+..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 7655544322 12356788899999999999999999999999999999999999999999999865432211 11
Q ss_pred CccccccCCCCCcccccC------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 277 MTSRVVTLWYRPPELLLG------ATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~------~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
.....+++.|+|||++.. ...++.++|||||||++|+|++ |.+||...++.+.+..+.........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~------- 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP------- 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCC-------
Confidence 123345778999998742 2356889999999999999999 78899888777766665432211100
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.......+++.+.+++..|+ .||.+|||++++++
T Consensus 232 ----------------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 232 ----------------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ----------------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 00112346677788898888 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=310.68 Aligned_cols=251 Identities=23% Similarity=0.311 Sum_probs=201.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCe----EEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ----IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
.++|++++.||+|+||.||+|.++.+|. .||+|.+..... ......+.+|+.+++.++|+||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS---S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec---C
Confidence 4789999999999999999999877665 589998765532 4455678899999999999999999999875 4
Q ss_pred eeEEEEeeccCChhh-hhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 193 SLYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~-~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
..++||||+.++.+. .+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 689999999865444 4444455699999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCC-CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 272 NHKQP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 272 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
..... .....++..|+|||.+.. ..++.++|||||||++|||++ |.+||.+.+..+....+.... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~--------- 230 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RL--------- 230 (279)
T ss_pred cccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-CC---------
Confidence 32211 111223567999998764 568899999999999999998 999999887666555543210 00
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......+..+.++|..||..||.+|||+.++++
T Consensus 231 ------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 231 ------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 011234567889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=312.56 Aligned_cols=261 Identities=19% Similarity=0.174 Sum_probs=189.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECCC---CeEEEeEEEecCCCCh--HH-------HHHHHHHHHHHHhCCCCCeeeeec
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLT---GQIVALKKVRFDNLEP--ES-------VRFMAREILILRRLDHPNVVKLEG 184 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~---g~~vAiK~i~~~~~~~--~~-------~~~~~~Ei~il~~l~HpnIv~l~~ 184 (495)
.++|++.+.||+|+||.||+|++..+ +..+|+|+........ +. ......+...+..++|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999998877 6778888754433211 10 011123334456678999999998
Q ss_pred eeeccCC--ceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEee
Q 011041 185 LVTSRMS--CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIAD 262 (495)
Q Consensus 185 ~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~D 262 (495)
+...... ...+++++++...+...... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 7654321 24577888876665544332 33468899999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCC------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 011041 263 FGLASFFDPNHK------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336 (495)
Q Consensus 263 FG~a~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 336 (495)
||+++.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+....+....+.
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 999987643211 11223468999999998876 56899999999999999999999999887433222221110
Q ss_pred cCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 337 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
+++..... -.......++.+.++++.|+..||.+||+..++++
T Consensus 249 ------~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 ------DFIKRLHE---------------GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ------HHHHHhhh---------------hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11110000 00012345778999999999999999999999985
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=330.11 Aligned_cols=239 Identities=24% Similarity=0.365 Sum_probs=198.1
Q ss_pred eeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEee
Q 011041 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (495)
Q Consensus 121 ~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~ 200 (495)
.-++-||.|+.|.||+|+ ..++.||||+++ +.-+.+|+-|++|+|+||+.+.|++.. ...++|||||
T Consensus 127 sELeWlGSGaQGAVF~Gr--l~netVAVKKV~---------elkETdIKHLRkLkH~NII~FkGVCtq--sPcyCIiMEf 193 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGR--LHNETVAVKKVR---------ELKETDIKHLRKLKHPNIITFKGVCTQ--SPCYCIIMEF 193 (904)
T ss_pred hhhhhhccCcccceeeee--ccCceehhHHHh---------hhhhhhHHHHHhccCcceeeEeeeecC--CceeEEeeec
Confidence 335679999999999996 457899999875 222368999999999999999999987 4568999999
Q ss_pred ccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccc
Q 011041 201 MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280 (495)
Q Consensus 201 ~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 280 (495)
|..+-+..++..+..++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++..... ....++
T Consensus 194 Ca~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSF 271 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSF 271 (904)
T ss_pred cccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhh
Confidence 999888888887888999999999999999999999999999999999999999999999999999876433 345678
Q ss_pred cccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCc
Q 011041 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQ 360 (495)
Q Consensus 281 ~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 360 (495)
+||..|||||++.. .+.+.++|||||||+|||||||..||.+-+...+ |+ ..|.-. .
T Consensus 272 aGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---Iw-GVGsNs------L------------ 328 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---IW-GVGSNS------L------------ 328 (904)
T ss_pred hhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchhee---EE-eccCCc------c------------
Confidence 99999999999875 6789999999999999999999999976543322 11 111110 0
Q ss_pred ccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCC
Q 011041 361 SYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402 (495)
Q Consensus 361 ~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp 402 (495)
-.......|+.++=||+.||.-.|..||+..++|.|-
T Consensus 329 -----~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 329 -----HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred -----cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 0111235677888899999999999999999999983
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=306.62 Aligned_cols=246 Identities=22% Similarity=0.282 Sum_probs=189.8
Q ss_pred eeecccCceEEEEEEECC---CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEee
Q 011041 124 DKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~ 200 (495)
+.||+|+||.||+|.+.. .+..||||.+... ........+.+|+.+++.++||||+++++++... +...|++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEec
Confidence 368999999999998653 3467999987532 2344566788899999999999999999976543 4568899999
Q ss_pred ccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC---CC
Q 011041 201 MEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK---QP 276 (495)
Q Consensus 201 ~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~ 276 (495)
+.++.+..+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9875554443 3344577888899999999999999999999999999999999999999999999975532211 11
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
.....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+... .+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~~-------------- 221 (262)
T cd05058 159 HTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RRL-------------- 221 (262)
T ss_pred cccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CCC--------------
Confidence 122345778999998865 568999999999999999999 57788776665544443221 000
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+|+.+.+|+..||..||++||++.+++.
T Consensus 222 ------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 222 ------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred ------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 001235677899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=307.51 Aligned_cols=251 Identities=25% Similarity=0.439 Sum_probs=202.5
Q ss_pred CeeeeeeecccCceEEEEEEECC-CCeEEEeEEEecCC--------CChHHHHHHHHHHHHHHh-CCCCCeeeeeceeec
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTL-TGQIVALKKVRFDN--------LEPESVRFMAREILILRR-LDHPNVVKLEGLVTS 188 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~-~g~~vAiK~i~~~~--------~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~ 188 (495)
.|++.+.||+|+||.||++++.. +++.+|+|.+.... ........+.+|+.++.. ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999887 78899999986432 123345567789988875 799999999999887
Q ss_pred cCCceeEEEEeeccCChhhhh----hCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCeeeCCCCcEEEeec
Q 011041 189 RMSCSLYLVFKYMEHDLAGLA----ASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADF 263 (495)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~----~~~~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NILl~~~~~vkL~DF 263 (495)
+...|++|||+.++.+..+ ......+++..++.++.||+.+|.|||+ .||+|+||||+|||++.++.+||+||
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 5689999999987544332 2344579999999999999999999996 78999999999999999999999999
Q ss_pred ccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 011041 264 GLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE 343 (495)
Q Consensus 264 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (495)
|++....... ......|+..|++||++.+ ..++.++|||||||++|+|++|.+||...+.......+......+.
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 233 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-- 233 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--
Confidence 9998765432 3345678999999999876 5589999999999999999999999987766655555433211110
Q ss_pred hhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
....+++++.+||.+||..||.+||++.|+..+
T Consensus 234 -------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 -------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 012456789999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=309.54 Aligned_cols=229 Identities=25% Similarity=0.318 Sum_probs=183.6
Q ss_pred cCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeeccCChhhh
Q 011041 129 GTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGL 208 (495)
Q Consensus 129 G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~l~~~ 208 (495)
|.||.||+|+++.+|+.||+|.+.... ...+|...+....||||+++++++.+ ....|++|||+.++.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCHHH
Confidence 899999999999999999999997542 22345555566679999999999887 567999999999765555
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccccccCCCCC
Q 011041 209 AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRP 288 (495)
Q Consensus 209 ~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~a 288 (495)
.......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... .....++..|+|
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 4444456999999999999999999999999999999999999999999999999988655432 233456778999
Q ss_pred cccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCccccccccc
Q 011041 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAE 368 (495)
Q Consensus 289 PE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (495)
||.+.+ ..++.++||||+||++|+|++|.+||...... + .. .. ...
T Consensus 151 PE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------~~---------~~-------~~~ 196 (237)
T cd05576 151 PEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------NT---------HT-------TLN 196 (237)
T ss_pred CcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------cc---------cc-------ccC
Confidence 998765 46789999999999999999999887532110 0 00 00 001
Q ss_pred ccCCCCCCcHHHHHHhccCCCCCccCH-----HHHHhCCCC
Q 011041 369 TFKDFPPSSLPLIETLLAIDPAERQTA-----TAALRSEFF 404 (495)
Q Consensus 369 ~~~~~s~~~~~Li~~~L~~dP~~R~ta-----~elL~hp~f 404 (495)
....+++.+.+||.+||+.||.+|+|+ ++++.||||
T Consensus 197 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 197 IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 123467788999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=309.24 Aligned_cols=253 Identities=19% Similarity=0.275 Sum_probs=198.0
Q ss_pred eeeeeeecccCceEEEEEEEC---CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC----c
Q 011041 120 FEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS----C 192 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----~ 192 (495)
|.+.+.||+|+||.||+|.+. .++..||||++..........+.+.+|+.+++.++||||+++++++..... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999864 357899999997665555566778899999999999999999998765321 1
Q ss_pred eeEEEEeeccCChhhhhh-C-----CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccc
Q 011041 193 SLYLVFKYMEHDLAGLAA-S-----PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~-~-----~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a 266 (495)
..+++++|+.++.+.... . ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 347888999866543322 1 1225789999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhh
Q 011041 267 SFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEY 344 (495)
Q Consensus 267 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (495)
........ .......+++.|++||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~---- 234 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RL---- 234 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cC----
Confidence 86533221 11122345678999998765 467889999999999999999 899998877666555443210 00
Q ss_pred hhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.....+++.+.+|+..||..+|.+||++.+++++
T Consensus 235 -----------------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 -----------------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0012456788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=307.03 Aligned_cols=250 Identities=18% Similarity=0.213 Sum_probs=187.7
Q ss_pred eeecccCceEEEEEEEC--CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeec
Q 011041 124 DKIGQGTYSNVYKARDT--LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
+.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.+++.++||||+++++++.+ ...+|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEECC
Confidence 35899999999999754 4567899998876543 2334567889999999999999999999876 45689999999
Q ss_pred cCChhhhhhC-----CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC-C
Q 011041 202 EHDLAGLAAS-----PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-Q 275 (495)
Q Consensus 202 ~~~l~~~~~~-----~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~ 275 (495)
.++.+..++. ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ .
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9765544332 123467778889999999999999999999999999999999999999999999875432211 1
Q ss_pred CCccccccCCCCCcccccCC------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 276 PMTSRVVTLWYRPPELLLGA------TDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~------~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
......+++.|+|||++.+. ..++.++|||||||++|||++ |.+||...+..+............
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLK-------- 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCC--------
Confidence 11234568889999988532 135789999999999999996 999998776655443322110000
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.+ .......+++.+.+|+..|+ .||.+|||+.++++
T Consensus 230 -~~--------------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 230 -LP--------------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred -CC--------------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 00 00011235567888999998 69999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=313.05 Aligned_cols=252 Identities=20% Similarity=0.298 Sum_probs=197.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCe----EEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ----IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
.++|+..+.||+|+||.||+|++..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---
Confidence 4789999999999999999999887776 46888876443 233344678899999999999999999988652
Q ss_pred eeEEEEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 193 SLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 193 ~~~lv~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
..++++||+.++ +...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 467899999865 4444444455689999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 272 NHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 272 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
.... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+....+ .....++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~-------- 231 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERLP-------- 231 (303)
T ss_pred cccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCC--------
Confidence 3221 1122345778999998865 568999999999999999997 89999876544433222 2110000
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.....+..+.++|..|+..||++||++.++++.
T Consensus 232 -------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 232 -------------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012245678899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=305.16 Aligned_cols=236 Identities=21% Similarity=0.264 Sum_probs=186.4
Q ss_pred eeecccCceEEEEEEECCCC----------eEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 124 DKIGQGTYSNVYKARDTLTG----------QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g----------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
+.||+|+||.||+|.+..++ ..|++|.+..... ....+.+|+.+|+.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR---DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec---CC
Confidence 36999999999999998777 3578887654321 15678899999999999999999998876 34
Q ss_pred eEEEEeeccCChhhhhhCCCC-CCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC-------cEEEeeccc
Q 011041 194 LYLVFKYMEHDLAGLAASPTI-KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-------ILTIADFGL 265 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~-~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~-------~vkL~DFG~ 265 (495)
.++||||+.++.+..+..... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 799999999877665554333 789999999999999999999999999999999999999887 799999999
Q ss_pred ccccCCCCCCCCccccccCCCCCcccccCC-CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChh
Q 011041 266 ASFFDPNHKQPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEE 343 (495)
Q Consensus 266 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (495)
+..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..+....... ..
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~----- 223 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QH----- 223 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CC-----
Confidence 976543 1234567789999998764 368899999999999999999 5778876653332222110 00
Q ss_pred hhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.........+.+||.+||..||.+|||+.++++
T Consensus 224 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 224 ------------------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ------------------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000011267889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=307.51 Aligned_cols=244 Identities=23% Similarity=0.334 Sum_probs=192.4
Q ss_pred eecccCceEEEEEEECCCC------eEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 125 KIGQGTYSNVYKARDTLTG------QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 125 ~LG~G~~g~Vy~a~~~~~g------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
.||+|+||.||+|++.... ..||||.+.... .......+.+|+.+++.++||||+++++++.. ....|+||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYIIM 78 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeEEEE
Confidence 6899999999999876544 789999886542 23345678889999999999999999999876 45799999
Q ss_pred eeccCChhhhhhC-------CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC-----cEEEeecccc
Q 011041 199 KYMEHDLAGLAAS-------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-----ILTIADFGLA 266 (495)
Q Consensus 199 e~~~~~l~~~~~~-------~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~-----~vkL~DFG~a 266 (495)
||+.++.+..... ....+++..+..++.||+.||.|||+++++|+||||+|||++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9998654443322 223478999999999999999999999999999999999999877 8999999998
Q ss_pred cccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhh
Q 011041 267 SFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEY 344 (495)
Q Consensus 267 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (495)
........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~------- 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG------- 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-------
Confidence 75532211 11123345778999998875 568999999999999999998 999998877766555442110
Q ss_pred hhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.......+|..+.+||.+||..||.+||++.++++
T Consensus 231 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 ---------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ---------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00112346678899999999999999999999975
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=304.28 Aligned_cols=242 Identities=22% Similarity=0.383 Sum_probs=195.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||++. .+++.||+|++.... ....+.+|+.+++.++||||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~ 75 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYI 75 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEE
Confidence 3679999999999999999985 578899999986432 23567889999999999999999998865 24799
Q ss_pred EEeeccCChh-hhhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLA-GLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~-~~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
+|||+.++.+ ..+... ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 9999986544 444332 335899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......+..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+.+...
T Consensus 154 --~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------------- 215 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR--------------- 215 (254)
T ss_pred --CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC---------------
Confidence 122234567999998865 568899999999999999997 9999988876665554432100
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......+++.+.+||.+||..||.+||++.+++.
T Consensus 216 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 216 -------------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred -------------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0011346778899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=318.46 Aligned_cols=257 Identities=25% Similarity=0.338 Sum_probs=191.3
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
+.|..-..||+|+||.||+|.... |..||||.+....... ...|.+|+.+|.+++|||+|+|+|||.+... ..+||
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LV 150 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLV 150 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEE
Confidence 667777899999999999998554 4899999876554322 3449999999999999999999999987422 59999
Q ss_pred EeeccCChhhhhhC-CCC-CCCHHHHHHHHHHHHHHHHHhhhCC---ceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 198 FKYMEHDLAGLAAS-PTI-KFTQAQVKCYMHQLLSGLEHCHNQH---VLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 198 ~e~~~~~l~~~~~~-~~~-~l~e~~~~~i~~qil~~L~~LH~~g---ivHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
+|||..+.+...+. ... .+++.....|+.+++.||+|||+.. |||||||++|||||++++.||+|||+|......
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 99999766655544 333 8999999999999999999999754 999999999999999999999999999654331
Q ss_pred CCCCCccc-cccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCChhhhhhC
Q 011041 273 HKQPMTSR-VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT---EVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 273 ~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~---~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
....... .||.+|+|||.+.. ...+.++|||||||+|+||++|+.+..... +.....-.........-..|
T Consensus 231 -~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei--- 305 (361)
T KOG1187|consen 231 -DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREI--- 305 (361)
T ss_pred -ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhe---
Confidence 1222222 79999999998865 568999999999999999999998877532 11111111111101000000
Q ss_pred CCCCCccCCCCccccccccccc--CCCC-----CCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 349 KLPHATIFKPQQSYKRCIAETF--KDFP-----PSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~--~~~s-----~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
+...+ ..++ ..+..+...|++.+|.+||++.|+++
T Consensus 306 -----------------iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 306 -----------------VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred -----------------eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 11111 1111 12566889999999999999999765
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=308.01 Aligned_cols=257 Identities=22% Similarity=0.351 Sum_probs=198.5
Q ss_pred CCeeeeeeecccCceEEEEEEEC----CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDT----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.+|++.+.||+|+||.||+|+.. .++..||+|++...... .....+.+|+.+++.+.|+||+++++++.......
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 57889999999999999999864 34889999999765433 45678899999999999999999999987755667
Q ss_pred eEEEEeeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+++|||+.++.+..+. .....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 99999999865444443 43446999999999999999999999999999999999999999999999999999876532
Q ss_pred CCCC--CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-----------HHHHHHhcCC
Q 011041 273 HKQP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ-----------LHKIFKLCGS 339 (495)
Q Consensus 273 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~-----------~~~i~~~~g~ 339 (495)
.... .....++..|++||.+.+ ..++.++|||||||++|+|++|..||........ ...+...+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 2111 112234567999998865 4688999999999999999999998865432210 1111110000
Q ss_pred CChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.. .......++.++.+|+.+||..||.+|||+.++++
T Consensus 242 ~~------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 242 GE------------------------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred CC------------------------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 00011235677899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=317.42 Aligned_cols=265 Identities=24% Similarity=0.376 Sum_probs=214.6
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-----ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-----EPESVRFMAREILILRRLDHPNVVKLEGLVTSRM 190 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 190 (495)
..++|-++.+||+|+|+.||+|.|....++||+|+-..... .....+...+|..|.+.|+||-||++|++|.-.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD- 539 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD- 539 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-
Confidence 35789999999999999999999999999999998654332 233455677999999999999999999999754
Q ss_pred CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhC--CceeccCCCCCeeeCC---CCcEEEeeccc
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ--HVLHRDIKGSNLLIDN---EGILTIADFGL 265 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~--givHrDlKp~NILl~~---~~~vkL~DFG~ 265 (495)
...+|-|+|||+|..+++++....-++|.+++.|+.||+.||.||.+. .|||-||||.||||.. .|.+||+|||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 467899999999988888888888899999999999999999999965 5999999999999954 47899999999
Q ss_pred ccccCCCCCCC------CccccccCCCCCcccccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHH--H
Q 011041 266 ASFFDPNHKQP------MTSRVVTLWYRPPELLLG---ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHK--I 333 (495)
Q Consensus 266 a~~~~~~~~~~------~~~~~gt~~y~aPE~l~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~--i 333 (495)
+++++...... .....||.||++||.+.- ....+.++||||+|||+|..+.|+.||...... +++.. |
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 99886543321 233578999999998843 235788999999999999999999999765433 33322 1
Q ss_pred HHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 334 FKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 334 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
++. .....|. -+.+++++++||++||.+--++|....++-.||||.-+
T Consensus 700 lkA----------------tEVqFP~----------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 700 LKA----------------TEVQFPP----------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred hcc----------------eeccCCC----------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 110 0001111 13477899999999999999999999999999999753
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=302.55 Aligned_cols=249 Identities=18% Similarity=0.260 Sum_probs=187.5
Q ss_pred eecccCceEEEEEEECCC--CeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeecc
Q 011041 125 KIGQGTYSNVYKARDTLT--GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME 202 (495)
Q Consensus 125 ~LG~G~~g~Vy~a~~~~~--g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~ 202 (495)
.||+|+||.||++..... ...+++|.+.... .......+.+|+.+++.++||||+++++++.+ ....|+||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEecCC
Confidence 599999999999975433 2456677765433 23445678899999999999999999999887 467899999999
Q ss_pred CChhhhhhCC----CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC-CCCC
Q 011041 203 HDLAGLAASP----TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-KQPM 277 (495)
Q Consensus 203 ~~l~~~~~~~----~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 277 (495)
++.+..+... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 7555443322 2346778888999999999999999999999999999999999999999999986432111 1122
Q ss_pred ccccccCCCCCcccccCC------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 278 TSRVVTLWYRPPELLLGA------TDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~------~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
...+++..|+|||++... ..++.++|||||||++|||++ |.+||...++.+.+..+.+..... .+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~----- 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK---LF----- 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc---cC-----
Confidence 345678899999987431 235778999999999999996 678898877777776654321110 00
Q ss_pred CCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
. ......+++.+.+||..|+ .||.+|||+.++++
T Consensus 231 ------~---------~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 231 ------K---------PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ------C---------CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0 0111235677888999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.30 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=208.4
Q ss_pred CCCeeeeeeecccCceEEEEEEEC-----CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
..+.+..+.||+|+||.||+|+-. .....||||.++... +.....+|+||+.+|..|+|||||+|+|++.. +
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~--~ 561 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCRE--G 561 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc--C
Confidence 356677889999999999999753 234689999987543 44567899999999999999999999999987 5
Q ss_pred ceeEEEEeeccCChhhhhh-C---------CCC----CCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCc
Q 011041 192 CSLYLVFKYMEHDLAGLAA-S---------PTI----KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI 257 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~-~---------~~~----~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~ 257 (495)
..+|||||||.++.+..++ . .+. .|+..+...|+.||+.|++||-++.+|||||-..|+||.++..
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence 6799999999976554332 1 112 3889999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 011041 258 LTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFK 335 (495)
Q Consensus 258 vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~ 335 (495)
|||+|||+++.+-..+. .......-...||+||.|+- ..|+.++||||+||+|+|+++ |+.||.|-+++++++.|..
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~ 720 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA 720 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence 99999999985532222 22223344678999999986 579999999999999999997 9999999999999998864
Q ss_pred hcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHH
Q 011041 336 LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399 (495)
Q Consensus 336 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL 399 (495)
.- +.....+.|.++++|+..|++.+|.+||+..||=
T Consensus 721 g~----------------------------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 721 GQ----------------------------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred CC----------------------------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 21 3344567899999999999999999999999873
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.84 Aligned_cols=203 Identities=30% Similarity=0.459 Sum_probs=175.0
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC----Cce
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SCS 193 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~ 193 (495)
..|..-+.||+|+||.||+++++.+|+.||||.++... .....+.+-+|+++|++|+|+|||++.++-+... ...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 44667788999999999999999999999999998654 3345567889999999999999999998876655 456
Q ss_pred eEEEEeeccCChhhhhhC---CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC--CC--cEEEeecccc
Q 011041 194 LYLVFKYMEHDLAGLAAS---PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN--EG--ILTIADFGLA 266 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~---~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~--~~--~vkL~DFG~a 266 (495)
-.+|||||.++.+...+. +...|+|.+...++..+..||.|||++|||||||||+||++-. +| .-||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 789999999876655543 2446999999999999999999999999999999999999843 34 4799999999
Q ss_pred cccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 011041 267 SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG 323 (495)
Q Consensus 267 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~ 323 (495)
+..+.+ ..+.+.+||+.|.+||++.....|+..+|.|||||++|+++||..||-.
T Consensus 172 rel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 172 RELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 988655 4788999999999999987557899999999999999999999999864
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=300.87 Aligned_cols=262 Identities=23% Similarity=0.369 Sum_probs=208.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHH-HhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILIL-RRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++.+-+..||.|+||+|++..++.+|+..|||.|+......+ ..++..|.... +.-+.||||++||.... ++..|
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke-q~rll~e~d~~mks~~cp~IVkfyGa~F~--EGdcW 139 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE-QKRLLMEHDTVMKSSNCPNIVKFYGALFS--EGDCW 139 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH-HHHHHHHHHHHHhhcCCcHHHHHhhhhhc--CCcee
Confidence 3566677889999999999999999999999999998765444 45566666654 44589999999998876 45689
Q ss_pred EEEeeccCChhhhhh----CCCCCCCHHHHHHHHHHHHHHHHHhh-hCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 196 LVFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCH-NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 196 lv~e~~~~~l~~~~~----~~~~~l~e~~~~~i~~qil~~L~~LH-~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
|-||+|+-++..++. -....++|.-+..|...++.||+||- +..||||||||+||||+..|.|||||||++..+.
T Consensus 140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 999999987665543 24557999999999999999999998 5689999999999999999999999999987654
Q ss_pred CCCCCCCccccccCCCCCcccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChhhhhhC
Q 011041 271 PNHKQPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAEKPIMPGRTE-VEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
.. -..+.-.|-..|||||.+.... .|+.++||||||++|||+.||.-|+.+-+. .+++..+. .|.|+.-..
T Consensus 220 ~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~l~~--- 292 (361)
T KOG1006|consen 220 DS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPILLF--- 292 (361)
T ss_pred HH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCeecC---
Confidence 32 2234457888999999996543 499999999999999999999999987443 35555443 244432111
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
....-.++..+..+|..||.+|-..||...+++.+||+..
T Consensus 293 ------------------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 293 ------------------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred ------------------cccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 1112347788999999999999999999999999999975
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=327.67 Aligned_cols=263 Identities=27% Similarity=0.434 Sum_probs=216.8
Q ss_pred CCCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeec---c
Q 011041 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS---R 189 (495)
Q Consensus 114 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~---~ 189 (495)
+...+.|++.+.||.|.+|.||+++++.+|+.+|+|+...+.- ..+.++-|..||+.+ +|||++.++++|.. .
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3446889999999999999999999999999999999876543 234466788999988 69999999998853 2
Q ss_pred CCceeEEEEeeccCChhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 190 MSCSLYLVFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 190 ~~~~~~lv~e~~~~~l~~~~~~~--~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
.++.+|||||||.+|...++... +..+.|..+..|++.++.||.+||.+.++|||||-.|||++.++.|||+|||.+.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 35689999999998866655432 5679999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCccccccCCCCCcccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 011041 268 FFDPNHKQPMTSRVVTLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE 343 (495)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (495)
..+.. .....+.+|||.|||||++... ..|+..+|+||||++..||.-|.||+.+.-+.-.+.+| .-.|++.
T Consensus 172 QldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPPk 247 (953)
T KOG0587|consen 172 QLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPPK 247 (953)
T ss_pred eeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCCcc
Confidence 77643 3445677999999999998532 34788999999999999999999999876665554443 3333322
Q ss_pred hhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
. ......+.++.+||..||.+|-.+||+..++|+|||++.
T Consensus 248 L-----------------------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 248 L-----------------------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred c-----------------------cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 1 112345677888999999999999999999999999983
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.29 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=206.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCe---E-EEeEEEecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ---I-VALKKVRFDN-LEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~---~-vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
.++-.+.++||+|+||.||+|+.+..+. . ||+|...... ...+....+.+|+++|+.++|||||++||+... .
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~--~ 233 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL--E 233 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC--C
Confidence 3555667899999999999998765432 3 8999988633 567888899999999999999999999999987 4
Q ss_pred ceeEEEEeeccCChhhhhhCCCC-CCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 192 CSLYLVFKYMEHDLAGLAASPTI-KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~-~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
.-+|||||+|.|+.+..++.... .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||+++...
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 56999999999876666665544 69999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
. .............|+|||.+.. .-|+.++|||||||++||+++ |..||.+.+..+...+|.......+
T Consensus 314 ~-~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~-------- 383 (474)
T KOG0194|consen 314 Q-YVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP-------- 383 (474)
T ss_pred c-eeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC--------
Confidence 1 1111111124567999999876 479999999999999999998 8899999999999888854221111
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
....-|.++..++..|+..||++|+|+.++.+
T Consensus 384 -------------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 384 -------------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred -------------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 11234567788999999999999999998875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=332.72 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=206.9
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCC-----eEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTG-----QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM 190 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 190 (495)
....-++++.||+|+||.||.|.-.... ..||||.+.+.. +......|.+|+.+|..++|||||+++|++.+
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-- 766 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-- 766 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--
Confidence 3466788899999999999999865332 348999887543 55667789999999999999999999999988
Q ss_pred CceeEEEEeeccCC-hhhhhhCC------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeec
Q 011041 191 SCSLYLVFKYMEHD-LAGLAASP------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADF 263 (495)
Q Consensus 191 ~~~~~lv~e~~~~~-l~~~~~~~------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DF 263 (495)
....+|++|||+++ |+..+... ...++..+...++.||+.|+.||+++++|||||-..|+||+....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 56789999999965 55555554 456899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCccc-cccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 011041 264 GLASFFDPNHKQPMTSR-VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPS 341 (495)
Q Consensus 264 G~a~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~ 341 (495)
|+|+.+-.......... .-...|||||.+.. ..++.++|||||||+|||+++ |..||.+.++.+++.-.++.- ..
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL- 923 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RL- 923 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-cc-
Confidence 99994322211111111 22356999999986 679999999999999999998 999999999999887655422 11
Q ss_pred hhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
+....+|..+++|+..|++.||++||+...+++
T Consensus 924 --------------------------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 --------------------------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred --------------------------CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 122457888999999999999999999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=315.11 Aligned_cols=275 Identities=24% Similarity=0.309 Sum_probs=188.2
Q ss_pred CCCCeeeeeeecccCceEEEEEEEC----------------CCCeEEEeEEEecCCCCh------------HHHHHHHHH
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDT----------------LTGQIVALKKVRFDNLEP------------ESVRFMARE 167 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~----------------~~g~~vAiK~i~~~~~~~------------~~~~~~~~E 167 (495)
..++|.+.++||+|+||+||+|.+. ..++.||||.+....... ...+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4689999999999999999999752 345679999986542110 011223457
Q ss_pred HHHHHhCCCCCe-----eeeeceeecc------CCceeEEEEeeccCChhhhhhCC------------------------
Q 011041 168 ILILRRLDHPNV-----VKLEGLVTSR------MSCSLYLVFKYMEHDLAGLAASP------------------------ 212 (495)
Q Consensus 168 i~il~~l~HpnI-----v~l~~~~~~~------~~~~~~lv~e~~~~~l~~~~~~~------------------------ 212 (495)
+.++.+++|.++ +++++++... .....||||||+.++.+..++..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788866654 6677776531 12468999999997655443321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccccccCCCCCcccc
Q 011041 213 TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL 292 (495)
Q Consensus 213 ~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l 292 (495)
...+++..++.++.||+.+|.|||+++|+||||||+|||++.++.+||+|||++...............+|+.|+|||++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 11245678899999999999999999999999999999999999999999999976543322111222448999999987
Q ss_pred cCCCC-------------------CC--chhhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 293 LGATD-------------------YG--VGVDLWSAGCILAELLAEKP-IMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 293 ~~~~~-------------------~~--~~~DvwSlGvil~elltG~~-pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
..... |+ ...||||+|||+|+|++|.. ||.+...... .++.. ......|.....
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~---~~~~~-~~~~~~~r~~~~ 458 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT---ELRQY-DNDLNRWRMYKG 458 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh---HHhhc-cchHHHHHhhcc
Confidence 54211 22 24799999999999999875 6654322111 11110 111122322110
Q ss_pred CCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCC---CCccCHHHHHhCCCCCC
Q 011041 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDP---AERQTATAALRSEFFTT 406 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP---~~R~ta~elL~hp~f~~ 406 (495)
.. + ....+..+++.+.|||.+||..+| .+|+|+.|+|+||||..
T Consensus 459 ~~---------~---~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 459 QK---------Y---DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cC---------C---CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00 0 011244578899999999999876 68999999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=282.48 Aligned_cols=243 Identities=38% Similarity=0.597 Sum_probs=196.6
Q ss_pred CceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeeccCChhhhh
Q 011041 130 TYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLA 209 (495)
Q Consensus 130 ~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~ 209 (495)
+||.||+|++..+|+.|++|++........ ...+.+|+.+++.++|+||+++++++.. ....+++|||+.++.+..+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHH
Confidence 589999999999999999999876543221 5788899999999999999999999887 4679999999998544444
Q ss_pred hCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccccccCCCCCc
Q 011041 210 ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPP 289 (495)
Q Consensus 210 ~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aP 289 (495)
......+++..+..++.+|+.+|.|||+.||+|+||+|.||+++.++.++|+|||++....... ......++..|++|
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p 155 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP 155 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence 4333348999999999999999999999999999999999999999999999999998765432 23455788899999
Q ss_pred ccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCChhhhhhCCCCCCccCCCCccccccccc
Q 011041 290 ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAE 368 (495)
Q Consensus 290 E~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (495)
|.+.+ ..++.++||||||+++|+|++|..||...... .....+........ .
T Consensus 156 E~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~ 208 (244)
T smart00220 156 EVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP--------------------------P 208 (244)
T ss_pred HHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc--------------------------c
Confidence 98865 56788999999999999999999999874333 33333221111100 0
Q ss_pred ccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 369 TFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 369 ~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
....++.++.+++.+||..||.+||++.++++||||
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 011166788999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=299.21 Aligned_cols=281 Identities=32% Similarity=0.521 Sum_probs=215.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECC---CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 192 (495)
.+.|..+++||+|+|++||++++.. ..+.||+|.|.... ....+.+|+++|..+ .+.||+++.+++.. +.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rn--nd 108 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRN--ND 108 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhcc--CC
Confidence 4679999999999999999999887 78899999987543 235688999999999 59999999999977 56
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC-CCcEEEeecccccccCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADFGLASFFDP 271 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~-~~~vkL~DFG~a~~~~~ 271 (495)
.+.+||||++++....+.. .++..+++.|++.++.||.++|.+|||||||||.|+|.+. .+.-.|+|||+|...+.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 8999999999977666554 4678999999999999999999999999999999999986 57889999999973211
Q ss_pred CC-------------------------------------------CCCCccccccCCCCCcccccCCCCCCchhhHHHHH
Q 011041 272 NH-------------------------------------------KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAG 308 (495)
Q Consensus 272 ~~-------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlG 308 (495)
.. .....+..||++|+|||++.....-+.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 00012457899999999999888889999999999
Q ss_pred HHHHHHHhCCCCCC-CCChHHHHHHHHHhcCCCC--------hh--hhhhCCCCCCc----cCCCC--cccc-----ccc
Q 011041 309 CILAELLAEKPIMP-GRTEVEQLHKIFKLCGSPS--------EE--YWKKSKLPHAT----IFKPQ--QSYK-----RCI 366 (495)
Q Consensus 309 vil~elltG~~pf~-~~~~~~~~~~i~~~~g~~~--------~~--~~~~~~~~~~~----~~~~~--~~~~-----~~~ 366 (495)
||+.-++++..||. ..++.+.+..|..+.|.-. .. .|.+...+... .|... ..+. .+.
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 99999999987765 4666677777766665432 11 33322211000 00000 0011 122
Q ss_pred ccccCC-CCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 367 AETFKD-FPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 367 ~~~~~~-~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.+...+ ++..+.+|+++||..||.+|.||+++|+||||..
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 233333 3458999999999999999999999999999983
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=298.15 Aligned_cols=257 Identities=21% Similarity=0.283 Sum_probs=203.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
+...+.++||+|.||.|.+|. ...+..||+|+++.+. .......|.+||++|.+|+|||||+|+|++.. +..++|+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~--DePicmI 613 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQ--DDPLCMI 613 (807)
T ss_pred hheehhhhhcCcccceeEEEE-ecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeec--CCchHHH
Confidence 567888999999999999997 4446899999998654 34445789999999999999999999999987 5679999
Q ss_pred EeeccCChhhhhhCCC-C-CCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC-
Q 011041 198 FKYMEHDLAGLAASPT-I-KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK- 274 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~-~-~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~- 274 (495)
+|||+.+.+..++... . .+.......|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++.+-.+..
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999976555444322 1 234455667999999999999999999999999999999999999999999985533322
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL--AEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ell--tG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
......+-...|||+|.++- ..++.++|+|+||+++||++ |...||...++.+..++....+......
T Consensus 694 ~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~--------- 763 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ--------- 763 (807)
T ss_pred eeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc---------
Confidence 22223355788999999875 57899999999999999986 5788998888777766654433222211
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
........+|..+.+||.+|+..|-.+||+.+++-.
T Consensus 764 ------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 764 ------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred ------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 012223557888999999999999999999999854
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.47 Aligned_cols=245 Identities=21% Similarity=0.348 Sum_probs=200.3
Q ss_pred eeeeecccCceEEEEEEECCC----CeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 122 KLDKIGQGTYSNVYKARDTLT----GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 122 ~~~~LG~G~~g~Vy~a~~~~~----g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
+.+.||.|.||.||+|....- .-.||||..+.+. ..+..+.|..|+.+|+.++|||||+|+|++.+ ...|||
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e---~P~Wiv 468 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---QPMWIV 468 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec---cceeEE
Confidence 346799999999999975432 3468999887653 45567889999999999999999999999986 358999
Q ss_pred EeeccCChhh-hhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 198 FKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 198 ~e~~~~~l~~-~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||++.-|.+. ++..+...++......|+.||+.+|.|||+..+|||||-..||||.....|||+|||+++.++......
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence 9999866554 445556679999999999999999999999999999999999999999999999999999887654433
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
.+...-..-|||||.+.- ..++.++|||-|||++||++. |..||.|-.+.+++..|.+.-.
T Consensus 549 aS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR----------------- 610 (974)
T KOG4257|consen 549 ASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER----------------- 610 (974)
T ss_pred ccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC-----------------
Confidence 332233567999998754 568999999999999999986 9999999877776665543211
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHH
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL 399 (495)
....+.+|+.++.|+.+|+.+||.+||+..++.
T Consensus 611 -----------lP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 611 -----------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred -----------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 112356889999999999999999999977654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=310.84 Aligned_cols=252 Identities=22% Similarity=0.366 Sum_probs=217.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCC---eEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTG---QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.....|.+.||.|.||.|++|+.+..| ..||||.++... .......|..|+.||-+++||||++|.|++.. ..-
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk--s~P 704 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK--SKP 704 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEec--Cce
Confidence 355678889999999999999988776 469999987543 45566788899999999999999999999987 567
Q ss_pred eEEEEeeccCCh-hhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDL-AGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l-~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
+.||+|||+.+. ...+....++|+.-+...+++.|+.|+.||-++|+|||||-..||||+.+..+|++|||+++.+.+.
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 999999999664 4455667788999999999999999999999999999999999999999999999999999988655
Q ss_pred CCCCCccccc--cCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 273 HKQPMTSRVV--TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 273 ~~~~~~~~~g--t~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
....+++.-| ...|.|||.+.- ..++.++||||+||+|+|.++ |..||+.-+++++++.|.+...-|++
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP------- 856 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP------- 856 (996)
T ss_pred CCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC-------
Confidence 4344444444 567999999865 578999999999999999875 99999999999999999876654442
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.+.|..+..|+..|+++|-.+||+..||+.
T Consensus 857 ---------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 857 ---------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred ---------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 478899999999999999999999999876
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.09 Aligned_cols=261 Identities=27% Similarity=0.408 Sum_probs=221.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|+++..+|.|+||.||+++|+.+++..|+|+++... .+...-++.||-+++..+|||||.+++.|.. ...+++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr--~dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR--RDKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhh--hcCcEE
Confidence 378999999999999999999999999999999998764 3455677889999999999999999999876 456999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
.||||+++.+..+..-.+.++|.++..+++..+.||+|||++|=+|||||-.|||+++.|.+||+|||.+..+... ...
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~K 168 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAK 168 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh-hhh
Confidence 9999999988888888889999999999999999999999999999999999999999999999999998766432 234
Q ss_pred CccccccCCCCCcccc--cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 277 MTSRVVTLWYRPPELL--LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l--~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
..++.||++|||||+- .....|+..+|||++|++..|+---+||....-+...+..+.+....|+.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~------------ 236 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT------------ 236 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc------------
Confidence 5678999999999986 23457999999999999999999888887776666666555443332221
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.+.-...++.+.+|++.+|.++|.+|||++.+|+|||.+.
T Consensus 237 ------------lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 237 ------------LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred ------------ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 1111234567888999999999999999999999999875
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=298.14 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=207.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCC-C--eEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLT-G--QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-g--~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.++..++++||+|+||+|++|.+... | -.||||.++.+.... ....|.+|+.+|.+|+|+|+++|||++.+ .-
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~---qp 184 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD---QP 184 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc---ch
Confidence 45677889999999999999988643 3 468999998776554 67889999999999999999999999986 34
Q ss_pred eEEEEeeccCChhhhhh-C-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 194 LYLVFKYMEHDLAGLAA-S-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~-~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
+.||||++..+.+...+ . ....|.......|+.||+.|+.||.++++|||||-..||||-....|||+||||.+.+..
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 88999999976444333 3 455788999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCC-c-cccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 272 NHKQPM-T-SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 272 ~~~~~~-~-~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
+..... . ..-....|.|||.|.. ..++.++|||++||+||||++ |..||.|.+...++++|-+.-
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e----------- 332 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE----------- 332 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc-----------
Confidence 543221 1 1123567999998865 678999999999999999997 899999999999998884210
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+.+|.++++++..|+..+|++|||...|.+
T Consensus 333 -----------------rLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 333 -----------------RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred -----------------cCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 12234568889999999999999999999988853
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=257.71 Aligned_cols=214 Identities=24% Similarity=0.413 Sum_probs=180.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++...+..||+|+||+|-+.++..+|...|+|.++.. .......++.+|+.+..+. ++|.+|+++|.+.. ...++
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t-vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egdvw 121 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT-VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGDVW 121 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh-cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cccEE
Confidence 46677788999999999999999999999999999754 3445566777888876665 89999999998776 56799
Q ss_pred EEEeeccCChhhhh---hCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 196 LVFKYMEHDLAGLA---ASPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 196 lv~e~~~~~l~~~~---~~~~~~l~e~~~~~i~~qil~~L~~LH~~-givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
|.||.|..++..++ ...+..++|..+-.++..++.||+|||++ .|||||+||+||||+.+|+||+||||++-.+.+
T Consensus 122 IcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 122 ICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred EeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 99999998766543 45677899999999999999999999965 899999999999999999999999999976643
Q ss_pred CCCCCCccccccCCCCCcccccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHH
Q 011041 272 NHKQPMTSRVVTLWYRPPELLLG---ATDYGVGVDLWSAGCILAELLAEKPIMPG-RTEVEQLHKIFK 335 (495)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DvwSlGvil~elltG~~pf~~-~~~~~~~~~i~~ 335 (495)
.- ..+...|-..|||||.+.. ...|+.++||||||+++.||.+++.||.. .++.+++.++.+
T Consensus 202 Si--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 202 SI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 21 2233467788999999843 24699999999999999999999999874 788899988875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=296.21 Aligned_cols=205 Identities=24% Similarity=0.394 Sum_probs=179.6
Q ss_pred CCCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChH------HHHHHHHHHHHHHhCC---CCCeeeeec
Q 011041 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPE------SVRFMAREILILRRLD---HPNVVKLEG 184 (495)
Q Consensus 114 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~------~~~~~~~Ei~il~~l~---HpnIv~l~~ 184 (495)
..+..+|..++.||.|+||.|++|.++.....|+||.|.++..-.+ ....+-.||+||..|+ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 3456789999999999999999999999999999999987754211 1223557999999997 999999999
Q ss_pred eeeccCCceeEEEEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeec
Q 011041 185 LVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADF 263 (495)
Q Consensus 185 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DF 263 (495)
+|++ +.++||+||-.+.+ .++.++.....++|.+++.|++|++.|+++||+.||||||||-||+.++.+|-+||+||
T Consensus 637 fFEd--dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 637 FFED--DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred eeec--CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 9998 67899999987643 44556666778999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 011041 264 GLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG 323 (495)
Q Consensus 264 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~ 323 (495)
|.+.... ..++..++||..|.|||++.|..+.+..-|||+||++||-++...-||+.
T Consensus 715 gsaa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 715 GSAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9997654 35678899999999999999988889999999999999999999888863
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=290.87 Aligned_cols=245 Identities=22% Similarity=0.364 Sum_probs=201.0
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+...-.+||-|.||.||.+.++.-...||||.++-+. -.++.|..|+.+|+.++|||+|+|+|+|.. .--+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~--EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH--EPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhcc--CCCeEEEE
Confidence 3444578999999999999999999999999987554 345678899999999999999999999987 45699999
Q ss_pred eeccC-ChhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 199 KYMEH-DLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 199 e~~~~-~l~~~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
|||.. +|+.++... ...++.-....++.||..|++||..+++|||||-..|.||.++..||++|||+++++....
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT--- 419 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT--- 419 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc---
Confidence 99985 455555443 3346667778889999999999999999999999999999999999999999999886543
Q ss_pred Cccccc---cCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 277 MTSRVV---TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 277 ~~~~~g---t~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
++.+.| ..-|.|||-|.- ..++.++|||+|||+|||+.| |..||+|.+-..++..+.+..
T Consensus 420 YTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy--------------- 483 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY--------------- 483 (1157)
T ss_pred eecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc---------------
Confidence 344444 567999998754 568999999999999999987 999999987665554443321
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.-+....+|+.+++|++.|++|.|.+||+..|+-+
T Consensus 484 -------------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 484 -------------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred -------------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 11233568899999999999999999999888754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=306.04 Aligned_cols=246 Identities=26% Similarity=0.394 Sum_probs=188.3
Q ss_pred eeeecccCce-EEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeEEEEee
Q 011041 123 LDKIGQGTYS-NVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKY 200 (495)
Q Consensus 123 ~~~LG~G~~g-~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~lv~e~ 200 (495)
-+.+|.|+.| .||+|. -.|+.||||.+- .+......+||..|+.- +|||||++++.-.+ ..++||..|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll-----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d--~qF~YIalEL 584 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLL-----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQD--RQFLYIALEL 584 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHh-----hHhHHHHHHHHHHHHhccCCCceEEEEeeccC--CceEEEEehH
Confidence 3668999887 689995 568899999864 45566788999999998 59999999665544 7899999999
Q ss_pred ccCChhhhhhCCCCC--C-CHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC---CC--cEEEeecccccccCCC
Q 011041 201 MEHDLAGLAASPTIK--F-TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EG--ILTIADFGLASFFDPN 272 (495)
Q Consensus 201 ~~~~l~~~~~~~~~~--l-~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~---~~--~vkL~DFG~a~~~~~~ 272 (495)
|...|..++...... . ..-..+.++.|++.||.+||+.+||||||||.||||+. ++ .++|+|||+++....+
T Consensus 585 C~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 585 CACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 999988877763111 1 11445788999999999999999999999999999976 33 6899999999988654
Q ss_pred CC--CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 273 HK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 273 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
.. ....+..||-+|+|||++.... -..++||+||||++|+.++| ..||...-. .-.+|+.. ...-.
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~--~~~L~------ 733 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTG--NYTLV------ 733 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcC--cccee------
Confidence 33 2244567899999999997643 46799999999999999986 899965322 22223221 11000
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
..+...+ .++.|||.+||.+||..||+|.++|.||||-+
T Consensus 734 ----------------~L~~~~d--~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 734 ----------------HLEPLPD--CEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred ----------------eeccCch--HHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 0000111 17899999999999999999999999999975
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=323.58 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=184.1
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
.|...+.||+|+||.||+|++..+|..||+|.+..... ....|+.++++++|||||++++++.+ ....|+||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~--~~~~~lv~ 762 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRS--EKGAYLIH 762 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEc--CCCCEEEE
Confidence 45666789999999999999999999999999864321 12246889999999999999999987 45789999
Q ss_pred eeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhh---hCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH---NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 199 e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH---~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||++++.+..+.. .+++..+..++.||+.||+||| +.+|+||||||+|||++.++..++. ||.......
T Consensus 763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 9999876666554 4789999999999999999999 6799999999999999999888775 665543321
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcC-CCChhhhhhCCCCCC
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCG-SPSEEYWKKSKLPHA 353 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~g-~~~~~~~~~~~~~~~ 353 (495)
.....+|+.|+|||++.+ ..|+.++|||||||++|||++|+.||...... ..+....+... ......|....+
T Consensus 835 -~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 909 (968)
T PLN00113 835 -DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI--- 909 (968)
T ss_pred -CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccc---
Confidence 123478899999998875 56899999999999999999999998542210 11111111100 000111100000
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.... ........++.+|+.+|++.||.+|||+.|+++.
T Consensus 910 ---~~~~-------~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 910 ---RGDV-------SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ---cCCC-------CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000 0000111346789999999999999999999873
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=268.40 Aligned_cols=197 Identities=25% Similarity=0.375 Sum_probs=162.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC--CCCCeeeeeceeeccC--Cc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL--DHPNVVKLEGLVTSRM--SC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~~--~~ 192 (495)
....++++.||+|.||.||+|+ .+++.||||++. ....+.+.+|-.|.... .|+||++++++-.... ..
T Consensus 209 l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CCchhhHHHhhcCccceeehhh--ccCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 5667888999999999999995 567999999975 45567788888888864 7999999988764321 34
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh---------CCceeccCCCCCeeeCCCCcEEEeec
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN---------QHVLHRDIKGSNLLIDNEGILTIADF 263 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~---------~givHrDlKp~NILl~~~~~vkL~DF 263 (495)
.++||++|.+.+.+..++... .+++.....++..|++||+|||+ ..|+|||||..||||..|++..|+||
T Consensus 282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 689999999977666666544 58999999999999999999995 46999999999999999999999999
Q ss_pred ccccccCCCCC-CCCccccccCCCCCcccccCCCCCC-----chhhHHHHHHHHHHHHhCCCCC
Q 011041 264 GLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYG-----VGVDLWSAGCILAELLAEKPIM 321 (495)
Q Consensus 264 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~-----~~~DvwSlGvil~elltG~~pf 321 (495)
|+|..+.+... ......+||..|||||+|.|...+. ...||||+|.+|+||++.-.-+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 99998865432 2334579999999999998765554 4589999999999999865433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=241.38 Aligned_cols=213 Identities=36% Similarity=0.593 Sum_probs=178.7
Q ss_pred ecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeeccCCh
Q 011041 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDL 205 (495)
Q Consensus 126 LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~l 205 (495)
||+|.+|.||++++..+++.+++|++....... ....+.+|+.+++.+.|++|+++++++.. ....+++|||+.+..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCCCc
Confidence 689999999999998889999999987654322 35678899999999999999999999987 467999999999554
Q ss_pred hhhhhCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC-CCcEEEeecccccccCCCCCCCCcccccc
Q 011041 206 AGLAASPT-IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADFGLASFFDPNHKQPMTSRVVT 283 (495)
Q Consensus 206 ~~~~~~~~-~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~-~~~vkL~DFG~a~~~~~~~~~~~~~~~gt 283 (495)
+..+.... ..+++..+..++.+++.+|.|||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 44444332 46899999999999999999999999999999999999999 89999999999987654321 12345678
Q ss_pred CCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccc
Q 011041 284 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYK 363 (495)
Q Consensus 284 ~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (495)
..|++||.+.....++.+.|+|+||+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 8899999886533678999999999999999
Q ss_pred cccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCC
Q 011041 364 RCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402 (495)
Q Consensus 364 ~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp 402 (495)
..+.++|..||..||.+||++.++++|+
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1234479999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=285.05 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=196.4
Q ss_pred eeeeeeecccCceEEEEEEEC----C---CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCC
Q 011041 120 FEKLDKIGQGTYSNVYKARDT----L---TGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~----~---~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 191 (495)
..+.+.||+|.||.|++|.-. . ....||+|.+...... .....+..|+.+|+.+ .|+||+.++|++.. .
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~--~ 374 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ--D 374 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc--C
Confidence 366679999999999999642 1 2467999998765544 6778899999999999 59999999999988 6
Q ss_pred ceeEEEEeeccCChhh-hhhCCC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC
Q 011041 192 CSLYLVFKYMEHDLAG-LAASPT---------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE 255 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~-~~~~~~---------------~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~ 255 (495)
+.+++|+||+.++.+. .+.... ..++..+...++.||+.|++||++..+|||||-..||||..+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN 454 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC
Confidence 7899999999965444 443333 248899999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCCCCCccccc--cCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC-hHHHHH
Q 011041 256 GILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRT-EVEQLH 331 (495)
Q Consensus 256 ~~vkL~DFG~a~~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~-~~~~~~ 331 (495)
..+||+|||+|+..............+ ...|||||.+.. ..|+.++||||+||+|||+++ |..|+++-. ..+.+.
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~ 533 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE 533 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence 999999999998543322211121222 334999999987 679999999999999999998 889998854 444444
Q ss_pred HHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 332 KIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 332 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.+.... ..+.....++++.++++.|++.||++||+..++..
T Consensus 534 ~l~~G~----------------------------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 534 FLKEGN----------------------------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHhcCC----------------------------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 332210 11222345788899999999999999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=245.12 Aligned_cols=212 Identities=35% Similarity=0.548 Sum_probs=175.8
Q ss_pred eeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEe
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFK 199 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e 199 (495)
|.+.+.||.|++|.||++.+..+++.+++|.+...... .....+.+|+..++.++|+||+++++++.. ....++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEEEe
Confidence 56788999999999999999988999999999865433 256788899999999999999999999876 467999999
Q ss_pred eccCChhhhhhCCCCC-CCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCc
Q 011041 200 YMEHDLAGLAASPTIK-FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278 (495)
Q Consensus 200 ~~~~~l~~~~~~~~~~-l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 278 (495)
|+.+..+..+...... +++..+..++.+++.+|.|||+++++|+||+|.||+++.++.++|+|||++............
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9998544444433334 899999999999999999999999999999999999999999999999999876543211234
Q ss_pred cccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChH-HHHHHHH
Q 011041 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG-RTEV-EQLHKIF 334 (495)
Q Consensus 279 ~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~-~~~~-~~~~~i~ 334 (495)
...++..|++||.+.+...++.++|||+||+++|+|++|++||.. .+.. ...+.|.
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 457788999999874445678899999999999999999999987 4444 4555554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=302.95 Aligned_cols=203 Identities=16% Similarity=0.197 Sum_probs=145.9
Q ss_pred hCCC-CCeeeeeceeecc-----CCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCC
Q 011041 173 RLDH-PNVVKLEGLVTSR-----MSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIK 246 (495)
Q Consensus 173 ~l~H-pnIv~l~~~~~~~-----~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlK 246 (495)
.++| .||+++++++... ....++++|||++++|...+......+++.+++.|++||+.||.|||++||||||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 3445 5777777776211 124578889999998887776656679999999999999999999999999999999
Q ss_pred CCCeeeCCCC-------------------cEEEeecccccccCCCCC---------------CCCccccccCCCCCcccc
Q 011041 247 GSNLLIDNEG-------------------ILTIADFGLASFFDPNHK---------------QPMTSRVVTLWYRPPELL 292 (495)
Q Consensus 247 p~NILl~~~~-------------------~vkL~DFG~a~~~~~~~~---------------~~~~~~~gt~~y~aPE~l 292 (495)
|+||||+..| .+||+|||+++....... ......+||++|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 9999996544 455666666543211000 001124689999999998
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCC
Q 011041 293 LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKD 372 (495)
Q Consensus 293 ~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (495)
.+ ..|+.++|||||||+||||++|.+||.... ..+..+.... .+ ... ..
T Consensus 188 ~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~-~~~--------------------------~~ 236 (793)
T PLN00181 188 NG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LP-PQI--------------------------LL 236 (793)
T ss_pred cc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cC-hhh--------------------------hh
Confidence 76 468999999999999999999998875422 1222221110 00 000 00
Q ss_pred CCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 373 FPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 373 ~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
-.+...+++..||..||.+|||+.|+|+||||..
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 1234567899999999999999999999999976
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=255.61 Aligned_cols=252 Identities=27% Similarity=0.326 Sum_probs=185.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHh--CCCCCeeeeeceeecc--CCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR--LDHPNVVKLEGLVTSR--MSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~--~~~ 192 (495)
..+..+.+.||+|-||.||+|.++ |+.||||++... +...+.||.+|.+. |+|+||+.+++.-... .-.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hheeEEEEEecCccccceeecccc--CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 467889999999999999999765 889999998632 23456678888876 5999999998765322 124
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh--------CCceeccCCCCCeeeCCCCcEEEeecc
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN--------QHVLHRDIKGSNLLIDNEGILTIADFG 264 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~--------~givHrDlKp~NILl~~~~~vkL~DFG 264 (495)
.+|||++|.+.+.+.+++.. ..++......++..++.||.|||. ..|.|||||..||||..+|.+.|+|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 69999999998888887776 478999999999999999999994 359999999999999999999999999
Q ss_pred cccccCCCCC---CCCccccccCCCCCcccccCCCCC-----CchhhHHHHHHHHHHHHhC----------CCCCCCC--
Q 011041 265 LASFFDPNHK---QPMTSRVVTLWYRPPELLLGATDY-----GVGVDLWSAGCILAELLAE----------KPIMPGR-- 324 (495)
Q Consensus 265 ~a~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~-----~~~~DvwSlGvil~elltG----------~~pf~~~-- 324 (495)
||.......+ ......+||..|||||+|...... =..+||||||.|++|++.. ++||.+-
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9987754422 345678999999999998543211 1358999999999999842 3566542
Q ss_pred --ChHHHHHHHHHhc-CCCChhhhhhCCCCCCccCCCCcccccccccccCCCC--CCcHHHHHHhccCCCCCccCHHHHH
Q 011041 325 --TEVEQLHKIFKLC-GSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFP--PSSLPLIETLLAIDPAERQTATAAL 399 (495)
Q Consensus 325 --~~~~~~~~i~~~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~~Li~~~L~~dP~~R~ta~elL 399 (495)
...+.+.+++=.- ..|. +...+...+ ..+..|++.|+..||.-|.||-.+-
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~------------------------ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPN------------------------IPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCCHHHHhcceeecccCCC------------------------CCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 1223333321100 0000 111111111 1345689999999999999987765
Q ss_pred h
Q 011041 400 R 400 (495)
Q Consensus 400 ~ 400 (495)
+
T Consensus 498 K 498 (513)
T KOG2052|consen 498 K 498 (513)
T ss_pred H
Confidence 3
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=269.69 Aligned_cols=250 Identities=23% Similarity=0.285 Sum_probs=198.9
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCe----EEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQ----IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
...+..++||+|+||+||+|.+-..|+ +||||++..... ......+..|+.+|..|+|||+++|++++... .
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~ 771 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLS---T 771 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccc---h
Confidence 345556889999999999998865554 689998875543 33445677899999999999999999999763 3
Q ss_pred eEEEEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
+.||++||+++ |++.+...+..+-......|..||+.||.|||++++|||||-..||||....+|||+|||+++.....
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 88999999965 55566666778889999999999999999999999999999999999999999999999999988665
Q ss_pred CCCCCcc-ccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 273 HKQPMTS-RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 273 ~~~~~~~-~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
..+.... ....+-|||-|.+.. ..|+.++||||+||++||++| |..|+.+....++-..+.+.. .
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-R----------- 918 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-R----------- 918 (1177)
T ss_pred cccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-c-----------
Confidence 5432222 122566889887764 679999999999999999997 889998877666543332110 0
Q ss_pred CCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
....+..+-++.-++-+||..|+..||+++++..
T Consensus 919 ----------------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 919 ----------------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ----------------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 0112345667888999999999999999998865
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-31 Score=242.89 Aligned_cols=257 Identities=21% Similarity=0.268 Sum_probs=192.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.+.|.+.+.||+|.||.+.+|.++.++..+++|.+.... .....|.+|...--.| .|.||+.-|++.... .+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhc-CceEE
Confidence 578999999999999999999999999999999987553 4456788888776666 589999888764332 45788
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC--CCcEEEeecccccccCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN--EGILTIADFGLASFFDPNH 273 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~--~~~vkL~DFG~a~~~~~~~ 273 (495)
+++||++.+.+..-.... .+.|...+.++.|+++||+|+|++++||||||.+||||-. ..+|||||||+.+..+..
T Consensus 99 F~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t- 176 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT- 176 (378)
T ss_pred EeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce-
Confidence 999999965554443332 4789999999999999999999999999999999999943 348999999998754321
Q ss_pred CCCCccccccCCCCCcccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCChhhhhhC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ-LHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~~~ 348 (495)
..-.--+..|.+||++... -...+.+|||.||+|+|.+++|.+||......+. ..+.+ .|.+.
T Consensus 177 ---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~---------~w~~r 244 (378)
T KOG1345|consen 177 ---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE---------QWLKR 244 (378)
T ss_pred ---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH---------HHhcc
Confidence 1112235669999987431 2245779999999999999999999974322111 00010 12221
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCc---cCHHHHHhCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER---QTATAALRSEFF 404 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R---~ta~elL~hp~f 404 (495)
+.+ .+...|..+++.+..++++-|..++.+| .++.......|.
T Consensus 245 k~~-------------~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 245 KNP-------------ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred cCc-------------cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 111 1445667789999999999999999999 666666666664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=270.62 Aligned_cols=266 Identities=24% Similarity=0.329 Sum_probs=200.4
Q ss_pred CCe-eeeeeecccCceEEEEEEECCCCeEEEeEEEecC----CCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 118 DTF-EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFD----NLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 118 ~~y-~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~----~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
+.| .....+|.|++|.|+.+........++.|..+.. .........+..|..+-..|.|+||+..+..+.+. .
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--~ 394 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--D 394 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc--c
Confidence 345 4557899999999999988877777777766522 11222222366788888889999998887777653 2
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
..+-+||||.+++...+ .....++..++..+++||+.||.|||++||.|||||++|+++..+|.+||+|||.+..+...
T Consensus 395 ~~~~~mE~~~~Dlf~~~-~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 395 GILQSMEYCPYDLFSLV-MSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cchhhhhcccHHHHHHH-hcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 23444999999554444 44457899999999999999999999999999999999999999999999999999877544
Q ss_pred CC---CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHhcCCCChhhhhhC
Q 011041 273 HK---QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLH-KIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 273 ~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~-~i~~~~g~~~~~~~~~~ 348 (495)
.. ......+|+..|+|||++.+...-...+||||.|++++.|++|+-||.-....+... .+.. ..|
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~-------~~~--- 543 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY-------SDQ--- 543 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc-------ccc---
Confidence 33 345667899999999999886555677999999999999999999997644332221 0000 000
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.....-....+..+|...+.+|.+||++||.+|.|+++||+.+||+..
T Consensus 544 -----------~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 544 -----------RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred -----------cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 000111223344577888999999999999999999999999999863
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=223.05 Aligned_cols=165 Identities=20% Similarity=0.260 Sum_probs=125.9
Q ss_pred ChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcccccc
Q 011041 204 DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVT 283 (495)
Q Consensus 204 ~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt 283 (495)
+|...+...+..+++.+++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...||
T Consensus 2 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------~~~g~ 67 (176)
T smart00750 2 SLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------QSRVD 67 (176)
T ss_pred cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------cCCCc
Confidence 444444444557999999999999999999999999 999999999999999 9999876432 22689
Q ss_pred CCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCChhhhhhCCCCCCccCCCCccc
Q 011041 284 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSY 362 (495)
Q Consensus 284 ~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 362 (495)
+.|+|||++.+ ..|+.++|||||||++|||++|.+||...... ..+..+......... .
T Consensus 68 ~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~---------------- 127 (176)
T smart00750 68 PYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP---R---------------- 127 (176)
T ss_pred ccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc---c----------------
Confidence 99999999876 56899999999999999999999999765543 233333221111000 0
Q ss_pred ccccccccCCCCC--CcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 363 KRCIAETFKDFPP--SSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 363 ~~~~~~~~~~~s~--~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
.......++. ++.+||.+||..||.+|||+.++++|+|+.
T Consensus 128 ---~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 128 ---DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ---ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0000112333 689999999999999999999999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-26 Score=225.60 Aligned_cols=263 Identities=32% Similarity=0.477 Sum_probs=205.9
Q ss_pred eeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh-HHHHHHHHHHHHHHhCCCC-CeeeeeceeeccCCceeEEE
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREILILRRLDHP-NVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~~~lv 197 (495)
|.+...||.|+||.||++.+. ..+++|.+....... .....+.+|+.++..+.|+ +|+++++++.. ....+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEEEEE
Confidence 778899999999999999877 788999987765433 2567888999999999988 79999999955 4458999
Q ss_pred EeeccCChhhhhhCCCC---CCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC-cEEEeecccccccCCCC
Q 011041 198 FKYMEHDLAGLAASPTI---KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNH 273 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~---~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~-~vkL~DFG~a~~~~~~~ 273 (495)
++|+.+..+........ .+++..+..++.|++.++.|+|+.|++||||||+||+++..+ .++++|||++..+....
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999876665544443 789999999999999999999999999999999999999988 79999999998654333
Q ss_pred CC-----CCccccccCCCCCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCC-Ch
Q 011041 274 KQ-----PMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAEKPIMPGRTE---VEQLHKIFKLCGSP-SE 342 (495)
Q Consensus 274 ~~-----~~~~~~gt~~y~aPE~l~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~g~~-~~ 342 (495)
.. .....+||..|++||++.+. ..+....|+||+|++++++++|..||..... ......+......+ ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 21 24667899999999998764 4788999999999999999999999887764 33333333332222 00
Q ss_pred hhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.... .. .. ......+.+++..++..+|..|.+..+...++|....
T Consensus 237 ~~~~-------------~~----~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 237 SPLS-------------PS----NP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cccC-------------cc----cc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 0000 00 00 1122457889999999999999999999988776643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=237.67 Aligned_cols=164 Identities=22% Similarity=0.244 Sum_probs=130.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECC-CCeEEEeEEEecCCC---ChHHHHHHHHHHHHHHhCCCCCeee-eeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTL-TGQIVALKKVRFDNL---EPESVRFMAREILILRRLDHPNVVK-LEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~-~g~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~-l~~~~~~~~~ 191 (495)
.+.|.+.+.||+|+||+||+|+++. +++.||||++..... .......+.+|+.+|+.|+|+||+. ++++
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~------ 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT------ 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc------
Confidence 5789999999999999999999876 788889998753311 2334567899999999999999985 4432
Q ss_pred ceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccC-CCCCeeeCCCCcEEEeecccccccC
Q 011041 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDI-KGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDl-Kp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
...||||||++|+.+.... . .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+++.+.
T Consensus 91 ~~~~LVmE~~~G~~L~~~~-~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR-P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHHhC-c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 2479999999987665321 1 11 1467899999999999999999999 9999999999999999999998765
Q ss_pred CCCC-------CCCccccccCCCCCccccc
Q 011041 271 PNHK-------QPMTSRVVTLWYRPPELLL 293 (495)
Q Consensus 271 ~~~~-------~~~~~~~gt~~y~aPE~l~ 293 (495)
.... ....+.++++.|+|||.+.
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 4321 1124567889999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-29 Score=254.31 Aligned_cols=243 Identities=26% Similarity=0.394 Sum_probs=204.8
Q ss_pred eecccCceEEEEEEE---CCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCceeEEEEee
Q 011041 125 KIGQGTYSNVYKARD---TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYLVFKY 200 (495)
Q Consensus 125 ~LG~G~~g~Vy~a~~---~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~lv~e~ 200 (495)
.+|+|+||.|++++. ...|..||+|+..+.............|..++..++ ||.+|+++..++. +..+|+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc--ccchhHhhhh
Confidence 379999999998753 356788999998876553333235567888999987 9999999999887 5679999999
Q ss_pred ccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccc
Q 011041 201 MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280 (495)
Q Consensus 201 ~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 280 (495)
..++.+.........+.+...+.+...++-+++++|+.||+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----- 153 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----- 153 (612)
T ss_pred cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-----
Confidence 999888777777778999999999999999999999999999999999999999999999999999876543322
Q ss_pred cccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCc
Q 011041 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQ 360 (495)
Q Consensus 281 ~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 360 (495)
|||..|||||++.+ ....+|+||||+++|+|++|..||.+ +++..|.+..-..+.
T Consensus 154 cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~------------------ 208 (612)
T KOG0603|consen 154 CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR------------------ 208 (612)
T ss_pred ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch------------------
Confidence 99999999998863 57889999999999999999999988 788888774433332
Q ss_pred ccccccccccCCCCCCcHHHHHHhccCCCCCccC-----HHHHHhCCCCCCCCCC
Q 011041 361 SYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEFFTTKPYA 410 (495)
Q Consensus 361 ~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----a~elL~hp~f~~~~~~ 410 (495)
.++..+.+++..|+..+|..|.- +.++++|+||+...|.
T Consensus 209 -----------~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 209 -----------ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred -----------hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 34567888999999999999965 5899999999987775
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=222.68 Aligned_cols=252 Identities=20% Similarity=0.243 Sum_probs=197.8
Q ss_pred CCeeeeeeecccCceEEEEEEECCCC-----eEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTG-----QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
.++++...+-+|.||.||.|.+++.. +.|-+|.++.. .++-++..+..|...|..+.|||+..+.++.... ..
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~-~~ 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED-YA 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec-cC
Confidence 56888899999999999999776443 34666766432 3455677888999999999999999998887653 45
Q ss_pred eeEEEEeeccCChhhhhhC--------CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecc
Q 011041 193 SLYLVFKYMEHDLAGLAAS--------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~--------~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG 264 (495)
..+..+.+++.+.+..... ....++..+...++.||..|++|||++||||.||-..|.+||+..+|||+|=.
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence 6788888988665554432 12247778888999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCc-cccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCh
Q 011041 265 LASFFDPNHKQPMT-SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSE 342 (495)
Q Consensus 265 ~a~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (495)
+++..-+.+..... +..-...||+||.+.. ..|+.++|+|||||+||||+| |+.|+..-++.+...-+.+..
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy----- 515 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY----- 515 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc-----
Confidence 99865443322221 1122556999998875 679999999999999999998 899998888887766554321
Q ss_pred hhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....-++|+++..++..|+..+|++||+.+|+..
T Consensus 516 -----------------------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 516 -----------------------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -----------------------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 11112357899999999999999999999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-27 Score=251.13 Aligned_cols=226 Identities=30% Similarity=0.371 Sum_probs=173.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|..+++|-.|+||.||.++|+.+.+.+|+ +|.+.++- +++ ||.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li------lRn---ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI------LRN---ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccchh------hhc---cccccCCccee----------------
Confidence 57899999999999999999999999999999 45544321 111 22223333333
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC--
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-- 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~-- 274 (495)
||...++.. .+.++... +.+++|||+.||+|||+||+|+||+.-|++|++|||+.+...-...
T Consensus 136 ------gDc~tllk~-~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ------GDCATLLKN-IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ------chhhhhccc-CCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 333323222 22344332 7799999999999999999999999999999999999865421100
Q ss_pred ------------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 011041 275 ------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342 (495)
Q Consensus 275 ------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (495)
..-...+|||.|+|||++.. ..|+..+|||+||+|+||.+.|..||.|+++++.+...+......++
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 01124589999999999986 57999999999999999999999999999999999888765433332
Q ss_pred hhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCc---cCHHHHHhCCCCCCCCCC
Q 011041 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER---QTATAALRSEFFTTKPYA 410 (495)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R---~ta~elL~hp~f~~~~~~ 410 (495)
. ...+++++.+||..+|+.+|..| ..+.++.+|+||+.-.|.
T Consensus 280 ~--------------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 280 E--------------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred c--------------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 2 24578999999999999999999 458889999999987775
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-25 Score=223.57 Aligned_cols=254 Identities=22% Similarity=0.217 Sum_probs=188.4
Q ss_pred CeeeeeeecccCceEEEEEEECCCC-eEEEeEEEecCCCChHHHHHHHHHHHHHHhCCC----CCeeeeeceeeccCCce
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTG-QIVALKKVRFDNLEPESVRFMAREILILRRLDH----PNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~~~~~~~~~~~ 193 (495)
+|.+.+.||+|+||.||.|.+..++ ..+|+|+.......... .+..|+.+|..+.. .++..+++... ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCce
Confidence 8999999999999999999988775 68899987754322111 56678899988863 58888888874 12567
Q ss_pred eEEEEeeccCChhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC-----CcEEEeeccccc
Q 011041 194 LYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-----GILTIADFGLAS 267 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~-----~~vkL~DFG~a~ 267 (495)
-||||+.++.+|..+.... ...|+...+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||+++
T Consensus 96 ~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 96 NFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred eEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 8999999999998877543 4789999999999999999999999999999999999999765 369999999998
Q ss_pred --ccCCCCC----CC---CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 011041 268 --FFDPNHK----QP---MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCG 338 (495)
Q Consensus 268 --~~~~~~~----~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g 338 (495)
.+..... .. .....||..|.++.+..+ ...+...|+||++.++.+|+.|..||.+........++.....
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 3321211 11 123459999999999887 5679999999999999999999999977654333333222111
Q ss_pred CCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 339 SPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
..... ......+.++..+...+-..+...+|....+..
T Consensus 255 ~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 255 KLLTD------------------------RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred hhccc------------------------cccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 00000 011122344555666666677788887766654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-25 Score=201.62 Aligned_cols=205 Identities=23% Similarity=0.258 Sum_probs=169.6
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~ 194 (495)
..+.|.++++||.|+||.+|+|....+|+.||||+-...... ..+..|.++.+.|. ...|+.+..+..+ ..+-
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e--~~yn 86 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTE--KDYN 86 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccc--cccc
Confidence 468999999999999999999999999999999987644322 34567899999986 4678777777766 4677
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC---CCcEEEeecccccccCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASFFDP 271 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~---~~~vkL~DFG~a~~~~~ 271 (495)
.+||++++-+|..+..-....|+...+.-++-|++.-++|+|.+++|||||||+|+|..- ...+.|+|||+|+.+.+
T Consensus 87 vlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 87 VLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred eeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 999999998888887777778999999999999999999999999999999999999854 35699999999987743
Q ss_pred CCCC------CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 011041 272 NHKQ------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV 327 (495)
Q Consensus 272 ~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~ 327 (495)
.... .-....||..|.+--...+. .-+...|+-|+|.+|.++.-|..||.|....
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~-eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGI-EQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhh-hhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 3221 12355789999987777663 4578899999999999999999999986543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=207.32 Aligned_cols=209 Identities=22% Similarity=0.275 Sum_probs=173.5
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~l 196 (495)
-.|.++++||+|+||++|.|++.-++++||||.-.... ....+..|.+..+.| ..++|...|-|... +.+-.|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqe--G~~NiL 101 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQE--GKYNIL 101 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccc--cchhhh
Confidence 46999999999999999999999999999999754332 234566788888887 57899988766544 667789
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC-----cEEEeecccccccCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-----ILTIADFGLASFFDP 271 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~-----~vkL~DFG~a~~~~~ 271 (495)
|||+++-+|.+++.-.+..|+...+..++.|++.-++|+|++.+|+|||||+|+||...+ .|-|+|||+|+.+.+
T Consensus 102 VidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 102 VIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 999999998888888888999999999999999999999999999999999999997543 589999999998744
Q ss_pred CCCC------CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHH
Q 011041 272 NHKQ------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR---TEVEQLHKI 333 (495)
Q Consensus 272 ~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~---~~~~~~~~i 333 (495)
.... ...+..||..||+=...+|. .-+...|+=|||-++++.|-|..||.|. +..+..++|
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGr-EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccc-hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 3221 12355799999999888884 4588999999999999999999999984 444555554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=200.96 Aligned_cols=141 Identities=21% Similarity=0.248 Sum_probs=110.1
Q ss_pred eeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHH------------------------HHHHHHHHHHHHhCCCCC
Q 011041 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES------------------------VRFMAREILILRRLDHPN 178 (495)
Q Consensus 123 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~------------------------~~~~~~Ei~il~~l~Hpn 178 (495)
...||+|+||.||+|.+. +|+.||||+++........ .....+|+.+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999987 8999999999765321111 123345999999998887
Q ss_pred eeeeeceeeccCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHh-hhCCceeccCCCCCeeeCCCCc
Q 011041 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC-HNQHVLHRDIKGSNLLIDNEGI 257 (495)
Q Consensus 179 Iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~L-H~~givHrDlKp~NILl~~~~~ 257 (495)
|.....+... ..+|||||++++.+.........+++..+..++.||+.+|.|| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~----~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLK----SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEec----CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 7544332222 2389999999865433322345789999999999999999999 799999999999999998 578
Q ss_pred EEEeeccccccc
Q 011041 258 LTIADFGLASFF 269 (495)
Q Consensus 258 vkL~DFG~a~~~ 269 (495)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=209.58 Aligned_cols=238 Identities=22% Similarity=0.306 Sum_probs=152.3
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCC----------CCCeeeeecee
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLD----------HPNVVKLEGLV 186 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~----------HpnIv~l~~~~ 186 (495)
..+...+.||.|+++.||.++|..||+.+|+|+...... .....+.+.+|......+. |-.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 356778899999999999999999999999999876654 3345667777765554432 21222222221
Q ss_pred e---------ccC---Cc---eeEEEEeeccCChhhhhhC----CCCCCCH--HHHHHHHHHHHHHHHHhhhCCceeccC
Q 011041 187 T---------SRM---SC---SLYLVFKYMEHDLAGLAAS----PTIKFTQ--AQVKCYMHQLLSGLEHCHNQHVLHRDI 245 (495)
Q Consensus 187 ~---------~~~---~~---~~~lv~e~~~~~l~~~~~~----~~~~l~e--~~~~~i~~qil~~L~~LH~~givHrDl 245 (495)
. ... .. ..+++|+-+.+++...... ....... .....+..|++..+++||..||||+||
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 110 01 3477888888887655321 1111122 222345589999999999999999999
Q ss_pred CCCCeeeCCCCcEEEeecccccccCCCCCCCCccccccCCCCCcccccCC-------CCCCchhhHHHHHHHHHHHHhCC
Q 011041 246 KGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA-------TDYGVGVDLWSAGCILAELLAEK 318 (495)
Q Consensus 246 Kp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~DvwSlGvil~elltG~ 318 (495)
||+|+|++.+|.++|+||+.....+.. ......+..|.+||+.... ..++.+.|.|+||+++|.|+||.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999999988765432 1113446779999976331 24788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCc
Q 011041 319 PIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392 (495)
Q Consensus 319 ~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R 392 (495)
.||.......... | . +. ...++|+.+++||..||+.||.+|
T Consensus 248 lPf~~~~~~~~~~-------------~---------------~----f~-~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPE-------------W---------------D----FS-RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSG-------------G---------------G----GT-TSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCcccccc-------------c---------------c----ch-hcCCcCHHHHHHHHHHccCCcccC
Confidence 9997654321100 0 1 11 123688889999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=198.62 Aligned_cols=174 Identities=11% Similarity=0.116 Sum_probs=132.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh-HHHHH------HHHHHHHHHhCCCCCeeeeeceeecc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRF------MAREILILRRLDHPNVVKLEGLVTSR 189 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~------~~~Ei~il~~l~HpnIv~l~~~~~~~ 189 (495)
.++|++++.||.|+||.||++.+ ++..+|||+++...... ..... +.+|+..+.++.|++|+.+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 47899999999999999999754 46689999997543322 22222 68999999999999999998886643
Q ss_pred C------CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeec
Q 011041 190 M------SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADF 263 (495)
Q Consensus 190 ~------~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DF 263 (495)
. ....+|+|||++|..+..+. .+++ ....+|+.+|..||+.||+||||||+||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 2 24589999999987655442 2333 2466999999999999999999999999999999 999999
Q ss_pred ccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHH
Q 011041 264 GLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315 (495)
Q Consensus 264 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ell 315 (495)
|.......... -+.+.-...|+.++|+|+|||++..+.
T Consensus 179 g~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 98865532111 111222245778999999999987765
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=193.70 Aligned_cols=142 Identities=21% Similarity=0.270 Sum_probs=112.7
Q ss_pred eeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh------------------------HHHHHHHHHHHHHHhCCCCC
Q 011041 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP------------------------ESVRFMAREILILRRLDHPN 178 (495)
Q Consensus 123 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~------------------------~~~~~~~~Ei~il~~l~Hpn 178 (495)
.+.||+|+||+||+|++. +|+.||||+++...... .....+.+|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 89999999998653210 01223468999999999998
Q ss_pred eeeeeceeeccCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCeeeCCCCc
Q 011041 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGI 257 (495)
Q Consensus 179 Iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NILl~~~~~ 257 (495)
|.....+... ..||||||++++...........+++..+..++.|++.+|.+||+ .||+||||||+|||++ ++.
T Consensus 81 i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 81 VPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 8655444432 248999999986322221223468889999999999999999999 9999999999999999 899
Q ss_pred EEEeecccccccC
Q 011041 258 LTIADFGLASFFD 270 (495)
Q Consensus 258 vkL~DFG~a~~~~ 270 (495)
++|+|||++....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.6e-23 Score=188.83 Aligned_cols=190 Identities=17% Similarity=0.149 Sum_probs=140.7
Q ss_pred eeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC--hHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCceeEEEE
Q 011041 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE--PESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 122 ~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
+...|++|+||+||.+.. .+..++.+.+...... .-....+.+|+++|++|. |++|++++++ ...|++|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvm 77 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDR 77 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEE
Confidence 457899999999998753 6777777766544331 112235789999999995 5889999885 1369999
Q ss_pred eeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccC-CCCCeeeCCCCcEEEeecccccccCCCCCC--
Q 011041 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDI-KGSNLLIDNEGILTIADFGLASFFDPNHKQ-- 275 (495)
Q Consensus 199 e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDl-Kp~NILl~~~~~vkL~DFG~a~~~~~~~~~-- 275 (495)
||+.|..+..... .. ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRPP------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhhh------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 9999876643221 11 2457899999999999999999999 799999999999999999999865543210
Q ss_pred --CC--------ccccccCCCCCcccccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCh
Q 011041 276 --PM--------TSRVVTLWYRPPELLLGATDYG-VGVDLWSAGCILAELLAEKPIMPGRTE 326 (495)
Q Consensus 276 --~~--------~~~~gt~~y~aPE~l~~~~~~~-~~~DvwSlGvil~elltG~~pf~~~~~ 326 (495)
.. .-...++.|+.|+.-.-....+ ...++++.|+-+|.++|+..++.+.++
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 00 0112478888888653322233 567999999999999999998877654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-23 Score=203.33 Aligned_cols=260 Identities=26% Similarity=0.380 Sum_probs=178.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCC-----------------------------------eEEEeEEEecCCC---Ch
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTG-----------------------------------QIVALKKVRFDNL---EP 158 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g-----------------------------------~~vAiK~i~~~~~---~~ 158 (495)
.++|+++..||+|....||.|+....| -+.|||++-.-.. ..
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 578999999999999999999654311 1346665532111 12
Q ss_pred HHHHHHHHHHHH------H--------Hh--------CCCCCeeeeeceeecc-------------------------CC
Q 011041 159 ESVRFMAREILI------L--------RR--------LDHPNVVKLEGLVTSR-------------------------MS 191 (495)
Q Consensus 159 ~~~~~~~~Ei~i------l--------~~--------l~HpnIv~l~~~~~~~-------------------------~~ 191 (495)
...+.+.+|..- + +. -+|||||++.++|.+. ..
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 223333333311 1 11 1699999998877542 23
Q ss_pred ceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee--CCCC--cEEEeeccccc
Q 011041 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI--DNEG--ILTIADFGLAS 267 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl--~~~~--~vkL~DFG~a~ 267 (495)
..+|+||.-..+.|..++..+ ..+....+-++.|+++|+.|||.+||.|||||.+|||| |+|+ .+.|+|||.+-
T Consensus 316 ~tlylvMkrY~~tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 316 KTLYLVMKRYRQTLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred ceEEEehhcchhhHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 578999999888888877665 46778888999999999999999999999999999999 3444 58999999874
Q ss_pred ccCCCC-----CCCCccccccCCCCCcccccCCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 011041 268 FFDPNH-----KQPMTSRVVTLWYRPPELLLGAT------DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336 (495)
Q Consensus 268 ~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~------~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 336 (495)
..+... ....-..-|....||||+..... .| .++|.|+.|-+.||+++..-||++..+.-.-..
T Consensus 394 Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny-~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r---- 468 (598)
T KOG4158|consen 394 ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNY-EKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR---- 468 (598)
T ss_pred eccccccccccccccccCCCcceecchhhhhcCCCCceeecc-chhhhhhhhhhHHHHhccCCcccccchheechh----
Confidence 332211 01112335677799999874321 12 368999999999999999999988443211100
Q ss_pred cCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC---HHHHHhCCCCCC
Q 011041 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT---ATAALRSEFFTT 406 (495)
Q Consensus 337 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t---a~elL~hp~f~~ 406 (495)
.+...++| .....+|+.+.+|+..+|+.||.+|++ |..+|+-..|..
T Consensus 469 -------~Yqe~qLP----------------alp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~ 518 (598)
T KOG4158|consen 469 -------TYQESQLP----------------ALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRM 518 (598)
T ss_pred -------hhhhhhCC----------------CCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcC
Confidence 11122222 223467889999999999999999998 456666444443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-23 Score=223.70 Aligned_cols=249 Identities=25% Similarity=0.355 Sum_probs=179.9
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCC--CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN--LEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
+|...+.||++-|=.|.+|++.+ |. |++|++-+.. ..-........|++ ...++|||++.+.-+.+. +...||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHHHH
Confidence 68888999999999999998664 44 8999986543 23334444445666 666799999998777655 567899
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccccccc-CCC-CC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPN-HK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~-~~~-~~ 274 (495)
|-+|+.+.|.+.+.. +.-+.+-+-+.|+.||+.||.-||..||+|||||.|||||+.-+-+.|+||..-+.. -+. +.
T Consensus 99 vRqyvkhnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 99 VRQYVKHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHHhhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 999999988765543 345788888999999999999999999999999999999999999999999876432 111 11
Q ss_pred CCCccccc----cCCCCCcccccCCC---------C-CCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 011041 275 QPMTSRVV----TLWYRPPELLLGAT---------D-YGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGS 339 (495)
Q Consensus 275 ~~~~~~~g----t~~y~aPE~l~~~~---------~-~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~ 339 (495)
..++-+.. -.+|+|||.+.... . .+++-||||+||+++||++ |.|||.- .++-.....- .
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~-~ 252 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGN-A 252 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccC-c
Confidence 11222222 34699999985421 1 5678999999999999988 7999942 2222211100 1
Q ss_pred CChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
...+. +.+... +..+++||..|++.||.+|.+|++.|+-
T Consensus 253 ~~~e~---------------------~Le~Ie--d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDPEQ---------------------LLEKIE--DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCHHH---------------------HHHhCc--CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 10000 111111 2478899999999999999999999983
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.7e-21 Score=183.99 Aligned_cols=145 Identities=20% Similarity=0.163 Sum_probs=114.3
Q ss_pred CCeeeeeeecccCceEEEEEE-ECCCCeEEEeEEEecCCCCh----------------------HHHHHHHHHHHHHHhC
Q 011041 118 DTFEKLDKIGQGTYSNVYKAR-DTLTGQIVALKKVRFDNLEP----------------------ESVRFMAREILILRRL 174 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~-~~~~g~~vAiK~i~~~~~~~----------------------~~~~~~~~Ei~il~~l 174 (495)
..|.+.+.||+|+||.||+|+ +..+|+.||||+++...... .....+.+|+.++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 468899999999999999998 67789999999997643210 0123467899999999
Q ss_pred CCCC--eeeeeceeeccCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-ceeccCCCCCee
Q 011041 175 DHPN--VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH-VLHRDIKGSNLL 251 (495)
Q Consensus 175 ~Hpn--Iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~g-ivHrDlKp~NIL 251 (495)
.+.+ ++++++ . ...|+||||++++.+.........+.+..+..++.||+.+|.+||+.| |+||||||+|||
T Consensus 108 ~~~~i~~p~~~~---~---~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 108 YEAGVPVPKPIA---W---RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred HhcCCCCCeeeE---e---cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 7633 333333 2 124899999999765444333445677778899999999999999999 999999999999
Q ss_pred eCCCCcEEEeeccccccc
Q 011041 252 IDNEGILTIADFGLASFF 269 (495)
Q Consensus 252 l~~~~~vkL~DFG~a~~~ 269 (495)
++ ++.++|+|||++...
T Consensus 182 i~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EE-CCCEEEEEChhhhcc
Confidence 99 889999999998754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.5e-21 Score=177.90 Aligned_cols=136 Identities=18% Similarity=0.211 Sum_probs=104.1
Q ss_pred eeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-----CCCCeeeeeceeeccCC-ceeE-
Q 011041 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-----DHPNVVKLEGLVTSRMS-CSLY- 195 (495)
Q Consensus 123 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~~-~~~~- 195 (495)
.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.| +||||+++++++++..+ +.++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 46899999999995 6777665 6999876432 2346789999999999 67999999999987532 3434
Q ss_pred EEEeecc--CChhhhhhCCCCCCCHHHHHHHHHHHHHHH-HHhhhCCceeccCCCCCeeeCC----CCcEEEeecccc
Q 011041 196 LVFKYME--HDLAGLAASPTIKFTQAQVKCYMHQLLSGL-EHCHNQHVLHRDIKGSNLLIDN----EGILTIADFGLA 266 (495)
Q Consensus 196 lv~e~~~--~~l~~~~~~~~~~l~e~~~~~i~~qil~~L-~~LH~~givHrDlKp~NILl~~----~~~vkL~DFG~a 266 (495)
+||||.+ ++.+..+.... .+++. ..++.|++.++ +|||+++||||||||+|||++. ++.++|+||+.+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 7899954 44444444433 46666 35688888888 9999999999999999999974 347999995544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-22 Score=214.31 Aligned_cols=263 Identities=25% Similarity=0.368 Sum_probs=207.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC-CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCceeE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDT-LTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~-~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~ 195 (495)
..|.+.+.||+|+|+.|-.+... .+...+|.|.+...............|..+-..+. |.|++.+++...+ ....+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~~~~~ 97 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--PRSYL 97 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC--Ccccc
Confidence 45777888999999999998764 34456777777655444555566677888888887 9999999998877 56789
Q ss_pred EEEeeccCChhhhhh-CCCC-CCCHHHHHHHHHHHHHHHHHhh-hCCceeccCCCCCeeeCCCC-cEEEeecccccccCC
Q 011041 196 LVFKYMEHDLAGLAA-SPTI-KFTQAQVKCYMHQLLSGLEHCH-NQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDP 271 (495)
Q Consensus 196 lv~e~~~~~l~~~~~-~~~~-~l~e~~~~~i~~qil~~L~~LH-~~givHrDlKp~NILl~~~~-~vkL~DFG~a~~~~~ 271 (495)
++++|..++.+.... .... ..+...+..++.|+..+|.|+| ..++.|+||||+|.+++..+ .+|+.|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999998887666655 5444 6788889999999999999999 99999999999999999999 999999999987755
Q ss_pred --CCCCCCccccc-cCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 272 --NHKQPMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 272 --~~~~~~~~~~g-t~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
+........+| ++.|+|||.+.+....+...|+||+|+++.-+++|..|+.......... ..|...
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-----------~~~~~~ 246 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-----------SSWKSN 246 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-----------eeeccc
Confidence 23333455688 9999999999876667889999999999999999999986544332100 011110
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
+ .+.-...+..++....+++.++|..+|..|.+.+++-.++|+..
T Consensus 247 ~-------------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 247 K-------------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred c-------------cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0 00012234567888999999999999999999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-20 Score=204.29 Aligned_cols=193 Identities=22% Similarity=0.255 Sum_probs=151.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC-hHHHHHHHHHHHHHHhCC---CCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLD---HPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~ 192 (495)
...|.|-+.||+|+||.||+|.+.. |+.||||+-...... --.. .+++.+|+ -+.|..+..++.. .+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~------~q~~~RLk~~~~~~~~~~~~a~~~--~~ 767 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC------LQVMERLKPQMLPSIMHISSAHVF--QN 767 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh------HHHHHhhchhhhcchHHHHHHHcc--CC
Confidence 5789999999999999999999877 999999987655432 1111 23344444 2345555555444 34
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC-------CCcEEEeeccc
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-------EGILTIADFGL 265 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~-------~~~vkL~DFG~ 265 (495)
.-++|+||.+.|.+..+....+.+++..+..+..||+..|++||.++|||+||||+|+||.. .--++|+|||.
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 57899999998766666667778999999999999999999999999999999999999942 23599999999
Q ss_pred ccccCC-CCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 011041 266 ASFFDP-NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKP 319 (495)
Q Consensus 266 a~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~ 319 (495)
+.-+.. .....+...++|-.+-.+|+..| ..+++.+|.|.|.-++|.||.|+.
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence 864421 12235667788999999998877 689999999999999999999964
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.5e-21 Score=193.52 Aligned_cols=177 Identities=28% Similarity=0.438 Sum_probs=133.0
Q ss_pred eeEEEEeeccCChhhhhhCCC---CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccccccc
Q 011041 193 SLYLVFKYMEHDLAGLAASPT---IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~---~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~ 269 (495)
++||.|++|..+.+.+++... ..-+......++.||..+++| +|.+|+|+||.||++..+..+||+|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 589999999988887777532 245677889999999999999 99999999999999999999999999999876
Q ss_pred CCCC-----CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-hcCCCChh
Q 011041 270 DPNH-----KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK-LCGSPSEE 343 (495)
Q Consensus 270 ~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~-~~g~~~~~ 343 (495)
.... ....+..+||.+||+||.+.+ ..|+.++||||||+|||||+.- |.. ..+....... --|..++.
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~---f~T--~~er~~t~~d~r~g~ip~~ 480 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQ---FST--QFERIATLTDIRDGIIPPE 480 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHH---hcc--HHHHHHhhhhhhcCCCChH
Confidence 5433 223456789999999999987 6799999999999999999971 211 1111111100 01122222
Q ss_pred hhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
+|. + -+.-.+|+..||...|.+||++.+.-.|.|.
T Consensus 481 ~~~-------------------------d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 481 FLQ-------------------------D-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred Hhh-------------------------c-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 221 1 2455689999999999999988877777664
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.7e-19 Score=167.91 Aligned_cols=137 Identities=18% Similarity=0.212 Sum_probs=109.6
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCCChH------HHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPE------SVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
+.||+|++|.||+|.+ .|..|++|+......... ....+.+|+.++..+.|++|+....++.+ ....+++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEE
Confidence 5799999999999976 677899998654332111 22457789999999999998777666554 3457899
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccccccc
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~ 269 (495)
|||++|..+........ . ....++.+|+.+|.+||+.|++|||++|.|||++ ++.++|+|||++...
T Consensus 78 ~e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 78 MEYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred EEEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 99999866655543321 2 7789999999999999999999999999999999 789999999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.7e-19 Score=166.47 Aligned_cols=139 Identities=22% Similarity=0.215 Sum_probs=108.1
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh--------------------HHHHHHHHHHHHHHhCCCCC
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP--------------------ESVRFMAREILILRRLDHPN 178 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~--------------------~~~~~~~~Ei~il~~l~Hpn 178 (495)
.|.+.+.||+|+||.||++.+. +|+.||||+++...... .......+|+.++..+.|.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4778899999999999999865 79999999987543110 01123667899999998874
Q ss_pred --eeeeeceeeccCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC
Q 011041 179 --VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG 256 (495)
Q Consensus 179 --Iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~ 256 (495)
++.+++ .+..++||||+++..+..... ......++.+|+.++.++|+.||+||||||+||+|+.++
T Consensus 95 i~v~~~~~------~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPID------WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceee------cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 333332 134589999999876544322 134567899999999999999999999999999999999
Q ss_pred cEEEeecccccccC
Q 011041 257 ILTIADFGLASFFD 270 (495)
Q Consensus 257 ~vkL~DFG~a~~~~ 270 (495)
.++|+|||++....
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.2e-20 Score=170.54 Aligned_cols=253 Identities=17% Similarity=0.212 Sum_probs=194.0
Q ss_pred cccCCCCCCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceee
Q 011041 108 AISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVT 187 (495)
Q Consensus 108 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 187 (495)
+++.++-....+..++.+|.+...|..|++++. |..++.|++..........+.|..|.-.|+-+.||||+.+++.+.
T Consensus 180 tlsr~~gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn 257 (448)
T KOG0195|consen 180 TLSRYTGIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN 257 (448)
T ss_pred ccccccCcchhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc
Confidence 445555555677778889999999999999765 556778888777666667778889999999999999999999998
Q ss_pred ccCCceeEEEEeeccCChhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhCC--ceeccCCCCCeeeCCCCcEEE--e
Q 011041 188 SRMSCSLYLVFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLIDNEGILTI--A 261 (495)
Q Consensus 188 ~~~~~~~~lv~e~~~~~l~~~~~~~--~~~l~e~~~~~i~~qil~~L~~LH~~g--ivHrDlKp~NILl~~~~~vkL--~ 261 (495)
. ...+.++..||+.+.+..++.. ....+..++..++.+|+.|+.|||+.. |.---|....++||++.+.+| +
T Consensus 258 s--ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarisma 335 (448)
T KOG0195|consen 258 S--PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMA 335 (448)
T ss_pred C--CCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecc
Confidence 7 4568999999997766655433 334678899999999999999999865 444568888999999876554 4
Q ss_pred ecccccccCCCCCCCCccccccCCCCCcccccCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 011041 262 DFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD--YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS 339 (495)
Q Consensus 262 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~ 339 (495)
|--++... ....-.|.||+||.+..... .-.++|+|||.++|+||.|...||..-.+.+.-.+|.-.-
T Consensus 336 d~kfsfqe--------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg-- 405 (448)
T KOG0195|consen 336 DTKFSFQE--------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG-- 405 (448)
T ss_pred cceeeeec--------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc--
Confidence 44333211 22344788999999876432 2357999999999999999999999988887766653211
Q ss_pred CChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHH
Q 011041 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399 (495)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL 399 (495)
....+.+.++..+..|+.-|+..||.+||....++
T Consensus 406 -------------------------lrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 406 -------------------------LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred -------------------------ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 11233456777888999999999999999987664
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.9e-18 Score=159.45 Aligned_cols=133 Identities=17% Similarity=0.200 Sum_probs=102.3
Q ss_pred eecccCceEEEEEEECCCCeEEEeEEEecCCCCh------HHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP------ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 125 ~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
.||+|+||.||++. .+|..|++|+........ .....+.+|+.++..+.|+++.....++.. ....++||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEE
Confidence 38999999999997 467889999865432211 123567789999999988876544434433 34578999
Q ss_pred eeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccccccc
Q 011041 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (495)
Q Consensus 199 e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~ 269 (495)
||++|..+........ ..++.||+.+|.+||+.||+|||++|+|||++ ++.++|+|||++...
T Consensus 77 e~~~g~~l~~~~~~~~-------~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGN-------DELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEECCccHHHHHhhcH-------HHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999876654443221 17899999999999999999999999999999 899999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.9e-18 Score=156.56 Aligned_cols=138 Identities=25% Similarity=0.270 Sum_probs=98.8
Q ss_pred eeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHH----------------------HHHHHHHHHhCCCCC--
Q 011041 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRF----------------------MAREILILRRLDHPN-- 178 (495)
Q Consensus 123 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~----------------------~~~Ei~il~~l~Hpn-- 178 (495)
++.||+|+||.||+|.+. +|+.||||++............ ...|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999976 7999999998764322111111 135666666664433
Q ss_pred eeeeeceeeccCCceeEEEEeeccCChhh-hhhCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCeeeCCCC
Q 011041 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEG 256 (495)
Q Consensus 179 Iv~l~~~~~~~~~~~~~lv~e~~~~~l~~-~~~~~~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NILl~~~~ 256 (495)
+++++++ ...++||||++++... ...... ... .++..++.+++.++.++|. .||+|+||||+||+++ ++
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 3444332 1358999999984221 111110 111 6778999999999999999 9999999999999999 89
Q ss_pred cEEEeecccccccC
Q 011041 257 ILTIADFGLASFFD 270 (495)
Q Consensus 257 ~vkL~DFG~a~~~~ 270 (495)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=178.45 Aligned_cols=139 Identities=14% Similarity=0.118 Sum_probs=107.3
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-C-----hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-E-----PESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
..|...+.||+|+||.||++.+.. ..+++|+...... . ......+.+|+.+++.++|++|+..+.+..+ .
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~ 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--P 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--C
Confidence 445667899999999999997643 3455554322211 1 1123567899999999999999887666655 3
Q ss_pred ceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccccccc
Q 011041 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~ 269 (495)
...++||||+++..+..... ....++.||+.+|.|||+.||+||||||+|||+ .++.++|+|||++...
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 45789999999876654432 457789999999999999999999999999999 6789999999999753
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.1e-17 Score=170.49 Aligned_cols=206 Identities=26% Similarity=0.397 Sum_probs=152.9
Q ss_pred HHhCCCCCeeeeeceeeccCCceeEEEEeeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCc-eeccCCCC
Q 011041 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHV-LHRDIKGS 248 (495)
Q Consensus 171 l~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~gi-vHrDlKp~ 248 (495)
|+.+.|.|+.+++|.+.+ ....++|.+||..+.+.+.. .....++.-....++++|+.||.|||+..| .|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~--~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD--GPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEec--CCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 457899999999999988 46789999999976665554 446678888999999999999999998766 99999999
Q ss_pred CeeeCCCCcEEEeecccccccCCC-CCCCCccccccCCCCCcccccCCCC------CCchhhHHHHHHHHHHHHhCCCCC
Q 011041 249 NLLIDNEGILTIADFGLASFFDPN-HKQPMTSRVVTLWYRPPELLLGATD------YGVGVDLWSAGCILAELLAEKPIM 321 (495)
Q Consensus 249 NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~------~~~~~DvwSlGvil~elltG~~pf 321 (495)
|.++|....+||+|||+....... .........-..-|.|||++.+... .+.+.||||+|+++||+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998776421 1111112223556999999866311 356799999999999999999999
Q ss_pred CCCCh----HHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHH
Q 011041 322 PGRTE----VEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATA 397 (495)
Q Consensus 322 ~~~~~----~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~e 397 (495)
..... .++...+.+ .+..+ +.| .+.. ...+++++..++..|+..+|.+||++++
T Consensus 159 ~~~~~~~~~~eii~~~~~-~~~~~--------------~rP------~i~~-~~e~~~~l~~l~~~cw~e~P~~rPs~~~ 216 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-GGSNP--------------FRP------SIEL-LNELPPELLLLVARCWEEIPEKRPSIEQ 216 (484)
T ss_pred ccccccCChHHHHHHHHh-cCCCC--------------cCc------chhh-hhhcchHHHHHHHHhcccChhhCccHHH
Confidence 86332 233333332 11100 000 0111 1145668999999999999999999999
Q ss_pred HHh
Q 011041 398 ALR 400 (495)
Q Consensus 398 lL~ 400 (495)
+-.
T Consensus 217 i~~ 219 (484)
T KOG1023|consen 217 IRS 219 (484)
T ss_pred HHh
Confidence 854
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.1e-17 Score=169.32 Aligned_cols=256 Identities=21% Similarity=0.253 Sum_probs=197.7
Q ss_pred CCCeeeeeeecc--cCceEEEEEEE--CCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQ--GTYSNVYKARD--TLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~--G~~g~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 191 (495)
...|.+...+|. |.+|.||.+.. ..++..+|+|.-+.....+.....=.+|+.-.+.+ .|+|.++.+..++. .
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~ 190 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--S 190 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--C
Confidence 356777888999 99999999988 88999999998443322122222223566666666 49999998888887 6
Q ss_pred ceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHH----HHHHhhhCCceeccCCCCCeeeCCC-CcEEEeecccc
Q 011041 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLS----GLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFGLA 266 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~----~L~~LH~~givHrDlKp~NILl~~~-~~vkL~DFG~a 266 (495)
+.+|+-+|+++..+..........+++..++.++.+... ||.++|+.+++|-|+||+||++..+ ...+++|||+.
T Consensus 191 ~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 191 GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 789999999999999888888878999999999999999 9999999999999999999999999 78999999999
Q ss_pred cccCCCCCCCC----ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHhcCCC
Q 011041 267 SFFDPNHKQPM----TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR--TEVEQLHKIFKLCGSP 340 (495)
Q Consensus 267 ~~~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~--~~~~~~~~i~~~~g~~ 340 (495)
..+........ ....|..-|++||++.+ -++...||++||.++.+..+|..++... +...++..++ .
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-----i 343 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-----I 343 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-----C
Confidence 88865542111 11246777999998865 5789999999999999999887655433 2222222211 0
Q ss_pred ChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 341 SEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
-.+.+...+.++...+..|+..||..|+++..++.|+++..
T Consensus 344 -------------------------p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 344 -------------------------PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred -------------------------chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 11223334455556899999999999999999999999874
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-16 Score=152.74 Aligned_cols=138 Identities=15% Similarity=0.175 Sum_probs=101.8
Q ss_pred eeec-ccCceEEEEEEECCCCeEEEeEEEecCCC-----------ChHHHHHHHHHHHHHHhCCCCCe--eeeeceeecc
Q 011041 124 DKIG-QGTYSNVYKARDTLTGQIVALKKVRFDNL-----------EPESVRFMAREILILRRLDHPNV--VKLEGLVTSR 189 (495)
Q Consensus 124 ~~LG-~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-----------~~~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~~ 189 (495)
..|| .|+.|+||.+.. .+..++||.+..... .......+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 788888888864 377899998854321 11233567889999999998875 6676664432
Q ss_pred CCc--eeEEEEeeccC-ChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccc
Q 011041 190 MSC--SLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266 (495)
Q Consensus 190 ~~~--~~~lv~e~~~~-~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a 266 (495)
... ..++||||+++ ..+..+... ..+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 221 23599999996 344433332 2455543 678999999999999999999999999999999999999988
Q ss_pred cc
Q 011041 267 SF 268 (495)
Q Consensus 267 ~~ 268 (495)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 64
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=4e-16 Score=137.66 Aligned_cols=133 Identities=23% Similarity=0.224 Sum_probs=109.0
Q ss_pred eeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCC--CCeeeeeceeeccCCceeEEEEe
Q 011041 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH--PNVVKLEGLVTSRMSCSLYLVFK 199 (495)
Q Consensus 122 ~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~~~lv~e 199 (495)
+++.||+|.++.||++.+.. ..+++|.+..... ...+.+|+.+++.+.| .++++++.++.. ....|++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEE
Confidence 45789999999999998643 6899998865432 3567889999999976 588898887765 357899999
Q ss_pred eccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhC---CceeccCCCCCeeeCCCCcEEEeeccccccc
Q 011041 200 YMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ---HVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (495)
Q Consensus 200 ~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~---givHrDlKp~NILl~~~~~vkL~DFG~a~~~ 269 (495)
|+.+..+... +......++.+++.+|.+||.. +++|+||+|+|||++..+.++|+|||++...
T Consensus 74 ~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 74 WIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 9987654332 5566678899999999999984 7999999999999999999999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.7e-17 Score=179.15 Aligned_cols=266 Identities=23% Similarity=0.259 Sum_probs=201.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.+.+.+.+-+-+|+++.++.+.-..+|...++|+..+... .....+...++-.++-...+|.+++..--+.. ....+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~--rsP~~ 880 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC--RSPLP 880 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC--CCCcc
Confidence 4678888899999999999998888888888887654332 22223334444444444456777665443333 45689
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC---
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN--- 272 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~--- 272 (495)
++++|.+++.+.-.+..-...++.-++.++..+...++|||...++|+|++|.|+|+..+|+.+++|||......-.
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999987655555554456788888999999999999999999999999999999999999999999844322100
Q ss_pred --C-----------------C--------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 011041 273 --H-----------------K--------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT 325 (495)
Q Consensus 273 --~-----------------~--------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~ 325 (495)
. . ..-...+||+.|.+||.+.+. ..+..+|+|++|++++|.++|.+||...+
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-RHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc-cCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 0 011235789999999999884 56889999999999999999999999999
Q ss_pred hHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHH---HHHhCC
Q 011041 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT---AALRSE 402 (495)
Q Consensus 326 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~---elL~hp 402 (495)
...++..|.+..- .|+ .-....++.+++++..+|..+|.+|..+. ++-.|+
T Consensus 1040 pq~~f~ni~~~~~-----~~p---------------------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~ 1093 (1205)
T KOG0606|consen 1040 PQQIFENILNRDI-----PWP---------------------EGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHP 1093 (1205)
T ss_pred hhhhhhccccCCC-----CCC---------------------CCccccChhhhhhhhhhhccCchhccCcccccccccCC
Confidence 9988877754221 121 12234678899999999999999999887 899999
Q ss_pred CCCCCCCCC
Q 011041 403 FFTTKPYAC 411 (495)
Q Consensus 403 ~f~~~~~~~ 411 (495)
||+...|..
T Consensus 1094 ~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1094 FFQDVDWEN 1102 (1205)
T ss_pred ccCCCCccc
Confidence 999887754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.4e-15 Score=154.33 Aligned_cols=260 Identities=20% Similarity=0.198 Sum_probs=189.2
Q ss_pred cccCCCCCCCCCeeeeeeecccCceEEEEEEEC-CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeece
Q 011041 108 AISGWTPRRADTFEKLDKIGQGTYSNVYKARDT-LTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGL 185 (495)
Q Consensus 108 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 185 (495)
....|+.....+|..+..||.|.|+.||.+..+ .++..|++|.....-.......+-..|+.+...+ -|.+++.++..
T Consensus 255 ~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 255 TTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred cccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence 334455666789999999999999999998755 6788999998765544333333444677777766 48899998777
Q ss_pred eeccCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC-CcEEEeecc
Q 011041 186 VTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFG 264 (495)
Q Consensus 186 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~-~~vkL~DFG 264 (495)
|.. ....|+-.|||++....+...-...+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||
T Consensus 335 W~~--~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 335 WSQ--LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred ccc--cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccc
Confidence 765 34567999999887666655444467888999999999999999999999999999999999886 788999999
Q ss_pred cccccCCCCCCCCccccccCCCC-CcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 011041 265 LASFFDPNHKQPMTSRVVTLWYR-PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE 343 (495)
Q Consensus 265 ~a~~~~~~~~~~~~~~~gt~~y~-aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (495)
..+.+.-. ......+-+++ ..|++.....+..+.|++|||..+.+.++|.+.-+..+.. ..|...
T Consensus 413 ~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~~------- 478 (524)
T KOG0601|consen 413 CWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRSG------- 478 (524)
T ss_pred ccccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeecc-------
Confidence 98643211 11222344455 3666766677889999999999999999997654322111 111000
Q ss_pred hhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
...........+..+.+.++..|+..|+.+.++..|.=|-
T Consensus 479 ----------------------~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 479 ----------------------DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ----------------------cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0011122335677789999999999999999998876553
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.3e-13 Score=127.60 Aligned_cols=139 Identities=18% Similarity=0.187 Sum_probs=100.9
Q ss_pred eeecccCceEEEEEEECC------CCeEEEeEEEecCCC--------------------ChHHHHHHH----HHHHHHHh
Q 011041 124 DKIGQGTYSNVYKARDTL------TGQIVALKKVRFDNL--------------------EPESVRFMA----REILILRR 173 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~------~g~~vAiK~i~~~~~--------------------~~~~~~~~~----~Ei~il~~ 173 (495)
..||.|--+.||.|.... .+..+|||+.+.... .......+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997553 357899998753210 011122333 89999999
Q ss_pred CCC--CCeeeeeceeeccCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHh-hhCCceeccCCCCCe
Q 011041 174 LDH--PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC-HNQHVLHRDIKGSNL 250 (495)
Q Consensus 174 l~H--pnIv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~L-H~~givHrDlKp~NI 250 (495)
+.. -++++++++. .-+|||||++++.+.........+++.++..++.+++.+|..| |..||||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 843 4566666542 2589999998753221111223466677788899999999999 899999999999999
Q ss_pred eeCCCCcEEEeeccccccc
Q 011041 251 LIDNEGILTIADFGLASFF 269 (495)
Q Consensus 251 Ll~~~~~vkL~DFG~a~~~ 269 (495)
|++ ++.+.|+|||.+...
T Consensus 157 L~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EEE-CCcEEEEECCCceeC
Confidence 997 478999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.8e-14 Score=152.35 Aligned_cols=146 Identities=18% Similarity=0.257 Sum_probs=98.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC---------------------------Ch-----HHHHH-
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL---------------------------EP-----ESVRF- 163 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~---------------------------~~-----~~~~~- 163 (495)
...|+. +.||.|++|+||+|+.+.+|+.||||+++..-. .. +..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 789999999999999988899999999975410 00 11122
Q ss_pred -----HHHHHHHHHhC----CCCCeeeeeceeeccCCceeEEEEeeccCChhhhhh--CCCC----CCCHHHHHHHHHHH
Q 011041 164 -----MAREILILRRL----DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAA--SPTI----KFTQAQVKCYMHQL 228 (495)
Q Consensus 164 -----~~~Ei~il~~l----~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~----~l~e~~~~~i~~qi 228 (495)
+.+|+..+.++ .+.+.+.+-.++.+- ....+|||||+.|.-+.... ...+ .+.+..+..++.||
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 33344444443 233333333333322 34578999999986554321 1111 35566666677776
Q ss_pred HHHHHHhhhCCceeccCCCCCeeeCCCC----cEEEeecccccccCC
Q 011041 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEG----ILTIADFGLASFFDP 271 (495)
Q Consensus 229 l~~L~~LH~~givHrDlKp~NILl~~~~----~vkL~DFG~a~~~~~ 271 (495)
+ ..|++|+|+||.||+|+.+| .++++|||++..++.
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 5 48999999999999999988 999999999987654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.1e-13 Score=144.36 Aligned_cols=142 Identities=18% Similarity=0.202 Sum_probs=94.2
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCCCh----------------------------H----H------HHHHH
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP----------------------------E----S------VRFMA 165 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~----------------------------~----~------~~~~~ 165 (495)
+.||.|++|+||+|+.+ +|+.||||+.+..-... . . .-.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 56999999999999865 78999999986432100 0 0 00244
Q ss_pred HHHHHHHhC----CCCCeeeeeceeeccCCceeEEEEeeccCChhhhhhCC-CCCCCHHHHHHHHHHHHH-HHHHhhhCC
Q 011041 166 REILILRRL----DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLS-GLEHCHNQH 239 (495)
Q Consensus 166 ~Ei~il~~l----~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~l~e~~~~~i~~qil~-~L~~LH~~g 239 (495)
+|+..+.++ .|.+-+.+-.++.+. ....+|||||++|..+...... ...+. ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 556555555 233333333333222 2346999999998655443221 11122 2345555555 478899999
Q ss_pred ceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 240 ivHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
++|+|+||.||+++.+|.++|+|||++..++
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=7.8e-13 Score=138.22 Aligned_cols=169 Identities=19% Similarity=0.295 Sum_probs=127.4
Q ss_pred EEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeeccCChhhhhhCCCCC
Q 011041 136 KARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK 215 (495)
Q Consensus 136 ~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~ 215 (495)
.|..+.++.+|.+...+.... .......+-++-|+.|+||||+++++.++. +..+|||+|-+.--. .... .
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV~Pl~--~~lk---~ 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERVRPLE--TVLK---E 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeeccccHH--HHHH---H
Confidence 456677888999988875543 445667788999999999999999999987 568999999876311 1111 2
Q ss_pred CCHHHHHHHHHHHHHHHHHhh-hCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccccccCCCCCcccccC
Q 011041 216 FTQAQVKCYMHQLLSGLEHCH-NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294 (495)
Q Consensus 216 l~e~~~~~i~~qil~~L~~LH-~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 294 (495)
+....+...+.||+.||.||| ..+++|++|.-.-|+|+..|..||++|-++........ ......---.|..|+.+..
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc
Confidence 336777888999999999997 67899999999999999999999999999865532221 1111122233777775432
Q ss_pred CCCCCchhhHHHHHHHHHHHHhC
Q 011041 295 ATDYGVGVDLWSAGCILAELLAE 317 (495)
Q Consensus 295 ~~~~~~~~DvwSlGvil~elltG 317 (495)
-+...|.|-|||++++++.|
T Consensus 180 ---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 ---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ---cccchhhhhHHHHHHHHhCc
Confidence 12457999999999999998
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.9e-13 Score=121.34 Aligned_cols=127 Identities=14% Similarity=0.138 Sum_probs=94.3
Q ss_pred eeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCe-eeeeceeeccCCceeEEEEeec
Q 011041 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV-VKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 123 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~~~lv~e~~ 201 (495)
++.|+.|.++.||+++.. +..|++|+...... ....+.+|+.+++.+.+.++ ++++.+... ..++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~----~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDPE----TGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeCC----CCeEEEEec
Confidence 467899999999999754 78899998754321 12245689999999865554 455544322 348999999
Q ss_pred cCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc-----eeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV-----LHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 202 ~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~gi-----vHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
++..+... ......++.+++.+|..||..++ +|+|++|.||+++ ++.++|+|||.+.
T Consensus 74 ~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 74 EGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 98654322 01123457899999999999885 9999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.1e-14 Score=135.80 Aligned_cols=239 Identities=20% Similarity=0.192 Sum_probs=152.8
Q ss_pred EEEEEEECCCCeEEEeEEEecCCC-C-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC---CceeEEEEeeccCChhh
Q 011041 133 NVYKARDTLTGQIVALKKVRFDNL-E-PESVRFMAREILILRRLDHPNVVKLEGLVTSRM---SCSLYLVFKYMEHDLAG 207 (495)
Q Consensus 133 ~Vy~a~~~~~g~~vAiK~i~~~~~-~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---~~~~~lv~e~~~~~l~~ 207 (495)
.||++-++..|..|..-.+..... + ....+....-..-|-++.|.|||+++.|+.+.. ...+.++.|||..+.+.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 467777777776665554432211 0 111112222233455567999999999997632 24578889999976554
Q ss_pred hhh----CCCCCCCHHHHHHHHHHHHHHHHHhhhC--CceeccCCCCCeeeCCCCcEEEeecccccccCCCCC----CCC
Q 011041 208 LAA----SPTIKFTQAQVKCYMHQLLSGLEHCHNQ--HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK----QPM 277 (495)
Q Consensus 208 ~~~----~~~~~l~e~~~~~i~~qil~~L~~LH~~--givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~----~~~ 277 (495)
..+ .....+.....++|+-||+.||.|||+. -|+|+++...-|++..+|-+|++---... +.+.-. ...
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhh
Confidence 333 3455688899999999999999999976 49999999999999999999975221111 100000 001
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPI-MPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
....+-++|.+||.=.. ...+.++|||++|....+|..|.-- -.+....+.-..|.+.......
T Consensus 240 ~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~len-------------- 304 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLEN-------------- 304 (458)
T ss_pred hccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeeccC--------------
Confidence 12245678999995332 3456789999999999999887642 2222222222222221111100
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
+--.++|.+||.-.|..||++.++|.||.+-
T Consensus 305 ------------------~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 305 ------------------GLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred ------------------ccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 1112369999999999999999999999854
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=6e-11 Score=112.22 Aligned_cols=142 Identities=18% Similarity=0.229 Sum_probs=105.1
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCC--CCeeeeeceeeccC-CceeEEEEee
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH--PNVVKLEGLVTSRM-SCSLYLVFKY 200 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~-~~~~~lv~e~ 200 (495)
+.|+.|.++.||++.... |..|++|+....... .....+.+|+.+++.+.+ .++++++.+..... ....++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 578999999999998643 678999987654321 134567889999999975 34566766654421 1356899999
Q ss_pred ccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh-------------------------------------------
Q 011041 201 MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN------------------------------------------- 237 (495)
Q Consensus 201 ~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~------------------------------------------- 237 (495)
++|..+...... ..+++.+...++.+++.+|.+||+
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 998755443321 356777777888888888888873
Q ss_pred -------------CCceeccCCCCCeeeCC--CCcEEEeecccccc
Q 011041 238 -------------QHVLHRDIKGSNLLIDN--EGILTIADFGLASF 268 (495)
Q Consensus 238 -------------~givHrDlKp~NILl~~--~~~vkL~DFG~a~~ 268 (495)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999998 67789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.7e-11 Score=105.87 Aligned_cols=133 Identities=22% Similarity=0.243 Sum_probs=95.3
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEE-ecCCCChHH-----HHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKV-RFDNLEPES-----VRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i-~~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
..+++|+-+.+|.+.. -|..+.+|.- .+....++. .....+|+.++.++.--.|...+=+..+ ...-.|+
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~~~~~I~ 77 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--PDNGLIV 77 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCCEEE
Confidence 3578999999999854 3445666643 222222222 3456689999999864444333323333 3346899
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccc
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~ 268 (495)
|||++|.++....... ...+++.+-.-+.-||..||||+||.++||++..++ +.++|||++.+
T Consensus 78 me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888655443 256778888888999999999999999999998765 99999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.2e-10 Score=104.28 Aligned_cols=143 Identities=16% Similarity=0.272 Sum_probs=100.7
Q ss_pred eeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-Ch-----HHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EP-----ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 122 ~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.+..|-+|+-+.|+++. ..|+.+.||.-..... .+ -......+|+++|.++.--.|.-..-++.+ ...-.
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D--~~~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID--TYGGQ 86 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe--cCCCe
Confidence 56789999999999995 5688888885322221 11 123567789999999864445333334444 23457
Q ss_pred EEEeeccC--ChhhhhhCCCCCCCHH-HHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC---cEEEeecccccc
Q 011041 196 LVFKYMEH--DLAGLAASPTIKFTQA-QVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASF 268 (495)
Q Consensus 196 lv~e~~~~--~l~~~~~~~~~~l~e~-~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~---~vkL~DFG~a~~ 268 (495)
|+|||++| .+...+......-.+. ....++++|-..|.-||.++|||+||..+||+|..+| .+.|+|||++..
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 89999998 4444443322222233 3378999999999999999999999999999997765 358999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.2e-10 Score=104.54 Aligned_cols=127 Identities=24% Similarity=0.271 Sum_probs=83.0
Q ss_pred EEEEEEECCCCeEEEeEEEecCCC------------------------ChHHHHHHHHHHHHHHhCCCC--Ceeeeecee
Q 011041 133 NVYKARDTLTGQIVALKKVRFDNL------------------------EPESVRFMAREILILRRLDHP--NVVKLEGLV 186 (495)
Q Consensus 133 ~Vy~a~~~~~g~~vAiK~i~~~~~------------------------~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~ 186 (495)
.||.|.. ..|..+|||+.+.... ..-......+|.+.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3899985 4678999998753210 011234567899999999765 567776543
Q ss_pred eccCCceeEEEEeecc--CChhhhhhCCCCCCCHHHHHHHHHHHHHHHHH-hhhCCceeccCCCCCeeeCCCCcEEEeec
Q 011041 187 TSRMSCSLYLVFKYME--HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH-CHNQHVLHRDIKGSNLLIDNEGILTIADF 263 (495)
Q Consensus 187 ~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~-LH~~givHrDlKp~NILl~~~~~vkL~DF 263 (495)
. -+|||||++ |..+..+... .++......++.+++..+.. +|..||||+||.+.|||++++ .+.|+||
T Consensus 80 ~------~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 R------NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp T------TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred C------CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 2 379999999 5444333222 12244567788888885555 579999999999999999987 8999999
Q ss_pred cccccc
Q 011041 264 GLASFF 269 (495)
Q Consensus 264 G~a~~~ 269 (495)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.6e-09 Score=110.41 Aligned_cols=215 Identities=19% Similarity=0.234 Sum_probs=154.7
Q ss_pred CceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeec--cCCceeEEEEeeccCC--h
Q 011041 130 TYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTS--RMSCSLYLVFKYMEHD--L 205 (495)
Q Consensus 130 ~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~~~lv~e~~~~~--l 205 (495)
--.+.|+|....+|..|++|.+.-...... .....-+++++++.|+|||.+.++|.. -.+..+++|++|.++. |
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST--NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc--ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 346889999999999999999943322111 122234778999999999999998862 2356899999999863 4
Q ss_pred hhhhhC--------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 206 AGLAAS--------------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 206 ~~~~~~--------------~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
..++.. .+...+|..+|.|+.||..||.++|+.|+..+-|.|.+||++.+-+++|...|+......
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 443322 233578999999999999999999999999999999999999999999988887765543
Q ss_pred CCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG-RTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~-~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
... |.+.+ -.+-|.=.||.+++.|.||..--.. ...... +
T Consensus 446 d~~---------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s-~------------------- 486 (655)
T KOG3741|consen 446 DPT---------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSS-H------------------- 486 (655)
T ss_pred CCC---------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHH-H-------------------
Confidence 321 11222 2356999999999999999542111 111111 0
Q ss_pred CCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
+......++.++.++|..+...++.+ -++.++|.|
T Consensus 487 ---------------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 487 ---------------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ---------------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 11222346778888999999999887 778888764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=3e-11 Score=126.97 Aligned_cols=156 Identities=21% Similarity=0.302 Sum_probs=115.9
Q ss_pred HHHHHHHHhh-hCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCc--------cccccCCCCCcccccCCCC
Q 011041 227 QLLSGLEHCH-NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT--------SRVVTLWYRPPELLLGATD 297 (495)
Q Consensus 227 qil~~L~~LH-~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~--------~~~gt~~y~aPE~l~~~~~ 297 (495)
+...||.|+| +.++||++|.|++|.++..|..||+.|+++....+....+.. -..-...|.|||++.+ ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 3449999999 468999999999999999999999999998765442221111 1123567999999877 56
Q ss_pred CCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCC
Q 011041 298 YGVGVDLWSAGCILAELL-AEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPS 376 (495)
Q Consensus 298 ~~~~~DvwSlGvil~ell-tG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 376 (495)
.+.++|++||||++|.+. .|++.|.+.+.......-....+. . ....-..+|++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~--------------~-----------~~~~s~~~p~e 240 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA--------------G-----------AFGYSNNLPSE 240 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc--------------c-----------cccccccCcHH
Confidence 789999999999999999 788887765433322211111000 0 01111568899
Q ss_pred cHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 377 SLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 377 ~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
+.+=|.++|..|+..||++.+++..|||.+..
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 99999999999999999999999999998744
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.9e-09 Score=102.99 Aligned_cols=133 Identities=15% Similarity=0.084 Sum_probs=90.3
Q ss_pred EEEEEEECCCCeEEEeEEEecCCCCh---------HHHHHHHHHHHHHHhCCCCCee--eeeceeeccC---CceeEEEE
Q 011041 133 NVYKARDTLTGQIVALKKVRFDNLEP---------ESVRFMAREILILRRLDHPNVV--KLEGLVTSRM---SCSLYLVF 198 (495)
Q Consensus 133 ~Vy~a~~~~~g~~vAiK~i~~~~~~~---------~~~~~~~~Ei~il~~l~HpnIv--~l~~~~~~~~---~~~~~lv~ 198 (495)
.|+++. ..|+.|.||......... .....+.+|...+..|..-+|. .++.+.+... ....+|||
T Consensus 37 rvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 355553 356788899663322110 0111367888888888544443 3344554321 23478999
Q ss_pred eeccCC-hhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC-------CCcEEEeeccccc
Q 011041 199 KYMEHD-LAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-------EGILTIADFGLAS 267 (495)
Q Consensus 199 e~~~~~-l~~~~~~~--~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~-------~~~vkL~DFG~a~ 267 (495)
|++++. .+..+... ....++.....++.+|+..+.-||..||+|+||++.||||+. ++.+.|+||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999984 33333221 234567788899999999999999999999999999999975 4679999999875
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.6e-09 Score=100.60 Aligned_cols=137 Identities=24% Similarity=0.240 Sum_probs=102.7
Q ss_pred eeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC--------------------hHHHHHHHHHHHHHHhCCCC--
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE--------------------PESVRFMAREILILRRLDHP-- 177 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~--------------------~~~~~~~~~Ei~il~~l~Hp-- 177 (495)
+.++..||.|--+.||.|.+. .|..+|||.=+....+ .......++|.++|++|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456788999999999999866 6889999975422110 11233467899999999644
Q ss_pred CeeeeeceeeccCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCc
Q 011041 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI 257 (495)
Q Consensus 178 nIv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~ 257 (495)
.+++.+++ +.-.+||||++|-.+.... ++...+..++..|+.-+.-+-..||||+|+.+=|||+++||.
T Consensus 172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 67776653 3458999999985544322 234555667777777777777999999999999999999999
Q ss_pred EEEeecccccc
Q 011041 258 LTIADFGLASF 268 (495)
Q Consensus 258 vkL~DFG~a~~ 268 (495)
+.++||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999986654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.5e-08 Score=101.20 Aligned_cols=252 Identities=14% Similarity=0.113 Sum_probs=153.5
Q ss_pred eeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHh-CCCCCeeeeec-----eeeccCCceeEE
Q 011041 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR-LDHPNVVKLEG-----LVTSRMSCSLYL 196 (495)
Q Consensus 123 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~-----~~~~~~~~~~~l 196 (495)
.+.||+|+-+.+|-.- +-+.. +.|+.......... + -+..|.. -+||-+-.-+. .+-.+....+-+
T Consensus 16 gr~LgqGgea~ly~l~--e~~d~-VAKIYh~Pppa~~a--q---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 16 GRPLGQGGEADLYTLG--EVRDQ-VAKIYHAPPPAAQA--Q---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CccccCCccceeeecc--hhhch-hheeecCCCchHHH--H---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 4679999999999652 22333 44777654322111 1 1222333 35664432111 011111233667
Q ss_pred EEeeccCC--hhhhhh-----CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccccccc
Q 011041 197 VFKYMEHD--LAGLAA-----SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (495)
Q Consensus 197 v~e~~~~~--l~~~~~-----~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~ 269 (495)
.|..+.+- ...++. +....+.+..+..+.+.|+.+...||+.|.+-+|+.++||||.+++.|.|+|=..-...
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec
Confidence 78777652 221111 22334677889999999999999999999999999999999999999999986544333
Q ss_pred CCCCCCCCccccccCCCCCccccc-C---CCCCCchhhHHHHHHHHHHHHhC-CCCCCCCC-------hHHHHHHHHHhc
Q 011041 270 DPNHKQPMTSRVVTLWYRPPELLL-G---ATDYGVGVDLWSAGCILAELLAE-KPIMPGRT-------EVEQLHKIFKLC 337 (495)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~l~-~---~~~~~~~~DvwSlGvil~elltG-~~pf~~~~-------~~~~~~~i~~~~ 337 (495)
. +.......+|...|.+||.-. + .-.-+...|.|-||+++|+||.| ..||.|.. ..+. .|....
T Consensus 168 ~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~--~Ia~g~ 243 (637)
T COG4248 168 A--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET--DIAHGR 243 (637)
T ss_pred c--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh--hhhcce
Confidence 2 223345568999999999753 1 11235678999999999999986 89998732 1110 111111
Q ss_pred CCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccC--CCCCccCHHHHH
Q 011041 338 GSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAI--DPAERQTATAAL 399 (495)
Q Consensus 338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~--dP~~R~ta~elL 399 (495)
.....+- ..-.++ ....--+..+++++..|+..|+.. ++.-|||++..+
T Consensus 244 f~ya~~~--------~~g~~p-----~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~ 294 (637)
T COG4248 244 FAYASDQ--------RRGLKP-----PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWV 294 (637)
T ss_pred eeechhc--------cCCCCC-----CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHH
Confidence 0000000 000000 112233456789999999999874 467899987654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.3e-08 Score=92.99 Aligned_cols=107 Identities=18% Similarity=0.192 Sum_probs=80.3
Q ss_pred HHHHHHHHHHHhCCCCC--eeeeeceeeccCC--ceeEEEEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 011041 162 RFMAREILILRRLDHPN--VVKLEGLVTSRMS--CSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236 (495)
Q Consensus 162 ~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~--~~~~lv~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH 236 (495)
....+|...+..|..-+ +++.+++.+.... ...++|+|++++. .+..+......++......++.+|...+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 35677888888874333 3455555554222 3458999999873 34444433223677788899999999999999
Q ss_pred hCCceeccCCCCCeeeCCCC---cEEEeecccccc
Q 011041 237 NQHVLHRDIKGSNLLIDNEG---ILTIADFGLASF 268 (495)
Q Consensus 237 ~~givHrDlKp~NILl~~~~---~vkL~DFG~a~~ 268 (495)
.+||+|+|+++.||||+.++ .+.|+||+.+..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2e-07 Score=88.07 Aligned_cols=139 Identities=20% Similarity=0.228 Sum_probs=98.3
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCCChH----------------------HHHHHHHHHHHHHhCC--CCCe
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPE----------------------SVRFMAREILILRRLD--HPNV 179 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~----------------------~~~~~~~Ei~il~~l~--HpnI 179 (495)
..|..|--+.||+|.. .++..||+|+.+....... .......|..-|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3678888889999973 5688999999864321111 1112446777788773 4455
Q ss_pred eeeeceeeccCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCeeeCCCCcE
Q 011041 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGIL 258 (495)
Q Consensus 180 v~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NILl~~~~~v 258 (495)
++.+++.. -.|||||++..-.-.=......+...++..+..+++..+.-|-. .|+||+||..=|||+. ++.+
T Consensus 133 P~Pi~~~~------nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 133 PEPIAFRN------NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCceeecC------CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 66666554 37999999876211111112234444788889999999998876 9999999999999999 8899
Q ss_pred EEeecccccccC
Q 011041 259 TIADFGLASFFD 270 (495)
Q Consensus 259 kL~DFG~a~~~~ 270 (495)
.|+|||-|....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999886543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=9.1e-08 Score=101.06 Aligned_cols=139 Identities=23% Similarity=0.330 Sum_probs=87.5
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCC---------------------------CCh-HH----------HHHHH
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDN---------------------------LEP-ES----------VRFMA 165 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~---------------------------~~~-~~----------~~~~~ 165 (495)
+.|+.++-|+||+|+.+ +|+.||||+.+..- ... +. .-.+.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56999999999999965 49999999986431 000 00 11234
Q ss_pred HHHHHHHhC-----CCCCeeeeeceeeccCCceeEEEEeeccCChhhhhh-CCCCCCC-----HHHHHHHHHHHHHHHHH
Q 011041 166 REILILRRL-----DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAA-SPTIKFT-----QAQVKCYMHQLLSGLEH 234 (495)
Q Consensus 166 ~Ei~il~~l-----~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~~~~l~-----e~~~~~i~~qil~~L~~ 234 (495)
+|+.-+.++ +.++|. +=.+|.+- ...-.|+|||++|--..... .....++ +.-+..++.|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~-VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~----- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVY-VPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL----- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeE-eceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH-----
Confidence 555555554 233332 21222211 34568999999984332221 1112233 333334444443
Q ss_pred hhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 235 LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
..|++|.|.+|.||+++.+|.+.+.|||+...+++.
T Consensus 283 --~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 283 --RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred --hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 489999999999999999999999999999776543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.7e-07 Score=84.30 Aligned_cols=139 Identities=14% Similarity=0.190 Sum_probs=97.7
Q ss_pred cccCceEEEEEEECCCCeEEEeEEEecC---CCC-hHHHHHHHHHHHHHHhCCCCC--eeeeeceee---ccCCceeEEE
Q 011041 127 GQGTYSNVYKARDTLTGQIVALKKVRFD---NLE-PESVRFMAREILILRRLDHPN--VVKLEGLVT---SRMSCSLYLV 197 (495)
Q Consensus 127 G~G~~g~Vy~a~~~~~g~~vAiK~i~~~---~~~-~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~---~~~~~~~~lv 197 (495)
|+|+-+-|+.... .|..|=+|..... ... +.....+.+|+..|+.|..-+ ++++. ++. .......+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 6688888888643 3446778875411 111 334567889999999985433 34443 222 2223457899
Q ss_pred EeeccC--ChhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCc--EEEeecccccc
Q 011041 198 FKYMEH--DLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI--LTIADFGLASF 268 (495)
Q Consensus 198 ~e~~~~--~l~~~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~--vkL~DFG~a~~ 268 (495)
+|-+++ +|...+... ....++.....++.+|+..|.-||..|+.|+|+-+.|||++.+|. |+++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998884 454443332 235677888899999999999999999999999999999987777 99999987653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=6.4e-09 Score=108.53 Aligned_cols=248 Identities=16% Similarity=0.097 Sum_probs=166.4
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCC-eeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN-VVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~~~l 196 (495)
.-|....-+++|+++.+++.+...+...+ .+.+... ....-++++|.+++||| .+..++-++. +.+.++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~--E~~~~i 311 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDG--EDYLWI 311 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCc--ccccch
Confidence 34566677899999999999877666555 6665432 23445889999999999 4444443333 568899
Q ss_pred EEeeccCC--hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHD--LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~--l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
+++++.++ ...........|.+-+...+.+.-+.+|+|||+.-=+|+| |||..+ +..|+.||+....+....
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-
Confidence 99999876 2222222233455556667778888999999988778999 877766 779999999987665432
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
...+..+|+.++|||+... ..+....|+|++|+-..+|.-|.+|-... ..........+...
T Consensus 386 -~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P----------------~~~~~~~g~~p~s~ 447 (829)
T KOG0576|consen 386 -KPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSP----------------PAVLPMIGNGPNSP 447 (829)
T ss_pred -ccccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCC----------------ccccCCCCCCCCcc
Confidence 3456688999999998876 56788899999998777777777765431 10000000000000
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
.... +..+.. ..-.++...||..-|..|+++..++-|.+|..-|.
T Consensus 448 ~L~~----~~aw~~------~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 448 MLTD----KSAWSP------VFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred ccch----hhhcCc------ccccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 0000 000111 11114678899999999999999999999987554
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.2e-06 Score=81.86 Aligned_cols=140 Identities=16% Similarity=0.220 Sum_probs=88.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHH-HH------HHHHHHHHHHhCC---CCCeeeeecee
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES-VR------FMAREILILRRLD---HPNVVKLEGLV 186 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-~~------~~~~Ei~il~~l~---HpnIv~l~~~~ 186 (495)
..+|.+.+.+-......|.+. .-+|..+.+|..+......+. .. ...+++..+..+. --.+..++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 367888888888887777766 356788999987644321110 00 1223444444442 22222222222
Q ss_pred ecc---CCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeec
Q 011041 187 TSR---MSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADF 263 (495)
Q Consensus 187 ~~~---~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DF 263 (495)
+-. .....+|+|||++|-.+.... .+++ .+...|..++.-||+.|++|+|+.|.|+++++++ ++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEEC
Confidence 211 123457899999986543322 1233 2446677889999999999999999999998655 999999
Q ss_pred cccc
Q 011041 264 GLAS 267 (495)
Q Consensus 264 G~a~ 267 (495)
+...
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.3e-06 Score=82.81 Aligned_cols=139 Identities=22% Similarity=0.314 Sum_probs=80.7
Q ss_pred eeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCC--Ceeeeeceeec-cCCceeEEEEe
Q 011041 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP--NVVKLEGLVTS-RMSCSLYLVFK 199 (495)
Q Consensus 123 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~-~~~~~~~lv~e 199 (495)
++.|+.|..+.||++.... ..+++|..... .....+.+|+.+++.|... .+++++.+... ......+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 5689999999999998654 48899986532 4556788899999988533 35566654322 22345799999
Q ss_pred eccCChhhh--------------------h-hC--CCCCCCHHH------HHHH---------------HHHHHH-HHHH
Q 011041 200 YMEHDLAGL--------------------A-AS--PTIKFTQAQ------VKCY---------------MHQLLS-GLEH 234 (495)
Q Consensus 200 ~~~~~l~~~--------------------~-~~--~~~~l~e~~------~~~i---------------~~qil~-~L~~ 234 (495)
++++..+.. + .. ....+.... .... ...+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 998753332 0 00 011111000 0000 111222 2333
Q ss_pred hh-------hCCceeccCCCCCeeeC-CCCcEEEeeccccc
Q 011041 235 CH-------NQHVLHRDIKGSNLLID-NEGILTIADFGLAS 267 (495)
Q Consensus 235 LH-------~~givHrDlKp~NILl~-~~~~vkL~DFG~a~ 267 (495)
++ ...++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 33 24699999999999999 66777899999774
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.1e-06 Score=83.74 Aligned_cols=134 Identities=16% Similarity=0.118 Sum_probs=80.4
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCC--eeeeeceeeccCCceeEEEEeec
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN--VVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
..||+|..+.||+. .|..+++|...... ....+.+|.++++.+..-+ +++.+++..+ .....+|||++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeeeec
Confidence 57899999999984 24567788875422 2234678999999985433 3566666654 44578899999
Q ss_pred cCCh-hh-h---------------------hhC-CCCCCCHHH-HHHHHHHH----------HH-HHHHhh----hCCce
Q 011041 202 EHDL-AG-L---------------------AAS-PTIKFTQAQ-VKCYMHQL----------LS-GLEHCH----NQHVL 241 (495)
Q Consensus 202 ~~~l-~~-~---------------------~~~-~~~~l~e~~-~~~i~~qi----------l~-~L~~LH----~~giv 241 (495)
+|.. .. . +.. ......... ...+..+| .. ...+|. ...++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 9841 10 0 000 000111111 00110010 11 112222 23478
Q ss_pred eccCCCCCeeeCCCCcEEEeecccccc
Q 011041 242 HRDIKGSNLLIDNEGILTIADFGLASF 268 (495)
Q Consensus 242 HrDlKp~NILl~~~~~vkL~DFG~a~~ 268 (495)
|+|+.|.||++++++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999988 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.38 E-value=8.5e-06 Score=75.39 Aligned_cols=129 Identities=25% Similarity=0.313 Sum_probs=91.9
Q ss_pred CCeeeeeeecccCc-eEEEEEEECCCCeEEEeEEEec---CC-------CCh---------HHHHHHHHHHHHHHhC---
Q 011041 118 DTFEKLDKIGQGTY-SNVYKARDTLTGQIVALKKVRF---DN-------LEP---------ESVRFMAREILILRRL--- 174 (495)
Q Consensus 118 ~~y~~~~~LG~G~~-g~Vy~a~~~~~g~~vAiK~i~~---~~-------~~~---------~~~~~~~~Ei~il~~l--- 174 (495)
.+++.++.||.|.- |.||+++ -.|..||||++.. .. ... ....-|..|.+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 9999995 5688999999432 10 000 1233567788777776
Q ss_pred CCCCe--eeeeceeecc----------------CCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 011041 175 DHPNV--VKLEGLVTSR----------------MSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236 (495)
Q Consensus 175 ~HpnI--v~l~~~~~~~----------------~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH 236 (495)
.+.++ |+++||+.-. .....-||.||+.... .+.. .-+.+|++-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 45566 9999987321 1123467888776543 1222 23678888899999
Q ss_pred hCCceeccCCCCCeeeCCCCcEEEeecccc
Q 011041 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLA 266 (495)
Q Consensus 237 ~~givHrDlKp~NILl~~~~~vkL~DFG~a 266 (495)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999985 4589999965
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.31 E-value=8.9e-06 Score=92.12 Aligned_cols=148 Identities=22% Similarity=0.323 Sum_probs=91.5
Q ss_pred eeeeecccCceEEEEEEECCCC--eEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCe--eeeeceeecc-CCceeE
Q 011041 122 KLDKIGQGTYSNVYKARDTLTG--QIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNV--VKLEGLVTSR-MSCSLY 195 (495)
Q Consensus 122 ~~~~LG~G~~g~Vy~a~~~~~g--~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnI--v~l~~~~~~~-~~~~~~ 195 (495)
.++.|+.|.+..+|+......+ ..+++|+....... .....+.+|+.+|+.|. |.+| ++++.++.+. ..+..|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 3577899999999998765432 46778876443221 12346889999999995 6665 6777766542 124578
Q ss_pred EEEeeccCChhhh------------------------hhC-C--C-------C--CCCHHHHHHHHHH------------
Q 011041 196 LVFKYMEHDLAGL------------------------AAS-P--T-------I--KFTQAQVKCYMHQ------------ 227 (495)
Q Consensus 196 lv~e~~~~~l~~~------------------------~~~-~--~-------~--~l~e~~~~~i~~q------------ 227 (495)
+||||++|..... +.. . . . .+...++..|..+
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 9999998753110 000 0 0 0 0112233322221
Q ss_pred ---HHHHHHHhhh-----------CCceeccCCCCCeeeCCC-Cc-EEEeecccccccC
Q 011041 228 ---LLSGLEHCHN-----------QHVLHRDIKGSNLLIDNE-GI-LTIADFGLASFFD 270 (495)
Q Consensus 228 ---il~~L~~LH~-----------~givHrDlKp~NILl~~~-~~-vkL~DFG~a~~~~ 270 (495)
+...+.+|.. ..+||+|+++.|||++.+ +. +-|.||.++..-+
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 2233455631 359999999999999853 33 5799999987644
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.29 E-value=7.1e-06 Score=79.10 Aligned_cols=134 Identities=19% Similarity=0.200 Sum_probs=79.2
Q ss_pred eecccCc-eEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCceeEEEEeecc
Q 011041 125 KIGQGTY-SNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYLVFKYME 202 (495)
Q Consensus 125 ~LG~G~~-g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~lv~e~~~ 202 (495)
.|-.|.+ ..||++.. .+..+.+|+..... ...+.+|+.+++.+. +--+++++++... ....++|||+++
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEEEeeC
Confidence 3445555 78999864 34677888765332 234667999988883 4446677776654 345789999998
Q ss_pred CChhhhhh--------------------C-C--CCCCCHH------HHHHH-------------------HHHHHHHHHH
Q 011041 203 HDLAGLAA--------------------S-P--TIKFTQA------QVKCY-------------------MHQLLSGLEH 234 (495)
Q Consensus 203 ~~l~~~~~--------------------~-~--~~~l~e~------~~~~i-------------------~~qil~~L~~ 234 (495)
|..+.... . . ...+... ..... ..+++.-|..
T Consensus 76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 155 (244)
T cd05150 76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA 155 (244)
T ss_pred CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence 85333111 0 0 0011100 00000 1111111111
Q ss_pred h----hhCCceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 235 C----HNQHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 235 L----H~~givHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
. ....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred hCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 1 12358999999999999998888899999774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.25 E-value=5e-06 Score=92.72 Aligned_cols=205 Identities=19% Similarity=0.176 Sum_probs=139.2
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeceeeccCCce--eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 011041 161 VRFMAREILILRRLDHPNVVKLEGLVTSRMSCS--LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238 (495)
Q Consensus 161 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~--~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~ 238 (495)
.....-|+..+..+.|+|++.++.|-..+.... ..+..+++.........+.-...+...++.+..+++.||.|+|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 344556777788889999999988765432222 233446666655556666666789999999999999999999998
Q ss_pred CceeccCCCC---CeeeCCCCcEEEe--ecccccccCCCCCCCCccccccCCCCCcccccCCCCCC--chhhHHHHHHHH
Q 011041 239 HVLHRDIKGS---NLLIDNEGILTIA--DFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYG--VGVDLWSAGCIL 311 (495)
Q Consensus 239 givHrDlKp~---NILl~~~~~vkL~--DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~--~~~DvwSlGvil 311 (495)
...|.-|... +-.++.++.+.++ ||+....+..... ......+..+.++|.... ..+. ...|+|.+|..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCcccccccccccc-ccchhhhhhHHHHHHHHH
Confidence 6555555444 4444556677777 9998877654322 233445667888887654 2333 336999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCC-CCCCcHHHHHHhccCCCC
Q 011041 312 AELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKD-FPPSSLPLIETLLAIDPA 390 (495)
Q Consensus 312 ~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~Li~~~L~~dP~ 390 (495)
..+..|..+-.... .+. ..... +.....+++.+|+.-|++
T Consensus 383 ~~~~~~~~i~~~~~------~~~---------------------------------~~l~~~~~~~~~d~~~~~~~~~~~ 423 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSA------VPV---------------------------------SLLDVLSTSELLDALPKCLDEDSE 423 (1351)
T ss_pred hhhhhcCccccccc------chh---------------------------------hhhccccchhhhhhhhhhcchhhh
Confidence 99988765321100 000 00011 112567789999999999
Q ss_pred CccCHHHHHhCCCCCCC
Q 011041 391 ERQTATAALRSEFFTTK 407 (495)
Q Consensus 391 ~R~ta~elL~hp~f~~~ 407 (495)
+|+.+.++|.|+|....
T Consensus 424 ~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 424 ERLSALELLTHPFLRFP 440 (1351)
T ss_pred hccchhhhhhchhcccc
Confidence 99999999999998753
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=7.1e-06 Score=73.63 Aligned_cols=130 Identities=22% Similarity=0.213 Sum_probs=90.5
Q ss_pred eeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCe-eeeeceeeccCCceeEEEEe
Q 011041 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV-VKLEGLVTSRMSCSLYLVFK 199 (495)
Q Consensus 121 ~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~~~lv~e 199 (495)
...+.||+|.+|.||+|.+. |..+|+|+-+.+. ....++.|+++|..+.--++ .+++.+..+ ++.||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~~------~i~me 92 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGED------FIRME 92 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEechh------hhhhh
Confidence 34577999999999999754 6689999876543 34567789999999976655 455544433 55699
Q ss_pred eccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCC-CCCeeeCCCCcEEEeeccccccc
Q 011041 200 YMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIK-GSNLLIDNEGILTIADFGLASFF 269 (495)
Q Consensus 200 ~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlK-p~NILl~~~~~vkL~DFG~a~~~ 269 (495)
|+.|--+....... + ++-+..+++.---|-..||-|+.|. |..++|..++.+.|+||..|++-
T Consensus 93 ~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 93 YIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 99984443332211 1 2234455666556678899999986 56666666669999999999743
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.7e-05 Score=83.75 Aligned_cols=140 Identities=16% Similarity=0.150 Sum_probs=86.2
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCCC-----------------------------hHHHH------HHHHHH
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-----------------------------PESVR------FMAREI 168 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~-----------------------------~~~~~------~~~~Ei 168 (495)
+.||.-+.|+||+|+.+. |+.||||+-+..-.. .+..+ .|.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 569999999999999776 999999987533100 00111 123344
Q ss_pred HHHHh----CCCCC------eeeeeceeeccCCceeEEEEeeccCCh---hhhhhCCCCCCCHHHHHHHHHHHHHHHHHh
Q 011041 169 LILRR----LDHPN------VVKLEGLVTSRMSCSLYLVFKYMEHDL---AGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235 (495)
Q Consensus 169 ~il~~----l~Hpn------Iv~l~~~~~~~~~~~~~lv~e~~~~~l---~~~~~~~~~~l~e~~~~~i~~qil~~L~~L 235 (495)
+-..+ +.|-+ |++++-.+ .....|+||||+|.- +..+... .++...+...+.+...-+ +
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~q--I 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQ--I 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHH--H
Confidence 33333 34555 44443332 335799999999842 2222222 344444433333332222 2
Q ss_pred hhCCceeccCCCCCeeeCC----CCcEEEeecccccccCCC
Q 011041 236 HNQHVLHRDIKGSNLLIDN----EGILTIADFGLASFFDPN 272 (495)
Q Consensus 236 H~~givHrDlKp~NILl~~----~~~vkL~DFG~a~~~~~~ 272 (495)
=..|++|+|-.|.||+|+. ++.+.+-|||+...+...
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2468999999999999984 678999999998766543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.05 E-value=2.9e-05 Score=74.47 Aligned_cols=72 Identities=14% Similarity=0.171 Sum_probs=43.2
Q ss_pred eeecccCce-EEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCC---CeeeeeceeeccCC-ceeEEEE
Q 011041 124 DKIGQGTYS-NVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP---NVVKLEGLVTSRMS-CSLYLVF 198 (495)
Q Consensus 124 ~~LG~G~~g-~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~~~~~-~~~~lv~ 198 (495)
+.|+.|+.. .||+. +..+.+|..... .....+.+|+++|..|... .+.++++....... ...|++|
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence 457766666 59976 235677864431 1234688899999888532 34444443332111 2458899
Q ss_pred eeccCC
Q 011041 199 KYMEHD 204 (495)
Q Consensus 199 e~~~~~ 204 (495)
++++|.
T Consensus 74 ~~i~G~ 79 (235)
T cd05155 74 RWLEGE 79 (235)
T ss_pred EeecCC
Confidence 998873
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.8e-06 Score=97.91 Aligned_cols=256 Identities=13% Similarity=-0.011 Sum_probs=160.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCe-EEEeEEE---ecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ-IVALKKV---RFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~-~vAiK~i---~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
+..|++.=-+|.|.+ +++.+..... -+.+|+. ....+.....+....|..-++...|+++.....-+....+.
T Consensus 1228 ~e~~EV~l~i~~~~~---~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFH---FRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred hhhhheeeeccccee---eccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence 345555544555544 3443321111 1233333 33334444455556666677778999999887777766677
Q ss_pred eeEEEEeeccCChhhhhhCC----CCCCCHHHHHHHHHHHHHHHHHhhhC-----CceeccCCCCCeeeCCCCcEEEeec
Q 011041 193 SLYLVFKYMEHDLAGLAASP----TIKFTQAQVKCYMHQLLSGLEHCHNQ-----HVLHRDIKGSNLLIDNEGILTIADF 263 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~----~~~l~e~~~~~i~~qil~~L~~LH~~-----givHrDlKp~NILl~~~~~vkL~DF 263 (495)
..|.+++|+.++.+..++.. ...+.+.-+.....+.+.+..-+|+. -.+|++||+-|.+|..+..+|++++
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence 78999999997766654432 22344444555555557777777743 2899999999999999999999999
Q ss_pred ccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 011041 264 GLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE 343 (495)
Q Consensus 264 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (495)
|+.+...+ ........++++.|+.|++.. ...++.++|+|..|+.+|++..|.++|. ..+..+++.. ..+.
T Consensus 1385 gLdKIknp-~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~rs~~n~~fi-----~flq~~Lkgi--idn~ 1455 (2724)
T KOG1826|consen 1385 GLDKIKNP-VLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLRSDGNAYFI-----FFLQPALKGI--IDNH 1455 (2724)
T ss_pred ccccccCc-hHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHHhcccHHHH-----HHHHHHHcCc--cccc
Confidence 99984332 223345567788999999654 3567888999999999999998887762 2222222211 1100
Q ss_pred hhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
. ..+...-.|.++-.+...+|-+.-..||.-...+.-+.|.
T Consensus 1456 ----------t-----------f~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1456 ----------T-----------FFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred ----------c-----------cccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 0 0011112234444455556666667788877777766654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00019 Score=66.86 Aligned_cols=129 Identities=20% Similarity=0.277 Sum_probs=87.4
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCC--------------CChHHHHHHHHHHHHHHhCC------CCCeeeee
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDN--------------LEPESVRFMAREILILRRLD------HPNVVKLE 183 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~--------------~~~~~~~~~~~Ei~il~~l~------HpnIv~l~ 183 (495)
..||+|+.=.||.- . .....+||++.... ..........+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46999999999854 3 34456899987665 11123455667777776665 88999999
Q ss_pred ceeeccCCceeEEEEeeccCC------hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC--
Q 011041 184 GLVTSRMSCSLYLVFKYMEHD------LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-- 255 (495)
Q Consensus 184 ~~~~~~~~~~~~lv~e~~~~~------l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~-- 255 (495)
|+.+. +...-+|+|.+... .+..+... ..+++ .. ...+-.-.+||-+++|+.+||+|.||++...
T Consensus 84 G~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 84 GFVET--NLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEEec--CCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 99988 55678888887531 22223322 23555 33 3334445578889999999999999999643
Q ss_pred C--cEEEee
Q 011041 256 G--ILTIAD 262 (495)
Q Consensus 256 ~--~vkL~D 262 (495)
+ .+.|+|
T Consensus 157 ~~~~lvlID 165 (199)
T PF10707_consen 157 GEFRLVLID 165 (199)
T ss_pred CceEEEEEe
Confidence 2 477776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.88 E-value=4.5e-05 Score=70.56 Aligned_cols=100 Identities=24% Similarity=0.259 Sum_probs=78.7
Q ss_pred HHHHHHHHhCCC-CCeeeeeceeeccCCceeEEEEeeccCC-hhhh--hhCCCCCCCHHHHHHHHHHHHHHHHHhhh---
Q 011041 165 AREILILRRLDH-PNVVKLEGLVTSRMSCSLYLVFKYMEHD-LAGL--AASPTIKFTQAQVKCYMHQLLSGLEHCHN--- 237 (495)
Q Consensus 165 ~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~~~lv~e~~~~~-l~~~--~~~~~~~l~e~~~~~i~~qil~~L~~LH~--- 237 (495)
..|.-+|+.+.+ +++++++|++- -++|.||.+.+ +... ....-..-++.....++.++++.+++|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 358888999975 69999999773 36788999864 2211 11112245889999999999999999997
Q ss_pred CCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 238 ~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
..+.-.|++++|+-|+++|++|++|...+...+
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 458889999999999999999999999886553
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00016 Score=69.14 Aligned_cols=73 Identities=14% Similarity=0.170 Sum_probs=46.2
Q ss_pred eeeecccCceEEEEEEECC-CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCC-eeeeeceeeccCCceeEEEEee
Q 011041 123 LDKIGQGTYSNVYKARDTL-TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN-VVKLEGLVTSRMSCSLYLVFKY 200 (495)
Q Consensus 123 ~~~LG~G~~g~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~~~lv~e~ 200 (495)
++.|..|-...||++.... .+..|++|+...... ......+|+.+++.+...+ .+++++... . .++|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~---~---~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQ---N---GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeC---C---cEEEEe
Confidence 4678889899999986443 356788997653221 1123347899999885333 445544332 1 379999
Q ss_pred ccCC
Q 011041 201 MEHD 204 (495)
Q Consensus 201 ~~~~ 204 (495)
++|.
T Consensus 74 i~G~ 77 (235)
T cd05157 74 IPGR 77 (235)
T ss_pred eCCC
Confidence 9874
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.80 E-value=9.9e-05 Score=71.73 Aligned_cols=132 Identities=20% Similarity=0.220 Sum_probs=75.3
Q ss_pred ecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCe-eeeeceeeccCCceeEEEEeeccCC
Q 011041 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV-VKLEGLVTSRMSCSLYLVFKYMEHD 204 (495)
Q Consensus 126 LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~~~lv~e~~~~~ 204 (495)
+..|-.+.+|+.. .++..+++|......... . -...+|..+++.+...++ ++++.... -++||||++|.
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~-~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-G-VDRQREYQILQALSALGLAPKPILVNE------HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccc-c-CcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEeccCc
Confidence 5668888999886 456678888754321111 0 124679999998854333 34443321 26899999874
Q ss_pred hhhh------------------hhC---CCCCCCH-HHHHHHHHHH---------HHHHHHhhh--------CCceeccC
Q 011041 205 LAGL------------------AAS---PTIKFTQ-AQVKCYMHQL---------LSGLEHCHN--------QHVLHRDI 245 (495)
Q Consensus 205 l~~~------------------~~~---~~~~l~e-~~~~~i~~qi---------l~~L~~LH~--------~givHrDl 245 (495)
.+.. +.. ....++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 3211 000 0111121 1222222222 111222211 25899999
Q ss_pred CCCCeeeCCCCcEEEeecccccc
Q 011041 246 KGSNLLIDNEGILTIADFGLASF 268 (495)
Q Consensus 246 Kp~NILl~~~~~vkL~DFG~a~~ 268 (495)
.|.||++++++ +.|+||..+..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998854
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00083 Score=69.23 Aligned_cols=77 Identities=19% Similarity=0.119 Sum_probs=53.4
Q ss_pred eeeecccCceEEEEEEECCCCeEEEeEEEecC-----CCChHHHHHHHHHHHHHHhCC---CCCeeeeeceeeccCCcee
Q 011041 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFD-----NLEPESVRFMAREILILRRLD---HPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 123 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~-----~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~~ 194 (495)
.+.||.|.+..||++.+...++.|.||.-... ...+-..++...|...|+.+. -.++++++.+.. ...
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~----~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE----ELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC----CCC
Confidence 46799999999999997654468999985311 001223456777888888862 346777876643 346
Q ss_pred EEEEeeccC
Q 011041 195 YLVFKYMEH 203 (495)
Q Consensus 195 ~lv~e~~~~ 203 (495)
++||||+++
T Consensus 107 ~lVME~L~~ 115 (401)
T PRK09550 107 VTVMEDLSD 115 (401)
T ss_pred EEEEecCCC
Confidence 899999875
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00075 Score=67.18 Aligned_cols=77 Identities=14% Similarity=0.172 Sum_probs=52.9
Q ss_pred eeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCC---CCeeeeeceeecc-CCceeEEE
Q 011041 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH---PNVVKLEGLVTSR-MSCSLYLV 197 (495)
Q Consensus 122 ~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~~-~~~~~~lv 197 (495)
-.+.||.|..+.||..... ++ .+.+|..+ .. .....+.+|+..|+.|.- -.++++++++... ..+..+||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~-~~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 18 RVECISEQPYAALWALYDS-QG-NPMPLMAR-SF---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eeeecCCccceeEEEEEcC-CC-CEEEEEec-cc---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 3467999999999998532 23 46677743 21 122578899999998843 3577888766542 13558999
Q ss_pred EeeccCC
Q 011041 198 FKYMEHD 204 (495)
Q Consensus 198 ~e~~~~~ 204 (495)
||++++.
T Consensus 92 mE~i~G~ 98 (297)
T PRK10593 92 LERLRGV 98 (297)
T ss_pred EeccCCE
Confidence 9998864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00034 Score=69.45 Aligned_cols=139 Identities=15% Similarity=0.128 Sum_probs=81.1
Q ss_pred eeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCC--eeeeeceee----ccCCceeE
Q 011041 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN--VVKLEGLVT----SRMSCSLY 195 (495)
Q Consensus 122 ~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~----~~~~~~~~ 195 (495)
-++.|..|....+|+... .+..+++|+... . ....+..|+.++..|.+.+ +++++.... ....+..+
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEK--V---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCC--C---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 356788888889999853 344688898753 1 1245667888888884332 444433211 01134578
Q ss_pred EEEeeccCChhhh---------------hhC--CCCC-------C-C--HHHHH--------HHHHHHHHHHHHhhh---
Q 011041 196 LVFKYMEHDLAGL---------------AAS--PTIK-------F-T--QAQVK--------CYMHQLLSGLEHCHN--- 237 (495)
Q Consensus 196 lv~e~~~~~l~~~---------------~~~--~~~~-------l-~--e~~~~--------~i~~qil~~L~~LH~--- 237 (495)
++++|++|..... +.. .... . . ..... .....+...+.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999998743210 000 0000 0 0 00000 011112233444442
Q ss_pred ----CCceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 238 ----QHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 238 ----~givHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
.+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998778999999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00079 Score=67.27 Aligned_cols=140 Identities=20% Similarity=0.253 Sum_probs=98.3
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCC-------------------CC---hH--HHHHHHHHHHHHHhCCCCCe
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-------------------LE---PE--SVRFMAREILILRRLDHPNV 179 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~-------------------~~---~~--~~~~~~~Ei~il~~l~HpnI 179 (495)
..|..|--+.||.|. ..+|..+|||+.+..- .. +. ..-....|++-|.+|..-.|
T Consensus 150 GCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 150 GCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred cccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 457788889999998 4578889999874210 00 11 11224468888888876665
Q ss_pred eeeeceeeccCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhh-hCCceeccCCCCCeeeCCCCcE
Q 011041 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH-NQHVLHRDIKGSNLLIDNEGIL 258 (495)
Q Consensus 180 v~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH-~~givHrDlKp~NILl~~~~~v 258 (495)
+-..-+.. ..-.|||+|++.+-...-......++...+..+-.|++.-+.-|- .+++||.||.-=|+|+. +|.+
T Consensus 229 P~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~l 303 (520)
T KOG2270|consen 229 PCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKL 303 (520)
T ss_pred CCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEE
Confidence 43322222 235899999986533333333456888889999999998888874 67999999999999885 4789
Q ss_pred EEeeccccccc
Q 011041 259 TIADFGLASFF 269 (495)
Q Consensus 259 kL~DFG~a~~~ 269 (495)
.|+|.+-+...
T Consensus 304 yiIDVSQSVE~ 314 (520)
T KOG2270|consen 304 YIIDVSQSVEH 314 (520)
T ss_pred EEEEccccccC
Confidence 99999977543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.001 Score=66.74 Aligned_cols=30 Identities=27% Similarity=0.476 Sum_probs=26.2
Q ss_pred CCceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 238 QHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 238 ~givHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 489999999999999976666899999874
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00056 Score=68.09 Aligned_cols=73 Identities=23% Similarity=0.244 Sum_probs=45.7
Q ss_pred eeeecccCceEEEEEEECC------CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCC-eeeeeceeeccCCceeE
Q 011041 123 LDKIGQGTYSNVYKARDTL------TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN-VVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 123 ~~~LG~G~~g~Vy~a~~~~------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~~~ 195 (495)
++.|..|-...||++.... +++.|++|+..... .......+|+.++..+...+ .+++++++.. .
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~------~ 73 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN------G 73 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC------C
Confidence 3567778788999887433 25788999865432 12234567888888885333 3455554432 3
Q ss_pred EEEeeccCC
Q 011041 196 LVFKYMEHD 204 (495)
Q Consensus 196 lv~e~~~~~ 204 (495)
+|+||++|.
T Consensus 74 ~v~e~i~G~ 82 (302)
T cd05156 74 RIEEFIPSR 82 (302)
T ss_pred chhheeCCC
Confidence 578888764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00051 Score=68.66 Aligned_cols=142 Identities=17% Similarity=0.148 Sum_probs=81.3
Q ss_pred eeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCC--eeeeeceee----ccCCce
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN--VVKLEGLVT----SRMSCS 193 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~----~~~~~~ 193 (495)
...++.++.|....||++.. .+| .+++|+..... . ...+..|+.++..|...+ +++++.... ....+.
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred ceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 44567788888889999863 344 57789875421 1 233456777777774222 344433211 111356
Q ss_pred eEEEEeeccCChhh---------------hhhCCCCCC--------CHHH-----HH----------HHHHHHHHHHHHh
Q 011041 194 LYLVFKYMEHDLAG---------------LAASPTIKF--------TQAQ-----VK----------CYMHQLLSGLEHC 235 (495)
Q Consensus 194 ~~lv~e~~~~~l~~---------------~~~~~~~~l--------~e~~-----~~----------~i~~qil~~L~~L 235 (495)
.+++|+|++|.... .+......+ .... .. .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999999873210 000000000 0000 00 0111233345555
Q ss_pred h-------hCCceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 236 H-------NQHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 236 H-------~~givHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
. ..+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3 3689999999999999998877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0014 Score=65.39 Aligned_cols=148 Identities=21% Similarity=0.247 Sum_probs=83.5
Q ss_pred eeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCC--eeeeeceeeccCCceeEEEE
Q 011041 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN--VVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 121 ~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~~~lv~ 198 (495)
.+++.+-.|.--.+|...+. ++.+++. ...............+|..+++.+.--- +...++++.+..-...|.||
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 34445544444455555433 7778888 3222234455677888999999884322 33344555443224679999
Q ss_pred eeccCChhhhhhCC------------------------------C--CCCCHHHHHHHHHHH--------------HHHH
Q 011041 199 KYMEHDLAGLAASP------------------------------T--IKFTQAQVKCYMHQL--------------LSGL 232 (495)
Q Consensus 199 e~~~~~l~~~~~~~------------------------------~--~~l~e~~~~~i~~qi--------------l~~L 232 (495)
+|++|......... . ..+...++..+..+. ..-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 99988311100000 0 001111111111111 1223
Q ss_pred HHhhh--------CCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 233 EHCHN--------QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 233 ~~LH~--------~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
.+|+. ..++|+|+.+.||+|++++.+-|+||+++..-++
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 33332 2599999999999999998899999999976544
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=9.9e-05 Score=72.38 Aligned_cols=139 Identities=16% Similarity=0.177 Sum_probs=94.5
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHH--------------------HHHHHHHHHHHHhCCC-
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES--------------------VRFMAREILILRRLDH- 176 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~--------------------~~~~~~Ei~il~~l~H- 176 (495)
.-|.+++.||-|--+.||.+-+. .|.+.++|.-+....+... .-...+|...|+.|..
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred hhhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 35677899999999999999754 5888999965432211110 1123468888888742
Q ss_pred -CCeeeeeceeeccCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC
Q 011041 177 -PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE 255 (495)
Q Consensus 177 -pnIv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~ 255 (495)
--+++.+++ +..++|||++.+--+..... ...+..+...+..-+--|-.+|+||+|..-=||+|+++
T Consensus 171 gfpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 171 GFPVPKPIDH------NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCCCCcccc------cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecC
Confidence 234444443 34688999988743322211 12234455666666777889999999999999999999
Q ss_pred CcEEEeeccccccc
Q 011041 256 GILTIADFGLASFF 269 (495)
Q Consensus 256 ~~vkL~DFG~a~~~ 269 (495)
+.++++||--....
T Consensus 239 ~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 239 DKIVVIDFPQMVST 252 (465)
T ss_pred CCEEEeechHhhcc
Confidence 99999999866443
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00038 Score=72.13 Aligned_cols=173 Identities=23% Similarity=0.289 Sum_probs=112.0
Q ss_pred HHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcee
Q 011041 163 FMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLH 242 (495)
Q Consensus 163 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givH 242 (495)
.+.-...+++.+.|+|...++++..... ....+|||+++.++........ +-.. +++ .+|+.|
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~-~r~IVV~e~~~~Sled~~~~~~--l~~~-------s~~-------~~~~~~ 90 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKH-ERVIVVMEHYTMSLEDILKTGN--LKDE-------SLL-------AHGVLH 90 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCcc-ceEEEEehhhccchHHHHHhcc--cchh-------hhc-------ccccce
Confidence 3445678899999999999998877653 4589999999987776554432 1100 111 222222
Q ss_pred ccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 011041 243 RDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP 322 (495)
Q Consensus 243 rDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~ 322 (495)
- | .++.+| -++. . | |- ..++++||||+|.|+.++.-|.-.|.
T Consensus 91 ~-----~-------~~~~td-~~~t------------~-----~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 91 L-----N-------IIYITD-HFLT------------K-----Y--PS------PIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred e-----h-------hhhccc-cccc------------c-----C--CC------CCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 2 2 233333 0000 0 1 11 12359999999999999999999888
Q ss_pred CCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCC
Q 011041 323 GRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402 (495)
Q Consensus 323 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp 402 (495)
..+..+.+..|.+....+....-- .+-.......+.-..+++.+|+...|..||...++++++
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~-----------------a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~ 195 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLST-----------------AMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRC 195 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHH-----------------HHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCc
Confidence 888888888887765443321100 000112223456678899999999999999999999999
Q ss_pred CCCCC
Q 011041 403 FFTTK 407 (495)
Q Consensus 403 ~f~~~ 407 (495)
-|+..
T Consensus 196 i~~ev 200 (725)
T KOG1093|consen 196 SFTEV 200 (725)
T ss_pred cHHHH
Confidence 88753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0023 Score=63.00 Aligned_cols=31 Identities=23% Similarity=0.359 Sum_probs=26.0
Q ss_pred CceeccCCCCCeeeCCCCc-EEEeeccccccc
Q 011041 239 HVLHRDIKGSNLLIDNEGI-LTIADFGLASFF 269 (495)
Q Consensus 239 givHrDlKp~NILl~~~~~-vkL~DFG~a~~~ 269 (495)
.++|+|++|.|||+++++. +-|+||+.+..-
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997565 469999988643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0043 Score=62.72 Aligned_cols=150 Identities=16% Similarity=0.239 Sum_probs=81.5
Q ss_pred ccCCCCCCCCCeeeeeeecccCceEEEEEEECCC---CeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCe-eeeec
Q 011041 109 ISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLT---GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV-VKLEG 184 (495)
Q Consensus 109 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~ 184 (495)
+++|.....++..+ +.|..|=...+|++..... +..|.+|+..... +..-.-.+|+.+++.+..-++ +++++
T Consensus 6 ~~~w~~~~~~~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~IdR~~E~~il~~l~~~gl~P~~l~ 81 (330)
T PLN02421 6 FKGWSDLDDSDFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVIDRERELQAIKYLSAAGFGAKLLG 81 (330)
T ss_pred CCccccCCcCceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeEechHHHHHHHHHHHhcCCCCceeE
Confidence 34454443344444 4455587788998864432 2378888765322 112223578899998865444 45655
Q ss_pred eeeccCCceeEEEEeeccCChhhh------------------hhCCC----CCCC-HHHHHHHHHHH-------------
Q 011041 185 LVTSRMSCSLYLVFKYMEHDLAGL------------------AASPT----IKFT-QAQVKCYMHQL------------- 228 (495)
Q Consensus 185 ~~~~~~~~~~~lv~e~~~~~l~~~------------------~~~~~----~~l~-e~~~~~i~~qi------------- 228 (495)
++.. + +|.+|+++..+.. +.... ..++ ...+..++.++
T Consensus 82 ~~~~---G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~ 155 (330)
T PLN02421 82 VFGN---G---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKK 155 (330)
T ss_pred EeCC---c---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhh
Confidence 5532 1 4778876542210 00100 0011 12233332222
Q ss_pred ---------HHHHH----HhhhC----CceeccCCCCCeeeCC-CCcEEEeecccccc
Q 011041 229 ---------LSGLE----HCHNQ----HVLHRDIKGSNLLIDN-EGILTIADFGLASF 268 (495)
Q Consensus 229 ---------l~~L~----~LH~~----givHrDlKp~NILl~~-~~~vkL~DFG~a~~ 268 (495)
..-+. ++... -++|+||.+.|||+++ ++.++++||..|..
T Consensus 156 ~~~~~~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 156 YETISFEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hcccCHHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11111 12122 2799999999999975 57899999998853
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0062 Score=61.97 Aligned_cols=151 Identities=16% Similarity=0.181 Sum_probs=83.4
Q ss_pred ccCCCCCCCCCeeeeeeecccCceEEEEEEECC----CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCe-eeee
Q 011041 109 ISGWTPRRADTFEKLDKIGQGTYSNVYKARDTL----TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV-VKLE 183 (495)
Q Consensus 109 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~ 183 (495)
...|.........-+..|-.|-...+|++.... +++.|.+|+..... ...+ ...+|+.+++.+..-++ ++++
T Consensus 27 ~~~w~~~~~~~~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~i-dR~~E~~~~~~l~~~gl~P~~~ 103 (344)
T PLN02236 27 ASKWGDVVDDEALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFF-DRDDEIRTFECMSRHGQGPRLL 103 (344)
T ss_pred cchhcCCCCcCcEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceee-chHHHHHHHHHHHHcCCCCceE
Confidence 344543212233344566668888999986432 34678899765432 1112 23578999998854444 4555
Q ss_pred ceeeccCCceeEEEEeeccCChhhh------------------hhC---CCCC-C-CHHHHHHHHHHHH-----------
Q 011041 184 GLVTSRMSCSLYLVFKYMEHDLAGL------------------AAS---PTIK-F-TQAQVKCYMHQLL----------- 229 (495)
Q Consensus 184 ~~~~~~~~~~~~lv~e~~~~~l~~~------------------~~~---~~~~-l-~e~~~~~i~~qil----------- 229 (495)
+.+.. + .|.+|+++..+.. +.. .... + ....+..++.++.
T Consensus 104 ~~~~~---g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~ 177 (344)
T PLN02236 104 GRFPN---G---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEF 177 (344)
T ss_pred EEECC---c---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhc
Confidence 55532 1 4788887632211 000 0000 1 1222333332221
Q ss_pred ------HHHHH----h----hhCCceeccCCCCCeeeCC-CCcEEEeecccccc
Q 011041 230 ------SGLEH----C----HNQHVLHRDIKGSNLLIDN-EGILTIADFGLASF 268 (495)
Q Consensus 230 ------~~L~~----L----H~~givHrDlKp~NILl~~-~~~vkL~DFG~a~~ 268 (495)
..+.. + +...++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 178 ~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 178 RLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11111 1 1236899999999999986 47899999998854
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0094 Score=61.42 Aligned_cols=76 Identities=17% Similarity=0.172 Sum_probs=50.8
Q ss_pred eeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-----ChHHHHHHHHHHHHHHhCC---CCCeeeeeceeeccCCce
Q 011041 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-----EPESVRFMAREILILRRLD---HPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 122 ~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~ 193 (495)
..+.||.|....||+..+. +..|+||.-..... .+........|+..|+.+. ..++++++.+..+ .
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----M 109 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----C
Confidence 3578999999999998763 45688997542111 0113444555677777663 3478888877754 3
Q ss_pred eEEEEeeccC
Q 011041 194 LYLVFKYMEH 203 (495)
Q Consensus 194 ~~lv~e~~~~ 203 (495)
.+++|||+++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 5788999966
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0077 Score=61.00 Aligned_cols=75 Identities=19% Similarity=0.176 Sum_probs=48.1
Q ss_pred eecccCceEEEEEEECCCCeEEEeEEEe----c-CCCChHHHHHHHHHHHHHHhCC--CC-CeeeeeceeeccCCceeEE
Q 011041 125 KIGQGTYSNVYKARDTLTGQIVALKKVR----F-DNLEPESVRFMAREILILRRLD--HP-NVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 125 ~LG~G~~g~Vy~a~~~~~g~~vAiK~i~----~-~~~~~~~~~~~~~Ei~il~~l~--Hp-nIv~l~~~~~~~~~~~~~l 196 (495)
.||.|....||++.+...++.|+||.-. . ....+-...+..-|...|+... -| .+++++.+-. ....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~----e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDT----EMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEcc----cccee
Confidence 4799999999999976444689999742 1 1111233445556788887763 23 5666655432 34579
Q ss_pred EEeeccC
Q 011041 197 VFKYMEH 203 (495)
Q Consensus 197 v~e~~~~ 203 (495)
|||+++.
T Consensus 78 vMEdL~~ 84 (370)
T TIGR01767 78 VMEDLSH 84 (370)
T ss_pred hHhhCcc
Confidence 9999853
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0073 Score=60.23 Aligned_cols=29 Identities=21% Similarity=0.408 Sum_probs=25.7
Q ss_pred CCceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 238 QHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 238 ~givHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
.+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57999999999999988 678999999763
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.012 Score=60.32 Aligned_cols=76 Identities=18% Similarity=0.162 Sum_probs=50.5
Q ss_pred eeeecccCceEEEEEEECCCCeEEEeEEEe----cCCCChHHHHHHHHHHHHHHhCC--CC-CeeeeeceeeccCCceeE
Q 011041 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVR----FDNLEPESVRFMAREILILRRLD--HP-NVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 123 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~----~~~~~~~~~~~~~~Ei~il~~l~--Hp-nIv~l~~~~~~~~~~~~~ 195 (495)
++.||.|.-.-||++.+...+..|+||.-. ...-.+-...+..-|..+|+.+. -| .+++++.+-. ....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~----e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS----VMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc----HHhh
Confidence 678999999999999875445678998642 11112334556667888888763 23 5666755433 3467
Q ss_pred EEEeecc
Q 011041 196 LVFKYME 202 (495)
Q Consensus 196 lv~e~~~ 202 (495)
+|||+++
T Consensus 110 ~vMEdL~ 116 (409)
T PRK12396 110 CVMEDLS 116 (409)
T ss_pred HHHHhCc
Confidence 8999885
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.013 Score=55.06 Aligned_cols=31 Identities=29% Similarity=0.595 Sum_probs=21.8
Q ss_pred CCceeccCCCCCeee-CCCCcEEEeecccccc
Q 011041 238 QHVLHRDIKGSNLLI-DNEGILTIADFGLASF 268 (495)
Q Consensus 238 ~givHrDlKp~NILl-~~~~~vkL~DFG~a~~ 268 (495)
.-++|+||.+.|||+ +.++.++|+||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 358999999999999 8889999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.016 Score=57.97 Aligned_cols=30 Identities=27% Similarity=0.291 Sum_probs=27.9
Q ss_pred CceeccCCCCCeeeCCCCcEEEeecccccc
Q 011041 239 HVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (495)
Q Consensus 239 givHrDlKp~NILl~~~~~vkL~DFG~a~~ 268 (495)
+++|+|+.+.|||+++++.+-|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.033 Score=57.39 Aligned_cols=90 Identities=18% Similarity=0.199 Sum_probs=49.2
Q ss_pred cccCCCCCCCCCeeeeeeecccCceEEEEEEECCC-CeEEEeEEE-ecC-CCChHHHHHHHHHHHHHHhCCCCCe-eeee
Q 011041 108 AISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLT-GQIVALKKV-RFD-NLEPESVRFMAREILILRRLDHPNV-VKLE 183 (495)
Q Consensus 108 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-g~~vAiK~i-~~~-~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~ 183 (495)
.+..|.....+... ++.|..|-...+|++..... +..+.+|.+ ... .......-.-.+|+.+++.|...++ .+++
T Consensus 41 ~~p~w~~~~~~~i~-i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~ 119 (383)
T PTZ00384 41 HVPFWNNVNPEFIE-IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKII 119 (383)
T ss_pred HCCccccCCcccEE-EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEE
Confidence 34456544334444 44666688899999964432 223323321 110 1111111223568999999965444 5666
Q ss_pred ceeeccCCceeEEEEeeccCC
Q 011041 184 GLVTSRMSCSLYLVFKYMEHD 204 (495)
Q Consensus 184 ~~~~~~~~~~~~lv~e~~~~~ 204 (495)
+.+.. +++.||++|.
T Consensus 120 ~~f~~------g~l~efIeGr 134 (383)
T PTZ00384 120 GRFGD------FTIQEWVEGN 134 (383)
T ss_pred EecCC------EEEEEEeccc
Confidence 66542 6888999874
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.027 Score=55.63 Aligned_cols=75 Identities=15% Similarity=0.185 Sum_probs=46.5
Q ss_pred eeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC---CCCeeeeeceeeccCCceeEEE
Q 011041 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD---HPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 121 ~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~~~lv 197 (495)
+..+.|+.|....+|+.. .+++.|.||+-.. .....+..|+.-|+.|. --.+++++++.... ..-||+
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fLl 90 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFLL 90 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceEE
Confidence 445679999999999986 6778899998762 22346778888888883 44577888877653 345999
Q ss_pred EeeccCC
Q 011041 198 FKYMEHD 204 (495)
Q Consensus 198 ~e~~~~~ 204 (495)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9998754
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.014 Score=58.63 Aligned_cols=72 Identities=26% Similarity=0.373 Sum_probs=56.3
Q ss_pred CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceeccCCCCCeeeCCCCcEEEeecccccc
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~-givHrDlKp~NILl~~~~~vkL~DFG~a~~ 268 (495)
..+.|++|++.++.+...- .-..+++..|+++-+..++-+..+ ..-|||+...||||+ +|+|.|+||-+++.
T Consensus 298 ~~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 5678888988776554221 124567788888888777777644 689999999999999 99999999999984
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.084 Score=53.20 Aligned_cols=136 Identities=17% Similarity=0.229 Sum_probs=77.6
Q ss_pred eecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCC------eeeeeceeeccCCc--eeEE
Q 011041 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN------VVKLEGLVTSRMSC--SLYL 196 (495)
Q Consensus 125 ~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~~~~~~~~--~~~l 196 (495)
.|.+ .-..||+.... .|. +++|+.+.. ... ..+.-|+..|+.|.-.+ |..+-|-....-.. +.+-
T Consensus 33 ~l~s-~eN~~f~~~~~-~g~-~iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 33 GLNS-EENSNFRVQTE-DGR-YILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred cccc-ccCceEEEEec-CCC-eEEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 3444 55678988643 343 489988765 333 34556778888773212 33333322222233 7888
Q ss_pred EEeeccCChhhh----------------hhC--CCC---------CCCHH----H---------HHHHHHHHHHHHHHhh
Q 011041 197 VFKYMEHDLAGL----------------AAS--PTI---------KFTQA----Q---------VKCYMHQLLSGLEHCH 236 (495)
Q Consensus 197 v~e~~~~~l~~~----------------~~~--~~~---------~l~e~----~---------~~~i~~qil~~L~~LH 236 (495)
+++|++|..... +.. .+. ...+. . -.....++...++.+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 999998754431 000 000 01111 0 0012334444455554
Q ss_pred h--------CC--ceeccCCCCCeeeCCCCc-EEEeeccccc
Q 011041 237 N--------QH--VLHRDIKGSNLLIDNEGI-LTIADFGLAS 267 (495)
Q Consensus 237 ~--------~g--ivHrDlKp~NILl~~~~~-vkL~DFG~a~ 267 (495)
+ .+ |||+|+.|.|||++.+.. +.++|||-+.
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3 34 999999999999999885 8999999763
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.12 Score=60.19 Aligned_cols=31 Identities=32% Similarity=0.611 Sum_probs=26.7
Q ss_pred CCceeccCCCCCeeeCCCC--cEE-Eeecccccc
Q 011041 238 QHVLHRDIKGSNLLIDNEG--ILT-IADFGLASF 268 (495)
Q Consensus 238 ~givHrDlKp~NILl~~~~--~vk-L~DFG~a~~ 268 (495)
.++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999999875 565 999998854
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.07 Score=56.06 Aligned_cols=86 Identities=10% Similarity=0.167 Sum_probs=52.5
Q ss_pred ccCCCCCCCCCeeeeeeecccCceEEEEEEECC--------CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCe-
Q 011041 109 ISGWTPRRADTFEKLDKIGQGTYSNVYKARDTL--------TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV- 179 (495)
Q Consensus 109 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~--------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI- 179 (495)
+.+|.....++. -++.|..|-.-.+|++.... .++.|.+++.-... +..-...+|..+++.+...+|
T Consensus 97 vp~W~~~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lIdR~~E~~v~~~ls~~gi~ 172 (442)
T PTZ00296 97 VPEWRRFTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELYNPISEFEVYKTMSKYRIA 172 (442)
T ss_pred CCccccCCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---cceeCHHHHHHHHHHHHHCCCC
Confidence 456664444555 66778888888999987542 14678888764322 111234468888888854444
Q ss_pred eeeeceeeccCCceeEEEEeeccCC
Q 011041 180 VKLEGLVTSRMSCSLYLVFKYMEHD 204 (495)
Q Consensus 180 v~l~~~~~~~~~~~~~lv~e~~~~~ 204 (495)
.++++.+.. +.+.+|++|.
T Consensus 173 P~l~~~f~g------g~I~efi~g~ 191 (442)
T PTZ00296 173 PQLLNTFSG------GRIEEWLYGD 191 (442)
T ss_pred CceEEEeCC------CEEEEeeCCc
Confidence 355555432 4567888764
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.37 Score=48.60 Aligned_cols=28 Identities=25% Similarity=0.201 Sum_probs=23.9
Q ss_pred CCceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 238 QHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 238 ~givHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4799999999999995 4 57899999764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.095 Score=49.26 Aligned_cols=116 Identities=18% Similarity=0.217 Sum_probs=70.8
Q ss_pred cCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeeccCChhhh
Q 011041 129 GTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGL 208 (495)
Q Consensus 129 G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~l~~~ 208 (495)
|+.++.-.+..+- | ...+|+++.-...-. ...+..+..++.++. .|+++.. + ....+-++.|+|-.--.
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~-~~~y~nky~v~Armh--GilrL~N---D-n~~~yGvIlE~Cy~~~i-- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCIN-DALYFNKYRVFARMH--GILRLKN---D-NNYKYGVILERCYKIKI-- 141 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCcccc-hhhhhhhhhHHHHhh--heeEeec---C-CCceeEEEEeeccCccc--
Confidence 4444544443222 3 345666654333212 234577888888875 5787752 2 24456678887753100
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHHHhh--hCCceeccCCCCCeeeCCCCcEEEeecccc
Q 011041 209 AASPTIKFTQAQVKCYMHQLLSGLEHCH--NQHVLHRDIKGSNLLIDNEGILTIADFGLA 266 (495)
Q Consensus 209 ~~~~~~~l~e~~~~~i~~qil~~L~~LH--~~givHrDlKp~NILl~~~~~vkL~DFG~a 266 (495)
.. ..++.-=+..|.-.| +.+.+|+|..|+||+-|..|.+||.|-+..
T Consensus 142 -------~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 142 -------NF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred -------ch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 01 111111245677778 347999999999999999999999998754
|
The function of this family is unknown. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.48 E-value=0.028 Score=51.70 Aligned_cols=30 Identities=30% Similarity=0.399 Sum_probs=26.3
Q ss_pred CceeccCCCCCeeeCCCCcEEEeeccccccc
Q 011041 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (495)
Q Consensus 239 givHrDlKp~NILl~~~~~vkL~DFG~a~~~ 269 (495)
-.+|+|+.|+||+++++| ++|+||+.+...
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g 107 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG 107 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence 469999999999998887 999999998654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 495 | ||||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-64 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-64 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-63 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-63 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-59 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-58 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-58 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-58 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-57 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-57 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-57 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-57 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-57 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-57 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-57 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-57 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-57 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-57 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-57 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-57 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-57 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-57 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-57 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-57 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-57 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-57 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-57 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-57 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-57 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-57 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-57 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-57 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-57 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-57 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-57 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-57 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-57 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-57 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-57 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-56 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-55 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-55 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-53 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-52 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-51 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-51 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-51 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-51 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-47 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-47 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-45 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-44 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-44 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-44 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-44 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-44 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-44 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-41 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-41 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-41 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-41 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-41 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-41 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-41 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-41 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-41 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-41 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-41 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-41 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-41 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-41 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-41 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-41 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-41 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-41 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-41 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-41 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-40 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-40 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-40 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-40 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-40 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-40 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-40 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-40 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-39 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-39 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-39 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-39 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-39 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-39 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-39 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-39 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-39 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-39 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-39 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-39 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-39 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-39 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-39 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-39 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-39 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-39 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-39 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-39 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-39 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-39 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-39 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-39 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-39 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-39 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-39 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-39 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-39 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-39 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-39 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-39 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-39 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-39 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-39 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-39 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-39 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-39 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-39 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-39 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-39 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-39 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-39 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-39 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-39 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-39 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-39 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-39 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-39 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-39 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-39 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-39 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-39 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-39 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-39 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-39 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-39 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-39 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-39 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-38 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-38 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-38 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-38 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-38 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-38 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-38 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-38 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-38 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-38 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-38 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-38 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-38 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-38 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-38 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-38 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-38 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-38 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-38 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-38 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-38 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-38 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-38 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-38 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-38 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-38 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-38 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-37 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-37 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-37 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-35 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-35 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-35 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-34 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-33 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-33 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-32 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-32 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-32 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-32 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-32 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-32 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-32 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-32 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-32 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-32 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-32 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-32 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-32 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-32 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-31 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-31 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-31 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-31 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-31 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-31 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-31 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-30 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-30 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-30 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-30 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-30 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-30 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-30 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-29 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-29 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-29 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-29 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-29 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-29 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-29 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-27 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-27 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-27 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-26 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-26 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-26 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-26 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-26 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-26 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-26 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-26 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-26 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-26 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-26 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-26 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-26 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-26 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-26 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-26 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-25 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-25 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-25 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-25 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-25 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-25 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-25 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-25 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-25 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-25 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-25 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-25 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-25 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-25 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-25 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-24 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-24 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-24 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-24 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-24 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-24 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-24 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-24 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-24 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-24 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-24 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-24 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-24 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-24 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-24 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-23 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-23 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-23 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-23 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-23 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-23 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-23 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-23 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-23 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-23 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-23 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-23 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-23 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-23 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-23 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-23 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-23 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-23 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-23 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-23 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-23 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-23 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-23 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-23 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-23 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-23 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-23 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-23 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-23 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-23 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-23 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-23 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-23 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-22 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-22 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-22 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-22 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-22 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-21 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-21 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-21 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-21 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-21 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-21 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-21 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-21 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-21 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-21 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-21 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-21 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-21 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-21 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-21 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-21 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-21 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-21 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-21 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-21 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-21 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-21 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-21 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-21 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-20 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-20 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-20 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-20 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-20 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-20 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-20 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-20 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-20 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-20 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-20 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-20 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-20 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-20 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-20 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-20 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-20 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-20 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-20 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-20 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-20 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-20 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-20 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-20 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-20 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-19 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-19 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-19 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-19 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-19 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-18 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-18 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-18 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-18 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-17 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-17 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-17 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-17 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-17 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-17 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-16 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-16 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-16 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-16 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-16 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-16 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-16 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-16 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 9e-16 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 9e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-15 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-15 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-14 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-14 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-14 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-14 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-14 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-14 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-14 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-14 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-14 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-14 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-14 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-14 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-14 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-14 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-14 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-14 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-14 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-14 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-14 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-11 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 6e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-11 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 7e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-11 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 8e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-10 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 9e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-06 |
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 531 bits (1371), Expect = 0.0
Identities = 139/343 (40%), Positives = 186/343 (54%), Gaps = 14/343 (4%)
Query: 107 EAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA- 165
+++ +EKL KIGQGT+ V+KAR TGQ VALKKV +N E E A
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITAL 64
Query: 166 REILILRRLDHPNVVKLEGLVTSRMS------CSLYLVFKYMEHDLAGLAASPTIKFTQA 219
REI IL+ L H NVV L + ++ S S+YLVF + EHDLAGL ++ +KFT +
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 220 QVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK---QP 276
++K M LL+GL + H +LHRD+K +N+LI +G+L +ADFGLA F
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336
T+RVVTLWYRPPELLLG DYG +DLW AGCI+AE+ PIM G TE QL I +L
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244
Query: 337 CGSPSEEYWKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSS--LPLIETLLAIDPAERQ 393
CGS + E W + + KR + + K + L LI+ LL +DPA+R
Sbjct: 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304
Query: 394 TATAALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEEARR 436
+ AL +FF + P D + T +
Sbjct: 305 DSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKHH 347
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 482 bits (1243), Expect = e-170
Identities = 131/344 (38%), Positives = 188/344 (54%), Gaps = 11/344 (3%)
Query: 113 TPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE--PESVRFMA-REIL 169
RA +EKLD +G+G ++ VYKARD T QIVA+KK++ + + + A REI
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 170 ILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLL 229
+L+ L HPN++ L + + + LVF +ME DL + ++ T + +K YM L
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRP 288
GLE+ H +LHRD+K +NLL+D G+L +ADFGLA SF PN T +VVT WYR
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRA 180
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK- 347
PELL GA YGVGVD+W+ GCILAELL P +PG ++++QL +IF+ G+P+EE W
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407
LP FK + F L LI+ L +P R TAT AL+ ++F+ +
Sbjct: 241 CSLPDYVTFKSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298
Query: 408 PYACDPSSLPKYPPTKEMDAKLRDEEARRLRAAGKANAEAKKAR 451
P LP+ E + + R +A + +
Sbjct: 299 PGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPK 342
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 409 bits (1053), Expect = e-140
Identities = 113/395 (28%), Positives = 180/395 (45%), Gaps = 45/395 (11%)
Query: 110 SGWTPRRADTFEKLD-KIGQGTYSNVYKAR--DTLTGQIVALKKVRFDNLEPESVRFMAR 166
S R D FE K+G+GTY +VYKA+ D + ALK++ + + R
Sbjct: 12 SSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR---- 67
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGL--------AASPTIKFTQ 218
EI +LR L HPNV+ L+ + S ++L+F Y EHDL + A ++ +
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 219 AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASFFDPNHK 274
VK ++Q+L G+ + H VLHRD+K +N+L+ G + IAD G A F+ K
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 275 Q--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV----- 327
+ VVT WYR PELLLGA Y +D+W+ GCI AELL +PI R E
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247
Query: 328 ----EQLHKIFKLCGSPSEEYWKK-SKLPHATIFKP---QQSYKRC-----IAETFKDFP 374
+QL +IF + G P+++ W+ K+P + + +Y C + +
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307
Query: 375 PSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLP---KYPPTKEMDAKLRD 431
+ L++ LL +DP +R T+ A++ +F P YP + + + D
Sbjct: 308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPD 367
Query: 432 EEARRLR---AAGKANAEAKKARSRDRAARAMPAP 463
++ + G + ++ P
Sbjct: 368 DKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPP 402
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 404 bits (1041), Expect = e-140
Identities = 114/322 (35%), Positives = 168/322 (52%), Gaps = 10/322 (3%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+T+ KLDK+G+GTY+ VYK + LT +VALK++R ++ E + RE+ +L+ L H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHA 60
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
N+V L ++ + S L LVF+Y++ DL VK ++ QLL GL +CH
Sbjct: 61 NIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRPPELLLGAT 296
Q VLHRD+K NLLI+ G L +ADFGLA P + VVTLWYRPP++LLG+T
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPPDILLGST 176
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHATI 355
DY +D+W GCI E+ +P+ PG T EQLH IF++ G+P+EE W
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236
Query: 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSS 415
+ + + L+ LL + R +A A++ FF +
Sbjct: 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK-- 294
Query: 416 LPKYPPTKEMD-AKLRDEEARR 436
LP + +L+ E + R
Sbjct: 295 LPDTTSIFALKEIQLQKEASLR 316
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 398 bits (1026), Expect = e-138
Identities = 118/302 (39%), Positives = 175/302 (57%), Gaps = 9/302 (2%)
Query: 110 SGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REI 168
+ + + ++KL+K+G+GTY VYKA+D+ G+IVALK++R D E E + A REI
Sbjct: 13 NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREI 70
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQL 228
+L+ L HPN+V L ++ S L LVF++ME DL + +Q+K Y++QL
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERC--LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYR 287
L G+ HCH +LHRD+K NLLI+++G L +ADFGLA F P T VVTLWYR
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYR 186
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
P++L+G+ Y VD+WS GCI AE++ KP+ PG T+ +QL KIF + G+P+ W +
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246
Query: 348 -SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406
+LP Q K+ + F + L+ +L DP +R +A A+ +F
Sbjct: 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306
Query: 407 KP 408
Sbjct: 307 LD 308
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 398 bits (1025), Expect = e-137
Identities = 112/322 (34%), Positives = 168/322 (52%), Gaps = 20/322 (6%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRL 174
+ F++L+K+G GTY+ VYK + TG VALK+V+ D+ E E A REI +++ L
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-E-EGTPSTAIREISLMKEL 60
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK-----FTQAQVKCYMHQLL 229
H N+V+L ++ + L LVF++M++DL S T+ VK + QLL
Sbjct: 61 KHENIVRLYDVIHTENK--LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRP 288
GL CH +LHRD+K NLLI+ G L + DFGLA F P + +S VVTLWYR
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRA 176
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK- 347
P++L+G+ Y +D+WS GCILAE++ KP+ PG + EQL IF + G+P+E W
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLP-----LIETLLAIDPAERQTATAALRSE 402
+KLP Q+ + + + + L + LL ++P R +A AL
Sbjct: 237 TKLPKYNPNIQQRPPRD-LRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
Query: 403 FFTTKPYACDPSSLPKYPPTKE 424
+F + +
Sbjct: 296 WFAEYYHHASMGGSRSHHHHHH 317
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 398 bits (1024), Expect = e-137
Identities = 108/305 (35%), Positives = 155/305 (50%), Gaps = 17/305 (5%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRF---MAREILIL 171
+E + +IG G Y VYKARD +G VALK VR N RE+ +L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 172 RRL---DHPNVVKLEGLVTSR---MSCSLYLVFKYMEHDLAG-LAASPTIKFTQAQVKCY 224
RRL +HPNVV+L + + + LVF++++ DL L +P +K
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL 284
M Q L GL+ H ++HRD+K N+L+ + G + +ADFGLA + +T VVTL
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALTPVVVTL 183
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344
WYR PE+LL +T Y VD+WS GCI AE+ KP+ G +E +QL KIF L G P E+
Sbjct: 184 WYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242
Query: 345 WKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
W + LP F P+ R + + S L+ +L +P +R +A AL+ +
Sbjct: 243 WPRDVSLPRGA-FPPRG--PRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
Query: 404 FTTKP 408
Sbjct: 300 LHKDE 304
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 394 bits (1015), Expect = e-136
Identities = 119/295 (40%), Positives = 172/295 (58%), Gaps = 10/295 (3%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDH 176
+EKL+KIG+GTY V+KA++ T +IVALK+VR D+ + E V A REI +L+ L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKH 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N+V+L ++ S L LVF++ + DL S VK ++ QLL GL CH
Sbjct: 61 KNIVRLHDVLHSDKK--LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRPPELLLGA 295
+++VLHRD+K NLLI+ G L +A+FGLA F P ++ VVTLWYRPP++L GA
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGA 176
Query: 296 TDYGVGVDLWSAGCILAELL-AEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHA 353
Y +D+WSAGCI AEL A +P+ PG +QL +IF+L G+P+EE W +KLP
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408
+ P + + L++ LL +P +R +A AL+ +F+
Sbjct: 237 KPY-PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 392 bits (1010), Expect = e-135
Identities = 116/328 (35%), Positives = 167/328 (50%), Gaps = 19/328 (5%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDT-LTGQIVALKKVRFDNLEPESVRFMA-REIL 169
R +E + +IG+G Y V+KARD G+ VALK+VR E + RE+
Sbjct: 5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVA 63
Query: 170 ILRRL---DHPNVVKLEGLVTSRMS---CSLYLVFKYMEHDLAG-LAASPTIKFTQAQVK 222
+LR L +HPNVV+L + T + L LVF++++ DL L P +K
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123
Query: 223 CYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282
M QLL GL+ H+ V+HRD+K N+L+ + G + +ADFGLA + +TS VV
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVV 181
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342
TLWYR PE+LL ++ Y VDLWS GCI AE+ KP+ G ++V+QL KI + G P E
Sbjct: 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 343 EYWKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401
E W + LP + I + D L+ L +PA+R +A +AL
Sbjct: 241 EDWPRDVALPRQAFHSKS---AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297
Query: 402 EFFTTKPYACD--PSSLPKYPPTKEMDA 427
+F + S LP T E++
Sbjct: 298 PYFQDLERCKENLDSHLPPSQNTSELNT 325
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 390 bits (1005), Expect = e-135
Identities = 110/291 (37%), Positives = 165/291 (56%), Gaps = 10/291 (3%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDH 176
+ + L+KIG+GTY VYKA++ G+ ALKK+R + E E + REI IL+ L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELKH 59
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N+VKL ++ ++ L LVF++++ DL L K ++ QLL+G+ +CH
Sbjct: 60 SNIVKLYDVIHTKKR--LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRPPELLLGA 295
++ VLHRD+K NLLI+ EG L IADFGLA F P T +VTLWYR P++L+G+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGS 175
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHAT 354
Y +D+WS GCI AE++ P+ PG +E +QL +IF++ G+P+ + W ++LP
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
K S + L+ +L +DP +R TA AL +F
Sbjct: 236 PNFTVYEPLP-WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 388 bits (999), Expect = e-133
Identities = 90/321 (28%), Positives = 161/321 (50%), Gaps = 9/321 (2%)
Query: 108 AISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-R 166
+ + +E L +G+G+Y V K R+ TG+IVA+KK + + + V+ +A R
Sbjct: 15 GTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMR 73
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMH 226
EI +L++L H N+V L + + YLVF++++H + V+ Y+
Sbjct: 74 EIKLLKQLRHENLVNLLEVC--KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF 131
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLW 285
Q+++G+ CH+ +++HRDIK N+L+ G++ + DFG A + P + V T W
Sbjct: 132 QIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYDDEVATRW 189
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
YR PELL+G YG VD+W+ GC++ E+ +P+ PG ++++QL+ I G+ +
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249
Query: 346 KK-SKLPHATIFK-PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
+ +K P + P+ + + + + L + L IDP +R L +F
Sbjct: 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
Query: 404 FTTKPYACDPSSLPKYPPTKE 424
F +A S + K+
Sbjct: 310 FQMDGFAERFSQELQLKVQKD 330
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 387 bits (997), Expect = e-133
Identities = 101/311 (32%), Positives = 155/311 (49%), Gaps = 9/311 (2%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDH 176
+ +EK+ KIG+G+Y V+K R+ TGQIVA+KK + ++ +A REI +L++L H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKH 61
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
PN+V L + R L+LVF+Y +H + + VK Q L + CH
Sbjct: 62 PNLVNLLEVF--RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
+ +HRD+K N+LI ++ + DFG A P+ V T WYR PELL+G
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--DYYDDEVATRWYRSPELLVGD 177
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHAT 354
T YG VD+W+ GC+ AELL+ P+ PG+++V+QL+ I K G + + S + +
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 355 IFK-PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDP 413
K P + F + +L L++ L +DP ER T L +F D
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDL 297
Query: 414 SSLPKYPPTKE 424
+ P
Sbjct: 298 AKEHDKPAENL 308
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 387 bits (997), Expect = e-133
Identities = 106/306 (34%), Positives = 169/306 (55%), Gaps = 14/306 (4%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILI 170
+ D + ++ K+G+GTY VYKA DT+T + VA+K++R ++ E E V A RE+ +
Sbjct: 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSL 86
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLS 230
L+ L H N+++L+ ++ L+L+F+Y E+DL + +K +++QL++
Sbjct: 87 LKELQHRNIIELKSVIHHNHR--LHLIFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLIN 143
Query: 231 GLEHCHNQHVLHRDIKGSNLLID-----NEGILTIADFGLASFF-DPNHKQPMTSRVVTL 284
G+ CH++ LHRD+K NLL+ +L I DFGLA F P T ++TL
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITL 201
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344
WYRPPE+LLG+ Y VD+WS CI AE+L + P+ PG +E++QL KIF++ G P +
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 345 WKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
W + LP P+ K L L+ +L +DP +R +A AL +
Sbjct: 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321
Query: 404 FTTKPY 409
F+ +
Sbjct: 322 FSHNDF 327
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 334 bits (859), Expect = e-111
Identities = 125/423 (29%), Positives = 187/423 (44%), Gaps = 33/423 (7%)
Query: 69 GEKRRSSKPNPRLS-NPPKHVHGEQVAAGWP-SWLSAVAGEAISGWTPRRADTFEKLDKI 126
G R +S P +V+ S ++ V G + ++ I
Sbjct: 3 GRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVI 62
Query: 127 GQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLV 186
G G++ VY+A+ +G++VA+KKV D RF RE+ I+R+LDH N+V+L
Sbjct: 63 GNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 187 TS----RMSCSLYLVFKYMEHDLAGLA---ASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
S + L LV Y+ + +A + VK YM+QL L + H+
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 240 VLHRDIKGSNLLID-NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDY 298
+ HRDIK NLL+D + +L + DFG A +P S + + +YR PEL+ GATDY
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDY 234
Query: 299 GVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358
+D+WSAGC+LAELL +PI PG + V+QL +I K+ G+P+ E ++ P+ T FK
Sbjct: 235 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN-PNYTEFKF 293
Query: 359 QQSYKRCIAETF-KDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT--KPYACDPSS 415
Q + F PP ++ L LL P R T A FF P P+
Sbjct: 294 PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNG 353
Query: 416 LP----------KYPPTKEMDAKLRDEEARR-LRAAGKANAEAKKARSRDRAARAMPAPE 464
+ + L AR A+ NA A + + A
Sbjct: 354 RDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAAS 413
Query: 465 ANA 467
A+A
Sbjct: 414 ASA 416
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = e-100
Identities = 103/307 (33%), Positives = 156/307 (50%), Gaps = 20/307 (6%)
Query: 108 AISGWTPRRAD-TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAR 166
A G T + + + IG G++ V++A+ + + VA+KKV D RF R
Sbjct: 29 ASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK------RFKNR 81
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAAS---PTIKFTQA 219
E+ I+R + HPNVV L+ S L LV +Y+ + +
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML 141
Query: 220 QVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID-NEGILTIADFGLASFFDPNHKQPMT 278
+K YM+QLL L + H+ + HRDIK NLL+D G+L + DFG A +P
Sbjct: 142 LIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNV 199
Query: 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCG 338
S + + +YR PEL+ GAT+Y +D+WS GC++AEL+ +P+ PG + ++QL +I K+ G
Sbjct: 200 SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG 259
Query: 339 SPSEEYWKKSKLPHATIFKPQQSYKRCIAETF-KDFPPSSLPLIETLLAIDPAERQTATA 397
+PS E K+ P+ K Q ++ F PP ++ LI LL P+ R TA
Sbjct: 260 TPSREQI-KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIE 318
Query: 398 ALRSEFF 404
AL FF
Sbjct: 319 ALCHPFF 325
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 3e-93
Identities = 96/365 (26%), Positives = 153/365 (41%), Gaps = 31/365 (8%)
Query: 96 GWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN 155
G S +S A A + + D F+ GQGT+ V ++ TG VA+KKV D
Sbjct: 1 GPGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD- 59
Query: 156 LEPESVRFMAREILILRRL---DHPNVVKLEGLVTSRMSCS-----LYLVFKYMEHDLAG 207
RF RE+ I++ L HPN+V+L+ + L +V +Y+ L
Sbjct: 60 -----PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHR 114
Query: 208 LAASPTIK---FTQAQVKCYMHQLLSGLEHCHNQ--HVLHRDIKGSNLLIDNE-GILTIA 261
+ + +K ++ QL+ + H +V HRDIK N+L++ G L +
Sbjct: 115 CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174
Query: 262 DFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIM 321
DFG A P+ +P + + + +YR PEL+ G Y VD+WS GCI AE++ +PI
Sbjct: 175 DFGSAKKLSPS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232
Query: 322 PGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQ---QSYKRCIAETFKDFPPSSL 378
G QLH+I ++ G PS E +K H + + ++ +
Sbjct: 233 RGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAY 292
Query: 379 PLIETLLAIDPAERQTATAALRSEFF------TTKPYACDPSSLPKYPPTKEMDAKLRDE 432
L+ LL P ER AL +F TK + + +
Sbjct: 293 DLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEA 352
Query: 433 EARRL 437
+ +L
Sbjct: 353 QKAKL 357
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 3e-91
Identities = 84/359 (23%), Positives = 149/359 (41%), Gaps = 53/359 (14%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
+ + +G G++ V + D +G+ ALKKV D R+ RE+ I++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKV 56
Query: 174 LDHPNVVKLEGLVTSRMSCS------------------------------------LYLV 197
LDH N++KL + L ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 198 FKYMEHDLAGLAASPTI---KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID- 253
+Y+ L + S + Y++QL + H+ + HRDIK NLL++
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 254 NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAE 313
+ L + DFG A P+ +P + + + +YR PEL+LGAT+Y +DLWS GC+ E
Sbjct: 177 KDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 314 LLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDF 373
L+ KP+ G T ++QL +I ++ G+P++E + PH T + + + +
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMN-PHYTEVRFPTLKAKDWRKILPEG 293
Query: 374 -PPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRD 431
P ++ L+E +L +P R A+ FF + + ++
Sbjct: 294 TPSLAIDLLEQILRYEPDLRINPYEAMAHPFF--DHLR-NSYESEVKNNSNFPHGVNQN 349
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 5e-90
Identities = 89/299 (29%), Positives = 149/299 (49%), Gaps = 23/299 (7%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DH 176
D ++ + K+G+G YS V++A + + V +K ++ P + + REI IL L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 90
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKY-MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
PN++ L +V +S + LVF++ D L T ++ YM+++L L++C
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC 146
Query: 236 HNQHVLHRDIKGSNLLIDNE-GILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
H+ ++HRD+K N++ID+E L + D+GLA F+ P Q RV + +++ PELL+
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVD 204
Query: 295 ATDYGVGVDLWSAGCILAELLAEK-PIMPGRTEVEQLHKIFKLCGSPSEE-YWKKSKLPH 352
Y +D+WS GC+LA ++ K P G +QL +I K+ G+ Y K +
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264
Query: 353 ATIFK---PQQSYKR----CIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
F + S KR +E P +L ++ LL D R TA A+ +F
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 1e-83
Identities = 99/311 (31%), Positives = 156/311 (50%), Gaps = 23/311 (7%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+ L +G G V+ A D + VA+KK+ + P+SV+ REI I+RRLDH N+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNI 70
Query: 180 VKLEGLVTSRMSCS------------LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQ 227
VK+ ++ S +Y+V +YME DLA + + + + +M+Q
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL--LEEHARLFMYQ 128
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPN--HKQPMTSRVVTL 284
LL GL++ H+ +VLHRD+K +NL I+ E +L I DFGLA DP+ HK ++ +VT
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344
WYR P LLL +Y +D+W+AGCI AE+L K + G E+EQ+ I + EE
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248
Query: 345 WKKSKLPHATIFKPQQSYKRC-IAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
++ + + + + ++ +E +L P +R TA AL +
Sbjct: 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308
Query: 404 FTTKPYACDPS 414
Y+ P
Sbjct: 309 M--SIYS-FPM 316
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 1e-82
Identities = 99/310 (31%), Positives = 157/310 (50%), Gaps = 20/310 (6%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLDHP 177
+ +G G Y +V A D +G+ VA+KK+ F + + RE+L+L+ + H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQHE 83
Query: 178 NVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
NV+ L + T S YLV +M+ DL + F++ +++ ++Q+L GL+
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEKIQYLVYQMLKGLK 140
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ H+ V+HRD+K NL ++ + L I DFGLA D MT VVT WYR PE++L
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVIL 196
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
Y VD+WS GCI+AE+L K + G+ ++QL +I K+ G P E+ +K A
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256
Query: 354 -TIFKPQQSYKRC-IAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYAC 411
+ + R + F P + L+E +L +D +R TA AL FF +P+
Sbjct: 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF--EPFR- 313
Query: 412 DPSSLPKYPP 421
DP +
Sbjct: 314 DPEEETEAQQ 323
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 3e-82
Identities = 112/460 (24%), Positives = 186/460 (40%), Gaps = 94/460 (20%)
Query: 46 GPNHRKESSNSNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVA 105
G +H ++ +N TV ++ + K +
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSD------------ 48
Query: 106 GEAISGWT-PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVR 162
W P R +E IG G+Y +V +A D L ++VA+KK+ F++ + R
Sbjct: 49 ------WQIPDR---YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED-LIDCKR 98
Query: 163 FMAREILILRRLDHPNVVKLEGLVTSRMSCS---LYLVFKYMEHDLAGLAASPTIKFTQA 219
+ REI IL RL+H +VVK+ +V + LY+V + + D L +P + T+
Sbjct: 99 -ILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP-VYLTEL 156
Query: 220 QVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA------------- 266
+K ++ LL G+++ H+ +LHRD+K +N L++ + + + DFGLA
Sbjct: 157 HIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 267 -------------SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAE 313
N K+ +T VVT WYR PEL+L +Y +D+WS GCI AE
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276
Query: 314 LLAE-----------KPIMPG--------------------RTEVEQLHKIFKLCGSPSE 342
LL P+ PG R +QL+ IF + G+PSE
Sbjct: 277 LLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSE 336
Query: 343 EYWKKSKLPHATIFKPQQSY--KRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
E + + A + +AE F ++ L++ +L +P +R T L
Sbjct: 337 EDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396
Query: 401 SEFFTTKPY---ACDPSSLPKYPPTKEMDAKLRDEEARRL 437
FF K + ++ K + + + R
Sbjct: 397 HPFF--KEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYA 434
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 5e-82
Identities = 101/310 (32%), Positives = 156/310 (50%), Gaps = 15/310 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDHPN 178
+ L IG+G Y V A D L VA+KK+ F++ + REI IL R H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHEN 86
Query: 179 VVKLEGLVTSRMSCS---LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
++ + ++ + +Y+V ME DL L + + + +++Q+L GL++
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYI 144
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP--MTSRVVTLWYRPPELLL 293
H+ +VLHRD+K SNLL++ L I DFGLA DP+H +T V T WYR PE++L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
+ Y +D+WS GCILAE+L+ +PI PG+ ++QL+ I + GSPS+E A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 354 T--IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYAC 411
+ K F + +L L++ +L +P +R AL + + Y
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL--EQYY- 321
Query: 412 DPSSLPKYPP 421
DPS P
Sbjct: 322 DPSDEPIAEA 331
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 7e-82
Identities = 90/330 (27%), Positives = 140/330 (42%), Gaps = 22/330 (6%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVR-FMA--------REILI 170
+ I G+Y V D+ G VA+K+V + +V REI +
Sbjct: 24 YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 171 LRRLDHPNVVKLEGLVTSRMSCS---LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQ 227
L HPN++ L + + LYLV + M DLA + I + ++ +M+
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
+L GL H V+HRD+ N+L+ + +TI DF LA + T V WYR
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYR 200
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
PEL++ + VD+WSAGC++AE+ K + G T QL+KI ++ G+P E
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260
Query: 348 SKLPHAT--IFKPQQSYKRC-IAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
P A + + P +L LI +L +P R + ALR +F
Sbjct: 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320
Query: 405 TTKPYACDPSSLPKYPPTK-EMDAKLRDEE 433
+ DP L + + D + D
Sbjct: 321 --ESLF-DPLDLTEGLSERFHFDESVTDVY 347
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 3e-81
Identities = 95/310 (30%), Positives = 151/310 (48%), Gaps = 19/310 (6%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLDHP 177
+ L +G G Y V A D TG VA+KK+ F + + RE+ +L+ + H
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMRHE 84
Query: 178 NVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
NV+ L + T + YLV +M DL L K + +++ ++Q+L GL
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLR 142
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ H ++HRD+K NL ++ + L I DFGLA D MT VVT WYR PE++L
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVIL 198
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
Y VD+WS GCI+AE++ K + G ++QL +I K+ G+P E+ ++ + A
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258
Query: 354 TIFKPQQSY--KRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYAC 411
+ K+ A + P ++ L+E +L +D +R TA AL +F +
Sbjct: 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF--ESLH- 315
Query: 412 DPSSLPKYPP 421
D P+
Sbjct: 316 DTEDEPQVQK 325
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 1e-80
Identities = 105/312 (33%), Positives = 154/312 (49%), Gaps = 19/312 (6%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLD 175
+ ++ L +G G Y +V A DT TG VA+KK+ F + + RE+ +L+ +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMK 86
Query: 176 HPNVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
H NV+ L + T S +YLV M DL + K T V+ ++Q+L G
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRG 144
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
L++ H+ ++HRD+K SNL ++ + L I DFGLA MT V T WYR PE+
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEI 200
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
+L Y VD+WS GCI+AELL + + PG ++QL I +L G+P E KK
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 352 HATIFKPQQSY--KRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409
A + + K A F P ++ L+E +L +D +R TA AL +F Y
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF--AQY 318
Query: 410 ACDPSSLPKYPP 421
DP P P
Sbjct: 319 H-DPDDEPVADP 329
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 3e-79
Identities = 97/335 (28%), Positives = 157/335 (46%), Gaps = 23/335 (6%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLD 175
+ F+ +G+G Y V A TG+IVA+KK+ FD P REI IL+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRTLREIKILKHFK 67
Query: 176 HPNVVKLEGLVTSRMSCS---LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
H N++ + + + +Y++ + M+ DL + ++ + ++ +++Q L +
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ--MLSDDHIQYFIYQTLRAV 125
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN---------HKQPMTSRVVT 283
+ H +V+HRD+K SNLLI++ L + DFGLA D + + M V T
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 284 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE 343
WYR PE++L + Y +D+WS GCILAEL +PI PGR QL IF + G+P +
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245
Query: 344 ---YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+S I + + F P + L++ +L DPA+R TA AL
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
Query: 401 SEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEEAR 435
+ + Y DP+ P+ P + +
Sbjct: 306 HPYL--QTYH-DPNDEPEGEPIPPSFFEFDHYKEA 337
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 3e-77
Identities = 104/365 (28%), Positives = 173/365 (47%), Gaps = 52/365 (14%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRL- 174
+E + K+G+G Y V+K+ D TG++VA+KK+ F N + REI+IL L
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN--STDAQRTFREIMILTELS 66
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
H N+V L ++ + +YLVF YME DL + + + ++QL+ +++
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKY 124
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLA--------------------SFFDPNHK 274
H+ +LHRD+K SN+L++ E + +ADFGL+ + + +
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIF 334
+T V T WYR PE+LLG+T Y G+D+WS GCIL E+L KPI PG + + QL +I
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244
Query: 335 KLCGSPSEEYW----------------KKSKLPHATIFKPQQSYKRCIAETF--KDFPPS 376
+ PS E +K ++ + +K + + D
Sbjct: 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEE 304
Query: 377 SLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYPPTKEM----DAKLRDE 432
+L L++ LL +P +R +A AL+ F + +P+ P + + K +
Sbjct: 305 ALDLLDKLLQFNPNKRISANDALKHPFV--SIFH-NPNEEPNCDHIITIPINDNVKHSID 361
Query: 433 EARRL 437
+ R L
Sbjct: 362 DYRNL 366
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 4e-77
Identities = 90/345 (26%), Positives = 162/345 (46%), Gaps = 42/345 (12%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLDHP 177
++ L IG G V A D + + VA+KK+ F N + RE+++++ ++H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHK 84
Query: 178 NVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
N++ L + T + S +Y+V + M+ +L + ++ ++Q+L G++
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIK 141
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H H+ ++HRD+K SN+++ ++ L I DFGLA + MT VVT +YR PE++L
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVIL 199
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK------ 347
G Y VD+WS GCI+ E++ + PG ++Q +K+ + G+P E+ KK
Sbjct: 200 G-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258
Query: 348 ---SKLPHATIFKPQQSYKR--------CIAETFKDFPPSSLPLIETLLAIDPAERQTAT 396
P S+++ +E K + L+ +L ID ++R +
Sbjct: 259 TYVENRPK----YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314
Query: 397 AALRSEFFTTKPYACDPSSLPKYPPTKEM----DAKLRDEEARRL 437
AL+ + + DPS PP + + EE + L
Sbjct: 315 EALQHPYI--NVWY-DPSEAEAPPPKIPDKQLDEREHTIEEWKEL 356
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 5e-76
Identities = 89/327 (27%), Positives = 159/327 (48%), Gaps = 38/327 (11%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLDHP 177
++ L IG G V A D + + VA+KK+ F N + RE+++++ ++H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHK 121
Query: 178 NVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
N++ L + T + + +YLV + M+ +L + ++ ++Q+L G++
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIK 178
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H H+ ++HRD+K SN+++ ++ L I DFGLA + MT VVT +YR PE++L
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVIL 236
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK------ 347
G Y VD+WS GCI+ E++ K + PGR ++Q +K+ + G+P E+ KK
Sbjct: 237 G-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295
Query: 348 ---SKLPHATIFKPQQSYKR--------CIAETFKDFPPSSLPLIETLLAIDPAERQTAT 396
P ++ + +E K + L+ +L IDPA+R +
Sbjct: 296 NYVENRPK----YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351
Query: 397 AALRSEFFTTKPYACDPSSLPKYPPTK 423
AL+ + + DP+ + PP
Sbjct: 352 DALQHPYI--NVWY-DPAEVEAPPPQI 375
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 240 bits (613), Expect = 3e-74
Identities = 99/365 (27%), Positives = 156/365 (42%), Gaps = 62/365 (16%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLD 175
D + IG+G+Y VY A D T + VA+KKV F++L + R + REI IL RL
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI-DCKR-ILREITILNRLK 83
Query: 176 HPNVVKLEGLVTSRMSCS---LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
+++L L+ LY+V + + DL L +P I T+ +K ++ LL G
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGE 142
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA---------------------SFFDP 271
H ++HRD+K +N L++ + + + DFGLA +
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-----------EKPI 320
N K+ +TS VVT WYR PEL+L +Y +D+WS GCI AELL P+
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262
Query: 321 MPG-----------------RTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT--IFKPQQS 361
PG ++ +QL+ IF + G+P+E+ K P I
Sbjct: 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHR 322
Query: 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYPP 421
+ + + + L+E++L +P +R T AL + K
Sbjct: 323 KPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL--KDVR-KKKLENFSTK 379
Query: 422 TKEMD 426
+
Sbjct: 380 KIILP 384
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 5e-64
Identities = 73/315 (23%), Positives = 125/315 (39%), Gaps = 55/315 (17%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL 174
R A FE++ +GQG + V KAR+ L + A+KK+R + ++ E+++L L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---SEVMLLASL 59
Query: 175 DHPNVVKL-----------EGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVK 222
+H VV+ + + + +L++ +Y E L L S + + +
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 223 CYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP------ 276
Q+L L + H+Q ++HRD+K N+ ID + I DFGLA +
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 277 -------MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ 329
+TS + T Y E+L G Y +D++S G I E++ P G V
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNI 237
Query: 330 LHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDP 389
L K+ + ++ + K +I L+ DP
Sbjct: 238 LKKLRSVSIEFPPDFDDN------------------KMKVEKK-------IIRLLIDHDP 272
Query: 390 AERQTATAALRSEFF 404
+R A L S +
Sbjct: 273 NKRPGARTLLNSGWL 287
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-60
Identities = 67/320 (20%), Positives = 124/320 (38%), Gaps = 51/320 (15%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN- 178
+ L +IG G S V++ + QI A+K V + + +++ EI L +L +
Sbjct: 30 YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 179 -VVKLEG-LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
+++L +T + +Y+V + DL + K Y +L + H
Sbjct: 89 KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH 144
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM-TSRVVTLWYRPPELLLGA 295
++H D+K +N LI + G+L + DFG+A+ P+ + S+V T+ Y PPE +
Sbjct: 145 QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 296 ----------TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE-EY 344
+ D+WS GCIL + K P + + Q+ K+ + E E+
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIEF 261
Query: 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
+ +D ++ L DP +R + L +
Sbjct: 262 PDI------------------PEKDLQDV-------LKCCLKRDPKQRISIPELLAHPYV 296
Query: 405 TTKPYACDPSSLPKYPPTKE 424
+ P + T+E
Sbjct: 297 QIQT---HPVNQMAKGTTEE 313
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 3e-59
Identities = 65/332 (19%), Positives = 124/332 (37%), Gaps = 48/332 (14%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN- 178
+ L +IG G S V++ + QI A+K V + + +++ EI L +L +
Sbjct: 11 YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 179 -VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
+++L + +Y+V + DL + K Y +L + H
Sbjct: 70 KIIRLYDYEITDQY--IYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ 126
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM-TSRVVTLWYRPPELLLG-- 294
++H D+K +N LI + G+L + DFG+A+ P+ + S+V T+ Y PPE +
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 295 --------ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346
+ D+WS GCIL + K P + + Q+ K+
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHA----------- 232
Query: 347 KSKLPHATIFKPQQSYK--RCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
I P + + +D ++ L DP +R + L +
Sbjct: 233 --------IIDPNHEIEFPDIPEKDLQDV-------LKCCLKRDPKQRISIPELLAHPYV 277
Query: 405 TTKPYACDPSSLPKYPPTKEMDAKLRDEEARR 436
+ + + + K + +L +
Sbjct: 278 QIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPN 309
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 195 bits (496), Expect = 1e-57
Identities = 78/403 (19%), Positives = 141/403 (34%), Gaps = 62/403 (15%)
Query: 48 NHRKESSNSNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGE 107
+H SS + R +P L S+ A E
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDD------------DDKASSSANE 49
Query: 108 AISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMARE 167
IS + + L +IG G S V++ + QI A+K V + + +++ E
Sbjct: 50 CIS----VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNE 104
Query: 168 ILILRRLDHPN--VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYM 225
I L +L + +++L + +Y+V + DL + K Y
Sbjct: 105 IAYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYW 161
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM-TSRVVTL 284
+L + H ++H D+K +N LI + G+L + DFG+A+ P+ + S+V +
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220
Query: 285 WYRPPELLLGATD----------YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIF 334
Y PPE + + D+WS GCIL + K P + + Q+ K+
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLH 278
Query: 335 KLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLP-LIETLLAIDPAERQ 393
I P + F D P L +++ L DP +R
Sbjct: 279 A-------------------IIDPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRI 313
Query: 394 TATAALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEEARR 436
+ L + + + + + K + +L +
Sbjct: 314 SIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPN 356
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 6e-57
Identities = 70/363 (19%), Positives = 120/363 (33%), Gaps = 60/363 (16%)
Query: 47 PNHRKESSNSNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAG 106
+ + + Q ++PR R S E
Sbjct: 8 SSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPE--------------- 52
Query: 107 EAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAR 166
+F++L ++G G+Y V+K R G++ A+K+ P+
Sbjct: 53 -------SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA 105
Query: 167 EILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYM 225
E+ ++ HP V+LE LYL + L + +AQV Y+
Sbjct: 106 EVGSHEKVGQHPCCVRLEQAWEEG--GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYL 163
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW 285
L L H H+Q ++H D+K +N+ + G + DFGL +
Sbjct: 164 RDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPR 221
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
Y PELL G YG D++S G + E+ +P E ++ +
Sbjct: 222 YMAPELLQG--SYGTAADVFSLGLTILEVACNME-LP--HGGEGWQQLRQG--------- 267
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
P+ + ++ + + +L DP R TA A L
Sbjct: 268 ---------YLPPE--FTAGLSSELRSV-------LVMMLEPDPKLRATAEALLALPVL- 308
Query: 406 TKP 408
+P
Sbjct: 309 RQP 311
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-56
Identities = 69/310 (22%), Positives = 123/310 (39%), Gaps = 58/310 (18%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
R F++++ IG G + V+KA+ + G+ +K+V+++N E RE+ L +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAE---REVKALAK 60
Query: 174 LDHPNVVKL--------------EGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFT 217
LDH N+V + + L++ ++ + L + K
Sbjct: 61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 218 QAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277
+ Q+ G+++ H++ +++RD+K SN+ + + + I DFGL + + K
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--R 178
Query: 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLC 337
T TL Y PE + DYG VDL++ G ILAELL T E L
Sbjct: 179 TRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLH-----VCDTAFETSKFFTDL- 231
Query: 338 GSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATA 397
+ + + K L++ LL+ P +R +
Sbjct: 232 --------RDGIISD------------IFDKKEKT-------LLQKLLSKKPEDRPNTSE 264
Query: 398 ALRSEFFTTK 407
LR+ K
Sbjct: 265 ILRTLTVWKK 274
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 3e-56
Identities = 60/303 (19%), Positives = 111/303 (36%), Gaps = 31/303 (10%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ D +GQG +NV++ R TG + A+K + M RE +L++L+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHK 67
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH----DLAGLAASP--TIKFTQAQVKCYMHQLLSG 231
N+VKL + + L+ ME L + P +++ + ++ G
Sbjct: 68 NIVKLFAIEEETTTRHKVLI---MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 232 LEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
+ H ++HR+IK N++ D + + + DFG A + + + S T Y
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYL 182
Query: 288 PPELLLGATD-------YGVGVDLWSAGCILAELLAEKP----IMPGRTEVEQLHKIFKL 336
P++ A YG VDLWS G R E ++KI
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT 396
S + +K++ + ++ + P++ +L D +
Sbjct: 243 KPSGAISGVQKAE-NGPIDWSGDMPVSCSLSRGLQV---LLTPVLANILEADQEKCWGFD 298
Query: 397 AAL 399
Sbjct: 299 QFF 301
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 7e-56
Identities = 76/303 (25%), Positives = 129/303 (42%), Gaps = 45/303 (14%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
P RA+ +E L IG G+Y K R G+I+ K++ + ++ + + E+ +LR
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH----DLAGL---AASPTIKFTQAQVKCYMH 226
L HPN+V+ + R + +LY+V ME+ DLA + + V M
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIV---MEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 227 QLLSGLEHCHNQH-----VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281
QL L+ CH + VLHRD+K +N+ +D + + + DFGLA + + + V
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFV 177
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS 341
T +Y PE + Y D+WS GC+L EL A P ++ E KI + G
Sbjct: 178 GTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKF- 233
Query: 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401
++P+ ++ + +I +L + R + L +
Sbjct: 234 ------RRIPY------------RYSDELNE-------IITRMLNLKDYHRPSVEEILEN 268
Query: 402 EFF 404
Sbjct: 269 PLI 271
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-54
Identities = 60/299 (20%), Positives = 111/299 (37%), Gaps = 31/299 (10%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ D +GQG +NV++ R TG + A+K + M RE +L++L+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHK 67
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH----DLAGLAASP--TIKFTQAQVKCYMHQLLSG 231
N+VKL + + L+ ME L + P +++ + ++ G
Sbjct: 68 NIVKLFAIEEETTTRHKVLI---MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 232 LEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
+ H ++HR+IK N++ D + + + DFG A + + + S T Y
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYL 182
Query: 288 PPELLLGATD-------YGVGVDLWSAGCILAELLAEKP----IMPGRTEVEQLHKIFKL 336
P++ A YG VDLWS G R E ++KI
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA 395
S + +K++ + ++ + P++ +L D +
Sbjct: 243 KPSGAISGVQKAE-NGPIDWSGDMPVSCSLSRGLQV---LLTPVLANILEADQEKCWGF 297
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 6e-54
Identities = 71/333 (21%), Positives = 129/333 (38%), Gaps = 59/333 (17%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL 174
R FE + +G+G + V++A++ + A+K++R N E + M RE+ L +L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-REVKALAKL 60
Query: 175 DHPNVVK----------LEGLVTSRMSCSLYLVFKYMEH-DLAGL--AASPTIKFTQAQV 221
+HP +V+ E L S LY+ + +L + ++
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 222 KCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD----------- 270
Q+ +E H++ ++HRD+K SN+ + ++ + DFGL + D
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQL 330
T +V T Y PE + G Y VD++S G IL ELL P T++E++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL-----YPFSTQMERV 234
Query: 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPA 390
+ + + K P F P +++ +L+ P
Sbjct: 235 RTLTDV---------RNLKFPP----------------LFTQKYPCEYVMVQDMLSPSPM 269
Query: 391 ERQTATAALRSEFFTTKPYACDPSSLPKYPPTK 423
ER A + + F + P ++
Sbjct: 270 ERPEAINIIENAVFEDLDF---PGKTVLRQRSR 299
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-53
Identities = 76/361 (21%), Positives = 137/361 (37%), Gaps = 49/361 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ + +L KIG+G++ + T G+ +K++ + + RE+ +L + HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 178 NVVK-LEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIK------FTQAQVKCYMHQLL 229
N+V+ E + SLY+V Y E DL I F + Q+ + Q+
Sbjct: 84 NIVQYRESFEENG---SLYIVMDYCEGGDLFKR-----INAQKGVLFQEDQILDWFVQIC 135
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRP 288
L+H H++ +LHRDIK N+ + +G + + DFG+A N + + T +Y
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLS 193
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348
PE+ Y D+W+ GC+L EL K + + KI GS
Sbjct: 194 PEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--GSF-------P 243
Query: 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408
+ + + L+ L +P +R + + L F +
Sbjct: 244 PVSL------------HYSYDLRS-------LVSQLFKRNPRDRPSVNSILEKGFIAKRI 284
Query: 409 YACDPSSLPKYPPTKEMDAKLRDEEARRLR-AAGKANAEAKKARSRDRAARAMPAPEANA 467
L + +K + R A+G+ + A+ + A P A
Sbjct: 285 EKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYK 344
Query: 468 E 468
+
Sbjct: 345 K 345
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-53
Identities = 90/362 (24%), Positives = 141/362 (38%), Gaps = 39/362 (10%)
Query: 79 PRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKAR 138
P ++P K A G P+ PR + + +G+G ++ ++
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEIS 61
Query: 139 DTLTGQIVALKKVRFDNLEPESVRF-MAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197
D T ++ A K V L R M+ EI I R L H +VV G +++V
Sbjct: 62 DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF--VFVV 119
Query: 198 FKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG 256
+ L L T+ + + Y+ Q++ G ++ H V+HRD+K NL ++ +
Sbjct: 120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 178
Query: 257 ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
+ I DFGLA+ + + ++ T Y PE+L + VD+WS GCI+ LL
Sbjct: 179 EVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLV 236
Query: 317 EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPS 376
KP E +I K EY +P K P
Sbjct: 237 GKPPFETSCLKETYLRIKKN------EY----SIP-------------------KHINPV 267
Query: 377 SLPLIETLLAIDPAERQTATAALRSEFFTT--KPYACDPSSLPKYPPTKEMDAKLRDEEA 434
+ LI+ +L DP R T L EFFT+ P + L PP + D
Sbjct: 268 AASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTI-PPRFSIAPSSLDPSN 326
Query: 435 RR 436
R+
Sbjct: 327 RK 328
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 8e-53
Identities = 66/311 (21%), Positives = 108/311 (34%), Gaps = 19/311 (6%)
Query: 106 GEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA 165
G + +E +++G G + V + TG+ VA+K+ R + L P++
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWC 60
Query: 166 REILILRRLDHPNVVKL----EGLVTSRMSCSLYLVFKYMEH-DLAGLAASP--TIKFTQ 218
EI I+++L+HPNVV +GL + L +Y E DL +
Sbjct: 61 LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 219 AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID---NEGILTIADFGLASFFDPNHKQ 275
++ + + S L + H ++HRD+K N+++ I I D G A D
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL- 179
Query: 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
T V TL Y PELL Y V VD WS G + E + + Q H +
Sbjct: 180 -CTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
Query: 336 LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA 395
+ + ++ +L +R T
Sbjct: 238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLS-----GILAGKLERWLQCMLMWHQRQRGTD 292
Query: 396 TAALRSEFFTT 406
F
Sbjct: 293 PQNPNVGCFQA 303
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-52
Identities = 84/300 (28%), Positives = 137/300 (45%), Gaps = 52/300 (17%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ ++++ K+G G Y V RD +T A+K +R ++ S + E+ +L+ LDHP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQAQVKCYMHQLLS 230
N++KL + + YLV ME G + KF + + Q+LS
Sbjct: 97 NIMKLYDFFEDKR--NYYLV---MEC-YKGGELFDEIIHRM---KFNEVDAAVIIKQVLS 147
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
G+ + H +++HRD+K NLL+++ + ++ I DFGL++ F+ + M R+ T +Y
Sbjct: 148 GVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYI 205
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS--EEYW 345
PE+L Y D+WS G IL LLA P G+T+ E L K+ K G + W
Sbjct: 206 APEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK--GKYTFDSPEW 261
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
K ++E KD I+ +L D R +A AL +
Sbjct: 262 KN------------------VSEGAKDL-------IKQMLQFDSQRRISAQQALEHPWIK 296
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-52
Identities = 81/306 (26%), Positives = 127/306 (41%), Gaps = 39/306 (12%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRF-MAREILILR 172
PR + + +G+G ++ ++ D T ++ A K V L R M+ EI I R
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSG 231
L H +VV G +++V + L L T+ + + Y+ Q++ G
Sbjct: 71 SLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLG 127
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
++ H V+HRD+K NL ++ + + I DFGLA+ + + ++ T Y PE+
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEV 186
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
L + VD+WS GCI+ LL KP E +I K EY +P
Sbjct: 187 LSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EY----SIP 235
Query: 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYAC 411
K P + LI+ +L DP R T L EFFT+
Sbjct: 236 -------------------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS---GY 273
Query: 412 DPSSLP 417
P+ LP
Sbjct: 274 IPARLP 279
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-52
Identities = 79/288 (27%), Positives = 122/288 (42%), Gaps = 34/288 (11%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDH 176
F KIG+G +S VY+A L G VALKKV+ +L R +EI +L++L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGL---AASPTIKFTQAQVKCYMHQLLSGL 232
PNV+K L +V + + DL+ + + V Y QL S L
Sbjct: 92 PNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL 292
EH H++ V+HRDIK +N+ I G++ + D GL FF + S V T +Y PE +
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 208
Query: 293 LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352
Y D+WS GC+L E+ A + P + L+ + K K + +
Sbjct: 209 HE-NGYNFKSDIWSLGCLLYEMAALQS--PFYGDKMNLYSLCK----------KIEQCDY 255
Query: 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ S + + + + DP +R T
Sbjct: 256 PPLPSDHYSEE------LRQL-------VNMCINPDPEKRPDVTYVYD 290
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 5e-52
Identities = 84/336 (25%), Positives = 153/336 (45%), Gaps = 55/336 (16%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ + + +G+G++ V K +D +T Q A+K + + + + + RE+ +L++LDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQAQVKCYMHQLLS 230
N++KL ++ S Y+V E G + +F++ + Q+ S
Sbjct: 82 NIMKLFEILEDSS--SFYIV---GEL-YTGGELFDEIIKRK---RFSEHDAARIIKQVFS 132
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
G+ + H +++HRD+K N+L+++ + + I DFGL++ F N M R+ T +Y
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYI 190
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS--EEYW 345
PE+L G Y D+WSAG IL LL+ P G+ E + L ++ G + W
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GKYAFDLPQW 246
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
+ I++ KD LI +L P+ R TAT L +
Sbjct: 247 RT------------------ISDDAKD-------LIRKMLTFHPSLRITATQCLEHPWI- 280
Query: 406 TKPYACDPSSLPKYPPTKEMDAKLRDEEARR-LRAA 440
+ Y+ + ++ P + +R +A + L A
Sbjct: 281 -QKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQA 315
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-51
Identities = 86/337 (25%), Positives = 147/337 (43%), Gaps = 57/337 (16%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDH 176
D ++ +G+G++ V +D +TGQ A+K + ++ + RE+ +L++LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQAQVKCYMHQLL 229
PN++KL + YLV E G ++ +F++ + Q+L
Sbjct: 86 PNIMKLYEFFEDKGY--FYLV---GEV-YTGGELFDEIISRK---RFSEVDAARIIRQVL 136
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASFFDPNHKQPMTSRVVTLWY 286
SG+ + H ++HRD+K NLL+++ + + I DFGL++ F+ + + M ++ T +Y
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYY 194
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS--EEY 344
PE+L G Y D+WS G IL LL+ P G E + L K+ K G +
Sbjct: 195 IAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--GKYTFELPQ 250
Query: 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
WKK ++E+ KD I +L P+ R +A AL E+
Sbjct: 251 WKK------------------VSESAKDL-------IRKMLTYVPSMRISARDALDHEWI 285
Query: 405 TTKPYACDPSSLPKYPPTKEMDAKLRDEEARR-LRAA 440
T P +R + + L A
Sbjct: 286 QT---YTKEQISVDVPSLDNAILNIRQFQGTQKLAQA 319
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-51
Identities = 65/300 (21%), Positives = 108/300 (36%), Gaps = 45/300 (15%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HP 177
+F D +G G + R + VA+K++ PE F RE+ +LR D HP
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRI-----LPECFSFADREVQLLRESDEHP 78
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
NV++ R Y+ + L + + Q SGL H H+
Sbjct: 79 NVIRYFCTEKDRQF--QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 238 QHVLHRDIKGSNLLIDNEG-----ILTIADFGLASFFDPNHK--QPMTSRVVTLWYRPPE 290
+++HRD+K N+LI I+DFGL + T + PE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 291 LLLGATD--YGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
+L VD++SAGC+ +++E + + + C K
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL-GACSLDCLHPEKH 255
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407
++ LIE ++A+DP +R +A L+ FF +
Sbjct: 256 ------------------EDVIARE-------LIEKMIAMDPQKRPSAKHVLKHPFFWSL 290
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-51
Identities = 79/307 (25%), Positives = 140/307 (45%), Gaps = 52/307 (16%)
Query: 106 GEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA 165
G + A+ + + +G+G++ V K +D +T Q A+K + + + + +
Sbjct: 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL 69
Query: 166 REILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQ 218
RE+ +L++LDHPN++KL ++ S Y+V + G + +F++
Sbjct: 70 REVELLKKLDHPNIMKLFEILEDSS--SFYIVGELYT----GGELFDEIIKRK---RFSE 120
Query: 219 AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNHKQ 275
+ Q+ SG+ + H +++HRD+K N+L++++ + I DFGL++ F N
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--T 178
Query: 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
M R+ T +Y PE+L G Y D+WSAG IL LL+ P G+ E + L ++
Sbjct: 179 KMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-- 234
Query: 336 LCGSPS--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ 393
G + W+ I++ KD LI +L P+ R
Sbjct: 235 ETGKYAFDLPQWRT------------------ISDDAKD-------LIRKMLTFHPSLRI 269
Query: 394 TATAALR 400
TAT L
Sbjct: 270 TATQCLE 276
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-50
Identities = 70/300 (23%), Positives = 137/300 (45%), Gaps = 35/300 (11%)
Query: 108 AISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRF-MAR 166
+++ + + F+ + +G+G+++ VY+A TG VA+K + + + +
Sbjct: 1 SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYM 225
E+ I +L HP++++L +YLV + + ++ + F++ + + +M
Sbjct: 61 EVKIHCQLKHPSILELYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM 118
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW 285
HQ+++G+ + H+ +LHRD+ SNLL+ + IADFGLA+ H++ T T
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTPN 177
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
Y PE+ + +G+ D+WS GC+ LL +P T L+K+ +Y
Sbjct: 178 YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------DY- 229
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
++P + LI LL +PA+R + ++ L F +
Sbjct: 230 ---EMP-------------------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-49
Identities = 72/302 (23%), Positives = 126/302 (41%), Gaps = 55/302 (18%)
Query: 113 TPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILR 172
+ + +D ++ +++G+G +S V + TG A K + L + + RE I R
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQAQVKCYM 225
+L HPN+V+L + YLVF + G +A +++A +
Sbjct: 61 KLQHPNIVRLHDSIQEES--FHYLVFDLVT----GGELFEDIVARE---FYSEADASHCI 111
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNHKQPMTSRVV 282
Q+L + +CH+ ++HR++K NLL+ ++ + +ADFGLA + + +
Sbjct: 112 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAG 169
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP--GRTEVEQLHKIFKLCGSP 340
T Y PE+L Y VD+W+ G IL LL P P + +I G+
Sbjct: 170 TPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYP--PFWDEDQHRLYAQI--KAGAY 224
Query: 341 S--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAA 398
W + K LI+++L ++P +R TA A
Sbjct: 225 DYPSPEWDT------------------VTPEAKS-------LIDSMLTVNPKKRITADQA 259
Query: 399 LR 400
L+
Sbjct: 260 LK 261
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-49
Identities = 80/323 (24%), Positives = 132/323 (40%), Gaps = 63/323 (19%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-----------FDNLEPESVRFMAR 166
+++ K+ K+G G Y V ++ A+K ++ + + +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQA 219
EI +L+ LDHPN++KL + + YLV E G + KF +
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKY--FYLV---TEF-YEGGELFEQIINRH---KFDEC 146
Query: 220 QVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASFFDPNHKQP 276
M Q+LSG+ + H +++HRDIK N+L++N + I DFGL+SFF +
Sbjct: 147 DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YK 204
Query: 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336
+ R+ T +Y PE+L Y D+WS G I+ LL P G+ + + + K+ K
Sbjct: 205 LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK- 261
Query: 337 CGSPS--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT 394
G WK I++ K+ I+ +L D +R T
Sbjct: 262 -GKYYFDFNDWKN------------------ISDEAKEL-------IKLMLTYDYNKRCT 295
Query: 395 ATAALRSEFFTTKPYACDPSSLP 417
A AL S + + S
Sbjct: 296 AEEALNSRWIKKYANNINKSDQK 318
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-49
Identities = 46/323 (14%), Positives = 81/323 (25%), Gaps = 56/323 (17%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES-VRFMAREILILRR 173
+ + ++ + G S V+ RD + ALK S + + R
Sbjct: 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 174 LDHPN------------------------VVKLEGLVTSRMSCSLYLVFKYMEHDLAGL- 208
L + +L + L+ DL L
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 209 -----AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADF 263
+ QL+ + ++ ++H NL I +G L + D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 264 GLASFFDPNHKQPMTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAEKPIMP 322
+ V + Y P E L + ++ W G + + P
Sbjct: 239 SALWKVG----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL--P 292
Query: 323 GRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIE 382
F L + WK+ L + + K LI
Sbjct: 293 -----------FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKT-------LIG 334
Query: 383 TLLAIDPAERQTATAALRSEFFT 405
L D R A+ + F
Sbjct: 335 RFLNFDRRRRLLPLEAMETPEFL 357
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 5e-49
Identities = 71/375 (18%), Positives = 126/375 (33%), Gaps = 64/375 (17%)
Query: 107 EAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAR 166
I + + +G G+ V + G+ VA+K+ + +
Sbjct: 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKR-----MLIDFCDIALM 57
Query: 167 EILILRRLD-HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLA------GLAASPTIKFTQA 219
EI +L D HPNV++ T+ LY+ + +L ++ +
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRF--LYIALELCNLNLQDLVESKNVSDENLKLQKEY 115
Query: 220 QVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILT-------------IADFGLA 266
+ Q+ SG+ H H+ ++HRD+K N+L+ T I+DFGL
Sbjct: 116 NPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 267 SFFDPNH---KQPMTSRVVTLWYRPPELLLGATD------YGVGVDLWSAGCILAELLAE 317
D + + + T +R PELL + + +D++S GC+ +L++
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 318 KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSS 377
P + + I + G S + K + D
Sbjct: 236 G-KHPFGDKYSRESNIIR--GIFSLDEMKCLHDRS-------------LIAEATD----- 274
Query: 378 LPLIETLLAIDPAERQTATAALRSEFFTTK----PYACDPSSLPKYPPTKEMDAKLRDEE 433
LI ++ DP +R TA LR F K + S + A L +
Sbjct: 275 --LISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLMKFD 332
Query: 434 ARRLRAAGKANAEAK 448
A + K
Sbjct: 333 AGSDFVIPSGDWTVK 347
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 6e-49
Identities = 79/336 (23%), Positives = 135/336 (40%), Gaps = 58/336 (17%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D ++ +++G+G +S V + TG A K + L + + RE I R+L HP
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQAQVKCYMHQLLS 230
N+V+L + YLVF + G +A +++A + Q+L
Sbjct: 89 NIVRLHDSIQEES--FHYLVFDLVT----GGELFEDIVARE---FYSEADASHCIQQILE 139
Query: 231 GLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
+ +CH+ ++HR++K NLL+ + +ADFGLA + + + T Y
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYL 197
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS--EEYW 345
PE+L Y VD+W+ G IL LL P + +I G+ W
Sbjct: 198 SPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEW 254
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
+ K LI+++L ++P +R TA AL+
Sbjct: 255 DT------------------VTPEAKS-------LIDSMLTVNPKKRITADQALKV---- 285
Query: 406 TKPYACDPSSLPKYPPTKEMDAKLRDEEARR-LRAA 440
P+ C+ + ++ L+ ARR L+ A
Sbjct: 286 --PWICNRERVASAIHRQDTVDCLKKFNARRKLKGA 319
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 9e-49
Identities = 54/295 (18%), Positives = 105/295 (35%), Gaps = 54/295 (18%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN 178
+ + K+G+G +S V G ALK++ + RE + R +HPN
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPN 87
Query: 179 VVKLEG--LVTSRMSCSLYLVFKYMEH-DLAGL---AASPTIKFTQAQVKCYMHQLLSGL 232
+++L L +L+ + + L T+ Q+ + + GL
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--------TL 284
E H + HRD+K +N+L+ +EG + D G + + + + + T+
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 285 WYRPPELLLGATDYGVG--VDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342
YR PEL + + D+WS GC+L ++ +
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG----------------------- 244
Query: 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLP-----LIETLLAIDPAER 392
P+ +F+ S + L+ +++ +DP +R
Sbjct: 245 --------PYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQR 291
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-48
Identities = 101/366 (27%), Positives = 155/366 (42%), Gaps = 84/366 (22%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAR----EILILR 172
A +E L IG+G++ V KA D Q VALK VR + + R EI IL
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-------NEKRFHRQAAEEIRILE 148
Query: 173 RL------DHPNVVKLEG---------LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFT 217
L + NV+ + + +S +LY + K ++ G F+
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIK--KNKFQG--------FS 198
Query: 218 QAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG--ILTIADFGLASFFDPNHKQ 275
V+ + H +L L+ H ++H D+K N+L+ +G + + DFG + + Q
Sbjct: 199 LPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH----Q 254
Query: 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
+ + + + +YR PE++LGA YG+ +D+WS GCILAELL P++PG E +QL + +
Sbjct: 255 RVYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE 313
Query: 336 LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKD----------------FPPSSLP 379
L G PS++ SK + + C T D PP S
Sbjct: 314 LLGMPSQKLLDASKRAK-NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESRE 372
Query: 380 ---------------LIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYPPTKE 424
++ L DPA R T ALR + + LPK PPT E
Sbjct: 373 WGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR--------LPK-PPTGE 423
Query: 425 MDAKLR 430
+ R
Sbjct: 424 KTSVKR 429
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-48
Identities = 87/343 (25%), Positives = 137/343 (39%), Gaps = 61/343 (17%)
Query: 113 TPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILR 172
R + ++ +++G+G +S V + L GQ A + L + + RE I R
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQAQVKCYM 225
L HPN+V+L ++ YL+F + G +A +++A +
Sbjct: 66 LLKHPNIVRLHDSISEEG--HHYLIFDLVT----GGELFEDIVARE---YYSEADASHCI 116
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNHKQPMTSRVV 282
Q+L + HCH V+HR++K NLL+ + +ADFGLA + +Q
Sbjct: 117 QQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAG 175
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP--GRTEVEQLHKIFKLCGSP 340
T Y PE+L YG VDLW+ G IL LL P P + +I G+
Sbjct: 176 TPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYP--PFWDEDQHRLYQQI--KAGAY 230
Query: 341 S--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAA 398
W + KD LI +L I+P++R TA A
Sbjct: 231 DFPSPEWDT------------------VTPEAKD-------LINKMLTINPSKRITAAEA 265
Query: 399 LRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEEARR-LRAA 440
L+ P+ S++ +E L+ ARR L+ A
Sbjct: 266 LKH------PWISHRSTVASCMHRQETVDCLKKFNARRKLKGA 302
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 6e-48
Identities = 76/325 (23%), Positives = 126/325 (38%), Gaps = 66/325 (20%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV------RFDNLEPESVRFMAREILIL 171
D + +G G V A + T + VA+K + E + + EI IL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL------AGLAASPTIKFTQAQVKCY 224
++L+HP ++K++ + Y+V + ME +L + +A K Y
Sbjct: 70 KKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGNK-------RLKEATCKLY 119
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNHKQPMTSRV 281
+Q+L +++ H ++HRD+K N+L+ ++ ++ I DFG + M +
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--MRTLC 177
Query: 282 VTLWYRPPELLLGATD--YGVGVDLWSAGCILAELLAEKPIMP---GRTEVEQLHKIFKL 336
T Y PE+L+ Y VD WS G IL L+ P P RT+V +I
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI--T 233
Query: 337 CGS---PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ 393
G E W + ++E D L++ LL +DP R
Sbjct: 234 SGKYNFIP-EVWAE------------------VSEKALD-------LVKKLLVVDPKARF 267
Query: 394 TATAALRSEFFTTKPYACDPSSLPK 418
T ALR + + L
Sbjct: 268 TTEEALRHPWLQDEDMKRKFQDLLS 292
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 7e-48
Identities = 79/308 (25%), Positives = 128/308 (41%), Gaps = 56/308 (18%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDH 176
+ + IG+G++ V A T A KK+ +E + + +EI I++ LDH
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDH 65
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQAQVKCYMHQLL 229
PN+++L +YLV + G + F ++ M +L
Sbjct: 66 PNIIRLYETFEDNTD--IYLVMELCT----GGELFERVVHKR---VFRESDAARIMKDVL 116
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNHKQPMTSRVVTLWY 286
S + +CH +V HRD+K N L + L + DFGLA+ F P + M ++V T +Y
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYY 174
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS--EEY 344
P++L G YG D WSAG ++ LL P T+ E + KI G+ + E+
Sbjct: 175 VSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPEKD 230
Query: 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
W ++ + LI LL P +R T+ AL E+F
Sbjct: 231 WLN------------------VSPQAES-------LIRRLLTKSPKQRITSLQALEHEWF 265
Query: 405 TTKPYACD 412
+ +
Sbjct: 266 EKQLSSSP 273
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 9e-48
Identities = 73/317 (23%), Positives = 128/317 (40%), Gaps = 58/317 (18%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVR----FMAREILI 170
+ +E + +G+G S V + T + A+K + E V+ +E+ I
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 171 LRRLD-HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG------LAASPTIKFTQAQVKC 223
LR++ HPN+++L+ + +LVF M+ L + ++ + +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNT--FFFLVFDLMK----KGELFDYLTEK--VTLSEKETRK 128
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVT 283
M LL + H +++HRD+K N+L+D++ + + DFG + DP + + T
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGT 186
Query: 284 LWYRPPELLLGATD-----YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCG 338
Y PE++ + + YG VD+WS G I+ LLA P R ++ L I + G
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MSG 244
Query: 339 SPS--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT 396
+ W ++T KD L+ L + P +R TA
Sbjct: 245 NYQFGSPEWDD------------------YSDTVKD-------LVSRFLVVQPQKRYTAE 279
Query: 397 AALRSEFFTTKPYACDP 413
AL FF
Sbjct: 280 EALAHPFFQQYVVEEVR 296
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-47
Identities = 74/314 (23%), Positives = 126/314 (40%), Gaps = 64/314 (20%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV------RFDNLEPESVRFMAREILIL 171
D + +G G V A + T + VA++ + E + + EI IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL------AGLAASPTIKFTQAQVKCY 224
++L+HP ++K++ + Y+V + ME +L + +A K Y
Sbjct: 195 KKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGNK-------RLKEATCKLY 244
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNHKQPMTSRV 281
+Q+L +++ H ++HRD+K N+L+ + + ++ I DFG + M +
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLC 302
Query: 282 VTLWYRPPELLLGATD--YGVGVDLWSAGCILAELLAEKPIMP---GRTEVEQLHKIFKL 336
T Y PE+L+ Y VD WS G IL L+ P P RT+V +I
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI--T 358
Query: 337 CGSPS--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT 394
G + E W + ++E D L++ LL +DP R T
Sbjct: 359 SGKYNFIPEVWAE------------------VSEKALD-------LVKKLLVVDPKARFT 393
Query: 395 ATAALRSEFFTTKP 408
ALR + +
Sbjct: 394 TEEALRHPWLQDED 407
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-47
Identities = 60/312 (19%), Positives = 117/312 (37%), Gaps = 43/312 (13%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMA----------- 165
+ + + QG ++ + + ALK K + +
Sbjct: 33 YRIIRTLNQGKFNKIILCEKD--NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 166 -REILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME--------HDLAGLAASPTIKF 216
E+ I+ + + + EG++T+ +Y++++YME L + T
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 217 TQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275
+KC + +L+ + HN+ ++ HRD+K SN+L+D G + ++DFG + +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-- 206
Query: 276 PMTSRVVTLWYRPPELLLGATDY-GVGVDLWSAGCILAELLAEK-PIMPGRTEVEQLHKI 333
+ T + PPE + Y G VD+WS G L + P + VE + I
Sbjct: 207 -IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265
Query: 334 FKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ 393
+ + P + + + ++ L +PAER
Sbjct: 266 RT------KNI----EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315
Query: 394 TATAALRSEFFT 405
T+ AL+ E+
Sbjct: 316 TSEDALKHEWLA 327
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-47
Identities = 92/398 (23%), Positives = 141/398 (35%), Gaps = 73/398 (18%)
Query: 41 RNGNGGPNHRKESSNSNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAG---- 96
+ KE + E R ++R + + ++ E
Sbjct: 7 HSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQP 66
Query: 97 --WPSWLSAVAGEAISGWTPRRADTFEKL----DKIGQGTYSNVYKARDTLTGQIVALK- 149
+ G A F + D IG+G S V + TG A+K
Sbjct: 67 KGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126
Query: 150 ----KVRFDNLEPESVRFM-AREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH 203
R + E VR RE ILR++ HP+++ L S ++LVF M
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS--FMFLVFDLMR- 183
Query: 204 DLAG-------LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG 256
++ + + M LL + H +++HRD+K N+L+D+
Sbjct: 184 ---KGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM 237
Query: 257 ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD-----YGVGVDLWSAGCIL 311
+ ++DFG + +P + + T Y PE+L + D YG VDLW+ G IL
Sbjct: 238 QIRLSDFGFSCHLEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
Query: 312 AELLAEKPIMP--GRTEVEQLHKIFKLCGSPS--EEYWKKSKLPHATIFKPQQSYKRCIA 367
LLA P P R ++ L I + G W +
Sbjct: 296 FTLLAGSP--PFWHRRQILMLRMI--MEGQYQFSSPEWDD------------------RS 333
Query: 368 ETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
T KD LI LL +DP R TA AL+ FF
Sbjct: 334 STVKD-------LISRLLQVDPEARLTAEQALQHPFFE 364
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-47
Identities = 70/339 (20%), Positives = 120/339 (35%), Gaps = 80/339 (23%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILRRL 174
+ IGQG+Y V A + T I A+K K + + P+ V + E+ ++++L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYME-------------------------------- 202
HPN+ +L + + LV +
Sbjct: 86 HHPNIARLYEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 203 --------HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI-- 252
+ G S + + M Q+ S L + HNQ + HRDIK N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 253 DNEGILTIADFGLASFFDPNHK---QPMTSRVVTLWYRPPELLLGATD-YGVGVDLWSAG 308
+ + + DFGL+ F + MT++ T ++ PE+L + YG D WSAG
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 309 CILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS--EEYWKKSKLPHATIFKPQQSYKRCI 366
+L LL PG + + + ++ + +
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLN--KKLCFENPNYNV------------------L 303
Query: 367 AETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
+ +D L+ LL + ER A AL+ + +
Sbjct: 304 SPLARD-------LLSNLLNRNVDERFDAMRALQHPWIS 335
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-47
Identities = 63/352 (17%), Positives = 131/352 (37%), Gaps = 42/352 (11%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ + + +G+G + V++ +T + + K V+ + V+ +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N++ L S L ++F+++ D+ + + + ++ Y+HQ+ L+ H
Sbjct: 62 NILHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 237 NQHVLHRDIKGSNLLIDNE--GILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
+ ++ H DI+ N++ + I +FG A P Y PE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQH 177
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMP--GRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352
D+WS G ++ LL+ P T + + I + EE +K+
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGIN--PFLAETNQQIIENIMNAEYTFDEEAFKE----- 229
Query: 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACD 412
I+ DF ++ LL + R TA+ AL+ + K
Sbjct: 230 -------------ISIEAMDF-------VDRLLVKERKSRMTASEALQHPWLKQKIERVS 269
Query: 413 PSSLPKYPPTKEMDAKLRDEEARRLRAAGK-ANAEAKKARSRDRAARAMPAP 463
+ + L ++ + +A + + A +++ A+ A
Sbjct: 270 TKVIRTLKHRRYYH-TLIKKDLNMVVSAARISCGGAIRSQKGVSVAKVKVAS 320
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-47
Identities = 89/340 (26%), Positives = 142/340 (41%), Gaps = 59/340 (17%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILRRL 174
D +E + IG+G +S V + + TGQ A+K +F + S + RE I L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEH----DLAGLAASPTIKFTQAQVKCYMHQLLS 230
HP++V+L +S LY+VF++M+ A +++A YM Q+L
Sbjct: 84 KHPHIVELLETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 231 GLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
L +CH+ +++HRD+K +L+ +N + + FG+A + RV T +
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRVGTPHFM 200
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP--GRTEVEQLHKIFK--LCGSPS-- 341
PE++ YG VD+W G IL LL+ P G E ++F+ + G
Sbjct: 201 APEVVKR-EPYGKPVDVWGCGVILFILLSGCL--PFYGTKE-----RLFEGIIKGKYKMN 252
Query: 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401
W I+E+ KD L+ +L +DPAER T AL
Sbjct: 253 PRQWSH------------------ISESAKD-------LVRRMLMLDPAERITVYEALNH 287
Query: 402 EFFTTKPYACDPSSLPKYPPTKEMDAKLRDEEARR-LRAA 440
+ + E +LR ARR L+ A
Sbjct: 288 PWL------KERDRYAYKIHLPETVEQLRKFNARRKLKGA 321
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-47
Identities = 66/291 (22%), Positives = 117/291 (40%), Gaps = 42/291 (14%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D F K+G G + +V+ + +G +K + D + + + EI +L+ LDHP
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHP 80
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYME----HDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
N++K+ + + +Y+V + E + A + ++ V M Q+++ L
Sbjct: 81 NIIKIFEVFEDYHN--MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 234 HCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPE 290
+ H+QHV+H+D+K N+L + + I DFGLA F + + T+ T Y PE
Sbjct: 139 YFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAPE 196
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS-EEYWKKSK 349
+ D D+WSAG ++ LL G + E K P+ +
Sbjct: 197 VFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPNYAVECRP-- 250
Query: 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ D ++ +L DP R +A L
Sbjct: 251 ----------------LTPQAVDL-------LKQMLTKDPERRPSAAQVLH 278
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-47
Identities = 57/313 (18%), Positives = 108/313 (34%), Gaps = 62/313 (19%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL 174
R F +L+KIG G + +V+K L G I A+K+ + + RE+ L
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 175 -DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGL---AASPTIKFTQAQVKCYMHQLL 229
H +VV+ + + +Y LA F +A++K + Q+
Sbjct: 68 GQHSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILT-------------------IADFGLASFFD 270
GL + H+ ++H DIK SN+ I I I D G +
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT--- 182
Query: 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQL 330
+ E+L + D+++ + +P +P +Q
Sbjct: 183 --RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP-LP--RNGDQW 237
Query: 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPA 390
H+I + G +P + +++ F + ++ ++ DP
Sbjct: 238 HEIRQ--GRLPR-------IP------------QVLSQEFTEL-------LKVMIHPDPE 269
Query: 391 ERQTATAALRSEF 403
R +A A ++
Sbjct: 270 RRPSAMALVKHSV 282
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-47
Identities = 73/397 (18%), Positives = 150/397 (37%), Gaps = 56/397 (14%)
Query: 68 RGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIG 127
G K R P++++ K + + D ++ L+++G
Sbjct: 10 HGSKVRGKYDGPKINDYDKFYEDIW---------KKYVPQPVEVKQGSVYDYYDILEELG 60
Query: 128 QGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLV 186
G + V++ + TG++ K + +V+ EI I+ +L HP ++ L
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKLINLHDAF 117
Query: 187 TSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDI 245
+ + L+ +++ +L A+ K ++A+V YM Q GL+H H ++H DI
Sbjct: 118 EDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 175
Query: 246 KGSNLLIDN--EGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVD 303
K N++ + + I DFGLA+ +P+ + + T + PE++ G D
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDR-EPVGFYTD 232
Query: 304 LWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYK 363
+W+ G + LL+ G ++E L + + E+ +
Sbjct: 233 MWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS---------------- 276
Query: 364 RCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYPPTK 423
++ KDF I+ LL +P +R T AL + T
Sbjct: 277 --VSPEAKDF-------IKNLLQKEPRKRLTVHDALEHPWLKGDHSN----------LTS 317
Query: 424 EMDAKLRDEEARRLRAAGKANAEAKKARSRDRAARAM 460
+ + ++ ++++ + A R ++
Sbjct: 318 RIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSL 354
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 3e-47
Identities = 79/421 (18%), Positives = 145/421 (34%), Gaps = 44/421 (10%)
Query: 55 NSNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTP 114
S + T V G++R+ + V++ + +++ + +
Sbjct: 90 QSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 115 RRADTFEKL----DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILI 170
+ D +++G G + V++ + TG A K V + + +EI
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQT 207
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVKCYMHQLL 229
+ L HP +V L + +++++M +L A K ++ + YM Q+
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 265
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDN--EGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
GL H H + +H D+K N++ L + DFGL + DP Q + T +
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFA 323
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
PE+ G G D+WS G + LL+ G + E L + + + +
Sbjct: 324 APEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 382
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407
I+E KDF I LL DP R T AL + T
Sbjct: 383 ------------------ISEDGKDF-------IRKLLLADPNTRMTIHQALEHPWLTP- 416
Query: 408 PYACDPSSLPKYPPTKEMDAKLRDEEARRLRAAGKANAEAKKARSRDRAARAMPAPEANA 467
+ K+RD + A + + + + P +
Sbjct: 417 ----GNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIR 472
Query: 468 E 468
+
Sbjct: 473 D 473
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 8e-47
Identities = 76/357 (21%), Positives = 133/357 (37%), Gaps = 69/357 (19%)
Query: 111 GWTPRRADTFEKL----DKIGQGTYSNVYKARDTLTGQIVALK-------KVRFDNLEPE 159
G P + E +++G G ++ V K R+ TG A K + + E
Sbjct: 1 GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 160 SVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG------LAASPT 213
+ RE+ ILR++ H NV+ L + +R + L+ + + +G LA
Sbjct: 61 EIE---REVSILRQVLHHNVITLHDVYENRTD--VVLILELV----SGGELFDFLAQKE- 110
Query: 214 IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASFF 269
++ + ++ Q+L G+ + H + + H D+K N+++ + + DFGLA
Sbjct: 111 -SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP--GRTEV 327
+ + T + PE++ G+ D+WS G I LL+ P G T+
Sbjct: 170 EDG--VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQ 224
Query: 328 EQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAI 387
E L I + EE++ +E KDF I LL
Sbjct: 225 ETLANITSVSYDFDEEFFSH------------------TSELAKDF-------IRKLLVK 259
Query: 388 DPAERQTATAALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEEARR-LRAAGKA 443
+ +R T ALR + T D + R + RR + +
Sbjct: 260 ETRKRLTIQEALRHPWITPV----DNQQAMVRRESVVNLENFRKQYVRRRWKLSFSI 312
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 9e-47
Identities = 61/298 (20%), Positives = 109/298 (36%), Gaps = 49/298 (16%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
++G+G++ V++ +D TG A+KKVR + E E++ L P +
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRI 112
Query: 180 VKLEGLVTSRMSCSLYLVFKYME----HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
V L G R + + + +E L + + Y+ Q L GLE+
Sbjct: 113 VPLYG--AVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYL 166
Query: 236 HNQHVLHRDIKGSNLLIDNEGILT-IADFGLASFFDPNHKQPMTSRVVTL----WYRPPE 290
H + +LH D+K N+L+ ++G + DFG A P+ + + PE
Sbjct: 167 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
+++G VD+WS+ C++ +L P T+ + K+ P
Sbjct: 227 VVMG-KPCDAKVDIWSSCCMMLHMLNGCH--P-WTQYFRGPLCLKIASEP---------- 272
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408
P + A I+ L +P R +A R +
Sbjct: 273 ------PPIREIPPSCAPLTAQA-------IQEGLRKEPVHRASAMELRRKVGKALQE 317
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-46
Identities = 80/288 (27%), Positives = 125/288 (43%), Gaps = 38/288 (13%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES-VRFMAREILILRRLDHPN 178
FE +G+G + NVY AR+ + I+ALK + LE + RE+ I L HPN
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
+++L G +YL+ +Y + + KF + + Y+ +L + L +CH+
Sbjct: 71 ILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS 127
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
+ V+HRDIK NLL+ + G L IADFG + + + + TL Y PPE++ G
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG---TLDYLPPEMIEG-RM 183
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357
+ VDLWS G + E L KP T E +I ++ E+ P
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------EF----TFP------ 227
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
+ LI LL +P++R L + T
Sbjct: 228 -------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-46
Identities = 79/365 (21%), Positives = 135/365 (36%), Gaps = 70/365 (19%)
Query: 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-------- 174
+ K+G G +S V+ A+D + VA+K VR D + E+ EI +L+R+
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKE 80
Query: 175 ---DHPNVVKLEG-------------LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQ 218
+++KL +V + +L + K EH
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH----------RGIPL 130
Query: 219 AQVKCYMHQLLSGLEHCH-NQHVLHRDIKGSNLLIDNE------GILTIADFGLASFFDP 271
VK QLL GL++ H ++H DIK N+L++ + IAD G A ++D
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190
Query: 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT------ 325
++ T+ + T YR PE+LLGA +G G D+WS C++ EL+ +
Sbjct: 191 HY----TNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLP------ 379
+ + + +I +L G + K T F + + F
Sbjct: 246 DDDHIAQIIELLGELPSYLLRNGKYTR-TFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 304
Query: 380 --------LIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRD 431
+ +L +DP +R A + + + + D
Sbjct: 305 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364
Query: 432 EEARR 436
EE R
Sbjct: 365 EEVRD 369
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-46
Identities = 82/301 (27%), Positives = 122/301 (40%), Gaps = 56/301 (18%)
Query: 113 TPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILIL 171
T TF ++ +G G +S V+ + LTG++ ALK ++ S+ EI +L
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVL 60
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQAQVKCY 224
+++ H N+V LE + S YLV + + G L +T+
Sbjct: 61 KKIKHENIVTLEDIYESTT--HYYLVMQLVS----GGELFDRILERG---VYTEKDASLV 111
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNHKQPMTSRV 281
+ Q+LS +++ H ++HRD+K NLL + + I DFGL+ M++
Sbjct: 112 IQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMSTAC 168
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS 341
T Y PE+L Y VD WS G I LL P TE + KI + G
Sbjct: 169 GTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE--GYYE 225
Query: 342 --EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
+W I+E+ KDF I LL DP ER T AL
Sbjct: 226 FESPFWDD------------------ISESAKDF-------ICHLLEKDPNERYTCEKAL 260
Query: 400 R 400
Sbjct: 261 S 261
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-46
Identities = 62/290 (21%), Positives = 110/290 (37%), Gaps = 38/290 (13%)
Query: 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLE 183
+IG+G++ VYK DT T VA +++ L + E +L+ L HPN+V+
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 184 G--LVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE--HCHNQ 238
T + + LV + M L ++ + Q+L GL+ H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 239 HVLHRDIKGSNLLID-NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
++HRD+K N+ I G + I D GLA+ + + T + PE +
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPE--MYEEK 205
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357
Y VD+++ G + E+ + P +E + +I++ S
Sbjct: 206 YDESVDVYAFGMCMLEMATSEY--PY-SECQNAAQIYRRVTSG----------------V 246
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407
S+ + K+ IE + + ER + L FF +
Sbjct: 247 KPASFDKVAIPEVKEI-------IEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-46
Identities = 49/347 (14%), Positives = 98/347 (28%), Gaps = 81/347 (23%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREILILRR 173
R T + +GQ +A D TG+ + F P +++ M E+L LR
Sbjct: 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129
Query: 174 L-------------------------DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGL 208
L ++++ S + ++ M+ +L
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189
Query: 209 ------AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIAD 262
+S Q++ L H+ ++H ++ ++++D G + +
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
Query: 263 FGLASFFDPNHKQPMTSRVVTLWYRPPELL----------LGATDYGVGVDLWSAGCILA 312
F V+ + PPEL T D W+ G ++
Sbjct: 250 FEHLVRDG-----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 313 ELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKD 372
+ + + IF+ C K+
Sbjct: 305 WIWCADLPITKDAALGGSEWIFRSC---------------------------------KN 331
Query: 373 FPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKY 419
P L+E L +R A+ + + ++LP Y
Sbjct: 332 IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR-TELSAALPLY 377
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-45
Identities = 81/383 (21%), Positives = 149/383 (38%), Gaps = 50/383 (13%)
Query: 35 AEAVEIRNGNGGPNHRKESSNSNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVA 94
+ V++ N K S + ++ + ++ P S + + A
Sbjct: 9 SSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPA 68
Query: 95 AGWPSWLSAVAGEAISGWTPRRAD-----TFEKLDKIGQGTYSNVYKARDTLTGQIVALK 149
P V T ++ T K + +G G + V+K +T TG +A K
Sbjct: 69 PPAPFDHRIV--------TAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAK 120
Query: 150 KVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME-HDLAG 207
++ ++ E V+ EI ++ +LDH N+++L S+ + LV +Y++ +L
Sbjct: 121 IIKTRGMKDKEEVK---NEISVMNQLDHANLIQLYDAFESKND--IVLVMEYVDGGELFD 175
Query: 208 LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN--EGILTIADFGL 265
+ T+ +M Q+ G+ H H ++LH D+K N+L N + I DFGL
Sbjct: 176 RIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGL 235
Query: 266 ASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT 325
A + P + + T + PE++ D+WS G I LL+ G
Sbjct: 236 ARRYKPR--EKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292
Query: 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLL 385
+ E L+ I +E ++ I+E K+F I LL
Sbjct: 293 DAETLNNILACRWDLEDEEFQD------------------ISEEAKEF-------ISKLL 327
Query: 386 AIDPAERQTATAALRSEFFTTKP 408
+ + R +A+ AL+ + +
Sbjct: 328 IKEKSWRISASEALKHPWLSDHK 350
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-45
Identities = 73/367 (19%), Positives = 127/367 (34%), Gaps = 52/367 (14%)
Query: 107 EAISGWTPRRADTFEKLDKIGQG--TYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFM 164
+ +S + P +E L IG+G V AR TG+ V ++++ + E V F+
Sbjct: 15 QGMSSFLPE-GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFL 73
Query: 165 AREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME----HDLAGLAASPTIKFTQAQ 220
E+ + + +HPN+V + L++V +M DL + +
Sbjct: 74 QGELHVSKLFNHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDL--ICTHFMDGMNELA 129
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG-LASFFDPNHKQ---- 275
+ + +L L++ H+ +HR +K S++LI +G + ++ S +Q
Sbjct: 130 IAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189
Query: 276 -PMTSRVVTLWYRPPELLL-GATDYGVGVDLWSAGCILAEL---------------LAEK 318
V L + PE+L Y D++S G EL L EK
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249
Query: 319 PIMP---------GRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAET 369
E + + S + S + P Y R +
Sbjct: 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPH 309
Query: 370 FKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT-TKPYACD--PSSLPKYPPTKEMD 426
F F +E L +P R +A+ L FF K A + P L P +
Sbjct: 310 FHHF-------VEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 362
Query: 427 AKLRDEE 433
+
Sbjct: 363 GSQSQDH 369
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-45
Identities = 73/347 (21%), Positives = 126/347 (36%), Gaps = 80/347 (23%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAR----EILILR 172
D +E IG+G++ V KA D + + VA+K ++ + + E+ +L
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-------NKKAFLNQAQIEVRLLE 105
Query: 173 RL------DHPNVVKLEG---------LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFT 217
+ +V L+ LV +S +LY + + + G +
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLR--NTNFRG--------VS 155
Query: 218 QAQVKCYMHQLLSGLEHCHNQ--HVLHRDIKGSNLLIDNEG--ILTIADFGLASFFDPNH 273
+ + Q+ + L ++H D+K N+L+ N + I DFG +
Sbjct: 156 LNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--- 212
Query: 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
Q + + + +YR PE+LLG Y + +D+WS GCIL E+ +P+ G EV+Q++KI
Sbjct: 213 -QRIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270
Query: 334 FKLCGSPSEEYWKKSKLPH--------------------ATIFKPQQSYKRCIAETFKDF 373
++ G P ++ P I
Sbjct: 271 VEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGG 330
Query: 374 PPSSLP---------------LIETLLAIDPAERQTATAALRSEFFT 405
P LI +L DP R AL+ FF
Sbjct: 331 PGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-45
Identities = 75/360 (20%), Positives = 141/360 (39%), Gaps = 68/360 (18%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILILRR 173
D ++ +++G G ++ V K R+ TG A K ++ S + RE+ IL+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYM----------EHDLAGLAASPTIKFTQAQVKC 223
+ HPNV+ L + ++ + L+ + + E + T+ +
Sbjct: 71 IQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKE----------SLTEEEATE 118
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE----GILTIADFGLASFFDPNHKQPMTS 279
++ Q+L+G+ + H+ + H D+K N+++ + + I DFGLA D +
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKN 176
Query: 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP--GRTEVEQLHKIFKLC 337
T + PE++ G+ D+WS G I LL+ P G T+ E L + +
Sbjct: 177 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANVSAVN 233
Query: 338 GSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATA 397
+EY+ + KDF I LL DP +R T
Sbjct: 234 YEFEDEYFSN------------------TSALAKDF-------IRRLLVKDPKKRMTIQD 268
Query: 398 ALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEEARRL--RAAGKANAEAKKARSRDR 455
+L+ + K +L + M+ K + AR+ +G + +A+ +
Sbjct: 269 SLQHPWIKPKD---TQQALSRKASAVNME-KFKKFAARKKSNNGSGGGLNDIFEAQKIEW 324
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 6e-45
Identities = 84/313 (26%), Positives = 127/313 (40%), Gaps = 54/313 (17%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESV-RFMAREILILRRLDHPN 178
F+ +G+G + NVY AR+ I+ALK + LE E V + REI I L HPN
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAG-----LAASPTIKFTQAQVKCYMHQLLSGLE 233
++++ R +YL+ +E G L +F + + +M +L L
Sbjct: 76 ILRMYNYFHDRKR--IYLM---LEFAPRGELYKELQKHG--RFDEQRSATFMEELADALH 128
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+CH + V+HRDIK NLL+ +G L IADFG S P+ ++ T TL Y PPE++
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGW-SVHAPSLRR-RTM-CGTLDYLPPEMIE 185
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
G + VDLW AG + E L P + E +I + + K P
Sbjct: 186 G-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------DL----KFP-- 232
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT--TKPYAC 411
S LI LL P +R + + ++
Sbjct: 233 -----------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRV-- 273
Query: 412 DPSSLPKYPPTKE 424
LP + +
Sbjct: 274 ----LPPVYQSTQ 282
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-45
Identities = 83/368 (22%), Positives = 136/368 (36%), Gaps = 78/368 (21%)
Query: 47 PNHRKESSNSNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAG 106
+H SS + E + S+ P P + G
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSN-------------- 47
Query: 107 EAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAR 166
+D FE ++G+G S VY+ + T + ALK ++ + + VR
Sbjct: 48 ------RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVR---T 97
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQA 219
EI +L RL HPN++KL+ + + + LV + + G + +++
Sbjct: 98 EIGVLLRLSHPNIIKLKEIFETPTE--ISLVLELVT----GGELFDRIVEKG---YYSER 148
Query: 220 QVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNHKQP 276
+ Q+L + + H ++HRD+K NLL + L IADFGL+ +
Sbjct: 149 DAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VL 206
Query: 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK- 335
M + T Y PE+L G YG VD+WS G I LL P E +F+
Sbjct: 207 MKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFE--PFYDERGD-QFMFRR 262
Query: 336 -LCGSPS--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
L +W + ++ KD + L+ +DP +R
Sbjct: 263 ILNCEYYFISPWWDE------------------VSLNAKDL-------VRKLIVLDPKKR 297
Query: 393 QTATAALR 400
T AL+
Sbjct: 298 LTTFQALQ 305
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-45
Identities = 69/301 (22%), Positives = 124/301 (41%), Gaps = 58/301 (19%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILILRR 173
D +E +++G G ++ V K R TG+ A K ++ L S + RE+ ILR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYME----HDLAGLAASPTI----KFTQAQVKCYM 225
+ HPN++ L + ++ + L+ + + D + T+ + ++
Sbjct: 65 IRHPNIITLHDIFENKTD--VVLILELVSGGELFDF--------LAEKESLTEDEATQFL 114
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI----LTIADFGLASFFDPNHKQPMTSRV 281
Q+L G+ + H++ + H D+K N+++ ++ + + + DFG+A + +
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIF 172
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP--GRTEVEQLHKIFKLCGS 339
T + PE++ G+ D+WS G I LL+ P G T+ E L I +
Sbjct: 173 GTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGETKQETLTNISAVNYD 229
Query: 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
EEY+ +E KDF I LL DP R T +L
Sbjct: 230 FDEEYFSN------------------TSELAKDF-------IRRLLVKDPKRRMTIAQSL 264
Query: 400 R 400
Sbjct: 265 E 265
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 8e-45
Identities = 71/357 (19%), Positives = 133/357 (37%), Gaps = 69/357 (19%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALK-------KVRFDNLEPESVRFMAREILI 170
D ++ +++G G ++ V K R+ TG A K + + E + RE+ I
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE---REVSI 68
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME----HDLAGLAASPTI----KFTQAQVK 222
LR++ HPN++ L + +R + L+ + + D + ++ +
Sbjct: 69 LRQVLHPNIITLHDVYENRTD--VVLILELVSGGELFD--------FLAQKESLSEEEAT 118
Query: 223 CYMHQLLSGLEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASFFDPNHKQPMT 278
++ Q+L G+ + H + + H D+K N+++ + + DFGLA +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFK 176
Query: 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP--GRTEVEQLHKIFKL 336
+ T + PE++ G+ D+WS G I LL+ P G T+ E L I +
Sbjct: 177 NIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANITAV 233
Query: 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT 396
EE++ + +E KDF I LL + +R T
Sbjct: 234 SYDFDEEFFSQ------------------TSELAKDF-------IRKLLVKETRKRLTIQ 268
Query: 397 AALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEEARR-LRAAGKANAEAKKARS 452
ALR + T D + + + RR + + +
Sbjct: 269 EALRHPWITPV----DTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLCNHLTR 321
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-44
Identities = 86/361 (23%), Positives = 136/361 (37%), Gaps = 80/361 (22%)
Query: 124 DKIGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILRRLD-HPNV 179
+G+G++S K + Q A+K K N + +EI L+ + HPN+
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--------KEITALKLCEGHPNI 68
Query: 180 VKLEGLVTSRMSCSLYLVFKYME------------HDLAGLAASPTIKFTQAQVKCYMHQ 227
VKL + ++ +LV + + H F++ + M +
Sbjct: 69 VKLHEVFHDQL--HTFLVMELLNGGELFERIKKKKH------------FSETEASYIMRK 114
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNHKQPMTSRVVTL 284
L+S + H H+ V+HRD+K NLL +E + I DFG A P+ QP+ + TL
Sbjct: 115 LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPCFTL 173
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELL-------AEKPIMPGRTEVEQLHKIFKLC 337
Y PE LL Y DLWS G IL +L + + + VE + KI
Sbjct: 174 HYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI--KK 230
Query: 338 GSPS--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA 395
G S E WK +++ KD LI+ LL +DP +R
Sbjct: 231 GDFSFEGEAWKN------------------VSQEAKD-------LIQGLLTVDPNKRLKM 265
Query: 396 TAALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEEARRLRAAGKANAEAKKARSRDR 455
+ +E+ + L A + A K E ++ D+
Sbjct: 266 SGLRYNEWLQDGSQLSS-NPLMTPDILGSSGAAVHTCVKATFHAFNKYKREGFCLQNVDK 324
Query: 456 A 456
A
Sbjct: 325 A 325
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-44
Identities = 71/348 (20%), Positives = 124/348 (35%), Gaps = 82/348 (23%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAR----EILILR 172
+ F + K+G GT+ V + + A+K VR +++ R E IL+
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKIEADILK 86
Query: 173 RL-----DHPNVVKLEG---------LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQ 218
++ ++ N+VK G L+ + SLY + ++ G F
Sbjct: 87 KIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIIT--RNNYNG--------FHI 136
Query: 219 AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSN-LLIDNEGILT------------------ 259
+K Y ++L L + + H D+K N LL D +
Sbjct: 137 EDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 260 ------IADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAE 313
+ DFG A+F H S + T YR PE++L + V D+WS GC+LAE
Sbjct: 197 KSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAE 251
Query: 314 LLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDF 373
L + +E L + + + ++ + + + + K E
Sbjct: 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSI 311
Query: 374 P-----PSSLP------------LIETLLAIDPAERQTATAALRSEFF 404
LP + ++L IDP R + L+ +F
Sbjct: 312 NSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-44
Identities = 60/286 (20%), Positives = 108/286 (37%), Gaps = 44/286 (15%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH-PNVVKLE 183
++G+G ++ V + TGQ A K ++ + + EI +L P V+ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 184 GLVTSRMSCSLYLVFKYME----HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
+ + + L+ +Y L ++ V + Q+L G+ + H +
Sbjct: 96 EVYENTS--EIILILEYAAGGEIFSL--CLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 240 VLHRDIKGSNLLIDNE---GILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
++H D+K N+L+ + G + I DFG++ + + T Y PE+L
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEYLAPEILNY-D 208
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMP--GRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
D+W+ G I LL P G E I ++ SEE +
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTS--PFVGEDNQETYLNISQVNVDYSEETFSS------- 259
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+++ DF I++LL +P +R TA L
Sbjct: 260 -----------VSQLATDF-------IQSLLVKNPEKRPTAEICLS 287
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 7e-44
Identities = 72/360 (20%), Positives = 123/360 (34%), Gaps = 80/360 (22%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ-IVALKKVRFDNLEPESVRFMAR----EILIL 171
+ +E + +G+GT+ V + D G+ VALK +R +V EI +L
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-------NVGKYREAARLEINVL 70
Query: 172 RRL------DHPNVVKLEG---------LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKF 216
+++ + V + + + + + K E++ +
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLK--ENNFQP--------Y 120
Query: 217 TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSN-LLIDNEGILT---------------- 259
V+ +QL L H + H D+K N L +++E
Sbjct: 121 PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 260 --IADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE 317
+ADFG A+F +H T+ V T YRPPE++L + D+WS GCIL E
Sbjct: 181 IRVADFGSATFDHEHH----TTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRG 235
Query: 318 KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSS 377
+ E L + K+ G +++ F + + +
Sbjct: 236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQK--YFYKGGLVWDENSSDGRYVKENC 293
Query: 378 LPL-----------------IETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYP 420
PL + +L DPA+R T AL FF + P
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNP 353
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 9e-44
Identities = 70/348 (20%), Positives = 124/348 (35%), Gaps = 80/348 (22%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTG-QIVALKKVRFDNLEPESVRFMAR----EILIL 171
+ +E +D +G+G + V + D G + VA+K V+ +V EI +L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVL 65
Query: 172 RRL------DHPNVVKLEG---------LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKF 216
L V++ +V + S Y K E+ F
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIK--ENGFLP--------F 115
Query: 217 TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSN-LLIDNEGILT---------------- 259
++ +Q+ + H+ + H D+K N L + ++
Sbjct: 116 RLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 260 --IADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE 317
+ DFG A++ D +H ++ V T YR PE++L + D+WS GCIL E
Sbjct: 176 IKVVDFGSATYDDEHH----STLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLG 230
Query: 318 KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSS 377
+ P E L + ++ G + +K++ F + + + +
Sbjct: 231 FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRK--YFHHDRLDWDEHSSAGRYVSRAC 288
Query: 378 LPL-----------------IETLLAIDPAERQTATAALRSEFFTTKP 408
PL I+ +L DPA+R T AL+ FF
Sbjct: 289 KPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 74/298 (24%), Positives = 121/298 (40%), Gaps = 58/298 (19%)
Query: 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVK 181
+G+GTY VY RD +A+K++ + + + EI + + L H N+V+
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 182 LEGLVTSRMSCSLYLVFKYMEHD-LAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQ 238
G + + + + + + L+ L S +K + + Y Q+L GL++ H+
Sbjct: 84 YLG--SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 239 HVLHRDIKGSNLLIDN-EGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLLGAT 296
++HRDIKG N+LI+ G+L I+DFG + + T TL Y PE++
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGP 199
Query: 297 D-YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355
YG D+WS GC + E+ KP P + + P A +
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKP--P----------------------FYELGEPQAAM 235
Query: 356 FK----------PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
FK P+ ++ K F I DP +R A L EF
Sbjct: 236 FKVGMFKVHPEIPES-----MSAEAKAF-------ILKCFEPDPDKRACANDLLVDEF 281
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-43
Identities = 71/319 (22%), Positives = 120/319 (37%), Gaps = 45/319 (14%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
D +E + IG G + V A + VA+K++ + + + + +EI + +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQ 69
Query: 174 LDHPNVVKLEG--LVTSRMSCSLYLVFKYME----HDL----AGLAASPTIKFTQAQVKC 223
HPN+V +V L+LV K + D+ + ++ +
Sbjct: 70 CHHPNIVSYYTSFVVKD----ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGL-ASFFDPNHKQPMTSR-- 280
+ ++L GLE+ H +HRD+K N+L+ +G + IADFG+ A R
Sbjct: 126 ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 281 -VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS 339
V T + PE++ Y D+WS G EL P HK
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--P-------YHKY-----P 231
Query: 340 PSEEYWKKSKLPHATIFKPQQSYKRCIA--ETFKDFPPSSLPLIETLLAIDPAERQTATA 397
P + + ++ Q + ++F+ I L DP +R TA
Sbjct: 232 PMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKM-------ISLCLQKDPEKRPTAAE 284
Query: 398 ALRSEFFTTKPYACDPSSL 416
LR +FF A + L
Sbjct: 285 LLRHKFFQK---AKNKEFL 300
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-43
Identities = 64/293 (21%), Positives = 105/293 (35%), Gaps = 56/293 (19%)
Query: 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKL 182
+G G V + TGQ ALK + + R +E+ + P++V +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLY----DSPKAR---QEVDHHWQASGGPHIVCI 87
Query: 183 EGLV--TSRMSCSLYLVFKYMEHDLAG------LAASPTIKFTQAQVKCYMHQLLSGLEH 234
+ L ++ + ME G + FT+ + M + + ++
Sbjct: 88 LDVYENMHHGKRCLLIIMECME----GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 235 CHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
H+ ++ HRD+K NLL ++ +L + DFG A N + + T +Y PE
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPCYTPYYVAPE- 199
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK--LCGSPS--EEYWKK 347
+LG Y D+WS G I+ LL P T + + G W +
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
++E K LI LL DP ER T T +
Sbjct: 260 ------------------VSEDAKQ-------LIRLLLKTDPTERLTITQFMN 287
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-42
Identities = 73/310 (23%), Positives = 118/310 (38%), Gaps = 59/310 (19%)
Query: 124 DKIGQGTYSNVYKARDTLTGQIVALK--------KVRFDNLEPESVRFMA---------- 165
D+IG+G+Y V A + A+K + P
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 166 ------REILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQ 218
+EI IL++LDHPNVVKL ++ LY+VF+ + + + ++
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSE 136
Query: 219 AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278
Q + Y L+ G+E+ H Q ++HRDIK SNLL+ +G + IADFG+++ F +
Sbjct: 137 DQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN 196
Query: 279 SRVVTLWYRPPELLLGAT-DY-GVGVDLWSAGCILAELLAEK-PIMPGRTEVEQLHKIFK 335
+ V T + PE L + G +D+W+ G L + + P M + KI
Sbjct: 197 T-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM-DERIMCLHSKIKS 254
Query: 336 LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA 395
+ + P KD LI +L +P R
Sbjct: 255 ------QAL----EFPDQPDIAED----------LKD-------LITRMLDKNPESRIVV 287
Query: 396 TAALRSEFFT 405
+ T
Sbjct: 288 PEIKLHPWVT 297
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-42
Identities = 76/331 (22%), Positives = 141/331 (42%), Gaps = 51/331 (15%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREILILRRLD 175
F L +IG G++ VY ARD ++VA+KK+ + + E + + +E+ L++L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 176 HPNVVKLEG--LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
HPN ++ G L +LV +Y + L + ++ H L GL
Sbjct: 113 HPNTIQYRGCYLREHT----AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR---VVTLWYRPPE 290
+ H+ +++HRD+K N+L+ G++ + DFG AS M V T ++ PE
Sbjct: 169 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS-------I-MAPANSFVGTPYWMAPE 220
Query: 291 LLLGATD--YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348
++L + Y VD+WS G I LAE P + + ++ + +
Sbjct: 221 VILAMDEGQYDGKVDVWSLG-ITCIELAE--RKPPLFNMNAMSALYHI-----------A 266
Query: 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408
+ + S E F++F +++ L P +R T+ L+ F
Sbjct: 267 QNESPALQSGHWS------EYFRNF-------VDSCLQKIPQDRPTSEVLLKHRFVLR-- 311
Query: 409 YACDPSSL-PKYPPTKEMDAKLRDEEARRLR 438
P+ + TK+ +L + + R+++
Sbjct: 312 -ERPPTVIMDLIQRTKDAVRELDNLQYRKMK 341
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-42
Identities = 75/311 (24%), Positives = 117/311 (37%), Gaps = 57/311 (18%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DH 176
D +E + IG G+YS + T A+K + +P EI IL R H
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT------EEIEILLRYGQH 75
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQAQVKCYMHQLL 229
PN++ L+ + +Y+V + M+ G L F++ + + +
Sbjct: 76 PNIITLKDVYDDGK--YVYVVTELMK----GGELLDKILRQK---FFSEREASAVLFTIT 126
Query: 230 SGLEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASFFDPNHKQPMTSRVVTLW 285
+E+ H Q V+HRD+K SN+L N + I DFG A + + T
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGLLMTPCYTAN 185
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKP---IMPGRTEVEQLHKIFKLCGSPSE 342
+ PE+L Y D+WS G +L +L P T E L +I S S
Sbjct: 186 FVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244
Query: 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
YW +++T KD L+ +L +DP +R TA LR
Sbjct: 245 GYWNS------------------VSDTAKD-------LVSKMLHVDPHQRLTAALVLRHP 279
Query: 403 FFTTKPYACDP 413
+
Sbjct: 280 WIVHWDQLPQY 290
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 70/362 (19%), Positives = 128/362 (35%), Gaps = 60/362 (16%)
Query: 56 SNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPR 115
SN++ ++ V P P L +PP + + +
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAII-- 60
Query: 116 RADTFEKLDK-IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL 174
D ++ + +G G V + + T + ALK ++ + R RE+ + R
Sbjct: 61 --DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR---REVELHWRA 111
Query: 175 -DHPNVVKLEGLV--TSRMSCSLYLVFKYMEHDLAG------LAASPTIKFTQAQVKCYM 225
P++V++ + L +V + ++ G + FT+ + M
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIM 167
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNHKQPMTSRVV 282
+ +++ H+ ++ HRD+K NLL ++ IL + DFG A + +T+
Sbjct: 168 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCY 225
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK--LCGSP 340
T +Y PE +LG Y D+WS G I+ LL P + + G
Sbjct: 226 TPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284
Query: 341 S--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAA 398
W + ++E K LI LL +P +R T T
Sbjct: 285 EFPNPEWSE------------------VSEEVKM-------LIRNLLKTEPTQRMTITEF 319
Query: 399 LR 400
+
Sbjct: 320 MN 321
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-41
Identities = 78/314 (24%), Positives = 132/314 (42%), Gaps = 44/314 (14%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
+G+G+Y V + D+ T A+K K + + + +EI +LRRL H NV++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN-VKKEIQLLRRLRHKNVIQL 71
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
++ + +Y+V +Y + + + P +F Q Y QL+ GLE+ H+Q ++
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM--TSRVVTLWYRPPELLLGATDY- 298
H+DIK NLL+ G L I+ G+A P TS+ + ++PPE+ G +
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-GSPAFQPPEIANGLDTFS 190
Query: 299 GVGVDLWSAGCILAELLAEKPIMP--GRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
G VD+WSAG L + P G + I K Y +P
Sbjct: 191 GFKVDIWSAGVTLYNITTGL--YPFEGDNIYKLFENIGK------GSY----AIP----- 233
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSL 416
D P L++ +L +PA+R + + +F K +
Sbjct: 234 --------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH--PPAEAP 277
Query: 417 PKYPPTKEMDAKLR 430
PP+ + + R
Sbjct: 278 VPIPPSPDTKDRWR 291
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-41
Identities = 76/295 (25%), Positives = 126/295 (42%), Gaps = 58/295 (19%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
+G+G Y V A + +T + VA+K R + PE+++ +EI I + L+H NVVK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKF 70
Query: 183 -EGLVTSRMSCSLYLV---------FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
+ YL F +E D I + + + HQL++G+
Sbjct: 71 YGHRREGNI---QYLFLEYCSGGELFDRIEPD---------IGMPEPDAQRFFHQLMAGV 118
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPEL 291
+ H + HRDIK NLL+D L I+DFGLA+ F N+++ + +++ TL Y PEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 292 LLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
L + VD+WS G +L +LA E P + +EY +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELP--------------WDQPSDSCQEYSDWKE- 223
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
+ +K + L L+ +L +P+ R T + ++
Sbjct: 224 --KKTYLNP----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-41
Identities = 66/318 (20%), Positives = 110/318 (34%), Gaps = 82/318 (25%)
Query: 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKL 182
D +G+G ++ V + +T Q A+K + S + RE+ +L + H NV++L
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--VFREVEMLYQCQGHRNVLEL 76
Query: 183 EGLVTSRMSCSLYLVFKYME------------HDLAGLAASPTIKFTQAQVKCYMHQLLS 230
YLVF+ M H F + + + + S
Sbjct: 77 IEFFEEED--RFYLVFEKMRGGSILSHIHKRRH------------FNELEASVVVQDVAS 122
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNH------KQPMTSRV 281
L+ HN+ + HRD+K N+L ++ + I DF L S N + +
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 282 VTLWYRPPELLLG----ATDYGVGVDLWSAGCIL-----------AELLAEKPIMPGRTE 326
+ Y PE++ A+ Y DLWS G IL ++ G
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 327 VEQLHKIFK--LCGSPS--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIE 382
+ +F+ G ++ W I+ KD LI
Sbjct: 243 PACQNMLFESIQEGKYEFPDKDWAH------------------ISCAAKD-------LIS 277
Query: 383 TLLAIDPAERQTATAALR 400
LL D +R +A L+
Sbjct: 278 KLLVRDAKQRLSAAQVLQ 295
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-41
Identities = 67/371 (18%), Positives = 129/371 (34%), Gaps = 61/371 (16%)
Query: 102 SAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALK-----KVRFDNL 156
AV E ++ + + + +G G + V+ A D + V +K KV D
Sbjct: 8 KAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW 67
Query: 157 -EPESVRFMAREILILRRLDHPNVVKL-EGLVTSRMSCSLYLVFKYMEHDLAG------L 208
E + + EI IL R++H N++K+ + LV ME +G +
Sbjct: 68 IEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF---FQLV---MEKHGSGLDLFAFI 121
Query: 209 AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268
P + + QL+S + + + ++HRDIK N++I + + + DFG A++
Sbjct: 122 DRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179
Query: 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE 328
+ + T+ Y PE+L+G G +++WS G L L
Sbjct: 180 LERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTL-------------- 223
Query: 329 QLHKIFKLCGS-PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAI 387
+ P E + + A I P + L+ LL
Sbjct: 224 -------VFEENPFCELEETVE---AAIHPP------------YLVSKELMSLVSGLLQP 261
Query: 388 DPAERQTATAALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEEARRLRAAGKANAEA 447
P R T + + T+P + + + ++ + + + ++
Sbjct: 262 VPERRTTLEKLVTDPWV-TQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQ 320
Query: 448 KKARSRDRAAR 458
+
Sbjct: 321 AQELCGGEGHH 331
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-41
Identities = 79/339 (23%), Positives = 134/339 (39%), Gaps = 59/339 (17%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
+G+G Y V A + +T + VA+K R + PE+++ +EI I + L+H NVVK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKF 70
Query: 183 -EGLVTSRMSCSLYLV---------FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
+ YL F +E D I + + + HQL++G+
Sbjct: 71 YGHRREGNI---QYLFLEYCSGGELFDRIEPD---------IGMPEPDAQRFFHQLMAGV 118
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPEL 291
+ H + HRDIK NLL+D L I+DFGLA+ F N+++ + +++ TL Y PEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 292 LLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
L + VD+WS G +L +LA E P + +EY +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELP--------------WDQPSDSCQEYSDWKE- 223
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410
+ +K + L L+ +L +P+ R T + ++ KP
Sbjct: 224 --KKTYLNP----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY-NKPLK 270
Query: 411 CDPSSLPKYPPTKEMDAKLRDEEARRLRAAGKANAEAKK 449
+ + N+ ++
Sbjct: 271 KGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRT 309
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 52/426 (12%), Positives = 107/426 (25%), Gaps = 76/426 (17%)
Query: 57 NNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRR 116
+ + + + + W + + R
Sbjct: 21 GTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGE----R 76
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES-VRFMAREILILRRL- 174
T + +GQ +A D TG+ + F P + ++ M E+L LR L
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 175 ------------------------DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAA 210
++++ S + ++ M+ +L
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
Query: 211 SPTIK------FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264
Q++ L H+ ++H ++ ++++D G + + F
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 265 LASFFDPNHKQPMTSRVVTLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAEKPI 320
+ P+ +L T D W+ G + +
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 321 MPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPL 380
+ IF+ C K+ P L
Sbjct: 317 NTDDAALGGSEWIFRSC---------------------------------KNIPQPVRAL 343
Query: 381 IETLLAIDPAERQTATAALRSEFFT---TKPYACDPSSLPKYPPTKEMDAKLRDEEARRL 437
+E L +R A+ + + T+ A P PT+E A
Sbjct: 344 LEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDE 403
Query: 438 RAAGKA 443
A +A
Sbjct: 404 AGAAEA 409
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-40
Identities = 78/324 (24%), Positives = 140/324 (43%), Gaps = 62/324 (19%)
Query: 122 KLDK-IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
+L K IG+G ++ V AR LTG+ VA+K + L P S++ + RE+ I++ L+HPN+V
Sbjct: 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 181 KL-EGLVTSRMSCSLYLVFKY----------MEHDLAGLAASPTIKFTQAQVKCYMHQLL 229
KL E + T + LYL+ +Y + H + + + + Q++
Sbjct: 78 KLFEVIETEKT---LYLIMEYASGGEVFDYLVAHG----------RMKEKEARSKFRQIV 124
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPP 289
S +++CH + ++HRD+K NLL+D + + IADFG ++ F K + + Y P
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFCGAPPYAAP 182
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349
EL G G VD+WS G IL L++ G+ E ++ + G ++
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRIPFY---- 236
Query: 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409
L++ L ++P +R T ++ +
Sbjct: 237 -----------------------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH- 272
Query: 410 ACDPSSLPKYPPTKEMDAKLRDEE 433
+ P E + + D++
Sbjct: 273 -----EEDELKPFVEPELDISDQK 291
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 9e-40
Identities = 74/323 (22%), Positives = 138/323 (42%), Gaps = 45/323 (13%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
+ +E + ++G G + VYKA++ TG + A K + + E + EI IL DH
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCDH 75
Query: 177 PNVVKLEG--LVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
P +VKL G + L+++ ++ + + T+ Q++ Q+L L
Sbjct: 76 PYIVKLLGAYYHDGK----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H++ ++HRD+K N+L+ EG + +ADFG+++ Q S + T ++ PE+++
Sbjct: 132 FLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL-KTLQKRDSFIGTPYWMAPEVVM 190
Query: 294 GAT----DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349
T Y D+WS G I +A+ I P E+ + + K+ S
Sbjct: 191 CETMKDTPYDYKADIWSLG-ITLIEMAQ--IEPPHHELNPMRVLLKIAKSDP------PT 241
Query: 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409
L + + + F+DF ++ L +P R +A L F ++
Sbjct: 242 LLTPSKWSVE----------FRDF-------LKIALDKNPETRPSAAQLLEHPFVSS--- 281
Query: 410 ACDPSSLPKYPPTKEMDAKLRDE 432
+L E A++ +E
Sbjct: 282 ITSNKAL--RELVAEAKAEVMEE 302
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-40
Identities = 56/250 (22%), Positives = 98/250 (39%), Gaps = 30/250 (12%)
Query: 98 PSWLSAVAGEAISGWTPRRAD----TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRF 153
P L +G S + + + + +G ++ VY+A+D +G+ ALK++
Sbjct: 4 PGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS 63
Query: 154 DNLEPESVRFMAREILILRRL-DHPNVVKLEG---LVTSRMSCSLYLVFKYMEHDLAGL- 208
+ E R + +E+ +++L HPN+V+ + E L
Sbjct: 64 NE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLV 121
Query: 209 ----AASPTIKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLIDNEGILTIAD 262
+ V +Q ++H H Q ++HRD+K NLL+ N+G + + D
Sbjct: 122 EFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD 181
Query: 263 FGLASFFDPNHKQPMTS-----------RVVTLWYRPPEL--LLGATDYGVGVDLWSAGC 309
FG A+ ++ R T YR PE+ L G D+W+ GC
Sbjct: 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGC 241
Query: 310 ILAELLAEKP 319
IL L +
Sbjct: 242 ILYLLCFRQH 251
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-39
Identities = 78/304 (25%), Positives = 130/304 (42%), Gaps = 46/304 (15%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ + +KIGQG VY A D TGQ VA++++ + + EIL++R +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNP 77
Query: 178 NVVKLEG--LVTSRMSCSLYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQLLSGL 232
N+V LV L++V +Y+ G + + + + Q+ + L L
Sbjct: 78 NIVNYLDSYLVGDE----LWVVMEYLA----GGSLTDVVTETCMDEGQIAAVCRECLQAL 129
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL 292
E H+ V+HRDIK N+L+ +G + + DFG + P + T V T ++ PE++
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVV 188
Query: 293 LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352
YG VD+WS G I+A + E P L ++ + + + E KL
Sbjct: 189 TR-KAYGPKVDIWSLG-IMAIEMIE--GEPPYLNENPLRALYLIATNGTPELQNPEKL-- 242
Query: 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACD 412
+ F+DF + L +D +R +A L+ +F A
Sbjct: 243 --------------SAIFRDF-------LNRCLEMDVEKRGSAKELLQHQFLKI---AKP 278
Query: 413 PSSL 416
SSL
Sbjct: 279 LSSL 282
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-39
Identities = 80/310 (25%), Positives = 140/310 (45%), Gaps = 56/310 (18%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
+ F KL+KIG+G++ V+K D T ++VA+K + + E E + + +EI +L + D
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDS 79
Query: 177 PNVVKLEG--LVTSRMSCSLYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQLLSG 231
P V K G L ++ L+++ +Y+ G +A ++ + Q+ + ++L G
Sbjct: 80 PYVTKYYGSYLKDTK----LWIIMEYL----GGGSALDLLEPGPLDETQIATILREILKG 131
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
L++ H++ +HRDIK +N+L+ G + +ADFG+A + T V T ++ PE+
Sbjct: 132 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEV 190
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKP----IMPGRTEVEQLHKIFKLCGSPS-EEYWK 346
+ + Y D+WS G EL +P + P + L I K P+ E +
Sbjct: 191 IKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKV----LFLIPK-NNPPTLEGNYS 244
Query: 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406
K K+F +E L +P+ R TA L+ +F
Sbjct: 245 KP---------------------LKEF-------VEACLNKEPSFRPTAKELLKHKFI-- 274
Query: 407 KPYACDPSSL 416
A S L
Sbjct: 275 LRNAKKTSYL 284
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-38
Identities = 85/325 (26%), Positives = 146/325 (44%), Gaps = 49/325 (15%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ F+ L+K+G+G+Y +VYKA TGQIVA+K+V ++ + + + +EI I+++ D P
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEII---KEISIMQQCDSP 84
Query: 178 NVVKLEG--LVTSRMSCSLYLVFKYME----HDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
+VVK G + L++V +Y D+ L T+ ++ + L G
Sbjct: 85 HVVKYYGSYFKNTD----LWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKG 137
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
LE+ H +HRDIK N+L++ EG +ADFG+A + + T ++ PE+
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-MAKRNTVIGTPFWMAPEV 196
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
+ Y D+WS G I A +AE P ++ + IF + +P + K
Sbjct: 197 IQEI-GYNCVADIWSLG-ITAIEMAE--GKPPYADIHPMRAIFMIPTNPPPTFRKPELW- 251
Query: 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYAC 411
++ F DF ++ L P +R TAT L+ F + A
Sbjct: 252 ---------------SDNFTDF-------VKQCLVKSPEQRATATQLLQHPFVRS---AK 286
Query: 412 DPSSL-PKYPPTKEMDAKLRDEEAR 435
S L ++ K ++ + R
Sbjct: 287 GVSILRDLINEAMDVKLKRQESQQR 311
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-38
Identities = 68/320 (21%), Positives = 116/320 (36%), Gaps = 65/320 (20%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALK-----KVRFDNLEPESVRFMAREILILRRL 174
+ +G+G + V+ VA+K +V + +SV E+ +L ++
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT-CPLEVALLWKV 91
Query: 175 D----HPNVVKL-EGLVTSRMSCSLYLVFKYMEHDLAG------LAASPTIKFTQAQVKC 223
HP V++L + T LV +E L + + + +C
Sbjct: 92 GAGGGHPGVIRLLDWFETQEG---FMLV---LERPLPAQDLFDYITEKGPLGEGPS--RC 143
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFGLASFFDPNHKQPMTSRVV 282
+ Q+++ ++HCH++ V+HRDIK N+LID G + DFG + H +P T
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFDG 200
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342
T Y PPE + + + +WS G +L ++ +CG
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDM---------------------VCGD--- 236
Query: 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
+P F+ Q P LI LA P+ R + L
Sbjct: 237 -------IP----FERDQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285
Query: 403 FFTTKPYACDPSSLPKYPPT 422
+ P P + K P
Sbjct: 286 WM-QTPAEDVPLNPSKGGPA 304
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-38
Identities = 71/304 (23%), Positives = 129/304 (42%), Gaps = 46/304 (15%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ KIG+G+ V AR+ +G+ VA+K + D + + + E++I+R H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHF 102
Query: 178 NVVKLEG--LVTSRMSCSLYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQLLSGL 232
NVV++ LV L+++ ++++ G A + + + Q+ +L L
Sbjct: 103 NVVEMYKSYLVGEE----LWVLMEFLQ----GGALTDIVSQVRLNEEQIATVCEAVLQAL 154
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL 292
+ H Q V+HRDIK ++L+ +G + ++DFG + + + S V T ++ PE++
Sbjct: 155 AYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVI 213
Query: 293 LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352
+ Y VD+WS G I+ + + P + + +L SP + K+
Sbjct: 214 SR-SLYATEVDIWSLG-IMVIEMVD--GEPPYFSDSPVQAMKRLRDSPPPKLKNSHKV-- 267
Query: 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACD 412
+ +DF +E +L DP ER TA L F
Sbjct: 268 --------------SPVLRDF-------LERMLVRDPQERATAQELLDHPFLLQ---TGL 303
Query: 413 PSSL 416
P L
Sbjct: 304 PECL 307
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 73/309 (23%), Positives = 128/309 (41%), Gaps = 54/309 (17%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-D 175
A FE ++ +G GTY VYK R TGQ+ A+K + ++ + + +EI +L++
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSH 79
Query: 176 HPNVVKLEG----LVTSRMSCSLYLVFKYME----HDLAGLAASPTIKFTQAQVKCYMHQ 227
H N+ G M L+LV ++ DL + + + + +
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICRE 137
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
+L GL H H V+HRDIKG N+L+ + + DFG+++ D + T + T ++
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWM 196
Query: 288 PPELLLGATD----YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSP--- 340
PE++ + Y DLWS G I A +AE P ++ + +F + +P
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLG-ITAIEMAE--GAPPLCDMHPMRALFLIPRNPAPR 253
Query: 341 -SEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
+ W K F+ F IE+ L + ++R +
Sbjct: 254 LKSKKWSKK---------------------FQSF-------IESCLVKNHSQRPATEQLM 285
Query: 400 RSEFFTTKP 408
+ F +P
Sbjct: 286 KHPFIRDQP 294
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 2e-37
Identities = 46/310 (14%), Positives = 93/310 (30%), Gaps = 64/310 (20%)
Query: 118 DTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREILILR 172
+G+G ++ VY+A D Q LK + N P + + L+
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLK 122
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH----DLAGLAASPTIK-FTQAQVKCYMHQ 227
+K + LV + + + L + K Q V + +
Sbjct: 123 PSMQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLI-----------DNEGILTIADFGLA---SFFDPNH 273
+L +E H+ ++H DIK N ++ D L + D G + F
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG- 239
Query: 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
T++ T ++ E+L + +D + + +L
Sbjct: 240 -TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCML------------------ 279
Query: 334 FKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ 393
G+ + + + KP+ ++R + +L I
Sbjct: 280 ---FGTYMKVKNEGGE------CKPEGLFRR-----LPHLDMWN-EFFHVMLNIPDCHHL 324
Query: 394 TATAALRSEF 403
+ LR +
Sbjct: 325 PSLDLLRQKL 334
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-37
Identities = 57/311 (18%), Positives = 102/311 (32%), Gaps = 80/311 (25%)
Query: 110 SGWTPRRADTFEKLD----KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA 165
SG ++ + +G G V + + T + ALK ++ + R
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR--- 58
Query: 166 REILILRRL-DHPNVVKLEGLV--TSRMSCSLYLVFKYMEHDLAG------LAASPTIKF 216
RE+ + R P++V++ + L +V + ++ G + F
Sbjct: 59 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAF 114
Query: 217 TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNH 273
T+ + M + +++ H+ ++ HRD+K NLL ++ IL + DFG A
Sbjct: 115 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------- 167
Query: 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
E Y D+WS G I+ LL P + +
Sbjct: 168 ---------------KETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 210
Query: 334 FK--LCGSPS--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDP 389
G W + ++E K LI LL +P
Sbjct: 211 KTRIRMGQYEFPNPEWSE------------------VSEEVKM-------LIRNLLKTEP 245
Query: 390 AERQTATAALR 400
+R T T +
Sbjct: 246 TQRMTITEFMN 256
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-37
Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL 174
+D ++ + IG G + RD LT ++VA+K + E+V+ REI+ R L
Sbjct: 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSL 73
Query: 175 DHPNVVKL-EGLVTSRMSCSLYLVFKYMEHDLAG-----LAASPTIKFTQAQVKCYMHQL 228
HPN+V+ E ++T L ++ ME+ G + + +F++ + + + QL
Sbjct: 74 RHPNIVRFKEVILTPTH---LAII---MEYASGGELYERICNAG--RFSEDEARFFFQQL 125
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGI--LTIADFGLASFFDPNHKQPMTSRVVTLWY 286
LSG+ +CH+ + HRD+K N L+D L I DFG + H QP ++ V T Y
Sbjct: 126 LSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKST-VGTPAY 183
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAELLA 316
PE+LL G D+WS G L +L
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLV 213
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-37
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 29/204 (14%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRF-MAREILILRRLDHPNVVKL-E 183
+G GT+ V LTG VA+K + + V + REI L+ HP+++KL +
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 184 GLVTSRMSCSLYLVFKYMEHDLAG-----LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
+ T ++V ME+ G + + + + + Q+LS +++CH
Sbjct: 79 VISTPTD---FFMV---MEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRH 130
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK------QPMTSRVVTLWYRPPELL 292
V+HRD+K N+L+D IADFGL++ P Y PE++
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN--------YAAPEVI 182
Query: 293 LGATDYGVGVDLWSAGCILAELLA 316
G G VD+WS G IL LL
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLC 206
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-37
Identities = 61/359 (16%), Positives = 109/359 (30%), Gaps = 99/359 (27%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVA----------------------LKKVR 152
R FE + +G+G + V++A++ + A L K+
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 153 FDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS------------------- 193
+ ++ + +K E S S
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 194 -------------LYLVFKYMEH-DLAGL--AASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
LY+ + +L Q+ +E H+
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLA-----------SFFDPNHKQPMTSRVVTLWY 286
+ ++HRD+K SN+ + ++ + DFGL T +V T Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346
PE + G +Y VD++S G IL ELL T++E++ I + +
Sbjct: 243 MSPEQIHG-NNYSHKVDIFSLGLILFELL-----YSFSTQMERVRIITDV---------R 287
Query: 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
K P F P +++ +L+ P ER AT + + F
Sbjct: 288 NLKFP----------------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-37
Identities = 74/326 (22%), Positives = 126/326 (38%), Gaps = 65/326 (19%)
Query: 122 KLDK-IGQGTYSNVYKARDTLTGQIVALK---KVRFDNLE-PESVRFMAREILILRRLDH 176
+ + +G+G++ V A T Q VALK + + V REI L+ L H
Sbjct: 12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---REISYLKLLRH 68
Query: 177 PNVVKL-EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
P+++KL + + T + +V +Y +L + T+ + + + Q++ +E+C
Sbjct: 69 PHIIKLYDVITTPTD---IVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYC 124
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK------QPMTSRVVTLWYRPP 289
H ++HRD+K NLL+D+ + IADFGL++ + P Y P
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN--------YAAP 176
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349
E++ G G VD+WS G +L +L + K+ Y
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS------CVY----V 226
Query: 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409
+P P + LI ++ DP +R T R +F
Sbjct: 227 MP-------------------DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV--- 264
Query: 410 ACDPSSLPKY-PPTKEMDAKLRDEEA 434
+LP Y P +E+ D
Sbjct: 265 -----NLPDYLRPMEEVQGSYADSRI 285
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 65/323 (20%), Positives = 106/323 (32%), Gaps = 70/323 (21%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA----REILILRRLD 175
++ +G G + +VY VA+K V D + E+++L+++
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 176 H--PNVVKL-EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTI----------KFTQAQVK 222
V++L + L+ +E P + +
Sbjct: 105 SGFSGVIRLLDWFERPDS---FVLI---LER------PEPVQDLFDFITERGALQEELAR 152
Query: 223 CYMHQLLSGLEHCHNQHVLHRDIKGSNLLID-NEGILTIADFGLASFFDPNHKQPMTSRV 281
+ Q+L + HCHN VLHRDIK N+LID N G L + DFG + T
Sbjct: 153 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD 209
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS 341
T Y PPE + +G +WS G +L ++ +CG
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM---------------------VCGD-- 246
Query: 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401
+P F+ + R + LI LA+ P++R T
Sbjct: 247 --------IP----FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294
Query: 402 EFFT--TKPYACDPSSLPKYPPT 422
+ P L P
Sbjct: 295 PWMQDVLLPQETAEIHLHSLSPG 317
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 53/226 (23%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILIL 171
R +D + +G+G + K TG+++ +K+ + E+ R +E+ ++
Sbjct: 5 RIFRPSD-LIHGEVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVM 61
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLS 230
R L+HPNV+K G++ L + +Y++ L G+ S ++ +Q + + S
Sbjct: 62 RCLEHPNVLKFIGVLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP-------------M 277
G+ + H+ +++HRD+ N L+ + +ADFGLA QP
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG 323
+ V ++ PE++ G Y VD++S G +L E++ P
Sbjct: 180 YTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-35
Identities = 82/333 (24%), Positives = 133/333 (39%), Gaps = 73/333 (21%)
Query: 122 KLDK-IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRF-MAREILILRRLDHPNV 179
L +G GT+ V + LTG VA+K + + V + REI L+ HP++
Sbjct: 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 180 VKL-EGLVTSRMSCSLYLVFKYMEHDLAG-----LAASPTIKFTQAQVKCYMHQLLSGLE 233
+KL + + T +++V ME+ G + + + + + + Q+LSG++
Sbjct: 79 IKLYQVISTPSD---IFMV---MEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVD 130
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK------QPMTSRVVTLWYR 287
+CH V+HRD+K N+L+D IADFGL++ P Y
Sbjct: 131 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN--------YA 182
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP--GRTEVEQLHKIFKLCGSPSEEYW 345
PE++ G G VD+WS+G IL LL +P KI +
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGT--LPFDDDHVPTLFKKICD------GIF- 233
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
P + PS + L++ +L +DP +R T E+F
Sbjct: 234 ---YTP-------------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271
Query: 406 TKPYACDPSSLPKY--PPTKEMDAKLRDEEARR 436
LPKY P + + D+EA +
Sbjct: 272 Q--------DLPKYLFPEDPSYSSTMIDDEALK 296
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 39/212 (18%), Positives = 76/212 (35%), Gaps = 22/212 (10%)
Query: 120 FEKLD---KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
F++L+ K+ + ++K G + +K ++ + R E LR H
Sbjct: 9 FKQLNFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYME----HDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
PNV+ + G S + L+ +M +++ L Q+Q + + G+
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNV--LHEGTNFVVDQSQAVKFALDMARGM 124
Query: 233 E--HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPE 290
H + + +++ID + I+ + F R+ + PE
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPE 178
Query: 291 LLLG--ATDYGVGVDLWSAGCILAELLA-EKP 319
L D+WS +L EL+ E P
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 64/305 (20%), Positives = 114/305 (37%), Gaps = 39/305 (12%)
Query: 109 ISGWT-PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMARE 167
I G + E L ++G GT V+K R TG ++A+K++R E + + +
Sbjct: 15 IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMD 73
Query: 168 ILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMH 226
+ ++ + D P +V+ G + + +++ + M L + +
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFIT--NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTV 131
Query: 227 QLLSGLEHCHNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW 285
++ L + +H V+HRD+K SN+L+D G + + DFG++ +
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGCAA 189
Query: 286 YRPPE----LLLGATDYGVGVDLWSAGCILAEL-LAEKPIMPGRTEVEQLHKIFKLCGSP 340
Y PE DY + D+WS G L EL + P +T+ E L K+ +
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ---EE 246
Query: 341 SEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
LP F F+ F ++ L D +R L
Sbjct: 247 PP------LLPGHMGFSGD----------FQSF-------VKDCLTKDHRKRPKYNKLLE 283
Query: 401 SEFFT 405
F
Sbjct: 284 HSFIK 288
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-34
Identities = 75/284 (26%), Positives = 121/284 (42%), Gaps = 44/284 (15%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRL 174
R + F+ +G+G++S V AR+ T + A+K + + ++ V ++ RE ++ RL
Sbjct: 28 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYME-----HDLAGLAASPTIKFTQAQVKCYMHQLL 229
DHP VKL T + LY Y + + F + + Y +++
Sbjct: 88 DHPFFVKLYF--TFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIV 140
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRP 288
S LE+ H + ++HRD+K N+L++ + + I DFG A P KQ + V T Y
Sbjct: 141 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348
PELL DLW+ GCI+ +L+A P E KI K +
Sbjct: 201 PELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK----------LEY 249
Query: 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
P + F P + L+E LL +D +R
Sbjct: 250 DFP-------------------EKFFPKARDLVEKLLVLDATKR 274
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-34
Identities = 48/213 (22%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES-----VRFMAREILILRRL 174
E +IG+G + V+K R +VA+K + + E E+ + RE+ I+ L
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
+HPN+VKL GL+ + +V +++ DL + M + G+E
Sbjct: 81 NHPNIVKLYGLMHN----PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 234 --HCHNQHVLHRDIKGSNLLIDNEG-----ILTIADFGLASFFDPNHKQPMTSRVVTLWY 286
N ++HRD++ N+ + + +ADFGL+ ++ + +
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV----HSVSGLLGNFQW 192
Query: 287 RPPELLLGATD-YGVGVDLWSAGCILAELLAEK 318
PE + + Y D +S IL +L +
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 71/316 (22%), Positives = 127/316 (40%), Gaps = 43/316 (13%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
+ D FEK+ ++G G V+K +G ++A K + + +P + RE+ +L +
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECN 89
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAAS---PTIKFTQAQVKCYMHQLLSGL 232
P +V G S + + ++M+ G + + + ++ GL
Sbjct: 90 SPYIVGFYGAFYS--DGEISICMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGL 144
Query: 233 EHCHNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
+ +H ++HRD+K SN+L+++ G + + DFG++ + S V T Y PE
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPER 201
Query: 292 LLGATDYGVGVDLWSAGCILAEL-LAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
L G T Y V D+WS G L E+ + PI P + +L ++ G +E +
Sbjct: 202 LQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260
Query: 351 ------------PHATIFK---------PQQSYKRCIAETFKDFPPSSLPLIETLLAIDP 389
P IF+ P + + F+DF + L +P
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF-------VNKCLIKNP 313
Query: 390 AERQTATAALRSEFFT 405
AER + F
Sbjct: 314 AERADLKQLMVHAFIK 329
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-33
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 120 FEKLD---KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
+ L+ KIG G++ V++A G VA+K + + E V RE+ I++RL H
Sbjct: 36 WCDLNIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGL--AASPTIKFTQAQVKCYMHQLLSGLE 233
PN+V G VT +L +V +Y+ L L + + + + + + G+
Sbjct: 94 PNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 234 --HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
H N ++HR++K NLL+D + + + DFGL+ S T + PE+
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEV 210
Query: 292 LLGATDYGVGVDLWSAGCILAELL 315
L D++S G IL EL
Sbjct: 211 LRD-EPSNEKSDVYSFGVILWELA 233
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 23/208 (11%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
E + +G+G + V KA + VA+K++ ++ F+ E+ L R++HPN+
Sbjct: 10 IEVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESESERKA---FI-VELRQLSRVNHPNI 63
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAGL--AASPTIKFTQAQVKCYMHQLLSGLEHCH 236
VKL G + + LV +Y E L + A P +T A + Q G+ + H
Sbjct: 64 VKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 237 NQH---VLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL 292
+ ++HRD+K NLL+ G +L I DFG A + MT+ + + PE+
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPEVF 175
Query: 293 LGATDYGVGVDLWSAGCILAELLA-EKP 319
G ++Y D++S G IL E++ KP
Sbjct: 176 EG-SNYSEKCDVFSWGIILWEVITRRKP 202
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 64/302 (21%), Positives = 117/302 (38%), Gaps = 47/302 (15%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILI-LRRL 174
+AD E + ++G+G Y V K R +GQI+A+K++R + + + + ++ I +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMRTV 63
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYME---HDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
D P V G + +++ + M+ + + ++
Sbjct: 64 DCPFTVTFYGALFRE--GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 232 LEHCHNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPE 290
LEH H++ V+HRD+K SN+LI+ G + + DFG++ + Y PE
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAPE 179
Query: 291 LLLGATD---YGVGVDLWSAGCILAEL-LAEKPIMPGRTEVEQLHKIFKLCGSP---SEE 343
+ + Y V D+WS G + EL + P T +QL ++ + +
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEEPSPQLPAD 237
Query: 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
+ F DF L + ER T ++ F
Sbjct: 238 KFSAE---------------------FVDF-------TSQCLKKNSKERPTYPELMQHPF 269
Query: 404 FT 405
FT
Sbjct: 270 FT 271
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 62/300 (20%), Positives = 122/300 (40%), Gaps = 39/300 (13%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL- 174
A+ + L +IG+G Y +V K +GQI+A+K++R ++ + + + ++ ++ R
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMDLDVVMRSS 78
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYM----EHDLAGLAASPTIKFTQAQVKCYMHQLLS 230
D P +V+ G + ++ + M + + + + + +
Sbjct: 79 DCPYIVQFYGALFR--EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 231 GLEHCHNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPP 289
L H ++HRDIK SN+L+D G + + DFG++ + + T Y P
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAP 194
Query: 290 ELLLGATD---YGVGVDLWSAGCILAEL-LAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
E + + Y V D+WS G L EL P + +QL ++ K G P
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDP----- 247
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
+L + ++ + + +F +F + L D ++R L+ F
Sbjct: 248 --PQLSN----SEEREF----SPSFINF-------VNLCLTKDESKRPKYKELLKHPFIL 290
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 46/197 (23%), Positives = 90/197 (45%), Gaps = 10/197 (5%)
Query: 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
+IG G++ VYK G VA+K + P+ ++ E+ +LR+ H N++
Sbjct: 29 GQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 183 EGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
G T+ L +V ++ E L + KF ++ Q G+++ H + ++
Sbjct: 86 MGYSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSII 142
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFDP-NHKQPMTSRVVTLWYRPPELLLGATD--Y 298
HRD+K +N+ + + + I DFGLA+ + ++ + PE++ Y
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 299 GVGVDLWSAGCILAELL 315
D+++ G +L EL+
Sbjct: 203 SFQSDVYAFGIVLYELM 219
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 62/248 (25%), Positives = 111/248 (44%), Gaps = 21/248 (8%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
++ + L+ +G + V+KA L + VA+K F + +S + E+ L +
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKA--QLLNEYVAVKI--FPIQDKQSWQN-EYEVYSLPGMK 76
Query: 176 HPNVVKLEGLVT--SRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQ--------AQVKCY 224
H N+++ G + + L+L+ + E L+ + + + + A+ Y
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAY 136
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-T 283
+H+ + GL+ H + HRDIK N+L+ N IADFGLA F+ T V T
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196
Query: 284 LWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS 339
Y PE+L GA D + +D+++ G +L EL + G + L ++
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256
Query: 340 PSEEYWKK 347
PS E ++
Sbjct: 257 PSLEDMQE 264
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 120 FEKLD---KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
FE+L+ IG+G + VY G+ VA++ + + + ++ RE++ R+ H
Sbjct: 32 FEQLEIGELIGKGRFGQVYHG--RWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
NVV G S L ++ + L + I + + +++ G+ +
Sbjct: 89 ENVVLFMGACMSPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASF----FDPNHKQPMTSRVVTLWYRPPEL 291
H + +LH+D+K N+ DN G + I DFGL S + + + L + PE+
Sbjct: 147 HAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 292 LLGATD--------YGVGVDLWSAGCILAELLA-EKP 319
+ + + D+++ G I EL A E P
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 5e-31
Identities = 77/381 (20%), Positives = 134/381 (35%), Gaps = 110/381 (28%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-- 174
+ + K+G G +S V+ + D + VA+K V+ E+ EI +L+ +
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRN 92
Query: 175 ---DHPN---VVKL------EGLVTSRMSCSLYLVFKYMEHDLAGL-AASPTIKFTQAQV 221
+ PN VV+L G+ + + C +VF+ + H L S V
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHI-C---MVFEVLGHHLLKWIIKSNYQGLPLPCV 148
Query: 222 KCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNE------------------------- 255
K + Q+L GL++ H + ++H DIK N+L+
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 256 ------------------------GILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
+ IAD G A + + + + +R YR E+
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ----YRSLEV 264
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT------EVEQLHKIFKLCGSPSEEYW 345
L+G+ Y D+WS C+ EL + + + + + I +L G +
Sbjct: 265 LIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323
Query: 346 KKSK-----------LPHATIFKPQQSYKRCI---------AETFKDFPPSSLPLIETLL 385
K L H T KP ++ + A F DF + +L
Sbjct: 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDF-------LLPML 376
Query: 386 AIDPAERQTATAALRSEFFTT 406
+ P +R TA LR + +
Sbjct: 377 ELIPEKRATAAECLRHPWLNS 397
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 58/232 (25%), Positives = 92/232 (39%), Gaps = 22/232 (9%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRL 174
+ D FE L IG+G +S V + TGQ+ A+K + + L+ V E +L
Sbjct: 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118
Query: 175 DHPNVVKLEGLVTSRMSCS------LYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQ 227
D + +L + LYLV +Y DL L + + + Y+ +
Sbjct: 119 DRRWITQLH--------FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
++ ++ H +HRDIK N+L+D G + +ADFG + V T Y
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230
Query: 288 PPELLLG------ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
PE+L YG D W+ G E+ + + E KI
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 26/218 (11%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
A + + +IG+G Y V+ G+ VA+K E+ F EI + H
Sbjct: 36 AKQIQMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTTE---EASWFRETEIYQTVLMRH 90
Query: 177 PNVVKLEGLVT--SRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
N++ + LYL+ Y E+ L S T+ +K + +SGL
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSM-LKL-AYSSVSGLC 148
Query: 234 HCHNQ--------HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ---PMTSRVV 282
H H + + HRD+K N+L+ G IAD GLA F + + P +RV
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 283 TLWYRPPELLLGAT-----DYGVGVDLWSAGCILAELL 315
T Y PPE+L + + D++S G IL E+
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 120 FEKLD---KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFM--AREILILRRL 174
F +L IG G + VY+A G VA+K R D E S +E + L
Sbjct: 6 FAELTLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
HPN++ L G+ +L LV ++ L + + I V + Q+ G+
Sbjct: 64 KHPNIIALRGVCLKEP--NLCLVMEFARGGPLNRVLSGKRIPPDIL-VN-WAVQIARGMN 119
Query: 234 HCHNQH---VLHRDIKGSNLLIDNEG--------ILTIADFGLASFFDPNHKQPMTSRVV 282
+ H++ ++HRD+K SN+LI + IL I DFGLA + H+ S
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAAG 176
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
+ PE++ + + G D+WS G +L ELL
Sbjct: 177 AYAWMAPEVIRASM-FSKGSDVWSYGVLLWELL 208
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 54/219 (24%), Positives = 84/219 (38%), Gaps = 28/219 (12%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
A L+ +G+G Y V++ + G+ VA+K + + F E+ L H
Sbjct: 7 ARDITLLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSW---FRETELYNTVMLRH 61
Query: 177 PNVVKLEGLVTSRMSCS--LYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYM-HQLLSGL 232
N++ + S L+L+ Y E L T+ + + SGL
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC---LRIVLSIASGL 118
Query: 233 EHCHNQH--------VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ---PMTSRV 281
H H + + HRD+K N+L+ G IAD GLA + Q RV
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 282 VTLWYRPPELLLGATDYGVG-----VDLWSAGCILAELL 315
T Y PE+L VD+W+ G +L E+
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 56/230 (24%), Positives = 92/230 (40%), Gaps = 20/230 (8%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRL 174
+ FE L IG+G + V + ++ A+K + ++ L+ E +L
Sbjct: 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG 131
Query: 175 DHPNVVKLEGLVTSRMSCS------LYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQ 227
D + L + LYLV Y DL L + + + + Y+ +
Sbjct: 132 DSKWITTLH--------YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
++ ++ H H +HRDIK N+L+D G + +ADFG + + V T Y
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 288 PPELLLGATD----YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
PE+L YG D WS G + E+L + + VE KI
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 7e-29
Identities = 66/287 (22%), Positives = 116/287 (40%), Gaps = 51/287 (17%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDH 176
+TF + +G+G + V + TG++ A KK+ + + + E IL +++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 177 PNVVKLEGLVTSRMSC-----SLYLVFKYME------HDLAGLAASPTIKFTQAQVKCYM 225
VV L +L LV M H + F +A+ Y
Sbjct: 244 RFVVSLA-------YAYETKDALCLVLTLMNGGDLKFH----IYHMGQAGFPEARAVFYA 292
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW 285
++ GLE H + +++RD+K N+L+D+ G + I+D GLA Q + RV T+
Sbjct: 293 AEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRVGTVG 350
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
Y PE++ Y D W+ GC+L E++A + R + + ++ +L
Sbjct: 351 YMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--------- 400
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
+ + + Y + + L LL DPAER
Sbjct: 401 ---------VKEVPEEYSERFSPQARS-------LCSQLLCKDPAER 431
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 51/215 (23%), Positives = 76/215 (35%), Gaps = 28/215 (13%)
Query: 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
+ IG+G + V++ G+ VA+K F EI L H N++
Sbjct: 45 VLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSW---FREAEIYQTVMLRHENIL 99
Query: 181 KLEGLVTSRMSCS--LYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYM-HQLLSGLEHCH 236
L+LV Y EH L T+ + SGL H H
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM---IKLALSTASGLAHLH 156
Query: 237 NQH--------VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH---KQPMTSRVVTLW 285
+ + HRD+K N+L+ G IAD GLA D RV T
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 286 YRPPELLLGATDYGVG-----VDLWSAGCILAELL 315
Y PE+L + + D+++ G + E+
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 9/223 (4%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRL 174
+A+ +E + IG+G + V R T ++ A+K + F+ ++ F E I+
Sbjct: 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 126
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
+ P VV+L + LY+V +YM DL L + + + Y +++ L+
Sbjct: 127 NSPWVVQLFY--AFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALD 182
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H+ +HRD+K N+L+D G L +ADFG + + V T Y PE+L
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 294 ---GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
G YG D WS G L E+L + V KI
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 37/226 (16%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDH 176
D + L+ IG+G Y VYK +L + VA+K F ++ F+ + I + ++H
Sbjct: 13 DNLKLLELIGRGRYGAVYKG--SLDERPVAVKV--FSFANRQN--FINEKNIYRVPLMEH 66
Query: 177 PNVVKLEG---LVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYM-HQLLSG 231
N+ + VT+ LV +Y + L + T + C + H + G
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVS---SCRLAHSVTRG 123
Query: 232 LEHCHNQH---------VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ------- 275
L + H + + HRD+ N+L+ N+G I+DFGL+ N
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 276 PMTSRVVTLWYRPPELLLGATD------YGVGVDLWSAGCILAELL 315
S V T+ Y PE+L GA + VD+++ G I E+
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 66/293 (22%), Positives = 114/293 (38%), Gaps = 63/293 (21%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDH 176
D FE L IG+G++ V + T ++ A+K + +E VR + +E+ I++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 177 PNVVKLEGLVTSRMSCS------LYLVFKYME------HDLAGLAASPTIKFTQAQVKCY 224
P +V L S +++V + H + F + VK +
Sbjct: 75 PFLVNLW--------YSFQDEEDMFMVVDLLLGGDLRYH------LQQNVHFKEETVKLF 120
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL 284
+ +L+ L++ NQ ++HRD+K N+L+D G + I DF +A+ +T+ T
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQITTMAGTK 178
Query: 285 WYRPPELLL--GATDYGVGVDLWSAGCILAELLAEKP---IMPGRTEVEQLHKIFKLCGS 339
Y PE+ Y VD WS G ELL + I + E +H
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET---- 234
Query: 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
P + + L++ LL +P +R
Sbjct: 235 ------TVVTYP-------------------SAWSQEMVSLLKKLLEPNPDQR 262
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 67/285 (23%), Positives = 115/285 (40%), Gaps = 44/285 (15%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDH 176
D F +G+G + V+ + TG++ A KK+ + + + E IL ++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 177 PNVVKLEGLVTSRMSC-----SLYLVFKYMEH-DL---AGLAASPTIKFTQAQVKCYMHQ 227
+V L L LV M D+ F + + Y Q
Sbjct: 245 RFIVSLA-------YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
++SGLEH H +++++RD+K N+L+D++G + I+D GLA + T +
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKGYAGTPGFM 356
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
PELLLG +Y VD ++ G L E++A + R E + ++ +
Sbjct: 357 APELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR----------- 404
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
+ + +Y F P+S E LL DP +R
Sbjct: 405 -------VLEQAVTYPD-------KFSPASKDFCEALLQKDPEKR 435
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 46/215 (21%), Positives = 84/215 (39%), Gaps = 19/215 (8%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDT-LTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
A +E I G +Y A D + G+ V LK + M E L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAM-AERQFLAEVV 137
Query: 176 HPNVVKLEGLV---TSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
HP++V++ V Y+V +Y+ L A+ Y+ ++L
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPA 194
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPE 290
L + H+ +++ D+K N+++ E + + D G S + + T ++ PE
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRIN------SFGYLYGTPGFQAPE 247
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT 325
++ V D+++ G LA L + P GR
Sbjct: 248 IVRTGPT--VATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFD-NLEPESV-RFMAREILILRRLDHP 177
++ +DK+G G S VY A DT+ VA+K + + E++ RF RE+ +L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRF-EREVHNSSQLSHQ 71
Query: 178 NVVKL------EGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVKCYMHQLLS 230
N+V + + YLV +Y+E L+ S + + +Q+L
Sbjct: 72 NIVSMIDVDEEDDCY--------YLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILD 122
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPP 289
G++H H+ ++HRDIK N+LID+ L I DFG+A T+ V+ T+ Y P
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSP 181
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEKP 319
E G D++S G +L E+L +P
Sbjct: 182 EQAKGEA-TDECTDIYSIGIVLYEMLVGEP 210
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 45/339 (13%), Positives = 94/339 (27%), Gaps = 76/339 (22%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE------PESVRFMAREILIL 171
+ ++ +KIG+G + V++ VA+K + + + ++ + EI+I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 172 RRL---------DHPNVVKLEGLVTSRMSCSLYLVFKY---------------------- 200
+ L + L + + S L+ +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 201 -----MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH-VLHRDIKGSNLLIDN 254
E L T + A K +HQL + L HRD+ N+L+
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 255 EGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 314
+ + P V++ DY + + ++
Sbjct: 198 TSLKKLHYTLNGKSSTI----PSCGLQVSII-----------DYTLSRLERDGIVVFCDV 242
Query: 315 LAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH---------ATIFKPQQSYKRC 365
++ + G + + I++L + W + + K +C
Sbjct: 243 SMDEDLFTG--DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKC 300
Query: 366 IAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
K T+L +AT L
Sbjct: 301 NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-26
Identities = 69/286 (24%), Positives = 117/286 (40%), Gaps = 49/286 (17%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA---REIL-ILRR 173
+ F IG+G + VY R TG++ A+K + ++ + +A R +L ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYME------HDLAGLAASPTIKFTQAQVKCYMHQ 227
D P +V + + L + M H L+ F++A ++ Y +
Sbjct: 249 GDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYH----LSQHG--VFSEADMRFYAAE 300
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
++ GLEH HN+ V++RD+K +N+L+D G + I+D GLA F K+ + V T Y
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHGYM 357
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ-LHKIFKLCGSPSEEYWK 346
PE+L Y D +S GC+L +LL P R + H+I ++
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHS--PFRQHKTKDKHEIDRM---------- 405
Query: 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
+ + L+E LL D R
Sbjct: 406 --------TLTMAVELPDSFSPELRS-------LLEGLLQRDVNRR 436
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 12/208 (5%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFD-NLEPESV-RFMAREILILRRLDHP 177
+E + +G G S V+ ARD + VA+K +R D +P RF RE L+HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRF-RREAQNAAALNHP 72
Query: 178 NVVKL--EGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
+V + G + Y+V +Y++ L + + T + + L
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNF 131
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT--SRVV-TLWYRPPEL 291
H ++HRD+K +N++I + + DFG+A + +T + V+ T Y PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS-GNSVTQTAAVIGTAQYLSPEQ 190
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKP 319
G + D++S GC+L E+L +P
Sbjct: 191 ARGDS-VDARSDVYSLGCVLYEVLTGEP 217
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFD-NLEPESVRFMAREILILRRLDHPNVVK 181
+G+G +VY+A DT+ +IVALK + + +P M RE RL P+VV
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 182 L------EGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
+ +G LY+ + + DLA + + + Q+ S L+
Sbjct: 99 IHDFGEIDGQ--------LYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDA 149
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLL 293
H HRD+K N+L+ + + DFG+AS + K V TL+Y PE
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFS 208
Query: 294 GATDYGVGVDLWSAGCILAELLAEKP 319
+ D+++ C+L E L P
Sbjct: 209 ESH-ATYRADIYALTCVLYECLTGSP 233
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 65/287 (22%), Positives = 119/287 (41%), Gaps = 59/287 (20%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDH 176
D F+++ +G G++ V + +G A+K + ++ + + E IL+ ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYME-----HDL--AGLAASPTIKFTQAQVKCYMHQLL 229
P +VKLE + + + +LY+V +Y+ L G +F++ + Y Q++
Sbjct: 101 PFLVKLEF--SFKDNSNLYMVMEYVAGGEMFSHLRRIG-------RFSEPHARFYAAQIV 151
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL----W 285
E+ H+ +++RD+K NLLID +G + + DFG A K+ + R TL
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA-------KR-VKGRTWTLCGTPE 203
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
PE++L Y VD W+ G ++ E+ A P ++ KI
Sbjct: 204 ALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS---------- 252
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
K + P F L+ LL +D +R
Sbjct: 253 GKVRFP-------------------SHFSSDLKDLLRNLLQVDLTKR 280
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 6/154 (3%)
Query: 118 DTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
+++ +G+G + V R TG+ VA+K ++ ++ +EI ILR
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIEILRN 79
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
L H N+VK +G+ T + L+ +++ L K Q Y Q+ G+
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
++ ++ +HRD+ N+L+++E + I DFGL
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 63/294 (21%), Positives = 116/294 (39%), Gaps = 69/294 (23%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDH 176
+ FE L +G+GT+ V ++ TG+ A+K ++ + + + V E +L+ H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 177 PNVVKLEGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQVKCYM 225
P + L+ L V +Y H S F++ + + Y
Sbjct: 208 PFLTALK-------YSFQTHDRLCFVMEYANGGELFFH------LSRERVFSEDRARFYG 254
Query: 226 HQLLSGLEHCHNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-- 282
+++S L++ H++ V++RD+K NL++D +G + I DFGL K+ +
Sbjct: 255 AEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC-------KEGIKDGATMK 307
Query: 283 ----TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCG 338
T Y PE+L DYG VD W G ++ E++ + + + I
Sbjct: 308 TFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--- 363
Query: 339 SPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
++ + P + P + L+ LL DP +R
Sbjct: 364 -------EEIRFP-------------------RTLGPEAKSLLSGLLKKDPKQR 391
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 60/287 (20%), Positives = 114/287 (39%), Gaps = 59/287 (20%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDH 176
F+ L +G G++ V+ R G+ A+K ++ + + + V E L+L + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYME-----HDL--AGLAASPTIKFTQAQVKCYMHQLL 229
P ++++ G T + + ++++ Y+E L + +F K Y ++
Sbjct: 66 PFIIRMWG--TFQDAQQIFMIMDYIEGGELFSLLRKSQ-------RFPNPVAKFYAAEVC 116
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW---- 285
LE+ H++ +++RD+K N+L+D G + I DFG A K + TL
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA-------KY-VPDVTYTLCGTPD 168
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
Y PE++ Y +D WS G ++ E+LA ++ KI
Sbjct: 169 YIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN---------- 217
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
+ + P F L+ L+ D ++R
Sbjct: 218 AELRFP-------------------PFFNEDVKDLLSRLITRDLSQR 245
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 68/293 (23%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDH 176
+ F+ L +G+GT+ V R+ TG+ A+K +R + + + V E +L+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 177 PNVVKLEGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQVKCYM 225
P + L+ L V +Y H S FT+ + + Y
Sbjct: 65 PFLTALK-------YAFQTHDRLCFVMEYANGGELFFH------LSRERVFTEERARFYG 111
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--- 282
+++S LE+ H++ V++RDIK NL++D +G + I DFGL K+ ++
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC-------KEGISDGATMKT 164
Query: 283 ---TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS 339
T Y PE+L DYG VD W G ++ E++ + + I
Sbjct: 165 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM---- 219
Query: 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
++ + P + P + L+ LL DP +R
Sbjct: 220 ------EEIRFP-------------------RTLSPEAKSLLAGLLKKDPKQR 247
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 69/297 (23%), Positives = 116/297 (39%), Gaps = 74/297 (24%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNL-EPESVRFMAREILILRR 173
FE L +GQG++ V+ + Q+ A+K ++ L + VR E IL
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 82
Query: 174 LDHPNVVKLEGLVTSRMSCS------LYLVFKY------MEHDLAGLAASPTIKFTQAQV 221
++HP +VKL + LYL+ + L+ FT+ V
Sbjct: 83 VNHPFIVKLH--------YAFQTEGKLYLILDFLRGGDLFTR----LSKEV--MFTEEDV 128
Query: 222 KCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281
K Y+ +L L+H H+ +++RD+K N+L+D EG + + DFGL+ K+ +
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS-------KESIDHEK 181
Query: 282 V------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
T+ Y PE++ + D WS G ++ E+L G+ E + I K
Sbjct: 182 KAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240
Query: 336 LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
K +P + P + L+ L +PA R
Sbjct: 241 ----------AKLGMP-------------------QFLSPEAQSLLRMLFKRNPANR 268
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 65/297 (21%), Positives = 115/297 (38%), Gaps = 72/297 (24%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNL--EPESVRFMAREILILR 172
+ FE L +G+G Y V++ R TG+I A+K ++ + + E IL
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 173 RLDHPNVVKLEGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQV 221
+ HP +V L + LYL+ +Y L F +
Sbjct: 77 EVKHPFIVDL-------IYAFQTGGKLYLILEYLSGGELFMQ----LEREG--IFMEDTA 123
Query: 222 KCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281
Y+ ++ L H H + +++RD+K N++++++G + + DFGL K+ +
Sbjct: 124 CFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC-------KESIHDGT 176
Query: 282 V------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
V T+ Y PE+L+ + + VD WS G ++ ++L P G + + KI K
Sbjct: 177 VTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235
Query: 336 LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
K LP + L++ LL + A R
Sbjct: 236 ----------CKLNLP-------------------PYLTQEARDLLKKLLKRNAASR 263
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREIL 169
+R + +G+G + V + TG++VA+K ++ D + +EI
Sbjct: 29 HKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK-QEID 85
Query: 170 ILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQL 228
ILR L H +++K +G + SL LV +Y+ L P AQ+ + Q+
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL--RDYLPRHSIGLAQLLLFAQQI 143
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
G+ + H QH +HRD+ N+L+DN+ ++ I DFGLA
Sbjct: 144 CEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREIL 169
R F + ++G+G + +V R TG++VA+KK++ + E F REI
Sbjct: 8 EERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIE 63
Query: 170 ILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQL 228
IL+ L H N+VK +G+ S +L L+ +Y+ + L + ++ Y Q+
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH---------KQPMTS 279
G+E+ + +HRD+ N+L++NE + I DFGL + + P+
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF- 182
Query: 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
WY PE L + + V D+WS G +L EL
Sbjct: 183 -----WY-APESLTESK-FSVASDVWSFGVVLYELF 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREIL 169
R F + ++G+G + +V R TG++VA+KK++ + E F REI
Sbjct: 39 EERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIE 94
Query: 170 ILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQL 228
IL+ L H N+VK +G+ S +L L+ +Y+ + L + ++ Y Q+
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH---------KQPMTS 279
G+E+ + +HRD+ N+L++NE + I DFGL + + P+
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF- 213
Query: 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
WY PE L + + V D+WS G +L EL
Sbjct: 214 -----WY-APESLTESK-FSVASDVWSFGVVLYELF 242
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-22
Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 6/159 (3%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDTLTG---QIVALKKVRFDNLEPESVRFMAREI 168
+ + IG+G + VY A+K + E +F+ E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEG 77
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQ 227
+I++ HPNV+ L G+ R S +V YM+H DL + T T + + Q
Sbjct: 78 IIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 136
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ G+++ ++ +HRD+ N ++D + + +ADFGLA
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-22
Identities = 41/279 (14%), Positives = 74/279 (26%), Gaps = 60/279 (21%)
Query: 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESV--RFMAREILILRRLDHPNVV 180
L G ++A DT + VAL V + P+ V + L L R+D P V
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETL-SRTLRLSRIDKPGVA 94
Query: 181 KLEGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
++ +V +R +V +++ L +A + + M L + + H
Sbjct: 95 RVLDVVHTRAGG--LVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG 149
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYG 299
V S + + +G + +A +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATMP--------DANPQ------------------- 182
Query: 300 VGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQ 359
D+ G L LL + +P L +
Sbjct: 183 --DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ---------PIEPADIDR- 230
Query: 360 QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAA 398
D P + + D R +T
Sbjct: 231 ------------DIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 35/150 (23%), Positives = 74/150 (49%), Gaps = 4/150 (2%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ ++IG+G + V+ R +VA+K R +F+ +E IL++ HP
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEARILKQYSHP 172
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N+V+L G+ T + +Y+V + ++ D + + + + +G+E+
Sbjct: 173 NIVRLIGVCTQKQP--IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
++ +HRD+ N L+ + +L I+DFG++
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 58/232 (25%), Positives = 107/232 (46%), Gaps = 23/232 (9%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILI 170
+ +K +G G + V R L + VA+K ++ E + F+ E I
Sbjct: 43 DATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASI 99
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLL 229
+ + DHPN+++LEG+VT S + +V +YME+ L +FT Q+ + +
Sbjct: 100 MGQFDHPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL---WY 286
SG+++ + +HRD+ N+LI++ + ++DFGL + + + T+R + W
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 287 RPPELLLGATDYGV---GVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
PE A Y D+WS G +L E+ E+P + + + +
Sbjct: 218 -SPE----AIAYRKFTSASDVWSYGIVLWEVMSYGERP-YWEMSNQDVIKAV 263
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
+ + ++G+G + +V R TG +VA+K+++ P+ R REI IL+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKA 80
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
L +VK G+ SL LV +Y+ L + +++ Y Q+ G+
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH---------KQPMTSRVVT 283
E+ ++ +HRD+ N+L+++E + IADFGLA + + P+
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----- 195
Query: 284 LWYRPPELLLGATDYGV---GVDLWSAGCILAELL 315
WY PE L + D+WS G +L EL
Sbjct: 196 -WY-APESLS----DNIFSRQSDVWSFGVVLYELF 224
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILI 170
EK IG G V R + GQ VA+K ++ E + F+ E I
Sbjct: 47 EASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEASI 103
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLL 229
+ + DHPN+++LEG+VT +V +YME+ L + +FT Q+ + +
Sbjct: 104 MGQFDHPNIIRLEGVVTR--GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVG 161
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL---WY 286
+G+ + + +HRD+ N+L+D+ + ++DFGL+ + + T+ + W
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221
Query: 287 RPPELLLGATDYGV---GVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
PE A + D+WS G ++ E+ E+P T + + +
Sbjct: 222 -APE----AIAFRTFSSASDVWSFGVVMWEVLAYGERP-YWNMTNRDVISSV 267
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 48/221 (21%), Positives = 86/221 (38%), Gaps = 13/221 (5%)
Query: 50 RKESSNSNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAI 109
+ S + + K+ S+ H+ + P + AV I
Sbjct: 28 PRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN---PELVQAVQHVVI 84
Query: 110 SGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQI---VALKKVRFDNLEPESVRFMAR 166
+ + IG+G + VY A+K + E +F+
Sbjct: 85 ----GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-T 139
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYM 225
E +I++ HPNV+ L G+ R S +V YM+H DL + T T + +
Sbjct: 140 EGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 198
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
Q+ G++ ++ +HRD+ N ++D + + +ADFGLA
Sbjct: 199 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 63/296 (21%), Positives = 112/296 (37%), Gaps = 69/296 (23%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRL 174
+ F L +G+G++ V + T ++ A+K ++ D ++ + V E +L
Sbjct: 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 175 D-HPNVVKLEGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQVK 222
P + +L SC LY V +Y M H +F +
Sbjct: 78 GKPPFLTQLH-------SCFQTMDRLYFVMEYVNGGDLMYH------IQQVGRFKEPHAV 124
Query: 223 CYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282
Y ++ GL ++ +++RD+K N+++D+EG + IADFG+ K+ + V
Sbjct: 125 FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-------KENIWDGVT 177
Query: 283 ------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336
T Y PE++ YG VD W+ G +L E+LA + G E E I +
Sbjct: 178 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME- 235
Query: 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
P K ++ + + L+ P +R
Sbjct: 236 ---------HNVAYP-------------------KSMSKEAVAICKGLMTKHPGKR 263
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 96.2 bits (239), Expect = 3e-21
Identities = 63/291 (21%), Positives = 113/291 (38%), Gaps = 59/291 (20%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILIL-RR 173
+ F L +G+G++ V + T ++ A+K ++ D ++ + V E +L
Sbjct: 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 398
Query: 174 LDHPNVVKLEGLVTSRMSC-----SLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQ 227
P + +L SC LY V +Y+ DL +F + Y +
Sbjct: 399 GKPPFLTQLH-------SCFQTMDRLYFVMEYVNGGDLM-YHIQQVGRFKEPHAVFYAAE 450
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV----- 282
+ GL ++ +++RD+K N+++D+EG + IADFG+ K+ + V
Sbjct: 451 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-------KENIWDGVTTKTFC 503
Query: 283 -TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS 341
T Y PE++ YG VD W+ G +L E+LA + G E E I +
Sbjct: 504 GTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME------ 556
Query: 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
P K ++ + + L+ P +R
Sbjct: 557 ----HNVAYP-------------------KSMSKEAVAICKGLMTKHPGKR 584
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 66/296 (22%), Positives = 107/296 (36%), Gaps = 73/296 (24%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILILRR 173
F L IG+G++ V AR A+K ++ + E + + R +L L+
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM-SERNVL-LKN 95
Query: 174 LDHPNVVKLEGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQVK 222
+ HP +V L LY V Y H F + + +
Sbjct: 96 VKHPFLVGLH-------FSFQTADKLYFVLDYINGGELFYH------LQRERCFLEPRAR 142
Query: 223 CYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282
Y ++ S L + H+ ++++RD+K N+L+D++G + + DFGL K+ +
Sbjct: 143 FYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC-------KENIEHNST 195
Query: 283 ------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336
T Y PE+L Y VD W G +L E+L P R E I
Sbjct: 196 TSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN- 253
Query: 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
K +L + S+ L+E LL D +R
Sbjct: 254 ---------KPLQLK-------------------PNITNSARHLLEGLLQKDRTKR 281
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 45/235 (19%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVR----FMAREILI 170
+K+G+G + VYK + VA+KK+ ++ + F EI +
Sbjct: 28 DERPISVGGNKMGEGGFGVVYKG--YVNNTTVAVKKLA-AMVDITTEELKQQFDQ-EIKV 83
Query: 171 LRRLDHPNVVKLEGLVTSRMSCS----LYLVFKYM-----EHDLAGLAASPTIKFTQ--- 218
+ + H N+V+L G S L LV+ YM L+ L +P + +
Sbjct: 84 MAKCQHENLVELLGF------SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 219 -----AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273
A G+ H H +HRDIK +N+L+D I+DFGLA +
Sbjct: 138 IAQGAAN----------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 274 KQPMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTE 326
+ MTSR+V T Y PE L G + D++S G +L E++ + R
Sbjct: 188 QTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 65/298 (21%), Positives = 118/298 (39%), Gaps = 73/298 (24%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILIL 171
D FE + +G+G++ V AR TG + A+K ++ D + + E + IL L
Sbjct: 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM-TEKRILSL 79
Query: 172 RRLDHPNVVKLEGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQ 220
R +HP + +L C L+ V ++ M H + +F +A+
Sbjct: 80 AR-NHPFLTQLF-------CCFQTPDRLFFVMEFVNGGDLMFH------IQKSRRFDEAR 125
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280
+ Y +++S L H++ +++RD+K N+L+D+EG +ADFG+ K+ + +
Sbjct: 126 ARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC-------KEGICNG 178
Query: 281 VVTLW------YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIF 334
V T Y PE+L YG VD W+ G +L E+L E + I
Sbjct: 179 VTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237
Query: 335 KLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
+ P + ++++ + +P R
Sbjct: 238 N----------DEVVYP-------------------TWLHEDATGILKSFMTKNPTMR 266
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 5e-21
Identities = 68/294 (23%), Positives = 120/294 (40%), Gaps = 60/294 (20%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRR-LD 175
F+ L IG+G+Y+ V R T +I A+K V+ + + E + ++ E + + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 176 HPNVVKLEGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQVKCY 224
HP +V L SC L+ V +Y M H K + + Y
Sbjct: 69 HPFLVGLH-------SCFQTESRLFFVIEYVNGGDLMFH------MQRQRKLPEEHARFY 115
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-- 282
++ L + H + +++RD+K N+L+D+EG + + D+G+ K+ +
Sbjct: 116 SAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLRPGDTTS 168
Query: 283 ----TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCG 338
T Y PE+L G DYG VD W+ G ++ E++A + P F + G
Sbjct: 169 TFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS--P-----------FDIVG 214
Query: 339 SPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
S I + Q R ++ ++++ L DP ER
Sbjct: 215 SSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS-------VLKSFLNKDPKER 261
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-21
Identities = 50/229 (21%), Positives = 104/229 (45%), Gaps = 22/229 (9%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQI----VALKKVRFDNLEPESVRFMAREILILRR 173
+ IG G + VYK + VA+K ++ E + V F+ E I+ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQ 102
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
H N+++LEG+++ + ++ +YME+ L +F+ Q+ + + +G+
Sbjct: 103 FSHHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL---WYRPP 289
++ N + +HRD+ N+L+++ + ++DFGL+ + + + T+ + W P
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT-AP 219
Query: 290 ELLLGATDYGV---GVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
E + Y D+WS G ++ E+ E+P + E + I
Sbjct: 220 EAIS----YRKFTSASDVWSFGIVMWEVMTYGERP-YWELSNHEVMKAI 263
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 7e-21
Identities = 60/239 (25%), Positives = 104/239 (43%), Gaps = 44/239 (18%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILIL 171
+ + F +G+G++ V+ A T Q A+K ++ D + + E + + +L
Sbjct: 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM-VEKRVL-S 72
Query: 172 RRLDHPNVVKLEGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQ 220
+HP + + +L+ V +Y M H KF ++
Sbjct: 73 LAWEHPFLTHMF-------CTFQTKENLFFVMEYLNGGDLMYH------IQSCHKFDLSR 119
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280
Y +++ GL+ H++ +++RD+K N+L+D +G + IADFG+ K+ M
Sbjct: 120 ATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC-------KENMLGD 172
Query: 281 VVTLW------YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
T Y PE+LLG Y VD WS G +L E+L + G+ E E H I
Sbjct: 173 AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 8e-21
Identities = 44/205 (21%), Positives = 87/205 (42%), Gaps = 8/205 (3%)
Query: 66 RPRGEKRRSSKPNPR-LSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLD 124
R P P +++P K + + S S +R +
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADI 342
Query: 125 KIGQGTYSNVYKAR-DTLTGQI-VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
++G G + +V + QI VA+K ++ + ++ M RE I+ +LD+P +V+L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 401
Query: 183 EGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
G+ + +L LV + L + + V +HQ+ G+++ ++ +
Sbjct: 402 IGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 242 HRDIKGSNLLIDNEGILTIADFGLA 266
HR++ N+L+ N I+DFGL+
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLS 483
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-20
Identities = 50/225 (22%), Positives = 98/225 (43%), Gaps = 15/225 (6%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
R T + K+G G Y VY+ VA+K ++ D +E E F+ E +++
Sbjct: 218 ERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK-EAAVMKE 272
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLSG 231
+ HPN+V+L G+ T Y++ ++M + +L L + + + Q+ S
Sbjct: 273 IKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRPPE 290
+E+ ++ +HR++ N L+ ++ +ADFGL+ + ++ W P
Sbjct: 331 MEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 390
Query: 291 LLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
L + + D+W+ G +L E+ P PG + +
Sbjct: 391 LAYNK--FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 432
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 67/294 (22%), Positives = 120/294 (40%), Gaps = 60/294 (20%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRR-LD 175
F+ L IG+G+Y+ V R T +I A++ V+ + + E + ++ E + + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 176 HPNVVKLEGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQVKCY 224
HP +V L SC L+ V +Y M H K + + Y
Sbjct: 112 HPFLVGLH-------SCFQTESRLFFVIEYVNGGDLMFH------MQRQRKLPEEHARFY 158
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-- 282
++ L + H + +++RD+K N+L+D+EG + + D+G+ K+ +
Sbjct: 159 SAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLRPGDTTS 211
Query: 283 ----TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCG 338
T Y PE+L G DYG VD W+ G ++ E++A + P F + G
Sbjct: 212 TFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS--P-----------FDIVG 257
Query: 339 SPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
S I + Q R + + ++++ L DP ER
Sbjct: 258 SSDNPDQNTEDYLFQVILEKQIRIPRSL-------SVKAASVLKSFLNKDPKER 304
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 39/191 (20%), Positives = 79/191 (41%), Gaps = 15/191 (7%)
Query: 89 HGEQVAAGWPSWLSAVAGEAISGWT-PRRADTFEKLDKIGQGTYSNVYKAR---DTLTGQ 144
H ++G S + R K +G+G + +V + + T
Sbjct: 6 HHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSL 63
Query: 145 IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVT---SRMSCSLYLVFKYM 201
VA+K ++ DN + E ++ HPNV++L G+ S+ ++ +M
Sbjct: 64 KVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123
Query: 202 EH-DL-----AGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE 255
++ DL + + +M + G+E+ N++ LHRD+ N ++ ++
Sbjct: 124 KYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD 183
Query: 256 GILTIADFGLA 266
+ +ADFGL+
Sbjct: 184 MTVCVADFGLS 194
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 38/156 (24%), Positives = 74/156 (47%), Gaps = 8/156 (5%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-DTLTGQI-VALKKVRFDNLEPESVRFMAREILIL 171
R + ++G G + +V + QI VA+K ++ + ++ M RE I+
Sbjct: 7 KRDNLLIADI-ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIM 64
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLS 230
+LD+P +V+L G+ + +L LV + L + + V +HQ+
Sbjct: 65 HQLDNPYIVRLIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 121
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
G+++ ++ +HRD+ N+L+ N I+DFGL+
Sbjct: 122 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 6/157 (3%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILI 170
P IG+G + VY Q A+K + + F+ RE L+
Sbjct: 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL-REGLL 75
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLL 229
+R L+HPNV+ L G++ +++ YM H DL SP T + + Q+
Sbjct: 76 MRGLNHPNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVA 134
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
G+E+ Q +HRD+ N ++D + +ADFGLA
Sbjct: 135 RGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 6e-20
Identities = 49/228 (21%), Positives = 94/228 (41%), Gaps = 22/228 (9%)
Query: 118 DTFEKLDKIGQGTYSNVYKAR---DTLTGQI-VALKKVRFDNLEPESVRFMAREILILRR 173
F+K+ +G G + VYK + +I VA+K++R + + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMAS 73
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
+D+P+V +L G+ + ++ L+ + M L + + Q+ G+
Sbjct: 74 VDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS--RVVTLWYRPPE 290
+ ++ ++HRD+ N+L+ + I DFGLA K+ +V W E
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALE 189
Query: 291 LLLGATDYGV---GVDLWSAGCILAELLA--EKPIMPGRTEVEQLHKI 333
+L + + D+WS G + EL+ KP G E +
Sbjct: 190 SIL----HRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSIL 232
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 6e-20
Identities = 38/169 (22%), Positives = 73/169 (43%), Gaps = 12/169 (7%)
Query: 101 LSAVAGEAISGW-TPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPE 159
++A SGW + + IG+G + +V G VA+K ++ D
Sbjct: 5 VAAQDEFYRSGWALNMKELKLLQ--TIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA 60
Query: 160 SVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFT 217
F+ E ++ +L H N+V+L G++ LY+V +YM L L +
Sbjct: 61 ---FL-AEASVMTQLRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG 115
Query: 218 QAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ + + +E+ + +HRD+ N+L+ + + ++DFGL
Sbjct: 116 GDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 61/240 (25%), Positives = 101/240 (42%), Gaps = 53/240 (22%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D F + +G+G + VYK R G +VA+K+++ + + ++F E+ ++ H
Sbjct: 30 DNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQT-EVEMISMAVHR 87
Query: 178 NVVKLEGLVTSRMSCS----LYLVFKYM-----EHDLAGLAAS------PT---IKFTQA 219
N+++L G C LV+ YM L S P I A
Sbjct: 88 NLLRLRGF------CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 220 QVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN--HKQPM 277
+ Y+H +HC ++HRD+K +N+L+D E + DFGLA D H +
Sbjct: 142 RGLAYLH------DHCD-PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH---V 191
Query: 278 TSRVV-TLWYRPPE-----LLLGATD-YGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQ 329
T+ V T+ + PE TD +G GV +L EL+ ++ R +
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV-------MLLELITGQRAFDLARLANDD 244
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 1e-19
Identities = 59/291 (20%), Positives = 120/291 (41%), Gaps = 21/291 (7%)
Query: 57 NNEQETTTVRPRGEKRRSSKPNPRLSN-PPKHVHGEQVAAGWPSWLSAVAGEAISGWTPR 115
N ++ +RP+ E R+ P+L+N + V V+ + + E + P
Sbjct: 322 NGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPS 381
Query: 116 RA------DTFEKLDKIGQGTYSNVYKARDTLTGQI---VALKKVRFDNLEPESVRFMAR 166
+ E IG+G + +V++ VA+K + + +F+ +
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL-Q 440
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYM 225
E L +R+ DHP++VKL G++T ++++ + +L A + Y
Sbjct: 441 EALTMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTL 284
+QL + L + ++ +HRDI N+L+ + + + DFGL+ D + + ++
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
W P + + D+W G + E+ KP G + + +I
Sbjct: 558 WMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 17/225 (7%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
PR + E K+GQG + V+ T + VA+K ++ + PE F+ +E ++++
Sbjct: 182 PRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKK 235
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLSG 231
L H +V+L +V+ +Y+V +YM L L Q+ Q+ SG
Sbjct: 236 LRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRPPE 290
+ + + +HRD++ +N+L+ + +ADFGLA D + ++ W P
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352
Query: 291 LLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
L G + + D+WS G +L EL P PG E L ++
Sbjct: 353 ALYGR--FTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQV 394
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 34/157 (21%), Positives = 71/157 (45%), Gaps = 13/157 (8%)
Query: 123 LDKIGQGTYSNVYKAR---DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+G+G + +V +A+ + + VA+K ++ D + + RE ++ DHP+V
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 180 VKLEGLVT----SRMSCSLYLVFKYMEH-DL-----AGLAASPTIKFTQAQVKCYMHQLL 229
KL G+ ++ +M+H DL A + +M +
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
G+E+ +++ +HRD+ N ++ + + +ADFGL+
Sbjct: 148 CGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 2e-19
Identities = 51/231 (22%), Positives = 95/231 (41%), Gaps = 29/231 (12%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILR 172
R T K ++G G + V GQ VA+K ++ ++ + F +E +
Sbjct: 6 KREEITLLK--ELGSGQFGVVKLG--KWKGQYDVAVKMIKEGSMSED--EFF-QEAQTMM 58
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSG 231
+L HP +VK G+ + +Y+V +Y+ + L S +Q+ + + G
Sbjct: 59 KLSHPKLVKFYGVCSKEYP--IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL----WYR 287
+ + +HRD+ N L+D + + ++DFG+ + S V T W
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKWS- 172
Query: 288 PPELLLGATDYGV---GVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
PE+ Y D+W+ G ++ E+ L + P T E + K+
Sbjct: 173 APEVFH----YFKYSSKSDVWAFGILMWEVFSLGKMP-YDLYTNSEVVLKV 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 40/155 (25%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
R T + K+G G Y VY+ VA+K ++ D +E E F+ +E +++
Sbjct: 11 ERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FL-KEAAVMKE 65
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLSG 231
+ HPN+V+L G+ T Y++ ++M + +L L + + + Q+ S
Sbjct: 66 IKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+E+ ++ +HRD+ N L+ ++ +ADFGL+
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 29/231 (12%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILR 172
TF + +IG G + V+ + VA+K +R + E F+ E ++
Sbjct: 6 DPSELTFVQ--EIGSGQFGLVHLGY--WLNKDKVAIKTIREGAMSEED--FI-EEAEVMM 58
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSG 231
+L HP +V+L G+ + + LV ++MEH L+ + F + + G
Sbjct: 59 KLSHPKLVQLYGVCLEQAP--ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL----WYR 287
+ + V+HRD+ N L+ ++ ++DFG+ F + TS T W
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWA- 172
Query: 288 PPELLLGATDYGV---GVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
PE+ + D+WS G ++ E+ + P R+ E + I
Sbjct: 173 SPEVFS----FSRYSSKSDVWSFGVLMWEVFSEGKIP-YENRSNSEVVEDI 218
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 58/245 (23%), Positives = 104/245 (42%), Gaps = 49/245 (20%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNL--EPESVRFMAREILILR 172
+ FE L +G G Y V+ R TG++ A+K ++ + + ++ E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 173 RLDH-PNVVKLEGLVTSRMSCS------LYLVFKY------MEHDLAGLAASPTIKFTQA 219
+ P +V L + L+L+ Y H L+ +FT+
Sbjct: 114 HIRQSPFLVTLH--------YAFQTETKLHLILDYINGGELFTH----LSQRE--RFTEH 159
Query: 220 QVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS 279
+V+ Y+ +++ LEH H +++RDIK N+L+D+ G + + DFGL+ K+ +
Sbjct: 160 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS-------KEFVAD 212
Query: 280 RVVTLW-------YRPPELLLGATDYGVG--VDLWSAGCILAELLAEKPIMPGRTEVEQL 330
+ Y P+++ G D G VD WS G ++ ELL E
Sbjct: 213 ETERAYDFCGTIEYMAPDIVRG-GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 271
Query: 331 HKIFK 335
+I +
Sbjct: 272 AEISR 276
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 54/231 (23%), Positives = 106/231 (45%), Gaps = 29/231 (12%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILR 172
+ TF K ++G G + V + GQ VA+K ++ ++ + F+ E ++
Sbjct: 22 DPKDLTFLK--ELGTGQFGVVKYGK--WRGQYDVAIKMIKEGSMSEDE--FI-EEAKVMM 74
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSG 231
L H +V+L G+ T + ++++ +YM + L +F Q+ +
Sbjct: 75 NLSHEKLVQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 132
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL----WYR 287
+E+ ++ LHRD+ N L++++G++ ++DFGL+ + + TS V + W
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWS- 188
Query: 288 PPELLLGATDYGV---GVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
PPE+L+ Y D+W+ G ++ E+ L + P T E I
Sbjct: 189 PPEVLM----YSKFSSKSDIWAFGVLMWEIYSLGKMP-YERFTNSETAEHI 234
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 35/148 (23%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 123 LDKIGQGTYSNVYKARDTLTGQI---VALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
IG+G + +V++ VA+K + + +F+ +E L +R+ DHP++
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEALTMRQFDHPHI 78
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
VKL G++T ++++ + +L A + Y +QL + L + ++
Sbjct: 79 VKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 135
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLA 266
+HRDI N+L+ + + + DFGL+
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 34/153 (22%), Positives = 68/153 (44%), Gaps = 8/153 (5%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQI---VALKKVRFDNLEPESVRFMAREILILRRL 174
+ +G+G + VY+ T VA+K + D +FM E +I++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM-SEAVIMKNL 70
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
DHP++VKL G++ +++ + + +L + Y Q+ +
Sbjct: 71 DHPHIVKLIGIIEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ + + +HRDI N+L+ + + + DFGL+
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-19
Identities = 40/170 (23%), Positives = 73/170 (42%), Gaps = 17/170 (10%)
Query: 110 SGWTPRRADTFE-------KLDKIGQGTYSNVYKARDTLTGQI---VALKKVRFDNLEPE 159
+G P ++ T L+K+G G++ V + VA+K ++ D L
Sbjct: 3 AGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP 62
Query: 160 SVR--FMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKF 216
F+ RE+ + LDH N+++L G+V + + +V + L F
Sbjct: 63 EAMDDFI-REVNAMHSLDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHF 118
Query: 217 TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ Y Q+ G+ + ++ +HRD+ NLL+ ++ I DFGL
Sbjct: 119 LLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-19
Identities = 62/232 (26%), Positives = 108/232 (46%), Gaps = 31/232 (13%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILR 172
PR + ++G G + V+ G VA+K ++ ++ P++ F+A E +++
Sbjct: 11 PRETLKLVE--RLGAGQFGEVWMG--YYNGHTKVAVKSLKQGSMSPDA--FLA-EANLMK 63
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLS 230
+L H +V+L +VT +Y++ +YME+ L L IK T ++ Q+
Sbjct: 64 QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL----WY 286
G+ ++ +HRD++ +N+L+ + IADFGLA + N T+R W
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWT 177
Query: 287 RPPELLLGATDYGV---GVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
PE A +YG D+WS G +L E+ P PG T E + +
Sbjct: 178 -APE----AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNL 223
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 33/146 (22%), Positives = 70/146 (47%), Gaps = 9/146 (6%)
Query: 125 KIGQGTYSNVYKARDTLTGQI--VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
++G G + V K + + VA+K ++ + +P + E ++++LD+P +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 183 EGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
G+ + S LV + E L L + + +HQ+ G+++ +
Sbjct: 84 IGICEAE---SWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLA 266
+HRD+ N+L+ + I+DFGL+
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-19
Identities = 33/168 (19%), Positives = 72/168 (42%), Gaps = 20/168 (11%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYK--ARDTLTGQ---IVALKKVRFDNLEPESVRFMAREI 168
R T + ++GQG++ VY+ A+ + + VA+K V E + F+ E
Sbjct: 23 AREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEA 79
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------AGLAASPTIKFTQ 218
+++ + +VV+L G+V+ ++ + M DL A +
Sbjct: 80 SVMKEFNCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 219 AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+++ ++ G+ + + +HRD+ N ++ + + I DFG+
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 8e-19
Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 17/225 (7%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
PR + E K+GQG + V+ T + VA+K ++ + PE F+ +E ++++
Sbjct: 265 PRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKK 318
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLSG 231
L H +V+L +V+ +Y+V +YM L L Q+ Q+ SG
Sbjct: 319 LRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRPPE 290
+ + + +HRD++ +N+L+ + +ADFGLA D + ++ W P
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435
Query: 291 LLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
L G + + D+WS G +L EL P PG E L ++
Sbjct: 436 ALYGR--FTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQV 477
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 34/154 (22%), Positives = 70/154 (45%), Gaps = 9/154 (5%)
Query: 118 DTFEKLDKIGQGTYSNVYKAR---DTLTGQI-VALKKVRFDNLEPESVRFMAREILILRR 173
F+K+ +G G + VYK + +I VA+K++R + + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMAS 73
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
+D+P+V +L G+ + ++ L+ + M L + + Q+ G+
Sbjct: 74 VDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ ++ ++HRD+ N+L+ + I DFGLA
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 35/146 (23%), Positives = 66/146 (45%), Gaps = 9/146 (6%)
Query: 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
L IG+G + +V G VA+K ++ D F+ E ++ +L H N+V+L
Sbjct: 198 LQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA---FL-AEASVMTQLRHSNLVQL 251
Query: 183 EGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
G++ LY+V +YM L L + + + + +E+ +
Sbjct: 252 LGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 310
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLA 266
+HRD+ N+L+ + + ++DFGL
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 47/208 (22%), Positives = 84/208 (40%), Gaps = 19/208 (9%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQ----IVALKKVRFDNLEPESVRFMAREILILRR 173
KL +G G + V+K G+ V +K + + +L +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT-DHMLAIGS 71
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
LDH ++V+L GL SL LV +Y+ L + + Q+ G+
Sbjct: 72 LDHAHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS--RVVTLWYRPPE 290
+ ++HR++ N+L+ + + +ADFG+A P+ KQ + S + W E
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM-ALE 187
Query: 291 LLLGATDYGV---GVDLWSAGCILAELL 315
+ +G D+WS G + EL+
Sbjct: 188 SIH----FGKYTHQSDVWSYGVTVWELM 211
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 5e-18
Identities = 43/174 (24%), Positives = 72/174 (41%), Gaps = 26/174 (14%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREI 168
A F + ++G+ + VYK Q VA+K ++ P F E
Sbjct: 7 SLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HEA 63
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------------AGLAASP 212
++ RL HPNVV L G+VT L ++F Y H DL +
Sbjct: 64 MLRARLQHPNVVCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 213 TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ Q+ +G+E+ + HV+H+D+ N+L+ ++ + I+D GL
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 9e-18
Identities = 42/156 (26%), Positives = 78/156 (50%), Gaps = 13/156 (8%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILR 172
PR + EK K+G G + V+ A T VA+K ++ ++ E+ F+ E +++
Sbjct: 186 PRESLKLEK--KLGAGQFGEVWMA--TYNKHTKVAVKTMKPGSMSVEA--FL-AEANVMK 238
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLS 230
L H +VKL +VT +Y++ ++M L L + K ++ + Q+
Sbjct: 239 TLQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 295
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
G+ ++ +HRD++ +N+L+ + IADFGLA
Sbjct: 296 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 39/236 (16%), Positives = 80/236 (33%), Gaps = 32/236 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQI-------VALKKVRFDNLEPESVRFMAREILI 170
+ + +GQGT++ ++K G V LK + + F +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFF-EAASM 65
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLL 229
+ +L H ++V G+ LV ++++ L QL
Sbjct: 66 MSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILT--------IADFGLASFFDPN--HKQPMTS 279
+ + ++H ++ N+L+ E ++D G++ P ++ +
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP- 182
Query: 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
W PPE + + + D WS G L E+ +KP + +L
Sbjct: 183 -----WV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFY 231
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 43/222 (19%), Positives = 83/222 (37%), Gaps = 42/222 (18%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLE- 183
KIG G + +Y A T + A V+ +E + + E+ +R+ + +K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVK---VEYQENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 184 ----------------GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQ 227
GL + ++V + + DL ++ F ++ V +
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQ-NGTFKKSTVLQLGIR 159
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLID--NEGILTIADFGLAS-FFDPNHKQPMTSRVVTL 284
+L LE+ H +H DIK +NLL+ N + +AD+GL+ + + +
Sbjct: 160 MLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ------ 213
Query: 285 WYRPPELLLGATDY-------GVGV----DLWSAGCILAELL 315
P + G ++ GV + D+ G + L
Sbjct: 214 -ENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWL 254
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 42/172 (24%), Positives = 73/172 (42%), Gaps = 24/172 (13%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTG--QIVALKKVRFDNLEPESVRFMAREILIL 171
F+ IG+G + V KAR G A+K+++ + + F E+ +L
Sbjct: 23 DWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVL 79
Query: 172 RRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------------AGLAASPTI 214
+L HPN++ L G R LYL +Y H +L +A S
Sbjct: 80 CKLGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 215 KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ Q+ + + G+++ + +HRD+ N+L+ + IADFGL+
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 66/242 (27%), Positives = 95/242 (39%), Gaps = 64/242 (26%)
Query: 120 FEKLDKIGQGTYSNVYKA--RDTLTGQIVALKKVRFDNLEPESVR----FMAREILILRR 173
F+ IG G + VYK RD G VALK+ PES + F EI L
Sbjct: 41 FDHKFLIGHGVFGKVYKGVLRD---GAKVALKR-----RTPESSQGIEEFET-EIETLSF 91
Query: 174 LDHPNVVKLEGLVTSRMSCS----LYLVFKYMEHD-----LAGLAASPT---------IK 215
HP++V L G C + L++KYME+ L G I
Sbjct: 92 CRHPHLVSLIGF------CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 216 FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275
A+ GL + H + ++HRD+K N+L+D + I DFG++ +
Sbjct: 146 IGAAR----------GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195
Query: 276 PMTSRVV-TLWYRPPE-----LLLGATD-YGVGVDLWSAGCILAELL-AEKPIMPGRTEV 327
+++ V TL Y PE L +D Y GV +L E+L A I+
Sbjct: 196 HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV-------VLFEVLCARSAIVQSLPRE 248
Query: 328 EQ 329
Sbjct: 249 MV 250
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 52/230 (22%), Positives = 88/230 (38%), Gaps = 57/230 (24%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRF--MAREILILRRL 174
F KIG G + + ++ T + VA+K LEP R + E ++L
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLEYRFYKQL 61
Query: 175 DH-PNVVKL-----EG----LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCY 224
+ ++ G +V + SL +F + F+ V
Sbjct: 62 GSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDR-----------TFSLKTVLMI 110
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLI-----DNEGILTIADFGLASFF-DPNHKQ--P 276
QL+S +E+ H++++++RD+K N LI + ++ I DF LA + DP K+ P
Sbjct: 111 AIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIP 170
Query: 277 MTSRVVTLWYRPPELLLGATDYG-----VGV------DLWSAGCILAELL 315
YR + L G Y +G DL + G + L
Sbjct: 171 ---------YREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFL 211
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 43/173 (24%), Positives = 74/173 (42%), Gaps = 26/173 (15%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYK--ARDTLTGQ---IVALKKVRFDNLEPESVRFMAREI 168
RR + ++G+G + V+ + L Q +VA+K ++ + E F RE
Sbjct: 39 KRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQ-REA 94
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL--------------AGLAASPT 213
+L L H ++V+ G+ T L +VF+YM H DL AG
Sbjct: 95 ELLTMLQHQHIVRFFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 214 IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
Q+ Q+ +G+ + H +HRD+ N L+ ++ I DFG++
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 44/174 (25%), Positives = 76/174 (43%), Gaps = 27/174 (15%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREI 168
RR ++ ++G+G + V+ A T +VA+K ++ D F RE
Sbjct: 13 KRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQ-REA 68
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------------AGLAASP 212
+L L H ++VK G+ L +VF+YM+H DL G
Sbjct: 69 ELLTNLQHEHIVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 213 TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ +Q+ Q+ SG+ + +QH +HRD+ N L+ ++ I DFG++
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 55/254 (21%), Positives = 96/254 (37%), Gaps = 57/254 (22%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREI 168
PR+ T + +G G + VY+ + + + VA+K + E + + F+ E
Sbjct: 28 PRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEA 84
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL------AGLAASPTIKFTQAQV 221
LI+ + +H N+V+ G+ + +++ + M DL S +
Sbjct: 85 LIISKFNHQNIVRCIGVSLQSL--PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 222 KCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNHKQPMT 278
+ G ++ H +HRDI N L+ G + I DFG+A
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------------ 190
Query: 279 SRVV--TLWYR------------PPELLLGATDYGV---GVDLWSAGCILAEL--LAEKP 319
R + +YR PPE + G+ D WS G +L E+ L P
Sbjct: 191 -RDIYRASYYRKGGCAMLPVKWMPPEAFM----EGIFTSKTDTWSFGVLLWEIFSLGYMP 245
Query: 320 IMPGRTEVEQLHKI 333
P ++ E L +
Sbjct: 246 Y-PSKSNQEVLEFV 258
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 8e-17
Identities = 58/266 (21%), Positives = 101/266 (37%), Gaps = 68/266 (25%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH-PNVVKL- 182
+IG+G++ +++ + L Q VA+K + P+ + E + L + +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTGIPNVY 72
Query: 183 ----EG----LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
EG LV + SL + KF+ V Q+L+ ++
Sbjct: 73 YFGQEGLHNVLVIDLLGPSLEDLLDLCGR-----------KFSVKTVAMAAKQMLARVQS 121
Query: 235 CHNQHVLHRDIKGSNLLI-----DNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRP 288
H + +++RDIK N LI N ++ + DFG+ F+ DP KQ + YR
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP-------YRE 174
Query: 289 PELLLGATDYG-----VGV------DLWSAGCILAELLAEKPIMP-----GRTEVEQLHK 332
+ L G Y +G DL + G + L + +P T ++ +
Sbjct: 175 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL--RGSLPWQGLKAATNKQKYER 232
Query: 333 IFK---------LC-GSPSE--EYWK 346
I + LC G P E +Y
Sbjct: 233 IGEKKQSTPLRELCAGFPEEFYKYMH 258
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 43/175 (24%), Positives = 72/175 (41%), Gaps = 26/175 (14%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREI 168
PR K +G+G + V +A T T + VA+K ++ E M E+
Sbjct: 25 PRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-SEL 81
Query: 169 LILRRLD-HPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------------AGLAAS 211
IL + H NVV L G T + L ++ ++ + +L
Sbjct: 82 KILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 212 PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
T + CY Q+ G+E ++ +HRD+ N+L+ + ++ I DFGLA
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 37/168 (22%), Positives = 69/168 (41%), Gaps = 20/168 (11%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREI 168
PR+ T + +G G + VY+ + + + VA+K + E + + F+ E
Sbjct: 69 PRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEA 125
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL------AGLAASPTIKFTQAQV 221
LI+ + +H N+V+ G+ + +++ + M DL S +
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSL--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183
Query: 222 KCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLA 266
+ G ++ H +HRDI N L+ G + I DFG+A
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 43/182 (23%), Positives = 80/182 (43%), Gaps = 34/182 (18%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREI 168
PR + + IG+G + V++AR +VA+K ++ + F RE
Sbjct: 45 PRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REA 101
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------------------- 205
++ D+PN+VKL G+ + + L+F+YM + DL
Sbjct: 102 ALMAEFDNPNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 206 -AGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264
A +++ + A+ C Q+ +G+ + + +HRD+ N L+ ++ IADFG
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 219
Query: 265 LA 266
L+
Sbjct: 220 LS 221
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 60/270 (22%), Positives = 103/270 (38%), Gaps = 62/270 (22%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
+ + KIG G++ ++Y D G+ VA+K P+ + E I + +
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQG 63
Query: 177 -PNVVKL-----EG----LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMH 226
+ + EG +V + SL +F + KF+ V
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-----------KFSLKTVLLLAD 112
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFF-DPNHKQPMTSRVV 282
Q++S +E+ H+++ +HRD+K N L+ ++ I DFGLA + D Q +
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP---- 168
Query: 283 TLWYRPPELLLGATDYG-----VGV------DLWSAGCILAELLAEK---PIMPGRTEVE 328
YR + L G Y +G+ DL S G +L + T+ +
Sbjct: 169 ---YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 225
Query: 329 QLHKIFK---------LC-GSPSE--EYWK 346
+ +I + LC G PSE Y
Sbjct: 226 KYERISEKKMSTPIEVLCKGYPSEFATYLN 255
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 38/182 (20%), Positives = 74/182 (40%), Gaps = 34/182 (18%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREI 168
PR+ K +G+G + V KA VA+K ++ + E + E
Sbjct: 21 PRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL-SEF 77
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------------------- 205
+L++++HP+V+KL G + L L+ +Y ++ L
Sbjct: 78 NVLKQVNHPHVIKLYGACSQDGP--LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 206 -AGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264
+ L T + + Q+ G+++ ++HRD+ N+L+ + I+DFG
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 265 LA 266
L+
Sbjct: 196 LS 197
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 42/177 (23%), Positives = 74/177 (41%), Gaps = 29/177 (16%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-------DTLTGQIVALKKVRFDNLEPESVRFMAR 166
PR T K +G+G + V A VA+K ++ D E + +
Sbjct: 33 PRDKLTLGK--PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-S 89
Query: 167 EILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------------AGLA 209
E+ +++ + H N++ L G T LY++ +Y +L +
Sbjct: 90 EMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 210 ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
P + T + +QL G+E+ +Q +HRD+ N+L+ ++ IADFGLA
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 38/177 (21%), Positives = 75/177 (42%), Gaps = 29/177 (16%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-------DTLTGQIVALKKVRFDNLEPESVRFMAR 166
PR K +G+G + V A VA+K ++ D E + +
Sbjct: 67 PRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-S 123
Query: 167 EILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------------AGLA 209
E+ +++ + H N++ L G T LY++ +Y +L +
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 210 ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+P + + + +Q+ G+E+ ++ +HRD+ N+L+ + ++ IADFGLA
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 42/177 (23%), Positives = 74/177 (41%), Gaps = 29/177 (16%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-------DTLTGQIVALKKVRFDNLEPESVRFMAR 166
PR T K +G+G + V A VA+K ++ D E + +
Sbjct: 79 PRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-S 135
Query: 167 EILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------------AGLA 209
E+ +++ + H N++ L G T LY++ +Y +L +
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193
Query: 210 ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
P + T + +QL G+E+ +Q +HRD+ N+L+ ++ IADFGLA
Sbjct: 194 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 7e-15
Identities = 39/177 (22%), Positives = 70/177 (39%), Gaps = 29/177 (16%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREI 168
PR +F K +G G + V +A + VA+K ++ E M E+
Sbjct: 21 PRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SEL 77
Query: 169 LILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL-----------------AGLA 209
+L L +H N+V L G T ++ +Y + DL +
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 210 ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ + + +Q+ G+ +++ +HRD+ N+L+ + I I DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 43/222 (19%), Positives = 76/222 (34%), Gaps = 39/222 (17%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLE- 183
IGQG + +Y A + + V +EP + E+ +R P ++
Sbjct: 42 PIGQGGFGCIYLADMN-SSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 184 ----------------GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQ 227
GL +++ DL + + +F++ V +
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLID--NEGILTIADFGLAS-FFDPNHKQPMTSRVVTL 284
+L LE+ H +H DIK SNLL++ N + + D+GLA + +
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA------ 214
Query: 285 WYRPPELLLGATDY-------GVGV----DLWSAGCILAELL 315
P G ++ GV DL G + + L
Sbjct: 215 -ADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL 255
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 40/173 (23%), Positives = 67/173 (38%), Gaps = 25/173 (14%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKA-----RDTLTGQIVALKKVRFDNLEPESVRFMAREI 168
PR F K +G G + V +A VA+K ++ E M E+
Sbjct: 44 PRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM-SEL 100
Query: 169 LILRRLD-HPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL-------------AGLAASPT 213
I+ L H N+V L G T + ++ +Y + DL A
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGP--VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 214 IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ + + Q+ G+ +++ +HRD+ N+L+ N + I DFGLA
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 57/227 (25%), Positives = 87/227 (38%), Gaps = 47/227 (20%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
PR + F KIG G++ +Y + T + VA+K P+ + E I R
Sbjct: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYRI 58
Query: 174 L-DHPNVVKL-----EG----LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKC 223
L + + EG LV + SL +F + K + V
Sbjct: 59 LQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR-----------KLSLKTVLM 107
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFF-DPNHKQPMTS 279
Q+++ +E H++ LHRDIK N L+ + I DFGLA + D + Q +
Sbjct: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP- 166
Query: 280 RVVTLWYRPPELLLGATDYG-----VGV------DLWSAGCILAELL 315
YR + L G Y +G+ DL S G +L L
Sbjct: 167 ------YRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFL 207
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 31/184 (16%), Positives = 55/184 (29%), Gaps = 50/184 (27%)
Query: 125 KIGQGTYSNVYKARDTLTGQI--------VALKKVRFDNLEPES------VRFMAREILI 170
+ +Y+A T T +LK L+ + F R
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK------LDAKDGRLFNEQNFFQRAAKP 102
Query: 171 --------LRRLDHPNVVKLEG----------LVTSRMSCSLYLVFKYMEHDLAGLAASP 212
L + G LV + SL SP
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV----------SP 152
Query: 213 TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI--DNEGILTIADFGLASFFD 270
++ V +LL LE H +H ++ N+ + +++ +T+A +G A +
Sbjct: 153 KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 271 PNHK 274
P+ K
Sbjct: 213 PSGK 216
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-14
Identities = 44/182 (24%), Positives = 71/182 (39%), Gaps = 34/182 (18%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREI 168
PR F K +G G + V A T VA+K ++ E M E+
Sbjct: 43 PRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SEL 99
Query: 169 LILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL--------------------- 205
++ +L H N+V L G T +YL+F+Y + DL
Sbjct: 100 KMMTQLGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 206 -AGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264
T + C+ +Q+ G+E + +HRD+ N+L+ + ++ I DFG
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 265 LA 266
LA
Sbjct: 218 LA 219
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.9 bits (139), Expect = 5e-09
Identities = 75/544 (13%), Positives = 158/544 (29%), Gaps = 147/544 (27%)
Query: 22 SVRVDRKVSAAAAAEAVEIRNG--NGGPNHRKESSNSNNEQETTTVRPRGEKRRSSKPNP 79
++ +++ + +E R+ N K N + Q +R + +P
Sbjct: 97 PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKY--NVSRLQPYLKLR---QALLELRPAK 151
Query: 80 RLSNPPKHVHGEQVAAGWPSWLSAVAGEAISG------------W-TPRRADTFEKLDKI 126
+ + G + +G +W+ A + W + ++ E + ++
Sbjct: 152 NVL-----IDG-VLGSG-KTWV---ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEM 201
Query: 127 GQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMARE-----ILILRRLDHPNVVK 181
Q + + + +K +R +++ E R + + +L+L + +
Sbjct: 202 LQKLLYQIDPNWTSRSDHSSNIK-LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWN 260
Query: 182 -LEG----LVTSR-MSCSLYLVFKY-----MEHDLAGLAASPT----IKFTQAQVK---- 222
L+T+R + +L ++H L +K+ + +
Sbjct: 261 AFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR 320
Query: 223 --CYMHQLLSGL-------EHCHNQHVLHRDIKGSNLLIDNE-GILTIAD----FGLASF 268
+ + + H + +I++ +L A+ F S
Sbjct: 321 EVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV 380
Query: 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL----LAEKPIMPGR 324
F P+ P T + +W+ + +D V + ++ +L L EK
Sbjct: 381 FPPSAHIP-TILLSLIWFDVIK-----SD----VMV-----VVNKLHKYSLVEKQPKEST 425
Query: 325 TEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIET- 383
+ ++ +L EY L H +I Y K F L
Sbjct: 426 ISIPSIY--LELKVKLENEY----AL-HRSIV---DHYN-----IPKTFDSDDLIPPYLD 470
Query: 384 ----------LLAIDPAERQTATAALRSEFF-----------TTKPYACDPSSLP----- 417
L I+ ER R F + + S L
Sbjct: 471 QYFYSHIGHHLKNIEHPER---MTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQL 527
Query: 418 -KYPPTKEMDAKLRDEEARRLRAAGK--ANAEAKKARSR--DRAARAMPAP------EAN 466
Y K + R + A E S+ D A+ A EA+
Sbjct: 528 KFY---KPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAH 584
Query: 467 AELQ 470
++Q
Sbjct: 585 KQVQ 588
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 7/124 (5%)
Query: 216 FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA--SFFDPNH 273
T + CY Q+ G+E ++ +HRD+ N+L+ + ++ I DFGLA + DP++
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLH 331
+ +R+ W PE + Y + D+WS G +L E+ L P PG E+
Sbjct: 250 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFC 306
Query: 332 KIFK 335
+ K
Sbjct: 307 RRLK 310
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 27/103 (26%), Positives = 46/103 (44%), Gaps = 15/103 (14%)
Query: 114 PRRADTFE------KLDK-IGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESV 161
P A +E KL K +G+G + V +A T T + VA+K ++ +
Sbjct: 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEH 69
Query: 162 RFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYLVFKYMEH 203
R + E+ IL + H NVV L G T + L ++ ++ +
Sbjct: 70 RALMSELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKF 111
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 495 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.22 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.13 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.87 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.7 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.59 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.38 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.33 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.23 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.2 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.83 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.81 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.59 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.57 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.53 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.49 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.44 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.35 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.27 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.26 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.25 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.25 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.15 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.59 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.38 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.62 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 91.18 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 83.49 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-64 Score=517.00 Aligned_cols=293 Identities=33% Similarity=0.548 Sum_probs=244.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc----CCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR----MSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----~~~ 192 (495)
.++|++++.||+|+||+||+|+++.+|+.||||++.+........+.+.+|+.+|+.|+|||||++++++... ...
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 3689999999999999999999999999999999987666666677888999999999999999999987642 236
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|||||||+|+|...+.. ...|++.+++.|++||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 133 ~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 7999999999887766554 558999999999999999999999999999999999999999999999999999876432
Q ss_pred ---CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 273 ---HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 273 ---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
......+.+||++|||||++.+...|+.++||||||||+|||++|++||.+.+..+++..|+...|.|+...|....
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 22345677999999999999887788999999999999999999999999999999999999999999988775432
Q ss_pred CCCCccC--CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCC
Q 011041 350 LPHATIF--KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 350 ~~~~~~~--~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~ 410 (495)
......+ .........+...++.++++++|||.+||++||.+|+|+.|+|+||||+....+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p 354 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP 354 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence 1111000 000001112344566788999999999999999999999999999999976543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-65 Score=505.62 Aligned_cols=262 Identities=28% Similarity=0.421 Sum_probs=229.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.|+|||||+++++|++ ...+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~y 108 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLY 108 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEE
Confidence 4689999999999999999999999999999999986533 23345678999999999999999999999988 57899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC-C
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-K 274 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~-~ 274 (495)
||||||+|+.+..++...+.|+|.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 999999987666665556689999999999999999999999999999999999999999999999999999875433 2
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
....+.+||+.|||||++.+ ..|+.++||||||||||+|++|.+||.+.+..+++.+|.+....+
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-------------- 253 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF-------------- 253 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--------------
T ss_pred ccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--------------
Confidence 34567799999999999986 578999999999999999999999999999999999987632111
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHH------HHhCCCCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATA------ALRSEFFTTKPYA 410 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~e------lL~hp~f~~~~~~ 410 (495)
...+|+++++||.+||++||.+|+|++| +++||||++..|.
T Consensus 254 ---------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~ 300 (311)
T 4aw0_A 254 ---------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 300 (311)
T ss_dssp ---------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred ---------------CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence 1347788999999999999999999988 5889999987764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-64 Score=490.19 Aligned_cols=256 Identities=27% Similarity=0.462 Sum_probs=209.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.|+|||||++++++.+ ...+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~ 89 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS--KDEII 89 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEE
Confidence 5789999999999999999999999999999999987654 33445678999999999999999999999987 56899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
|||||++|+++..+.. ...+++.+++.++.||+.||+|||++||+||||||+||||+.++++||+|||+|+..... .
T Consensus 90 ivmEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~ 166 (275)
T 3hyh_A 90 MVIEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--N 166 (275)
T ss_dssp EEEECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC--C
Confidence 9999998888776654 457999999999999999999999999999999999999999999999999999876543 2
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
...+.+||+.|||||++.+...++.++|||||||+||+|++|++||.+.+..+.+..|......
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~---------------- 230 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT---------------- 230 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----------------
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence 3456799999999999988665678999999999999999999999999888888887653211
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
....+|+++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 231 -------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 231 -------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 11347888999999999999999999999999999975
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-64 Score=506.53 Aligned_cols=260 Identities=23% Similarity=0.440 Sum_probs=222.5
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+........+.+.+|+.+|+.|+|||||++++++++ +..+|
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~--~~~~y 99 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLY 99 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEE
Confidence 3689999999999999999999999999999999999887777778889999999999999999999999987 57899
Q ss_pred EEEeeccCChhhh-hh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 196 LVFKYMEHDLAGL-AA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 196 lv~e~~~~~l~~~-~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
||||||+|+.+.. +. .....++|.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999755544 43 344568999999999999999999999999999999999999999999999999998764321
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
...++.+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+++.+|......
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-------------- 243 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-------------- 243 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--------------
T ss_pred -ccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC--------------
Confidence 12345689999999999886 57999999999999999999999999999999999888763211
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.....+|+++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 244 --------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 244 --------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred --------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 1123578889999999999999999999999999999753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-64 Score=503.98 Aligned_cols=257 Identities=26% Similarity=0.438 Sum_probs=224.3
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
..|+++++||+|+||+||+|+++.+|+.||||++.+.... ..+.+.+|+.+|+.|+|||||+++++|.+ ...+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 6799999999999999999999999999999999865432 23457899999999999999999999988 5689999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
||||+++.+..++.. ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.... ...
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 227 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 227 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCB
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Ccc
Confidence 999998766665543 469999999999999999999999999999999999999999999999999998775432 335
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (495)
.+.+||++|||||++.+ ..|+.++||||||||||||++|.+||.+.+..+++..|..... +.
T Consensus 228 ~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~---------------- 289 (346)
T 4fih_A 228 KSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PR---------------- 289 (346)
T ss_dssp CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CC----------------
T ss_pred cccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CC----------------
Confidence 67799999999998876 5789999999999999999999999999999998888865321 11
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
...+..+|+++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 290 ---------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 290 ---------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp ---------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ---------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 11224578899999999999999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-62 Score=504.25 Aligned_cols=257 Identities=26% Similarity=0.438 Sum_probs=225.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
+.|+++++||+|+||.||+|+++.+|+.||||++.+.... ..+.+.+|+.+|+.|+|||||+++++|.+ ...+|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEE--CCEEEEE
Confidence 6799999999999999999999999999999999876432 23567899999999999999999999988 5689999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
||||+|+.+..++.. ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.|||+|||+|..+.... ...
T Consensus 227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 304 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 304 (423)
T ss_dssp EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCB
T ss_pred EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-ccc
Confidence 999998776666543 369999999999999999999999999999999999999999999999999998775432 345
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (495)
.+.+||++|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|..... +.
T Consensus 305 ~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~---------------- 366 (423)
T 4fie_A 305 KSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PR---------------- 366 (423)
T ss_dssp CCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC----------------
T ss_pred cccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CC----------------
Confidence 67899999999999876 5789999999999999999999999999999998888865321 10
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......+|+++.+||.+||++||.+|+|+.|+|+||||+..
T Consensus 367 ---------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 367 ---------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp ---------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ---------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 11234578899999999999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-63 Score=489.46 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=218.3
Q ss_pred CCCeeeeeeecccCceEEEEEEEC---CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.++|++++.||+|+||+||+|++. .+++.||||++.+..........+.+|+.+|++|+|||||++++++++ +..
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~ 100 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT--EGK 100 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE--TTE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCE
Confidence 368999999999999999999874 578899999998654433334467789999999999999999999988 578
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|||||||+|+.+..++.....+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 99999999987666666556689999999999999999999999999999999999999999999999999998654332
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
....+.+||+.|||||++.+ ..|+.++|||||||+||||++|.+||.+.+..+++.+|.+....
T Consensus 181 -~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-------------- 244 (304)
T 3ubd_A 181 -KKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG-------------- 244 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------------
T ss_pred -ccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCC--------------
Confidence 33456799999999999886 57899999999999999999999999999999999988763211
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-----HHHHHhCCCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEFFTTKPY 409 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----a~elL~hp~f~~~~~ 409 (495)
....+|+++.+||.+||++||.+||| ++|+|+||||++..|
T Consensus 245 ---------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 245 ---------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp ---------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ---------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 11347889999999999999999998 589999999998654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-61 Score=476.31 Aligned_cols=258 Identities=23% Similarity=0.298 Sum_probs=218.0
Q ss_pred CCe-eeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc--CCcee
Q 011041 118 DTF-EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR--MSCSL 194 (495)
Q Consensus 118 ~~y-~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~~ 194 (495)
++| ++.++||+|+||+||+|+++.++..||+|++..........+.+.+|+.+|+.|+|||||+++++|++. ....+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 344 777889999999999999999999999999988777777778899999999999999999999998652 23568
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--ceeccCCCCCeeeCC-CCcEEEeecccccccCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLIDN-EGILTIADFGLASFFDP 271 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~g--ivHrDlKp~NILl~~-~~~vkL~DFG~a~~~~~ 271 (495)
|||||||+++.+..++.....+++..++.|+.||+.||+|||++| ||||||||+||||+. +|.+||+|||+|+....
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999998777766666668999999999999999999999999 999999999999985 79999999999986432
Q ss_pred CCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
....+.+||+.|||||++.+ .|+.++||||||||||||+||++||.+.+....+.+..... ..+..
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~-~~~~~-------- 250 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKPAS-------- 250 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCCGG--------
T ss_pred ---CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC-CCCCC--------
Confidence 23466799999999998865 59999999999999999999999998876655544433211 11111
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
....+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 251 -----------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 251 -----------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 11346778999999999999999999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=479.15 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=216.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.+.|++.++||+|+||+||+|+++.+|+.||||++++.... .+|+.+|+.|+|||||++++++.+ ...+||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~--~~~~~i 127 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVRE--GPWVNI 127 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 46799999999999999999999999999999999875432 369999999999999999999987 568999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC-cEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~-~vkL~DFG~a~~~~~~~~~ 275 (495)
|||||+|+.+..++.....|++.+++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+......
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999876666665566899999999999999999999999999999999999999998 6999999999877543211
Q ss_pred ----CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 276 ----PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 276 ----~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
.....+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+.+|.... ++
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~---------- 274 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP--PP---------- 274 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC--CG----------
T ss_pred cceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC--CC----------
Confidence 1234589999999999987 579999999999999999999999999988877777776521 11
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHH-------------HhCCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAA-------------LRSEFFTTK 407 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~el-------------L~hp~f~~~ 407 (495)
..+....+|+++.+||.+||++||.+|||+.|+ |+|||+...
T Consensus 275 --------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 275 --------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp --------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred --------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 122345688899999999999999999999998 468998753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-59 Score=476.36 Aligned_cols=283 Identities=27% Similarity=0.388 Sum_probs=222.2
Q ss_pred CCCCeeeeeeecccCceEEEEEEEC---CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCC
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 191 (495)
..++|++++.||+|+||+||+|+++ .+++.||||++.... ....+.+|+.+|+.+ +|||||+++++|.+ .
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~ 92 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK--N 92 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--T
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE--C
Confidence 3478999999999999999999875 467899999986543 234577899999998 69999999999987 5
Q ss_pred ceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC-CcEEEeecccccccC
Q 011041 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFGLASFFD 270 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~-~~vkL~DFG~a~~~~ 270 (495)
.++||||||++++.+..+.. .+++.+++.|++||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+...
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 78999999999765555553 58999999999999999999999999999999999999876 899999999997654
Q ss_pred CCC---------------------------CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC-
Q 011041 271 PNH---------------------------KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP- 322 (495)
Q Consensus 271 ~~~---------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~- 322 (495)
... ....++.+||++|+|||++.+...|+.++||||+|||+|||++|++||.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 321 1223456899999999999887779999999999999999999998885
Q ss_pred CCChHHHHHHHHHhcCCCChhhhhhCC---------CCCCc------------c----CCCCcccccccccccCCCCCCc
Q 011041 323 GRTEVEQLHKIFKLCGSPSEEYWKKSK---------LPHAT------------I----FKPQQSYKRCIAETFKDFPPSS 377 (495)
Q Consensus 323 ~~~~~~~~~~i~~~~g~~~~~~~~~~~---------~~~~~------------~----~~~~~~~~~~~~~~~~~~s~~~ 377 (495)
+.++.+++..|+..+|.+....+.... .+... . +...........+.+..+|+++
T Consensus 250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a 329 (361)
T 4f9c_A 250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA 329 (361)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence 577889999999999876544332210 00000 0 0000000011123345688899
Q ss_pred HHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 378 LPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 378 ~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
+|||.+||++||.+|+|++|+|+||||++-
T Consensus 330 ~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 330 YDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=458.78 Aligned_cols=262 Identities=22% Similarity=0.383 Sum_probs=198.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC------
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM------ 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 190 (495)
.++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|+.|+|||||+++++|.+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 357999999999999999999999999999999998654 3445567889999999999999999999987532
Q ss_pred ----CceeEEEEeeccCChhhhhhCCCCC---CCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeec
Q 011041 191 ----SCSLYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADF 263 (495)
Q Consensus 191 ----~~~~~lv~e~~~~~l~~~~~~~~~~---l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DF 263 (495)
..++|||||||.++.+..+...... .++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 2358999999998766655544333 455678999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCC-----------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 011041 264 GLASFFDPNHK-----------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHK 332 (495)
Q Consensus 264 G~a~~~~~~~~-----------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~ 332 (495)
|+|+.+..... ...++.+||+.|||||++.+ ..|+.++||||||||||||++ ||.+.. +....
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~ 236 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRT 236 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHH
Confidence 99987654321 12245689999999999886 579999999999999999996 675432 33333
Q ss_pred HHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCC
Q 011041 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 333 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~ 410 (495)
+........+..| ...++.+.+||.+||+.||.+|||+.|+|+||||++..|+
T Consensus 237 ~~~~~~~~~p~~~-------------------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 237 LTDVRNLKFPPLF-------------------------TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289 (299)
T ss_dssp HHHHHTTCCCHHH-------------------------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred HHHHhcCCCCCCC-------------------------cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence 3222211111111 1234567889999999999999999999999999876554
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-58 Score=491.90 Aligned_cols=266 Identities=24% Similarity=0.376 Sum_probs=233.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|+.|+|||||+++++|.+ ...+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 578999999999999999999999999999999997653 3445678899999999999999999999987 678999
Q ss_pred EEeeccCChh-hhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC--CcEEEeecccccccCCCC
Q 011041 197 VFKYMEHDLA-GLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE--GILTIADFGLASFFDPNH 273 (495)
Q Consensus 197 v~e~~~~~l~-~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~--~~vkL~DFG~a~~~~~~~ 273 (495)
|||||.|+.+ ..+......|++.+++.|++||+.||+|||++||+||||||+||||+.+ +.+||+|||+|+.+...
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999987544 4454556689999999999999999999999999999999999999864 89999999999987644
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......+||++|||||++.+ ..|+.++||||||||||||++|.+||.+.+..+++.+|......++...|
T Consensus 311 -~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 380 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF-------- 380 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGG--------
T ss_pred -CceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccc--------
Confidence 33466789999999999887 57899999999999999999999999999999999998775544443333
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPS 414 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~~~~~ 414 (495)
..+|+++++||.+||++||.+|||+.|+|+||||+...++....
T Consensus 381 -----------------~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~~~ 424 (573)
T 3uto_A 381 -----------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 424 (573)
T ss_dssp -----------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTTTC
T ss_pred -----------------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCchh
Confidence 45788999999999999999999999999999999877765443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=487.65 Aligned_cols=262 Identities=26% Similarity=0.368 Sum_probs=218.7
Q ss_pred CCCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC----ChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc
Q 011041 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILILRRLDHPNVVKLEGLVTSR 189 (495)
Q Consensus 114 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 189 (495)
+...++|++++.||+|+||.||+|+++.+|+.||||++.+... .........+++.+++.++|||||+++++|.+
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~- 263 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT- 263 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-
Confidence 4457899999999999999999999999999999999976432 12222233345677778899999999999988
Q ss_pred CCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccccccc
Q 011041 190 MSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (495)
Q Consensus 190 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~ 269 (495)
...+|||||||.|+.+..++.....|+|..++.|+.||+.||+|||++|||||||||+||||+.+|+|||+|||+|+.+
T Consensus 264 -~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 264 -PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred -CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 5789999999998777666666668999999999999999999999999999999999999999999999999999877
Q ss_pred CCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChhhhh
Q 011041 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---VEQLHKIFKLCGSPSEEYWK 346 (495)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~g~~~~~~~~ 346 (495)
... ...+.+||+.|||||++.+...|+.++||||||||||||++|.+||.+.+. .++...+....
T Consensus 343 ~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--------- 410 (689)
T 3v5w_A 343 SKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--------- 410 (689)
T ss_dssp SSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC---------
T ss_pred CCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC---------
Confidence 543 235679999999999997656799999999999999999999999987543 23333333211
Q ss_pred hCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-----HHHHHhCCCCCCCCC
Q 011041 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEFFTTKPY 409 (495)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----a~elL~hp~f~~~~~ 409 (495)
......+|+++.+||.+||+.||.+|++ ++|+++||||++..|
T Consensus 411 --------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 411 --------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred --------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 0112457889999999999999999998 899999999998655
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-56 Score=443.31 Aligned_cols=256 Identities=22% Similarity=0.316 Sum_probs=208.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.++||+|+||+||+|++.. .||||+++.........+.|.+|+.+|++|+|||||++++++.+ ..+||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~i 108 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLAI 108 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEEE
Confidence 4789999999999999999997543 59999998766677778889999999999999999999998864 35899
Q ss_pred EEeeccCChhhh-hhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC-C
Q 011041 197 VFKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-K 274 (495)
Q Consensus 197 v~e~~~~~l~~~-~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~-~ 274 (495)
|||||+++.+.. +......+++.++..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+...... .
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 999999765554 44556689999999999999999999999999999999999999999999999999998764322 2
Q ss_pred CCCccccccCCCCCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
......+||+.|||||++.+. ..|+.++|||||||+||||+||++||.+.+....+..+......++.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~---------- 258 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD---------- 258 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC----------
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC----------
Confidence 334567899999999998643 35899999999999999999999999998777666555432211110
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
+.....++|+++.+||.+||+.||.+|||+.|++++
T Consensus 259 -------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 259 -------------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp -------------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred -------------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 122335678889999999999999999999987543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-56 Score=438.32 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=209.2
Q ss_pred CCCeeeeeeecccCceEEEEEEEC-----CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
.++|.+.+.||+|+||+||+|++. .++..||||+++.. .....+.|.+|+.+|++|+|||||++++++.+ .
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--G 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee--C
Confidence 478999999999999999999875 46889999999753 45566789999999999999999999999987 5
Q ss_pred ceeEEEEeeccCChhhhhhC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcE
Q 011041 192 CSLYLVFKYMEHDLAGLAAS-------------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGIL 258 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~-------------~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~v 258 (495)
..+|||||||+++.+..++. ....+++.++..|+.||+.||.|||+++||||||||+||||+.++.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 67999999999765554432 23469999999999999999999999999999999999999999999
Q ss_pred EEeecccccccCCCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 011041 259 TIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKL 336 (495)
Q Consensus 259 kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~ 336 (495)
||+|||+|+........ .....+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..|...
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999866433221 1234578999999999976 579999999999999999998 99999999998888887652
Q ss_pred cCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 337 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.. ......+|+++.+||.+||+.||.+|||+.++++
T Consensus 247 ~~----------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~ 282 (299)
T 4asz_A 247 RV----------------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHT 282 (299)
T ss_dssp CC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC----------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11 0112357888999999999999999999999953
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-55 Score=438.20 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=205.0
Q ss_pred CCCeeeeeeecccCceEEEEEEEC-----CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
.++|.+.++||+|+||+||+|+++ .++..||||+++.. .....+.|.+|+.+|++|+|||||++++++.+ .
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE--G 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--C
Confidence 368999999999999999999865 46899999999743 45566789999999999999999999999987 5
Q ss_pred ceeEEEEeeccCChhhhhhCC---------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC
Q 011041 192 CSLYLVFKYMEHDLAGLAASP---------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG 256 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~---------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~ 256 (495)
..+|||||||+++.+..++.. ...+++.++..|+.||+.||.|||+++||||||||+||||+.++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 679999999998766554321 23599999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011041 257 ILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIF 334 (495)
Q Consensus 257 ~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~ 334 (495)
.+||+|||+++....... ......+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..|.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999987643322 22345679999999999876 579999999999999999998 999999999888888776
Q ss_pred HhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 335 KLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 335 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
..... .....+|+++.+||.+||+.||.+|||+.|++++
T Consensus 275 ~g~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 275 QGREL----------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HTCCC----------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cCCCC----------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 52110 1123578889999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=427.49 Aligned_cols=286 Identities=39% Similarity=0.692 Sum_probs=243.5
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|++++.||+|+||+||+|++..+|+.||||++............+.+|+.+++.++||||+++++++.+ ...+|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--CCEEEEE
Confidence 68999999999999999999999999999999998776666666788899999999999999999999987 5689999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
|||++++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 158 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SCC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-ccc
Confidence 9999999988887777789999999999999999999999999999999999999999999999999998765332 334
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHhcCCCChhhhhhCC-CCCCcc
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKP-IMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPHATI 355 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~-pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~-~~~~~~ 355 (495)
...+||+.|+|||++.+...++.++|||||||++|+|++|.. +|.+.+..+.+..+....+.+....|.... .+...
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~- 237 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK- 237 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC-
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc-
Confidence 556889999999999876668999999999999999997655 577888889999999999999888776532 11111
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
..+.......+......+++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 1111111122334455678889999999999999999999999999999863
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-54 Score=430.58 Aligned_cols=287 Identities=39% Similarity=0.712 Sum_probs=238.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|++. +|+.||+|++............+.+|+.+|+.++||||+++++++.+ ...+|+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 96 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS--ERCLTL 96 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC--SSCEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc--CCEEEE
Confidence 589999999999999999999985 58999999998665444556778899999999999999999999987 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 97 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 175 (311)
T 3niz_A 97 VFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RS 175 (311)
T ss_dssp EEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C-
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-cc
Confidence 99999999888888777789999999999999999999999999999999999999999999999999998765332 23
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC-Ccc
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH-ATI 355 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~-~~~ 355 (495)
....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|....-.. ...
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 4456889999999999876778999999999999999999999999999999999999999998887776532110 000
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.................+++++.+||.+||++||.+|||+.|+|+||||++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 0000001112334456678899999999999999999999999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-55 Score=432.99 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=210.9
Q ss_pred CCCCeeeeeeecccCceEEEEEEEC-----CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM 190 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 190 (495)
..++++++++||+|+||+||+|+.. .+++.||||+++... .....+.|.+|+.+|++|+|||||+++|++.+
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-- 100 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-- 100 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE--
Confidence 3568999999999999999999853 467899999987543 33445678999999999999999999999987
Q ss_pred CceeEEEEeeccCChhhhhh-CC---------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC
Q 011041 191 SCSLYLVFKYMEHDLAGLAA-SP---------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN 254 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~-~~---------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~ 254 (495)
+..+|||||||+++.+..++ .. ...+++.++..|+.||+.||.|||+++||||||||+||||++
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 56799999999976555443 21 235899999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCC-CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 011041 255 EGILTIADFGLASFFDPNH-KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHK 332 (495)
Q Consensus 255 ~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~ 332 (495)
++++||+|||+++...... .......+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+++..
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999998664332 223455689999999999876 579999999999999999998 8999999998888877
Q ss_pred HHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 333 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
|...... ....++|+++.+||.+||+.||.+|||+.|++++
T Consensus 260 i~~~~~~----------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 260 IRNRQVL----------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCC----------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7542111 1124577889999999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=449.26 Aligned_cols=294 Identities=33% Similarity=0.550 Sum_probs=228.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc---CCce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR---MSCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---~~~~ 193 (495)
.++|++++.||+|+||+||+|+++.+|+.||||++............+.+|+.+|+.++|||||++++++... ....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4789999999999999999999999999999999977655666778899999999999999999999998542 1357
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|+||||+++++...+.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++......
T Consensus 132 ~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 999999999888776655 4579999999999999999999999999999999999999999999999999998764322
Q ss_pred C--------------------------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-----------
Q 011041 274 K--------------------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA----------- 316 (495)
Q Consensus 274 ~--------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt----------- 316 (495)
. ...+..+||++|+|||++.....|+.++||||||||||||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 1 134566889999999987666779999999999999999998
Q ss_pred CCCCCCCCC--------------------hHHHHHHHHHhcCCCChhhhhhCCCCCCccC--CCCcccccccccccCCCC
Q 011041 317 EKPIMPGRT--------------------EVEQLHKIFKLCGSPSEEYWKKSKLPHATIF--KPQQSYKRCIAETFKDFP 374 (495)
Q Consensus 317 G~~pf~~~~--------------------~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~s 374 (495)
|.++|.+.+ ..+++..|+..+|.+..+.|..........+ .........+...++.++
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 370 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS 370 (458)
T ss_dssp CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSC
T ss_pred ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCC
Confidence 889998865 3688899999999999887754322111000 000011122445567788
Q ss_pred CCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCCC
Q 011041 375 PSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYAC 411 (495)
Q Consensus 375 ~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~~ 411 (495)
+++.+||.+||++||.+|||++|+|+||||+...++.
T Consensus 371 ~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 9999999999999999999999999999999876654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=421.51 Aligned_cols=283 Identities=38% Similarity=0.692 Sum_probs=234.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|++++.||+|+||.||+|++ .+|+.||+|++............+.+|+.+++.++||||+++++++.+ ...+|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc--CCeEEEE
Confidence 6899999999999999999998 678999999997654433334667899999999999999999999987 5679999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
|||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (288)
T 1ob3_A 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY 157 (288)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-ccc
Confidence 9999998888777766789999999999999999999999999999999999999999999999999998764322 223
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC-CCCCc-c
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPHAT-I 355 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~-~~~~~-~ 355 (495)
...+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+....|+... .+... .
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 456789999999999776678999999999999999999999999999999999999999988877775421 11100 0
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
+... ...........+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 238 ~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 238 FTVY--EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCC--CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccc--cCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0000 001123344567889999999999999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=436.67 Aligned_cols=289 Identities=35% Similarity=0.582 Sum_probs=230.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.+. ||||+++++++.......+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 47899999999999999999999999999999999766556667778889999999997 99999999999865556799
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC---
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN--- 272 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~--- 272 (495)
+||||+++++...+.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 88 lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 9999999887776654 36899999999999999999999999999999999999999999999999999865321
Q ss_pred -----------------CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 011041 273 -----------------HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335 (495)
Q Consensus 273 -----------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 335 (495)
.....+..+||++|+|||++.+...|+.++||||||||+|||++|.+||.+.+..+++..|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 112234568999999999998767899999999999999999999999999999999999999
Q ss_pred hcCCCChhhhhhCCCCCCccCCC---------Ccc----c---cccc--ccccCCCCCCcHHHHHHhccCCCCCccCHHH
Q 011041 336 LCGSPSEEYWKKSKLPHATIFKP---------QQS----Y---KRCI--AETFKDFPPSSLPLIETLLAIDPAERQTATA 397 (495)
Q Consensus 336 ~~g~~~~~~~~~~~~~~~~~~~~---------~~~----~---~~~~--~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~e 397 (495)
.++.|..+.+.....+....+.. ... + ...+ ......+++++.+||.+||++||.+|||+.|
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 99999988775543322111000 000 0 0000 0011256888999999999999999999999
Q ss_pred HHhCCCCCCC
Q 011041 398 ALRSEFFTTK 407 (495)
Q Consensus 398 lL~hp~f~~~ 407 (495)
+|+||||+..
T Consensus 326 ~l~Hp~~~~~ 335 (388)
T 3oz6_A 326 ALKHPFVSIF 335 (388)
T ss_dssp HTTSTTTTTT
T ss_pred HhCCHHHHHh
Confidence 9999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-54 Score=452.11 Aligned_cols=285 Identities=29% Similarity=0.529 Sum_probs=230.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC----Cc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~ 192 (495)
.++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++|||||++++++.... ..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999999999999999999876556666778899999999999999999999986532 24
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+||||||+++++...+.. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 141 ~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 6899999999998776643 4899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
...+..+||++|+|||++.+ ..|+.++||||||||||+|++|++||.+.+..+++.+|++.+|.+..++|.......
T Consensus 218 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 218 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp --CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred --cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 33466789999999999987 578999999999999999999999999999999999999999999988776532100
Q ss_pred CccCCC-----Ccccccccccc-c-------CCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 353 ATIFKP-----QQSYKRCIAET-F-------KDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 353 ~~~~~~-----~~~~~~~~~~~-~-------~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
...... ...+....... + ...++++.+||.+||++||.+|||++|+|+||||+..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 000000 00000000000 0 0014568999999999999999999999999999853
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-53 Score=423.89 Aligned_cols=260 Identities=27% Similarity=0.441 Sum_probs=227.7
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
..++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET--EKTLY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEE
Confidence 3578999999999999999999999999999999998877677777889999999999999999999999987 56899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+||||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+... .
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~ 168 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--G 168 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--C
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--C
Confidence 99999987665555544457999999999999999999999999999999999999999999999999999876543 2
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
.....+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+.......
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------------- 233 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI--------------- 233 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------------
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------------
Confidence 34567899999999999876555689999999999999999999999999888888776532111
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
...+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 234 --------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 234 --------------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp --------------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred --------------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 123677899999999999999999999999999998643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=438.35 Aligned_cols=294 Identities=31% Similarity=0.528 Sum_probs=239.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC---ce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS---CS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---~~ 193 (495)
.++|++++.||+|+||.||+|+++.+|+.||||++............+.+|+.+|+.++||||+++++++..... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999999999999999998765566677889999999999999999999999876321 56
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|+||||++++|...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 105 ~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 999999999987776654 4579999999999999999999999999999999999999999999999999998765432
Q ss_pred C---------------------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-----------CCCCC
Q 011041 274 K---------------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-----------EKPIM 321 (495)
Q Consensus 274 ~---------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-----------G~~pf 321 (495)
. ...+..+||++|+|||++.....|+.++||||||||+|||++ |.|+|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f 263 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence 1 124677899999999987666779999999999999999997 67777
Q ss_pred CCCC-----------------hHHHHHHHHHhcCCCChhhhhhCCCCCCccC--CCCcccccccccccCCCCCCcHHHHH
Q 011041 322 PGRT-----------------EVEQLHKIFKLCGSPSEEYWKKSKLPHATIF--KPQQSYKRCIAETFKDFPPSSLPLIE 382 (495)
Q Consensus 322 ~~~~-----------------~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~s~~~~~Li~ 382 (495)
.+.+ ..+++..|+..+|.|+.+.|..........+ .............++.+++++.+||.
T Consensus 264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 343 (432)
T 3n9x_A 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE 343 (432)
T ss_dssp CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 7765 4788999999999999887765322111000 00000111133445678999999999
Q ss_pred HhccCCCCCccCHHHHHhCCCCCCCCCCC
Q 011041 383 TLLAIDPAERQTATAALRSEFFTTKPYAC 411 (495)
Q Consensus 383 ~~L~~dP~~R~ta~elL~hp~f~~~~~~~ 411 (495)
+||++||.+|||+.|+|+||||+...++.
T Consensus 344 ~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 344 SMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp HHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred HHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 99999999999999999999999866543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=428.41 Aligned_cols=261 Identities=23% Similarity=0.356 Sum_probs=230.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh----HHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP----ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
.+.|++++.||+|+||.||+|+++.+|+.||+|++.+..... ...+.+.+|+.+|+.++||||+++++++.+ ..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--RT 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--CC
Confidence 477999999999999999999999999999999998764322 134678899999999999999999999987 56
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC----cEEEeecccccc
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG----ILTIADFGLASF 268 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~----~vkL~DFG~a~~ 268 (495)
.+|+||||+.++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 8999999998776666666667899999999999999999999999999999999999998877 799999999987
Q ss_pred cCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
+... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|......++...|
T Consensus 169 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--- 242 (361)
T 2yab_A 169 IEDG--VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF--- 242 (361)
T ss_dssp CCTT--CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH---
T ss_pred cCCC--CccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc---
Confidence 6543 23456789999999999876 56899999999999999999999999999999999998876666655555
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
..+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 243 ----------------------~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 243 ----------------------SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp ----------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred ----------------------cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 3477889999999999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=425.44 Aligned_cols=297 Identities=42% Similarity=0.735 Sum_probs=241.7
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh---HHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP---ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
..++|++++.||+|+||.||+|++..+|+.||||++....... .....+.+|+.+++.++||||+++++++.+ ..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 85 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KS 85 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TT
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee--CC
Confidence 3578999999999999999999999999999999997543211 122467789999999999999999999987 56
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|+||||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 86 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 86 NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred ceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 79999999999888777777678999999999999999999999999999999999999999999999999999876533
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC-CC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LP 351 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~-~~ 351 (495)
. ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.+++...+.+....|+... ++
T Consensus 166 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 166 N-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp C-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred c-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 2 334556899999999998776678999999999999999999999999999999999999999999888886532 22
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCCCCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLP 417 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~~~~~~~p 417 (495)
....+..... ..+...+..+++++.+||.+||..||.+|||+.|+|+||||+..+++......|
T Consensus 245 ~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~~~~~ 308 (346)
T 1ua2_A 245 DYVTFKSFPG--IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 308 (346)
T ss_dssp TCCCCCCCCC--CCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSC
T ss_pred ccccccccCC--CChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCcccCC
Confidence 2111111111 112334567788999999999999999999999999999999987765544433
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=424.00 Aligned_cols=290 Identities=37% Similarity=0.685 Sum_probs=224.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|+++.+|+.||||++..... ......+.+|+.+|+.++||||+++++++.+ ...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHT--ENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECC--TTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEE--CCeEEE
Confidence 4689999999999999999999999999999999986542 2233567789999999999999999999987 568999
Q ss_pred EEeeccCChhhhhhCC-----CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 197 VFKYMEHDLAGLAASP-----TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~-----~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
||||+++++...+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 81 v~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 81 VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 9999998877655432 24589999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC-C
Q 011041 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-L 350 (495)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~-~ 350 (495)
.. ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..|...++.+....|.... +
T Consensus 161 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 161 PV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp CC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred Cc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 32 233456889999999999876678999999999999999999999999999999999999999999888876532 1
Q ss_pred CCCcc---CCCCcccccc-cccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCC
Q 011041 351 PHATI---FKPQQSYKRC-IAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 351 ~~~~~---~~~~~~~~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~ 410 (495)
+.... ..+....... .......+++++.+||.+||+.||.+|||+.|+|+||||+...+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 11110 0111111111 112233578889999999999999999999999999999975443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=430.58 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=208.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCC-----CeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCC-CCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLT-----GQIVALKKVRFDNLEPESVRFMAREILILRRLDH-PNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~ 190 (495)
.++|++++.||+|+||+||+|++..+ ++.||||++.... .....+.+.+|+.+|.+++| ||||++++++...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 47899999999999999999987654 4689999987543 34556778999999999965 8999999998653
Q ss_pred CceeEEEEeeccCChhhhhhCC----------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC
Q 011041 191 SCSLYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN 254 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~----------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~ 254 (495)
+..+|||||||+++.+..++.. ...+++.++..|+.||+.||+|||+++||||||||+||||+.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 4568999999998665544321 235899999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 011041 255 EGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHK 332 (495)
Q Consensus 255 ~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~ 332 (495)
++.+||+|||+|+.+...... .....+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+.+
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999876433221 2245678999999999986 579999999999999999998 9999998765444444
Q ss_pred HHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 333 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
++.....+ .....+|+++.+||..||+.||.+|||+.|+++|
T Consensus 300 ~i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 43321111 1123467889999999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=426.99 Aligned_cols=288 Identities=32% Similarity=0.536 Sum_probs=234.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC----c
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS----C 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----~ 192 (495)
.++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 478999999999999999999999999999999997665556667788999999999999999999999876321 3
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|+||||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~- 180 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 180 (367)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc-
Confidence 5799999997766665544 3689999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.....+||++|+|||++.+...|+.++||||||||+|+|++|++||.+.+..+++..|++..|.++.+.+.......
T Consensus 181 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 257 (367)
T 1cm8_A 181 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257 (367)
T ss_dssp ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence 23556899999999999876679999999999999999999999999999999999999999999988776432111
Q ss_pred CccCC--CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCC
Q 011041 353 ATIFK--PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 353 ~~~~~--~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~ 410 (495)
...+. -.......+...+..+++.+.+||.+||+.||.+|||+.|+|+||||+....+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317 (367)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence 10000 00000112334556778899999999999999999999999999999975443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=425.91 Aligned_cols=296 Identities=45% Similarity=0.727 Sum_probs=241.9
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC-----
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----- 190 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 190 (495)
..++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 358999999999999999999999999999999999766554444456778999999999999999999987642
Q ss_pred -CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccccccc
Q 011041 191 -SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (495)
Q Consensus 191 -~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~ 269 (495)
...+|+||||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 3468999999999998888877778999999999999999999999999999999999999999999999999999876
Q ss_pred CCCC---CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 011041 270 DPNH---KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (495)
Q Consensus 270 ~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (495)
.... .......+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+.+..+...++.++...|+
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 254 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 4221 2233556889999999999876678999999999999999999999999999999999999999998887776
Q ss_pred hCCCCC-CccCCCCcccccccccccC--CCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCCC
Q 011041 347 KSKLPH-ATIFKPQQSYKRCIAETFK--DFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYAC 411 (495)
Q Consensus 347 ~~~~~~-~~~~~~~~~~~~~~~~~~~--~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~~ 411 (495)
...... .............+...+. ..++.+.+||.+||++||.+|||+.|+|+||||+..+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 422110 0000000000000000000 1356789999999999999999999999999999876653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=422.27 Aligned_cols=291 Identities=35% Similarity=0.671 Sum_probs=228.4
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
..++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++.+ ...+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 109 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH--NHRLH 109 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE--TTEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec--CCEEE
Confidence 3578999999999999999999999999999999998765555555677899999999999999999999987 56899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeC-----CCCcEEEeecccccccC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID-----NEGILTIADFGLASFFD 270 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~-----~~~~vkL~DFG~a~~~~ 270 (495)
+||||+++++...+... ..+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++..+.
T Consensus 110 lv~e~~~~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAENDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99999999777666543 4699999999999999999999999999999999999994 45569999999998765
Q ss_pred CCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC-
Q 011041 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK- 349 (495)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~- 349 (495)
... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.+++...+.+....|....
T Consensus 189 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 189 IPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred Ccc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 332 234556789999999999876678999999999999999999999999999999999999999998887775421
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~ 410 (495)
.+......+..............+++++.+||.+||++||.+|||+.|+|+||||++..|.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence 1111100000000000111112367889999999999999999999999999999987653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=413.81 Aligned_cols=286 Identities=36% Similarity=0.639 Sum_probs=233.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC---hHHHHHHHHHHHHHHhC---CCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE---PESVRFMAREILILRRL---DHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~ 190 (495)
.++|++++.||+|+||.||+|++..+|+.||||++...... ......+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 47899999999999999999999999999999999754321 11223456777777776 4999999999987632
Q ss_pred C---ceeEEEEeeccCChhhhhhCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccc
Q 011041 191 S---CSLYLVFKYMEHDLAGLAASPT-IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266 (495)
Q Consensus 191 ~---~~~~lv~e~~~~~l~~~~~~~~-~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a 266 (495)
. ..+++||||+++++...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 2 2589999999998877766543 34999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 011041 267 SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (495)
Q Consensus 267 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (495)
...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+.++....+.++...|.
T Consensus 168 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 168 RIYSYQ--MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp TTSTTC--CCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred cccCCC--cccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 876533 33456789999999999876 568999999999999999999999999999999999999999999988886
Q ss_pred hCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.........+.+. ....+......+++++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 245 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 245 RDVSLPRGAFPPR--GPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SSCSSCGGGSCCC--CCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred chhhccccccCCC--CCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 5332211122111 1122344556788899999999999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=425.60 Aligned_cols=288 Identities=38% Similarity=0.669 Sum_probs=232.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|++++.||+|+||.||+|++..+++.||||++...... .....+.+|+.+|+.++||||+++++++.+ ...+|+|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEee--CCEEEEE
Confidence 6899999999999999999999999999999999754321 111234579999999999999999999987 5679999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
|||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~ 157 (324)
T 3mtl_A 79 FEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTY 157 (324)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-ccc
Confidence 9999998888877766779999999999999999999999999999999999999999999999999998654332 234
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC-ccC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA-TIF 356 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~-~~~ 356 (495)
...+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..+.+.++.+....|+....... ..+
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 4568899999999998767789999999999999999999999999999999999999999998887764211100 000
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
.........+......+++++.+||.+||++||.+|||+.|+|+||||.....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 00011111123344567889999999999999999999999999999987543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=432.89 Aligned_cols=285 Identities=35% Similarity=0.552 Sum_probs=232.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc----CCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR----MSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----~~~ 192 (495)
..+|++++.||+|+||.||+|++..+|+.||||++..... ...+|+.+|+.|+|||||++++++... ...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 4579999999999999999999999999999999975432 234799999999999999999988542 234
Q ss_pred eeEEEEeeccCChhhhhh---CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC-CcEEEeecccccc
Q 011041 193 SLYLVFKYMEHDLAGLAA---SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFGLASF 268 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~---~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~-~~vkL~DFG~a~~ 268 (495)
++++||||+++++...+. .....+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++.
T Consensus 127 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 578999999987765543 345679999999999999999999999999999999999999965 6789999999987
Q ss_pred cCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
+... ......+||++|+|||++.+...|+.++||||||||||||++|++||.+.+..+++.+|++.+|.+..+.|...
T Consensus 207 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 207 LVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CCTT--CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cccC--CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 6433 22345689999999999987667999999999999999999999999999999999999999999998887654
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
.........+......+.......+++++.+||.+||.+||.+|||+.|+|+||||.....
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 3221111111111111111122457889999999999999999999999999999986443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-52 Score=422.36 Aligned_cols=260 Identities=26% Similarity=0.432 Sum_probs=228.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|+++.+|+.||+|++..........+.+.+|+.+|+.|+||||+++++++.+ ....|+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~l 105 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 105 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 367999999999999999999999999999999999877777777889999999999999999999999987 568999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC---CcEEEeecccccccCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE---GILTIADFGLASFFDPNH 273 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~---~~vkL~DFG~a~~~~~~~ 273 (495)
||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++......
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~- 184 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence 99999987665555556689999999999999999999999999999999999999865 45999999999876533
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..+......++...|
T Consensus 185 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 254 (362)
T 2bdw_A 185 -EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW-------- 254 (362)
T ss_dssp -CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGG--------
T ss_pred -cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccc--------
Confidence 23456689999999999876 56899999999999999999999999999988888888765444333333
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
..+++++.+||.+||..||.+|||+.++|+||||..
T Consensus 255 -----------------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 255 -----------------DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp -----------------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred -----------------cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 346788999999999999999999999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=408.75 Aligned_cols=290 Identities=33% Similarity=0.553 Sum_probs=234.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--KRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec--CCeEEE
Confidence 468999999999999999999999999999999998776666667788899999999999999999999987 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||++++++..+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 158 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DY 158 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-cc
Confidence 99999999888777666789999999999999999999999999999999999999999999999999998765332 23
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC--c
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA--T 354 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~--~ 354 (495)
....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+......+........ .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 34568899999999998767789999999999999999999999999999999999988888776543322110000 0
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
...+.......+...+..+++++.+||.+||..||.+|||+.|+|+||||++..+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 0001111111123344678888999999999999999999999999999997543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-52 Score=432.89 Aligned_cols=261 Identities=28% Similarity=0.439 Sum_probs=227.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|+++.+|+.||+|++............+.+|+.+|+.++|||||++++++.+ ....|+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~l 87 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE--EGHHYL 87 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC--SSEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE--CCEEEE
Confidence 478999999999999999999999999999999999877666677789999999999999999999999987 678999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeC---CCCcEEEeecccccccCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID---NEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~---~~~~vkL~DFG~a~~~~~~~ 273 (495)
||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+ .++.+||+|||++.......
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 999999866655554456799999999999999999999999999999999999998 46789999999998765432
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..+......++...|
T Consensus 168 -~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 237 (444)
T 3soa_A 168 -QAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW-------- 237 (444)
T ss_dssp -CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTT--------
T ss_pred -ceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccc--------
Confidence 23356789999999999876 56899999999999999999999999999999998888775544443333
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
..+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 238 -----------------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 238 -----------------DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp -----------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred -----------------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 357888999999999999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=423.58 Aligned_cols=288 Identities=34% Similarity=0.547 Sum_probs=224.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc----CCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR----MSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----~~~ 192 (495)
.++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++... ...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 3789999999999999999999999999999999976655566677888999999999999999999998653 125
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|+||||++++|...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 108 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~- 184 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD- 184 (367)
T ss_dssp CCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred eEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc-
Confidence 6899999998766655443 4699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.....+||++|+|||++.+...|+.++||||||||+|+|++|.+||.+.+..+++..|++.+|.|..+.|.......
T Consensus 185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 185 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred ---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 23556899999999998876779999999999999999999999999999999999999999999988776532110
Q ss_pred CccC--CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCC
Q 011041 353 ATIF--KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 353 ~~~~--~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~ 410 (495)
...+ .-.......+...+...++.+.+||.+||+.||.+|||+.|+|+||||+....+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence 0000 000000111334456678899999999999999999999999999999975444
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=418.78 Aligned_cols=260 Identities=26% Similarity=0.402 Sum_probs=223.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++.+ ...+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe--CCEEE
Confidence 5789999999999999999999999999999999976422 22345678899999999999999999999987 56899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+||||+.++.+.........+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++....... .
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 160 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-C
Confidence 999999987666555555679999999999999999999999999999999999999999999999999998643222 3
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|......
T Consensus 161 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~---------------- 223 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR---------------- 223 (337)
T ss_dssp CBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------
T ss_pred cccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence 3456789999999999876 56899999999999999999999999999888887777542111
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPY 409 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~ 409 (495)
....+++++.+||.+||..||.+|| ++.++++||||....|
T Consensus 224 -------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 224 -------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred -------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 1134678899999999999999999 9999999999997655
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=413.73 Aligned_cols=259 Identities=20% Similarity=0.334 Sum_probs=226.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|++..+|+.||+|++... ......+.+|+.+|+.++||||+++++++.+ ...+|+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFES--MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEec--CCEEEE
Confidence 47899999999999999999999999999999998743 3445678899999999999999999999987 568999
Q ss_pred EEeeccCChh-hhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC--CCcEEEeecccccccCCCC
Q 011041 197 VFKYMEHDLA-GLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN--EGILTIADFGLASFFDPNH 273 (495)
Q Consensus 197 v~e~~~~~l~-~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~--~~~vkL~DFG~a~~~~~~~ 273 (495)
||||++++.+ ..+......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+...
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 9999987544 444444557999999999999999999999999999999999999987 789999999999877543
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......++...|
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 227 (321)
T 1tki_A 158 -DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-------- 227 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH--------
T ss_pred -CccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhh--------
Confidence 23455689999999999876 46799999999999999999999999999999999988876655555444
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
..+|+++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 228 -----------------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 228 -----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp -----------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred -----------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 35788899999999999999999999999999998643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=425.45 Aligned_cols=261 Identities=25% Similarity=0.372 Sum_probs=219.9
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCce
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 193 (495)
..++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.+ +||||+++++++.+ ...
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~ 98 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDR 98 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCE
Confidence 35899999999999999999999999999999999986432 233456678899999998 79999999999987 568
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|+||||+.++.+..+......+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||++.......
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 99999999987666655555679999999999999999999999999999999999999999999999999998643222
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+.+|.......
T Consensus 179 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~------------- 243 (353)
T 3txo_A 179 -VTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY------------- 243 (353)
T ss_dssp --------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------
T ss_pred -ccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 33456689999999999876 568999999999999999999999999999999988887632111
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCH------HHHHhCCCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA------TAALRSEFFTTKPY 409 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta------~elL~hp~f~~~~~ 409 (495)
...+++++.+||.+||+.||.+||++ .++++||||+...|
T Consensus 244 ----------------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 244 ----------------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp ----------------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred ----------------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 12367789999999999999999998 99999999998665
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=420.58 Aligned_cols=282 Identities=29% Similarity=0.505 Sum_probs=232.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc-------
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR------- 189 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------- 189 (495)
.++|++++.||+|+||.||+|++..+|+.||||++..+.. ...+|+.+|+.++|||||++++++...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4789999999999999999999999999999999975532 223799999999999999999998542
Q ss_pred -----------------------------CCceeEEEEeeccCChhhhh---hCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 011041 190 -----------------------------MSCSLYLVFKYMEHDLAGLA---ASPTIKFTQAQVKCYMHQLLSGLEHCHN 237 (495)
Q Consensus 190 -----------------------------~~~~~~lv~e~~~~~l~~~~---~~~~~~l~e~~~~~i~~qil~~L~~LH~ 237 (495)
...++++||||+++++...+ ......+++..++.++.||+.||.|||+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 23458999999998755443 3456689999999999999999999999
Q ss_pred CCceeccCCCCCeeeC-CCCcEEEeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh
Q 011041 238 QHVLHRDIKGSNLLID-NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316 (495)
Q Consensus 238 ~givHrDlKp~NILl~-~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt 316 (495)
+||+||||||+||||+ .++.+||+|||++..+.... .....+||+.|+|||++.+...|+.++|||||||++|+|++
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 9999999999999998 68999999999998765432 33556889999999999876679999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHH
Q 011041 317 EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT 396 (495)
Q Consensus 317 G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~ 396 (495)
|.+||.+.+..+++..|.+.+|.+..+.|............+......+.......+|+++.+||.+||++||.+|||+.
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 99999999999999999999999998877654332222222221111222223345788899999999999999999999
Q ss_pred HHHhCCCCCC
Q 011041 397 AALRSEFFTT 406 (495)
Q Consensus 397 elL~hp~f~~ 406 (495)
|+|+||||+.
T Consensus 318 e~l~hp~f~~ 327 (383)
T 3eb0_A 318 EAMAHPFFDH 327 (383)
T ss_dssp HHHTSGGGHH
T ss_pred HHhcCHHHHH
Confidence 9999999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=409.63 Aligned_cols=260 Identities=24% Similarity=0.369 Sum_probs=226.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh----HHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP----ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
.+.|++.+.||+|+||.||+|++..+|+.||+|++....... ...+.+.+|+.+|+.++||||+++++++.+ ..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~ 87 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KT 87 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CC
Confidence 367999999999999999999999999999999998754321 135678899999999999999999999987 56
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC----cEEEeecccccc
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG----ILTIADFGLASF 268 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~----~vkL~DFG~a~~ 268 (495)
.+|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 7999999998876666666667899999999999999999999999999999999999999887 899999999987
Q ss_pred cCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...........|
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 241 (326)
T 2y0a_A 168 IDFGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF--- 241 (326)
T ss_dssp CCTTS--CCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH---
T ss_pred CCCCC--ccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc---
Confidence 75432 3355689999999998875 56899999999999999999999999999988888888765544444333
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
..+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 242 ----------------------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 242 ----------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp ----------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred ----------------------ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 346788999999999999999999999999999985
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=433.80 Aligned_cols=269 Identities=22% Similarity=0.315 Sum_probs=225.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.+|..++||||+++++++.+ ...+|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~~ 150 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD--DNNLY 150 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCEEE
Confidence 5789999999999999999999999999999999975321 11122347789999999999999999999987 56899
Q ss_pred EEEeeccCChhh-hhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 196 LVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 196 lv~e~~~~~l~~-~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|||||+.++.+. .+......+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||++........
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 999999765544 4444456899999999999999999999999999999999999999999999999999987654433
Q ss_pred CCCccccccCCCCCccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 275 QPMTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
......+||+.|+|||++. +...|+.++|||||||++|||++|.+||.+.+..+.+.+|+.......
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------- 301 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ--------- 301 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC---------
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc---------
Confidence 3334568999999999986 235689999999999999999999999999999999888865321110
Q ss_pred CCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCC--ccCHHHHHhCCCCCCCCCCC
Q 011041 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE--RQTATAALRSEFFTTKPYAC 411 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--R~ta~elL~hp~f~~~~~~~ 411 (495)
.......+++++.+||.+||+.+|.+ |++++|+++||||++..|..
T Consensus 302 ---------------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 302 ---------------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp ---------------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred ---------------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence 11122457889999999999999988 99999999999999877754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=412.06 Aligned_cols=258 Identities=22% Similarity=0.359 Sum_probs=223.4
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|++++.||+|+||.||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++||||+++++++.+ ...+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~ 81 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQI 81 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe--CCEE
Confidence 35789999999999999999999999999999999975422 12335667889999999999999999999987 5689
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 999999998666655555567999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+.+|......
T Consensus 160 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------------- 221 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--------------- 221 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC---------------
T ss_pred --cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------------
Confidence 345689999999999876 56899999999999999999999999999988888888653211
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPY 409 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~ 409 (495)
....+++++.+||.+||..||.+|+ +++++++||||+...|
T Consensus 222 --------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 222 --------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred --------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence 1134678899999999999999999 9999999999997665
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=412.31 Aligned_cols=289 Identities=33% Similarity=0.552 Sum_probs=239.0
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC---Cc
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM---SC 192 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---~~ 192 (495)
..++|++++.||+|+||.||+|++..++..||||++.... .......+.+|+.+|+.++||||+++++++.... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 3578999999999999999999999999999999997533 3455577889999999999999999999986532 24
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|+||||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 104 ~~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 6899999999987776654 36999999999999999999999999999999999999999999999999999876533
Q ss_pred CC--CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 273 HK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 273 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
.. ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..|...++.+..+.|.....
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 21 2234568999999999987766789999999999999999999999999999999999999999998877654211
Q ss_pred CCCccC--CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 351 PHATIF--KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 351 ~~~~~~--~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.....+ .........+...+..+++++.+||.+||.+||.+|||+.|+|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 000000 000000111334456778899999999999999999999999999999875
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=419.71 Aligned_cols=287 Identities=27% Similarity=0.493 Sum_probs=224.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC----Cc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~ 192 (495)
.++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 57899999999999999999999999999999999876556666778889999999999999999999987632 13
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|+||||+++++...+.. .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 104 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEEECCSEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 7899999999988776643 5899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+++..+.+.++.+..+.|.......
T Consensus 181 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 181 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp -----------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred --cccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 22345689999999999876 568999999999999999999999999999999999999999998887765421100
Q ss_pred CccCC-----CCcccccccccc--------cCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 353 ATIFK-----PQQSYKRCIAET--------FKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 353 ~~~~~-----~~~~~~~~~~~~--------~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
..... ....+....... ....++++.+||.+||..||.+|||+.|+|+||||+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 00000 000000000000 0011456899999999999999999999999999986433
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=413.71 Aligned_cols=286 Identities=34% Similarity=0.572 Sum_probs=234.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc----
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC---- 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~---- 192 (495)
.++|.+.+.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 3789999999999999999999999999999999987665666677889999999999999999999999764221
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|+||||+.+++..... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 121 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp CCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 249999999987766553 35999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..+++.......
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 198 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred ----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 3456889999999999876678999999999999999999999999999999999999999999887765432110
Q ss_pred CccC--CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 353 ATIF--KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 353 ~~~~--~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
...+ .............+..+++++.+||.+||++||.+|||+.|+|+||||+....
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 332 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 332 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence 0000 00000011123344567889999999999999999999999999999986543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-51 Score=418.83 Aligned_cols=284 Identities=34% Similarity=0.545 Sum_probs=231.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC----Cc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~ 192 (495)
..+|.+++.||+|+||.||+|++..++. ||+|++..... ...+|+.+|+.++||||+++++++.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 4689999999999999999999887776 88888865432 1236999999999999999999986532 23
Q ss_pred eeEEEEeeccCChhhhhh---CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeC-CCCcEEEeecccccc
Q 011041 193 SLYLVFKYMEHDLAGLAA---SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID-NEGILTIADFGLASF 268 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~---~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~-~~~~vkL~DFG~a~~ 268 (495)
.+|+||||+.++++.... .....+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||++..
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 488999999998765443 2355799999999999999999999999999999999999999 799999999999987
Q ss_pred cCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
+.... .....+||++|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+++..|.+.+|.+..+.|...
T Consensus 192 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 192 LIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 64432 3356688999999999987677999999999999999999999999999999999999999999998877653
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
.........+..............+++++.+||.+||++||.+|||+.|+|+||||+...+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 2211111111111111111222347889999999999999999999999999999997544
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=410.57 Aligned_cols=288 Identities=29% Similarity=0.568 Sum_probs=236.2
Q ss_pred CCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 115 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
...++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++.+ ....
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 99 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK--KKRW 99 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec--CCEE
Confidence 34689999999999999999999999999999999998776666667778899999999999999999999987 5679
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+||||++++++..+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 178 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 178 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence 9999999999888776666679999999999999999999999999999999999999999999999999998664332
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh---CCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK---SKLP 351 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~---~~~~ 351 (495)
.......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+......+.. ....
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 2334567899999999998766789999999999999999999999999999999999998888876543321 1000
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.....+..............+++.+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 259 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 259 -AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp -TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred -ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 000001111111233444578889999999999999999999999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-51 Score=411.57 Aligned_cols=261 Identities=23% Similarity=0.396 Sum_probs=218.9
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCce
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 193 (495)
..++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|..+ +||||+++++++.+ ...
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 84 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR 84 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCE
Confidence 46789999999999999999999999999999999987654 455667788999999998 89999999999987 568
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.......
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999886665555545579999999999999999999999999999999999999999999999999998643222
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHHhcCCCChhh
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR---------TEVEQLHKIFKLCGSPSEEY 344 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~---------~~~~~~~~i~~~~g~~~~~~ 344 (495)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||... +.......|....
T Consensus 165 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------- 235 (345)
T 3a8x_A 165 -DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------- 235 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-------
T ss_pred -CcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-------
Confidence 23456789999999999876 56899999999999999999999999752 2222333332210
Q ss_pred hhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCH------HHHHhCCCCCCCCC
Q 011041 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA------TAALRSEFFTTKPY 409 (495)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta------~elL~hp~f~~~~~ 409 (495)
......+++++.+||.+||+.||.+||++ .++++||||+...|
T Consensus 236 ----------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 236 ----------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp ----------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 01123467889999999999999999995 89999999998765
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=420.48 Aligned_cols=260 Identities=22% Similarity=0.390 Sum_probs=216.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCcee
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 194 (495)
.++|++++.||+|+||.||+|+++.+++.||||++.+... .......+.+|+.+|..+ +|||||++++++.+ ...+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 128 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRL 128 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCEE
Confidence 5789999999999999999999999999999999987644 333445678899999887 89999999999987 5689
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+||||+.++.+.........+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++...... .
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~ 207 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-G 207 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC-C
Confidence 999999998766665555567999999999999999999999999999999999999999999999999999863322 2
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhcCCCChhhh
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---------VEQLHKIFKLCGSPSEEYW 345 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~---------~~~~~~i~~~~g~~~~~~~ 345 (495)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+... ......|....
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-------- 278 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------- 278 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--------
T ss_pred CccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--------
Confidence 33456789999999999886 5789999999999999999999999975321 22233332211
Q ss_pred hhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCH------HHHHhCCCCCCCCC
Q 011041 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA------TAALRSEFFTTKPY 409 (495)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta------~elL~hp~f~~~~~ 409 (495)
......+++++.+||.+||+.||.+|+++ .|+++||||+...|
T Consensus 279 ---------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 279 ---------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred ---------------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 01123477889999999999999999985 89999999998765
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-51 Score=420.80 Aligned_cols=291 Identities=35% Similarity=0.644 Sum_probs=219.9
Q ss_pred CCeee-eeeecccCceEEEEEEEC--CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 118 DTFEK-LDKIGQGTYSNVYKARDT--LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 118 ~~y~~-~~~LG~G~~g~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
+.|++ .++||+|+||.||+|+++ .+++.||||++...... ..+.+|+.+|+.|+|||||++++++.......+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 56777 458999999999999966 57899999999765433 356789999999999999999999976557789
Q ss_pred EEEEeeccCChhhhhhC--------CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee----CCCCcEEEee
Q 011041 195 YLVFKYMEHDLAGLAAS--------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI----DNEGILTIAD 262 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~--------~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl----~~~~~vkL~D 262 (495)
|+||||+++++...+.. ....+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|
T Consensus 96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99999999988766542 22359999999999999999999999999999999999999 6778999999
Q ss_pred cccccccCCCCC--CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHH
Q 011041 263 FGLASFFDPNHK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---------VEQLH 331 (495)
Q Consensus 263 FG~a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~---------~~~~~ 331 (495)
||++..+..... ......+||++|+|||++.+...|+.++||||||||||+|++|.+||.+.+. .+++.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999987653221 2334568999999999998766799999999999999999999999987665 58899
Q ss_pred HHHHhcCCCChhhhhhCC-CCCCccC--------CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCC
Q 011041 332 KIFKLCGSPSEEYWKKSK-LPHATIF--------KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402 (495)
Q Consensus 332 ~i~~~~g~~~~~~~~~~~-~~~~~~~--------~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp 402 (495)
.|+..+|.+....|.... ++..... .........+.......++.+.+||.+||++||.+|||+.|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 999999999988876531 1111000 0000011111222233478899999999999999999999999999
Q ss_pred CCCCCCCCCC
Q 011041 403 FFTTKPYACD 412 (495)
Q Consensus 403 ~f~~~~~~~~ 412 (495)
||+..+++..
T Consensus 336 ~f~~~~~~~~ 345 (405)
T 3rgf_A 336 YFLEDPLPTS 345 (405)
T ss_dssp GGTSSSCCCS
T ss_pred hhccCCCCcc
Confidence 9999877654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=416.59 Aligned_cols=261 Identities=24% Similarity=0.362 Sum_probs=222.5
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCce
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 193 (495)
..++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|..+ +||||+++++++.+ ...
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~~ 92 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KEN 92 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CCE
Confidence 36899999999999999999999999999999999976422 122345677899999887 99999999999987 567
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|+||||+.++.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++.......
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 99999999886666555555579999999999999999999999999999999999999999999999999998643222
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|......
T Consensus 173 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-------------- 236 (345)
T 1xjd_A 173 -AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF-------------- 236 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------------
T ss_pred -CcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCC--------------
Confidence 23456789999999999876 56899999999999999999999999999988888887542110
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHH-HHHhCCCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT-AALRSEFFTTKPY 409 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~-elL~hp~f~~~~~ 409 (495)
....+++++.+||.+||..||.+||++. ++++||||+...|
T Consensus 237 ---------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 237 ---------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp ---------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred ---------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 1124678899999999999999999998 9999999998665
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-51 Score=402.32 Aligned_cols=260 Identities=27% Similarity=0.382 Sum_probs=214.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh------------------------HHHHHHHHHHHHHH
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP------------------------ESVRFMAREILILR 172 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~------------------------~~~~~~~~Ei~il~ 172 (495)
.++|++.+.||+|+||.||+|++..+|+.||||++....... ...+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 578999999999999999999999999999999997654211 12356889999999
Q ss_pred hCCCCCeeeeeceeeccCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee
Q 011041 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (495)
Q Consensus 173 ~l~HpnIv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl 252 (495)
.++||||+++++++.+.....+|+||||++++.+..+.. ...+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 999999999999998755678999999999876655443 3479999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCCCCccccccCCCCCcccccCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 011041 253 DNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD--YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQL 330 (495)
Q Consensus 253 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~ 330 (495)
+.++.+||+|||++..+.... ......+||+.|+|||++.+... ++.++|||||||++|+|++|.+||.+.+.....
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 999999999999998765432 22345689999999999876432 478899999999999999999999988777666
Q ss_pred HHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
..+....... .....+++++.+||.+||..||.+|||+.|+|+||||+
T Consensus 250 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 250 SKIKSQALEF---------------------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHCCCCC---------------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHhcccCCC---------------------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 6554321111 01235778899999999999999999999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=425.88 Aligned_cols=277 Identities=24% Similarity=0.326 Sum_probs=226.3
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|..++||||+++++++.+ ...+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~ 136 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD--ENYL 136 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEE
Confidence 35899999999999999999999999999999999975322 12233457889999999999999999999987 5689
Q ss_pred EEEEeeccCChhh-hhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 195 YLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 195 ~lv~e~~~~~l~~-~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
||||||+.++.+. .+......+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||++.......
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 9999999765444 443334579999999999999999999999999999999999999999999999999998765443
Q ss_pred CCCCccccccCCCCCcccccC------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 011041 274 KQPMTSRVVTLWYRPPELLLG------ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~------~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (495)
.......+||+.|+|||++.+ ...|+.++|||||||++|||++|.+||.+.+..+.+.+|........
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~------ 290 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS------ 290 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC------
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC------
Confidence 322345689999999999862 34689999999999999999999999999999988888865211000
Q ss_pred CCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCc---cCHHHHHhCCCCCCCCCCCCCCCCCCC
Q 011041 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER---QTATAALRSEFFTTKPYACDPSSLPKY 419 (495)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R---~ta~elL~hp~f~~~~~~~~~~~~p~~ 419 (495)
+......+|+++.+||.+||+ ||.+| ++++|+++||||+...|..-....|.+
T Consensus 291 ------------------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~ 346 (412)
T 2vd5_A 291 ------------------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPF 346 (412)
T ss_dssp ------------------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSC
T ss_pred ------------------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCC
Confidence 001123578899999999999 99998 599999999999988886543333433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-52 Score=428.54 Aligned_cols=267 Identities=25% Similarity=0.335 Sum_probs=223.7
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|++++.||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.+|+.++|||||++++++.+ ...+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~ 144 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYL 144 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEE
Confidence 35799999999999999999999999999999999975321 11122347789999999999999999999987 5789
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||||+.++.+..+... ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++........
T Consensus 145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 999999987655544433 3699999999999999999999999999999999999999999999999999987654432
Q ss_pred CCCccccccCCCCCcccccCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGAT---DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~---~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
......+||+.|+|||++.+.. .|+.++|||||||+||||++|.+||.+.+..+.+.+|........
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---------- 293 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT---------- 293 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC----------
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc----------
Confidence 2334678999999999997633 278999999999999999999999999999999888875321110
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCC--ccCHHHHHhCCCCCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE--RQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--R~ta~elL~hp~f~~~~~~ 410 (495)
......+++++.+||.+||+.+|.+ |++++|+++||||+...|.
T Consensus 294 ---------------~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 294 ---------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp ---------------CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred ---------------CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 0011357889999999999999988 9999999999999987764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=414.70 Aligned_cols=259 Identities=23% Similarity=0.377 Sum_probs=224.1
Q ss_pred CCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 115 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
...++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++.+ ...
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 115 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSN 115 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCE
Confidence 346899999999999999999999999999999999975432 22335678899999999999999999999987 568
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999987665555544457999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+.+|......
T Consensus 195 ---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-------------- 256 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-------------- 256 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------------
T ss_pred ---cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 245689999999999876 56899999999999999999999999999988888888653211
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-----HHHHHhCCCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEFFTTKPY 409 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----a~elL~hp~f~~~~~ 409 (495)
....+++++.+||.+||+.||.+||+ +.++++||||+...|
T Consensus 257 ---------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 257 ---------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp ---------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred ---------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 11346788999999999999999998 999999999997655
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=414.38 Aligned_cols=261 Identities=22% Similarity=0.335 Sum_probs=223.0
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCce
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 193 (495)
..++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|..+ +||||+++++++.+ ...
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCE
Confidence 46899999999999999999999999999999999976432 123346678899999988 89999999999987 568
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.......
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 99999999886665555545579999999999999999999999999999999999999999999999999998643222
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+.+|......
T Consensus 176 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~-------------- 239 (353)
T 2i0e_A 176 -VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-------------- 239 (353)
T ss_dssp -CCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------------
T ss_pred -cccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC--------------
Confidence 23456789999999999876 56899999999999999999999999999998888888652211
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPY 409 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~ 409 (495)
....+++++.+||.+||..||.+|| ++.++++||||+...|
T Consensus 240 ---------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 240 ---------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp ---------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred ---------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence 1134778899999999999999999 5799999999998665
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=401.12 Aligned_cols=257 Identities=25% Similarity=0.442 Sum_probs=219.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEE--CCEEEE
Confidence 47899999999999999999999999999999999765432 23567899999999999999999999987 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||+.++.+..+.... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 172 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (297)
T ss_dssp EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-cc
Confidence 99999876665554433 68999999999999999999999999999999999999999999999999998765433 23
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+....+..+........
T Consensus 173 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 236 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--------------- 236 (297)
T ss_dssp BCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC---------------
T ss_pred cCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------
Confidence 455689999999999876 5689999999999999999999999999888877776654321110
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.....+++.+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 237 -----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 237 -----------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp -----------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred -----------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 112346778899999999999999999999999999985
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=403.52 Aligned_cols=263 Identities=27% Similarity=0.402 Sum_probs=216.4
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
..++|++++.||+|+||.||+|++..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.+ ....|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~ 81 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQY 81 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEE
Confidence 35899999999999999999999999999999999976543 2233567899999999999999999999987 56899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC-C
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-K 274 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~-~ 274 (495)
+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... .
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999987776666666789999999999999999999999999999999999999999999999999998654222 2
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+...............
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------- 227 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------------- 227 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--------------
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--------------
Confidence 233456899999999999876556889999999999999999999998766543222221111000
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 228 ------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 228 ------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp ------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ------------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 01123467888999999999999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=415.78 Aligned_cols=281 Identities=31% Similarity=0.489 Sum_probs=229.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC------CCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL------DHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~~~~~~~ 190 (495)
..+|++++.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.+ +|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--
Confidence 46899999999999999999999999999999999743 34456777899998887 57799999999987
Q ss_pred CceeEEEEeeccCChhhhhhCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCc--EEEeeccccc
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPT-IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI--LTIADFGLAS 267 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~-~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~--vkL~DFG~a~ 267 (495)
...+|+||||+.+++...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++.
T Consensus 171 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 171 RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 56899999999998887766543 45999999999999999999999999999999999999999987 9999999997
Q ss_pred ccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 011041 268 FFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (495)
.... .....+||+.|+|||++.+ ..|+.++||||||||||||++|.+||.+.+..+++..+...++.++...+..
T Consensus 251 ~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 251 YEHQ----RVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp ETTC----CCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ecCC----cccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 6542 2345689999999999987 4689999999999999999999999999999999999999999999877654
Q ss_pred CCCCCCccCC------------------------------CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHH
Q 011041 348 SKLPHATIFK------------------------------PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATA 397 (495)
Q Consensus 348 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~e 397 (495)
.......... .......+........++.+.+||.+||++||.+|||+.|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 3210000000 0000000001111123567899999999999999999999
Q ss_pred HHhCCCCCCC
Q 011041 398 ALRSEFFTTK 407 (495)
Q Consensus 398 lL~hp~f~~~ 407 (495)
+|+||||+..
T Consensus 406 ~L~Hpw~~~~ 415 (429)
T 3kvw_A 406 ALRHPWLRRR 415 (429)
T ss_dssp HHTSTTTC--
T ss_pred HhCChhhccC
Confidence 9999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=407.49 Aligned_cols=254 Identities=24% Similarity=0.293 Sum_probs=188.7
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC--ceeE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS--CSLY 195 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--~~~~ 195 (495)
.+|.+.+.||+|+||+||+|++ +|+.||||++.... ......+.|+.++..++|||||++++++..... ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4689999999999999999986 58999999986432 222334456777778999999999999876432 3689
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhC--------CceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ--------HVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~--------givHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
||||||+++.+..++.. ..+++..+..++.||+.||.|||++ +||||||||+||||+.++++||+|||+|+
T Consensus 78 lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999997766655543 3689999999999999999999987 99999999999999999999999999998
Q ss_pred ccCCCCC---CCCccccccCCCCCcccccCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------------
Q 011041 268 FFDPNHK---QPMTSRVVTLWYRPPELLLGAT-----DYGVGVDLWSAGCILAELLAEKPIMPGRTE------------- 326 (495)
Q Consensus 268 ~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DvwSlGvil~elltG~~pf~~~~~------------- 326 (495)
....... ......+||+.|||||++.+.. .|+.++|||||||+||||+||.+||...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 7654332 1223468999999999987532 367899999999999999999887754322
Q ss_pred -HHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCccccccccccc--CCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 327 -VEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETF--KDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 327 -~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.+.+.+.....+ ..|. +.... ...+..+.+||.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~-----------------~rp~------~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 237 SVEEMRKVVCEQK-----------------LRPN------IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CHHHHHHHHTTSC-----------------CCCC------CCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHhccc-----------------CCCC------CCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 111111110000 0000 00000 012235678999999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-52 Score=417.76 Aligned_cols=259 Identities=26% Similarity=0.450 Sum_probs=215.2
Q ss_pred CCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 115 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
...++|.+++.||+|+||.||+|++..+|+.||||++...... ......+.+|+.+|+.++||||+++++++.+ ...
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~ 83 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT--PTD 83 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCE
Confidence 3468999999999999999999999999999999999753221 1223468899999999999999999999987 567
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|+||||++++++..+... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 84 ~~lv~E~~~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 84 IVMVIEYAGGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp EEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred EEEEEECCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 9999999988877766543 47999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+...++
T Consensus 162 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-------------------- 220 (336)
T 3h4j_B 162 -NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-------------------- 220 (336)
T ss_dssp -BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--------------------
T ss_pred -cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--------------------
Confidence 23456689999999999987555589999999999999999999999765432211110
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
..........+++++.+||.+||..||.+|||+.|+++||||+..
T Consensus 221 ---------~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 221 ---------NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ---------CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ---------HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 000111223467889999999999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=413.98 Aligned_cols=261 Identities=24% Similarity=0.395 Sum_probs=220.2
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|++++.||+|+||.||+|++..+|+.||||++.+... .......+.+|+.+|+.++|||||++++++.+ ...+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~ 90 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD--EEDM 90 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEE
Confidence 35899999999999999999999999999999999975432 22345678899999999999999999999987 5679
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+||||+.++.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+...
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-- 168 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-- 168 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC--
Confidence 999999988777766666678999999999999999999999999999999999999999999999999999876533
Q ss_pred CCCccccccCCCCCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChhhhhhCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAEKPIMPGRTE---VEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
......+||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+. .+....+....
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~------------ 236 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV------------ 236 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC------------
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc------------
Confidence 334667899999999998642 3589999999999999999999999986433 23333332211
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-HHHHHhCCCCCCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-ATAALRSEFFTTKPY 409 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-a~elL~hp~f~~~~~ 409 (495)
......+++.+.+||.+||..||.+||+ +.++++||||+...|
T Consensus 237 -----------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 237 -----------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred -----------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 1112346788999999999999999998 999999999998655
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=414.60 Aligned_cols=261 Identities=24% Similarity=0.357 Sum_probs=215.7
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHH-HHhCCCCCeeeeeceeeccCCce
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILI-LRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
..++|++++.||+|+||.||+|+++.+++.||||++.+... .......+.+|..+ ++.++|||||++++++.+ ...
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--~~~ 113 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADK 113 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC--SSE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--CCE
Confidence 35789999999999999999999999999999999987654 23344556677776 567899999999999987 568
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|+||||+.++.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||++.......
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 99999999987666555555679999999999999999999999999999999999999999999999999998643222
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+.+|.....
T Consensus 194 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--------------- 256 (373)
T 2r5t_A 194 -STTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--------------- 256 (373)
T ss_dssp -CCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC---------------
T ss_pred -CccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc---------------
Confidence 23456789999999999876 5689999999999999999999999999998888888865211
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCH----HHHHhCCCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA----TAALRSEFFTTKPY 409 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta----~elL~hp~f~~~~~ 409 (495)
.....+++++.+||.+||+.||.+|+++ .++++||||+...|
T Consensus 257 --------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 257 --------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW 302 (373)
T ss_dssp --------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred --------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence 1123577889999999999999999996 69999999998665
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-51 Score=412.32 Aligned_cols=290 Identities=29% Similarity=0.477 Sum_probs=226.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC-----C
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM-----S 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~ 191 (495)
.++|++.+.||+|+||.||+|++..+|+.||||++...... .....+|+..+..++||||+++++++.... .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 57899999999999999999999999999999998754322 234557888889999999999999986521 2
Q ss_pred ceeEEEEeeccCChhhhhh---CCCCCCCHHHHHHHHHHHHHHHHHhh--hCCceeccCCCCCeeeCC-CCcEEEeeccc
Q 011041 192 CSLYLVFKYMEHDLAGLAA---SPTIKFTQAQVKCYMHQLLSGLEHCH--NQHVLHRDIKGSNLLIDN-EGILTIADFGL 265 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~---~~~~~l~e~~~~~i~~qil~~L~~LH--~~givHrDlKp~NILl~~-~~~vkL~DFG~ 265 (495)
..+|+||||+++++...+. .....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 3489999999998765433 45667999999999999999999999 999999999999999997 89999999999
Q ss_pred ccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 011041 266 ASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345 (495)
Q Consensus 266 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (495)
+..+.... .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+..+.|
T Consensus 179 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 179 AKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 98765432 2345678999999999877667899999999999999999999999999999999999999999998887
Q ss_pred hhCCCCCCcc---CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCCC
Q 011041 346 KKSKLPHATI---FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYAC 411 (495)
Q Consensus 346 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~~ 411 (495)
.......... ......+...........++++.+||.+||++||.+|||+.|+|+||||+....+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA 325 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence 7643221111 01111122222222333567899999999999999999999999999999765443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=410.20 Aligned_cols=260 Identities=24% Similarity=0.431 Sum_probs=222.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|+++.+|+.||+|++.... ......+.+|+.+|+.++||||+++++++.+ ...+|+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe--CCEEEE
Confidence 478999999999999999999999999999999997543 3345578899999999999999999999987 568999
Q ss_pred EEeeccCChhhh-hhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC--CCcEEEeecccccccCCCC
Q 011041 197 VFKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN--EGILTIADFGLASFFDPNH 273 (495)
Q Consensus 197 v~e~~~~~l~~~-~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~--~~~vkL~DFG~a~~~~~~~ 273 (495)
||||+.++.+.. +......+++..+..++.||+.||.|||++||+||||||+||||+. ++.+||+|||++......
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 999998765544 4444557999999999999999999999999999999999999974 578999999999876543
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+..
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 271 (387)
T 1kob_A 205 -EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE----------- 271 (387)
T ss_dssp -SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS-----------
T ss_pred -cceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----------
Confidence 23345689999999999876 56899999999999999999999999999988888877653322211
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
..+..+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 272 --------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 272 --------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp --------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred --------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 12345788899999999999999999999999999998754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=403.16 Aligned_cols=286 Identities=34% Similarity=0.575 Sum_probs=233.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC----c
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS----C 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----~ 192 (495)
.++|.+.+.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 368999999999999999999999999999999998765556667788899999999999999999999876422 2
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|+||||+.+++..... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 103 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp CCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 459999999987665543 25999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.++.+++....-..
T Consensus 180 ----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 180 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred ----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 3456789999999998875678999999999999999999999999999999999999999999887765422100
Q ss_pred CccC--CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 353 ATIF--KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 353 ~~~~--~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
...+ .........+...+..+++++.+||.+||..||.+|||+.++|+||||+....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence 0000 00000011123334567888999999999999999999999999999986543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=410.04 Aligned_cols=261 Identities=28% Similarity=0.439 Sum_probs=216.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC---ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL---EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.+.|++++.||+|+||.||+|+++.+|+.||||++..... .....+.+.+|+.+|+.++||||+++++++.+ ...
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~ 100 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--DGM 100 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 3689999999999999999999999999999999974321 11234678899999999999999999999987 568
Q ss_pred eEEEEeeccCChhh-hhh---CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCc---EEEeecccc
Q 011041 194 LYLVFKYMEHDLAG-LAA---SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI---LTIADFGLA 266 (495)
Q Consensus 194 ~~lv~e~~~~~l~~-~~~---~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~---vkL~DFG~a 266 (495)
+|+||||++++.+. .+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999975443 332 23346899999999999999999999999999999999999987654 999999999
Q ss_pred cccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 011041 267 SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (495)
Q Consensus 267 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (495)
....... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+. ..+.+..+...........|
T Consensus 181 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~- 256 (351)
T 3c0i_A 181 IQLGESG-LVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQW- 256 (351)
T ss_dssp EECCTTS-CBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHH-
T ss_pred eEecCCC-eeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccc-
Confidence 8765432 22345689999999999876 56899999999999999999999999885 34555666554333333333
Q ss_pred hCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
..+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus 257 ------------------------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 257 ------------------------SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp ------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ------------------------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 3577889999999999999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=405.86 Aligned_cols=279 Identities=23% Similarity=0.369 Sum_probs=226.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-----CCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-----HPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~~~~~~~~~ 191 (495)
.++|++++.||+|+||.||+|++..+++.||||++.. .......+.+|+.+++.+. ||||+++++++.. .
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~--~ 108 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY--Y 108 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE--T
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE--C
Confidence 4789999999999999999999999999999999863 2345566788999999996 9999999999987 5
Q ss_pred ceeEEEEeeccCChhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC----------------
Q 011041 192 CSLYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---------------- 254 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~---------------- 254 (495)
..+|+||||+++++...+... ...+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 109 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 109 DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 679999999977777666543 345999999999999999999999999999999999999975
Q ss_pred ---------CCcEEEeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 011041 255 ---------EGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT 325 (495)
Q Consensus 255 ---------~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~ 325 (495)
++.+||+|||++...... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 789999999999865432 245688999999999886 568999999999999999999999999999
Q ss_pred hHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccc-----------------cccccccCCCCCCcHHHHHHhccCC
Q 011041 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYK-----------------RCIAETFKDFPPSSLPLIETLLAID 388 (495)
Q Consensus 326 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~s~~~~~Li~~~L~~d 388 (495)
..+.+..+....+.++...+..........+....... .+........++.+.+||.+||++|
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 99999999999888887665442211111000000000 0000111122356779999999999
Q ss_pred CCCccCHHHHHhCCCCC
Q 011041 389 PAERQTATAALRSEFFT 405 (495)
Q Consensus 389 P~~R~ta~elL~hp~f~ 405 (495)
|.+|||+.|+|+||||+
T Consensus 344 P~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 344 PTLRPSPAELLKHKFLE 360 (360)
T ss_dssp GGGSCCHHHHTTSGGGC
T ss_pred hhhCCCHHHHhcCcccC
Confidence 99999999999999995
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=402.49 Aligned_cols=261 Identities=24% Similarity=0.401 Sum_probs=212.0
Q ss_pred CCCCeeeeeeecccCceEEEEEEEC---CCCeEEEeEEEecCCC--ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNL--EPESVRFMAREILILRRLDHPNVVKLEGLVTSRM 190 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~---~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 190 (495)
..++|++++.||+|+||.||+|++. .+|+.||||++.+... .......+.+|+.+|+.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 92 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT-- 92 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--
Confidence 3578999999999999999999985 6899999999986543 22344567889999999999999999999987
Q ss_pred CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
...+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 56799999999876665555545579999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+.++......
T Consensus 173 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~----------- 239 (327)
T 3a62_A 173 HDG-TVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN----------- 239 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-----------
T ss_pred cCC-ccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence 222 22345689999999999876 56899999999999999999999999999988888887653211
Q ss_pred CCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCC
Q 011041 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPY 409 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~ 409 (495)
....+++++.+||.+||..||.+|| ++.++|+||||+...|
T Consensus 240 ------------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 240 ------------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp ------------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred ------------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 1134678899999999999999999 8999999999987654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=391.59 Aligned_cols=263 Identities=25% Similarity=0.415 Sum_probs=226.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||+|++..+|+.||+|++............+.+|+.+++.++||||+++++++.. ....|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc--CCEEEE
Confidence 578999999999999999999999999999999998877777777889999999999999999999999987 567899
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCc---EEEeecccccccCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI---LTIADFGLASFFDPNH 273 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~---vkL~DFG~a~~~~~~~ 273 (495)
||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++. +||+|||++......
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~- 161 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 161 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-
Confidence 9999988655444444457999999999999999999999999999999999999987655 999999999876543
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.......+..
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------- 229 (284)
T 3kk8_A 162 -EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---------- 229 (284)
T ss_dssp -CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT----------
T ss_pred -ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch----------
Confidence 22345679999999999876 568999999999999999999999999998888887776543332221
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
....+++++.+||.+||..||.+|||+.|+|+||||+....
T Consensus 230 ---------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 230 ---------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp ---------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred ---------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 12457788999999999999999999999999999987543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-50 Score=411.07 Aligned_cols=292 Identities=21% Similarity=0.294 Sum_probs=219.3
Q ss_pred CCCCeeeeeeeccc--CceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 116 RADTFEKLDKIGQG--TYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 116 ~~~~y~~~~~LG~G--~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
..++|++++.||+| +||.||+|++..+|+.||||++............+.+|+.+|+.++|||||++++++.+ ...
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 100 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNE 100 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE--CCE
Confidence 35889999999999 99999999999999999999998877677778889999999999999999999999987 568
Q ss_pred eEEEEeeccCChhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 194 LYLVFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~--~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
+|+||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999766555443 235699999999999999999999999999999999999999999999999999865422
Q ss_pred CC------CCCCccccccCCCCCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-----
Q 011041 272 NH------KQPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS----- 339 (495)
Q Consensus 272 ~~------~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~----- 339 (495)
.. .......+||+.|+|||++.+. ..|+.++||||||||+|+|++|.+||.+.+..+.+..+......
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 11 1112334789999999998764 46899999999999999999999999987776665544321110
Q ss_pred ---CChhhhhhC-------CCCCCc-cCCCC-cccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 340 ---PSEEYWKKS-------KLPHAT-IFKPQ-QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 340 ---~~~~~~~~~-------~~~~~~-~~~~~-~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
+....+... ...... ...+. .............+++++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 000000000 000000 00000 000001112345578889999999999999999999999999999875
Q ss_pred CC
Q 011041 408 PY 409 (495)
Q Consensus 408 ~~ 409 (495)
.+
T Consensus 341 ~~ 342 (389)
T 3gni_B 341 KR 342 (389)
T ss_dssp --
T ss_pred hh
Confidence 44
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=422.05 Aligned_cols=259 Identities=27% Similarity=0.434 Sum_probs=224.5
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|.+++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~ 91 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--PSDI 91 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEE
Confidence 35889999999999999999999999999999999975432 12235678899999999999999999999987 5679
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-- 169 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-- 169 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT--
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc--
Confidence 999999988766666666678999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+.+|......
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------- 234 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY--------------- 234 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC---------------
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC---------------
Confidence 23456689999999999987655689999999999999999999999998888888777543211
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
....+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 235 --------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 235 --------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp --------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred --------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 112467789999999999999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=425.95 Aligned_cols=259 Identities=30% Similarity=0.508 Sum_probs=219.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|+++.++..||||++.+..........+.+|+.+|+.++|||||++++++.+ ...+|+
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED--KRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 357999999999999999999999999999999998765544445678899999999999999999999987 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC---CcEEEeecccccccCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE---GILTIADFGLASFFDPNH 273 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~---~~vkL~DFG~a~~~~~~~ 273 (495)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.. +.+||+|||++..+...
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~- 192 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence 99999986655444444579999999999999999999999999999999999999764 55999999999877543
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......+....|
T Consensus 193 -~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 261 (494)
T 3lij_A 193 -KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEW-------- 261 (494)
T ss_dssp -BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGG--------
T ss_pred -ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhc--------
Confidence 23456689999999998864 5899999999999999999999999999999999888776554444333
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
..+|+.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 262 -----------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 262 -----------------KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred -----------------ccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 357888999999999999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=397.35 Aligned_cols=260 Identities=24% Similarity=0.356 Sum_probs=224.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh----HHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP----ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
.++|++++.||+|+||.||+|++..+|+.||+|++....... ...+.+.+|+.+|+.++||||+++++++.+ ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN--RT 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 467999999999999999999999999999999998654321 135678899999999999999999999987 56
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC----cEEEeecccccc
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG----ILTIADFGLASF 268 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~----~vkL~DFG~a~~ 268 (495)
.+|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 7999999998766655555566799999999999999999999999999999999999999888 799999999987
Q ss_pred cCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+...
T Consensus 169 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---- 241 (321)
T 2a2a_A 169 IEDG--VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF---- 241 (321)
T ss_dssp CCTT--CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH----
T ss_pred cCcc--ccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhh----
Confidence 6543 23355679999999998876 5689999999999999999999999999998888888766544433332
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
+..+++.+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 242 ---------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 242 ---------------------FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp ---------------------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred ---------------------hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 2356788999999999999999999999999999985
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=401.55 Aligned_cols=258 Identities=27% Similarity=0.379 Sum_probs=202.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.+.|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+|+.++||||+++++++.+ ...+|+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 125 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFET--PTEISL 125 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEec--CCeEEE
Confidence 467999999999999999999999999999999997542 23567789999999999999999999987 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC---CCcEEEeecccccccCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASFFDPNH 273 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~---~~~vkL~DFG~a~~~~~~~ 273 (495)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++......
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence 9999998666666666667999999999999999999999999999999999999975 889999999999876432
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChhhhhhCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE-QLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+ .+..+.........
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~---------- 272 (349)
T 2w4o_A 205 -VLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFIS---------- 272 (349)
T ss_dssp ---------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCT----------
T ss_pred -cccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCC----------
Confidence 22345689999999999876 568999999999999999999999998766554 45555432222111
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
.....++.++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 273 ---------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 273 ---------------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp ---------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred ---------------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 12245778899999999999999999999999999998743
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=423.22 Aligned_cols=260 Identities=29% Similarity=0.464 Sum_probs=222.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh-----------HHHHHHHHHHHHHHhCCCCCeeeeece
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-----------ESVRFMAREILILRRLDHPNVVKLEGL 185 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~l~~~ 185 (495)
.++|++++.||+|+||.||+|+++.+++.||||++.+..... ...+.+.+|+.+|+.++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 578999999999999999999999999999999998654321 235678899999999999999999999
Q ss_pred eeccCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC---cEEEee
Q 011041 186 VTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIAD 262 (495)
Q Consensus 186 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~---~vkL~D 262 (495)
+.+ ...+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|
T Consensus 115 ~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 987 578999999998865554444445799999999999999999999999999999999999998876 699999
Q ss_pred cccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 011041 263 FGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342 (495)
Q Consensus 263 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (495)
||++..+... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......++.
T Consensus 193 fg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 268 (504)
T 3q5i_A 193 FGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268 (504)
T ss_dssp CTTCEECCTT--SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred CCCCEEcCCC--CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 9999877543 23456689999999998864 5899999999999999999999999999999999988775555554
Q ss_pred hhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
..| ..+|+++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 269 ~~~-------------------------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 269 NDW-------------------------KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp HHH-------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred ccc-------------------------CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 444 3478889999999999999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=422.60 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=214.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~ 224 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLC 224 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE--TTEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee--CCEEE
Confidence 5789999999999999999999999999999999975432 23345567789999999999999999999987 56799
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
+||||++++.+.........+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||++...... .
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~ 303 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-G 303 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC-C
Confidence 999999987666665555679999999999999999999998 99999999999999999999999999999764322 2
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..+......
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--------------- 367 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--------------- 367 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------
T ss_pred cccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC---------------
Confidence 33456789999999999876 57899999999999999999999999999888888777542211
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPY 409 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~ 409 (495)
....+++++.+||.+||..||.+|| |+.|+|+||||+...|
T Consensus 368 --------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 368 --------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred --------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 1134678899999999999999999 9999999999998654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=424.79 Aligned_cols=260 Identities=28% Similarity=0.486 Sum_probs=222.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||+||+|+++.+|+.||||++.+..........+.+|+.+|+.++|||||++++++.+ ...+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 98 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYI 98 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc--CCEEEE
Confidence 368999999999999999999999999999999997543323345678899999999999999999999987 568999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeC---CCCcEEEeecccccccCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID---NEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~---~~~~vkL~DFG~a~~~~~~~ 273 (495)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++..+...
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 177 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-
Confidence 999998866554444445799999999999999999999999999999999999995 4568999999999876543
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+......+....|
T Consensus 178 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 246 (486)
T 3mwu_A 178 -TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW-------- 246 (486)
T ss_dssp -----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGG--------
T ss_pred -CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccc--------
Confidence 23456689999999999876 5899999999999999999999999999999998888765444433333
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
..+|+++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 247 -----------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 247 -----------------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp -----------------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred -----------------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 3477889999999999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=425.20 Aligned_cols=261 Identities=30% Similarity=0.483 Sum_probs=227.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+.... ......+.+|+.+|+.++|||||++++++.+ ...+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEE
Confidence 46899999999999999999999999999999999876542 3456778899999999999999999999987 56899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee---CCCCcEEEeecccccccCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl---~~~~~vkL~DFG~a~~~~~~ 272 (495)
+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+...
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999887665555555679999999999999999999999999999999999999 46789999999999877543
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......+....|
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------- 251 (484)
T 3nyv_A 183 --KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW------- 251 (484)
T ss_dssp --CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG-------
T ss_pred --cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccc-------
Confidence 23456689999999999876 5899999999999999999999999999999999888765444433333
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
..+|+++.+||.+||++||.+|||+.|+|+||||+...
T Consensus 252 ------------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 252 ------------------KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp ------------------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred ------------------ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 34778899999999999999999999999999998643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=396.52 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=209.5
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~l 196 (495)
++|+++++||+|+||+||+|++..+|+.||||++...............|+..+..+ +||||+++++++.+ ...+|+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEE
Confidence 679999999999999999999999999999999876655555555555666666655 99999999999987 678999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .
T Consensus 135 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--~ 212 (311)
T 3p1a_A 135 QTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--A 212 (311)
T ss_dssp EEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred EEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC--C
Confidence 99999998888777666679999999999999999999999999999999999999999999999999998765432 2
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
.....||+.|+|||++.+ .++.++|||||||++|||++|..||.+..... .+.. +..+.
T Consensus 213 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~--~~~~~-------------- 271 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ--GYLPP-------------- 271 (311)
T ss_dssp --CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT--TCCCH--------------
T ss_pred CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc--cCCCc--------------
Confidence 345579999999999876 58999999999999999999987776543322 2211 11111
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.....+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 272 -----------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 272 -----------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -----------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -----------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 122457888999999999999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=407.21 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=214.3
Q ss_pred eeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEe
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFK 199 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e 199 (495)
|...+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.+|+.|+||||+++++++.+ ...+|+|||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~E 166 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFES--KNDIVLVME 166 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEe
Confidence 334678999999999999999999999999998643 3455678899999999999999999999987 567999999
Q ss_pred eccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee--CCCCcEEEeecccccccCCCCCCC
Q 011041 200 YMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI--DNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 200 ~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl--~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
|++++ |...+......+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+.... .
T Consensus 167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~ 244 (373)
T 2x4f_A 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--K 244 (373)
T ss_dssp CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--B
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--c
Confidence 99875 444454455579999999999999999999999999999999999999 567899999999998775432 2
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..|......+...
T Consensus 245 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~------------- 310 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE------------- 310 (373)
T ss_dssp CCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSG-------------
T ss_pred cccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChh-------------
Confidence 345579999999998865 578999999999999999999999999999999988887654333222
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.+..+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 311 ------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 311 ------------EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 234578899999999999999999999999999999863
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=406.17 Aligned_cols=255 Identities=26% Similarity=0.374 Sum_probs=213.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.... ..+|+.+|.++ +||||+++++++.+ ...+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~ 92 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDD--GKYVY 92 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEE
Confidence 47899999999999999999999999999999999865432 34688888888 79999999999987 57899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC----CcEEEeecccccccCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE----GILTIADFGLASFFDP 271 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~----~~vkL~DFG~a~~~~~ 271 (495)
+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||..+ +.+||+|||++.....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999876555555555679999999999999999999999999999999999998543 3599999999987654
Q ss_pred CCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHHHhcCCCChhhhhhC
Q 011041 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG---RTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~---~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+ .+..+.+..|..........+
T Consensus 173 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~---- 246 (342)
T 2qr7_A 173 EN-GLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY---- 246 (342)
T ss_dssp TT-CCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTT----
T ss_pred CC-CceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccc----
Confidence 32 23456689999999999875 4588999999999999999999999986 345566666654332222222
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
+..+++++.+||.+||..||.+|||+.++|+||||..
T Consensus 247 ---------------------~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 247 ---------------------WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp ---------------------TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ---------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 2457888999999999999999999999999999965
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=404.80 Aligned_cols=289 Identities=29% Similarity=0.465 Sum_probs=229.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC---------ChHHHHHHHHHHHHHHhCCCCCeeeeeceee
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL---------EPESVRFMAREILILRRLDHPNVVKLEGLVT 187 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 187 (495)
.++|++++.||+|+||.||+|++.. |..||||++..... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 4789999999999999999999865 89999999865432 1233477889999999999999999999985
Q ss_pred c---cCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecc
Q 011041 188 S---RMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264 (495)
Q Consensus 188 ~---~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG 264 (495)
. .....+|+||||+++++...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecC
Confidence 4 2235789999999999998888777789999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh
Q 011041 265 LASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344 (495)
Q Consensus 265 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (495)
++...... .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....
T Consensus 180 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (362)
T 3pg1_A 180 LAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257 (362)
T ss_dssp C-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence 99755433 2234567899999999988766789999999999999999999999999999999999999999988665
Q ss_pred hhhCCCCCCccCC---CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 345 WKKSKLPHATIFK---PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 345 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
+.....+....+. ...............+++.+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 4332111000000 000001112334456778899999999999999999999999999999753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=411.12 Aligned_cols=257 Identities=21% Similarity=0.295 Sum_probs=201.0
Q ss_pred CCCCeeee-eeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHH-hCCCCCeeeeeceeec--cCC
Q 011041 116 RADTFEKL-DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILR-RLDHPNVVKLEGLVTS--RMS 191 (495)
Q Consensus 116 ~~~~y~~~-~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~--~~~ 191 (495)
..++|.+. +.||+|+||+||+|+++.+|+.||||++... ..+.+|+.++. .++||||+++++++.. ...
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 35788887 6899999999999999999999999999632 34668888875 4589999999998864 224
Q ss_pred ceeEEEEeeccCChhh-hhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC---CCcEEEeecccc
Q 011041 192 CSLYLVFKYMEHDLAG-LAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLA 266 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~-~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~---~~~vkL~DFG~a 266 (495)
..+||||||+.++.+. .+... ...+++..++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 5789999999875444 44433 346999999999999999999999999999999999999998 789999999999
Q ss_pred cccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHhcCCCCh
Q 011041 267 SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE----QLHKIFKLCGSPSE 342 (495)
Q Consensus 267 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~----~~~~i~~~~g~~~~ 342 (495)
...... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+... ....+.......+.
T Consensus 212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 212 KETTSH--NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp EECC-------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred cccCCC--CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 876433 23456789999999998865 578999999999999999999999998765422 22333221111111
Q ss_pred hhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
..+..+++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 289 -------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 289 -------------------------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp -------------------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 1224578889999999999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=404.38 Aligned_cols=261 Identities=26% Similarity=0.377 Sum_probs=201.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|++..+|+.||||++...... ...+.+|+.+++.++||||+++++++.+ ...+|+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILT--PTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEee--CCEEEE
Confidence 57899999999999999999999999999999999865432 2457799999999999999999999987 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCc--EEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI--LTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~--vkL~DFG~a~~~~~~~~ 274 (495)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++......
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-- 171 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 171 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence 9999987665555544557999999999999999999999999999999999999987765 999999999754322
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+......... .
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~------~----- 240 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY------S----- 240 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC------C-----
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC------C-----
Confidence 22345689999999999987544455599999999999999999999886543333322221100000 0
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......+++++.+||.+||..||.+|||+.|+|+||||...
T Consensus 241 ------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 241 ------------IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp ------------CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred ------------CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 00112467889999999999999999999999999999653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=396.28 Aligned_cols=293 Identities=32% Similarity=0.542 Sum_probs=232.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc---CCce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR---MSCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---~~~~ 193 (495)
.++|++.+.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+|+.++||||+++++++... ....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 478999999999999999999999999999999996432 345556788999999999999999999987642 1357
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
.|+||||+.+++...+.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 89 ~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp EEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 899999999887766654 368999999999999999999999999999999999999999999999999998764322
Q ss_pred CC---------CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh
Q 011041 274 KQ---------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344 (495)
Q Consensus 274 ~~---------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (495)
.. .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence 11 123457899999999987666789999999999999999999999999999999999998888776322
Q ss_pred hhhC-CCCCCc-cCCCC-cccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCCCC
Q 011041 345 WKKS-KLPHAT-IFKPQ-QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACD 412 (495)
Q Consensus 345 ~~~~-~~~~~~-~~~~~-~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~~~ 412 (495)
.... ...... ..... ......+...+..+++++.+||.+||..||.+|||+.++|+||||+...++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 317 (353)
T 2b9h_A 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPND 317 (353)
T ss_dssp TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccc
Confidence 1110 000000 00000 00001123344578889999999999999999999999999999998665543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=392.91 Aligned_cols=288 Identities=37% Similarity=0.621 Sum_probs=234.3
Q ss_pred CCCeeeeeeecccCceEEEEEEEC-CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC---CCCCeeeeeceeec---c
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT-LTGQIVALKKVRFDNLEPESVRFMAREILILRRL---DHPNVVKLEGLVTS---R 189 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~-~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~---~ 189 (495)
.++|++++.||+|+||.||+|++. .+|+.||||++............+.+|+.+++.+ +||||+++++++.. .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 478999999999999999999995 7789999999976443222223455777777766 89999999999862 1
Q ss_pred CCceeEEEEeeccCChhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccc
Q 011041 190 MSCSLYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (495)
Q Consensus 190 ~~~~~~lv~e~~~~~l~~~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~ 268 (495)
....+|+||||+++++...+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 90 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 24679999999998877766543 34599999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....|...
T Consensus 170 ~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 170 YSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred ccCC--CCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 5432 22345678999999999876 46899999999999999999999999999999999999999999888877653
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
.......+... ....+......+++.+.+||.+||..||.+|||+.++|+||||+...+
T Consensus 247 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 247 VALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp CSSCGGGSCCC--CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccchhhhccc--CcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 22111111111 111234445678889999999999999999999999999999987543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=398.83 Aligned_cols=256 Identities=29% Similarity=0.449 Sum_probs=194.8
Q ss_pred CCeeee---eeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCce
Q 011041 118 DTFEKL---DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 118 ~~y~~~---~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 193 (495)
++|++. +.||+|+||.||+|++..+|+.||||++... ....+.+|+.+++.+. ||||+++++++.+ ...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~ 80 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHD--QLH 80 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCE
Confidence 456665 7899999999999999999999999999743 3456778999999997 9999999999987 568
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC---cEEEeecccccccC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFD 270 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~---~vkL~DFG~a~~~~ 270 (495)
.|+||||++++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999999866655555556899999999999999999999999999999999999998766 89999999998665
Q ss_pred CCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHhcCCCChh
Q 011041 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE-------VEQLHKIFKLCGSPSEE 343 (495)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~-------~~~~~~i~~~~g~~~~~ 343 (495)
... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+. .+.+..+......+..+
T Consensus 161 ~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (325)
T 3kn6_A 161 PDN-QPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238 (325)
T ss_dssp C------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred CCC-CcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence 432 33456688999999999876 5689999999999999999999999987543 34455554333333333
Q ss_pred hhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.| ..+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus 239 ~~-------------------------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 239 AW-------------------------KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HH-------------------------HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred cc-------------------------cCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 22 3478889999999999999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=392.47 Aligned_cols=291 Identities=33% Similarity=0.564 Sum_probs=226.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc-------
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR------- 189 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------- 189 (495)
.++|++++.||+|+||.||+|++..+|+.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 47899999999999999999999999999999999754 355667888999999999999999999987432
Q ss_pred -----CCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeC-CCCcEEEeec
Q 011041 190 -----MSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID-NEGILTIADF 263 (495)
Q Consensus 190 -----~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~-~~~~vkL~DF 263 (495)
....+|+||||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp ---CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 2367899999999877665543 4689999999999999999999999999999999999997 5679999999
Q ss_pred ccccccCCCC--CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 011041 264 GLASFFDPNH--KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS 341 (495)
Q Consensus 264 G~a~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~ 341 (495)
|++....... ........+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+......+.
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 9998764321 12234557799999999987766789999999999999999999999999999999999988877766
Q ss_pred hhhhhhCCCCCCccC-CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCCC
Q 011041 342 EEYWKKSKLPHATIF-KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYAC 411 (495)
Q Consensus 342 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~~ 411 (495)
...+........... .........+......+++++.+||.+||..||.+|||+.++|+||||+...++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 655433110000000 0000000112334456889999999999999999999999999999999876653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=385.17 Aligned_cols=257 Identities=31% Similarity=0.458 Sum_probs=223.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||+|++..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 83 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFED--NTDIYL 83 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeEEE
Confidence 3679999999999999999999999999999999976543 234678899999999999999999999987 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee---CCCCcEEEeecccccccCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl---~~~~~vkL~DFG~a~~~~~~~ 273 (495)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+...
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~- 162 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162 (277)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence 99999886655544445579999999999999999999999999999999999999 77899999999999876543
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+......++...|
T Consensus 163 -~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 231 (277)
T 3f3z_A 163 -KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW-------- 231 (277)
T ss_dssp -SCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH--------
T ss_pred -cchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh--------
Confidence 23355679999999998865 4899999999999999999999999999998888888775555544433
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
..+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 232 -----------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 232 -----------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred -----------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 346788999999999999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=391.53 Aligned_cols=281 Identities=29% Similarity=0.526 Sum_probs=223.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|+||.||+|++..+++.||||++.... ...+.+|+.+|+.+. ||||+++++++.+......+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 578999999999999999999999999999999987432 356889999999997 99999999999876567899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC-cEEEeecccccccCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNHK 274 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~-~vkL~DFG~a~~~~~~~~ 274 (495)
+||||+.++.+..+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..+....
T Consensus 110 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~- 185 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 185 (330)
T ss_dssp EEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred EEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-
Confidence 9999999876665553 489999999999999999999999999999999999999777 89999999998765432
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhcCCCChhhh-hhCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP-GRTEVEQLHKIFKLCGSPSEEYW-KKSKLPH 352 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~-~~~~~~~~~~i~~~~g~~~~~~~-~~~~~~~ 352 (495)
.....+||+.|+|||++.+...++.++|||||||++|+|++|..||. +.+..+.+..+....+.+....+ .......
T Consensus 186 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 186 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 33556889999999998876678999999999999999999998885 56667777777776665432211 1111110
Q ss_pred CccC------CCCcccccc-cccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 353 ATIF------KPQQSYKRC-IAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 353 ~~~~------~~~~~~~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
...+ .....+... .......+++++.+||.+||++||.+|||+.|+|+||||++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 0000 000001100 011122368889999999999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=399.86 Aligned_cols=257 Identities=26% Similarity=0.463 Sum_probs=221.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.+.|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++.. ....|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 130 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAW 130 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCeEE
Confidence 3569999999999999999999999999999999986644 34445678899999999999999999999987 56899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+||||+.+++...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 131 lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred EEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 99999999888777655668999999999999999999999999999999999999999999999999999876432
Q ss_pred CCccccccCCCCCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 276 PMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
...+||+.|+|||++.+ ...++.++|||||||++|||++|.+||.+.+..+.+..+.......
T Consensus 208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~------------- 272 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA------------- 272 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-------------
T ss_pred --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------
Confidence 34579999999999853 3568999999999999999999999999988877776665421100
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.....+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 273 --------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 273 --------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred --------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 0113467788999999999999999999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=394.18 Aligned_cols=264 Identities=22% Similarity=0.316 Sum_probs=221.4
Q ss_pred CCCeeee-eeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCcee
Q 011041 117 ADTFEKL-DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 117 ~~~y~~~-~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 194 (495)
.+.|.+. +.||+|+||.||+|++..+|+.||||++............+.+|+.+++.+ .||||+++++++.+ ...+
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~~ 104 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEI 104 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCeE
Confidence 3678887 889999999999999999999999999987655555567788999999999 56999999999987 5679
Q ss_pred EEEEeeccCChhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC---CCcEEEeeccccccc
Q 011041 195 YLVFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASFF 269 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~--~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~---~~~vkL~DFG~a~~~ 269 (495)
|+||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 99999999865555443 2457999999999999999999999999999999999999988 789999999999876
Q ss_pred CCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+...
T Consensus 185 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------ 255 (327)
T 3lm5_A 185 GHA--CELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE------ 255 (327)
T ss_dssp -----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT------
T ss_pred CCc--cccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch------
Confidence 533 22345689999999998876 568999999999999999999999999999888888876654433322
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~ 410 (495)
.+..+++.+.+||.+||..||.+|||+.++|+||||+...|.
T Consensus 256 -------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 256 -------------------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp -------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred -------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 224567889999999999999999999999999999987664
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=392.29 Aligned_cols=265 Identities=25% Similarity=0.315 Sum_probs=208.2
Q ss_pred CCCCCCeeee-eeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCC
Q 011041 114 PRRADTFEKL-DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 114 ~~~~~~y~~~-~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 191 (495)
.+..+.|++. +.||+|+||.||+|++..+++.||||++.... ......+.+|+.+|.++ +||||+++++++.+ .
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~ 83 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--E 83 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--T
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--C
Confidence 3446789996 78999999999999999999999999997653 23345788999999995 79999999999987 5
Q ss_pred ceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCc---EEEeecccccc
Q 011041 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI---LTIADFGLASF 268 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~---vkL~DFG~a~~ 268 (495)
..+|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++..
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 689999999987655555444457999999999999999999999999999999999999998776 99999999976
Q ss_pred cCCCCC------CCCccccccCCCCCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------------
Q 011041 269 FDPNHK------QPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTE------------ 326 (495)
Q Consensus 269 ~~~~~~------~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~------------ 326 (495)
...... ......+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 532211 12234569999999999864 13478899999999999999999999987642
Q ss_pred ---HHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCC
Q 011041 327 ---VEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403 (495)
Q Consensus 327 ---~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~ 403 (495)
...+..+.......+... +..+++++.+||.+||..||.+|||+.|+|+|||
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKD-------------------------WAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHH-------------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred hHHHHHHHHHhccCcccCchh-------------------------cccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence 223333433222222221 2357788999999999999999999999999999
Q ss_pred CCCC
Q 011041 404 FTTK 407 (495)
Q Consensus 404 f~~~ 407 (495)
|+..
T Consensus 299 ~~~~ 302 (316)
T 2ac3_A 299 VQGC 302 (316)
T ss_dssp CC--
T ss_pred hcCC
Confidence 9864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=400.02 Aligned_cols=266 Identities=25% Similarity=0.379 Sum_probs=217.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCC---CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN---LEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.++|++++.||+|+||.||+|++..++..||+|++.... ......+.+.+|+.+|+.++||||+++++++.+ ...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~ 102 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED--EQY 102 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--CCe
Confidence 368999999999999999999999999999999997542 234556788999999999999999999999987 568
Q ss_pred eEEEEeeccCChhhhhhCC----------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 011041 194 LYLVFKYMEHDLAGLAASP----------------------------------------TIKFTQAQVKCYMHQLLSGLE 233 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~----------------------------------------~~~l~e~~~~~i~~qil~~L~ 233 (495)
.|+||||+.++.+...... ...+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999987655544320 112468889999999999999
Q ss_pred HhhhCCceeccCCCCCeeeCCCC--cEEEeecccccccCCCCC---CCCccccccCCCCCcccccCC-CCCCchhhHHHH
Q 011041 234 HCHNQHVLHRDIKGSNLLIDNEG--ILTIADFGLASFFDPNHK---QPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSA 307 (495)
Q Consensus 234 ~LH~~givHrDlKp~NILl~~~~--~vkL~DFG~a~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwSl 307 (495)
|||++||+||||||+||||+.++ .+||+|||++..+..... .......||+.|+|||++.+. ..++.++|||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99999999999999999998776 899999999986533211 123456799999999998643 568999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccC
Q 011041 308 GCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAI 387 (495)
Q Consensus 308 Gvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~ 387 (495)
||++|+|++|.+||.+.+..+.+..+......+.... ...+++++.+||.+||..
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPN-------------------------YNVLSPLARDLLSNLLNR 317 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGG-------------------------GGGSCHHHHHHHHHHSCS
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcc-------------------------cccCCHHHHHHHHHHcCC
Confidence 9999999999999999999888888776433322221 234678899999999999
Q ss_pred CCCCccCHHHHHhCCCCCCCCC
Q 011041 388 DPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 388 dP~~R~ta~elL~hp~f~~~~~ 409 (495)
||.+|||+.++|+||||+...+
T Consensus 318 ~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 318 NVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp CTTTSCCHHHHHHSHHHHTTSS
T ss_pred ChhHCCCHHHHhcChhhccChH
Confidence 9999999999999999987544
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=404.28 Aligned_cols=281 Identities=23% Similarity=0.384 Sum_probs=226.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC--------CCCeeeeeceeec
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD--------HPNVVKLEGLVTS 188 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l~~~~~~ 188 (495)
.++|++++.||+|+||.||+|++..+++.||||++... ......+.+|+.+|+.+. |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 47899999999999999999999999999999999743 445667889999999985 7889999998873
Q ss_pred c--CCceeEEEEeeccCChhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhC-CceeccCCCCCeeeCCCC--------
Q 011041 189 R--MSCSLYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEG-------- 256 (495)
Q Consensus 189 ~--~~~~~~lv~e~~~~~l~~~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~-givHrDlKp~NILl~~~~-------- 256 (495)
. ....+|+||||++++++..+... ...+++..++.++.||+.||.|||++ ||+||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred cCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 2 24679999999999988877654 35799999999999999999999998 999999999999999775
Q ss_pred -----------------------------------------cEEEeecccccccCCCCCCCCccccccCCCCCcccccCC
Q 011041 257 -----------------------------------------ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295 (495)
Q Consensus 257 -----------------------------------------~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 295 (495)
.+||+|||++...... ....+||+.|+|||++.+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~- 267 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG- 267 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT-
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC-
Confidence 7999999999876432 345689999999999987
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccc------
Q 011041 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRT------EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYK------ 363 (495)
Q Consensus 296 ~~~~~~~DvwSlGvil~elltG~~pf~~~~------~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~------ 363 (495)
..|+.++||||||||||+|++|.+||.+.+ ..+.+..+...++.++...|......... +.......
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF-FTKKGDLKHITKLK 346 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGT-BCTTSSBSSCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccc-cCCccccccccccC
Confidence 468999999999999999999999998755 56788889999999887766543322111 00000000
Q ss_pred -----ccccc---ccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 364 -----RCIAE---TFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 364 -----~~~~~---~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
..+.. .....++.+.+||.+||++||.+|||+.|+|+||||++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 00000 01112346789999999999999999999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=427.31 Aligned_cols=261 Identities=26% Similarity=0.421 Sum_probs=217.1
Q ss_pred CCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 115 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
...++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||++++++.+ ...
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~ 258 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDA 258 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee--CCE
Confidence 346889999999999999999999999999999999975432 12234567899999999999999999999987 568
Q ss_pred eEEEEeeccCChhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 194 LYLVFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~--~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
+|+||||+.++.+..++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||++.....
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999987655544332 23499999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCChhhhhh
Q 011041 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE----VEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~----~~~~~~i~~~~g~~~~~~~~~ 347 (495)
. ......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+. .+....+....
T Consensus 339 ~--~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~---------- 405 (576)
T 2acx_A 339 G--QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP---------- 405 (576)
T ss_dssp T--CCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC----------
T ss_pred C--ccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc----------
Confidence 3 23455689999999999876 5689999999999999999999999988643 23333332210
Q ss_pred CCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCC
Q 011041 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPY 409 (495)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~ 409 (495)
......+++++.+||.+||+.||.+|| ++.|+++||||+...|
T Consensus 406 -------------------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 406 -------------------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred -------------------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 011235788999999999999999999 8999999999998654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=397.46 Aligned_cols=259 Identities=30% Similarity=0.471 Sum_probs=222.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC--Ch----HHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL--EP----ESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~--~~----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 190 (495)
++|++.+.||+|+||.||+|++..+|+.||||++..... .. ...+.+.+|+.+++.+ +||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 679999999999999999999999999999999986542 21 2245678999999999 89999999999987
Q ss_pred CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
....|+||||+.++.+..+......+++..+..++.||+.||.|||+.||+||||||+||||+.+|.+||+|||++..+.
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 56899999999986665555445579999999999999999999999999999999999999999999999999998775
Q ss_pred CCCCCCCccccccCCCCCcccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 011041 271 PNHKQPMTSRVVTLWYRPPELLLG-----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345 (495)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (495)
.. ......+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+....+..+......+....|
T Consensus 252 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 252 PG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 43 23456689999999998853 235789999999999999999999999998888888877665444443333
Q ss_pred hhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
..+++.+.+||.+||..||.+|||+.++|+||||+
T Consensus 330 -------------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 330 -------------------------DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp -------------------------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred -------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 34677899999999999999999999999999996
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=399.20 Aligned_cols=279 Identities=27% Similarity=0.459 Sum_probs=224.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CC-----CeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HP-----NVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~~~~~~~~ 190 (495)
.++|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.+. |+ +|+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-- 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--
Confidence 57899999999999999999999999999999999743 344567778999999885 54 49999999887
Q ss_pred CceeEEEEeeccCChhhhhhCCC-CCCCHHHHHHHHHHHHHHHHHhh--hCCceeccCCCCCeeeC--CCCcEEEeeccc
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPT-IKFTQAQVKCYMHQLLSGLEHCH--NQHVLHRDIKGSNLLID--NEGILTIADFGL 265 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~-~~l~e~~~~~i~~qil~~L~~LH--~~givHrDlKp~NILl~--~~~~vkL~DFG~ 265 (495)
...+|+||||+++++...+.... ..+++..++.++.||+.||.||| +.||+||||||+||||+ .++.+||+|||+
T Consensus 128 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 128 RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 56899999999998877766543 46999999999999999999999 57999999999999995 478899999999
Q ss_pred ccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 011041 266 ASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345 (495)
Q Consensus 266 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (495)
+...... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+++..|....+.++...+
T Consensus 208 a~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 208 SCQLGQR----IYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ceecccc----cccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9876432 345689999999999887 46899999999999999999999999999999999999999999887766
Q ss_pred hhCCC--------CCCc-----------cCCCCcccccccccccC-----------C---C----CCCcHHHHHHhccCC
Q 011041 346 KKSKL--------PHAT-----------IFKPQQSYKRCIAETFK-----------D---F----PPSSLPLIETLLAID 388 (495)
Q Consensus 346 ~~~~~--------~~~~-----------~~~~~~~~~~~~~~~~~-----------~---~----s~~~~~Li~~~L~~d 388 (495)
..... +... .+.+. .. ..+...+. . . ++++.+||.+||++|
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 360 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPP-GT-RKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD 360 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCT-TC-SCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCc-ch-hhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence 43210 0000 00000 00 00000000 0 0 025789999999999
Q ss_pred CCCccCHHHHHhCCCCCCC
Q 011041 389 PAERQTATAALRSEFFTTK 407 (495)
Q Consensus 389 P~~R~ta~elL~hp~f~~~ 407 (495)
|.+|||+.|+|+||||+..
T Consensus 361 P~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 361 PKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TTTSCCHHHHTTSGGGCC-
T ss_pred hhhCCCHHHHhcCcccccC
Confidence 9999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=434.11 Aligned_cols=261 Identities=22% Similarity=0.335 Sum_probs=224.8
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCce
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 193 (495)
..++|++++.||+|+||.||+|+++.+++.||||++.+... .....+.+.+|+.+|..+ +||||+++++++.+ ...
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCE
Confidence 46899999999999999999999999999999999975422 223345677899999988 79999999999987 568
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+||||||+.++.+..++.....+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++.......
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 99999999987666666555679999999999999999999999999999999999999999999999999998643222
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......+||+.|+|||++.+ ..|+.++||||||||||||++|.+||.+.+..+++.+|......
T Consensus 497 -~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-------------- 560 (674)
T 3pfq_A 497 -VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-------------- 560 (674)
T ss_dssp -CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCC--------------
T ss_pred -cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC--------------
Confidence 33456789999999999876 57899999999999999999999999999999998888652211
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCH-----HHHHhCCCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA-----TAALRSEFFTTKPY 409 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta-----~elL~hp~f~~~~~ 409 (495)
....+++++.+||.+||+.||.+|+++ .|+++||||+...|
T Consensus 561 ---------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 561 ---------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp ---------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred ---------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence 123578889999999999999999997 99999999998765
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=406.91 Aligned_cols=260 Identities=25% Similarity=0.391 Sum_probs=206.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC------hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE------PESVRFMAREILILRRLDHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 190 (495)
.++|.+.+.||+|+||.||+|++..+++.||||++.+.... ......+.+|+.+|+.++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 47899999999999999999999999999999999764321 1223357899999999999999999999864
Q ss_pred CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC---cEEEeeccccc
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLAS 267 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~---~vkL~DFG~a~ 267 (495)
...|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++.
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 35899999999876666666667899999999999999999999999999999999999997544 59999999998
Q ss_pred ccCCCCCCCCccccccCCCCCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChhh
Q 011041 268 FFDPNHKQPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE-QLHKIFKLCGSPSEEY 344 (495)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~g~~~~~~ 344 (495)
..... ......+||+.|+|||++.+ ...|+.++|||||||++|+|++|.+||.+..... ....+......+...
T Consensus 291 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~- 367 (419)
T 3i6u_A 291 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE- 367 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH-
T ss_pred ecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch-
Confidence 76533 23456689999999999853 3568899999999999999999999998755433 233333222222222
Q ss_pred hhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.+..+++.+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 368 ------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 368 ------------------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ------------------------hhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 23457888999999999999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=387.43 Aligned_cols=258 Identities=30% Similarity=0.452 Sum_probs=216.8
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|++++.||+|+||.||+|++..++..||+|++..... .......+.+|+.+++.++||||+++++++.+ ....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec--CCEE
Confidence 36889999999999999999999999999999999875432 12224568899999999999999999999987 5679
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+||||++++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-- 162 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 162 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence 999999997666555544457999999999999999999999999999999999999999999999999998655432
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.......
T Consensus 163 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 226 (279)
T 3fdn_A 163 -RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-------------- 226 (279)
T ss_dssp ------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC--------------
T ss_pred -cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCC--------------
Confidence 2245678999999998876 567899999999999999999999999988888877775432111
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
...+++.+.+||.+||..||.+|||+.|+|+||||+..+
T Consensus 227 ---------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 227 ---------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp ---------------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred ---------------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 123567789999999999999999999999999998754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=395.59 Aligned_cols=262 Identities=28% Similarity=0.395 Sum_probs=224.3
Q ss_pred CCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 115 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
...++|.+++.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 115 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDF 115 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCe
Confidence 345789999999999999999999999999999999986543 45566788999999999999999999999987 568
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|+||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 116 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 99999999976665555545679999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 196 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------- 259 (335)
T 2owb_A 196 -ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-------------- 259 (335)
T ss_dssp -CCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--------------
T ss_pred -ccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC--------------
Confidence 22345678999999999876 56799999999999999999999999998877776666442111
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
....+++.+.+||.+||..||.+|||+.|+|+||||+....
T Consensus 260 ---------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 260 ---------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp ---------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred ---------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 11246677899999999999999999999999999987544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=388.77 Aligned_cols=256 Identities=24% Similarity=0.405 Sum_probs=217.9
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
.|...+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++.. ....|+||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLV--GEELWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 48888999999999999999999999999999986543 234567899999999999999999999987 56799999
Q ss_pred eeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCc
Q 011041 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278 (495)
Q Consensus 199 e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 278 (495)
||+.++.+..+... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ....
T Consensus 122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 199 (321)
T 2c30_A 122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 199 (321)
T ss_dssp CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBC
T ss_pred ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-cccc
Confidence 99998777666654 369999999999999999999999999999999999999999999999999998765432 2234
Q ss_pred cccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCC
Q 011041 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (495)
Q Consensus 279 ~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 358 (495)
..+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......
T Consensus 200 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------------ 260 (321)
T 2c30_A 200 SLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK------------------ 260 (321)
T ss_dssp CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC------------------
T ss_pred cccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC------------------
Confidence 5689999999998876 568999999999999999999999999988877776664421100
Q ss_pred CcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 359 ~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 261 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 261 --------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp --------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred --------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 00112467789999999999999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=384.74 Aligned_cols=257 Identities=27% Similarity=0.420 Sum_probs=209.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|.+.+.||+|+||.||+|++..++..||+|++..... ....+.+.+|+.+|+.++||||+++++++.+ ....|+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFED--YHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheec--CCeEEE
Confidence 4789999999999999999999999999999999986543 2335678899999999999999999999987 567999
Q ss_pred EEeeccCCh-hhhhhC---CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee---CCCCcEEEeeccccccc
Q 011041 197 VFKYMEHDL-AGLAAS---PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFF 269 (495)
Q Consensus 197 v~e~~~~~l-~~~~~~---~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl---~~~~~vkL~DFG~a~~~ 269 (495)
||||+.++. ...+.. ....+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999998754 443322 24579999999999999999999999999999999999999 44678999999999876
Q ss_pred CCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 178 ~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------- 244 (285)
T 3is5_A 178 KSD--EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY--------- 244 (285)
T ss_dssp -----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------
T ss_pred CCc--ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc---------
Confidence 543 22345678999999998754 68999999999999999999999999988777666554321111
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
......+++++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 245 -----------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 245 -----------------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp -----------------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred -----------------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 1112346788999999999999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=384.67 Aligned_cols=260 Identities=25% Similarity=0.393 Sum_probs=202.6
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
..++|++++.||+|+||.||+|++..+|+.||||++............+.++...++.++||||+++++++.+ ....|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--~~~~~ 82 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR--EGDVW 82 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSSEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec--cCCEE
Confidence 3578999999999999999999999999999999997665444445556666666888999999999999987 56799
Q ss_pred EEEeeccCChhhhhh---CCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 196 LVFKYMEHDLAGLAA---SPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 196 lv~e~~~~~l~~~~~---~~~~~l~e~~~~~i~~qil~~L~~LH~~-givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
+||||+++++...+. .....+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++.....
T Consensus 83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 999999987755443 3556899999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCCCCccccccCCCCCcccc---cCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCChhhhhh
Q 011041 272 NHKQPMTSRVVTLWYRPPELL---LGATDYGVGVDLWSAGCILAELLAEKPIMPG-RTEVEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~l---~~~~~~~~~~DvwSlGvil~elltG~~pf~~-~~~~~~~~~i~~~~g~~~~~~~~~ 347 (495)
.. ......||+.|+|||++ .....++.++|||||||++|+|++|..||.. ......+..+.......
T Consensus 163 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 233 (290)
T 3fme_A 163 DV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ------- 233 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC-------
T ss_pred cc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC-------
Confidence 32 22345789999999997 3445689999999999999999999999987 34444444443321100
Q ss_pred CCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.....+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 234 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 234 --------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp --------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred --------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 011346778999999999999999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=417.33 Aligned_cols=262 Identities=26% Similarity=0.391 Sum_probs=218.5
Q ss_pred CCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 115 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
...++|.+++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++.+ ...
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~ 259 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET--KTD 259 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee--CCE
Confidence 346899999999999999999999999999999999975432 12234568899999999999999999999987 567
Q ss_pred eEEEEeeccCChhhhhhCC----CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccccccc
Q 011041 194 LYLVFKYMEHDLAGLAASP----TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~----~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~ 269 (495)
+|+||||+.++.+..++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999997655544322 346999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHhcCCCChhhh
Q 011041 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT----EVEQLHKIFKLCGSPSEEYW 345 (495)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~----~~~~~~~i~~~~g~~~~~~~ 345 (495)
.... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+ ..+....+.....
T Consensus 340 ~~~~-~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~------- 410 (543)
T 3c4z_A 340 KAGQ-TKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV------- 410 (543)
T ss_dssp CTTC-CCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC-------
T ss_pred cCCC-cccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc-------
Confidence 5432 22345689999999999876 578999999999999999999999998864 2444444443111
Q ss_pred hhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-----HHHHHhCCCCCCCCC
Q 011041 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEFFTTKPY 409 (495)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----a~elL~hp~f~~~~~ 409 (495)
.....+++++.+||.+||+.||.+||+ +.++++||||+...|
T Consensus 411 ----------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 411 ----------------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred ----------------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 112357888999999999999999995 599999999998655
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=391.88 Aligned_cols=264 Identities=22% Similarity=0.319 Sum_probs=215.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC--ce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS--CS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--~~ 193 (495)
.++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++++..... ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 5789999999999999999999999999999999987644 44556788999999999999999999999876322 24
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
.|+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 59999999876666555545579999999999999999999999999999999999999999999999999998764332
Q ss_pred C--CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 274 K--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 274 ~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+......+..
T Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------- 240 (311)
T 3ork_A 171 NSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS--------- 240 (311)
T ss_dssp -----------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH---------
T ss_pred cccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc---------
Confidence 2 12234578999999999876 56899999999999999999999999999888877766553322221
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.....+++++.+||.+||..||.+||++.++|.|+|+..
T Consensus 241 ----------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 241 ----------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ----------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 122457888999999999999999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=382.69 Aligned_cols=262 Identities=27% Similarity=0.387 Sum_probs=224.0
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|.+.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+ ....
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 90 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFV 90 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--CCEE
Confidence 45789999999999999999999999999999999986643 45566788899999999999999999999987 5679
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+||||++++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 169 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG- 169 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc-
Confidence 9999999976665555555579999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 232 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY---------------- 232 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC----------------
T ss_pred cccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC----------------
Confidence 22345678999999998876 5679999999999999999999999999887776665543110
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~ 410 (495)
.....+++.+.+||.+||..||.+|||+.++|+||||+..+.+
T Consensus 233 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 233 -------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred -------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 1113466788999999999999999999999999999876554
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=379.32 Aligned_cols=260 Identities=23% Similarity=0.298 Sum_probs=216.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc--CCcee
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR--MSCSL 194 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~~ 194 (495)
...|.+.+.||+|+||.||+|.+..++..||+|++............+.+|+.+|+.++||||+++++++... ....+
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 4668999999999999999999999999999999987777777788899999999999999999999988652 24568
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--ceeccCCCCCeeeC-CCCcEEEeecccccccCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLID-NEGILTIADFGLASFFDP 271 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~g--ivHrDlKp~NILl~-~~~~vkL~DFG~a~~~~~ 271 (495)
|+||||++++.+..+......+++..++.++.||+.||.|||++| |+||||||+||||+ .++.+||+|||++.....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 999999988666665555567999999999999999999999999 99999999999998 789999999999976543
Q ss_pred CCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+................+
T Consensus 185 ~---~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------- 248 (290)
T 1t4h_A 185 S---FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----------- 248 (290)
T ss_dssp T---SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-----------
T ss_pred c---ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc-----------
Confidence 2 2345679999999998864 58999999999999999999999999866655444332211110
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.......++++.+||.+||..||.+|||+.++|+||||++.
T Consensus 249 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 249 ---------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp ---------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ---------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 01123356778999999999999999999999999999863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=386.10 Aligned_cols=258 Identities=28% Similarity=0.397 Sum_probs=217.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|.+++.||+|+||.||+|++..+|+.||||++..... .....+.+|+.+++.++||||+++++++.+ ...+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 83 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYES--TTHYYL 83 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhccc--CCEEEE
Confidence 3689999999999999999999999999999999986432 223567899999999999999999999987 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee---CCCCcEEEeecccccccCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl---~~~~~vkL~DFG~a~~~~~~~ 273 (495)
||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-- 161 (304)
T 2jam_A 84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-- 161 (304)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--
T ss_pred EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--
Confidence 99999875554444444579999999999999999999999999999999999999 7789999999999976432
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+...
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------- 229 (304)
T 2jam_A 162 -GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESP---------- 229 (304)
T ss_dssp -BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTT----------
T ss_pred -CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcc----------
Confidence 22345678999999998876 568999999999999999999999999998888888776543222211
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
....+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus 230 ---------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 230 ---------------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ---------------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ---------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 224577889999999999999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=396.49 Aligned_cols=251 Identities=21% Similarity=0.323 Sum_probs=211.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChH------HHHHHHHHHHHHHhCCCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPE------SVRFMAREILILRRLDHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 190 (495)
.++|++++.||+|+||.||+|+++.+|+.||||++........ ....+.+|+.+|+.++||||+++++++.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--
Confidence 4789999999999999999999999999999999987643221 33456789999999999999999999987
Q ss_pred CceeEEEEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccccccc
Q 011041 191 SCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (495)
Q Consensus 191 ~~~~~lv~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~ 269 (495)
...+|+||||+..+ .+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 56899999998754 55555555567999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||...... ...
T Consensus 181 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------~~~-- 239 (335)
T 3dls_A 181 ERG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------------VEA-- 239 (335)
T ss_dssp CTT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------TTT--
T ss_pred CCC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------Hhh--
Confidence 543 23456689999999999987555589999999999999999999999652210 000
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.......+++++.+||.+||..||.+|||+.++|+||||+.
T Consensus 240 ----------------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 240 ----------------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp ----------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred ----------------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 00112346788999999999999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=387.27 Aligned_cols=258 Identities=23% Similarity=0.375 Sum_probs=203.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC------
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM------ 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 190 (495)
.++|++++.||+|+||.||+|+++.+|+.||||++.... .....+.+.+|+.+|+.++|||||++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 468999999999999999999999999999999998654 3345577889999999999999999999885532
Q ss_pred -------------------------------------------------CceeEEEEeeccCChhhhhhCCCC---CCCH
Q 011041 191 -------------------------------------------------SCSLYLVFKYMEHDLAGLAASPTI---KFTQ 218 (495)
Q Consensus 191 -------------------------------------------------~~~~~lv~e~~~~~l~~~~~~~~~---~l~e 218 (495)
...+|+||||+.++.+..+..... ..++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 124899999999866655544332 3566
Q ss_pred HHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC-----------CCCccccccCCCC
Q 011041 219 AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-----------QPMTSRVVTLWYR 287 (495)
Q Consensus 219 ~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~-----------~~~~~~~gt~~y~ 287 (495)
..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ ......+||+.|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 77899999999999999999999999999999999999999999999987754321 1234457999999
Q ss_pred CcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccc
Q 011041 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIA 367 (495)
Q Consensus 288 aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (495)
|||++.+ ..++.++|||||||++|+|++|..|+.. .......+.. +..+ .
T Consensus 244 aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~--~~~~-~------------------------ 293 (332)
T 3qd2_B 244 SPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRN--LKFP-L------------------------ 293 (332)
T ss_dssp CHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHT--TCCC-H------------------------
T ss_pred ChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhc--cCCC-c------------------------
Confidence 9999876 5689999999999999999998776421 1111111111 1111 1
Q ss_pred cccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 368 ETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 368 ~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.+...++++.+||.+||..||.+|||+.|+|+||||++
T Consensus 294 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 294 -LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp -HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred -ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 11223566789999999999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=380.53 Aligned_cols=259 Identities=25% Similarity=0.394 Sum_probs=218.0
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh----HHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP----ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
++|++++.||+|+||.||+|++..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN--KTD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC--CCe
Confidence 57999999999999999999999999999999998654321 135678899999999999999999999987 567
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC----cEEEeeccccccc
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG----ILTIADFGLASFF 269 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~----~vkL~DFG~a~~~ 269 (495)
.|+||||+.++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999998765555554455799999999999999999999999999999999999998877 8999999999876
Q ss_pred CCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...........
T Consensus 163 ~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 234 (283)
T 3bhy_A 163 EAGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY----- 234 (283)
T ss_dssp C----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHH-----
T ss_pred cCCC--cccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchh-----
Confidence 4332 2345678999999998875 5689999999999999999999999999988888777765433333222
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
+..+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 235 --------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 235 --------------------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp --------------------HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred --------------------cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 2456778999999999999999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=379.34 Aligned_cols=262 Identities=26% Similarity=0.416 Sum_probs=221.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC---C----hHHHHHHHHHHHHHHhCC-CCCeeeeeceeec
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL---E----PESVRFMAREILILRRLD-HPNVVKLEGLVTS 188 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~---~----~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 188 (495)
.++|++.+.||+|+||.||+|+++.+|+.||||++..... . ....+.+.+|+.+|+++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 5889999999999999999999999999999999986542 1 123456789999999995 9999999999987
Q ss_pred cCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccc
Q 011041 189 RMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (495)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~ 268 (495)
....|+||||++++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 96 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred --CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 578999999999765555554455799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCccccccCCCCCccccc-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 011041 269 FDPNHKQPMTSRVVTLWYRPPELLL-----GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE 343 (495)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (495)
.... .......||+.|+|||++. ....++.++|||||||++|+|++|.+||.+.+..+....+..........
T Consensus 174 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1phk_A 174 LDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 251 (298)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred cCCC--cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence 6543 2334567899999999885 23467899999999999999999999999988888777776543222211
Q ss_pred hhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
....+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 252 -------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 252 -------------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp -------------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred -------------------------cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 123467889999999999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=377.22 Aligned_cols=261 Identities=27% Similarity=0.408 Sum_probs=216.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|++..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 82 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 82 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEE
Confidence 3689999999999999999999999999999999976543 2345678899999999999999999999987 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC-CC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-KQ 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~ 275 (495)
||||++++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ..
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 99999986666666666679999999999999999999999999999999999999999999999999998654322 12
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE-QLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+... .+..+.....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 226 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------------- 226 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT----------------
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc----------------
Confidence 23456789999999998775555789999999999999999999998765432 2222211100
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.......+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 227 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 227 -----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp -----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -----------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 001123467889999999999999999999999999999863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=383.69 Aligned_cols=258 Identities=28% Similarity=0.425 Sum_probs=218.1
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|++.+.||+|+||.||+|++..++..||||++...... ......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 89 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKRI 89 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc--CCEE
Confidence 357899999999999999999999999999999999754221 1224568899999999999999999999987 5689
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-- 167 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-- 167 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc--
Confidence 999999987555444444457999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.....
T Consensus 168 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---------------- 229 (284)
T 2vgo_A 168 -RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL---------------- 229 (284)
T ss_dssp -CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC----------------
T ss_pred -ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc----------------
Confidence 2245578999999999876 5679999999999999999999999999888777766654211
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
.....+++++.+||.+||..||.+|||+.++|+||||+...
T Consensus 230 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 230 -------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp -------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred -------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 11134677889999999999999999999999999998643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=399.20 Aligned_cols=260 Identities=23% Similarity=0.378 Sum_probs=209.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC--CCCeeeeeceeeccCCcee
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD--HPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~~ 194 (495)
.++|++++.||+|+||.||+|.+.. ++.||||++............+.+|+.+|+.|. ||||+++++++.. ...+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~ 131 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 131 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--CCEE
Confidence 3579999999999999999999765 899999999887767777788999999999996 5999999999887 5679
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|||||+.+++|...+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+.....
T Consensus 132 ~lv~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 132 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 99999776666665554 34789999999999999999999999999999999999995 58999999999987654322
Q ss_pred C-CCccccccCCCCCcccccC----------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCh
Q 011041 275 Q-PMTSRVVTLWYRPPELLLG----------ATDYGVGVDLWSAGCILAELLAEKPIMPGRTE-VEQLHKIFKLCGSPSE 342 (495)
Q Consensus 275 ~-~~~~~~gt~~y~aPE~l~~----------~~~~~~~~DvwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~g~~~~ 342 (495)
. .....+||+.|+|||++.+ ...|+.++||||||||||+|++|.+||.+... ...+..+.......
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~-- 287 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI-- 287 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC--
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC--
Confidence 1 2345689999999999865 13589999999999999999999999987643 34444443211000
Q ss_pred hhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
......+.++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 288 -------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 288 -------------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp -------------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred -------------------------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 01112356789999999999999999999999999998643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=383.45 Aligned_cols=262 Identities=27% Similarity=0.395 Sum_probs=212.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|+||.||+|++..++..||+|++..... .......+.+|+.+++.++||||+++++++.+ ...+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE--DDCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC--SSEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee--CCeEE
Confidence 4789999999999999999999999999999999976544 45566789999999999999999999999987 56899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+||||++++.+..+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999998666655555557999999999999999999999999999999999999999999999999999876544333
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+...++..... +..
T Consensus 168 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~------------- 232 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-PNV------------- 232 (294)
T ss_dssp -------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC-CCH-------------
T ss_pred ccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC-CCc-------------
Confidence 3445679999999999887 5689999999999999999999999999887776655443211 100
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
......++|+.+.+||.+||..||.+||+..+.|.+.|..
T Consensus 233 ----------~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 233 ----------TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp ----------HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred ----------chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 1122356788899999999999999999666666666643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=380.21 Aligned_cols=254 Identities=20% Similarity=0.262 Sum_probs=208.3
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|++++.||+|+||.||+|++..+++.||||++............+.+|+.++..+ +||||+++++++.+ ...+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~ 86 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHM 86 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeE
Confidence 34789999999999999999999999999999999987665555667788999999999 99999999999987 5689
Q ss_pred EEEEeeccCChhhhhhCC----CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC---------------
Q 011041 195 YLVFKYMEHDLAGLAASP----TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE--------------- 255 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~----~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~--------------- 255 (495)
|+||||++++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999987544443322 2568999999999999999999999999999999999999844
Q ss_pred ----CcEEEeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 011041 256 ----GILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLH 331 (495)
Q Consensus 256 ----~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~ 331 (495)
..+||+|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++|.++|..... ..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~ 238 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WH 238 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HH
T ss_pred cCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HH
Confidence 47999999999876533 2346899999999998755677899999999999999999988755432 22
Q ss_pred HHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 332 KIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 332 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.+.... .......+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus 239 ~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 239 EIRQGR----------------------------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHTTC----------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHcCC----------------------------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 222110 111224577889999999999999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=386.59 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=209.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC------ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL------EPESVRFMAREILILRRLDHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 190 (495)
.++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 3689999999999999999999999999999999976432 122334578999999999999999999998763
Q ss_pred CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCc---EEEeeccccc
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI---LTIADFGLAS 267 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~---vkL~DFG~a~ 267 (495)
..|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++.
T Consensus 88 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 88 --DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp --SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred --ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 38999999988666555556668999999999999999999999999999999999999987664 9999999998
Q ss_pred ccCCCCCCCCccccccCCCCCccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCChhh
Q 011041 268 FFDPNHKQPMTSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSEEY 344 (495)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~g~~~~~~ 344 (495)
..... .......||+.|+|||++. +...++.++|||||||++|+|++|.+||.+.... .....+.........
T Consensus 166 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 241 (322)
T 2ycf_A 166 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP-- 241 (322)
T ss_dssp ECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH--
T ss_pred ecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc--
Confidence 76432 1223457899999999874 3456899999999999999999999999875543 233333332222211
Q ss_pred hhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.....+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 242 -----------------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 242 -----------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp -----------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred -----------------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 222457788999999999999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=389.95 Aligned_cols=259 Identities=24% Similarity=0.383 Sum_probs=207.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCC--CCeeeeeceeeccCCcee
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH--PNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~~ 194 (495)
.++|++++.||+|+||.||+|.+. +++.||||++............+.+|+.+|+.++| +||+++++++.+ ...+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~ 84 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 84 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--CCEE
Confidence 578999999999999999999974 68899999998877777777889999999999976 999999999987 5689
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+|||+.++++...+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+.....
T Consensus 85 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 85 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 99999877777666554 45799999999999999999999999999999999999997 68899999999987654322
Q ss_pred C-CCccccccCCCCCcccccC----------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCh
Q 011041 275 Q-PMTSRVVTLWYRPPELLLG----------ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSE 342 (495)
Q Consensus 275 ~-~~~~~~gt~~y~aPE~l~~----------~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~g~~~~ 342 (495)
. .....+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.... ..+..+......
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--- 239 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE--- 239 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC---
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc---
Confidence 2 2345689999999999853 246899999999999999999999999875433 333333211000
Q ss_pred hhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.......++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 240 ------------------------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 240 ------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp ------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ------------------------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 01112234578999999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=379.57 Aligned_cols=263 Identities=27% Similarity=0.453 Sum_probs=220.4
Q ss_pred CCCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 115 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
...++|++++.||+|+||.||+|++..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.+.....+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 34689999999999999999999999999999999999877777777889999999999999999999998865556789
Q ss_pred EEEEeeccCC-hhhhhhC---CCCCCCHHHHHHHHHHHHHHHHHhhhCC-----ceeccCCCCCeeeCCCCcEEEeeccc
Q 011041 195 YLVFKYMEHD-LAGLAAS---PTIKFTQAQVKCYMHQLLSGLEHCHNQH-----VLHRDIKGSNLLIDNEGILTIADFGL 265 (495)
Q Consensus 195 ~lv~e~~~~~-l~~~~~~---~~~~l~e~~~~~i~~qil~~L~~LH~~g-----ivHrDlKp~NILl~~~~~vkL~DFG~ 265 (495)
|+||||++++ |...+.. ....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999874 4443332 2345999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 011041 266 ASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345 (495)
Q Consensus 266 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (495)
+....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.....
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~------- 233 (279)
T 2w5a_A 163 ARILNHDT-SFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF------- 233 (279)
T ss_dssp HHHC---C-HHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-------
T ss_pred heeecccc-ccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc-------
Confidence 98764321 11234578999999999876 4689999999999999999999999999887777766654211
Q ss_pred hhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......+++++.+||.+||..||.+|||+.|+|+|+|++..
T Consensus 234 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 234 ---------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ---------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 01123467889999999999999999999999999999863
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=381.85 Aligned_cols=265 Identities=28% Similarity=0.410 Sum_probs=219.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC--ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL--EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
.++|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++........
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4789999999999999999999999999999999975432 12345678899999999999999999999865446689
Q ss_pred EEEEeeccCChhhhhhC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 195 YLVFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
|+||||+.+++...+.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 99999999987665543 35579999999999999999999999999999999999999999999999999998764322
Q ss_pred -CCCCccccccCCCCCcccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 274 -KQPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 274 -~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
........||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~------------- 230 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY------------- 230 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-------------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-------------
Confidence 12223457899999999987532 347899999999999999999999999887777776644211
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~ 410 (495)
.....+++.+.+||.+||..||.+|||+.++|+||||+....+
T Consensus 231 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 231 ----------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp ----------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred ----------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 1123467788999999999999999999999999999875443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=381.29 Aligned_cols=259 Identities=27% Similarity=0.441 Sum_probs=191.7
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|++.+.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++.+ ....
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 86 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED--SNYV 86 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--SSEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--CCeE
Confidence 35789999999999999999999999999999999975322 11224678899999999999999999999987 5689
Q ss_pred EEEEeeccCChhh-hhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 195 YLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 195 ~lv~e~~~~~l~~-~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
|+||||++++.+. .+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999875444 444445679999999999999999999999999999999999999999999999999998765332
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..+...
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------------- 227 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA----------------- 227 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-----------------
T ss_pred C-cceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-----------------
Confidence 2 2234578999999998876 56789999999999999999999999876544333222100
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.......++.++.+||.+||..||.+|||+.++|+||||...
T Consensus 228 ------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 228 ------------DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp ------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ------------ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 001123467788999999999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=378.64 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=209.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++.. ....|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 87 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST--PTDFF 87 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCeEE
Confidence 5789999999999999999999999999999999975322 12234578899999999999999999999987 56799
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+||||+.++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~ 165 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--E 165 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC--c
Confidence 99999987655554444457999999999999999999999999999999999999999999999999999876543 2
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+......
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 229 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY---------------- 229 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc----------------
Confidence 2345578999999999887544578999999999999999999999988877776666432111
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
....++.++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 230 -------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 230 -------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 112356778999999999999999999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=381.78 Aligned_cols=280 Identities=23% Similarity=0.382 Sum_probs=225.1
Q ss_pred CCCeeeeeeecccCceEEEEEEE-CCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCC------Ceeeeeceeecc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARD-TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP------NVVKLEGLVTSR 189 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp------nIv~l~~~~~~~ 189 (495)
.++|++++.||+|+||.||+|++ ..+|+.||||++... ......+.+|+.+++.++|+ +|+++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~- 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH- 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-
Confidence 47899999999999999999998 568999999998643 34556788999999998655 49999999987
Q ss_pred CCceeEEEEeeccCChhhhhhCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC--------------
Q 011041 190 MSCSLYLVFKYMEHDLAGLAASPT-IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-------------- 254 (495)
Q Consensus 190 ~~~~~~lv~e~~~~~l~~~~~~~~-~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~-------------- 254 (495)
...+|+||||+++++...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 89 -~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 89 -HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred -CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 56899999999888877665443 46899999999999999999999999999999999999987
Q ss_pred -----CCcEEEeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 011041 255 -----EGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ 329 (495)
Q Consensus 255 -----~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~ 329 (495)
++.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999875432 245688999999999876 5689999999999999999999999999999999
Q ss_pred HHHHHHhcCCCChhhhhhCCCCCCc-----cCCCCcccccccc----------cccCCCCCCcHHHHHHhccCCCCCccC
Q 011041 330 LHKIFKLCGSPSEEYWKKSKLPHAT-----IFKPQQSYKRCIA----------ETFKDFPPSSLPLIETLLAIDPAERQT 394 (495)
Q Consensus 330 ~~~i~~~~g~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~----------~~~~~~s~~~~~Li~~~L~~dP~~R~t 394 (495)
+..+....+.++...+......... .+.........+. ......++++.+||.+||..||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 9999999998887766543211000 0000000000000 001112456789999999999999999
Q ss_pred HHHHHhCCCCCC
Q 011041 395 ATAALRSEFFTT 406 (495)
Q Consensus 395 a~elL~hp~f~~ 406 (495)
+.|+|+||||+.
T Consensus 323 ~~ell~hp~f~~ 334 (339)
T 1z57_A 323 LREALKHPFFDL 334 (339)
T ss_dssp HHHHTTSGGGGG
T ss_pred HHHHhcCHHHHH
Confidence 999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=383.98 Aligned_cols=281 Identities=24% Similarity=0.378 Sum_probs=226.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCC-eEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCC------eeeeeceeecc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTG-QIVALKKVRFDNLEPESVRFMAREILILRRLDHPN------VVKLEGLVTSR 189 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~~~~~ 189 (495)
.++|++++.||+|+||.||+|++..++ ..||+|++... ......+.+|+.+++.+.|++ |+.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-
Confidence 478999999999999999999998777 79999999643 345567888999999997665 8899888877
Q ss_pred CCceeEEEEeeccCChhhhhhCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee----------------
Q 011041 190 MSCSLYLVFKYMEHDLAGLAASPT-IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI---------------- 252 (495)
Q Consensus 190 ~~~~~~lv~e~~~~~l~~~~~~~~-~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl---------------- 252 (495)
...+|+||||++++++..+.... ..+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 94 -~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 94 -HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred -CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 56899999999998888766543 569999999999999999999999999999999999999
Q ss_pred ---CCCCcEEEeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 011041 253 ---DNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ 329 (495)
Q Consensus 253 ---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~ 329 (495)
+.++.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999999865432 245689999999999876 5689999999999999999999999999999999
Q ss_pred HHHHHHhcCCCChhhhhhCCCCCCc-----cCCCCcccccccccc----------cCCCCCCcHHHHHHhccCCCCCccC
Q 011041 330 LHKIFKLCGSPSEEYWKKSKLPHAT-----IFKPQQSYKRCIAET----------FKDFPPSSLPLIETLLAIDPAERQT 394 (495)
Q Consensus 330 ~~~i~~~~g~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~----------~~~~s~~~~~Li~~~L~~dP~~R~t 394 (495)
+..+.+..+.++..++......... ...........+... ....++++.+||.+||..||.+|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 9999999998888766543211000 000000000000000 0111346789999999999999999
Q ss_pred HHHHHhCCCCCCC
Q 011041 395 ATAALRSEFFTTK 407 (495)
Q Consensus 395 a~elL~hp~f~~~ 407 (495)
+.|+|+||||+..
T Consensus 328 ~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 328 LAEALLHPFFAGL 340 (355)
T ss_dssp HHHHTTSGGGGGC
T ss_pred HHHHhcChhhcCC
Confidence 9999999999863
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=399.00 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=211.1
Q ss_pred CCCeeeeeeecccCceEEEEEEEC---CCCeEEEeEEEecCCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNL--EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~---~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 190 (495)
.++|++++.||+|+||.||+|++. .+|+.||||++..... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 478999999999999999999984 5899999999865321 112234566799999999 69999999999987
Q ss_pred CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
...+|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 56799999999986665555445579999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCccccccCCCCCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCChhhh
Q 011041 271 PNHKQPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTE----VEQLHKIFKLCGSPSEEYW 345 (495)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~----~~~~~~i~~~~g~~~~~~~ 345 (495)
..........+||+.|+|||++.+. ..++.++|||||||+||+|++|..||...+. ......+....
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------- 282 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-------- 282 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--------
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC--------
Confidence 3333333456899999999998753 4578999999999999999999999986433 22222222210
Q ss_pred hhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCC
Q 011041 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPY 409 (495)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~ 409 (495)
......+++.+.+||.+||..||.+|| |+.++++||||+...|
T Consensus 283 ---------------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 283 ---------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred ---------------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 011234677789999999999999999 9999999999997544
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=377.27 Aligned_cols=260 Identities=28% Similarity=0.473 Sum_probs=219.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++.+ ...+|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 98 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYI 98 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC--CCeEEE
Confidence 468999999999999999999999999999999998665444456778899999999999999999999987 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC---CcEEEeecccccccCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE---GILTIADFGLASFFDPNH 273 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~---~~vkL~DFG~a~~~~~~~ 273 (495)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++.......
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 99999876554443334479999999999999999999999999999999999999764 479999999998765432
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......+..
T Consensus 179 --~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 243 (287)
T 2wei_A 179 --KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL----------- 243 (287)
T ss_dssp --SCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-----------
T ss_pred --ccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-----------
Confidence 2345578999999998875 4899999999999999999999999999888877777553222211
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
..+..+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus 244 --------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 244 --------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp --------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred --------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 1124577889999999999999999999999999999753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=379.23 Aligned_cols=257 Identities=23% Similarity=0.328 Sum_probs=206.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||+|++ +|..||||++............+.+|+.+|++++||||+++++++.+ ...+|+
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 111 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ--PPNLSI 111 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--TTCCEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCceEE
Confidence 57899999999999999999976 58899999998877777777889999999999999999999999987 557999
Q ss_pred EEeeccCChhhhhhCCCC---CCCHHHHHHHHHHHHHHHHHhhhCC--ceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 197 VFKYMEHDLAGLAASPTI---KFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~---~l~e~~~~~i~~qil~~L~~LH~~g--ivHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
||||+.++.+..+..... .+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.....
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999998865555444332 3999999999999999999999999 99999999999999999999999999976543
Q ss_pred CCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~----------- 258 (309)
T 3p86_A 192 TF-LSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL----------- 258 (309)
T ss_dssp -----------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC-----------
T ss_pred cc-cccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----------
Confidence 22 22345689999999999876 568999999999999999999999999988877766653322111
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh--CCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR--SEFFTT 406 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~--hp~f~~ 406 (495)
.....+++++.+||.+||..||.+|||+.++++ .++++.
T Consensus 259 ----------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 259 ----------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ----------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 122457788999999999999999999999987 455544
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=393.02 Aligned_cols=266 Identities=17% Similarity=0.188 Sum_probs=195.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhC--CCCCeeeee-------cee
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL--DHPNVVKLE-------GLV 186 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l--~HpnIv~l~-------~~~ 186 (495)
..+|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3569999999999999999999999999999999998665 345566788886555555 699988755 333
Q ss_pred eccCC---------------ceeEEEEeeccCChhhhhhCCCCCCCHHHH------HHHHHHHHHHHHHhhhCCceeccC
Q 011041 187 TSRMS---------------CSLYLVFKYMEHDLAGLAASPTIKFTQAQV------KCYMHQLLSGLEHCHNQHVLHRDI 245 (495)
Q Consensus 187 ~~~~~---------------~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~------~~i~~qil~~L~~LH~~givHrDl 245 (495)
..... ..+||||||++++|...+......+++... ..++.||+.||.|||++||+||||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 32211 448999999998877766543334444444 567799999999999999999999
Q ss_pred CCCCeeeCCCCcEEEeecccccccCCCCCCCCccccccCCCCCcccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 011041 246 KGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAEKPIMPGR 324 (495)
Q Consensus 246 Kp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DvwSlGvil~elltG~~pf~~~ 324 (495)
||+||||+.++.+||+|||++...... .....+|+.|+|||++.+ ...|+.++|||||||+||+|++|.+||.+.
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999876422 124567899999999864 246899999999999999999999999876
Q ss_pred ChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 325 TEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 325 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
+... ...|....... .............+++.+.+||.+||+.||.+|||+.++|+||||
T Consensus 297 ~~~~-------------~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 356 (371)
T 3q60_A 297 TPGI-------------KGSWKRPSLRV-------PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356 (371)
T ss_dssp CTTC-------------TTCCCBCCTTS-------CCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred Cccc-------------ccchhhhhhhh-------ccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence 4321 00011000000 000001112234678899999999999999999999999999999
Q ss_pred CC
Q 011041 405 TT 406 (495)
Q Consensus 405 ~~ 406 (495)
+.
T Consensus 357 ~~ 358 (371)
T 3q60_A 357 LQ 358 (371)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=388.90 Aligned_cols=285 Identities=22% Similarity=0.328 Sum_probs=215.2
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
..++|++++.||+|+||.||+|++..+|..||+|++.... .......+.+|+.+|+.++||||+++++++.+ ...+|
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 107 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEIS 107 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE--TTEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE--CCEEE
Confidence 4578999999999999999999999999999999998653 45566788999999999999999999999987 56799
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~-givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
+||||+.++.+..+......+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++......
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 9999998866555555455799999999999999999999985 9999999999999999999999999999765322
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc-CCCChhhhhhCCCC-C
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLC-GSPSEEYWKKSKLP-H 352 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~-g~~~~~~~~~~~~~-~ 352 (495)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.... +......+...... .
T Consensus 186 -~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp -C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred -cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 2245578999999999876 568999999999999999999999999877665433321111 11111100000000 0
Q ss_pred CccC----CCCccc----ccccc-----cccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 353 ATIF----KPQQSY----KRCIA-----ETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 353 ~~~~----~~~~~~----~~~~~-----~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
...+ .+.... ..... .....++.++.+||.+||.+||.+|||+.|+|+||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 0000 000000 00000 0112356789999999999999999999999999999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=387.24 Aligned_cols=279 Identities=19% Similarity=0.269 Sum_probs=210.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||+|++..+|+.||||++..... ....+.+.+|+.+|+.++||||+++++++........|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 4789999999999999999999999999999999975432 223456779999999999999999999998765568899
Q ss_pred EEeeccCChhhhhhCC---CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee----CCCCcEEEeeccccccc
Q 011041 197 VFKYMEHDLAGLAASP---TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASFF 269 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~---~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl----~~~~~vkL~DFG~a~~~ 269 (495)
||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 9999986555444332 2239999999999999999999999999999999999999 77888999999999877
Q ss_pred CCCCCCCCccccccCCCCCcccccC-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHhcC
Q 011041 270 DPNHKQPMTSRVVTLWYRPPELLLG-------ATDYGVGVDLWSAGCILAELLAEKPIMPGRT----EVEQLHKIFKLCG 338 (495)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DvwSlGvil~elltG~~pf~~~~----~~~~~~~i~~~~g 338 (495)
.... .....+||+.|+|||++.. ...++.++|||||||++|+|++|.+||.... ..+.+.++....
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~- 243 (319)
T 4euu_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK- 243 (319)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC-
T ss_pred CCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC-
Confidence 5432 3345679999999998852 2568999999999999999999999997533 345555554422
Q ss_pred CCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCC
Q 011041 339 SPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402 (495)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp 402 (495)
+...|..........+.-.... .........+++.+.+||.+||++||.+|||+.|+|+||
T Consensus 244 --p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 244 --PSGAISGVQKAENGPIDWSGDM-PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp --CTTCCEEEECSTTCCEEEESSC-CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred --CcccchhhhcccCCccccCccC-CcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 2111111000000000000000 000011122345678999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=386.80 Aligned_cols=282 Identities=26% Similarity=0.442 Sum_probs=221.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-----------CCCeeeeece
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-----------HPNVVKLEGL 185 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~~~ 185 (495)
.++|++++.||+|+||.||+|++..+|+.||||++... ......+.+|+.+++.+. |+||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 57899999999999999999999999999999999743 344567889999999886 8999999999
Q ss_pred eeccC--CceeEEEEeeccCChhhhhhC-CCCCCCHHHHHHHHHHHHHHHHHhhhC-CceeccCCCCCeeeC------CC
Q 011041 186 VTSRM--SCSLYLVFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLID------NE 255 (495)
Q Consensus 186 ~~~~~--~~~~~lv~e~~~~~l~~~~~~-~~~~l~e~~~~~i~~qil~~L~~LH~~-givHrDlKp~NILl~------~~ 255 (495)
+.... ...+++||||+++++...+.. ....+++..++.++.||+.||.|||++ ||+||||||+||||+ ..
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 87532 237899999997777776654 344699999999999999999999998 999999999999994 44
Q ss_pred CcEEEeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------hHHH
Q 011041 256 GILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT------EVEQ 329 (495)
Q Consensus 256 ~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~------~~~~ 329 (495)
+.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+ ..+.
T Consensus 175 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceEEEcccccccccCCC----CCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 58999999999876532 345588999999999987 468999999999999999999999998754 5677
Q ss_pred HHHHHHhcCCCChhhhhhCCCCCCccCCCCcc-----------cccccc---cccCCCCCCcHHHHHHhccCCCCCccCH
Q 011041 330 LHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS-----------YKRCIA---ETFKDFPPSSLPLIETLLAIDPAERQTA 395 (495)
Q Consensus 330 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~---~~~~~~s~~~~~Li~~~L~~dP~~R~ta 395 (495)
+..+...++.++...|...+.... .+..... ....+. .....+++++.+||.+||+.||.+|||+
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRT-FFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHH-HBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHhcCCCCHHHHhccchhhh-hcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 888889999988776654321100 0000000 000000 0112234678899999999999999999
Q ss_pred HHHHhCCCCCCC
Q 011041 396 TAALRSEFFTTK 407 (495)
Q Consensus 396 ~elL~hp~f~~~ 407 (495)
.|+|+||||+..
T Consensus 329 ~ell~hp~f~~~ 340 (373)
T 1q8y_A 329 GGLVNHPWLKDT 340 (373)
T ss_dssp HHHHTCGGGTTC
T ss_pred HHHhhChhhhcc
Confidence 999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=402.71 Aligned_cols=251 Identities=18% Similarity=0.254 Sum_probs=198.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHH---HHHhCCCCCeeeee-------ce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREIL---ILRRLDHPNVVKLE-------GL 185 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~---il~~l~HpnIv~l~-------~~ 185 (495)
.++|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+. +|+.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 5789999999999999999999999999999999986533 4456678899995 45555899999998 55
Q ss_pred eeccCC----------c-----eeEEEEeeccCChhhhhhCCCCCCC-------HHHHHHHHHHHHHHHHHhhhCCceec
Q 011041 186 VTSRMS----------C-----SLYLVFKYMEHDLAGLAASPTIKFT-------QAQVKCYMHQLLSGLEHCHNQHVLHR 243 (495)
Q Consensus 186 ~~~~~~----------~-----~~~lv~e~~~~~l~~~~~~~~~~l~-------e~~~~~i~~qil~~L~~LH~~givHr 243 (495)
+.+... . ..||||||++++|...+... ..++ +..+..|+.||+.||.|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 543211 0 38999999987776655432 2233 48888899999999999999999999
Q ss_pred cCCCCCeeeCCCCcEEEeecccccccCCCCCCCCccccccCCCCCcccccCC----------CCCCchhhHHHHHHHHHH
Q 011041 244 DIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA----------TDYGVGVDLWSAGCILAE 313 (495)
Q Consensus 244 DlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DvwSlGvil~e 313 (495)
||||+||||+.++.+||+|||++..... .....+| +.|+|||++.+. ..|+.++|||||||+|||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 9999999999999999999999986432 2345577 999999998763 268999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc
Q 011041 314 LLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ 393 (495)
Q Consensus 314 lltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ 393 (495)
|++|.+||.+.+..+.+.. +......+++++.+||.+||..||.+||
T Consensus 306 lltg~~Pf~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rp 352 (377)
T 3byv_A 306 IWCADLPITKDAALGGSEW---------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRL 352 (377)
T ss_dssp HHHSSCCC------CCSGG---------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGCC
T ss_pred HHHCCCCCcccccccchhh---------------------------------hhhhccCCCHHHHHHHHHHcCCCchhCC
Confidence 9999999976543222111 1122346788999999999999999999
Q ss_pred CHHHHHhCCCCCC
Q 011041 394 TATAALRSEFFTT 406 (495)
Q Consensus 394 ta~elL~hp~f~~ 406 (495)
|+.++|+||||+.
T Consensus 353 t~~e~l~hp~f~~ 365 (377)
T 3byv_A 353 LPLQAMETPEYEQ 365 (377)
T ss_dssp CHHHHHTSHHHHH
T ss_pred CHHHHhhChHHHH
Confidence 9999999999964
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=379.98 Aligned_cols=269 Identities=25% Similarity=0.347 Sum_probs=194.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|++..+++.||||++..... ......+.+|+.+++.++||||+++++++.. ....|+
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 90 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVV--KDELWL 90 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEES--SSCEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEee--cCCcEE
Confidence 5789999999999999999999999999999999875432 2344567899999999999999999999987 457999
Q ss_pred EEeeccCChhhhhhC--------CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccc
Q 011041 197 VFKYMEHDLAGLAAS--------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (495)
Q Consensus 197 v~e~~~~~l~~~~~~--------~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~ 268 (495)
||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 999998754443332 345699999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCC----CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh
Q 011041 269 FDPNHK----QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344 (495)
Q Consensus 269 ~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (495)
...... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..............
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccc
Confidence 643211 1223457899999999986545689999999999999999999999998776655544332111000000
Q ss_pred hhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.........+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus 251 -------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 251 -------------------VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp -----------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred -------------------cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 00122345677889999999999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=375.65 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=211.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.+.|++++.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 93 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYH--DGKLWI 93 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--C-CEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee--CCeEEE
Confidence 478999999999999999999999999999999987543 2345678899999999999999999999987 567999
Q ss_pred EEeeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||||+.++.+..+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 172 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q 172 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence 99999886655443 334579999999999999999999999999999999999999999999999999975432110 1
Q ss_pred CCccccccCCCCCccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 276 PMTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~----~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
......||+.|+|||++. ....++.++|||||||++|+|++|.+||.+.+....+..+.......
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 241 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT----------- 241 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----------
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-----------
Confidence 123457899999999884 34568899999999999999999999999988877766665421110
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 242 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 242 ---------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp ---------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred ---------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 00112356778999999999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=372.04 Aligned_cols=257 Identities=27% Similarity=0.459 Sum_probs=218.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.+.|++++.||+|+||.||+|++..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+ ...+|+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEE
Confidence 36799999999999999999999999999999999866432 345678899999999999999999999987 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
||||++++.+..+... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 175 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 175 (303)
T ss_dssp EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CC
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-cc
Confidence 9999998666655544 479999999999999999999999999999999999999999999999999998765432 22
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+.... +
T Consensus 176 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~---------------- 236 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--P---------------- 236 (303)
T ss_dssp BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--C----------------
T ss_pred cCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--C----------------
Confidence 345678999999999876 568899999999999999999999999887776665553311 0
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 237 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 237 ----------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp ----------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ----------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 01123567789999999999999999999999999999753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=378.28 Aligned_cols=260 Identities=24% Similarity=0.400 Sum_probs=208.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC----C
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM----S 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~----~ 191 (495)
.++|++++.||+|+||.||+|++..+|+.||||++..... ....+.+|+.+++.+ +||||+++++++.... .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 5789999999999999999999999999999999975532 235678899999999 8999999999987632 4
Q ss_pred ceeEEEEeeccCChhhhhh-C-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeeccccccc
Q 011041 192 CSLYLVFKYMEHDLAGLAA-S-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~-~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~ 269 (495)
..+|+||||++++.+..+. . ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 6799999999875444333 2 2357999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCCccccccCCCCCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 011041 270 DPNHKQPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345 (495)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (495)
.... .......||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+....+..+......
T Consensus 180 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------ 252 (326)
T 2x7f_A 180 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP------ 252 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC------
T ss_pred CcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc------
Confidence 4322 22345578999999999863 246889999999999999999999999988877666555331100
Q ss_pred hhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 253 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 253 ---------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp ---------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ---------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 00123467889999999999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=383.09 Aligned_cols=275 Identities=22% Similarity=0.370 Sum_probs=216.1
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh---------------HHHHHHHHHHHHHHhCCCCCee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP---------------ESVRFMAREILILRRLDHPNVV 180 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~---------------~~~~~~~~Ei~il~~l~HpnIv 180 (495)
..++|++++.||+|+||.||+|++ +|+.||||++....... .....+.+|+.+++.++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 357999999999999999999998 89999999997542211 1126788999999999999999
Q ss_pred eeeceeeccCCceeEEEEeeccCChhhhh------hCC--CCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCee
Q 011041 181 KLEGLVTSRMSCSLYLVFKYMEHDLAGLA------ASP--TIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLL 251 (495)
Q Consensus 181 ~l~~~~~~~~~~~~~lv~e~~~~~l~~~~------~~~--~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NIL 251 (495)
++++++.+ ...+|+||||++++.+..+ ... ...+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 107 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred eEEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999987 5689999999998555444 333 5679999999999999999999999 99999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCh-HHH
Q 011041 252 IDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGV-GVDLWSAGCILAELLAEKPIMPGRTE-VEQ 329 (495)
Q Consensus 252 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~~DvwSlGvil~elltG~~pf~~~~~-~~~ 329 (495)
|+.++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|.+||.+.+. .+.
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 999999999999999876433 2345678999999999887545665 99999999999999999999998777 666
Q ss_pred HHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 330 LHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 330 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
+..+.......+... .....+. ...........+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 262 ~~~i~~~~~~~~~~~--------~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 262 FNNIRTKNIEYPLDR--------NHFLYPL--TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHTSCCCCCCCSS--------SSSTTTT--CC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHhccCcCCccch--------hhhhccc--cccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 666543221111100 0000000 0000112225678889999999999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=372.53 Aligned_cols=259 Identities=27% Similarity=0.418 Sum_probs=202.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc-------
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR------- 189 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------- 189 (495)
.++|++++.||+|+||.||+|++..+|+.||||++... ......+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 36799999999999999999999999999999999643 45567788999999999999999999987542
Q ss_pred ----CCceeEEEEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecc
Q 011041 190 ----MSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264 (495)
Q Consensus 190 ----~~~~~~lv~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG 264 (495)
....+|+||||++++ +...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 145789999999874 544444455578999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-------------CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHH
Q 011041 265 LASFFDPNH-------------KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG-RTEVEQL 330 (495)
Q Consensus 265 ~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~-~~~~~~~ 330 (495)
++....... ........||+.|+|||++.+...++.++|||||||++|+|++ ||.. .+..+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 998664221 1223456789999999998775678999999999999999998 4443 2333333
Q ss_pred HHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
..+.......+. ......++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 239 ~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 239 KKLRSVSIEFPP-------------------------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHSTTCCCCT-------------------------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HhccccccccCc-------------------------cccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 333321111110 111234566899999999999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=371.89 Aligned_cols=258 Identities=27% Similarity=0.432 Sum_probs=210.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|++..+|+.||||++.... ....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 101 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFK--NTDLWI 101 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEE
Confidence 578999999999999999999999999999999998643 23567789999999999999999999987 567999
Q ss_pred EEeeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||||++++.+..+. .....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 180 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-A 180 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-S
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-c
Confidence 99999985554443 345679999999999999999999999999999999999999999999999999998765332 2
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..... .
T Consensus 181 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~-------------- 243 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP--P-------------- 243 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--C--------------
T ss_pred ccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC--c--------------
Confidence 2345578999999999876 4689999999999999999999999998877665544432110 0
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
.......+++.+.+||.+||..||.+|||+.++|+||||+...
T Consensus 244 ----------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 244 ----------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp ----------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred ----------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 0001123577889999999999999999999999999998743
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=377.49 Aligned_cols=262 Identities=18% Similarity=0.270 Sum_probs=193.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCe---EEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc-
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC- 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~- 192 (495)
.++|++++.||+|+||.||+|++..++. .||||++..........+.+.+|+.+++.++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4789999999999999999999887775 899999987665566678899999999999999999999998763221
Q ss_pred ---eeEEEEeeccCChhhhhhC------CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeec
Q 011041 193 ---SLYLVFKYMEHDLAGLAAS------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADF 263 (495)
Q Consensus 193 ---~~~lv~e~~~~~l~~~~~~------~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DF 263 (495)
..|+||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence 2399999999865544332 2225899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 011041 264 GLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPS 341 (495)
Q Consensus 264 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~ 341 (495)
|++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~--- 257 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR--- 257 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---
T ss_pred cccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC---
Confidence 99987643322 12233456888999999876 568999999999999999999 9999999888777766643211
Q ss_pred hhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-------HHHHHhCCCCCCC
Q 011041 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-------ATAALRSEFFTTK 407 (495)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-------a~elL~hp~f~~~ 407 (495)
......+++++.+||.+||..||.+||| +++++.|+|+...
T Consensus 258 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 258 -------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred -------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 1112356788999999999999999999 7888899999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=381.51 Aligned_cols=253 Identities=21% Similarity=0.314 Sum_probs=208.4
Q ss_pred CCCeeeeeeecccCceEEEEEEEC-------CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeec
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT-------LTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS 188 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 188 (495)
.++|++++.||+|+||.||+|++. .++..||||++... ........+.+|+.+|+.+ +||||+++++++.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 478999999999999999999874 35678999999754 3445567889999999999 89999999999987
Q ss_pred cCCceeEEEEeeccCChhhhhh-CC---------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee
Q 011041 189 RMSCSLYLVFKYMEHDLAGLAA-SP---------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (495)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~-~~---------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl 252 (495)
...+|+||||+.++.+..++ .. ...+++.++..++.||+.||.|||++||+||||||+||||
T Consensus 159 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 159 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred --CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 56799999999875544433 22 2358999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011041 253 DNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (495)
Q Consensus 253 ~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~ 330 (495)
+.++.+||+|||++........ .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999999986653322 22334567889999999876 568999999999999999999 99999988777666
Q ss_pred HHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
..+..... ......+++++.+||.+||..||.+|||+.|++++
T Consensus 316 ~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 316 KLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHTTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55533110 01123467789999999999999999999999973
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=372.36 Aligned_cols=261 Identities=22% Similarity=0.340 Sum_probs=199.5
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
..++|++++.||+|+||.||+|++..+|+.||||++............+..+..+++.++||||+++++++.+ ...+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~ 100 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT--NTDVF 100 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCcEE
Confidence 3578999999999999999999999999999999998765544445556666677888999999999999987 56899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~-givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
+||||+++.+..+.......+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++.......
T Consensus 101 lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (318)
T 2dyl_A 101 IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK- 179 (318)
T ss_dssp EEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence 9999996555555444456799999999999999999999995 99999999999999999999999999997664332
Q ss_pred CCCccccccCCCCCccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 275 QPMTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAEKPIMPGR-TEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DvwSlGvil~elltG~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
......||+.|+|||++. ....++.++|||||||++|+|++|..||... +..+.+..+.......
T Consensus 180 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 249 (318)
T 2dyl_A 180 -AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL--------- 249 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC---------
T ss_pred -cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC---------
Confidence 234557899999999985 2356889999999999999999999999874 4555555554321100
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
......+++++.+||.+||..||.+|||+.++|+||||+.
T Consensus 250 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 250 -----------------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp -----------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred -----------------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 0111346788999999999999999999999999999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=363.56 Aligned_cols=250 Identities=20% Similarity=0.323 Sum_probs=210.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|++. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+ ....|+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEec--CCceEE
Confidence 478999999999999999999987 5778999999865433 2467899999999999999999999987 567999
Q ss_pred EEeeccCChhh-hhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l~~-~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||||++++.+. .+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999876544 44455667999999999999999999999999999999999999999999999999999876443322
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------------- 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------------
T ss_pred cccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC---------------
Confidence 3344567888999999875 568999999999999999999 99999998888877776542111
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.....+++.+.+||.+||..||.+|||+.++++|
T Consensus 227 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 227 -------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1112356788999999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=366.28 Aligned_cols=253 Identities=23% Similarity=0.403 Sum_probs=205.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|.+.+.||+|+||.||+|++..+++.||+|++.. ......+.+.+|+.+|+.++||||+++++++.+ ....|+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK--DKRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec--CCeeEE
Confidence 5789999999999999999999999999999998854 346667889999999999999999999999987 567999
Q ss_pred EEeeccCChhh-hhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l~~-~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||||+.++.+. .+......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999875554 44444667999999999999999999999999999999999999999999999999999876433221
Q ss_pred C-------------CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 011041 276 P-------------MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342 (495)
Q Consensus 276 ~-------------~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (495)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.......... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~------~~~~~ 237 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF------GLNVR 237 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS------SBCHH
T ss_pred ccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH------hhhhh
Confidence 1 125679999999999876 578999999999999999999999987532210000 00000
Q ss_pred hhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.. ........+|+.+.+||.+||..||.+|||+.++++
T Consensus 238 ~~--------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 238 GF--------------------LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HH--------------------HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cc--------------------ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00 001123567899999999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=372.37 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=209.4
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCe---EEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
..++|++.+.||+|+||.||+|++..+|. .||||++.... .....+.+.+|+.+|+.++||||+++++++.+ ..
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 123 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--GR 123 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG--GG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CC
Confidence 35789999999999999999999986554 59999997543 45556788999999999999999999999987 56
Q ss_pred eeEEEEeeccCChh-hhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 193 SLYLVFKYMEHDLA-GLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 193 ~~~lv~e~~~~~l~-~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
..|+||||++++.+ ..+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 79999999987544 44445556899999999999999999999999999999999999999999999999999987754
Q ss_pred CCCCC--CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 272 NHKQP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 272 ~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 274 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP-------- 274 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC--------
T ss_pred CccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC--------
Confidence 32221 123345788999999875 468999999999999999999 999999998888877765432111
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
....+++.+.+||..||..||.+|||+.++++
T Consensus 275 --------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 275 --------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12356788999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=371.40 Aligned_cols=252 Identities=20% Similarity=0.215 Sum_probs=207.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.| +||||+++++++.. ....|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~ 81 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNA 81 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccE
Confidence 46899999999999999999999999999999999765432 3467899999999 99999999999987 56899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCc-----EEEeecccccccC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI-----LTIADFGLASFFD 270 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~-----vkL~DFG~a~~~~ 270 (495)
+||||++++|..++......+++..+..++.||+.||.|||++||+||||||+||||+.++. +||+|||++..+.
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 82 MVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999976777666655568999999999999999999999999999999999999999887 9999999998764
Q ss_pred CCCCC------CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCC
Q 011041 271 PNHKQ------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---VEQLHKIFKLCGSPS 341 (495)
Q Consensus 271 ~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~g~~~ 341 (495)
..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+. .+.+..+.......+
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 43221 1245689999999999886 5689999999999999999999999998543 344444433221111
Q ss_pred hhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.+ .....+| ++.+||..||..||.+||++.++++
T Consensus 241 ~~------------------------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 IE------------------------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HH------------------------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HH------------------------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11 1123355 8899999999999999999998876
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=378.18 Aligned_cols=255 Identities=22% Similarity=0.342 Sum_probs=207.5
Q ss_pred CCCeeeeeeecccCceEEEEEE-----ECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 190 (495)
.++|++++.||+|+||.||+|+ +..+++.||||++.... .....+.+.+|+.+|..+ +|||||++++++.+.
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~- 98 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 98 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence 5789999999999999999998 56677999999997543 445567789999999999 799999999998764
Q ss_pred CceeEEEEeeccCChhhhhhCCCC--------------------------------------------------------
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPTI-------------------------------------------------------- 214 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~-------------------------------------------------------- 214 (495)
+..+|+||||+.++.+..+.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 456899999999755544432221
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC-CCCcccccc
Q 011041 215 ----------KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-QPMTSRVVT 283 (495)
Q Consensus 215 ----------~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt 283 (495)
.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ .......||
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 289999999999999999999999999999999999999999999999999986643222 223445789
Q ss_pred CCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCccc
Q 011041 284 LWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSY 362 (495)
Q Consensus 284 ~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 362 (495)
+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+.........+
T Consensus 259 ~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---------------------- 315 (359)
T 3vhe_A 259 LKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM---------------------- 315 (359)
T ss_dssp GGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC----------------------
T ss_pred ceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC----------------------
Confidence 99999999876 568999999999999999998 999999877555554443322111
Q ss_pred ccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 363 KRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 363 ~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.....+++++.+||..||..||.+|||+.++++|
T Consensus 316 -----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 -----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1123467789999999999999999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=362.01 Aligned_cols=253 Identities=18% Similarity=0.202 Sum_probs=209.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.+ +|+||+++++++.. ....|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 82 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNV 82 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeE
Confidence 47899999999999999999999999999999998754322 3467899999999 89999999999876 56899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCc-----EEEeecccccccC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI-----LTIADFGLASFFD 270 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~-----vkL~DFG~a~~~~ 270 (495)
+||||++++|...+......+++..+..++.||+.||.|||++||+||||||+||||+.++. +||+|||++....
T Consensus 83 lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999977777766655567999999999999999999999999999999999999987776 9999999998765
Q ss_pred CCCC------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCC
Q 011041 271 PNHK------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT---EVEQLHKIFKLCGSPS 341 (495)
Q Consensus 271 ~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~---~~~~~~~i~~~~g~~~ 341 (495)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+ ..+.+..+......++
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 4322 12345679999999999876 568999999999999999999999998843 3444444433221111
Q ss_pred hhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.......+|+++.+||..||..||.+|||+.++++
T Consensus 242 ------------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 242 ------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp ------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 12223467889999999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=382.35 Aligned_cols=259 Identities=18% Similarity=0.287 Sum_probs=210.5
Q ss_pred CCCCCeeeeeeecccCceEEEEEE-----ECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc
Q 011041 115 RRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR 189 (495)
Q Consensus 115 ~~~~~y~~~~~LG~G~~g~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 189 (495)
...++|++++.||+|+||.||+|+ +..++..||||++... ........+.+|+.+|+.++|||||++++++.+
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~- 145 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ- 145 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence 345789999999999999999999 4567889999998643 344555678899999999999999999999987
Q ss_pred CCceeEEEEeeccCChh-hhhhCC------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC---cEE
Q 011041 190 MSCSLYLVFKYMEHDLA-GLAASP------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILT 259 (495)
Q Consensus 190 ~~~~~~lv~e~~~~~l~-~~~~~~------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~---~vk 259 (495)
....|+||||+.++.+ ..+... ...+++..+..++.||+.||.|||++||+||||||+||||+.++ .+|
T Consensus 146 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 146 -SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred -CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 5678999999977544 443321 24589999999999999999999999999999999999999655 599
Q ss_pred EeecccccccCCC-CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 011041 260 IADFGLASFFDPN-HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLC 337 (495)
Q Consensus 260 L~DFG~a~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~ 337 (495)
|+|||++..+... .........||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999754221 1122345578999999999876 568999999999999999998 999999998888777765422
Q ss_pred CCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 338 GSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
.. .....+++.+.+||.+||+.||.+|||+.+++++.++.
T Consensus 304 ~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 304 RM----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 11234677899999999999999999999999987764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=363.61 Aligned_cols=259 Identities=25% Similarity=0.395 Sum_probs=204.7
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|.....||+|+||.||+|++..++..||||++.... ....+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 97 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE--NGFIKIF 97 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe--CCcEEEE
Confidence 45556669999999999999999999999999997653 3345678899999999999999999999987 5689999
Q ss_pred EeeccCChhhhhh-CC--CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC-CCcEEEeecccccccCCCC
Q 011041 198 FKYMEHDLAGLAA-SP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADFGLASFFDPNH 273 (495)
Q Consensus 198 ~e~~~~~l~~~~~-~~--~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~-~~~vkL~DFG~a~~~~~~~ 273 (495)
|||+.++.+..+. .. ...+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 9999865544433 22 235679999999999999999999999999999999999987 8999999999998764322
Q ss_pred CCCCccccccCCCCCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+................
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------- 243 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV------------- 243 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-------------
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-------------
Confidence 223455789999999998653 24789999999999999999999999865443221111111100
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.......+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus 244 -------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 244 -------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp -------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred -------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 011224567889999999999999999999999999999863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=362.91 Aligned_cols=250 Identities=18% Similarity=0.304 Sum_probs=206.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|.+. ++..||+|++....... ..+.+|+.+++.++||||+++++++.+ ...+|+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 96 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFI 96 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEec--CCCeEE
Confidence 578999999999999999999876 67789999998654332 457899999999999999999999977 567999
Q ss_pred EEeeccCChh-hhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDLA-GLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l~-~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||||+.++.+ ..+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 9999976544 444443567999999999999999999999999999999999999999999999999999876443222
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.......
T Consensus 177 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 241 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-------------- 241 (283)
T ss_dssp STTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC--------------
T ss_pred cccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC--------------
Confidence 2334456888999999875 468999999999999999998 999999988888777775432111
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
....+++.+.+||..||..||.+|||+.++|+|
T Consensus 242 --------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 242 --------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp --------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 112356778999999999999999999999975
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=359.66 Aligned_cols=251 Identities=18% Similarity=0.275 Sum_probs=208.4
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
..++|++++.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+++.++||||+++++++.+ ....|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSK--EYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCceE
Confidence 3578999999999999999999876 5778999999765433 2457899999999999999999999976 56799
Q ss_pred EEEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 196 LVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 196 lv~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
+||||++++ +...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999876 4444444444699999999999999999999999999999999999999999999999999987654433
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.......
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 225 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY------------- 225 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC-------------
T ss_pred hcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCC-------------
Confidence 22334456778999999875 468899999999999999999 999999988887776664321110
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
....+++.+.+||..||..||.+|||+.+++++
T Consensus 226 ---------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 226 ---------------RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ---------------CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112356778999999999999999999999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=362.50 Aligned_cols=251 Identities=20% Similarity=0.319 Sum_probs=197.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCC---CeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLT---GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.++|++.+.||+|+||.||+|++..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~ 89 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SS
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---Cc
Confidence 57899999999999999999998654 5679999886532 34556778899999999999999999999854 46
Q ss_pred eEEEEeeccCChh-hhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDLA-GLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l~-~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.|+||||+.++.+ ..+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 8999999997544 444444557999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
.........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.....
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~------------- 235 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------------- 235 (281)
T ss_dssp ---------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-------------
T ss_pred cccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC-------------
Confidence 3333344466889999999875 568999999999999999996 9999999887777666643210
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......+|+.+.+||.+||..||.+|||+.++++
T Consensus 236 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 236 ---------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0112357788999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=365.72 Aligned_cols=256 Identities=23% Similarity=0.293 Sum_probs=200.1
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|++.+.||+|+||.||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~ 109 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQL 109 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeE
Confidence 36889999999999999999999999999999999876533 34455788899999999999999999999987 5689
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+||||++++.+..+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999999865555554445799999999999999999999999999999999999999999999999999987654433
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+ ......
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~-------------- 253 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPR-------------- 253 (309)
T ss_dssp -------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCC--------------
T ss_pred ccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCC--------------
Confidence 34456689999999998876 56889999999999999999999999887655332222 211100
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-CHHHHHh
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-TATAALR 400 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-ta~elL~ 400 (495)
.......+|+++.+||.+||..||.+|| |++++++
T Consensus 254 -----------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 254 -----------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp -----------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -----------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 1122356888999999999999999999 7888875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=361.18 Aligned_cols=247 Identities=17% Similarity=0.236 Sum_probs=202.0
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCC-------eEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeec
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTG-------QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTS 188 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g-------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 188 (495)
..++|++.+.||+|+||.||+|++..++ ..||+|++.... ....+.+.+|+.+|+.++||||+++++++.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 4578999999999999999999998877 479999986543 3445678899999999999999999999987
Q ss_pred cCCceeEEEEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCc--------EE
Q 011041 189 RMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI--------LT 259 (495)
Q Consensus 189 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~--------vk 259 (495)
....|+||||+.++ |...+......+++..+..++.||+.||.|||++||+||||||+||||+.++. +|
T Consensus 84 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 84 --GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp --TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred --CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 45789999999865 44444444445999999999999999999999999999999999999998887 99
Q ss_pred EeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcC
Q 011041 260 IADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCG 338 (495)
Q Consensus 260 L~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~~~i~~~~g 338 (495)
|+|||++..... .....||+.|+|||++.+...++.++|||||||++|+|++| .+||...+..... .+....
T Consensus 162 l~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~- 234 (289)
T 4fvq_A 162 LSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDR- 234 (289)
T ss_dssp ECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTT-
T ss_pred eccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhcc-
Confidence 999999875432 23456899999999998756789999999999999999995 5555554444333 222211
Q ss_pred CCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 339 SPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.......++++.+||.+||+.||.+|||+.++++|
T Consensus 235 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 ----------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp ----------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 01123457889999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=371.37 Aligned_cols=261 Identities=24% Similarity=0.399 Sum_probs=189.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHH-HHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREIL-ILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|+||.||+|++..+|+.||||++..... ......+.+|+. +++.++||||+++++++.. ....|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~--~~~~~ 97 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR--EGDCW 97 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC--SSEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe--CCceE
Confidence 5789999999999999999999999999999999986543 333444555655 7777899999999999987 56799
Q ss_pred EEEeeccCChhhhhh----CCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 196 LVFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 196 lv~e~~~~~l~~~~~----~~~~~l~e~~~~~i~~qil~~L~~LH~~-givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
+||||+.+++...+. .....+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++....
T Consensus 98 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp EEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred EEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 999999997665543 2355799999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCCCCccccccCCCCCccccc---CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCChhhhh
Q 011041 271 PNHKQPMTSRVVTLWYRPPELLL---GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSEEYWK 346 (495)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~ 346 (495)
... ......||+.|+|||++. ....++.++|||||||++|+|++|..||.+.+.. +.+..+.. +.+
T Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~------ 247 (327)
T 3aln_A 178 DSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDP------ 247 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC--SCC------
T ss_pred ccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc--CCC------
Confidence 332 223447899999999983 2346899999999999999999999999865432 11111100 000
Q ss_pred hCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
..........+++.+.+||..||..||.+|||+.++|+||||..
T Consensus 248 ----------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 248 ----------------PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp ----------------CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ----------------CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 00011122457788999999999999999999999999999964
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=358.64 Aligned_cols=255 Identities=20% Similarity=0.314 Sum_probs=198.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||+|++.. .||+|++..........+.+.+|+.+|+.++||||++++++... ...++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~l 96 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAI 96 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC---CccEE
Confidence 5789999999999999999997543 59999998776677777889999999999999999999997643 45899
Q ss_pred EEeeccCChhh-hhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC-CC
Q 011041 197 VFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN-HK 274 (495)
Q Consensus 197 v~e~~~~~l~~-~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~-~~ 274 (495)
||||+.++.+. .+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ..
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 99999875554 44455667999999999999999999999999999999999999999999999999999765432 12
Q ss_pred CCCccccccCCCCCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.......||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 246 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD---------- 246 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC----------
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc----------
Confidence 23345678999999998852 356788999999999999999999999987776666555432211110
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
+......+|+.+.+||..||..||.+|||+.++++
T Consensus 247 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 247 -------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11223457788999999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=371.28 Aligned_cols=253 Identities=22% Similarity=0.343 Sum_probs=208.8
Q ss_pred CCCeeeeeeecccCceEEEEEEEC-----CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
.++|++++.||+|+||.||+|++. .+++.||||++.... .......+.+|+.+|+.++||||+++++++.+ .
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 122 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV--G 122 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--S
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc--C
Confidence 578999999999999999999987 456899999987543 45556788999999999999999999999977 5
Q ss_pred ceeEEEEeeccCChhhhhhCC------------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCC
Q 011041 192 CSLYLVFKYMEHDLAGLAASP------------------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKG 247 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~------------------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp 247 (495)
..+|+||||+.++.+..+... ...+++.+++.++.||+.||.|||++||+||||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 679999999987544443321 15799999999999999999999999999999999
Q ss_pred CCeeeCCCCcEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 011041 248 SNLLIDNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRT 325 (495)
Q Consensus 248 ~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~ 325 (495)
+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 999999999999999999976543221 22234567999999999875 468999999999999999999 999999988
Q ss_pred hHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 326 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
..+....+..... ......+++++.+||..||..||.+|||+.+++++
T Consensus 282 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 282 HEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHhCCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 8777766643210 01123567789999999999999999999999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=371.21 Aligned_cols=251 Identities=22% Similarity=0.366 Sum_probs=200.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh----HHHHHHHHHHHHHHhC----CCCCeeeeeceeec
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP----ESVRFMAREILILRRL----DHPNVVKLEGLVTS 188 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l----~HpnIv~l~~~~~~ 188 (495)
.++|++.+.||+|+||.||+|++..+|+.||||++....... .....+.+|+.++..+ +|+||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 478999999999999999999999999999999997654321 2233456799999998 89999999999877
Q ss_pred cCCceeEEEEee-ccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeC-CCCcEEEeecccc
Q 011041 189 RMSCSLYLVFKY-MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID-NEGILTIADFGLA 266 (495)
Q Consensus 189 ~~~~~~~lv~e~-~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~-~~~~vkL~DFG~a 266 (495)
....++|||| +.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++
T Consensus 110 --~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 110 --QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred --CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 4578999998 66554444444445799999999999999999999999999999999999999 7899999999999
Q ss_pred cccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 011041 267 SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (495)
Q Consensus 267 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (495)
...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+... +....
T Consensus 188 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~--------- 249 (312)
T 2iwi_A 188 ALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAE--------- 249 (312)
T ss_dssp EECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTC---------
T ss_pred hhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhhc---------
Confidence 876543 234567899999999987655556689999999999999999999975321 11100
Q ss_pred hCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 250 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 250 --------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred --------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 01123467788999999999999999999999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=354.41 Aligned_cols=250 Identities=18% Similarity=0.238 Sum_probs=210.1
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
..++|++++.||+|+||.||+|++. |..||+|++..........+.+.+|+.+++.++||||+++++++.+......+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 3578999999999999999999875 88999999988776777778899999999999999999999999875557899
Q ss_pred EEEeeccCChh-hhhhCCC-CCCCHHHHHHHHHHHHHHHHHhhhCC--ceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 196 LVFKYMEHDLA-GLAASPT-IKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 196 lv~e~~~~~l~-~~~~~~~-~~l~e~~~~~i~~qil~~L~~LH~~g--ivHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
+||||++++.+ ..+.... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999987544 4444332 25899999999999999999999999 99999999999999999999999998765322
Q ss_pred CCCCCCccccccCCCCCcccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 272 NHKQPMTSRVVTLWYRPPELLLGAT--DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
....||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 230 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--------- 230 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC---------
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC---------
Confidence 3457899999999987632 23348999999999999999999999988877766664422111
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+++++.+||.+||..||.+|||+.++++
T Consensus 231 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 231 ------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112357788999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=365.99 Aligned_cols=253 Identities=19% Similarity=0.295 Sum_probs=208.4
Q ss_pred CCCeeeeeeecccCceEEEEEEE-----CCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
.++|.+.+.||+|+||.||+|++ ..++..||||++... ......+.+.+|+.+|+.++||||+++++++.+ .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 98 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--D 98 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec--C
Confidence 47899999999999999999988 355689999998754 345666788999999999999999999999977 5
Q ss_pred ceeEEEEeeccCChhhhhhCCC------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCC
Q 011041 192 CSLYLVFKYMEHDLAGLAASPT------------------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKG 247 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~------------------------~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp 247 (495)
...|+||||+.++.+..+.... ..+++..+..++.||+.||.|||++||+||||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 6799999999865444433221 2389999999999999999999999999999999
Q ss_pred CCeeeCCCCcEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 011041 248 SNLLIDNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRT 325 (495)
Q Consensus 248 ~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~ 325 (495)
+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999987643321 12234467889999999876 568999999999999999999 999999888
Q ss_pred hHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 326 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.......+..... ......+++++.+||.+||..||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 258 PERLFNLLKTGHR----------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GGGHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhcCCc----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7666655532110 01123577889999999999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=373.52 Aligned_cols=253 Identities=20% Similarity=0.304 Sum_probs=209.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECC-------CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeec
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTL-------TGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS 188 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 188 (495)
.++|.+++.||+|+||.||+|++.. .+..||||++... ........+.+|+.+++.+ +|||||++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4789999999999999999999753 3468999999765 3455667888999999999 99999999999987
Q ss_pred cCCceeEEEEeeccCChhhhhh-CC---------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee
Q 011041 189 RMSCSLYLVFKYMEHDLAGLAA-SP---------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (495)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~-~~---------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl 252 (495)
...+|+||||+.++.+..+. .. ...+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 147 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 147 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred --CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 56799999999875444433 22 2359999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011041 253 DNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (495)
Q Consensus 253 ~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~ 330 (495)
+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999987654322 22344567899999999876 568999999999999999999 99999998877776
Q ss_pred HHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
..+..... ......+++++.+||.+||..||.+|||+.+++++
T Consensus 304 ~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 304 KLLKEGHR----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHTTCC----------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCC----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66543210 01123567889999999999999999999999974
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=373.86 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=206.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh----HHHHHHHHHHHHHHhCC--CCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP----ESVRFMAREILILRRLD--HPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~ 190 (495)
.++|++++.||+|+||.||+|++..+|+.||||++....... .....+.+|+.+++.+. |+||+++++++..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~-- 119 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 119 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec--
Confidence 578999999999999999999999999999999997654321 12234667999999996 5999999999987
Q ss_pred CceeEEEEeeccC--ChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeC-CCCcEEEeeccccc
Q 011041 191 SCSLYLVFKYMEH--DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID-NEGILTIADFGLAS 267 (495)
Q Consensus 191 ~~~~~lv~e~~~~--~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~-~~~~vkL~DFG~a~ 267 (495)
....++||||+.+ ++...+ .....+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++.
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHH-HHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CCcEEEEEEcCCCCccHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 5679999999974 444443 3345799999999999999999999999999999999999999 78999999999998
Q ss_pred ccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 011041 268 FFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (495)
..... ......||+.|+|||++.+...++.++|||||||++|+|++|..||...+. +... .
T Consensus 199 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~--~-------- 259 (320)
T 3a99_A 199 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--Q-------- 259 (320)
T ss_dssp ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--C--------
T ss_pred ccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc--c--------
Confidence 76532 234567999999999987655567899999999999999999999965321 1110 0
Q ss_pred CCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus 260 -------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 260 -------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp -------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 01123567889999999999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=373.90 Aligned_cols=260 Identities=23% Similarity=0.315 Sum_probs=179.8
Q ss_pred CCCeeeee-eecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc--CCce
Q 011041 117 ADTFEKLD-KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR--MSCS 193 (495)
Q Consensus 117 ~~~y~~~~-~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 193 (495)
.++|.+++ .||+|+||.||+|+++.+|+.||||++... . .........++.++||||+++++++... ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 47899966 599999999999999999999999999743 1 1222233446677999999999998652 2345
Q ss_pred eEEEEeeccCC-hhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC---CCcEEEeecccccc
Q 011041 194 LYLVFKYMEHD-LAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASF 268 (495)
Q Consensus 194 ~~lv~e~~~~~-l~~~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~---~~~vkL~DFG~a~~ 268 (495)
+|+||||+.++ |...+... ...+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++..
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 89999999885 44444433 246999999999999999999999999999999999999986 45699999999986
Q ss_pred cCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+........ .
T Consensus 181 ~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------~ 250 (336)
T 3fhr_A 181 TTQN---ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ------Y 250 (336)
T ss_dssp C--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred cccc---ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc------c
Confidence 6432 2345678999999998865 5688999999999999999999999987665443222111100000 0
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......+..+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 251 ---------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 251 ---------------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ---------------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 00111234578889999999999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=362.44 Aligned_cols=270 Identities=23% Similarity=0.371 Sum_probs=201.5
Q ss_pred CCCCeeeeeeecccCceEEEEEE----ECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 116 RADTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
..++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+|+.++||||+++++++.....
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 35789999999999999999998 6778999999998743 35556788999999999999999999999876445
Q ss_pred ceeEEEEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 192 CSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 192 ~~~~lv~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
..+|+||||+.++ |...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 6789999999775 444444444569999999999999999999999999999999999999999999999999998764
Q ss_pred CCCC--CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 271 PNHK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 271 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...... +. ...+......+...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~---~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FM---RMIGNDKQGQMIVF 239 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HH---HHHCTTCCTHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHH--HH---hhhcCccccchhHH
Confidence 3321 12233457888999999876 46899999999999999999999998653221 11 11111110000000
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
... .... ..........+|+++.+||..||..||.+|||+.++++
T Consensus 240 ~~~--~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 240 HLI--ELLK-----NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHH--HHHH-----TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHH--HHHh-----ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 0000 00001123457788999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=363.35 Aligned_cols=260 Identities=23% Similarity=0.379 Sum_probs=206.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC--CCCeeeeeceeeccCCcee
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD--HPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~~ 194 (495)
.++|++++.||+|+||.||+|++. +++.||||++............+.+|+.+++.+. |+||+++++++.. ...+
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~ 103 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 103 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--SSEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--CCEE
Confidence 478999999999999999999975 5889999999887667777788999999999997 5999999999987 5679
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+|||+.++++...+.. ...+++..++.++.||+.||.|||++||+||||||+||||++ +.+||+|||++........
T Consensus 104 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 104 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EEEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred EEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence 99999777777666554 347899999999999999999999999999999999999964 8999999999987643322
Q ss_pred C-CCccccccCCCCCcccccCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCh
Q 011041 275 Q-PMTSRVVTLWYRPPELLLGA----------TDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSE 342 (495)
Q Consensus 275 ~-~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~g~~~~ 342 (495)
. ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...... ..+..+......
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--- 258 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE--- 258 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC---
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc---
Confidence 1 22345789999999998641 36889999999999999999999999875433 333333211000
Q ss_pred hhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
.......++++.+||.+||..||.+|||+.++|+||||+...
T Consensus 259 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 259 ------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp ------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred ------------------------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 011123456789999999999999999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=361.39 Aligned_cols=250 Identities=20% Similarity=0.337 Sum_probs=210.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||+|++..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 86 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYI 86 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCEEE
Confidence 578999999999999999999999999999999997543 345678899999999999999999999977 567999
Q ss_pred EEeeccCChhh-hhhC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAG-LAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~-~~~~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||+.++.+. .+.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 99999965444 4332 345699999999999999999999999999999999999999999999999999987754433
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+.....
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~--------------- 230 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------------- 230 (288)
T ss_dssp EEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------------
T ss_pred ccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC---------------
Confidence 33344567889999999875 468999999999999999999 9999998877666555533210
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......+|+.+.+||..||..||.+|||+.++++
T Consensus 231 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 231 -------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 1112356788999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=355.60 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=204.8
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHH-----HHHHHHHHHHHhCCCCCeeeeeceeeccC
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESV-----RFMAREILILRRLDHPNVVKLEGLVTSRM 190 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~-----~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 190 (495)
..++|++.+.||+|+||.||+|++..+++.||||++.......... +.+.+|+.+++.++||||+++++++.+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 95 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP- 95 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT-
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC-
Confidence 3578999999999999999999999999999999987654322211 6788999999999999999999998663
Q ss_pred CceeEEEEeeccC-ChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--ceeccCCCCCeeeCCCCc-----EEEee
Q 011041 191 SCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLIDNEGI-----LTIAD 262 (495)
Q Consensus 191 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~g--ivHrDlKp~NILl~~~~~-----vkL~D 262 (495)
.++||||+.+ ++...+......+++..+..++.||+.||.|||++| |+||||||+||||+.++. +||+|
T Consensus 96 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 96 ---PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp ---TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred ---CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 3799999985 555666666678999999999999999999999999 999999999999988776 99999
Q ss_pred cccccccCCCCCCCCccccccCCCCCcccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCC
Q 011041 263 FGLASFFDPNHKQPMTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ--LHKIFKLCGS 339 (495)
Q Consensus 263 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~i~~~~g~ 339 (495)
||++..... ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+.... ...+.. .+.
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~ 247 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-EGL 247 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH-SCC
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc-cCC
Confidence 999975432 2345689999999998843 34578999999999999999999999987654332 222221 111
Q ss_pred CChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
. ......+++++.+||.+||..||.+|||+.++++
T Consensus 248 ~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 248 R--------------------------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp C--------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C--------------------------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 1122456788999999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=353.54 Aligned_cols=250 Identities=26% Similarity=0.361 Sum_probs=197.0
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC--hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE--PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
..++|++.+.||+|+||.||+|++. |..||||++...... ....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 80 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK--EPN 80 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC--C--
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--CCc
Confidence 3578999999999999999999864 889999998764332 2335678899999999999999999999987 567
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCC---ceeccCCCCCeeeCC--------CCcEEEee
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH---VLHRDIKGSNLLIDN--------EGILTIAD 262 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~g---ivHrDlKp~NILl~~--------~~~vkL~D 262 (495)
.|+||||++++.+..+.. ...+++..+..++.||+.||.|||++| |+||||||+||||+. ++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999998877766654 347999999999999999999999999 999999999999986 67899999
Q ss_pred cccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 011041 263 FGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342 (495)
Q Consensus 263 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (495)
||++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+......
T Consensus 160 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--- 232 (271)
T 3dtc_A 160 FGLAREWHRTT---KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA--- 232 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC---
T ss_pred CCccccccccc---ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC---
Confidence 99998664332 234578999999999876 56899999999999999999999999998877666555321110
Q ss_pred hhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
......+++.+.+||.+||..||.+|||+.|++++
T Consensus 233 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 233 ------------------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 01123567789999999999999999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=361.43 Aligned_cols=256 Identities=18% Similarity=0.260 Sum_probs=201.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECC---CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc-
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC- 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~- 192 (495)
.++|.+.+.||+|+||.||+|++.. ++..||+|++............+.+|+.+++.++||||+++++++......
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 4789999999999999999998765 567899999987766677778899999999999999999999998764322
Q ss_pred --eeEEEEeeccCChhhhhh------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecc
Q 011041 193 --SLYLVFKYMEHDLAGLAA------SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264 (495)
Q Consensus 193 --~~~lv~e~~~~~l~~~~~------~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG 264 (495)
..|+||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecC
Confidence 469999999976554443 334579999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCh
Q 011041 265 LASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSE 342 (495)
Q Consensus 265 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (495)
++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---- 267 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR---- 267 (313)
T ss_dssp CC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----
T ss_pred cceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC----
Confidence 9987643321 12233456889999999876 568999999999999999999 9999998887776666543210
Q ss_pred hhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
......+++++.+||.+||..||.+|||+.+++++
T Consensus 268 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 ------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11124577889999999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=365.68 Aligned_cols=253 Identities=21% Similarity=0.272 Sum_probs=204.0
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeE----EEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQI----VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
..++|++++.||+|+||.||+|++..+++. ||+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 86 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG--- 86 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---
Confidence 357899999999999999999999988876 6666664332 12223456689999999999999999999864
Q ss_pred ceeEEEEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 192 CSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 192 ~~~~lv~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
...++||||+.++ +...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 4589999999864 555555555679999999999999999999999999999999999999999999999999998775
Q ss_pred CCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 271 PNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 271 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------- 235 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER---------- 235 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB----------
T ss_pred cccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC----------
Confidence 44322 2344567889999999875 468999999999999999999 9999998877666655543210
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
......+++++.+||.+||..||.+|||+.++++|
T Consensus 236 ------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 236 ------------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ------------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123367789999999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=354.93 Aligned_cols=254 Identities=19% Similarity=0.227 Sum_probs=206.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.+.|++++..+.++... ....|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCC-CCceEE
Confidence 57899999999999999999999999999999998765432 3477899999999998877776665443 567899
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeC---CCCcEEEeecccccccCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID---NEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~---~~~~vkL~DFG~a~~~~~~~ 273 (495)
||||+++++...+......+++..+..++.||+.||.|||++||+||||||+||||+ .++.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 999997777776665556799999999999999999999999999999999999994 78899999999998765433
Q ss_pred CC------CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChhh
Q 011041 274 KQ------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---VEQLHKIFKLCGSPSEEY 344 (495)
Q Consensus 274 ~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~g~~~~~~ 344 (495)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+. .+.+..+.......+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred cccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---
Confidence 21 2345679999999999876 5689999999999999999999999987432 233333332211111
Q ss_pred hhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.......+|+++.+||..||+.||.+|||+.++++
T Consensus 239 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 ---------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ---------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ---------------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11223457888999999999999999999999886
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=376.21 Aligned_cols=252 Identities=22% Similarity=0.348 Sum_probs=207.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|.+.+.||+|+||.||+|++..+++.||||++... ........+.+|+.+|+.++|||||++++++.. ...+|+
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 189 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYI 189 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS--SSSCEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec--CCCcEE
Confidence 57899999999999999999999999999999998743 344555678899999999999999999999976 457999
Q ss_pred EEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||||+.++ +...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999865 44444444456999999999999999999999999999999999999999999999999999765332111
Q ss_pred -CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 276 -PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 276 -~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+......
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 334 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL-------------- 334 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC--------------
T ss_pred ecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 1122245778999999875 468999999999999999998 99999998877766555331100
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+|+++.+||..||..||.+|||+.++++
T Consensus 335 --------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 335 --------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 111346778899999999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=352.64 Aligned_cols=250 Identities=20% Similarity=0.320 Sum_probs=208.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||+|++. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCeEE
Confidence 478999999999999999999986 6788999999865433 2567899999999999999999999987 467999
Q ss_pred EEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||||++++ +...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999875 44444444567999999999999999999999999999999999999999999999999999876432222
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~--------------- 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------------- 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------------
T ss_pred ccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC---------------
Confidence 2334467889999999875 468999999999999999999 89999998888777766432110
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.....+++.+.+||.+||..||.+|||+.+++++
T Consensus 225 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 225 -------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0112356778999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=366.98 Aligned_cols=270 Identities=22% Similarity=0.266 Sum_probs=200.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC--Ccee
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM--SCSL 194 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~~ 194 (495)
.++|++++.||+|+||.||+|++. ++.||||++... ........+|+.+|+.++|||||++++++.... ...+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 578999999999999999999865 799999999643 233445667999999999999999999997643 3457
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhC----------CceeccCCCCCeeeCCCCcEEEeecc
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ----------HVLHRDIKGSNLLIDNEGILTIADFG 264 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~----------givHrDlKp~NILl~~~~~vkL~DFG 264 (495)
|+||||+.++.+..+... ..+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||
T Consensus 98 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999988555544433 3599999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC-CCCccccccCCCCCcccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 011041 265 LASFFDPNHK-QPMTSRVVTLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS 339 (495)
Q Consensus 265 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~ 339 (495)
++..+..... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+................
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 9987654322 223446899999999998763 34567889999999999999999999876543222111122222
Q ss_pred CChhhhhhCCCCCCccCCCCccccccccccc--CCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETF--KDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
+....+......... .+ . +...+ ...++++.+||.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~--~~--~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 257 PSLEDMQEVVVHKKK--RP--V----LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CCHHHHHHHHTTSCC--CC--C----CCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CchhhhhhhhhcccC--CC--C----ccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 222222110000000 00 0 00000 011234889999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=371.89 Aligned_cols=265 Identities=19% Similarity=0.190 Sum_probs=200.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCC-----CeEEEeEEEecCCCCh-HHH--------HHHHHHHHHHHhCCCCCeeee
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLT-----GQIVALKKVRFDNLEP-ESV--------RFMAREILILRRLDHPNVVKL 182 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-----g~~vAiK~i~~~~~~~-~~~--------~~~~~Ei~il~~l~HpnIv~l 182 (495)
.++|++++.||+|+||.||+|++..+ ++.||||++....... ... ..+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 57899999999999999999998765 5889999987653110 000 123345566777889999999
Q ss_pred eceeeccC--CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeC--CCCcE
Q 011041 183 EGLVTSRM--SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID--NEGIL 258 (495)
Q Consensus 183 ~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~--~~~~v 258 (495)
++++.... ....||||||++++|...+......+++..+..++.||+.||.|||++||+||||||+||||+ .++.+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 99987632 256899999996666666666556899999999999999999999999999999999999999 88999
Q ss_pred EEeecccccccCCCCC------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 011041 259 TIADFGLASFFDPNHK------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHK 332 (495)
Q Consensus 259 kL~DFG~a~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~ 332 (495)
||+|||++..+..... ......+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.........
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 9999999977643221 11234569999999999876 4689999999999999999999999986443322222
Q ss_pred HHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 333 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
............+.. .++ ....+|+++.+||..||..||.+||++.++++
T Consensus 273 ~~~~~~~~~~~~~~~----------------~~~--~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIRYRENIASLMD----------------KCF--PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHCHHHHHH----------------HHS--CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhhhHHHHHH----------------Hhc--ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 211110001000000 000 01467888999999999999999999999885
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=366.98 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=203.9
Q ss_pred CCCeeeeeeecccCceEEEEEEE-----CCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 190 (495)
.++|++.+.||+|+||.||+|++ ..++..||||++.... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 120 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 120 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence 47899999999999999999997 3467789999997543 333456788999999999 89999999999987
Q ss_pred CceeEEEEeeccCC-hhhhhhCCC----------------------CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCC
Q 011041 191 SCSLYLVFKYMEHD-LAGLAASPT----------------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKG 247 (495)
Q Consensus 191 ~~~~~lv~e~~~~~-l~~~~~~~~----------------------~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp 247 (495)
...+|+||||++++ |...+.... ..+++..+..++.||+.||.|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 56799999999874 444443332 2379999999999999999999999999999999
Q ss_pred CCeeeCCCCcEEEeecccccccCCCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 011041 248 SNLLIDNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRT 325 (495)
Q Consensus 248 ~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~ 325 (495)
+||||+.++.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999876433221 1234467889999998876 568999999999999999998 999999877
Q ss_pred hHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 326 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
....+..+......+ .....+++++.+||.+||..||.+|||+.++++|
T Consensus 280 ~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 280 VDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 655555544321111 1123467889999999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=365.19 Aligned_cols=258 Identities=24% Similarity=0.320 Sum_probs=206.4
Q ss_pred cCCCCCCCCCeeeeeeecccCceEEEEEEECCCCeEE--EeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeecee
Q 011041 110 SGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIV--ALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLV 186 (495)
Q Consensus 110 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~v--AiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 186 (495)
..++....++|++.+.||+|+||.||+|++..+|..+ |+|.+.... .......+.+|+.+|+.+ +||||+++++++
T Consensus 17 ~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 17 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp CCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred cccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 3444555689999999999999999999999999866 999887432 334456788999999999 899999999999
Q ss_pred eccCCceeEEEEeeccCC-hhhhhhCCC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCe
Q 011041 187 TSRMSCSLYLVFKYMEHD-LAGLAASPT---------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNL 250 (495)
Q Consensus 187 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~---------------~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NI 250 (495)
.+ ...+|+||||++++ |...+.... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 96 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 173 (327)
T 1fvr_A 96 EH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 173 (327)
T ss_dssp EE--TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred ee--CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceE
Confidence 87 56899999999875 444443322 3699999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 011041 251 LIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQ 329 (495)
Q Consensus 251 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~ 329 (495)
||+.++.+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.
T Consensus 174 l~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~ 250 (327)
T 1fvr_A 174 LVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250 (327)
T ss_dssp EECGGGCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred EEcCCCeEEEcccCcCcccccc--ccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH
Confidence 9999999999999999754322 12233466889999999875 467999999999999999998 9999999887776
Q ss_pred HHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 330 LHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 330 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
...+.... .......+++++.+||.+||..||.+|||+.+++++
T Consensus 251 ~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 251 YEKLPQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHGGGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhhcCC----------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 65553211 001123467789999999999999999999999974
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=354.77 Aligned_cols=254 Identities=19% Similarity=0.230 Sum_probs=202.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.+.|++++..+.++... ....++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCC-CCceEE
Confidence 57899999999999999999999999999999987654322 2467899999999988887777666443 567899
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee---CCCCcEEEeecccccccCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl---~~~~~vkL~DFG~a~~~~~~~ 273 (495)
||||+++++...+......+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999777777766556679999999999999999999999999999999999999 788999999999998765433
Q ss_pred C------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCChhh
Q 011041 274 K------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV---EQLHKIFKLCGSPSEEY 344 (495)
Q Consensus 274 ~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~---~~~~~i~~~~g~~~~~~ 344 (495)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.. ..+..+.......+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred cCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch---
Confidence 2 12235678999999999876 56899999999999999999999999875432 22223222111111
Q ss_pred hhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.......+|+++.+||..||..||.+|||+.++++
T Consensus 239 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 ---------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ---------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ---------------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11223457888999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=362.19 Aligned_cols=253 Identities=23% Similarity=0.370 Sum_probs=188.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeec------c
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTS------R 189 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~------~ 189 (495)
..+|++.+.||+|+||.||+|++..+|+.||||++... .......+.+|+.+++.+. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 35899999999999999999999999999999998654 3455667889999999995 9999999998842 2
Q ss_pred CCceeEEEEeeccCChhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhCC--ceeccCCCCCeeeCCCCcEEEeeccc
Q 011041 190 MSCSLYLVFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLIDNEGILTIADFGL 265 (495)
Q Consensus 190 ~~~~~~lv~e~~~~~l~~~~~~--~~~~l~e~~~~~i~~qil~~L~~LH~~g--ivHrDlKp~NILl~~~~~vkL~DFG~ 265 (495)
....+|+||||+++++...+.. ....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 2456899999999988776543 4457999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCC-----------CCccccccCCCCCccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 011041 266 ASFFDPNHKQ-----------PMTSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHK 332 (495)
Q Consensus 266 a~~~~~~~~~-----------~~~~~~gt~~y~aPE~l~--~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~ 332 (495)
+......... ......||+.|+|||++. ....++.++|||||||++|+|++|..||.+......+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 9876543221 112456899999999883 235688999999999999999999999976554332221
Q ss_pred HHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCC
Q 011041 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402 (495)
Q Consensus 333 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp 402 (495)
... .......++.+.+||.+||+.||.+|||+.|+++|-
T Consensus 265 ~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 265 KYS-------------------------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp -CC-------------------------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ccc-------------------------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 100 011134566789999999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=359.84 Aligned_cols=254 Identities=20% Similarity=0.304 Sum_probs=207.8
Q ss_pred CCCeeeeeeecccCceEEEEEEE-----CCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 190 (495)
.++|++.+.||+|+||.||+|++ ..+++.||||++.... .....+.+.+|+.+|+.+ +||||+++++++.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 47899999999999999999985 4678899999997553 344567889999999999 99999999999987
Q ss_pred CceeEEEEeeccCC-hhhhhhCCC-----------------CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee
Q 011041 191 SCSLYLVFKYMEHD-LAGLAASPT-----------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (495)
Q Consensus 191 ~~~~~lv~e~~~~~-l~~~~~~~~-----------------~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl 252 (495)
....|+||||+.++ +...+.... ..+++..+..++.||+.||.|||++||+||||||+||||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 56789999999874 444433222 248999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011041 253 DNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (495)
Q Consensus 253 ~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~ 330 (495)
+.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+....+
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 99999999999999876543321 1233467889999998876 568999999999999999998 99999987765555
Q ss_pred HHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
..+......+ .....+++++.+||.+||..||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 258 YKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCCCC---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 5544322111 1113467789999999999999999999999974
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=356.75 Aligned_cols=252 Identities=19% Similarity=0.250 Sum_probs=205.6
Q ss_pred CCCeeeee-eecccCceEEEEEE--ECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLD-KIGQGTYSNVYKAR--DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~-~LG~G~~g~Vy~a~--~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.++|++.+ .||+|+||.||+|. +..+++.||||++..........+.+.+|+.+++.++||||+++++++. ...
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---AES 91 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE---SSS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC---CCC
Confidence 46899998 99999999999995 4567899999999876555556778999999999999999999999984 356
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
.|+||||+.++.+..+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 89999999976666555555679999999999999999999999999999999999999999999999999998765432
Q ss_pred CC--CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 274 KQ--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 274 ~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.... .
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--~---------- 238 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--R---------- 238 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--C----------
T ss_pred CcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--C----------
Confidence 21 1122346788999999875 457899999999999999999 999999988777666554311 0
Q ss_pred CCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......+++.+.+||..||..||.+|||+.++++
T Consensus 239 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 239 ----------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112356788999999999999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=355.16 Aligned_cols=252 Identities=19% Similarity=0.276 Sum_probs=204.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECC---CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.++|.+.+.||+|+||.||+|++.. ++..||+|++.... .....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 86 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---EP 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---SS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CC
Confidence 5789999999999999999998653 34579999987653 44566788999999999999999999999865 34
Q ss_pred eEEEEeeccCChhh-hhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l~~-~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.|+||||+.++.+. .+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 79999999975444 44444456999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
.........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+......
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~------------ 233 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL------------ 233 (281)
T ss_dssp ------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC------------
T ss_pred cccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC------------
Confidence 3333344567889999999865 568999999999999999998 99999887776666555432111
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.....+++.+.+||.+||..||.+|||+.+++++
T Consensus 234 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 234 ----------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 0113467789999999999999999999999974
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=370.41 Aligned_cols=252 Identities=21% Similarity=0.349 Sum_probs=197.4
Q ss_pred CCCeeeeeeecccCceEEEEEEEC---CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.++|.+.+.||+|+||.||+|++. .++..||||++.... .....+.+.+|+.+|++++||||+++++++.. ...
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCc
Confidence 468999999999999999999876 467789999987543 45556788999999999999999999999977 567
Q ss_pred eEEEEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
+|+||||++++ |...+......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999765 44445455567999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCC--ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 273 HKQPM--TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 273 ~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
..... ....+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+......
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~---------- 269 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL---------- 269 (373)
T ss_dssp -------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC----------
T ss_pred CccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 22211 22245778999999875 568999999999999999998 99999998887777666432111
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....++..+.+||..||..||.+|||+.++++
T Consensus 270 ------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 270 ------------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ------------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 111246678899999999999999999999886
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=376.65 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=195.6
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.+|.+.+.||+|+||+||. ....+|+.||||++..... ..+.+|+.+|+.+ +|||||++++++.+ ...+||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKD--RQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEEE
Confidence 5699999999999999763 3456889999999975432 2345799999999 79999999999887 568999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC-----CCcEEEeecccccccCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-----EGILTIADFGLASFFDP 271 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~-----~~~vkL~DFG~a~~~~~ 271 (495)
||||+++++...+......+++..+..++.||+.||.|||++||+||||||+||||+. ...+||+|||++.....
T Consensus 96 v~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 96 AIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 9999999888888777666777788899999999999999999999999999999953 23588999999987653
Q ss_pred CCC--CCCccccccCCCCCcccccC--CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 011041 272 NHK--QPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (495)
Q Consensus 272 ~~~--~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (495)
... ......+||+.|+|||++.+ ...++.++||||||||+|+|++ |.+||........ ..+. +......+
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~---~~~~~~~~- 250 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILL---GACSLDCL- 250 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHT---TCCCCTTS-
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHh---ccCCcccc-
Confidence 321 22345679999999999874 2457789999999999999999 8999966544332 2211 11110000
Q ss_pred hCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
......+..+.+||.+||+.||.+|||+.++|+||||..
T Consensus 251 ---------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 251 ---------------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp ---------------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ---------------------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 000112344788999999999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=361.88 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=206.9
Q ss_pred CCCeeeeeeecccCceEEEEEEEC-------CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeec
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT-------LTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS 188 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 188 (495)
.++|++++.||+|+||.||+|++. .++..||||++.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 478999999999999999999975 467789999987543 445567888999999999 89999999999977
Q ss_pred cCCceeEEEEeeccCChhhhhh-CCC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee
Q 011041 189 RMSCSLYLVFKYMEHDLAGLAA-SPT---------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (495)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~-~~~---------------~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl 252 (495)
...+|+||||+.++.+..+. ... ..+++..+..++.||+.||.|||++||+||||||+||||
T Consensus 113 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 113 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp --SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred --CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 56799999999875444433 322 248999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011041 253 DNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (495)
Q Consensus 253 ~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~ 330 (495)
+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 9999999999999987653321 11233456889999999876 468999999999999999999 99999998877776
Q ss_pred HHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
..+..... ......+++++.+||.+||..||.+|||+.+++++
T Consensus 270 ~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 270 KLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 66544210 01123467789999999999999999999999973
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=360.33 Aligned_cols=255 Identities=22% Similarity=0.341 Sum_probs=205.9
Q ss_pred CCCeeeeeeecccCceEEEEEEE-----CCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 190 (495)
.++|++.+.||+|+||.||+|++ ..+++.||||++.... .......+.+|+.++..+ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence 47899999999999999999985 4577999999997553 445566788999999999 799999999998764
Q ss_pred CceeEEEEeeccCChhhhhhCCCC----------------CCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPTI----------------KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN 254 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~----------------~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~ 254 (495)
+..+|+||||+.++.+..+..... .+++..+..++.||+.||.|||++||+||||||+||||+.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 456899999999755444433222 2899999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 011041 255 EGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHK 332 (495)
Q Consensus 255 ~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~ 332 (495)
++.+||+|||++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~ 262 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence 99999999999986643322 11234567899999999876 568999999999999999998 9999988765444433
Q ss_pred HHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 333 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.......+ .....+++.+.+||..||..||.+|||+.++++|
T Consensus 263 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 263 RLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33221110 1113467789999999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=351.41 Aligned_cols=253 Identities=21% Similarity=0.270 Sum_probs=209.1
Q ss_pred CCCeeeee-eecccCceEEEEEEEC--CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLD-KIGQGTYSNVYKARDT--LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~-~LG~G~~g~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.++|.+.+ .||+|+||.||+|++. .++..||||++.... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 83 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EA 83 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---CC
Confidence 46788887 9999999999999864 568899999997653 45566788999999999999999999999953 45
Q ss_pred eEEEEeeccCChhhh-hhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~-~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.|+||||+.++.+.. +......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 899999999865554 4445567999999999999999999999999999999999999999999999999999876433
Q ss_pred CC--CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 273 HK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 273 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~------------ 230 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK------------ 230 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC------------
T ss_pred cceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC------------
Confidence 22 11233456889999999875 468999999999999999998 999999988877766664321
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp 402 (495)
.......+|+++.+||..||..||.+|||+.++++|.
T Consensus 231 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 231 ----------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp ----------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred ----------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 0111235778899999999999999999999999863
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=363.66 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=198.4
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEE----EeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIV----ALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~v----AiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
..++|++++.||+|+||.||+|++..+|+.| |+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 89 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--
Confidence 3578999999999999999999998888765 666654322 234456788999999999999999999999863
Q ss_pred ceeEEEEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 192 CSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 192 ~~~~lv~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
..++|+||+.++ +...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp -SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred -CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 378889998865 444555556679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 271 PNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 271 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~--------- 238 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--------- 238 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---------
T ss_pred CCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC---------
Confidence 43322 2233456889999999876 568999999999999999999 99999988776655544322110
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.....++.++.+||.+||+.||.+|||+.+++++
T Consensus 239 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 239 -------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1123456778999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=382.06 Aligned_cols=275 Identities=21% Similarity=0.320 Sum_probs=207.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||+|++..+|+.||||++..... ......+.+|+.+|+.++||||+++++++........|+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 4789999999999999999999999999999999975432 223456779999999999999999999998765567899
Q ss_pred EEeeccCChhhhhhCCC---CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee----CCCCcEEEeeccccccc
Q 011041 197 VFKYMEHDLAGLAASPT---IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASFF 269 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~---~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl----~~~~~vkL~DFG~a~~~ 269 (495)
||||+.++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++...
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 99999876555544432 239999999999999999999999999999999999999 77788999999999876
Q ss_pred CCCCCCCCccccccCCCCCcccccCC-------CCCCchhhHHHHHHHHHHHHhCCCCCCC----CChHHHHHHHHHhcC
Q 011041 270 DPNHKQPMTSRVVTLWYRPPELLLGA-------TDYGVGVDLWSAGCILAELLAEKPIMPG----RTEVEQLHKIFKLCG 338 (495)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~DvwSlGvil~elltG~~pf~~----~~~~~~~~~i~~~~g 338 (495)
.... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+ ....+.+.++.. +
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~ 242 (396)
T 4eut_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--G 242 (396)
T ss_dssp CCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH--S
T ss_pred cCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc--C
Confidence 5432 23456799999999988541 3578899999999999999999999975 334455555543 2
Q ss_pred CCChhhhhhCCCCCCcc--CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 339 SPSEEYWKKSKLPHATI--FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 339 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.|. ..|.......... +....+. .......+++.+.+||.+||.+||.+|||+.++++
T Consensus 243 ~p~-~~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 243 KPS-GAISGVQKAENGPIDWSGDMPV---SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CCT-TCCEEEECSTTCCEEEESSCCT---TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCc-ccchhheeccCCCcccCccCCc---ccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 222 2111100000000 0000000 00011123456789999999999999999999865
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=362.99 Aligned_cols=261 Identities=16% Similarity=0.246 Sum_probs=212.0
Q ss_pred CCCeeeeeeecccCceEEEEEEEC-----CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
.++|++.+.||+|+||.||+|++. .++..||||++.... .......+.+|+.+|+.++||||+++++++.+ .
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 100 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 100 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--S
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc--C
Confidence 478999999999999999999876 467899999987543 34455678899999999999999999999977 5
Q ss_pred ceeEEEEeeccCChhhhhhCC----------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEe
Q 011041 192 CSLYLVFKYMEHDLAGLAASP----------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIA 261 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~----------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~ 261 (495)
...|+||||+.++.+..+... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence 678999999987544433221 2457999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 011041 262 DFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGS 339 (495)
Q Consensus 262 DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~ 339 (495)
|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-- 257 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-- 257 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC--
T ss_pred cCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC--
Confidence 9999976543221 11233467899999999875 568999999999999999999 899999988777766654321
Q ss_pred CChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC------CCCCCCCC
Q 011041 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS------EFFTTKPY 409 (495)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h------p~f~~~~~ 409 (495)
.......+++.+.+||.+||..||.+|||+.++++| ++|+...+
T Consensus 258 --------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~ 307 (322)
T 1p4o_A 258 --------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 307 (322)
T ss_dssp --------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCS
T ss_pred --------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccccc
Confidence 011123567889999999999999999999999986 56554333
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=363.38 Aligned_cols=259 Identities=18% Similarity=0.290 Sum_probs=205.7
Q ss_pred CCCCCeeeeeeecccCceEEEEEE-----ECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc
Q 011041 115 RRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR 189 (495)
Q Consensus 115 ~~~~~y~~~~~LG~G~~g~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 189 (495)
...++|++++.||+|+||.||+|+ +..++..||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 104 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ- 104 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC-
Confidence 345899999999999999999998 55678899999986432 44556678899999999999999999999987
Q ss_pred CCceeEEEEeeccCC-hhhhhhCCC------CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC---CCcEE
Q 011041 190 MSCSLYLVFKYMEHD-LAGLAASPT------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILT 259 (495)
Q Consensus 190 ~~~~~~lv~e~~~~~-l~~~~~~~~------~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~---~~~vk 259 (495)
....|+||||+.++ |...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+. +..+|
T Consensus 105 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 105 -SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred -CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 45689999999765 444443322 35899999999999999999999999999999999999985 44699
Q ss_pred EeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 011041 260 IADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLC 337 (495)
Q Consensus 260 L~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~ 337 (495)
|+|||++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 999999975532221 22334577999999999875 468999999999999999998 999999988777766664321
Q ss_pred CCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 338 GSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
.. .....+++.+.+||.+||..||.+|||+.++++|.|+.
T Consensus 263 ~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 263 RM----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 10 11235677899999999999999999999999998864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=350.19 Aligned_cols=248 Identities=21% Similarity=0.361 Sum_probs=206.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|++. ++..||+|++...... .+.+.+|+.+|+.++||||+++++++.+ ...|+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 84 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYI 84 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC---CCcEE
Confidence 478999999999999999999975 5678999999765433 3568899999999999999999999864 35899
Q ss_pred EEeeccCChhhhhhCCC--CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAGLAASPT--IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~--~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||+.++.+..+.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999876555554432 2689999999999999999999999999999999999999999999999999987754433
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--------------- 228 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------- 228 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------------
T ss_pred ccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC---------------
Confidence 33344567889999999875 468999999999999999999 9999999888777666643210
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......+++++.+||..||..||.+|||+.++++
T Consensus 229 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 229 -------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0112356788999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=366.03 Aligned_cols=260 Identities=17% Similarity=0.146 Sum_probs=197.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECC---CCeEEEeEEEecCCCChH---------HHHHHHHHHHHHHhCCCCCeeeeec
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNLEPE---------SVRFMAREILILRRLDHPNVVKLEG 184 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~---~g~~vAiK~i~~~~~~~~---------~~~~~~~Ei~il~~l~HpnIv~l~~ 184 (495)
.++|++++.||+|+||.||+|++.. ++..||||++........ ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4789999999999999999999987 788999999986542110 1123567888999999999999999
Q ss_pred eeecc--CCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC--cEEE
Q 011041 185 LVTSR--MSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG--ILTI 260 (495)
Q Consensus 185 ~~~~~--~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~--~vkL 260 (495)
++... ....+|+||||++++|.. +......+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~~~~L~~-~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERLGIDLQK-ISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECEEEEHHH-HCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEeccCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 98762 246799999999544544 444444899999999999999999999999999999999999998877 9999
Q ss_pred eecccccccCCCCC------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHH
Q 011041 261 ADFGLASFFDPNHK------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR--TEVEQLHK 332 (495)
Q Consensus 261 ~DFG~a~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~--~~~~~~~~ 332 (495)
+|||++..+..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+. +.......
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 99999987643211 11245579999999999886 46899999999999999999999999652 33333332
Q ss_pred HHHhcCCCChhhhhhCCCCCCccCCCCccccccccccc--CCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETF--KDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 333 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
........+.... ... ..+|+++.+||..||..||.+|||+.++++
T Consensus 274 ~~~~~~~~~~~~~----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 274 KTNLLDELPQSVL----------------------KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHTTTHHHH----------------------HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhhcccccHHHH----------------------hhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 2222222222111 111 257889999999999999999999999987
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=356.73 Aligned_cols=269 Identities=21% Similarity=0.355 Sum_probs=201.7
Q ss_pred CCCeeeeeeecccCceEEEEEE----ECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
.+.|++++.||+|+||.||+|+ +..+++.||+|++.... .......+.+|+.+|+.++||||+++++++......
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 3679999999999999999998 67789999999997553 233456788999999999999999999999875557
Q ss_pred eeEEEEeeccCChh-hhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 193 SLYLVFKYMEHDLA-GLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 193 ~~~lv~e~~~~~l~-~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
.+|+||||+.++.+ ..+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 79999999987544 44434555799999999999999999999999999999999999999999999999999987754
Q ss_pred CCC--CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 272 NHK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 272 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
... .......||..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+ ....+..........
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~---~~~~~~~~~~~~~~~- 251 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPM--ALF---LKMIGPTHGQMTVTR- 251 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH--HHH---HHHHCSCCGGGHHHH-
T ss_pred CCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchh--hHH---hhccCCcccccCHHH-
Confidence 332 12334567889999999876 467899999999999999999998864321 111 111111111000000
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
... .............+++++.+||.+||..||.+|||+.++++
T Consensus 252 ~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LVN-------TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHH-------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHH-------HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 000 00000011122457788999999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=383.55 Aligned_cols=250 Identities=20% Similarity=0.346 Sum_probs=209.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||+|+++.++..||||++..... ..+.+.+|+.+|+.++|||||++++++.. ...+||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l 293 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYI 293 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEec--CCcEEE
Confidence 4789999999999999999999999999999999976543 24568899999999999999999999987 457999
Q ss_pred EEeeccCChh-hhhhC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLA-GLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~-~~~~~-~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||+.++.+ ..+.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999996544 44432 345699999999999999999999999999999999999999999999999999987654332
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......+++.|+|||++.+ ..++.++|||||||+||||++ |.+||.+.+..+....+.....
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------------- 437 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------------- 437 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------------
T ss_pred eecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 22334456788999999875 468999999999999999999 9999999877666655532110
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......+|+.+.+||.+||+.||.+|||+.++++
T Consensus 438 -------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 438 -------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 0112356788999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=377.62 Aligned_cols=258 Identities=25% Similarity=0.370 Sum_probs=192.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.+.|.+.+.||+|+||+||.+ ...+|+.||||++... ..+.+.+|+.+|+.+ +|||||++++++.+ ...+|
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~ 85 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLY 85 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEE
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEE
Confidence 456777899999999999875 4567999999998743 234577899999986 89999999999877 56899
Q ss_pred EEEeeccCChhhhhhCCCCC------CCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC-------------C
Q 011041 196 LVFKYMEHDLAGLAASPTIK------FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-------------G 256 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~------l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~-------------~ 256 (495)
+||||++++|...+...... .++..+..++.||+.||.|||++||+||||||+||||+.+ +
T Consensus 86 lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 86 IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 99999998777666543221 1334567899999999999999999999999999999754 4
Q ss_pred cEEEeecccccccCCCCCC---CCccccccCCCCCcccccC------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 011041 257 ILTIADFGLASFFDPNHKQ---PMTSRVVTLWYRPPELLLG------ATDYGVGVDLWSAGCILAELLA-EKPIMPGRTE 326 (495)
Q Consensus 257 ~vkL~DFG~a~~~~~~~~~---~~~~~~gt~~y~aPE~l~~------~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~ 326 (495)
.+||+|||++......... .....+||+.|+|||++.+ ...++.++|||||||++|||++ |.+||.+...
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 8999999999877543221 2234689999999999865 2468999999999999999999 9999987654
Q ss_pred HHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 327 VEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 327 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.+ ..+.......... . ......+++++.+||.+||+.||.+|||+.++|+||||..
T Consensus 246 ~~--~~i~~~~~~~~~~----------~------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 246 RE--SNIIRGIFSLDEM----------K------------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HH--HHHHHTCCCCCCC----------T------------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hH--HHHhcCCCCcccc----------c------------ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 43 2232221111000 0 0000123467899999999999999999999999999964
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=354.61 Aligned_cols=254 Identities=30% Similarity=0.469 Sum_probs=195.3
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~ 107 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNEL 107 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCcE
Confidence 35789999999999999999999999999999999986443 45667788999999999999999999999987 5689
Q ss_pred EEEEeeccCChhhhhhC----CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 195 YLVFKYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~----~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
|+||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999855444332 35579999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCChhhhhhC
Q 011041 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE--VEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ......+.. ...+.
T Consensus 188 ~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~------- 257 (310)
T 2wqm_A 188 SKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPP------- 257 (310)
T ss_dssp ------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TCSCC-------
T ss_pred CCC-ccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-ccCCC-------
Confidence 332 22344578999999998876 5689999999999999999999999986432 223333221 11100
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+++++.+||.+||..||.+|||+.++++
T Consensus 258 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 258 -------------------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp -------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 011346778999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=365.56 Aligned_cols=268 Identities=22% Similarity=0.279 Sum_probs=203.3
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
..++|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.+ ....|
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 111 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDE--RNEMI 111 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC--TTCCE
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEE
Confidence 3578999999999999999999964 68999999887543 3445678899999999999999999999976 56799
Q ss_pred EEEeeccCChhhhhhCCC----CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 196 LVFKYMEHDLAGLAASPT----IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~----~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
+||||+.++.+..+.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999876555544322 3589999999999999999999999999999999999999999999999999986543
Q ss_pred CCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC
Q 011041 272 NHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (495)
Q Consensus 272 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (495)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+....+.... .......+
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~ 265 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV-----ESHNNGQL 265 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH-----HHHTTTCC
T ss_pred ccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh-----hccccccH
Confidence 222 22344568999999999876 468999999999999999999999998754322111110000 00000000
Q ss_pred CCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
... ..+. .........+..+.+||.+||..||.+|||+.+++++
T Consensus 266 ~~~--~~~~-----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 266 EQI--VDPN-----LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp CSS--SSSS-----CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHh--cChh-----hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 0000 0001112234567899999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=361.52 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=198.6
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEE----EeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIV----ALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~v----AiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
..++|++++.||+|+||.||+|++..+++.| |+|.+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 89 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS--
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC--
Confidence 3578999999999999999999999888876 555554322 334456788999999999999999999999863
Q ss_pred ceeEEEEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 192 CSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 192 ~~~~lv~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
..++|++|+.++ +...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 90 -~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp -SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred -CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 378888988865 444555556679999999999999999999999999999999999999999999999999998764
Q ss_pred CCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 271 PNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 271 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
.... .......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~--------- 238 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--------- 238 (327)
T ss_dssp -----------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---------
T ss_pred CccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 3322 12233456889999999876 568999999999999999999 99999988777665555332111
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+++++.+||.+||..||.+|||+.++++
T Consensus 239 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 239 -------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp -------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112346677899999999999999999999997
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=361.79 Aligned_cols=268 Identities=22% Similarity=0.304 Sum_probs=206.7
Q ss_pred CCCCeeeeeeecccCceEEEEEE----ECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 116 RADTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
..++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+|+.++||||+++++++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 35799999999999999999998 5778999999998754 35556778999999999999999999999876556
Q ss_pred ceeEEEEeeccCChhhh-hhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 192 CSLYLVFKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~-~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
..+|+||||++++.+.. +......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 78999999997655444 43334469999999999999999999999999999999999999999999999999998765
Q ss_pred CCCC--CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC--hhhhh
Q 011041 271 PNHK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS--EEYWK 346 (495)
Q Consensus 271 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~--~~~~~ 346 (495)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........... ....... .....
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM--GCERDVPALSRLLE 255 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC--C----CCHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc--ccccccccHHHHHH
Confidence 3322 12234567889999999876 4679999999999999999999999976433211100 0000000 00000
Q ss_pred hCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
... ..........+++++.+||.+||..||.+|||+.+++++
T Consensus 256 ~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 256 LLE-------------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Hhh-------------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 000111234577889999999999999999999999653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=356.78 Aligned_cols=254 Identities=19% Similarity=0.315 Sum_probs=202.3
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCC----eEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTG----QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
..++|.+.+.||+|+||.||+|++..++ ..||||++.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 118 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--Y 118 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--S
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec--C
Confidence 4578999999999999999999887553 459999997543 44556678899999999999999999999977 5
Q ss_pred ceeEEEEeeccCChh-hhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 192 CSLYLVFKYMEHDLA-GLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~-~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
...|+||||+.++.+ ..+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 679999999987544 4444455679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCC--CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 011041 271 PNHKQP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 271 ~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (495)
...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+......
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-------- 269 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-------- 269 (333)
T ss_dssp ------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--------
T ss_pred cccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC--------
Confidence 432211 122345788999999875 568999999999999999998 99999998887777666432111
Q ss_pred CCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.....+++.+.+||.+||..||.+||++.+++++
T Consensus 270 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 270 --------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp --------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0113467788999999999999999999999863
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=350.67 Aligned_cols=254 Identities=20% Similarity=0.257 Sum_probs=204.2
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCC---CeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLT---GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
...+|++.+.||+|+||.||+|++..+ +..||+|.+... ........+.+|+.+++.++||||+++++++... ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC-CC
Confidence 356799999999999999999997543 346899988753 2455667888999999999999999999986543 45
Q ss_pred eeEEEEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 193 SLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 193 ~~~lv~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
..|+||||++++ |...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 789999999985 5445555566799999999999999999999999999999999999999999999999999986643
Q ss_pred CCC---CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 011041 272 NHK---QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 272 ~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (495)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.......
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 252 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL------- 252 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCC-------
T ss_pred cchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCC-------
Confidence 221 12234567889999999876 568999999999999999999 778888877766665554321111
Q ss_pred CCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
....+++.+.+||.+||..||.+|||+.++++
T Consensus 253 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 253 ---------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11345678999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=348.24 Aligned_cols=254 Identities=25% Similarity=0.303 Sum_probs=204.5
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCe---EEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
..-.|.+.+.||+|+||.||+|++..++. .||+|++... ......+.+.+|+.+++.++||||+++++++.+. +.
T Consensus 19 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~ 96 (298)
T 3pls_A 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP-EG 96 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SS
T ss_pred cceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC-CC
Confidence 34568888999999999999999765544 7999998643 3445667888999999999999999999999764 34
Q ss_pred eeEEEEeeccC-ChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 193 SLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 193 ~~~lv~e~~~~-~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
..++||||+.+ ++...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 45899999975 45555555566799999999999999999999999999999999999999999999999999976543
Q ss_pred CC---CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 011041 272 NH---KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 272 ~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (495)
.. ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-------- 247 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-------- 247 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC--------
T ss_pred CcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC--------
Confidence 21 122334567899999999876 568999999999999999999 56667666666655555432111
Q ss_pred CCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+++.+.+||..||..||.+|||+.++++
T Consensus 248 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 248 --------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 112346778999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=359.80 Aligned_cols=253 Identities=20% Similarity=0.288 Sum_probs=206.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCe-----EEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ-----IVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 190 (495)
.++|++.+.||+|+||.||+|++..++. .||+|++.... .......+.+|+.+|+.+ +||||+++++++.+
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 121 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTH-- 121 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--
Confidence 4789999999999999999999987664 79999987543 445567789999999999 89999999999987
Q ss_pred CceeEEEEeeccCChhhhhhC--------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC
Q 011041 191 SCSLYLVFKYMEHDLAGLAAS--------------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG 256 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~--------------~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~ 256 (495)
...+|+||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 567999999998744433321 134689999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011041 257 ILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIF 334 (495)
Q Consensus 257 ~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~ 334 (495)
.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+..+.
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 9999999999866433221 1234467889999998876 468999999999999999998 999999877665555554
Q ss_pred HhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 335 KLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 335 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+. .....++.+.+||..||..||.+|||+.++++
T Consensus 281 ~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 281 KDGYQMA---------------------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCCCCC---------------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 4221110 11235677899999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=375.59 Aligned_cols=248 Identities=21% Similarity=0.353 Sum_probs=205.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||+|++. ++..||||++..... ..+.+.+|+.+|+.++|||||++++++.. ..+|+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---~~~~l 259 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI 259 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEeC---CccEE
Confidence 478999999999999999999976 467899999976442 35678899999999999999999999863 46899
Q ss_pred EEeeccCChhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~--~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||+.++.+..++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 9999987554444332 23689999999999999999999999999999999999999999999999999987643222
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......+|+.|+|||++.+ ..++.++|||||||+||||++ |.+||.+.+..+.+..+......+
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------------- 405 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP------------- 405 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC-------------
T ss_pred eccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 22233456788999999875 468999999999999999999 999999998888877765432111
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
....+|+++.+||.+||..||.+|||+.++++
T Consensus 406 ---------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 406 ---------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ---------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 12346788999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=356.78 Aligned_cols=263 Identities=24% Similarity=0.347 Sum_probs=201.4
Q ss_pred CCe-eeeeeecccCceEEEEEE----ECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 118 DTF-EKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 118 ~~y-~~~~~LG~G~~g~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
++| ++++.||+|+||.||++. +..+|+.||||++... ........+.+|+.+|+.++||||+++++++.+....
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 445 999999999999998875 4468899999999765 3455567889999999999999999999999876567
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|+||||+.++.+..+.... .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred eEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 899999999876555554433 4999999999999999999999999999999999999999999999999999877543
Q ss_pred CC--CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh----hh
Q 011041 273 HK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY----WK 346 (495)
Q Consensus 273 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~----~~ 346 (495)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+...... +.
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-----ELIGIAQGQMTVLRLT 261 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHHCSCCHHHHHHHHH
T ss_pred ccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-----hhhcccccchhHHHHH
Confidence 22 12234467889999999876 4678999999999999999999999975432110 0000000000 00
Q ss_pred hCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.. . ...........+++++.+||..||..||.+|||+.++++
T Consensus 262 ~~-~-----------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 262 EL-L-----------ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HH-H-----------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH-H-----------hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00 0 000011122457788999999999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=372.13 Aligned_cols=245 Identities=20% Similarity=0.347 Sum_probs=201.7
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
..++|++++.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.+|+.++|||||++++++... ...+|
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~ 263 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLY 263 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCceE
Confidence 3578999999999999999999865 7899999997543 345688999999999999999999998663 34689
Q ss_pred EEEeeccCChhh-hhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 196 LVFKYMEHDLAG-LAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 196 lv~e~~~~~l~~-~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+||||+.++.+. .+... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 999999875444 44332 234799999999999999999999999999999999999999999999999999865322
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.....+++.|+|||++.+ ..++.++|||||||+||||++ |..||.+.+..+....+.....
T Consensus 343 ---~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-------------- 404 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------------- 404 (450)
T ss_dssp -------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC--------------
T ss_pred ---ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence 123367889999999876 568999999999999999998 9999998877776666543210
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......+|+++.+||..||..||.+|||+.++++
T Consensus 405 --------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 405 --------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0112357788999999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=362.70 Aligned_cols=255 Identities=18% Similarity=0.174 Sum_probs=199.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCC--------CeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeee-------
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLT--------GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVK------- 181 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~--------g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~------- 181 (495)
.++|++.+.||+|+||.||+|++..+ ++.||||++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 57899999999999999999999874 889999999754 35678999999999999988
Q ss_pred --------eeceeeccCCceeEEEEeeccCChhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee
Q 011041 182 --------LEGLVTSRMSCSLYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (495)
Q Consensus 182 --------l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl 252 (495)
+++++... +...|+||||++++|...+... ...+++..+..++.||+.||.|||++||+||||||+||||
T Consensus 114 ~~~~~i~~~~~~~~~~-~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQ-DKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEET-TTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccC-CcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 45555442 5689999999965666555433 3579999999999999999999999999999999999999
Q ss_pred CCCC--cEEEeecccccccCCCCC------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 011041 253 DNEG--ILTIADFGLASFFDPNHK------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR 324 (495)
Q Consensus 253 ~~~~--~vkL~DFG~a~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~ 324 (495)
+.++ .+||+|||++..+..... .......||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9998 999999999987643221 12244589999999998876 56899999999999999999999999876
Q ss_pred C-hHHHH-HHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 325 T-EVEQL-HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 325 ~-~~~~~-~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
. ..+.+ ..+......+... .. .......+++++.+||..||..||.+|||+.++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~-~~-------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPF-VG-------------------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCE-EC-------------------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhhh-hh-------------------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 4 33333 3222211111100 00 00112356788999999999999999999999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=349.41 Aligned_cols=247 Identities=25% Similarity=0.409 Sum_probs=201.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeec--------
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTS-------- 188 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 188 (495)
.++|++++.||+|+||.||+|++..+|+.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 367999999999999999999999999999999997543 246689999999999999999998854
Q ss_pred ------cCCceeEEEEeeccCChhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEE
Q 011041 189 ------RMSCSLYLVFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTI 260 (495)
Q Consensus 189 ------~~~~~~~lv~e~~~~~l~~~~~~--~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL 260 (495)
.....+|+||||++++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 11345899999999854444432 2357999999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 011041 261 ADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSP 340 (495)
Q Consensus 261 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~ 340 (495)
+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .....+...
T Consensus 164 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~~---- 234 (284)
T 2a19_B 164 GDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDG---- 234 (284)
T ss_dssp CCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHTT----
T ss_pred Ccchhheeccccc--cccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhcc----
Confidence 9999998765432 2345578999999999876 568999999999999999999998874211 111111100
Q ss_pred ChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 341 SEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
.....+++.+.+||.+||..||.+|||+.++++|.+.-
T Consensus 235 ---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 235 ---------------------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp ---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01123667789999999999999999999999987653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=363.17 Aligned_cols=272 Identities=20% Similarity=0.274 Sum_probs=199.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||+|++. +|+.||||++...... .....+.+|+.+++.++||||+++++++.+ ....++
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 104 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLL 104 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECC--SSCCEE
T ss_pred hhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEec--CCceEE
Confidence 478999999999999999999844 6899999998765322 122357899999999999999999999987 567899
Q ss_pred EEeeccCChhhhhhCC----CCCCCHHHHHHHHHHHHHHHHHhhhC---CceeccCCCCCeeeCCCCcEEEeeccccccc
Q 011041 197 VFKYMEHDLAGLAASP----TIKFTQAQVKCYMHQLLSGLEHCHNQ---HVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~----~~~l~e~~~~~i~~qil~~L~~LH~~---givHrDlKp~NILl~~~~~vkL~DFG~a~~~ 269 (495)
||||+.++.+..+... ...+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence 9999988655544332 23499999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
............||+.|+|||++.+ ..++.++|||||||++|+|++|.+||....... ........|....
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~~ 255 (326)
T 3uim_A 185 DYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLAN--------DDDVMLLDWVKGL 255 (326)
T ss_dssp CSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT--------TSCSBHHHHHTTT
T ss_pred CcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCccccccccc--------ccchhHHHHHHHH
Confidence 5544444455679999999999876 458999999999999999999999995211000 0000000011100
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~ 403 (495)
........... ...........+..+.+||..||+.||.+|||+.++++|-.
T Consensus 256 ~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 256 LKEKKLEALVD--VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TSSCCSTTSSC--TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhchhhhhhcC--hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 00000000000 00000011122356889999999999999999999999754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=371.12 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=203.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||+|++.. +..||||++...... .+.+.+|+.+|+.++||||+++++++.+ ..+|+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~i 255 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 255 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEE
Confidence 4789999999999999999999875 467999999765433 3567899999999999999999999865 45899
Q ss_pred EEeeccCChhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~~--~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||+.++.+..++. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 999998765554443 234689999999999999999999999999999999999999999999999999987654332
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......+|+.|+|||++.+ ..++.++|||||||+||||++ |.+||.+.+..+.+..+......
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------------- 400 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------------- 400 (452)
T ss_dssp -------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred ecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 23334456889999999875 468999999999999999999 99999999888877776432110
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh--CCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR--SEFFTT 406 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~--hp~f~~ 406 (495)
.....+|+.+.+||.+||..||.+|||+.++++ ..+|..
T Consensus 401 --------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 401 --------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred --------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 112356778999999999999999999999987 366654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=386.56 Aligned_cols=245 Identities=19% Similarity=0.261 Sum_probs=202.7
Q ss_pred eeecccCceEEEEEEE--CCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeec
Q 011041 124 DKIGQGTYSNVYKARD--TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
+.||+|+||.||+|.+ ..+++.||||++..........+.+.+|+.+|+.|+|||||++++++.. ..+|+||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEEcc
Confidence 4799999999999954 5677899999998665555566789999999999999999999999865 3489999999
Q ss_pred cCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC--CCCcc
Q 011041 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK--QPMTS 279 (495)
Q Consensus 202 ~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~~~~ 279 (495)
.++.+..++.....+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||++..+..... .....
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 9876666665566899999999999999999999999999999999999999999999999999987654322 12233
Q ss_pred ccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCC
Q 011041 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (495)
Q Consensus 280 ~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 358 (495)
..+|+.|+|||++.+ ..|+.++|||||||+||||++ |.+||.+.+..+....+......
T Consensus 532 ~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~------------------- 591 (635)
T 4fl3_A 532 GKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------------------- 591 (635)
T ss_dssp ---CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------------------
T ss_pred CCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence 456889999999875 568999999999999999998 99999999888877776542110
Q ss_pred CcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 359 ~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+|+++.+||..||..||.+|||+.++++
T Consensus 592 ---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 592 ---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 112357788999999999999999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=347.32 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=193.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||+|++. ++.||||++... ...+.+.+|+.+|+.++||||+++++++.+ ..|+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~l 76 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN----PVCL 76 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TTEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CcEE
Confidence 578999999999999999999864 789999998633 345678899999999999999999998864 3799
Q ss_pred EEeeccCChhhhhhCCCC---CCCHHHHHHHHHHHHHHHHHhhh---CCceeccCCCCCeeeCCCCc-EEEeeccccccc
Q 011041 197 VFKYMEHDLAGLAASPTI---KFTQAQVKCYMHQLLSGLEHCHN---QHVLHRDIKGSNLLIDNEGI-LTIADFGLASFF 269 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~---~l~e~~~~~i~~qil~~L~~LH~---~givHrDlKp~NILl~~~~~-vkL~DFG~a~~~ 269 (495)
||||++++.+..+..... .+++..+..++.||+.||.|||+ +||+||||||+||||+.++. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999998755554443322 47899999999999999999999 89999999999999998886 799999999765
Q ss_pred CCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCChhhhhh
Q 011041 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE--VEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~ 347 (495)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+.. +.
T Consensus 157 ~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~-------- 221 (307)
T 2eva_A 157 QTH----MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GT-------- 221 (307)
T ss_dssp ------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TC--------
T ss_pred ccc----cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CC--------
Confidence 432 234578999999999876 5689999999999999999999999986432 222222211 00
Q ss_pred CCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh-----CCCCCCC
Q 011041 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR-----SEFFTTK 407 (495)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~-----hp~f~~~ 407 (495)
.......+|+.+.+||.+||..||.+|||+.++++ ..+|...
T Consensus 222 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 222 ------------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp ------------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred ------------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 01122457788999999999999999999999987 4556543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=347.92 Aligned_cols=255 Identities=25% Similarity=0.309 Sum_probs=194.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHh--CCCCCeeeeeceeecc--CCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR--LDHPNVVKLEGLVTSR--MSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~--~~~ 192 (495)
.++|++++.||+|+||.||+|++ +|+.||||++... ....+.+|.+++.. ++||||+++++++... ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 57899999999999999999986 6899999998643 23455567777776 7999999999986542 235
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhh--------hCCceeccCCCCCeeeCCCCcEEEeecc
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH--------NQHVLHRDIKGSNLLIDNEGILTIADFG 264 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH--------~~givHrDlKp~NILl~~~~~vkL~DFG 264 (495)
.+|+||||+.++.+..+... ..+++..+..++.||+.||.||| ++||+||||||+||||+.++.+||+|||
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence 68999999998666555543 47999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCC---CCccccccCCCCCcccccCCC-----CCCchhhHHHHHHHHHHHHhC----------CCCCCCCC-
Q 011041 265 LASFFDPNHKQ---PMTSRVVTLWYRPPELLLGAT-----DYGVGVDLWSAGCILAELLAE----------KPIMPGRT- 325 (495)
Q Consensus 265 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DvwSlGvil~elltG----------~~pf~~~~- 325 (495)
++......... .....+||+.|+|||++.+.. .++.++|||||||++|||++| .+||....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 99766433221 123458999999999987643 344789999999999999999 88886532
Q ss_pred ---hHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 326 ---EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 326 ---~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
....+..+....+..+. .+ ........++++.+||.+||..||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~--------------~~-------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 239 NDPSFEDMRKVVCVDQQRPN--------------IP-------NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SSCCHHHHHHHHTTSCCCCC--------------CC-------GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCcchhhhhHHHhccCCCCC--------------CC-------hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 22333333221111000 00 00001123456889999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=376.42 Aligned_cols=252 Identities=17% Similarity=0.201 Sum_probs=196.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCC-CCeeee------------
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDH-PNVVKL------------ 182 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~H-pnIv~l------------ 182 (495)
...|.+.+.||+|+||+||+|++..+|+.||||++..... .....+.+.+|+.+++.+.| .|+..+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 4568999999999999999999999999999999874433 33345678899999999987 322111
Q ss_pred ---------eceeeccC---CceeEEEEeeccCChhhhhh------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecc
Q 011041 183 ---------EGLVTSRM---SCSLYLVFKYMEHDLAGLAA------SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRD 244 (495)
Q Consensus 183 ---------~~~~~~~~---~~~~~lv~e~~~~~l~~~~~------~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrD 244 (495)
..++.... ...++++|+++.+++..++. .....+++..+..++.||+.||.|||++||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 11111111 23578899998888776652 3344578889999999999999999999999999
Q ss_pred CCCCCeeeCCCCcEEEeecccccccCCCCCCCCccccccCCCCCccccc---------CCCCCCchhhHHHHHHHHHHHH
Q 011041 245 IKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL---------GATDYGVGVDLWSAGCILAELL 315 (495)
Q Consensus 245 lKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~~~DvwSlGvil~ell 315 (495)
|||+||||+.++.+||+|||++...... ....+| +.|+|||++. ....|+.++|||||||++|+|+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999865432 345577 9999999983 3356888999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCH
Q 011041 316 AEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA 395 (495)
Q Consensus 316 tG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta 395 (495)
+|+.||.+.+..+.... +......+|+++.+||.+||..||.+|||+
T Consensus 312 tg~~Pf~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~ 358 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEW---------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLP 358 (413)
T ss_dssp HSSCCCCTTGGGSCSGG---------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCcchhhhHHH---------------------------------HHhhcccCCHHHHHHHHHHccCChhhCcCH
Confidence 99999987653221111 111223678889999999999999999999
Q ss_pred HHHHhCCCCCC
Q 011041 396 TAALRSEFFTT 406 (495)
Q Consensus 396 ~elL~hp~f~~ 406 (495)
.++|+||||+.
T Consensus 359 ~~~l~~~~~~~ 369 (413)
T 3dzo_A 359 LQAMETPEYEQ 369 (413)
T ss_dssp HHHTTSHHHHH
T ss_pred HHHHhCHHHHH
Confidence 99999999964
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=363.20 Aligned_cols=255 Identities=20% Similarity=0.256 Sum_probs=196.5
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCC---CeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLT---GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
....|++.+.||+|+||.||+|++..+ +..||+|.+... ........+.+|+.+|+.++||||+++++++... ..
T Consensus 87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~ 164 (373)
T 3c1x_A 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EG 164 (373)
T ss_dssp TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC-SS
T ss_pred hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CC
Confidence 345789999999999999999987543 246899988653 2445667889999999999999999999987543 45
Q ss_pred eeEEEEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 193 SLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 193 ~~~lv~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
..|+||||+.++ |...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 689999999874 5555555556789999999999999999999999999999999999999999999999999986543
Q ss_pred CCCC---CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 011041 272 NHKQ---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 272 ~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (495)
.... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+......
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~-------- 315 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-------- 315 (373)
T ss_dssp -------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC--------
T ss_pred cccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 2211 1233456889999999875 568999999999999999999 78999887766655554331100
Q ss_pred CCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.....+|+.+.+||.+||..||.+|||+.+++++
T Consensus 316 --------------------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 316 --------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0113467789999999999999999999999873
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=371.90 Aligned_cols=254 Identities=21% Similarity=0.240 Sum_probs=204.7
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCC-eeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN-VVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~~ 194 (495)
..++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.|.|++ |+.+..++.. ....
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~ 78 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVE--GDYN 78 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEee--CCEE
Confidence 357899999999999999999999999999999998765432 23678999999998754 4445444444 5678
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee---CCCCcEEEeecccccccCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDP 271 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl---~~~~~vkL~DFG~a~~~~~ 271 (495)
||||||++++|..++......+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||++..+..
T Consensus 79 ~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 9999999777777776556689999999999999999999999999999999999999 5789999999999987754
Q ss_pred CCCC------CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCh
Q 011041 272 NHKQ------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---VEQLHKIFKLCGSPSE 342 (495)
Q Consensus 272 ~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~g~~~~ 342 (495)
.... .....+||+.|+|||++.+ ..++.++||||||||||||++|..||.+... .+.+.++........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~- 236 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS- 236 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC-
T ss_pred CccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc-
Confidence 3321 1235689999999999876 5689999999999999999999999988544 333333332211111
Q ss_pred hhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
+......+++++.+||..||..||.+||++.++++
T Consensus 237 -----------------------~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 -----------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp -----------------------HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -----------------------HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 22233567889999999999999999999998875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=355.83 Aligned_cols=255 Identities=20% Similarity=0.295 Sum_probs=199.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc--CCcee
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR--MSCSL 194 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~~ 194 (495)
.++|++++.||+|+||.||+|++..+|+.||||++... .....+.+.+|+.+++.++||||+++++++... .....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 47899999999999999999999999999999998754 345667888999999999999999999998632 24578
Q ss_pred EEEEeeccCChhhh-hhC---CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 195 YLVFKYMEHDLAGL-AAS---PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 195 ~lv~e~~~~~l~~~-~~~---~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
|+||||+.++.+.. +.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 99999999854433 322 45679999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCC--------CCccccccCCCCCcccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcC
Q 011041 271 PNHKQ--------PMTSRVVTLWYRPPELLLGAT--DYGVGVDLWSAGCILAELLAEKPIMPGRTE--VEQLHKIFKLCG 338 (495)
Q Consensus 271 ~~~~~--------~~~~~~gt~~y~aPE~l~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~--~~~~~~i~~~~g 338 (495)
..... ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||..... ......+.. ..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~ 264 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-QL 264 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-C-
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-cC
Confidence 21100 012345799999999986532 368899999999999999999999953110 001111110 00
Q ss_pred CCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 339 SPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.......+++++.+||.+||..||.+|||+.+++++
T Consensus 265 ---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 265 ---------------------------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 001123567789999999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=347.94 Aligned_cols=244 Identities=20% Similarity=0.334 Sum_probs=193.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|.+ +|+.||||++.... ..+.+.+|+.+++.++||||+++++++... ...+|+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCceEE
Confidence 57899999999999999999976 48899999987543 346688999999999999999999987553 357899
Q ss_pred EEeeccCChhhhhhCCC--CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAGLAASPT--IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~--~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||+.++.+..+.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 99999875444333222 13899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 171 --~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---------------- 231 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------------- 231 (278)
T ss_dssp -------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC----------------
T ss_pred --ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------
Confidence 223467889999999875 568999999999999999998 999999877666655543210
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.......+++.+.+||.+||..||.+|||+.++++
T Consensus 232 ------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 232 ------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 00112356788999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=350.13 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=197.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECC-CC--eEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTL-TG--QIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~-~g--~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
.++|++++.||+|+||.||+|++.. ++ ..||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 4789999999999999999998643 33 3689999876543 345667889999999999999999999999763
Q ss_pred eeEEEEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 193 SLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 193 ~~~lv~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
..++||||+.++ +...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 94 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 94 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 389999999864 4444444445699999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC--CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 272 NHKQ--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 272 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......+
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 244 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-------- 244 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--------
T ss_pred cccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC--------
Confidence 3221 1233467888999999875 467899999999999999999 999999998887777664321111
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+++++.+||.+||..||.+|||+.++++
T Consensus 245 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 245 -------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 112356788999999999999999999999997
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=352.56 Aligned_cols=251 Identities=20% Similarity=0.255 Sum_probs=201.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||+|++.. .||+|++..........+.+.+|+.+++.++||||+++++++.+ ...+|+
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~i 106 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS--PPHLAI 106 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC--SSCEEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCceEE
Confidence 5789999999999999999998764 49999997654444444567789999999999999999999987 457999
Q ss_pred EEeeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC---
Q 011041 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN--- 272 (495)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~--- 272 (495)
||||+.++.+..+. .....+++..+..++.||+.||.|||++||+||||||+||||+ ++.+||+|||++......
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 99999876555444 4445799999999999999999999999999999999999998 689999999998765321
Q ss_pred -CCCCCccccccCCCCCcccccC--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 011041 273 -HKQPMTSRVVTLWYRPPELLLG--------ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE 343 (495)
Q Consensus 273 -~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (495)
.........||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--- 262 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN--- 262 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC---
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC---
Confidence 1122344568999999999864 2457899999999999999999999999988777766654321100
Q ss_pred hhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....++.++.+||..||..||.+|||+.++++
T Consensus 263 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 263 ------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp ------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred ------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011247889999999999999999999999997
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=365.98 Aligned_cols=250 Identities=18% Similarity=0.237 Sum_probs=191.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC------ChHHHHHHHHHHHHHHhCC---------CCCeee
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL------EPESVRFMAREILILRRLD---------HPNVVK 181 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~---------HpnIv~ 181 (495)
.++|++++.||+|+||+||+|++ +|+.||||++..... .....+.+.+|+.+|+.|+ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46899999999999999999987 689999999987642 2233467889999999886 555555
Q ss_pred eece-----------------eecc-----------CCceeEEEEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 011041 182 LEGL-----------------VTSR-----------MSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGL 232 (495)
Q Consensus 182 l~~~-----------------~~~~-----------~~~~~~lv~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L 232 (495)
++++ +.+. ....+||||||+.++ ++..+.. ..+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 5544 4321 146799999999876 5555533 4689999999999999999
Q ss_pred HHhh-hCCceeccCCCCCeeeCCCC--------------------cEEEeecccccccCCCCCCCCccccccCCCCCccc
Q 011041 233 EHCH-NQHVLHRDIKGSNLLIDNEG--------------------ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291 (495)
Q Consensus 233 ~~LH-~~givHrDlKp~NILl~~~~--------------------~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~ 291 (495)
.||| ++||+||||||+||||+.++ .+||+|||+++.... ...+||+.|+|||+
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSGG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChhh
Confidence 9999 99999999999999999887 899999999987653 24589999999999
Q ss_pred ccCCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccc
Q 011041 292 LLGATDYGVGVDLWSAGCI-LAELLAEKPIMPGRTE-VEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAET 369 (495)
Q Consensus 292 l~~~~~~~~~~DvwSlGvi-l~elltG~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (495)
+.+.. +.++||||||++ .+++++|..||.+... ......+......... .....
T Consensus 249 ~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~ 304 (336)
T 2vuw_A 249 FTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK----------------------CNTPA 304 (336)
T ss_dssp GCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSC----------------------CCSHH
T ss_pred hcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcc----------------------cchhh
Confidence 98743 889999998777 7888999999854221 1122233221110000 00111
Q ss_pred cCCCCCCcHHHHHHhccCCCCCccCHHHHH-hCCCCC
Q 011041 370 FKDFPPSSLPLIETLLAIDPAERQTATAAL-RSEFFT 405 (495)
Q Consensus 370 ~~~~s~~~~~Li~~~L~~dP~~R~ta~elL-~hp~f~ 405 (495)
...+++++.+||.+||++| |+.|+| +||||+
T Consensus 305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 2346778999999999988 999999 999995
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=350.50 Aligned_cols=262 Identities=24% Similarity=0.271 Sum_probs=200.5
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCC--CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN--LEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
..|...+.||+|+||.||+|++ ++..||+|++.... ......+.+.+|+.+++.++||||+++++++.+ ....|
T Consensus 31 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 106 (307)
T 2nru_A 31 PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD--GDDLC 106 (307)
T ss_dssp BTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCE
T ss_pred cccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec--CCceE
Confidence 3455668999999999999975 68899999987543 234456788999999999999999999999987 46799
Q ss_pred EEEeeccCChhhhhhC---CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 196 LVFKYMEHDLAGLAAS---PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~---~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
+||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccc
Confidence 9999997654443332 2346999999999999999999999999999999999999999999999999999876433
Q ss_pred CCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC--hhhhhhCC
Q 011041 273 HKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS--EEYWKKSK 349 (495)
Q Consensus 273 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~--~~~~~~~~ 349 (495)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+....+..+........ -..|-...
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK 264 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSS
T ss_pred cccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccc
Confidence 221 1234578999999998865 478999999999999999999999987655433333322211111 01110000
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
+.......+..+.+||..||..||.+|||+.+++++
T Consensus 265 ----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 265 ----------------MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp ----------------CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 001111234567889999999999999999999874
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=349.51 Aligned_cols=239 Identities=21% Similarity=0.299 Sum_probs=186.3
Q ss_pred CCCeeee-eeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHH-HhCCCCCeeeeeceeec--cCCc
Q 011041 117 ADTFEKL-DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILIL-RRLDHPNVVKLEGLVTS--RMSC 192 (495)
Q Consensus 117 ~~~y~~~-~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~--~~~~ 192 (495)
.++|.++ +.||+|+||.||+|++..+++.||||++... ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 4678888 7899999999999999999999999999642 3466889888 56699999999999865 2245
Q ss_pred eeEEEEeeccCC-hhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC---CCcEEEeeccccc
Q 011041 193 SLYLVFKYMEHD-LAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLAS 267 (495)
Q Consensus 193 ~~~lv~e~~~~~-l~~~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~---~~~vkL~DFG~a~ 267 (495)
.+|+||||+.++ +...+... ...+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 789999999874 44444332 346999999999999999999999999999999999999998 7899999999986
Q ss_pred ccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 011041 268 FFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (495)
... ...|+.++|||||||++|+|++|.+||.+.+.......+....
T Consensus 169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~---------- 214 (299)
T 3m2w_A 169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---------- 214 (299)
T ss_dssp ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSS----------
T ss_pred ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHH----------
Confidence 432 1346889999999999999999999998765433211110000
Q ss_pred CCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.... ..........+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 215 --------~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 215 --------RMGQ---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp --------CTTC---CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred --------hhcc---ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 0000 000111224678899999999999999999999999999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=388.66 Aligned_cols=281 Identities=22% Similarity=0.274 Sum_probs=206.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeec----cCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTS----RMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~ 192 (495)
.++|++.+.||+|+||.||+|++..+|+.||||++... ........+.+|+.+|+.++||||+++++++.. ....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 47899999999999999999999999999999998754 355666788999999999999999999998754 1246
Q ss_pred eeEEEEeeccCChhhhhhCC---CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCc---EEEeecccc
Q 011041 193 SLYLVFKYMEHDLAGLAASP---TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI---LTIADFGLA 266 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~---~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~---vkL~DFG~a 266 (495)
..|+||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 78999999977555444332 236899999999999999999999999999999999999997765 999999999
Q ss_pred cccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 011041 267 SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (495)
Q Consensus 267 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (495)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+............ +.
T Consensus 172 ~~~~~~~--~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~--~~ 246 (676)
T 3qa8_A 172 KELDQGE--LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI--VV 246 (676)
T ss_dssp CBTTSCC--CCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C--CS
T ss_pred ccccccc--ccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh--hh
Confidence 8775432 3355689999999999876 57899999999999999999999999876544332111110000000 00
Q ss_pred hCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.........+....+ ........+++.+.+||..||.+||.+|||+.++|+||||+.
T Consensus 247 ~~~l~g~~~~~~~lp---~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLP---TPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCCCSSSCCCCSSSC---CSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhccccccccccC---CchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 000000000000000 011122335677899999999999999999999999999974
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=376.28 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=208.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||.||+|++.. +..||||++...... .+.+.+|+.+|+.|+|||||++++++.+ ..+||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~l 338 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 338 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceE
Confidence 4679999999999999999999875 467999999865433 3568899999999999999999999865 45899
Q ss_pred EEeeccCChhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~~--~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||+.++.+..++. ....+++.++..++.||+.||.|||++|||||||||+||||+.++.+||+|||++........
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 999998755544443 234689999999999999999999999999999999999999999999999999987643221
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......++..|+|||++.+ ..++.++|||||||+||||++ |..||.+.+..+.+..+......
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------------- 483 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------------- 483 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred ecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 12233456788999999875 468999999999999999999 99999998888877776432110
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC--CCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS--EFFTT 406 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h--p~f~~ 406 (495)
.....+++++.+||.+||..||.+|||+.++++. .+|..
T Consensus 484 --------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 484 --------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred --------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 1123567789999999999999999999999873 55543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=377.42 Aligned_cols=251 Identities=21% Similarity=0.270 Sum_probs=202.3
Q ss_pred CCCeeeee-eecccCceEEEEEEEC--CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLD-KIGQGTYSNVYKARDT--LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~-~LG~G~~g~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.++|.+.+ .||+|+||.||+|.++ .++..||||+++... .....+.+.+|+.+|+.++|||||++++++.. ..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~ 409 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EA 409 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SS
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CC
Confidence 35566666 8999999999999875 456789999997653 33445778899999999999999999999875 35
Q ss_pred eEEEEeeccCChhhhh-hCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDLAGLA-ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~-~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
+|+||||+.++.+..+ ......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 8999999998655544 445567999999999999999999999999999999999999999999999999999876433
Q ss_pred CCC--CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 273 HKQ--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 273 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
... ......+|+.|+|||++.+ ..|+.++|||||||+||||++ |.+||.+.+..+.+..+.....
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~----------- 557 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----------- 557 (613)
T ss_dssp ------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-----------
T ss_pred CceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 221 1122345689999999875 568999999999999999998 9999999988887777654210
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......+|+++.+||..||..||.+|||+.++++
T Consensus 558 -----------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 558 -----------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred -----------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0112357888999999999999999999999853
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=348.84 Aligned_cols=270 Identities=23% Similarity=0.377 Sum_probs=202.5
Q ss_pred CCCCeeeeeeecccCceEEEEEE----ECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 116 RADTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
..++|++++.||+|+||.||+|+ +..+|+.||||++... .....+.+.+|+.+|+.++||||+++++++.....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 35789999999999999999998 4678999999998754 34556778999999999999999999999876545
Q ss_pred ceeEEEEeeccCC-hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 192 CSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 192 ~~~~lv~e~~~~~-l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
..+++||||++++ |...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 5789999999874 544454445579999999999999999999999999999999999999999999999999998765
Q ss_pred CCCC--CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 271 PNHK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 271 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
.... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||..... .+ ....+......+...
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~--~~---~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPA--EF---MRMIGNDKQGQMIVF 270 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HH---HHHHCTTCCTHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--HH---HHhhccccchhhhHH
Confidence 4322 11223456788999999876 4578999999999999999999998864311 11 111111111000000
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.+. ..... .........+++++.+||.+||..||.+|||+.++++
T Consensus 271 ~~~--~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 271 HLI--ELLKN-----NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHH--HHHHT-----TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHH--HHhhc-----CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 00000 0000112457788999999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=353.88 Aligned_cols=241 Identities=18% Similarity=0.182 Sum_probs=189.8
Q ss_pred CCCeeeeeeecccCceEEEEE-----EECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC---CCCeeeeeceeec
Q 011041 117 ADTFEKLDKIGQGTYSNVYKA-----RDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD---HPNVVKLEGLVTS 188 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a-----~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~ 188 (495)
.++|.+.+.||+|+||.||+| .+..+++.||||++.... ...+.+|+.+++.+. |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 478999999999999999999 467889999999987542 345678888888886 9999999999987
Q ss_pred cCCceeEEEEeeccCChhhhhhC-----CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC---------
Q 011041 189 RMSCSLYLVFKYMEHDLAGLAAS-----PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN--------- 254 (495)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~~-----~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~--------- 254 (495)
....|+||||++++.+..+.. ....+++..++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 139 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 139 --QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp --SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred --CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 567899999998765544432 4557999999999999999999999999999999999999998
Q ss_pred --CCcEEEeecccccccCC-CCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 011041 255 --EGILTIADFGLASFFDP-NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLH 331 (495)
Q Consensus 255 --~~~vkL~DFG~a~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~ 331 (495)
++.+||+|||++..+.. .........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~---- 291 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG---- 291 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCC----
Confidence 89999999999975431 12233456689999999999887 45899999999999999999999999653221
Q ss_pred HHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccC--CCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 332 KIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFK--DFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 332 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.|. +...+. ..++.+.+++..||..||.+|++..+.|.
T Consensus 292 ------------~~~-------------------~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 292 ------------ECK-------------------PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp ------------EEE-------------------ECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred ------------cee-------------------echhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 000 000011 12345677999999999999976555554
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=354.12 Aligned_cols=276 Identities=25% Similarity=0.287 Sum_probs=189.7
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHH--HHhCCCCCeeeeeceeec---cC
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILI--LRRLDHPNVVKLEGLVTS---RM 190 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~i--l~~l~HpnIv~l~~~~~~---~~ 190 (495)
..++|++++.||+|+||.||+|++ +++.||||++.... ...+..|..+ +..++||||+++++.+.. ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 468999999999999999999965 68999999997432 2233334444 555899999999875532 22
Q ss_pred CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhC---------CceeccCCCCCeeeCCCCcEEEe
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ---------HVLHRDIKGSNLLIDNEGILTIA 261 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~---------givHrDlKp~NILl~~~~~vkL~ 261 (495)
...+|+||||++++.+..+.... .+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred CceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 34679999999875554444322 458999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCC-------CCCCccccccCCCCCcccccCC------CCCCchhhHHHHHHHHHHHHhCCCCC-CCCChH
Q 011041 262 DFGLASFFDPNH-------KQPMTSRVVTLWYRPPELLLGA------TDYGVGVDLWSAGCILAELLAEKPIM-PGRTEV 327 (495)
Q Consensus 262 DFG~a~~~~~~~-------~~~~~~~~gt~~y~aPE~l~~~------~~~~~~~DvwSlGvil~elltG~~pf-~~~~~~ 327 (495)
|||++..+.... .......+||+.|+|||++.+. ..++.++|||||||++|||++|..|| .+....
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 999998764321 1222355799999999998752 34567899999999999999996554 443321
Q ss_pred HHHHHHHHhcC-CCChhhhhhCCCCCCccCCCCccccccccccc---CCCCCCcHHHHHHhccCCCCCccCHHHHH----
Q 011041 328 EQLHKIFKLCG-SPSEEYWKKSKLPHATIFKPQQSYKRCIAETF---KDFPPSSLPLIETLLAIDPAERQTATAAL---- 399 (495)
Q Consensus 328 ~~~~~i~~~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~~Li~~~L~~dP~~R~ta~elL---- 399 (495)
+....+....+ .+....+....... ...+ . +...+ ..+++++.+||.+||..||.+|||+.|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~--~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSRE--KQRP--K----FPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTS--CCCC--C----CCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhccc--ccCC--C----CCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 11111111111 11111111000000 0000 0 00000 11233589999999999999999999994
Q ss_pred --hCCCCCCC
Q 011041 400 --RSEFFTTK 407 (495)
Q Consensus 400 --~hp~f~~~ 407 (495)
.++|-++.
T Consensus 315 ~ll~~~~~~~ 324 (336)
T 3g2f_A 315 ELMMIWERNK 324 (336)
T ss_dssp HHHHCCCC--
T ss_pred HHHHHHHhcc
Confidence 47787664
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=346.37 Aligned_cols=255 Identities=25% Similarity=0.302 Sum_probs=188.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC--CCCCeeeeeceeeccCC--c
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL--DHPNVVKLEGLVTSRMS--C 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~~~--~ 192 (495)
.++|++++.||+|+||.||+|++. |+.||||++... ......+|..++..+ +||||+++++++..... .
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 368999999999999999999875 899999998643 223344556666554 99999999999876422 6
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhC--------CceeccCCCCCeeeCCCCcEEEeecc
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ--------HVLHRDIKGSNLLIDNEGILTIADFG 264 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~--------givHrDlKp~NILl~~~~~vkL~DFG 264 (495)
.+|+||||+.++.+..+... ..+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 79999999988555444432 3699999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCC---CCccccccCCCCCcccccCCCCCCc------hhhHHHHHHHHHHHHhC----------CCCCCCCC
Q 011041 265 LASFFDPNHKQ---PMTSRVVTLWYRPPELLLGATDYGV------GVDLWSAGCILAELLAE----------KPIMPGRT 325 (495)
Q Consensus 265 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~------~~DvwSlGvil~elltG----------~~pf~~~~ 325 (495)
++..+...... .....+||+.|+|||++.+.. +.. ++|||||||++|||++| ..||....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 99766433221 123558999999999987643 333 49999999999999999 66665422
Q ss_pred ----hHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 326 ----EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 326 ----~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
....+..+.......+ . .. .......+++++.+||.+||..||.+|||+.++++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~-----------------~--~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRP-----------------S--FP--NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCC-----------------C--CC--GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCchhhhHHHHhhhccCc-----------------c--cc--ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2222222221110000 0 00 000011344568899999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=375.23 Aligned_cols=251 Identities=20% Similarity=0.319 Sum_probs=205.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCC---CeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLT---GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.++|++.+.||+|+||.||+|++..+ +..||||++.... .....+.+.+|+.+|+.++||||+++++++.+ ..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~ 464 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 464 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---Cc
Confidence 47899999999999999999998643 5679999886432 44555778899999999999999999999854 45
Q ss_pred eEEEEeeccCChhh-hhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l~~-~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
+|+||||+.++.+. .+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 89999999965444 44444557999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
.........+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+......
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~------------ 611 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------------ 611 (656)
T ss_dssp ---------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC------------
T ss_pred cceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 3333344567889999999875 478999999999999999997 99999999888887777542111
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+|+.+.+||.+||..||.+|||+.++++
T Consensus 612 ----------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 612 ----------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112356788999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=342.25 Aligned_cols=253 Identities=24% Similarity=0.289 Sum_probs=194.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHh--CCCCCeeeeeceeeccCC--ce
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR--LDHPNVVKLEGLVTSRMS--CS 193 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~~--~~ 193 (495)
++|++.+.||+|+||.||+|++ +|+.||||++... ....+.+|+.++.. ++||||+++++++..... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 6899999999999999999987 5899999998642 34567789999988 799999999999876422 27
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhh--------hCCceeccCCCCCeeeCCCCcEEEeeccc
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH--------NQHVLHRDIKGSNLLIDNEGILTIADFGL 265 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH--------~~givHrDlKp~NILl~~~~~vkL~DFG~ 265 (495)
+|+||||+.++.+..+... ..+++..++.++.||+.||.||| ++||+||||||+||||+.++.+||+|||+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 8999999998555444432 36899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCC---CCccccccCCCCCcccccCCCC-----CCchhhHHHHHHHHHHHHhC----------CCCCCCCC--
Q 011041 266 ASFFDPNHKQ---PMTSRVVTLWYRPPELLLGATD-----YGVGVDLWSAGCILAELLAE----------KPIMPGRT-- 325 (495)
Q Consensus 266 a~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~-----~~~~~DvwSlGvil~elltG----------~~pf~~~~-- 325 (495)
+......... ......||+.|+|||++.+... ++.++|||||||++|+|++| ..||....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 9876543321 2345579999999999876422 23689999999999999999 67886542
Q ss_pred --hHHHHHHHHHhcC-CCC-hhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 326 --EVEQLHKIFKLCG-SPS-EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 326 --~~~~~~~i~~~~g-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
..+.+........ .+. ...| .....++.+.+||..||..||.+|||+.++++|
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQKLRPNIPNRW-----------------------QSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGG-----------------------GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHHHHhCCCCcccc-----------------------cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 1222222211000 000 0000 001223467889999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=335.32 Aligned_cols=228 Identities=18% Similarity=0.130 Sum_probs=184.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.++..++||||+++++++.+ ....|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 107 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT--RAGGL 107 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE--CCcEE
Confidence 3689999999999999999999999999999999987654 35566788999999999999999999999987 56799
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+||||++++.+..+...+ ..+.++..++.||+.||.|||++||+||||||+||||+.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999876666555443 4667889999999999999999999999999999999999999998543
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
|++ .++.++|||||||++|+|++|..||.+.+..+.+.......
T Consensus 175 ----------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~------------------ 218 (286)
T 3uqc_A 175 ----------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT------------------ 218 (286)
T ss_dssp ----------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT------------------
T ss_pred ----------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh------------------
Confidence 332 36899999999999999999999998865432110000000
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.............+|+++.+||.+||..||.+| |+.++++
T Consensus 219 ----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 219 ----AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp ----TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred ----ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 000001223345688899999999999999999 9999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=373.64 Aligned_cols=243 Identities=23% Similarity=0.309 Sum_probs=198.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECC-CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC---c
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTL-TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS---C 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---~ 192 (495)
.++|++++.||+|+||.||+|++.. +|+.||||++... ........+.+|+.+|+.++|||||++++++..... .
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4789999999999999999999976 7999999988653 245566778899999999999999999999976422 1
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
..||||||++++.+...... .+++.++..|+.||+.||.|||++|||||||||+||||+.+ .+||+|||++......
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 26999999998766555443 79999999999999999999999999999999999999885 8999999999876432
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
...+||+.|+|||++.+ .++.++||||||||||+|++|.+||.+.... +.+...
T Consensus 235 -----~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~~~--------- 288 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPEDD--------- 288 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCTTC---------
T ss_pred -----CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc----------cccccc---------
Confidence 45679999999999865 3589999999999999999999998652110 000000
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
.....++.+.+||.+||..||.+||+..++|.|+|+.
T Consensus 289 ----------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 289 ----------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ----------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0011345678899999999999999999999988864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=319.02 Aligned_cols=189 Identities=16% Similarity=0.068 Sum_probs=137.1
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCC----C----hHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCcee
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----E----PESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~----~----~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++.|++|.+..++....|+.|++|++.+... . ....+.+.+|+++|+++ .|+||+++++++++ +..+
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~ 317 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSG 317 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEE
Confidence 347788888888888888999999999987532 1 23345689999999999 79999999999998 6789
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||||++|+.+..++.....+++. .|+.||+.||+|||++|||||||||+||||+.+|+|||+|||+|+......
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~- 393 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC- 393 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-
Confidence 9999999998888877777788875 478999999999999999999999999999999999999999998765432
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPI 320 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~p 320 (495)
....+.+||+.|+|||++.+ .+...+|+||+|+++|+|+++..+
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred ccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence 34566799999999999876 467789999999999888766443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=262.80 Aligned_cols=187 Identities=17% Similarity=0.144 Sum_probs=139.2
Q ss_pred eeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChH------HHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPE------SVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 121 ~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
...+.||+|+||.||+| ...+..+++|++........ ..+.+.+|+.+|++++||||+++..++.. ....
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD--LDNK 414 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE--TTTT
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe--CCcc
Confidence 34568999999999999 45578899998765433211 23457899999999999999955444444 3457
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||||++++.+..+... +..++.||+.||.|||++||+||||||+||||+. .+||+|||+++.......
T Consensus 415 ~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999986655555443 5689999999999999999999999999999999 999999999988754221
Q ss_pred CC------CccccccCCCCCcccccC-CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 011041 275 QP------MTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAEKPIM 321 (495)
Q Consensus 275 ~~------~~~~~gt~~y~aPE~l~~-~~~~~~~~DvwSlGvil~elltG~~pf 321 (495)
.. ....+||+.|+|||++.+ ...|+..+|+|+..+-..+.+.++.+|
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 135689999999999854 134778899999998888888776655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7e-26 Score=222.43 Aligned_cols=147 Identities=14% Similarity=0.088 Sum_probs=117.4
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh----------------HHHHHHHHHHHHHHhCCCCCeee
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP----------------ESVRFMAREILILRRLDHPNVVK 181 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~----------------~~~~~~~~Ei~il~~l~HpnIv~ 181 (495)
..|.+++.||+|+||.||+|++ .+|+.||||+++...... .....+.+|+.+|+.++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 4566779999999999999999 889999999997543211 23566889999999999 5 67
Q ss_pred eeceeeccCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEe
Q 011041 182 LEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIA 261 (495)
Q Consensus 182 l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~ 261 (495)
+.+++.. ...|+||||++++.+..+ . . .....++.||+.||.|||++||+||||||+||||+ ++.+||+
T Consensus 166 v~~~~~~---~~~~lvmE~~~g~~L~~l-~----~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 166 VPKVYAW---EGNAVLMELIDAKELYRV-R----V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp SCCEEEE---ETTEEEEECCCCEEGGGC-C----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred cCeEEec---cceEEEEEecCCCcHHHc-c----h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEE
Confidence 7776654 347999999988655442 1 1 23457999999999999999999999999999999 9999999
Q ss_pred ecccccccCCCCCCCCccccccCCCCCccccc
Q 011041 262 DFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293 (495)
Q Consensus 262 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~ 293 (495)
|||++.. +..|+|||++.
T Consensus 235 DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp CCTTCEE--------------TTSTTHHHHHH
T ss_pred ECCCCeE--------------CCCCCHHHHHH
Confidence 9999863 34578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3e-22 Score=193.89 Aligned_cols=141 Identities=16% Similarity=0.214 Sum_probs=108.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeE--EEeEEEecCCCCh----------------------HHHHHHHHHHHHHHh
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQI--VALKKVRFDNLEP----------------------ESVRFMAREILILRR 173 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~--vAiK~i~~~~~~~----------------------~~~~~~~~Ei~il~~ 173 (495)
.-|.+.+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+.+|..
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3478999999999999999998778999 9999976432110 112367899999999
Q ss_pred CCCCCe--eeeeceeeccCCceeEEEEeeccC-C----hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhh-hCCceeccC
Q 011041 174 LDHPNV--VKLEGLVTSRMSCSLYLVFKYMEH-D----LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH-NQHVLHRDI 245 (495)
Q Consensus 174 l~HpnI--v~l~~~~~~~~~~~~~lv~e~~~~-~----l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH-~~givHrDl 245 (495)
|.|++| +.++++ ...+|||||+++ + .+..... .+++..+..++.||+.+|.||| ++||+||||
T Consensus 127 l~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 127 AKEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGR---ELKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp HHHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGG---GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred HHhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhh---ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 988865 333332 246899999953 1 2222221 1245678899999999999999 999999999
Q ss_pred CCCCeeeCCCCcEEEeeccccccc
Q 011041 246 KGSNLLIDNEGILTIADFGLASFF 269 (495)
Q Consensus 246 Kp~NILl~~~~~vkL~DFG~a~~~ 269 (495)
||+||||+. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2e-18 Score=174.83 Aligned_cols=140 Identities=17% Similarity=0.192 Sum_probs=99.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC---------------ChHHH-----HHHHHHHHHHHhCCCC
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL---------------EPESV-----RFMAREILILRRLDHP 177 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~---------------~~~~~-----~~~~~Ei~il~~l~Hp 177 (495)
.-|.+++.||+|+||.||+|.+. +|+.||||+++.... ..... ....+|...|.+|.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34999999999999999999975 699999999764211 00000 1123466666666444
Q ss_pred CeeeeeceeeccCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC-
Q 011041 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG- 256 (495)
Q Consensus 178 nIv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~- 256 (495)
++.-. ..+.. ...+|||||++|..+..+.. ...+..++.||+.+|.|||++|||||||||.||||+++|
T Consensus 174 gv~vp-~p~~~---~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 174 GFPVP-EPIAQ---SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp TCSCC-CEEEE---ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred CCCCC-eeeec---cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence 43221 11111 12479999999866544322 234567899999999999999999999999999998876
Q ss_pred ---------cEEEeecccccc
Q 011041 257 ---------ILTIADFGLASF 268 (495)
Q Consensus 257 ---------~vkL~DFG~a~~ 268 (495)
.+.|+||+-+..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 389999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=6.9e-13 Score=127.70 Aligned_cols=139 Identities=14% Similarity=0.118 Sum_probs=108.0
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~l 196 (495)
+.|.+...++.|+++.||++.. .+..+++|+...... .....+.+|+.+|+.|. +..++++++++.+ ....|+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~l 87 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNL 87 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEE
Confidence 4688889999999999999964 367899999864211 11235788999999984 6778889888876 567899
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh---------------------------------------
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN--------------------------------------- 237 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~--------------------------------------- 237 (495)
||||++|..+..... +......++.++..+|..||+
T Consensus 88 v~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999976654421 122335778899999999998
Q ss_pred --------------------CCceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 238 --------------------QHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 238 --------------------~givHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
..++|+|++|.|||+++++.+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876666799999774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.28 E-value=6.5e-12 Score=120.10 Aligned_cols=134 Identities=13% Similarity=0.101 Sum_probs=97.6
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCC--eeeeeceeeccCCceeE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN--VVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~~~ 195 (495)
..|.+....+.|..+.||++. ..+|..|++|+..... ...+.+|+.+|+.+.+.+ +++++++... ....|
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~ 91 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDW 91 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEE
T ss_pred CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCCE
Confidence 345554444567779999996 4567789999876431 234678999999985444 5668777665 45689
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCC------------------------------------
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH------------------------------------ 239 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~g------------------------------------ 239 (495)
+||||++|..+. . . ... ...++.++...|..||+..
T Consensus 92 ~v~e~i~G~~l~-~-~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL-S-S---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT-T-S---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC-c-C---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999986653 1 1 112 2356778888888888753
Q ss_pred ----------------------ceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 240 ----------------------VLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 240 ----------------------ivHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
++|+|++|.|||+++++.+.|+|||.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.22 E-value=4e-11 Score=120.94 Aligned_cols=144 Identities=15% Similarity=0.223 Sum_probs=105.1
Q ss_pred eeeeeecccCceEEEEEEECCCCeEEEeEEEe--cCCCChHHHHHHHHHHHHHHhCC--CCCeeeeeceeeccCC-ceeE
Q 011041 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLD--HPNVVKLEGLVTSRMS-CSLY 195 (495)
Q Consensus 121 ~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~--~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~-~~~~ 195 (495)
..++.|+.|.++.||++... +..+++|+.. .... ......+.+|+.+|+.|. +..+++++.++.+... +..|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 34678999999999998743 4578888765 3221 122356788999999996 4557888887765311 4589
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh--------------------------------------
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-------------------------------------- 237 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~-------------------------------------- 237 (495)
+||||++|..+.... ...+++.+...++.+++..|..||+
T Consensus 118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999999986543211 1246788889999999999999997
Q ss_pred --------------------CCceeccCCCCCeeeCCCCc--EEEeeccccccc
Q 011041 238 --------------------QHVLHRDIKGSNLLIDNEGI--LTIADFGLASFF 269 (495)
Q Consensus 238 --------------------~givHrDlKp~NILl~~~~~--vkL~DFG~a~~~ 269 (495)
..++|+|+++.|||++.++. +.|+||+.+..-
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36999999999999998753 699999988653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.13 E-value=2e-11 Score=120.33 Aligned_cols=183 Identities=16% Similarity=0.152 Sum_probs=120.1
Q ss_pred eeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCC--eeeeeceeeccC-CceeEEEE
Q 011041 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPN--VVKLEGLVTSRM-SCSLYLVF 198 (495)
Q Consensus 123 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hpn--Iv~l~~~~~~~~-~~~~~lv~ 198 (495)
++.++.|.+..||++. ..+++|+... ......+.+|+.+|+.| .+.. +++++....... ....|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 3568999999999873 4588998542 24456788999999988 3333 344444332211 12458999
Q ss_pred eeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh-----------------------------------------
Q 011041 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN----------------------------------------- 237 (495)
Q Consensus 199 e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~----------------------------------------- 237 (495)
++++|..+..... ..++..+...++.|+...|..||+
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999865432111 246777888888888888888885
Q ss_pred -----------------CCceeccCCCCCeeeCC--CCcEEEeecccccccCCCCCCCCccccccCCC---CCccccc--
Q 011041 238 -----------------QHVLHRDIKGSNLLIDN--EGILTIADFGLASFFDPNHKQPMTSRVVTLWY---RPPELLL-- 293 (495)
Q Consensus 238 -----------------~givHrDlKp~NILl~~--~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y---~aPE~l~-- 293 (495)
..++|+|++|.|||+++ .+.+.|+||+.+...++... ......+ ..|+...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-----l~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-----FISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-----HHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-----HHHHHhhccccCHHHHHHH
Confidence 23799999999999998 45688999999876433211 0011111 2222110
Q ss_pred -C---C-------CCCCchhhHHHHHHHHHHHHhCCCCC
Q 011041 294 -G---A-------TDYGVGVDLWSAGCILAELLAEKPIM 321 (495)
Q Consensus 294 -~---~-------~~~~~~~DvwSlGvil~elltG~~pf 321 (495)
. . .......+.|++++++|.+.+|.++|
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 0 00122368999999999999998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.70 E-value=1.6e-07 Score=92.49 Aligned_cols=136 Identities=14% Similarity=0.172 Sum_probs=94.7
Q ss_pred eeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCC---CeeeeeceeeccCCceeEEEEe
Q 011041 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP---NVVKLEGLVTSRMSCSLYLVFK 199 (495)
Q Consensus 123 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~~~~~~~~~lv~e 199 (495)
++.++.|....||+. |..+++|+.. .......+.+|+.+|+.|.+. .+++++.+.... .+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~-~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS-DGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT-TSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC-CCceEEEEe
Confidence 456889999999988 5678889742 234556788999999999652 355666655422 456789999
Q ss_pred eccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhC-----------------------------------------
Q 011041 200 YMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ----------------------------------------- 238 (495)
Q Consensus 200 ~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~----------------------------------------- 238 (495)
|++|..+....- ..++..+...++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999865443211 1235555556666666666666532
Q ss_pred -------------------CceeccCCCCCeeeCC---CCc-EEEeecccccccC
Q 011041 239 -------------------HVLHRDIKGSNLLIDN---EGI-LTIADFGLASFFD 270 (495)
Q Consensus 239 -------------------givHrDlKp~NILl~~---~~~-vkL~DFG~a~~~~ 270 (495)
.++|+|++|.|||++. ++. +.|+||+.+...+
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3599999999999988 455 4899999886543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=3.2e-07 Score=88.08 Aligned_cols=133 Identities=15% Similarity=0.153 Sum_probs=91.4
Q ss_pred eecccCce-EEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCceeEEEEeecc
Q 011041 125 KIGQGTYS-NVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYLVFKYME 202 (495)
Q Consensus 125 ~LG~G~~g-~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~lv~e~~~ 202 (495)
.+..|..| .||+......+..+.+|+-.. .....+.+|+.+|+.|. +--+.+++.+..+ ....|+|||+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEEEEEeeC
Confidence 34445444 699988777778899998652 34567889999999884 3346777777766 467899999999
Q ss_pred CChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh---------------------------------------------
Q 011041 203 HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN--------------------------------------------- 237 (495)
Q Consensus 203 ~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~--------------------------------------------- 237 (495)
|..+...... .......+..++...|.-||.
T Consensus 104 G~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 104 GKTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp SEEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred CccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 8644332211 111223445555555555553
Q ss_pred -------------CCceeccCCCCCeeeCCCCcEEEeecccccc
Q 011041 238 -------------QHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (495)
Q Consensus 238 -------------~givHrDlKp~NILl~~~~~vkL~DFG~a~~ 268 (495)
..++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1279999999999999877778999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=1.4e-06 Score=88.71 Aligned_cols=78 Identities=18% Similarity=0.145 Sum_probs=49.1
Q ss_pred eeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-C----hHHHHHHHHHHHHHHhCCC--C-CeeeeeceeeccCCce
Q 011041 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-E----PESVRFMAREILILRRLDH--P-NVVKLEGLVTSRMSCS 193 (495)
Q Consensus 122 ~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~----~~~~~~~~~Ei~il~~l~H--p-nIv~l~~~~~~~~~~~ 193 (495)
.++.||.|.++.||++....++..|+||....... . ......+..|+.+|+.+.. + .+++++.+. ...
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d----~~~ 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD----TEM 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE----TTT
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc----CCc
Confidence 45789999999999997666678899998653211 0 0122346678999988732 3 344565432 223
Q ss_pred eEEEEeeccC
Q 011041 194 LYLVFKYMEH 203 (495)
Q Consensus 194 ~~lv~e~~~~ 203 (495)
.++||||+++
T Consensus 110 ~~lvmE~l~g 119 (397)
T 2olc_A 110 AVTVMEDLSH 119 (397)
T ss_dssp TEEEECCCTT
T ss_pred cEEEEEeCCC
Confidence 5899999976
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=2e-06 Score=86.19 Aligned_cols=86 Identities=9% Similarity=0.047 Sum_probs=54.3
Q ss_pred eeeeeee-cccCceEEEEEEEC--C----CCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCC-C--CCeeeeeceeec
Q 011041 120 FEKLDKI-GQGTYSNVYKARDT--L----TGQIVALKKVRFDNL-EPESVRFMAREILILRRLD-H--PNVVKLEGLVTS 188 (495)
Q Consensus 120 y~~~~~L-G~G~~g~Vy~a~~~--~----~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~ 188 (495)
...++.| +.|....+|+.... . ++..+++|+...... .......+.+|+.+|+.|. + -.+++++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3445778 89999999988643 1 256788997643220 0000134678888888884 2 356777776654
Q ss_pred cC-CceeEEEEeeccCCh
Q 011041 189 RM-SCSLYLVFKYMEHDL 205 (495)
Q Consensus 189 ~~-~~~~~lv~e~~~~~l 205 (495)
.. .+..|+||||++|..
T Consensus 102 ~~~~g~~~~v~e~l~G~~ 119 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVV 119 (357)
T ss_dssp STTTSSCEEEEECCCCBC
T ss_pred CCccCCceEEEEecCCCC
Confidence 21 135689999998743
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.20 E-value=7.6e-06 Score=80.96 Aligned_cols=136 Identities=18% Similarity=0.203 Sum_probs=77.1
Q ss_pred eeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC--CCCeeeeece-----e-eccCCce
Q 011041 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD--HPNVVKLEGL-----V-TSRMSCS 193 (495)
Q Consensus 122 ~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~-----~-~~~~~~~ 193 (495)
-++.|+.|..+.||++... +..+++|+.... . ..+..|+.+++.|. .-.+++++.. + .. .+.
T Consensus 36 ~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~--~~~ 105 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTD--SGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKH--GSF 105 (346)
T ss_dssp EEEECC----CEEEEEEET--TEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEE--TTE
T ss_pred EeeeccccccCcEEEEEeC--CCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEE--CCE
Confidence 3456777788999998743 345899988642 2 23345566666552 1134444431 1 12 456
Q ss_pred eEEEEeeccCChh----------------hhh--hCCC--C-------CC-CHH--------H-----------------
Q 011041 194 LYLVFKYMEHDLA----------------GLA--ASPT--I-------KF-TQA--------Q----------------- 220 (495)
Q Consensus 194 ~~lv~e~~~~~l~----------------~~~--~~~~--~-------~l-~e~--------~----------------- 220 (495)
.|++|+|++|..+ .+. .... . .+ ... .
T Consensus 106 ~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 185 (346)
T 2q83_A 106 LFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFS 185 (346)
T ss_dssp EEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHH
T ss_pred EEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHH
Confidence 8999999987421 111 0100 0 00 110 0
Q ss_pred ------HHHHHHHHHHHHHHhh-------------hCCceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 221 ------VKCYMHQLLSGLEHCH-------------NQHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 221 ------~~~i~~qil~~L~~LH-------------~~givHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
+..+..++..++.+|+ ...++|+|+++.|||++.++.+.|+||+.+.
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 186 QLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1112223444566665 3679999999999999888899999999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.83 E-value=4.3e-05 Score=78.34 Aligned_cols=33 Identities=12% Similarity=0.334 Sum_probs=28.9
Q ss_pred hhCCceeccCCCCCeeeCCCCcEEEeeccccccc
Q 011041 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (495)
Q Consensus 236 H~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~ 269 (495)
+...++|+|++|.|||++.++ ++|+||+.+..-
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 467899999999999999877 999999988653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.81 E-value=0.00014 Score=71.45 Aligned_cols=74 Identities=19% Similarity=0.181 Sum_probs=56.8
Q ss_pred eeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC---CCCeeeeeceeeccCCceeEEEE
Q 011041 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD---HPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 122 ~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
-++.|+.|....+|+... ++..+++|+.... ....+.+|+..|+.|. ...+++++.+... ....|+||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lvm 110 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLLL 110 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEEE
Confidence 457799999999999863 4667889987632 3567889999999883 3567788777665 45789999
Q ss_pred eeccCC
Q 011041 199 KYMEHD 204 (495)
Q Consensus 199 e~~~~~ 204 (495)
||+++.
T Consensus 111 e~l~G~ 116 (312)
T 3jr1_A 111 EALNKS 116 (312)
T ss_dssp ECCCCC
T ss_pred EeccCC
Confidence 999874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.59 E-value=0.0002 Score=70.21 Aligned_cols=142 Identities=11% Similarity=0.095 Sum_probs=77.3
Q ss_pred eeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCC--eeeeeceeec----cCCce
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN--VVKLEGLVTS----RMSCS 193 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~----~~~~~ 193 (495)
..-++.|+.|....||++... +| .+++|+..... ....+..|+.+++.|...+ +++++..... ...+.
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred ceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 345677888999999998743 34 68899886421 1234556788887773222 3344321100 01245
Q ss_pred eEEEEeeccCChhh----------------hhh-CCCCC------CCHHHHHHH---------------HHHHHHHHHHh
Q 011041 194 LYLVFKYMEHDLAG----------------LAA-SPTIK------FTQAQVKCY---------------MHQLLSGLEHC 235 (495)
Q Consensus 194 ~~lv~e~~~~~l~~----------------~~~-~~~~~------l~e~~~~~i---------------~~qil~~L~~L 235 (495)
.+++|+|++|.... +.. ..... .....-... -..+...++++
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 78999999874210 110 00000 111000000 01133444555
Q ss_pred h-------hCCceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 236 H-------NQHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 236 H-------~~givHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
+ ..+++|+|+.+.|||+++++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 4 2469999999999999987666899999774
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00043 Score=67.31 Aligned_cols=68 Identities=16% Similarity=0.082 Sum_probs=42.4
Q ss_pred eeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCe-eeeeceeeccCCceeEEEEeec
Q 011041 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV-VKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 123 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~~~lv~e~~ 201 (495)
++.|+.|....+|++ ..|++|+..... .......+|+.+++.+...++ ++++.+..+ .-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~----~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVDPA----TGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECTT----TCCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEECC----CCEEEEeec
Confidence 678999999999998 458888875421 111123468888877742222 455544322 246899999
Q ss_pred -cC
Q 011041 202 -EH 203 (495)
Q Consensus 202 -~~ 203 (495)
++
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 65
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00026 Score=68.39 Aligned_cols=76 Identities=16% Similarity=0.203 Sum_probs=52.6
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCC---CeeeeeceeeccCCceeE
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP---NVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~~~~~~~~~ 195 (495)
+..-++.+|.|..+.||+.+ ..+|+.|.+|+...... .....+.+|+..|+.|.-- -+++++.+. .-+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~------~~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD------DRT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE------TTE
T ss_pred CeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc------Cce
Confidence 45567889999999999997 45788999997653322 2234578899999988421 234444432 237
Q ss_pred EEEeeccC
Q 011041 196 LVFKYMEH 203 (495)
Q Consensus 196 lv~e~~~~ 203 (495)
+||||+.+
T Consensus 87 lv~e~l~~ 94 (288)
T 3f7w_A 87 LAMEWVDE 94 (288)
T ss_dssp EEEECCCC
T ss_pred EEEEeecc
Confidence 89999875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00042 Score=71.21 Aligned_cols=72 Identities=17% Similarity=0.214 Sum_probs=48.6
Q ss_pred eeeeecccCceEEEEEEECC-------CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCe-eeeeceeeccCCce
Q 011041 122 KLDKIGQGTYSNVYKARDTL-------TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV-VKLEGLVTSRMSCS 193 (495)
Q Consensus 122 ~~~~LG~G~~g~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~ 193 (495)
.++.|+.|....||++.... .+..|.+|+..... . ...+.+|+.+++.|...+| +++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC-----
Confidence 45678999999999997542 25678899874321 1 1344579999998843333 667665532
Q ss_pred eEEEEeeccC
Q 011041 194 LYLVFKYMEH 203 (495)
Q Consensus 194 ~~lv~e~~~~ 203 (495)
.+|+||++|
T Consensus 148 -g~v~e~l~G 156 (429)
T 1nw1_A 148 -GRLEEYIPS 156 (429)
T ss_dssp -EEEECCCCE
T ss_pred -CEEEEEeCC
Confidence 388999976
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00032 Score=70.87 Aligned_cols=148 Identities=16% Similarity=0.195 Sum_probs=85.8
Q ss_pred CCCCCCCCCeeeeeeecccCceEEEEEEECC-------CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeee
Q 011041 111 GWTPRRADTFEKLDKIGQGTYSNVYKARDTL-------TGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKL 182 (495)
Q Consensus 111 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l 182 (495)
.|.....+.+. ++.|..|-...+|++.... ++..|.+|+.-.. ......+.+|..+++.|. +.-.+++
T Consensus 44 ~W~~~~~~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~l 119 (379)
T 3feg_A 44 AWRRVQPEELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQL 119 (379)
T ss_dssp GGGGCCGGGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCE
T ss_pred cCCCCCcCceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeE
Confidence 34433334444 4567788889999997542 3567889975221 122455668999998884 3223666
Q ss_pred eceeeccCCceeEEEEeeccCChhhh------------------hhCC----CCCC--CHHHHHHHHHHHHH--------
Q 011041 183 EGLVTSRMSCSLYLVFKYMEHDLAGL------------------AASP----TIKF--TQAQVKCYMHQLLS-------- 230 (495)
Q Consensus 183 ~~~~~~~~~~~~~lv~e~~~~~l~~~------------------~~~~----~~~l--~e~~~~~i~~qil~-------- 230 (495)
++++.+ .+||||++|..+.. +... .... -..++..++.++-.
T Consensus 120 l~~~~~------g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~ 193 (379)
T 3feg_A 120 YGVFPE------GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPE 193 (379)
T ss_dssp EEEETT------EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCS
T ss_pred EEEcCC------ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccch
Confidence 665543 28999998732110 0111 1111 23556666655422
Q ss_pred -----------HHHHhh----h----CCceeccCCCCCeeeCCC----CcEEEeecccccc
Q 011041 231 -----------GLEHCH----N----QHVLHRDIKGSNLLIDNE----GILTIADFGLASF 268 (495)
Q Consensus 231 -----------~L~~LH----~----~givHrDlKp~NILl~~~----~~vkL~DFG~a~~ 268 (495)
.+..|. . ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 194 ~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 194 MNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp CCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 233332 1 359999999999999876 7899999998853
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00035 Score=70.15 Aligned_cols=73 Identities=7% Similarity=0.029 Sum_probs=42.9
Q ss_pred eeeeecccCceEEEEEEECC--------CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCC-eeeeeceeeccCCc
Q 011041 122 KLDKIGQGTYSNVYKARDTL--------TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN-VVKLEGLVTSRMSC 192 (495)
Q Consensus 122 ~~~~LG~G~~g~Vy~a~~~~--------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~ 192 (495)
.+..|+.|....||++.... .+..|++|+..... ........|..+++.|...+ ++++++.+.
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----- 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTFN----- 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEET-----
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEecC-----
Confidence 35678889889999997543 13678888764321 11112357888888874333 446665431
Q ss_pred eeEEEEeeccC
Q 011041 193 SLYLVFKYMEH 203 (495)
Q Consensus 193 ~~~lv~e~~~~ 203 (495)
-++||||++|
T Consensus 109 -~~~v~e~i~G 118 (369)
T 3c5i_A 109 -GGRIEEWLYG 118 (369)
T ss_dssp -TEEEEECCCS
T ss_pred -CcEEEEEecC
Confidence 2689999986
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0022 Score=66.32 Aligned_cols=73 Identities=16% Similarity=0.096 Sum_probs=47.6
Q ss_pred eeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCe-eeeeceeeccCCceeEEEEee
Q 011041 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV-VKLEGLVTSRMSCSLYLVFKY 200 (495)
Q Consensus 122 ~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~~~lv~e~ 200 (495)
.++.|+.|-...+|++.....+..|++|+...... ..-...+|..+|+.|...++ +++++++. + .+||||
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~idR~~E~~vl~~L~~~gl~P~ll~~~~---~---G~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EIINREREKKISCILYNKNIAKKIYVFFT---N---GRIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCSCHHHHHHHHHHHTTSSSBCCEEEEET---T---EEEEEC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhcCHHHHHHHHHHHHhcCCCCCEEEEeC---C---eEEEEe
Confidence 45678999999999998655457889998743211 11112579999999865444 56776653 2 259999
Q ss_pred ccC
Q 011041 201 MEH 203 (495)
Q Consensus 201 ~~~ 203 (495)
++|
T Consensus 183 I~G 185 (458)
T 2qg7_A 183 MDG 185 (458)
T ss_dssp CCS
T ss_pred eCC
Confidence 986
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0018 Score=59.51 Aligned_cols=96 Identities=15% Similarity=0.036 Sum_probs=62.5
Q ss_pred hhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhh-hCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCcccccc
Q 011041 205 LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH-NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVT 283 (495)
Q Consensus 205 l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH-~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt 283 (495)
|...+...+..++|+++|.++.|.+..|.-+- ...-..+=+-|..|+|..+|.|.+.+ ..+. ...
T Consensus 35 L~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~~ 100 (229)
T 2yle_A 35 LEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AGE 100 (229)
T ss_dssp HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-------------------
T ss_pred HHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------ccc
Confidence 44555556778999999999999999987762 11112333457899999999988763 1110 112
Q ss_pred CCCCCcccccCCCCCCchhhHHHHHHHHHHHHh
Q 011041 284 LWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316 (495)
Q Consensus 284 ~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt 316 (495)
..+.+||... ...+.+.=|||||++||..+-
T Consensus 101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 101 PPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred cCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 2467888753 245688899999999999984
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.002 Score=63.95 Aligned_cols=32 Identities=28% Similarity=0.402 Sum_probs=28.5
Q ss_pred CCceeccCCCCCeeeCCCCcEEEeeccccccc
Q 011041 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (495)
Q Consensus 238 ~givHrDlKp~NILl~~~~~vkL~DFG~a~~~ 269 (495)
..++|+|+.+.|||++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998889999999987654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0018 Score=63.44 Aligned_cols=137 Identities=13% Similarity=0.088 Sum_probs=78.2
Q ss_pred eeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCC--Ceeeeeceeec----cCCceeEEE
Q 011041 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP--NVVKLEGLVTS----RMSCSLYLV 197 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~----~~~~~~~lv 197 (495)
..|+ |....||++.. .+|+.+++|+....... ...+..|+.+++.|... .+++++.. .. ...+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEE
Confidence 4566 88889998753 34667999998643222 23556788888877422 24445443 11 013456889
Q ss_pred EeeccCChhh----------------h--hhCC-----CCCCCHHH----------------------HHHHHHHHHHHH
Q 011041 198 FKYMEHDLAG----------------L--AASP-----TIKFTQAQ----------------------VKCYMHQLLSGL 232 (495)
Q Consensus 198 ~e~~~~~l~~----------------~--~~~~-----~~~l~e~~----------------------~~~i~~qil~~L 232 (495)
|+|++|.... + .... ...++... ....+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999873210 0 0000 00112111 011222222223
Q ss_pred HHh----hhCCceeccCCCCCeeeCCCCcEEEeecccccc
Q 011041 233 EHC----HNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (495)
Q Consensus 233 ~~L----H~~givHrDlKp~NILl~~~~~vkL~DFG~a~~ 268 (495)
.-+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 222 234689999999999999 4 899999997753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00081 Score=66.31 Aligned_cols=33 Identities=30% Similarity=0.351 Sum_probs=28.2
Q ss_pred hCCceeccCCCCCeeeCCC----CcEEEeeccccccc
Q 011041 237 NQHVLHRDIKGSNLLIDNE----GILTIADFGLASFF 269 (495)
Q Consensus 237 ~~givHrDlKp~NILl~~~----~~vkL~DFG~a~~~ 269 (495)
...++|||+.+.|||++.+ +.+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3579999999999999875 68999999988653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0065 Score=62.13 Aligned_cols=87 Identities=9% Similarity=0.064 Sum_probs=52.0
Q ss_pred cccCCCCCCCCCeeeeeeecccCceEEEEEEECCC-------CeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCe
Q 011041 108 AISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLT-------GQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNV 179 (495)
Q Consensus 108 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-------g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnI 179 (495)
.+.+|.....+. .-++.|..|-...+|++..... +..|++|+..... +..-...+|..+++.|. +.-.
T Consensus 61 ~~p~w~~~~~~~-~~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~ 136 (424)
T 3mes_A 61 NIPGWKEINESY-IEVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIA 136 (424)
T ss_dssp HSTTCTTCCGGG-EEEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSS
T ss_pred HcCccccCCCCc-eEEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCC
Confidence 345555322222 3456778888899999976521 5778888854321 11122457888888874 3224
Q ss_pred eeeeceeeccCCceeEEEEeeccCC
Q 011041 180 VKLEGLVTSRMSCSLYLVFKYMEHD 204 (495)
Q Consensus 180 v~l~~~~~~~~~~~~~lv~e~~~~~ 204 (495)
+++++.+. -++||||++|.
T Consensus 137 P~l~~~~~------~~~I~efI~G~ 155 (424)
T 3mes_A 137 PNIIADFP------EGRIEEFIDGE 155 (424)
T ss_dssp CCEEEEET------TEEEEECCCSE
T ss_pred CCEEEEcC------CCEEEEEeCCc
Confidence 56665332 27899999874
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.62 E-value=0.077 Score=53.61 Aligned_cols=29 Identities=28% Similarity=0.543 Sum_probs=24.8
Q ss_pred ceeccCCCCCeee------CCCCcEEEeecccccc
Q 011041 240 VLHRDIKGSNLLI------DNEGILTIADFGLASF 268 (495)
Q Consensus 240 ivHrDlKp~NILl------~~~~~vkL~DFG~a~~ 268 (495)
++|+|+.+.|||+ ++++.+.|+||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4467799999998854
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=91.18 E-value=0.024 Score=58.68 Aligned_cols=65 Identities=11% Similarity=0.167 Sum_probs=19.3
Q ss_pred eeeeeecccCceEEEEEEECCCCeEEEe------EEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeec
Q 011041 121 EKLDKIGQGTYSNVYKARDTLTGQIVAL------KKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTS 188 (495)
Q Consensus 121 ~~~~~LG~G~~g~Vy~a~~~~~g~~vAi------K~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 188 (495)
.+.+.|| ||.||++........||+ |.........+....+.+|..+++.++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3445676 999999987665568999 7665444444555667889999999999999999987754
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=83.49 E-value=16 Score=35.41 Aligned_cols=140 Identities=11% Similarity=0.150 Sum_probs=76.0
Q ss_pred CeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeece-------------
Q 011041 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGL------------- 185 (495)
Q Consensus 119 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~------------- 185 (495)
.+..++..-.|..|.++... ++..|.||-. . .-..+.+-.++...-.+.-|+..-+.-.
T Consensus 70 ~v~~I~~s~~Gstgvff~~t---d~~~~VVK~s--~---~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L~~ 141 (342)
T 1cja_A 70 QFKGIERSEKGTEGLFFVET---ESGVFIVKRS--T---NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAA 141 (342)
T ss_dssp GEEEEEECCSTTSCEEEEEE---SSCEEEEECC--T---THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHH
T ss_pred CeeEEEeccCCCCCeEEEEe---CCCEEEEeCc--H---HHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHHHH
Confidence 47777888888766655554 4668888943 1 2233444445554445566654322111
Q ss_pred -------eeccCCceeEEEEeeccCChhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhCC----c-eeccCCCCCee
Q 011041 186 -------VTSRMSCSLYLVFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQH----V-LHRDIKGSNLL 251 (495)
Q Consensus 186 -------~~~~~~~~~~lv~e~~~~~l~~~~~~~--~~~l~e~~~~~i~~qil~~L~~LH~~g----i-vHrDlKp~NIL 251 (495)
+........+++|+|+.|-.+...... ...+.+.....+. -+-+++.+..++ . -+.--.++|||
T Consensus 142 ~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~LG--~Ii~FDi~InN~DR~Pl~W~n~GN~~NIL 219 (342)
T 1cja_A 142 IDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLG--SLMALDVIVNNSDRLPIAWTNEGNLDNIM 219 (342)
T ss_dssp HCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHH--HHHHHHHHHTCCSSSCSSSCSCCCGGGEE
T ss_pred hhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHHhhc--hhheehhhhcCCccCcccccCCCChhheE
Confidence 011112356799999986443322111 0123333332221 134566666543 1 11225789999
Q ss_pred eCCCCc-EEEeecccccc
Q 011041 252 IDNEGI-LTIADFGLASF 268 (495)
Q Consensus 252 l~~~~~-vkL~DFG~a~~ 268 (495)
++.++. +.++|-+++..
T Consensus 220 ~~~~n~~~~~IDhn~af~ 237 (342)
T 1cja_A 220 LSERGATVVPIDSKIIPL 237 (342)
T ss_dssp EESBTTCEEECSCCCCCC
T ss_pred EeCCCCeEEEEcCCcccc
Confidence 987654 88999998854
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 495 | ||||
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-84 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-81 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-75 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-74 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-73 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-73 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-72 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-71 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-70 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-70 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-69 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-68 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-67 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-66 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-66 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-65 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-65 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-65 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-64 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-64 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-64 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-63 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-63 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-63 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-61 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-59 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-57 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-57 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-53 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-52 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-52 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-52 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-52 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-49 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-49 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-46 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-41 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-37 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-29 |
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 259 bits (663), Expect = 9e-84
Identities = 136/311 (43%), Positives = 180/311 (57%), Gaps = 12/311 (3%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL 174
+EKL KIGQGT+ V+KAR TGQ VALKKV +N + REI IL+ L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 175 DHPNVVKLEGLVTSRMS------CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQL 228
H NVV L + ++ S S+YLVF + EHDLAGL ++ +KFT +++K M L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN---HKQPMTSRVVTLW 285
L+GL + H +LHRD+K +N+LI +G+L +ADFGLA F T+RVVTLW
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
YRPPELLLG DYG +DLW AGCI+AE+ PIM G TE QL I +LCGS + E W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 346 KK-SKLPHATIFKPQQSYKRCIAETFKDF--PPSSLPLIETLLAIDPAERQTATAALRSE 402
+ + KR + + K + P +L LI+ LL +DPA+R + AL +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 403 FFTTKPYACDP 413
FF + P D
Sbjct: 307 FFWSDPMPSDL 317
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (644), Expect = 3e-81
Identities = 123/302 (40%), Positives = 175/302 (57%), Gaps = 9/302 (2%)
Query: 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL---EPESVRFMAREILILRRLDHP 177
EKLD +G+G ++ VYKARD T QIVA+KK++ + + R REI +L+ L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
N++ L + ++ LVF +ME DL + ++ T + +K YM L GLE+ H
Sbjct: 61 NIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
+LHRD+K +NLL+D G+L +ADFGLA F ++ T +VVT WYR PELL GA
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YTHQVVTRWYRAPELLFGARM 177
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHATIF 356
YGVGVD+W+ GCILAELL P +PG ++++QL +IF+ G+P+EE W LP F
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSL 416
K + F L LI+ L +P R TAT AL+ ++F+ +P L
Sbjct: 238 KSFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 295
Query: 417 PK 418
P+
Sbjct: 296 PR 297
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 1e-75
Identities = 104/329 (31%), Positives = 162/329 (49%), Gaps = 13/329 (3%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
+ L IG+G Y V A D + VA+KK+ + R + REI IL R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 65
Query: 177 PNVVKLEGLV---TSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
N++ + ++ T +YLV M DL L + + + +++Q+L GL+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLK 123
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP--MTSRVVTLWYRPPEL 291
+ H+ +VLHRD+K SNLL++ L I DFGLA DP+H +T V T WYR PE+
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
+L + Y +D+WS GCILAE+L+ +PI PG+ ++QL+ I + GSPS+E
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 352 HATIFKPQQSYKRCI--AETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409
A + +K + F + +L L++ +L +P +R AL +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY- 302
Query: 410 ACDPSSLPKYPPTKEMDAKLRDEEARRLR 438
DPS P + D +L D +L+
Sbjct: 303 --DPSDEPIAEAPFKFDMELDDLPKEKLK 329
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 6e-74
Identities = 119/294 (40%), Positives = 168/294 (57%), Gaps = 6/294 (2%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ F+K++KIG+GTY VYKAR+ LTG++VALKK+R D REI +L+ L+HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N+VKL ++ + LYLVF+++ DL + AS +K Y+ QLL GL CH
Sbjct: 62 NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ VLHRD+K NLLI+ EG + +ADFGLA F + T VVTLWYR PE+LLG
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCK 178
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
Y VD+WS GCI AE++ + + PG +E++QL +IF+ G+P E W
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT--TKP 408
+ ++ ++ L+ +L DP +R +A AAL FF TKP
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 3e-73
Identities = 108/342 (31%), Positives = 159/342 (46%), Gaps = 18/342 (5%)
Query: 99 SWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP 158
S ++ V G + ++ IG G++ VY+A+ +G++VA+KKV D
Sbjct: 1 SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--- 57
Query: 159 ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLA---AS 211
RF RE+ I+R+LDH N+V+L S L LV Y+ + +A +
Sbjct: 58 ---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114
Query: 212 PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFD 270
VK YM+QL L + H+ + HRDIK NLL+D + +L + DFG A
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174
Query: 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQL 330
+P S + + +YR PEL+ GATDY +D+WSAGC+LAELL +PI PG + V+QL
Sbjct: 175 RG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232
Query: 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPA 390
+I K+ G+P+ E ++ + PQ PP ++ L LL P
Sbjct: 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292
Query: 391 ERQTATAALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDE 432
R T A FF LP T + E
Sbjct: 293 ARLTPLEACAHSFF--DELRDPNVKLPNGRDTPALFNFTTQE 332
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (594), Expect = 4e-73
Identities = 98/326 (30%), Positives = 159/326 (48%), Gaps = 13/326 (3%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ L +G G Y V A D TG VA+KK+ + RE+ +L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 178 NVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
NV+ L + T + YLV +M DL L K + +++ ++Q+L GL
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLR 135
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ H ++HRD+K NL ++ + L I DFGLA D MT VVT WYR PE++L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRWYRAPEVIL 191
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
Y VD+WS GCI+AE++ K + G ++QL +I K+ G+P E+ ++ + A
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 354 TIFKPQ--QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYAC 411
+ + K+ A + P ++ L+E +L +D +R TA AL +F +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311
Query: 412 DPSSLPKYPPTKEMDAKLRDEEARRL 437
D + KY + + D +E +R+
Sbjct: 312 DEPQVQKYDDSFD-DVDRTLDEWKRV 336
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 2e-72
Identities = 108/321 (33%), Positives = 156/321 (48%), Gaps = 12/321 (3%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ ++ L +G G Y +V A DT TG VA+KK+ + RE+ +L+ + H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 178 NVVKLEGLVTSRMSC----SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
NV+ L + T S +YLV M DL + K T V+ ++Q+L GL+
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLK 135
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ H+ ++HRD+K SNL ++ + L I DFGLA D MT V T WYR PE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIML 191
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK--SKLP 351
Y VD+WS GCI+AELL + + PG ++QL I +L G+P E KK S+
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYAC 411
I Q K A F P ++ L+E +L +D +R TA AL +F
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311
Query: 412 DPSSLPKYPPTKEMDAKLRDE 432
D Y + E L DE
Sbjct: 312 DEPVADPYDQSFESRDLLIDE 332
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 227 bits (578), Expect = 1e-71
Identities = 104/287 (36%), Positives = 159/287 (55%), Gaps = 4/287 (1%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ + L+KIG+GTY VYKA++ G+ ALKK+R + + REI IL+ L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
N+VKL ++ ++ L LVF++++ DL L K ++ QLL+G+ +CH+
Sbjct: 61 NIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
+ VLHRD+K NLLI+ EG L IADFGLA F ++ +VTLWYR P++L+G+
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMGSKK 177
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357
Y +D+WS GCI AE++ P+ PG +E +QL +IF++ G+P+ + W
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
K S + L+ +L +DP +R TA AL +F
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 2e-70
Identities = 73/289 (25%), Positives = 124/289 (42%), Gaps = 30/289 (10%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ ++ + +G+G Y V A + +T + VA+K V +EI I + L+H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHE 63
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
NVVK G R YL +Y P I + + + HQL++G+ + H
Sbjct: 64 NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLLGAT 296
+ HRDIK NLL+D L I+DFGLA+ F N+++ + +++ TL Y PELL
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
+ VD+WS G +L +LA + ++ Q + +K +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP------------- 228
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
+K + L L+ +L +P+ R T + ++
Sbjct: 229 -------------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (570), Expect = 2e-70
Identities = 113/297 (38%), Positives = 165/297 (55%), Gaps = 7/297 (2%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+EKL+KIG+GTY V+KA++ T +IVALK+VR D+ + REI +L+ L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
N+V+L ++ S LVF++ + DL S VK ++ QLL GL CH+
Sbjct: 62 NIVRLHDVLHSDKKL--TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
++VLHRD+K NLLI+ G L +A+FGLA F + ++ VVTLWYRPP++L GA
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKL 178
Query: 298 YGVGVDLWSAGCILAELL-AEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
Y +D+WSAGCI AEL A +P+ PG +QL +IF+L G+P+EE W
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDP 413
P + + L++ LL +P +R +A AL+ +F+ C P
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD---FCPP 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 222 bits (566), Expect = 6e-69
Identities = 74/341 (21%), Positives = 129/341 (37%), Gaps = 37/341 (10%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D ++ +++G G + V++ + TG A K V + + +EI + L HP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHP 83
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
+V L + +++++M +L A K ++ + YM Q+ GL H H
Sbjct: 84 TLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 237 NQHVLHRDIKGSNLLIDNE--GILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
+ +H D+K N++ + L + DFGL + DP +T+ T + PE+ G
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG--TAEFAAPEVAEG 199
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
G D+WS G + LL+ G + E L + + + +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG------- 251
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPS 414
I+E KD I LL DP R T AL + T S
Sbjct: 252 -----------ISEDGKD-------FIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
Query: 415 SLP--KYPPTKEMDAKLRDEEARRLRAAGKANAEAKKARSR 453
+P +Y ++ D L G+ + + + R
Sbjct: 294 QIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHR 334
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 1e-68
Identities = 67/306 (21%), Positives = 122/306 (39%), Gaps = 23/306 (7%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
+ D FEK+ ++G G V+K +G ++A K + + + + RE+ +L +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-RELQVLHECN 62
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
P +V G S + + ++M+ + + + ++ GL +
Sbjct: 63 SPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 236 HNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
+H ++HRD+K SN+L+++ G + + DFG++ + S V T Y PE L G
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQG 177
Query: 295 ATDYGVGVDLWSAGCILAELLAEK-PIMPGRTEVEQLHKIFKLCG----SPSEEYWKKSK 349
T Y V D+WS G L E+ + PI P + +L ++ G +P
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLP----------LIETLLAIDPAERQTATAAL 399
L + + + + PP LP + L +PAER +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 400 RSEFFT 405
F
Sbjct: 297 VHAFIK 302
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 218 bits (555), Expect = 3e-67
Identities = 70/338 (20%), Positives = 134/338 (39%), Gaps = 40/338 (11%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D ++ L+++G G + V++ + TG++ K + P + EI I+ +L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHP 86
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
++ L + + L+ +++ +L A+ K ++A+V YM Q GL+H H
Sbjct: 87 KLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 237 NQHVLHRDIKGSNLLID--NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
++H DIK N++ + + I DFGLA+ +P+ +T T + PE++
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDR 202
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
G D+W+ G + LL+ G ++E L + + E+ +
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS------- 254
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPS 414
P + I+ LL +P +R T AL + D S
Sbjct: 255 ------------------VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG-----DHS 291
Query: 415 SLPKYPPTKEMDAKLRDEEARRLRAAGKANAEAKKARS 452
+L P+ + + + + A + A
Sbjct: 292 NLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANF 329
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 214 bits (545), Expect = 3e-66
Identities = 75/324 (23%), Positives = 138/324 (42%), Gaps = 39/324 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDH 176
F L +IG G++ VY ARD ++VA+KK+ + + E + + +E+ L++L H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
PN ++ G + +LV +Y + L + ++ H L GL + H
Sbjct: 75 PNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ +++HRD+K N+L+ G++ + DFG AS P S V T ++ PE++L
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPEVILAMD 187
Query: 297 D--YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
+ Y VD+WS G EL KP + + L+ I + SP+ +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPALQ----------- 235
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPS 414
+ +++ L P +R T+ L+ F +
Sbjct: 236 ---------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIM 280
Query: 415 SLPKYPPTKEMDAKLRDEEARRLR 438
L + TK+ +L + + R+++
Sbjct: 281 DLIQR--TKDAVRELDNLQYRKMK 302
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 6e-66
Identities = 109/298 (36%), Positives = 157/298 (52%), Gaps = 13/298 (4%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLT-GQIVALKKVRFDNLEPESVRFMAREILILRR 173
R +E + +IG+G Y V+KARD G+ VALK+VR E RE+ +LR
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 174 L---DHPNVVKLEGLVT---SRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMH 226
L +HPNVV+L + T + L LVF++++ D L P +K M
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWY 286
QLL GL+ H+ V+HRD+K N+L+ + G + +ADFGLA + +TS VVTLWY
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWY 181
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346
R PE+LL ++ Y VDLWS GCI AE+ KP+ G ++V+QL KI + G P EE W
Sbjct: 182 RAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
+ F + + I + D L+ L +PA+R +A +AL +F
Sbjct: 241 RDVALPRQAFHSKSAQP--IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (537), Expect = 2e-65
Identities = 69/293 (23%), Positives = 123/293 (41%), Gaps = 36/293 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D +E + ++G G + VYKA++ T + A K + + E + EI IL DHP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHP 69
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N+VKL + L+++ ++ + + T++Q++ Q L L + H
Sbjct: 70 NIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ ++HRD+K N+L +G + +ADFG+++ Q S + T ++ PE+++ T
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCET 186
Query: 297 D----YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352
Y D+WS G L E+ +P + L KI K P+ +
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-SEPPTLAQPSR----- 240
Query: 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
+ FKD ++ L + R T + L+ F T
Sbjct: 241 -------------WSSNFKD-------FLKKCLEKNVDARWTTSQLLQHPFVT 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 5e-65
Identities = 75/297 (25%), Positives = 126/297 (42%), Gaps = 39/297 (13%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
RA+ +E L IG G+Y K R G+I+ K++ + ++ + + E+ +LR L
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGL---AASPTIKFTQAQVKCYMHQLLSG 231
HPN+V+ + R + +LY+V +Y E DLA + + V M QL
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 232 LEHCHNQH-----VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWY 286
L+ CH + VLHRD+K +N+ +D + + + DFGLA + + + V T +Y
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYY 180
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346
PE + Y D+WS GC+L EL A P ++ E KI + K
Sbjct: 181 MSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE---------GK 230
Query: 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
++P+ + +I +L + R + L +
Sbjct: 231 FRRIPY-------------------RYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 6e-65
Identities = 80/289 (27%), Positives = 125/289 (43%), Gaps = 36/289 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVR-FMAREILILRRLDH 176
+ FE +G+G + NVY AR+ + I+ALK + LE V + RE+ I L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
PN+++L G + +YL+ +Y KF + + Y+ +L + L +CH
Sbjct: 66 PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
++ V+HRDIK NLL+ + G L IADFG + + T+ TL Y PPE++ G
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRM 180
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
+ VDLWS G + E L KP T E +I ++ + +
Sbjct: 181 -HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD-------------- 225
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
+ LI LL +P++R L + T
Sbjct: 226 ---------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 1e-64
Identities = 88/345 (25%), Positives = 162/345 (46%), Gaps = 23/345 (6%)
Query: 109 ISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREI 168
+ T ++ L IG G V A D + + VA+KK+ + RE+
Sbjct: 8 VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCY 224
++++ ++H N++ L + T + + +YLV + M+ L ++ ++
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYL 124
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL 284
++Q+L G++H H+ ++HRD+K SN+++ ++ L I DFGLA + MT VVT
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTR 182
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344
+YR PE++LG Y VD+WS GCI+ E++ K + PGR ++Q +K+ + G+P E+
Sbjct: 183 YYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 345 WKKSKLPHATIFKPQQSYKR-------------CIAETFKDFPPSSLPLIETLLAIDPAE 391
KK + + + Y +E K + L+ +L IDPA+
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 392 RQTATAALRSEFFTTKPYACDPSSLPKYPPTKEMDAKLRDEEARR 436
R + AL+ + + + P K++D + E +
Sbjct: 302 RISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 346
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 4e-64
Identities = 73/305 (23%), Positives = 126/305 (41%), Gaps = 35/305 (11%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+ + +KIGQG VY A D TGQ VA++++ + EIL++R +PN+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNI 79
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
V L++V +Y+ + Q+ + L LE H+
Sbjct: 80 VNYLDSYLV--GDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYG 299
V+HRDIK N+L+ +G + + DFG + P + ++ V T ++ PE++ YG
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTR-KAYG 194
Query: 300 VGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQ 359
VD+WS G + E++ +P + L+ I G+P + +K
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEK------------ 241
Query: 360 QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKY 419
++ F+D + L +D +R +A L+ +F K S P
Sbjct: 242 ------LSAIFRD-------FLNRCLDMDVEKRGSAKELLQHQFL--KIAKPLSSLTPLI 286
Query: 420 PPTKE 424
KE
Sbjct: 287 AAAKE 291
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 208 bits (530), Expect = 6e-64
Identities = 87/301 (28%), Positives = 152/301 (50%), Gaps = 23/301 (7%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DH 176
D ++ + K+G+G YS V++A + + V +K ++ P + + REI IL L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 89
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
PN++ L +V +S + LVF+++ + D L T ++ YM+++L L++C
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC 145
Query: 236 HNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
H+ ++HRD+K N++ID+E L + D+GLA F+ P Q RV + +++ PELL+
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVD 203
Query: 295 ATDYGVGVDLWSAGCILAELLAEK-PIMPGRTEVEQLHKIFKLCGSPS-EEYWKKSKLPH 352
Y +D+WS GC+LA ++ K P G +QL +I K+ G+ +Y K +
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 353 ATIFK-------PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405
F ++ + +E P +L ++ LL D R TA A+ +F
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
Query: 406 T 406
T
Sbjct: 324 T 324
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-63
Identities = 76/297 (25%), Positives = 125/297 (42%), Gaps = 34/297 (11%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRR 173
+R + F+ +G+G++S V AR+ T + A+K + ++ + V ++ RE ++ R
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
LDHP VKL LY Y ++ F + + Y +++S LE
Sbjct: 65 LDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELL 292
+ H + ++HRD+K N+L++ + + I DFG A P KQ + V T Y PELL
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 293 LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352
+ DLW+ GCI+ +L+A P E KI KL E+++ K
Sbjct: 183 TEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----- 236
Query: 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409
+D L+E LL +D +R P+
Sbjct: 237 -----------------ARD-------LVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 3e-63
Identities = 57/348 (16%), Positives = 126/348 (36%), Gaps = 41/348 (11%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ + + +G+G + V++ +T + + K V+ + V+ +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N++ L S L ++F+++ D+ + + + ++ Y+HQ+ L+ H
Sbjct: 62 NILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 237 NQHVLHRDIKGSNLLIDN--EGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
+ ++ H DI+ N++ + I +FG A Y PE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAPEYYAPEVHQH 177
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
D+WS G ++ LL+ T + + I + EE +
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPS 414
K+ ++ ++ LL + R TA+ AL+ + K
Sbjct: 228 ----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271
Query: 415 SLPKYPPTKEMDAKLRDE-----EARRLRAAGKANAEAKKARSRDRAA 457
+ + ++ + A R+ G ++ + ++ + A
Sbjct: 272 VIRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKVKVA 319
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 205 bits (523), Expect = 4e-63
Identities = 81/332 (24%), Positives = 130/332 (39%), Gaps = 42/332 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D ++ D +G G +S V A D T ++VA+K + LE + EI +L ++ HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME-NEIAVLHKIKHP 67
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N+V L+ + S LYL+ + + +L +T+ + Q+L +++ H
Sbjct: 68 NIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH 124
Query: 237 NQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ ++HRD+K NLL D + + I+DFGL+ DP +++ T Y PE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPGYVAPEVLA 182
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
Y VD WS G I LL P + + +I K YW
Sbjct: 183 Q-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW-------- 233
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDP 413
D S+ I L+ DP +R T AL+ +
Sbjct: 234 -----------------DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKN 276
Query: 414 SSLPKYPPTKEMDAKLRDEEARRLRAAGKANA 445
K+ AK + + A A A
Sbjct: 277 IHQSVSEQIKKNFAK------SKWKQAFNATA 302
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 199 bits (507), Expect = 4e-61
Identities = 70/301 (23%), Positives = 121/301 (40%), Gaps = 44/301 (14%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES-------VRFMAREILI 170
+ +E + +G+G S V + T + A+K + S +E+ I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 171 LRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQL 228
LR++ HPN+++L+ + +LVF M+ +L ++ + + M L
Sbjct: 63 LRKVSGHPNIIQLKDTYETN--TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRAL 119
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRP 288
L + H +++HRD+K N+L+D++ + + DFG + DP K + T Y
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLA 177
Query: 289 PELLLGATD-----YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE 343
PE++ + + YG VD+WS G I+ LLA P R ++ L I
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
W D+ + L+ L + P +R TA AL F
Sbjct: 238 EW-------------------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272
Query: 404 F 404
F
Sbjct: 273 F 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-59
Identities = 63/299 (21%), Positives = 124/299 (41%), Gaps = 38/299 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPE----SVRFMAREILILRR 173
D ++ +++G G ++ V K R+ TG A K ++ + S + RE+ IL+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
+ HPNV+ L + ++ + L+ + + + T+ + ++ Q+L+G+
Sbjct: 70 IQHPNVITLHEVYENKT--DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGI----LTIADFGLASFFDPNHKQPMTSRVVTLWYRPP 289
+ H+ + H D+K N+++ + + + I DFGLA D ++ + T + P
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAP 185
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349
E++ G+ D+WS G I LL+ G T+ E L + + +EY+
Sbjct: 186 EIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF---- 240
Query: 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408
+ + I LL DP +R T +L+ + K
Sbjct: 241 ---------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 2e-57
Identities = 53/288 (18%), Positives = 109/288 (37%), Gaps = 33/288 (11%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+IG G++ VYK + VA+K + P+ ++ E+ +LR+ H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N++ G T+ L +V ++ E L KF ++ Q G+++ H
Sbjct: 65 NILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLLGA 295
+ ++HRD+K +N+ + + + I DFGLA+ ++ ++ + PE++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 296 TD--YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
Y D+++ G +L EL+ + +Q+ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------------------ 223
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401
+ +++ + P + L+ L ER L S
Sbjct: 224 -----RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 188 bits (479), Expect = 5e-57
Identities = 62/297 (20%), Positives = 109/297 (36%), Gaps = 32/297 (10%)
Query: 113 TPRR-ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILI 170
TP +D +E + +G G S V+ ARD + VA+K +R D +P RE
Sbjct: 1 TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN 60
Query: 171 LRRLDHPNVVKLEGLVTSR--MSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQL 228
L+HP +V + + Y+V +Y++ T + +
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 120
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF--DPNHKQPMTSRVVTLWY 286
L H ++HRD+K +N++I + + DFG+A N + + T Y
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346
PE G + D++S GC+L E+L +P G + V ++ + P
Sbjct: 181 LSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH- 238
Query: 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
+ ++ LA +P R A +R++
Sbjct: 239 ------------------------EGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 6e-57
Identities = 61/291 (20%), Positives = 109/291 (37%), Gaps = 37/291 (12%)
Query: 120 FEKLD-KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN 178
F K D +IG+G++ VYK DT T VA +++ L + E +L+ L HPN
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 179 VVKLEG--LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
+V+ T + + LV + M ++ + Q+L GL+ H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 237 --NQHVLHRDIKGSNLLIDNE-GILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
++HRD+K N+ I G + I D GLA+ + + + T + PE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYE 186
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
Y VD+++ G + E+ + Q+++ P+
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS----------- 233
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
+ + K+ +IE + + ER + L FF
Sbjct: 234 --------FDKVAIPEVKE-------IIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 182 bits (462), Expect = 2e-53
Identities = 75/313 (23%), Positives = 124/313 (39%), Gaps = 42/313 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA----REILILRR 173
+ F IG+G + VY R TG++ A+K + ++ + +A + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
D P +V + + L + M S F++A ++ Y +++ GLE
Sbjct: 64 GDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H HN+ V++RD+K +N+L+D G + I+D GLA F + V T Y PE+L
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQ 178
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
Y D +S GC+L +LL ++ H+I ++ + + E
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELP-------- 229
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER-----QTATAALRSEFFTTKP 408
F P L+E LL D R + A S FF +
Sbjct: 230 -----------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF--RS 270
Query: 409 YACDPSSLPKYPP 421
L KYPP
Sbjct: 271 LDWQMVFLQKYPP 283
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 7e-53
Identities = 60/293 (20%), Positives = 119/293 (40%), Gaps = 41/293 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+T + ++++G G + V+ VA+K ++ ++ P++ E ++++L H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFL---AEANLMKQLQHQ 68
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAG--LAASPTIKFTQAQVKCYMHQLLSGLEHC 235
+V+L +VT +Y++ +YME+ L IK T ++ Q+ G+
Sbjct: 69 RLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
++ +HRD++ +N+L+ + IADFGLA + N + + PE +
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 296 TDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
T + + D+WS G +L E++ + PG T E + + + + P
Sbjct: 186 T-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---------GYRMVRP--- 232
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR--SEFFT 405
+ P L+ P +R T +FFT
Sbjct: 233 ----------------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-52
Identities = 65/290 (22%), Positives = 119/290 (41%), Gaps = 36/290 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL--EPESVRFMAREILILRRLD 175
+ F +G+G++ V+ A T Q A+K ++ D + + + M + ++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
HP + + ++ + L+ V +Y+ KF ++ Y +++ GL+
Sbjct: 62 HPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H++ +++RD+K N+L+D +G + IADFG+ + + T Y PE+LLG
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPEILLGQ 178
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355
Y VD WS G +L E+L + G+ E E H I
Sbjct: 179 K-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----------------------I 215
Query: 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS-EFF 404
Y R + + KD L+ L +P +R +R F
Sbjct: 216 RMDNPFYPRWLEKEAKD-------LLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-52
Identities = 64/349 (18%), Positives = 124/349 (35%), Gaps = 41/349 (11%)
Query: 118 DTFEKLDK-IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-D 175
D ++ + +G G V + + T + ALK ++ RE+ + R
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQ 63
Query: 176 HPNVVKLEGLVTSRMSC--SLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLSG 231
P++V++ + + + L +V + ++ +L + FT+ + M +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 232 LEHCHNQHVLHRDIKGSNLLID---NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRP 288
+++ H+ ++ HRD+K NLL IL + DFG A ++ +T+ T +Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVA 181
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348
PE+L Y D+WS G I+ LL P + + E+
Sbjct: 182 PEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT-TK 407
+ + LI LL +P +R T T + + +
Sbjct: 241 ---------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279
Query: 408 PYACDPSSLPKYPPTKEMDAKLRDEEARRLRAAGKANAEAKKARSRDRA 456
P + + + EE A + + E K + + A
Sbjct: 280 KVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDA 328
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 176 bits (448), Expect = 5e-52
Identities = 57/293 (19%), Positives = 111/293 (37%), Gaps = 42/293 (14%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDH 176
F+ L +G G++ V+ R G+ A+K ++ + + + V E L+L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
P ++++ G ++++ Y+E + +F K Y ++ LE+ H
Sbjct: 64 PFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
++ +++RD+K N+L+D G + I DFG A + + T Y PE++
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVSTKP 177
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
Y +D WS G ++ E+LA ++ KI + + P
Sbjct: 178 -YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------AELRFP----- 221
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER-----QTATAALRSEFF 404
F L+ L+ D ++R +F
Sbjct: 222 --------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 9e-52
Identities = 62/292 (21%), Positives = 102/292 (34%), Gaps = 46/292 (15%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILILRRLD 175
++ +G G + +VY VA+K V D + E + + E+++L+++
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 176 --HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
V++L S L L DL + + + Q+L +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVR 124
Query: 234 HCHNQHVLHRDIKGSNLLID-NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL 292
HCHN VLHRDIK N+LID N G L + DFG + T T Y PPE +
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 181
Query: 293 LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352
+G +WS G +L +++ E+ + F+
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------------- 224
Query: 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404
+ LI LA+ P++R T +
Sbjct: 225 ------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 4e-51
Identities = 69/293 (23%), Positives = 119/293 (40%), Gaps = 39/293 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDH 176
+ F+ L +G+GT+ V R+ TG+ A+K +R + + + V E +L+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
P + L+ + L V +Y S FT+ + + Y +++S LE+ H
Sbjct: 65 PFLTALK--YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
++ V++RDIK NL++D +G + I DFGL + M + T Y PE+L
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLED-N 180
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
DYG VD W G ++ E++ + + I ++ + P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----------EEIRFP----- 225
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER-----QTATAALRSEFF 404
+ P + L+ LL DP +R A + FF
Sbjct: 226 --------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 4e-50
Identities = 65/313 (20%), Positives = 122/313 (38%), Gaps = 49/313 (15%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
++ K+GQG + V+ T + VA+K ++ + PE+ +E ++++L H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL---QEAQVMKKLRHE 72
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLA--ASPTIKFTQAQVKCYMHQLLSGLEHC 235
+V+L +V+ +Y+V +YM Q+ Q+ SG+ +
Sbjct: 73 KLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
+ +HRD++ +N+L+ + +ADFGLA + N + + PE L
Sbjct: 130 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 296 TDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
+ + D+WS G +L EL + + PG E L ++ + P
Sbjct: 190 R-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP----------- 237
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR--SEFFTTKPYACD 412
+ P S L+ +P ER T ++FT
Sbjct: 238 -----------------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT------- 273
Query: 413 PSSLPKYPPTKEM 425
S+ P+Y P + +
Sbjct: 274 -STEPQYQPGENL 285
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 1e-49
Identities = 52/309 (16%), Positives = 104/309 (33%), Gaps = 38/309 (12%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL 174
R + + KIG G++ ++Y D G+ VA+K P+ + E I + +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMM 59
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
+ + +V + + L L + KF+ V Q++S +E+
Sbjct: 60 QGGVGIPTIRWCGAEGDY-NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 235 CHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPN------HKQPMTSRVVTLW 285
H+++ +HRD+K N L+ ++ I DFGLA + + + T
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
Y LG + DL S G +L G + K ++
Sbjct: 179 YASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-------- 229
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR--SEF 403
++ I K +P + ++ ++ + +
Sbjct: 230 -------------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
Query: 404 FTTKPYACD 412
F + ++ D
Sbjct: 277 FHRQGFSYD 285
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-49
Identities = 59/289 (20%), Positives = 101/289 (34%), Gaps = 37/289 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKAR---DTLTGQIVALKKVRFDNL-EPESVRFMAREILILRR 173
L+K+G G++ V + + VA+K ++ D L +PE++ RE+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
LDH N+++L G+V + + +V + L F + Y Q+ G+
Sbjct: 68 LDHRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPEL 291
+ ++ +HRD+ NLL+ ++ I DFGL N M +
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 292 LLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
L + D W G L E+ + G + LHKI K
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP------- 237
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
+D P ++ A P +R T A
Sbjct: 238 --------------------EDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (432), Expect = 3e-49
Identities = 60/319 (18%), Positives = 117/319 (36%), Gaps = 47/319 (14%)
Query: 99 SWLSAVAGEAISGWTPRRADT-----FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRF 153
+L+ + + W +T F+++ +G G++ V + +G A+K +
Sbjct: 17 EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 154 DNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASP 212
+ + + + E IL+ ++ P +VKLE + + + + + L
Sbjct: 77 QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG 136
Query: 213 TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272
+F++ + Y Q++ E+ H+ +++RD+K NLLID +G + + DFG A
Sbjct: 137 --RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR---- 190
Query: 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHK 332
K + T PE++L Y VD W+ G ++ E+ A P ++ K
Sbjct: 191 VKGRTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
I F L+ LL +D +R
Sbjct: 250 IVSGKVRFPSH-----------------------------FSSDLKDLLRNLLQVDLTKR 280
Query: 393 -----QTATAALRSEFFTT 406
++F T
Sbjct: 281 FGNLKNGVNDIKNHKWFAT 299
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 4e-49
Identities = 67/299 (22%), Positives = 121/299 (40%), Gaps = 39/299 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNL--EPESVRFMAREILILR 172
+ FE L +G G Y V+ R TG++ A+K ++ + + ++ E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 173 RLDH-PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
+ P +V L + L+L+ Y+ S +FT+ +V+ Y+ +++
Sbjct: 84 HIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 141
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
LEH H +++RDIK N+L+D+ G + + DFGL+ F + + T+ Y P++
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 292 LLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
+ G + + VD WS G ++ ELL E +I + Y
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----- 256
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER-----QTATAALRSEFF 404
++ + LI+ LL DP +R + A FF
Sbjct: 257 --------------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 6e-49
Identities = 56/285 (19%), Positives = 105/285 (36%), Gaps = 37/285 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ +IG G + V+ L VA+K +R + E E ++ +L HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHP 60
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
+V+L G+ + LVF++MEH L+ + F + + G+ +
Sbjct: 61 KLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
V+HRD+ N L+ ++ ++DFG+ F + T + + PE+ +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-S 177
Query: 297 DYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355
Y D+WS G ++ E+ +E K R+ E + I +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI----------------STGFRL 221
Query: 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+KP + ++ P +R + LR
Sbjct: 222 YKP------------RLASTHVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-48
Identities = 56/298 (18%), Positives = 114/298 (38%), Gaps = 43/298 (14%)
Query: 118 DTFEKLD-KIGQGTYSNVYKA--RDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL 174
D D ++G G + +V + R VA+K ++ + ++ M RE I+ +L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQL 66
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
D+P +V+L G+ + +L LV + L + + V +HQ+ G++
Sbjct: 67 DNPYIVRLIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 123
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN--HKQPMTSRVVTLWYRPPEL 291
+ ++ +HRD+ N+L+ N I+DFGL+ + + ++ L + PE
Sbjct: 124 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 292 LLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
+ + D+WS G + E L+ + E + I + K+ +
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---------GKRMEC 233
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT---AALRSEFFT 405
P + PP L+ +R +R+ +++
Sbjct: 234 P-------------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-48
Identities = 51/301 (16%), Positives = 106/301 (35%), Gaps = 41/301 (13%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKA--RDTLTGQIVALKKVRFDNLEPESVRFMAREIL 169
+ R+ T E ++G G + V K + + VA+K ++ + +P + E
Sbjct: 2 YLDRKLLTLED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 60
Query: 170 ILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLL 229
++++LD+P +V++ G+ + S LV + E + +HQ+
Sbjct: 61 VMQQLDNPYIVRMIGICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYR 287
G+++ + +HRD+ N+L+ + I+DFGL+ + + +
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346
PE + + D+WS G ++ E + + G E + K +
Sbjct: 178 APECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---------GE 227
Query: 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT---AALRSEF 403
+ P P L+ D R LR+ +
Sbjct: 228 RMGCP-------------------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
Query: 404 F 404
+
Sbjct: 269 Y 269
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 9e-48
Identities = 53/293 (18%), Positives = 107/293 (36%), Gaps = 44/293 (15%)
Query: 111 GWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILI 170
GW + + L IG+G + +V G VA+K ++ + + E +
Sbjct: 1 GWALNMKE-LKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIK----NDATAQAFLAEASV 53
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQL 228
+ +L H N+V+L G++ LY+V +YM L L + + + +
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRP 288
+E+ + +HRD+ N+L+ + + ++DFGL + + + +
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTA 168
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
PE L + D+WS G +L E+ + + P + + ++ K K
Sbjct: 169 PEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---------GYK 218
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
P PP+ +++ +D A R +
Sbjct: 219 MDAP-------------------DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-47
Identities = 54/288 (18%), Positives = 113/288 (39%), Gaps = 38/288 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLT---GQIVALKKVRFDNLEPESVRFMAREILILRRL 174
+ E IG+G + +V++ VA+K + + +F+ +E L +R+
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEALTMRQF 65
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
DHP++VKL G++T ++++ + +L A + Y +QL + L
Sbjct: 66 DHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ ++ +HRDI N+L+ + + + DFGL+ + + + + + + + PE +
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 294 GATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352
+ D+W G + E+L G + + +I ++ +P
Sbjct: 183 F-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---------GERLPMP- 231
Query: 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ PP+ L+ A DP+ R T
Sbjct: 232 ------------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 1e-47
Identities = 49/283 (17%), Positives = 107/283 (37%), Gaps = 37/283 (13%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
L ++G G + V + VA+K ++ ++ + E ++ L H +
Sbjct: 6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHEKL 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
V+L G+ T + ++++ +YM + L +F Q+ + +E+ ++
Sbjct: 62 VQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDY 298
LHRD+ N L++++G++ ++DFGL+ + + + + PPE+L+ + +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178
Query: 299 GVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357
D+W+ G ++ E+ + K T E I + + PH
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ---------GLRLYRPH----- 224
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
++ + ER T L
Sbjct: 225 --------------LASEKVYTIMYSCWHEKADERPTFKILLS 253
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 164 bits (415), Expect = 2e-47
Identities = 50/299 (16%), Positives = 93/299 (31%), Gaps = 41/299 (13%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
++ +IG+G++ +++ + L Q VA+K + P+ + E + L
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAG 59
Query: 177 -PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
+ + LV + L L KF+ V Q+L+ ++
Sbjct: 60 CTGIPNVYYFGQEG--LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 236 HNQHVLHRDIKGSNLLIDN-----EGILTIADFGLASFFDPN------HKQPMTSRVVTL 284
H + +++RDIK N LI ++ + DFG+ F+ + + T
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344
Y LG + DL + G + L G K ++
Sbjct: 178 RYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG------- 229
Query: 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEF 403
KK P + E FP + + L+ F
Sbjct: 230 EKKQSTP--------------LRELCAGFPEEFYKYMHYARNLAFDATPDY-DYLQGLF 273
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (411), Expect = 5e-47
Identities = 51/283 (18%), Positives = 105/283 (37%), Gaps = 31/283 (10%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
K+G G Y VY+ VA+K ++ D +E E +E +++ + HP
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL---KEAAVMKEIKHP 73
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
N+V+L G+ T + F + L L + + + Q+ S +E+
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
++ +HRD+ N L+ ++ +ADFGL+ + + + PE L
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357
+ + D+W+ G +L E+ ++ Q++++ +
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------------- 230
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
K E + P L+ +P++R + +
Sbjct: 231 -----KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (407), Expect = 2e-46
Identities = 57/293 (19%), Positives = 118/293 (40%), Gaps = 41/293 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRL 174
+ IG G + V L G+ VA+K ++ E + F+ E I+ +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASIMGQF 84
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
DHPNV+ LEG+VT S + ++ ++ME+ L +FT Q+ + + +G++
Sbjct: 85 DHPNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV----TLWYRPP 289
+ + + +HRD+ N+L+++ + ++DFGL+ F + + P + + + + P
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348
E + + D+WS G ++ E+++ + T + ++ I + P
Sbjct: 203 EAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM----- 256
Query: 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401
D P + L+ D R + +
Sbjct: 257 -----------------------DCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 162 bits (411), Expect = 3e-46
Identities = 74/342 (21%), Positives = 134/342 (39%), Gaps = 51/342 (14%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+ + K+G G +S V+ A+D + VA+K VR D + E+ EI +L+R++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADN 71
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHD---------------LAGLAASPTIKFTQAQVKCY 224
K + + + + L F + + LA + VK
Sbjct: 72 TKEDSMGANHI-LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 225 MHQLLSGLEHCHNQH-VLHRDIKGSNLLIDNEGI------LTIADFGLASFFDPNHKQPM 277
QLL GL++ H + ++H DIK N+L++ + IAD G A ++D ++ +
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT------EVEQLH 331
+R YR PE+LLGA +G G D+WS C++ EL+ + + + +
Sbjct: 191 QTR----EYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 332 KIFKLCGSPSEEYWKKSKLPHATI-------------FKPQQSYKRCIAETFKDFPPSSL 378
+I +L G + K F P + + KD
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 379 PLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPKYP 420
+ +L +DP +R A + + + +P
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVNHPWL-KDTLGMEEIRVPDRE 346
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-44
Identities = 66/301 (21%), Positives = 103/301 (34%), Gaps = 29/301 (9%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
A T + IG+G + V++ + G+ VA+K + E F EI L H
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIF---SSREERSWFREAEIYQTVMLRH 56
Query: 177 PNVVKLEGLVTSRMSC--SLYLVFKYMEH-DLA------GLAASPTIKFTQAQVKCYMHQ 227
N++ L+LV Y EH L + IK + H
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ---PMTSRVVTL 284
+ + + HRD+K N+L+ G IAD GLA D RV T
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 285 WYRPPELLLGA-----TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS 339
Y PE+L + + D+++ G + E+ I G E QL +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI-GGIHEDYQLPYYDLVPSD 235
Query: 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
PS E +K +P + E + ++ + A R TA
Sbjct: 236 PSVEEMRKVVCEQ--KLRPNIPNRWQSCEALRVM----AKIMRECWYANGAARLTALRIK 289
Query: 400 R 400
+
Sbjct: 290 K 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 3e-44
Identities = 60/318 (18%), Positives = 120/318 (37%), Gaps = 65/318 (20%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTL-----TGQIVALKKVRFDNLEPESVRFMAREI 168
PR + E + IG+G + V++AR +VA+K ++ + F RE
Sbjct: 11 PR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REA 67
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGL------------------- 208
++ D+PN+VKL G + + L+F+YM + DL
Sbjct: 68 ALMAEFDNPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 209 ----AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264
++ + A+ C Q+ +G+ + + +HRD+ N L+ ++ IADFG
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 185
Query: 265 LASFFDP-NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMP 322
L+ ++ + + + + + PPE + Y D+W+ G +L E+ +
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYY 244
Query: 323 GRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIE 382
G E ++ + + + ++ P L+
Sbjct: 245 GMAHEEVIYYV------------RDGNIL----------------ACPENCPLELYNLMR 276
Query: 383 TLLAIDPAERQTATAALR 400
+ PA+R + + R
Sbjct: 277 LCWSKLPADRPSFCSIHR 294
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 5e-44
Identities = 64/314 (20%), Positives = 111/314 (35%), Gaps = 62/314 (19%)
Query: 118 DTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILR 172
+ E +G G + V A T VA+K ++ E M E+ ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SELKMMT 95
Query: 173 RL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKF-------------- 216
+L H N+V L G T S +YL+F+Y + DL S KF
Sbjct: 96 QLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 217 --------TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268
T + C+ +Q+ G+E + +HRD+ N+L+ + ++ I DFGLA
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 269 FDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTE 326
+ + + + + PE L Y + D+WS G +L E+ + PG
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 327 VEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLA 386
+K+ + FK Q ++++ A
Sbjct: 273 DANFYKLIQ------------------NGFKMDQP---------FYATEEIYIIMQSCWA 305
Query: 387 IDPAERQTATAALR 400
D +R +
Sbjct: 306 FDSRKRPSFPNLTS 319
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-43
Identities = 48/289 (16%), Positives = 96/289 (33%), Gaps = 34/289 (11%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILR 172
+ F+K+ +G G + VYK G+ V + K + P++ + + E ++
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
+D+P+V +L G+ + + L + + Q+ G+
Sbjct: 67 SVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPEL 291
+ ++ ++HRD+ N+L+ + I DFGLA K+ + + E
Sbjct: 125 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
+L Y D+WS G + EL+ ++ I + K +LP
Sbjct: 185 ILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----------KGERLP 233
Query: 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
++ ID R +
Sbjct: 234 Q-----------------PPICTIDVYMIMVKCWMIDADSRPKFRELII 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-41
Identities = 54/309 (17%), Positives = 103/309 (33%), Gaps = 57/309 (18%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTL-----TGQIVALKKVRFDNLEPESVRFMAREILILR 172
+ +G G + V +A VA+K ++ E M E+ +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLS 81
Query: 173 RL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH------------------DLAGLAASPT 213
L +H N+V L G T ++ +Y + +
Sbjct: 82 YLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 214 IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273
+ + + +Q+ G+ +++ +HRD+ N+L+ + I I DFGLA +
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 274 KQPMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLH 331
+ + + PE + Y D+WS G L EL + PG + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 332 KIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE 391
K+ K + ++ E P +++T DP +
Sbjct: 259 KMIK------------------------EGFRMLSPE---HAPAEMYDIMKTCWDADPLK 291
Query: 392 RQTATAALR 400
R T ++
Sbjct: 292 RPTFKQIVQ 300
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 5e-41
Identities = 55/285 (19%), Positives = 102/285 (35%), Gaps = 39/285 (13%)
Query: 124 DKIGQGTYSNVYKARD---TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
+ IG+G + VY A+K + E +F+ E +I++ HPNV+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNVL 91
Query: 181 KLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
L G + R S +V YM+H DL + T T + + Q+ G++ ++
Sbjct: 92 SLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFDPN---HKQPMTSRVVTLWYRPPELLLGAT 296
+HRD+ N ++D + + +ADFGLA T + + + E L
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-Q 209
Query: 297 DYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355
+ D+WS G +L EL+ P P + + + ++ P
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---------GRRLLQP---- 256
Query: 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ P ++ R + + +
Sbjct: 257 ---------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-39
Identities = 51/290 (17%), Positives = 108/290 (37%), Gaps = 38/290 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQ----IVALKKVRFDNLEPESVRFMAREILILRR 173
+ IG G + VYK + VA+K ++ E + V F+ E I+ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQ 65
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGL 232
H N+++LEG+++ + ++ +YME+ +F+ Q+ + + +G+
Sbjct: 66 FSHHNIIRLEGVISKYKP--MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF--DPNHKQPMTSRVVTLWYRPPE 290
++ N + +HRD+ N+L+++ + ++DFGL+ DP + + + + PE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
+ D+WS G ++ E++ ++ K
Sbjct: 184 AISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN--------------- 227
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
T D P + L+ + A R +
Sbjct: 228 ------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-39
Identities = 56/305 (18%), Positives = 102/305 (33%), Gaps = 50/305 (16%)
Query: 118 DTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILR 172
D + +G+G + V +A T T + VA+K ++ E M+ +++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGL---------------AASPTIKFT 217
H NVV L G T + +V +L+ T
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 218 QAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277
+ CY Q+ G+E ++ +HRD+ N+L+ + ++ I DFGLA +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 278 TSRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFK 335
L + PE + Y + D+WS G +L E+ + PG E+ + K
Sbjct: 193 KGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 336 LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA 395
+ P + +P++R T
Sbjct: 252 ---------------------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 284
Query: 396 TAALR 400
+ +
Sbjct: 285 SELVE 289
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-39
Identities = 62/324 (19%), Positives = 115/324 (35%), Gaps = 56/324 (17%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQI--VALKKVRFDNLEPESVRFMAREILILRRL- 174
+ + D IG+G + V KAR G A+K+++ + + F E+ +L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLG 68
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEH----------------DLAGLAASPTIKFTQ 218
HPN++ L G LYL +Y H +A S +
Sbjct: 69 HHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 219 AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278
Q+ + + G+++ + +HRD+ N+L+ + IADFGL+ + K T
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLC 337
+ + + E L + Y D+WS G +L E+++ G T E K+ +
Sbjct: 185 MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 241
Query: 338 GSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATA 397
+ + P + L+ P ER +
Sbjct: 242 -------GYRLEKP-------------------LNCDDEVYDLMRQCWREKPYERPSFAQ 275
Query: 398 ALR--SEFFTTKPYACDPSSLPKY 419
L + + + + K+
Sbjct: 276 ILVSLNRMLEERKTYVNTTLYEKF 299
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-37
Identities = 49/321 (15%), Positives = 110/321 (34%), Gaps = 50/321 (15%)
Query: 98 PSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTL-----TGQIVALKKVR 152
P + SA W R + ++GQG++ VY+ VA+K V
Sbjct: 1 PEYFSAADVYVPDEWEVAR-EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN 59
Query: 153 FDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME---------- 202
E + F+ E +++ + +VV+L G+V+ ++ + M
Sbjct: 60 EAASMRERIEFL-NEASVMKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRS 116
Query: 203 HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIAD 262
A + +++ ++ G+ + + +HRD+ N ++ + + I D
Sbjct: 117 LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176
Query: 263 FGLASFF-DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPI 320
FG+ + ++ + ++ + + PE L + D+WS G +L E+ +
Sbjct: 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP 235
Query: 321 MPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPL 380
G + + L + + + + + P L
Sbjct: 236 YQGLSNEQVLRFVM----------------------------EGGLLDKPDNCPDMLFEL 267
Query: 381 IETLLAIDPAERQTATAALRS 401
+ +P R + + S
Sbjct: 268 MRMCWQYNPKMRPSFLEIISS 288
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-37
Identities = 53/307 (17%), Positives = 103/307 (33%), Gaps = 54/307 (17%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLT-------GQIVALKKVRFDNLEPESVRFMAREILI 170
D +G+G + V A VA+K ++ D E + ++ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH----------------DLAGLAASPTI 214
H N++ L G T LY++ +Y + +P
Sbjct: 73 KMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 215 KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274
+ + + +Q+ G+E+ ++ +HRD+ N+L+ + ++ IADFGLA
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 275 QPMT-SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
T + + + + PE L Y D+WS G +L E+ VE+L K+
Sbjct: 191 YKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 334 FKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ 393
K + + ++ P++R
Sbjct: 250 LKEGHRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRP 282
Query: 394 TATAALR 400
T +
Sbjct: 283 TFKQLVE 289
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 112 bits (281), Expect = 1e-29
Identities = 26/203 (12%), Positives = 66/203 (32%), Gaps = 30/203 (14%)
Query: 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFM--------AREILILRRLD 175
+G+G S V+ +K + + + V+ + + R +
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 176 HPNVVKLEG--LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
+ KL+G + ++ + ++ + + +L +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMILEEVA 117
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR---VVTLWYRPPE 290
+++ ++H D+ N+L+ EGI I DF + + + R + ++
Sbjct: 118 KFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITYFS--- 173
Query: 291 LLLGATDYGVGVDLWSAGCILAE 313
Y D+ SA + +
Sbjct: 174 -----RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 495 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.47 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.16 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.06 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.31 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.27 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.89 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-62 Score=485.40 Aligned_cols=292 Identities=41% Similarity=0.723 Sum_probs=245.4
Q ss_pred eeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh---HHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEE
Q 011041 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP---ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (495)
Q Consensus 122 ~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~ 198 (495)
.+++||+|+||+||+|+++.+|+.||||+++...... .....+.+|+.+|+.++|||||++++++.+ ...+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCceeehh
Confidence 5789999999999999999999999999997654321 123468899999999999999999999987 56799999
Q ss_pred eeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCCc
Q 011041 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278 (495)
Q Consensus 199 e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 278 (495)
||+.++++..+......+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~~ 158 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYT 158 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCCC
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc-cccc
Confidence 999999888888878889999999999999999999999999999999999999999999999999998765433 3345
Q ss_pred cccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCC-CCCccCC
Q 011041 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL-PHATIFK 357 (495)
Q Consensus 279 ~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~~~~ 357 (495)
..+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.++.+++.+|.+.++.+....|..... .....+.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 568999999999998767789999999999999999999999999999999999999999999887765322 1111111
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCCCCCCCCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSLPK 418 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~~~~~~~p~ 418 (495)
... ...+...+..+++++++||.+||++||++||||.|+|+||||++.|.++++..+|.
T Consensus 239 ~~~--~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~ 297 (299)
T d1ua2a_ 239 SFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297 (299)
T ss_dssp CCC--CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCC
T ss_pred cCC--CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCC
Confidence 111 11233445678889999999999999999999999999999999998887776663
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-61 Score=472.19 Aligned_cols=261 Identities=28% Similarity=0.410 Sum_probs=218.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .+..+.+.+|+.+|+.++|||||++++++.+ ...+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CceeEE
Confidence 5789999999999999999999999999999999986543 2334568899999999999999999999988 578999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC-CC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-KQ 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~ 275 (495)
||||++++.+..++.....+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|....... ..
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999987666666667789999999999999999999999999999999999999999999999999998764332 23
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
..+..+||+.|+|||++.+...++.++||||||||||||++|++||.+.++......+.......
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~--------------- 225 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------- 225 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---------------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------
Confidence 34567899999999999876556788999999999999999999998766544433332211111
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
......+|+++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 226 -----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 -----------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp -----------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred -----------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 1112357888999999999999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-62 Score=470.89 Aligned_cols=255 Identities=31% Similarity=0.459 Sum_probs=223.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||++++++.+ ...+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--CCEEE
Confidence 5789999999999999999999999999999999975432 22334678899999999999999999999987 56899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
|||||++++.+...+.....+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++......
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence 99999998776666555567999999999999999999999999999999999999999999999999999866432
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
.....+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.+|.+....
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------- 222 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---------------- 222 (263)
T ss_dssp CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC----------------
T ss_pred cccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence 2356789999999999987 56899999999999999999999999999988888887643211
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
....+|+++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 223 -------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 223 -------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 11346788999999999999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-60 Score=468.54 Aligned_cols=290 Identities=40% Similarity=0.735 Sum_probs=241.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||+||+|+++.+|+.||||++............+.+|+.+|++++|||||++++++.+ ...+|+
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~i 78 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYL 78 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc--ccceeE
Confidence 378999999999999999999999999999999997665444445678899999999999999999999988 578999
Q ss_pred EEeeccCChhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||||+.++++.... .....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++....... .
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~ 157 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 157 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence 99999998776654 445679999999999999999999999999999999999999999999999999998765432 3
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC-CCCCc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPHAT 354 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~-~~~~~ 354 (495)
.....+||+.|+|||++.....++.++|||||||++|+|++|++||.+.+..+++.++.+..+.+.+..|.... .+...
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 34566899999999998877777999999999999999999999999999999999999999999887776422 11111
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~ 410 (495)
...+ .............+++++.+||.+||+.||.+|||+.|+|+||||++.+.|
T Consensus 238 ~~~~-~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 238 PSFP-KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TTSC-CCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccc-cccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 1111 111112334455778899999999999999999999999999999875443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-60 Score=465.19 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=212.9
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+........+.+.+|+.+|++++|||||++++++.+..+..+|
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 35789999999999999999999999999999999998877777778899999999999999999999999776567799
Q ss_pred EEEeeccCChhhhhhC----CCCCCCHHHHHHHHHHHHHHHHHhhhCC-----ceeccCCCCCeeeCCCCcEEEeecccc
Q 011041 196 LVFKYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQH-----VLHRDIKGSNLLIDNEGILTIADFGLA 266 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~----~~~~l~e~~~~~i~~qil~~L~~LH~~g-----ivHrDlKp~NILl~~~~~vkL~DFG~a 266 (495)
|||||++++.+..+.. ....+++..++.++.||+.||.|||+.| ||||||||+||||+.++.+||+|||++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 9999999765554432 3457999999999999999999999876 999999999999999999999999999
Q ss_pred cccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 011041 267 SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (495)
Q Consensus 267 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (495)
..+.... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+...+|.....
T Consensus 162 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~-------- 231 (269)
T d2java1 162 RILNHDT-SFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-------- 231 (269)
T ss_dssp HHC------------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--------
T ss_pred eecccCC-CccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 8875432 23456789999999999876 5789999999999999999999999999998888887755211
Q ss_pred hCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
......+|+++.+||.+||+.||.+|||+.|+|+|||+
T Consensus 232 --------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 232 --------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 11123578889999999999999999999999999996
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-59 Score=473.98 Aligned_cols=268 Identities=24% Similarity=0.380 Sum_probs=231.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|++|+|||||++++++.+ ...+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 100 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 100 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 578999999999999999999999999999999997543 3455778899999999999999999999987 578999
Q ss_pred EEeeccCChh-hhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC--CCcEEEeecccccccCCCC
Q 011041 197 VFKYMEHDLA-GLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN--EGILTIADFGLASFFDPNH 273 (495)
Q Consensus 197 v~e~~~~~l~-~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~--~~~vkL~DFG~a~~~~~~~ 273 (495)
|||||+++.+ ..+......+++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||++..+...
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 9999997655 444455667999999999999999999999999999999999999964 678999999999877543
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|......++...
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 248 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA--------- 248 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGG---------
T ss_pred -cccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc---------
Confidence 33456789999999999987 5689999999999999999999999999999999999876544433222
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACDPSSL 416 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~~~~~~~ 416 (495)
+..+|+++.+||.+||+.||.+|||+.|+|+||||+...++.....+
T Consensus 249 ----------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~ 295 (350)
T d1koaa2 249 ----------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 295 (350)
T ss_dssp ----------------GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSCCCCB
T ss_pred ----------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCchhhC
Confidence 23578889999999999999999999999999999987666544433
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-60 Score=469.74 Aligned_cols=262 Identities=28% Similarity=0.428 Sum_probs=222.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|++++|||||++++++.+ +..+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ 84 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLY 84 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--CCEEE
Confidence 4689999999999999999999999999999999976432 22345678899999999999999999999987 57899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC-C
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-K 274 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~-~ 274 (495)
|||||++++.+..+......+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 999999987665555555689999999999999999999999999999999999999999999999999998775432 2
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
....+.+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+++.+|.+....
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--------------- 228 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD--------------- 228 (288)
T ss_dssp -----CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC---------------
T ss_pred cccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCC---------------
Confidence 23456689999999999987 57899999999999999999999999999999988888653211
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHH------HHhCCCCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATA------ALRSEFFTTKPYA 410 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~e------lL~hp~f~~~~~~ 410 (495)
....+++++.+||.+||+.||.+|||++| +++||||++..|.
T Consensus 229 --------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 229 --------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp --------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred --------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 11347788999999999999999999988 5889999887664
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-60 Score=465.63 Aligned_cols=256 Identities=25% Similarity=0.449 Sum_probs=222.2
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
++|++++.||+|+||+||+|+++.+|+.||||++.+.... ..+.+.+|+.+|+.++|||||++++++.+ ...+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEE--CCEEEEE
Confidence 5799999999999999999999999999999999865432 24678899999999999999999999987 5689999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 277 (495)
|||+.++.+..+... ..+++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||++..+.... ...
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~ 173 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 173 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-ccc
Confidence 999998766655543 369999999999999999999999999999999999999999999999999998775433 334
Q ss_pred ccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCC
Q 011041 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (495)
Q Consensus 278 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (495)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+..... +..
T Consensus 174 ~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~~--------------- 236 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PEL--------------- 236 (293)
T ss_dssp CCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CCC---------------
T ss_pred cccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCC---------------
Confidence 56789999999999876 5789999999999999999999999999998888777765321 110
Q ss_pred CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 358 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.....+|+++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 237 ----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 237 ----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ----------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ----------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 112347888999999999999999999999999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-60 Score=468.31 Aligned_cols=260 Identities=28% Similarity=0.416 Sum_probs=207.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.+.|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+.+|+.++|||||++++++.+ +..+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYES--GGHLYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 367999999999999999999999999999999998765432 23567899999999999999999999987 578999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeC---CCCcEEEeecccccccCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID---NEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~---~~~~vkL~DFG~a~~~~~~~ 273 (495)
|||||+++.+..++.....+++.+++.|+.||+.||+|||++|||||||||+|||+. +++.+||+|||++......
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~- 163 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 163 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence 999999765555555566899999999999999999999999999999999999995 5789999999999876543
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
....+.+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+....|.+....++.
T Consensus 164 -~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 230 (307)
T d1a06a_ 164 -SVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS----------- 230 (307)
T ss_dssp ----------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT-----------
T ss_pred -CeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC-----------
Confidence 23456789999999999876 57899999999999999999999999999998888888764332222
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
....++|+++.+||.+||++||.+|||+.|+|+||||++.
T Consensus 231 --------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 231 --------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp --------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred --------------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1234678899999999999999999999999999999863
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-60 Score=472.57 Aligned_cols=260 Identities=26% Similarity=0.402 Sum_probs=228.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||++++++.+ ...+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc--ccccc
Confidence 5789999999999999999999999999999999986532 22345678899999999999999999999988 57899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+|||||.++.+..+......++|..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...... .
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~ 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC-c
Confidence 999999988777767666789999999999999999999999999999999999999999999999999998764332 3
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+.++......
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~---------------- 223 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR---------------- 223 (337)
T ss_dssp CBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------
T ss_pred ccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCC----------------
Confidence 4566799999999999887 57899999999999999999999999999998888887653211
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPY 409 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~ 409 (495)
....+|+++++||.+||++||.+|+ +++|+++||||+...|
T Consensus 224 -------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 224 -------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred -------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 1235788999999999999999999 4999999999987544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-59 Score=460.00 Aligned_cols=286 Identities=37% Similarity=0.649 Sum_probs=240.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||+||+|+++ +|+.||||++............+.+|+.+|++++|||||++++++.+ ....|+
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i 77 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVL 77 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc--CCceeE
Confidence 368999999999999999999986 78999999998765444445778899999999999999999999987 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
+|||+.++++..+......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++....... ..
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 156 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc-cc
Confidence 99999999999888888899999999999999999999999999999999999999999999999999998765432 22
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccC
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (495)
....+|++.|+|||++.+...++.++|||||||++|||++|++||.+.++.+++.++....+.+....|...........
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 34557899999999998877889999999999999999999999999999999999999999998887764321111111
Q ss_pred CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 357 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.............+..+++++.|||++||++||++|||+.|+|+||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 11111112234455677889999999999999999999999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-59 Score=460.36 Aligned_cols=262 Identities=24% Similarity=0.367 Sum_probs=226.7
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh----HHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP----ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
++|++++.||+|+||+||+|+++.+|+.||||++.+..... ...+.+.+|+.+|++|+|||||++++++.+ ...
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCE
Confidence 67999999999999999999999999999999998754422 235678899999999999999999999988 578
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC----cEEEeeccccccc
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG----ILTIADFGLASFF 269 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~----~vkL~DFG~a~~~ 269 (495)
+|||||||+++.+..++.....+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||++...
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999876665555556899999999999999999999999999999999999998876 5999999999877
Q ss_pred CCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
.... .....+||+.|+|||++.+ ..|+.++|||||||+||||++|.+||.+.+..+.+..|......+....+
T Consensus 168 ~~~~--~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~---- 240 (293)
T d1jksa_ 168 DFGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF---- 240 (293)
T ss_dssp TTSC--BCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHH----
T ss_pred CCCc--cccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhc----
Confidence 5432 3356689999999999876 57899999999999999999999999999999999888765444443332
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
..+|+++.+||.+||+.||.+|||++|+|+||||+...+
T Consensus 241 ---------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 241 ---------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp ---------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred ---------------------CCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 457888999999999999999999999999999987544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-59 Score=466.55 Aligned_cols=255 Identities=27% Similarity=0.466 Sum_probs=223.6
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
..|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+.+|++|+|||||++++++.+ ...+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--CCEEEE
Confidence 3599999999999999999999999999999999876553 4455678999999999999999999999987 568999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
|||||.++++..+......+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||++.....
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----- 167 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence 999999988877666667899999999999999999999999999999999999999999999999999987543
Q ss_pred CccccccCCCCCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 277 MTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
....+||+.|+|||++.+. ..|+.++|||||||++|||++|.+||.+.+..+.+.++......+.
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~------------- 234 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL------------- 234 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-------------
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-------------
Confidence 2456899999999998652 4589999999999999999999999999998888877765221100
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
....+|+++.+||.+||+.||.+|||++|+|+||||..
T Consensus 235 --------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 235 --------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp --------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred --------------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 11346788999999999999999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.4e-59 Score=469.94 Aligned_cols=259 Identities=24% Similarity=0.437 Sum_probs=226.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ......+.+|+.+|++|+|||||+++++|.+ +..+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i 103 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 103 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 467999999999999999999999999999999998653 3445678899999999999999999999987 578999
Q ss_pred EEeeccCChhh-hhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeC--CCCcEEEeecccccccCCCC
Q 011041 197 VFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID--NEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 197 v~e~~~~~l~~-~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~--~~~~vkL~DFG~a~~~~~~~ 273 (495)
|||||+++.+. .+......|++.+++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|..+...
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 99999976554 4455556799999999999999999999999999999999999998 5789999999999887643
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+++.+|......++..
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---------- 250 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED---------- 250 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS----------
T ss_pred -CceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc----------
Confidence 33456789999999999876 578999999999999999999999999999999999887754433322
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.+..+|+++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 251 ---------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 251 ---------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ---------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ---------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 234578899999999999999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-60 Score=462.78 Aligned_cols=258 Identities=25% Similarity=0.369 Sum_probs=220.3
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
+.|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+ ...+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCeEEEE
Confidence 57999999999999999999999999999999998653 3445678899999999999999999999987 5689999
Q ss_pred EeeccCChhhhh-hCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 198 FKYMEHDLAGLA-ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 198 ~e~~~~~l~~~~-~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
|||+.++.+..+ ......+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|....... ..
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 999998766554 4445579999999999999999999999999999999999999999999999999997653211 12
Q ss_pred CccccccCCCCCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 277 MTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
..+.+||+.|+|||++.+ ...|+.++|||||||+||+|++|.+||.+.+..+.+.++.+.....
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~------------ 234 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT------------ 234 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC------------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 245689999999999852 3568999999999999999999999999999888888876531100
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
......+|+++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 235 --------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 235 --------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp --------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred --------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0112347888999999999999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-59 Score=452.20 Aligned_cols=255 Identities=23% Similarity=0.306 Sum_probs=215.4
Q ss_pred eeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc--CCceeEEE
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR--MSCSLYLV 197 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~~~lv 197 (495)
|++.++||+|+||+||+|+++.++..||+|++..........+.+.+|+++|++++|||||++++++++. ....+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 4677889999999999999999999999999988776677778899999999999999999999998652 24578999
Q ss_pred EeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--ceeccCCCCCeeeC-CCCcEEEeecccccccCCCCC
Q 011041 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLID-NEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~g--ivHrDlKp~NILl~-~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|||++++.+..+......+++..++.++.||+.||+|||++| |+||||||+||||+ +++.+||+|||+++.....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-- 168 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 168 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC--
Confidence 999998777666655668999999999999999999999999 99999999999996 4789999999999865432
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
.....+||+.|+|||++.+ .|+.++|||||||++|||++|++||.+.+....+.+.... +..+..
T Consensus 169 -~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~~~----------- 233 (270)
T d1t4ha_ 169 -FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPAS----------- 233 (270)
T ss_dssp -SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCGG-----------
T ss_pred -ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCCcc-----------
Confidence 3356789999999999865 5899999999999999999999999886655544333221 111111
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFT 405 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~ 405 (495)
....+++++.+||.+||..||++|||++|+|+||||+
T Consensus 234 --------------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 234 --------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp --------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred --------------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 1234677899999999999999999999999999995
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-60 Score=471.97 Aligned_cols=284 Identities=23% Similarity=0.339 Sum_probs=215.2
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
..++|++++.||+|+||+||+|+++.+|+.||+|++++.. .......+.+|+.+|+.++|||||+++++|.+ ...+|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~ 80 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEIS 80 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--SSEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEE
Confidence 3578999999999999999999999999999999998653 34445678899999999999999999999987 56799
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|||||+.++.+..+......+++..++.++.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|..+...
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999987666666555679999999999999999999997 59999999999999999999999999999876432
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCChhhhh----hCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ-LHKIFKLCGSPSEEYWK----KSK 349 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~----~~~ 349 (495)
...+.+||++|+|||++.+ ..|+.++||||||||+|||++|+.||.+.+..+. ...+....+.+...... ...
T Consensus 159 -~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp -TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred -ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 2346799999999999987 5799999999999999999999999988664332 22222223322211100 000
Q ss_pred CC-CCccCCCCcccccc----cccc-----cCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 350 LP-HATIFKPQQSYKRC----IAET-----FKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 350 ~~-~~~~~~~~~~~~~~----~~~~-----~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.. ......+....... .... ...+|+++.+||.+||++||.+|||++|+|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 00 00000000000000 0000 1235678999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-59 Score=464.74 Aligned_cols=257 Identities=22% Similarity=0.361 Sum_probs=227.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++.+ ...+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ 80 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIF 80 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee--CCeee
Confidence 5789999999999999999999999999999999975432 22345678899999999999999999999987 67899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
+||||+.++.+..+......+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|......
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 99999999888777777778999999999999999999999999999999999999999999999999999876532
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
..+.+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+.+|......
T Consensus 158 -~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~---------------- 219 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR---------------- 219 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC----------------
T ss_pred -cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC----------------
Confidence 346789999999999876 56899999999999999999999999999999998888653211
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPY 409 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~ 409 (495)
....+|+++.+||.+||..||.+|+ |++++|+||||++..|
T Consensus 220 -------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 220 -------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred -------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence 1134778899999999999999996 9999999999998654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-58 Score=456.31 Aligned_cols=286 Identities=38% Similarity=0.641 Sum_probs=235.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCC-CeEEEeEEEecCCCChHHHHHHHHHHHHHHhC---CCCCeeeeeceeec---c
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLT-GQIVALKKVRFDNLEPESVRFMAREILILRRL---DHPNVVKLEGLVTS---R 189 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~---~ 189 (495)
.++|++++.||+|+||+||+|++..+ ++.||||++............+.+|+.+|+.| +||||+++++++.. .
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999999765 67899999976544333333455788887766 79999999999853 2
Q ss_pred CCceeEEEEeeccCChhhhh-hCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccc
Q 011041 190 MSCSLYLVFKYMEHDLAGLA-ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (495)
Q Consensus 190 ~~~~~~lv~e~~~~~l~~~~-~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~ 268 (495)
....+|++|||++++++.+. ......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 24578999999999876544 45566799999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
.... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+++.+|+..++.+....|+..
T Consensus 166 ~~~~--~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 166 YSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hccc--ccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 5432 23456789999999999876 57899999999999999999999999999999999999999999998888654
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
.......+... ...........+++.+.+||.+||++||.+|||+.|+|+||||++-
T Consensus 243 ~~~~~~~~~~~--~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 243 VALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CSSCGGGSCCC--CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccchhhhhccc--cccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 32222222111 1112334456788899999999999999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-58 Score=459.22 Aligned_cols=295 Identities=45% Similarity=0.724 Sum_probs=238.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC------
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM------ 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 190 (495)
.++|+++++||+|+||+||+|+++.+|+.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 68999999999999999999999999999999999876555555567889999999999999999999875421
Q ss_pred CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
...+|+||||+.++++.........+++..++.+++||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 34689999999999998888888889999999999999999999999999999999999999999999999999997664
Q ss_pred CCC---CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 011041 271 PNH---KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 271 ~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (495)
... .....+.+||++|+|||++.+...|+.++|||||||++|||++|++||.+.++.+.+..+....+.+....|..
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 322 22334568999999999998877899999999999999999999999999999999999999999988776654
Q ss_pred CCCCCC-ccCCCCccccccccccc--CCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCCC
Q 011041 348 SKLPHA-TIFKPQQSYKRCIAETF--KDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYAC 411 (495)
Q Consensus 348 ~~~~~~-~~~~~~~~~~~~~~~~~--~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~~ 411 (495)
...... ................+ ...+++++|||.+||++||++|||+.|+|+||||+..|.|.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~ 315 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence 221110 00100000111111111 11356788999999999999999999999999999866543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-58 Score=467.73 Aligned_cols=258 Identities=23% Similarity=0.377 Sum_probs=226.5
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|++++.||+|+||.||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++.+ ...+
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~ 116 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNL 116 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc--cccc
Confidence 36899999999999999999999999999999999975432 22345678899999999999999999999987 5679
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
|+||||+.++.+.........+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 999999998877666655668999999999999999999999999999999999999999999999999999877532
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
....+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.+....+.+|......+
T Consensus 195 --~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~-------------- 257 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-------------- 257 (350)
T ss_dssp --BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------
T ss_pred --cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC--------------
Confidence 345789999999999987 568999999999999999999999999999988888886532111
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKPY 409 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~~ 409 (495)
...+|+++.+||.+||.+||.+|+ |++++|+||||++..|
T Consensus 258 ---------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 258 ---------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp ---------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred ---------------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 235788899999999999999995 9999999999997655
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-58 Score=462.75 Aligned_cols=282 Identities=35% Similarity=0.564 Sum_probs=235.4
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeec----cCCce
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTS----RMSCS 193 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~ 193 (495)
-+|+.+++||+|+||+||+|+++.+|+.||||++..+.. ...+|+.+|++|+|||||+++++|.. ....+
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 369999999999999999999999999999999986542 23479999999999999999999854 23456
Q ss_pred eEEEEeeccCChhhhhh---CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC-cEEEeeccccccc
Q 011041 194 LYLVFKYMEHDLAGLAA---SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFF 269 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~---~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~-~vkL~DFG~a~~~ 269 (495)
+||||||+++++...+. .....+++.+++.|++||+.||+|||++||+||||||+||||+.++ .+||+|||++..+
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 89999999988655443 3556799999999999999999999999999999999999999875 8999999999876
Q ss_pred CCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
... ....+.+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.+..+++.+|++.+|.+..+.|....
T Consensus 174 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTT--SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCC--cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 543 334567899999999998877789999999999999999999999999999999999999999999988887643
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
........+..............+++++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 3222222222111122223345678899999999999999999999999999999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-58 Score=455.97 Aligned_cols=258 Identities=20% Similarity=0.335 Sum_probs=226.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+|+.+|+.++|||||++++++++ ...+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFES--MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 478999999999999999999999999999999997653 334568899999999999999999999987 578999
Q ss_pred EEeeccCChhhh-hhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCC--CcEEEeecccccccCCCC
Q 011041 197 VFKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE--GILTIADFGLASFFDPNH 273 (495)
Q Consensus 197 v~e~~~~~l~~~-~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~--~~vkL~DFG~a~~~~~~~ 273 (495)
|||||.++.+.. +......+++.+++.|+.||+.||+|||++||+||||||+||||+.+ +.+||+|||++......
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 999999755544 44445579999999999999999999999999999999999999854 58999999999876433
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+.+|.+....++...|
T Consensus 158 -~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 227 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-------- 227 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH--------
T ss_pred -CcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhc--------
Confidence 23455688999999998876 56899999999999999999999999999999999999886666655544
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
..+|+++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 228 -----------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 228 -----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -----------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -----------------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 3478889999999999999999999999999999753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-57 Score=458.65 Aligned_cols=290 Identities=32% Similarity=0.530 Sum_probs=236.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC----Cc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~ 192 (495)
.++|++++.||+|+||+||+|+++.+|+.||||++.+........+.+.+|+.+|+.++|||||+++++|.... ..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 47899999999999999999999999999999999877666677788999999999999999999999987632 23
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+|+||||++.++...... ..|++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~- 173 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 173 (346)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred eEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC-
Confidence 6899999997666555433 3699999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
..+..+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++..+|.......
T Consensus 174 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 174 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence 23567899999999999877778999999999999999999999999999999999999999999988776533211
Q ss_pred CccCC--CCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCCCC
Q 011041 353 ATIFK--PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYACD 412 (495)
Q Consensus 353 ~~~~~--~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~~~ 412 (495)
..... ........+...+..+++++.+||.+||.+||.+|||+.|+|+||||+....+.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~ 312 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 312 (346)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccc
Confidence 10000 0000111234455678889999999999999999999999999999997544433
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.8e-57 Score=444.19 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=224.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh-------HHHHHHHHHHHHHHhCC-CCCeeeeeceeec
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-------ESVRFMAREILILRRLD-HPNVVKLEGLVTS 188 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~-------~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 188 (495)
.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ...+.+.+|+.+|++|+ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999999999999999998765421 22346789999999997 9999999999987
Q ss_pred cCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccc
Q 011041 189 RMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (495)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~ 268 (495)
+..+||||||++++.+..++.....+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++..
T Consensus 82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred --CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 678999999998765555554556899999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCCCCCccccccCCCCCcccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 011041 269 FDPNHKQPMTSRVVTLWYRPPELLLG-----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE 343 (495)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (495)
+.... .....+||+.|+|||++.+ ...|+.++|||||||+||+|++|.+||.+.+..+.+..|......++.
T Consensus 160 ~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~- 236 (277)
T d1phka_ 160 LDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS- 236 (277)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-
T ss_pred ccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC-
Confidence 76542 3456789999999999853 345788999999999999999999999999999988888764322221
Q ss_pred hhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCC
Q 011041 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTT 406 (495)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~ 406 (495)
.....+|+++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 237 ------------------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 237 ------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp ------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ------------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 123458889999999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.8e-58 Score=463.65 Aligned_cols=262 Identities=26% Similarity=0.370 Sum_probs=216.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC----hHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE----PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.... ........+|+.+++.++|||||++++++.+ ..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~~ 80 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PD 80 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--SS
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE--CC
Confidence 68999999999999999999999999999999999754321 1122233345777888899999999999987 56
Q ss_pred eeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
.+||||||+.++.+..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 89999999998776666655668999999999999999999999999999999999999999999999999999877543
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.....+||+.|+|||++.+...|+.++|||||||+||||++|++||.+.+..+....+ .......
T Consensus 161 ---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-~~~~~~~----------- 225 (364)
T d1omwa3 161 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMA----------- 225 (364)
T ss_dssp ---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-HHSSSCC-----------
T ss_pred ---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcccCC-----------
Confidence 2345689999999999976567999999999999999999999999886544332222 1111111
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccC-----HHHHHhCCCCCCCCC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEFFTTKPY 409 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----a~elL~hp~f~~~~~ 409 (495)
......+|+++.+||.+||+.||.+||| |+|+|+||||++..|
T Consensus 226 --------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 226 --------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp --------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred --------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 1112457889999999999999999999 899999999998654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=441.09 Aligned_cols=288 Identities=38% Similarity=0.658 Sum_probs=244.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
+++|++++.||+|+||+||+|+++.+|+.||||+++...........+.+|+.+|+.++|||||++++++.+ ....++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~i 78 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTL 78 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc--ccceeE
Confidence 368999999999999999999999999999999998876666677889999999999999999999999988 567999
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCCC
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 276 (495)
|++++.++.+..+......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++....... ..
T Consensus 79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~~ 157 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RC 157 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-SC
T ss_pred EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-cc
Confidence 99999999888887778889999999999999999999999999999999999999999999999999998765433 23
Q ss_pred CccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCcc
Q 011041 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPI-MPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (495)
Q Consensus 277 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (495)
.....+++.|+|||++.+...++.++|||||||++|||++|..| |.+.+..+++.++....+.+....|..........
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 34556789999999988766789999999999999999998866 66778888999999999998877765422111111
Q ss_pred CCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
..+..............+++.+.+||.+||++||.+||||+|+|+||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 1111112222444456678889999999999999999999999999999863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-57 Score=452.23 Aligned_cols=260 Identities=24% Similarity=0.374 Sum_probs=222.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHH-hCCCCCeeeeeceeeccCCcee
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILR-RLDHPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~~ 194 (495)
.++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.++. .++|||||++++++.+ ...+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~ 78 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENL 78 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCce
Confidence 3789999999999999999999999999999999976432 1233455667777765 6899999999999988 5689
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||||++++.+..++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~- 157 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 157 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc-
Confidence 9999999987777666666689999999999999999999999999999999999999999999999999998665332
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
...+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+++.+|.... +.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~------------- 221 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PF------------- 221 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CC-------------
T ss_pred ccccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CC-------------
Confidence 33456789999999999987 578999999999999999999999999999998888885421 11
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHH-HHHhCCCCCCCCC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT-AALRSEFFTTKPY 409 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~-elL~hp~f~~~~~ 409 (495)
..+.+|+++.+||.+||++||.+|||+. ++++||||++..|
T Consensus 222 --------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 222 --------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp --------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred --------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence 1134788999999999999999999995 8999999987543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-55 Score=439.45 Aligned_cols=291 Identities=32% Similarity=0.541 Sum_probs=231.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC---Cce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM---SCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---~~~ 193 (495)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+.+|+.+|+.|+||||+++++++.... ...
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 367999999999999999999999999999999997654 3455667889999999999999999999986532 234
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|++|++++++|...+.. ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++.......
T Consensus 86 ~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 677777776677666543 369999999999999999999999999999999999999999999999999998664322
Q ss_pred C--CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 274 K--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 274 ~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
. ......+||+.|+|||++.....|+.++||||+||++|+|++|.+||.+.+..++...+...++.+...........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 1 22455689999999999877677899999999999999999999999999999999999988888876544322111
Q ss_pred CCc--cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCCC
Q 011041 352 HAT--IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPYA 410 (495)
Q Consensus 352 ~~~--~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~~ 410 (495)
... ...............+..+++++++||.+||++||.+|||+.|+|+||||+....+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 000 00000011111334456778899999999999999999999999999999975443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-56 Score=449.60 Aligned_cols=286 Identities=29% Similarity=0.499 Sum_probs=227.6
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc----CCce
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR----MSCS 193 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----~~~~ 193 (495)
++|+++++||+|+||+||+|+++.+|+.||||++.+..........+.+|+.+|+.++|||||+++++|... ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 689999999999999999999999999999999998776777777899999999999999999999998643 2468
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|+||||+.++++.... ..+++..++.+++||+.||.|||++||+||||||+|||++.++.+|++|||++......
T Consensus 97 ~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~- 172 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS- 172 (355)
T ss_dssp EEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc-
Confidence 99999999999887764 36899999999999999999999999999999999999999999999999998866543
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
......+||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+...++.++....+.+..++|........
T Consensus 173 -~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 173 -FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ---------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred -cccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 33456689999999999987 5789999999999999999999999999999999999999999998888754221000
Q ss_pred -----ccCCCCcccccc--------cccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 354 -----TIFKPQQSYKRC--------IAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 354 -----~~~~~~~~~~~~--------~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
............ .......+++++.+||.+||.+||++||||+|+|+||||+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 000000000000 00111123567899999999999999999999999999987543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=443.22 Aligned_cols=285 Identities=35% Similarity=0.558 Sum_probs=229.9
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeecc----CCce
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR----MSCS 193 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----~~~~ 193 (495)
++|++++.||+|+||+||+|+++.+|+.||||++.+..........+.+|+.+|+.|+|||||++++++... ....
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 679999999999999999999999999999999987766667777889999999999999999999998642 1234
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+|+++++++++|... ... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 98 ~~i~~~~~gg~L~~~-~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNI-VKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp CEEEEECCSEEHHHH-HTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred EEEEEeecCCchhhh-ccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--
Confidence 555555544555444 433 3699999999999999999999999999999999999999999999999999976542
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
...+..||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......|....+.+..+.+........
T Consensus 174 --~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp --GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred --ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 235568999999999988877789999999999999999999999999999999999999999988776543221100
Q ss_pred ccC--CCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCC
Q 011041 354 TIF--KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKP 408 (495)
Q Consensus 354 ~~~--~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~ 408 (495)
..+ .........+...+..+++++++||.+||++||.+|||+.|+|+||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 000 0000011123344567888999999999999999999999999999999754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.3e-55 Score=437.90 Aligned_cols=284 Identities=29% Similarity=0.501 Sum_probs=228.7
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCcee
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~ 194 (495)
..++|+++++||+|+||+||+|+++.+|+.||||++.... .+.+.+|+.+|+.+. ||||+++++++.......+
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 3478999999999999999999999999999999987532 356789999999995 9999999999987656789
Q ss_pred EEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC-cEEEeecccccccCCCC
Q 011041 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNH 273 (495)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~-~vkL~DFG~a~~~~~~~ 273 (495)
|+||||+.++.+.... ..+++..++.+++||+.||+|||++|||||||||+||||+.++ .+||+|||++......
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~- 183 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 183 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-
Confidence 9999999987765543 3699999999999999999999999999999999999998765 6999999999877544
Q ss_pred CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCChhhhhh-CCCC
Q 011041 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG-RTEVEQLHKIFKLCGSPSEEYWKK-SKLP 351 (495)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~-~~~~~~~~~i~~~~g~~~~~~~~~-~~~~ 351 (495)
......++|+.|+|||++.+...|+.++|||||||++|+|++|..||.. .+..++...+...+|.+....|.. ....
T Consensus 184 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 184 -QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp -CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred -CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 2345668999999999998877789999999999999999999999876 456677788888877654433322 2111
Q ss_pred CCccC------CCCccccc-ccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCCCC
Q 011041 352 HATIF------KPQQSYKR-CIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTKPY 409 (495)
Q Consensus 352 ~~~~~------~~~~~~~~-~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~~~ 409 (495)
....+ ........ ........+++++.|||++||++||.+|||++|+|+||||++..|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 11111 00111111 111223446788999999999999999999999999999997544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=435.75 Aligned_cols=251 Identities=23% Similarity=0.326 Sum_probs=209.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCCh----HHHHHHHHHHHHHHhCC--CCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP----ESVRFMAREILILRRLD--HPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~ 190 (495)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+..... .....+.+|+.+|++++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence 468999999999999999999999999999999998654321 11233568999999996 8999999999987
Q ss_pred CceeEEEEeeccC-ChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC-CCcEEEeecccccc
Q 011041 191 SCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADFGLASF 268 (495)
Q Consensus 191 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~-~~~vkL~DFG~a~~ 268 (495)
...+|+||||+.+ +++..+......+++.+++.++.||+.||+|||++||+||||||+||||+. ++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 5689999999975 444444444567999999999999999999999999999999999999985 47999999999987
Q ss_pred cCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
.... ..++.+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+ .+.+..
T Consensus 161 ~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~----------- 220 (273)
T d1xwsa_ 161 LKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ----------- 220 (273)
T ss_dssp CCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC-----------
T ss_pred cccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcc-----------
Confidence 5432 34567899999999999876667888999999999999999999997632 122210
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
......+|+++.+||.+||..||.+|||++|+|+||||++.
T Consensus 221 ------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 221 ------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp ------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ------------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 01123578899999999999999999999999999999863
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-56 Score=446.95 Aligned_cols=260 Identities=22% Similarity=0.310 Sum_probs=207.4
Q ss_pred CCCeeeee-eecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHh-CCCCCeeeeeceeec--cCCc
Q 011041 117 ADTFEKLD-KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR-LDHPNVVKLEGLVTS--RMSC 192 (495)
Q Consensus 117 ~~~y~~~~-~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~--~~~~ 192 (495)
.++|+++. .||+|+||+||+|+++.+|+.||||+++.. ..+.+|+.++.+ ++|||||+++++|++ ..+.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 57899886 599999999999999999999999999742 356789998765 489999999999875 2346
Q ss_pred eeEEEEeeccCC-hhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC---CCcEEEeeccccc
Q 011041 193 SLYLVFKYMEHD-LAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLAS 267 (495)
Q Consensus 193 ~~~lv~e~~~~~-l~~~~~~~-~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~---~~~vkL~DFG~a~ 267 (495)
.+|||||||+|+ |...+... ...|+|.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 799999999875 44444443 357999999999999999999999999999999999999986 5679999999998
Q ss_pred ccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 011041 268 FFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (495)
...... .....+||+.|+|||++.+ ..|+.++||||||||||+|+||++||.+.+.......+..........
T Consensus 163 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~---- 235 (335)
T d2ozaa1 163 ETTSHN--SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE---- 235 (335)
T ss_dssp ECCCCC--CCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS----
T ss_pred eccCCC--ccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC----
Confidence 775432 3456789999999998876 578999999999999999999999999877666555443321110000
Q ss_pred CCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCCCCC
Q 011041 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFFTTK 407 (495)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f~~~ 407 (495)
. .......+|+++.+||.+||++||.+|||+.|+|+||||...
T Consensus 236 ---------~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 236 ---------F--------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp ---------C--------CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ---------C--------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 0 001123478889999999999999999999999999999753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.2e-55 Score=427.70 Aligned_cols=262 Identities=23% Similarity=0.317 Sum_probs=213.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccC--Cce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRM--SCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~ 193 (495)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||++++++.... ...
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 3679999999999999999999999999999999987655 4556678999999999999999999999987643 245
Q ss_pred eEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 011041 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~ 273 (495)
+||||||++++.+.........+++.+++.|+.||+.||+|||++|||||||||+||||+.++.++|+|||++.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999987777666666689999999999999999999999999999999999999999999999999987653322
Q ss_pred --CCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 274 --KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 274 --~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
.......+||+.|+|||++.+ ..|+.++||||||||+|+|+||.+||.+.+..+.+.++......++.
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------- 235 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS--------- 235 (277)
T ss_dssp -------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG---------
T ss_pred ccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc---------
Confidence 223456689999999999876 57899999999999999999999999999998888887654322221
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhCCCC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEFF 404 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~hp~f 404 (495)
....++|+++.+||.+||.+||.+||+..+.|.|+|+
T Consensus 236 ----------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 236 ----------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp ----------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ----------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 2234688899999999999999999954444445554
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-55 Score=425.43 Aligned_cols=256 Identities=20% Similarity=0.302 Sum_probs=209.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||+||+|+.. ..||||+++.........+.+.+|+.+|++++|||||++++++.+ ..+||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEEEE
Confidence 478999999999999999999743 359999998776667778889999999999999999999998754 45899
Q ss_pred EEeeccCChh-hhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCC-C
Q 011041 197 VFKYMEHDLA-GLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-K 274 (495)
Q Consensus 197 v~e~~~~~l~-~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~-~ 274 (495)
||||++++.+ ..+......+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|....... .
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 9999996554 4454556679999999999999999999999999999999999999999999999999998764322 2
Q ss_pred CCCccccccCCCCCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.......||+.|+|||++.+. ..|+.++|||||||+||||+||+.||.+.+....+..+......++.
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~---------- 230 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD---------- 230 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC----------
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc----------
Confidence 234566899999999998643 35899999999999999999999999998877666655443221110
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
+.....++|+++.+||.+||..||.+|||+.|++++
T Consensus 231 -------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 231 -------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp -------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 223345678899999999999999999999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-54 Score=423.08 Aligned_cols=250 Identities=20% Similarity=0.337 Sum_probs=207.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++.+.||+|+||+||+|+++.+|+.||||++..+... .+.+.+|+.+|++++|||||++++++.+ ...+||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEee--CCeeEE
Confidence 46899999999999999999999999999999999765433 4568899999999999999999999987 567999
Q ss_pred EEeeccCChhhhhh--CCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAGLAA--SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~--~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||++++.+..++ .....+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.......
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999976554433 3456799999999999999999999999999999999999999999999999999987755443
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPI-MPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......||+.|+|||++.+ ..|+.++|||||||++|||++|..| |.+.+.......+.... .
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~-~-------------- 234 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-R-------------- 234 (287)
T ss_dssp EEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-C--------------
T ss_pred eeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC-C--------------
Confidence 33444568999999999876 5789999999999999999996555 44555444444332210 0
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......+|+++.+||.+||+.||.+|||+.|+++
T Consensus 235 -------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 235 -------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1112457888999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=419.61 Aligned_cols=254 Identities=22% Similarity=0.377 Sum_probs=212.6
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|+++ ++..||||++...... .+.+.+|+.+|++++|||||++++++.+ ..+|+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc---CCeEE
Confidence 378999999999999999999976 5788999999765433 3568899999999999999999998764 35799
Q ss_pred EEeeccCChhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~--~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||+.++.+...... ...+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.......
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 9999998776554432 23589999999999999999999999999999999999999999999999999998765544
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||...+..+.+..+......
T Consensus 165 ~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~-------------- 229 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------------- 229 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred ccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--------------
Confidence 44456688999999999875 568999999999999999999 56777777777777766432100
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh--CCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR--SEFFTT 406 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~--hp~f~~ 406 (495)
.....+|+++.+||.+||+.||.+|||+.++++ |+||+.
T Consensus 230 --------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 230 --------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 112357788999999999999999999999998 788753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=412.77 Aligned_cols=250 Identities=20% Similarity=0.317 Sum_probs=200.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|++. +++.||||+++..... .+.+.+|+.+|++++|||||++++++.. ...+|+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~~l 77 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICL 77 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceecc--CCceEE
Confidence 368999999999999999999976 5678999999865433 3468899999999999999999999987 457999
Q ss_pred EEeeccCChhhh-hhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l~~~-~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||||+.++.+.. +......+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++........
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999999765554 4555667999999999999999999999999999999999999999999999999999877654444
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
......||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+.+..+......+
T Consensus 158 ~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-------------- 222 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------------- 222 (263)
T ss_dssp -------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC--------------
T ss_pred eecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence 4455678999999999876 568999999999999999999 678888888877777775421110
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
....+++++.+||..||+.||.+|||++|+|+|
T Consensus 223 --------------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 223 --------------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 112457789999999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-53 Score=417.93 Aligned_cols=253 Identities=21% Similarity=0.363 Sum_probs=200.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCe---EEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.++|++.+.||+|+||+||+|+++.+|+ .||||.+.... .....+.+.+|+.+|++|+|||||++++++.+ ...
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK--STP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEee--CCE
Confidence 4789999999999999999999987765 58888876543 44556778999999999999999999999977 567
Q ss_pred eEEEEeeccCChhhh-hhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~-~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
+|+|||||+++.+.. +......+++.++..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 999999999876654 4455667999999999999999999999999999999999999999999999999999876543
Q ss_pred CCC----CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 011041 273 HKQ----PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (495)
Q Consensus 273 ~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (495)
... ......||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+..+......+
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~------- 253 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP------- 253 (299)
T ss_dssp --------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-------
T ss_pred CCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 221 1123457999999999876 578999999999999999998 899999999888887775421111
Q ss_pred CCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
...++|+++.+||.+||+.||.+|||+.|++++
T Consensus 254 ---------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 254 ---------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 123567889999999999999999999998863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-53 Score=409.11 Aligned_cols=250 Identities=18% Similarity=0.304 Sum_probs=215.0
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|+++++||+|+||+||+|+++ +++.||||++++..... +.+.+|+.++++++|||||++++++.+ +..+|+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~~~~~i 76 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECC--SSSEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEee--CCceEE
Confidence 368999999999999999999985 78899999998765543 467899999999999999999999987 567999
Q ss_pred EEeeccCCh-hhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC
Q 011041 197 VFKYMEHDL-AGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (495)
Q Consensus 197 v~e~~~~~l-~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 275 (495)
||||+.++. ..........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 999998665 4444566667999999999999999999999999999999999999999999999999999877655444
Q ss_pred CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCc
Q 011041 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (495)
Q Consensus 276 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (495)
......||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+...+|.+....+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 221 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-------------- 221 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC--------------
T ss_pred eecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC--------------
Confidence 4556678999999999876 568999999999999999998 899999999888887775422111
Q ss_pred cCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.....++++.+||.+||+.||.+|||+.++|+|
T Consensus 222 --------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 222 --------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp --------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 113466789999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=417.51 Aligned_cols=249 Identities=20% Similarity=0.283 Sum_probs=203.9
Q ss_pred eeecccCceEEEEEEEC--CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEEEeec
Q 011041 124 DKIGQGTYSNVYKARDT--LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 124 ~~LG~G~~g~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
++||+|+||+||+|.++ .+++.||||++..........+.+.+|+.+|++++|||||++++++.+ ...||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEEcC
Confidence 46999999999999864 456889999997665556667789999999999999999999999865 3478999999
Q ss_pred cCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCCC--CCcc
Q 011041 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ--PMTS 279 (495)
Q Consensus 202 ~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~--~~~~ 279 (495)
+++.+..+......+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+...... ....
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 98777666666668999999999999999999999999999999999999999999999999999876543221 2234
Q ss_pred ccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCCccCCC
Q 011041 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (495)
Q Consensus 280 ~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 358 (495)
..||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+....|.+.. .
T Consensus 170 ~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~--~------------------ 228 (277)
T d1xbba_ 170 GKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--R------------------ 228 (277)
T ss_dssp -CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--C------------------
T ss_pred cCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC--C------------------
Confidence 578999999999876 568999999999999999998 899999988887776664311 0
Q ss_pred CcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHH---HhCCCC
Q 011041 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAA---LRSEFF 404 (495)
Q Consensus 359 ~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~el---L~hp~f 404 (495)
......+|+++.+||.+||+.||.+|||+.++ |+|+|+
T Consensus 229 --------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 229 --------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 01123578889999999999999999999998 566654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-53 Score=414.42 Aligned_cols=256 Identities=21% Similarity=0.296 Sum_probs=212.9
Q ss_pred CCCeeeeee-ecccCceEEEEEEECC--CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLDK-IGQGTYSNVYKARDTL--TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~~-LG~G~~g~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.++|.+.+. ||+|+||+||+|+++. ++..||||+++... .....+.+.+|+.+|++++|||||++++++.+ ..
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~ 82 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EA 82 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SS
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---Ce
Confidence 367888885 9999999999998764 45689999997543 45566788999999999999999999999865 35
Q ss_pred eEEEEeeccCChhhhh-hCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDLAGLA-ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~~-~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
+||||||++++.+..+ ......+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+...
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 8999999998655554 455668999999999999999999999999999999999999999999999999999877543
Q ss_pred CC--CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 273 HK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 273 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
.. .......||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+.+..|.+...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~----------- 230 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----------- 230 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-----------
T ss_pred ccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 22 22334578999999999875 468999999999999999998 9999999888887777653210
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHH---HhCCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAA---LRSEFFT 405 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~el---L~hp~f~ 405 (495)
......+|+++.+||..||..||.+|||+.++ |+|+|++
T Consensus 231 -----------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 -----------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 01124578889999999999999999999888 6677764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=430.87 Aligned_cols=265 Identities=25% Similarity=0.393 Sum_probs=219.6
Q ss_pred CCCeeeeeeecccCceEEEEEEE---CCCCeEEEeEEEecCCC--ChHHHHHHHHHHHHHHhCCC-CCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARD---TLTGQIVALKKVRFDNL--EPESVRFMAREILILRRLDH-PNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~---~~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~ 190 (495)
.++|++++.||+|+||+||+|++ +.+|+.||||++.+... .....+.+.+|+.+|++++| |||+++++++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-- 100 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 100 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--
Confidence 58899999999999999999987 45789999999865432 12234567789999999976 899999999988
Q ss_pred CceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccC
Q 011041 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~ 270 (495)
...+|++|||+.++.+.........+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||++..+.
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 56899999999987777666666688999999999999999999999999999999999999999999999999998775
Q ss_pred CCCCCCCccccccCCCCCcccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 271 PNHKQPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
...........||+.|++||++.+.. .++.++|||||||+||+|++|.+||.+.+..+....+.+....+.
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~-------- 252 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-------- 252 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--------
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC--------
Confidence 44444455678999999999987643 478899999999999999999999998776655555544221110
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCcc-----CHHHHHhCCCCCCCC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEFFTTKP 408 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----ta~elL~hp~f~~~~ 408 (495)
......+|+++.+||.+||.+||.+|| |++|+|+||||+...
T Consensus 253 -----------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 253 -----------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred -----------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 112245788999999999999999999 599999999998754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-53 Score=422.71 Aligned_cols=254 Identities=21% Similarity=0.292 Sum_probs=206.3
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCe-----EEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ-----IVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 190 (495)
.++|++++.||+|+||+||+|++..+++ .||+|++.... .......+.+|+.+|.++ +|||||++++++.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-- 112 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 112 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--
Confidence 3789999999999999999999876543 69999886543 233445788999999998 89999999999987
Q ss_pred CceeEEEEeeccCChhhhhh-CCC----------------------CCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCC
Q 011041 191 SCSLYLVFKYMEHDLAGLAA-SPT----------------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKG 247 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~-~~~----------------------~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp 247 (495)
...+|||||||+++.+..++ ... ..+++..+..|+.||+.||.|||++|||||||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence 56799999999976555443 221 2489999999999999999999999999999999
Q ss_pred CCeeeCCCCcEEEeecccccccCCCCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 011041 248 SNLLIDNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRT 325 (495)
Q Consensus 248 ~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~ 325 (495)
+|||++.++.+||+|||+|+........ ...+..||+.|+|||++.+ ..|+.++|||||||+||||++ |.+||.+.+
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999876543322 2235578999999999876 578999999999999999997 899999987
Q ss_pred hHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 326 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
..+.+.++......+ .....+|+++.+||.+||+.||.+|||++|+++|
T Consensus 272 ~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 272 VDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCCCC---------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 777766665432111 1123467889999999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=408.59 Aligned_cols=252 Identities=20% Similarity=0.307 Sum_probs=199.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCC---eEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCce
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTG---QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 193 (495)
.++|++++.||+|+||.||+|++..++ ..||||+++.. ......+.+.+|+.+|++++|||||++++++.+ ..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---Ce
Confidence 368999999999999999999987543 56888887543 245556778999999999999999999999864 46
Q ss_pred eEEEEeeccCChhhh-hhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 011041 194 LYLVFKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (495)
Q Consensus 194 ~~lv~e~~~~~l~~~-~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~ 272 (495)
+|+||||+.++.+.. .......+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 899999999765544 4455667999999999999999999999999999999999999999999999999999877554
Q ss_pred CCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCC
Q 011041 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (495)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (495)
.........||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+.++.....
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~------------- 227 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------------- 227 (273)
T ss_dssp ---------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-------------
T ss_pred cceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence 4444455678999999999875 578999999999999999998 8999999998888877754211
Q ss_pred CCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
......+|+++.+||.+||..||.+|||+.|+++|
T Consensus 228 ---------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 228 ---------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01224578889999999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=408.49 Aligned_cols=255 Identities=23% Similarity=0.346 Sum_probs=205.9
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||+||+|+++.+ ..||||++...... .+.+.+|+.+|++++|||||++++++.+ ..+|+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec---CCeEE
Confidence 47899999999999999999998765 56999999765433 3568899999999999999999999854 35799
Q ss_pred EEeeccCChhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~~--~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||+.++.+..... ....+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 999999876554433 234699999999999999999999999999999999999999999999999999987755444
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.......||+.|+|||++.+ ..++.++|||||||+||||++ |.+||.+.+..+.+..+......
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~-------------- 233 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------------- 233 (285)
T ss_dssp -------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred eeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--------------
Confidence 44455689999999999875 578999999999999999999 56677777777777776542211
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh--CCCCCCC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR--SEFFTTK 407 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~--hp~f~~~ 407 (495)
.....+|+++.+||.+||+.||++|||+++++. ++||+..
T Consensus 234 --------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 --------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred --------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 112457788999999999999999999999988 8999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=402.05 Aligned_cols=252 Identities=19% Similarity=0.312 Sum_probs=199.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCC----eEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTG----QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
.+.|++.+.||+|+||.||+|+++.++ ..||||++.... .......+.+|+.+|++++|||||++++++.+ ..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~--~~ 82 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YK 82 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec--CC
Confidence 467999999999999999999987655 479999997543 44555678899999999999999999999987 46
Q ss_pred eeEEEEeeccCChhhh-hhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 193 SLYLVFKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~-~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
.+++||||+.++++.. .......+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 7899999999876654 444556799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC--CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 272 NHKQ--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 272 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
.... ......||+.|+|||++.+ ..|+.++|||||||+||||++| .+||.+.+..+.+..+......
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~--------- 232 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL--------- 232 (283)
T ss_dssp -----------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------
T ss_pred CCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC---------
Confidence 3221 2234568999999999876 5789999999999999999985 6666667776666665432110
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
....++|+++.+||.+||..||.+|||+.|+++
T Consensus 233 -------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 233 -------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 112346778999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=410.22 Aligned_cols=252 Identities=21% Similarity=0.301 Sum_probs=202.1
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCe----EEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ----IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
.++|++++.||+|+||+||+|++..+|+ .||+|++.... .....+.+.+|+.+|++++|||||++++++.+.
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--- 83 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 83 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 3679999999999999999999988886 47777775432 333456788999999999999999999999763
Q ss_pred eeEEEEeecc-CChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 193 SLYLVFKYME-HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 193 ~~~lv~e~~~-~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
..++++||+. ++++..+......+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||++.....
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 3566777766 556666666677899999999999999999999999999999999999999999999999999987754
Q ss_pred CCCC-CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCC
Q 011041 272 NHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (495)
Q Consensus 272 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (495)
.... ......||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+....+..... +
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~-~--------- 232 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-L--------- 232 (317)
T ss_dssp TCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC-C---------
T ss_pred ccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-C---------
Confidence 3322 2234568999999999876 578999999999999999998 8999998887776666544211 0
Q ss_pred CCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.....+|+++.+||.+||..||.+|||+.|+++|
T Consensus 233 ------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 233 ------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 1123467789999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-51 Score=401.81 Aligned_cols=255 Identities=22% Similarity=0.322 Sum_probs=196.7
Q ss_pred CCCeeeeeeecccCceEEEEEEECC-----CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTL-----TGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 190 (495)
.++|++++.||+|+||.||+|++.. +++.||||++.... .....+.+.+|+.++.++ +|+|||.+++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~- 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-
Confidence 3789999999999999999999754 45789999987543 344456677788877776 689999999987654
Q ss_pred CceeEEEEeeccCChhhhhhC----------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC
Q 011041 191 SCSLYLVFKYMEHDLAGLAAS----------------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN 254 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~----------------~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~ 254 (495)
+..+|+|||||+++.+..++. ....+++.++..|+.||+.||.|||++|||||||||+||||+.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 457899999999765554432 1235899999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHH
Q 011041 255 EGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHK 332 (495)
Q Consensus 255 ~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~~~ 332 (495)
++.+||+|||+|+....... ......+||+.|+|||++.+ ..|+.++|||||||++|||++| .+||.+.+..+.+..
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999986643332 23345679999999999876 5789999999999999999986 678988766555555
Q ss_pred HHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 333 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
++.....+ .....+++++.+||.+||+.||.+|||+.|+++|
T Consensus 249 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 249 RLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44321111 1123467889999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-50 Score=399.95 Aligned_cols=252 Identities=22% Similarity=0.353 Sum_probs=208.6
Q ss_pred CCCeeeeeeecccCceEEEEEEEC-----CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
.++|++++.||+|+||+||+|+++ .+++.||||++.... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~ 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV--G 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--S
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeecc--C
Confidence 368999999999999999999875 456899999987543 45556788999999999999999999999987 5
Q ss_pred ceeEEEEeeccCChhhhhhC------------------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCC
Q 011041 192 CSLYLVFKYMEHDLAGLAAS------------------------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKG 247 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~------------------------~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp 247 (495)
...+++|||+.++.+..++. ....+++..+..|+.||+.||+|||++|||||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 67999999998765444331 122489999999999999999999999999999999
Q ss_pred CCeeeCCCCcEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCC
Q 011041 248 SNLLIDNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRT 325 (495)
Q Consensus 248 ~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~ 325 (495)
+||||+.++.+||+|||++........ ...++..||+.|+|||++.+ ..|+.++|||||||++|||++| .+||.+.+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999986643322 22345678999999999876 5789999999999999999998 57899999
Q ss_pred hHHHHHHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 326 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
..+.+..+.+.. ......++|+++.+||.+||+.||.+|||+.|+++
T Consensus 248 ~~e~~~~v~~~~----------------------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 248 HEEVIYYVRDGN----------------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCC----------------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 988887775421 11123467888999999999999999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-51 Score=396.96 Aligned_cols=253 Identities=25% Similarity=0.341 Sum_probs=199.9
Q ss_pred CCCeeeeeeecccCceEEEEEEEC-CCC--eEEEeEEEecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCc
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT-LTG--QIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~-~~g--~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 192 (495)
.++|++++.||+|+||.||+|+.. .++ ..||||++.+... .....+.+.+|+.+|+.++|||||++++++.+ .
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~ 83 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---P 83 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---c
Confidence 367999999999999999999864 333 4689999976654 34556788999999999999999999999975 3
Q ss_pred eeEEEEeeccCChhh-hhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCC
Q 011041 193 SLYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~-~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~ 271 (495)
.+++||||++++.+. .+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 579999999865444 4444455799999999999999999999999999999999999999999999999999997754
Q ss_pred CCCC--CCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhC
Q 011041 272 NHKQ--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (495)
Q Consensus 272 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (495)
.... ......||..|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+.+.+|.+....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~-------- 234 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-------- 234 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--------
T ss_pred CCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC--------
Confidence 3221 2233467889999999876 578999999999999999998 899999999999888876532111
Q ss_pred CCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.....+|+++.+||.+||..||.+|||+.++++
T Consensus 235 -------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 235 -------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112457888999999999999999999999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=390.54 Aligned_cols=245 Identities=20% Similarity=0.333 Sum_probs=197.5
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~l 196 (495)
.++|++++.||+|+||.||+|++ +|..||||+++.+. ..+.+.+|+.+|++++|||||++++++.+. ...+||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~l 78 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI 78 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcEEE
Confidence 57899999999999999999987 47899999997543 335688999999999999999999988543 356899
Q ss_pred EEeeccCChhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 011041 197 VFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~--~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 274 (495)
||||++++.+..++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 9999998766554432 234899999999999999999999999999999999999999999999999999865432
Q ss_pred CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhCCCCCC
Q 011041 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (495)
Q Consensus 275 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (495)
.....+|+.|+|||++.+ ..|+.++|||||||++|||+| |++||.+.+..+....|.+..
T Consensus 157 --~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~---------------- 217 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------------- 217 (262)
T ss_dssp -------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC----------------
T ss_pred --CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 234567999999999876 578999999999999999998 799999888777776663211
Q ss_pred ccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.......+++++.+||.+||..||.+|||+.+++++
T Consensus 218 ------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 218 ------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 011234567889999999999999999999999873
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=392.87 Aligned_cols=252 Identities=20% Similarity=0.308 Sum_probs=204.2
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCC-------eEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeec
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTG-------QIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS 188 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g-------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 188 (495)
.++|++++.||+|+||.||+|++..++ ..||||++..+. .......+.+|+.++.++ +|||||++++++.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 379999999999999999999876554 479999997654 445566788899999888 89999999999987
Q ss_pred cCCceeEEEEeeccCChhhhhhCC----------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee
Q 011041 189 RMSCSLYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (495)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~~~----------------~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl 252 (495)
+..+|+||||++++.+..++.. ...+++..+..++.||+.||+|||++|||||||||+|||+
T Consensus 91 --~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 91 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp --SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred --CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 5679999999998766554432 2358999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011041 253 DNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (495)
Q Consensus 253 ~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~ 330 (495)
+.++.+||+|||++........ .......||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 9999999999999987644322 23345678999999999876 579999999999999999998 79999988877766
Q ss_pred HHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
..+.... .+ .....+|+++.+||.+||+.||.+|||+.|+|+
T Consensus 248 ~~i~~~~-~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEGH-RM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTTC-CC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCC-CC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 6553311 11 112357788999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-50 Score=397.34 Aligned_cols=252 Identities=24% Similarity=0.308 Sum_probs=205.0
Q ss_pred CCCCeeeeeeecccCceEEEEEEECCCCeE--EEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccCCc
Q 011041 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQI--VALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSC 192 (495)
Q Consensus 116 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 192 (495)
..++|++.+.||+|+||.||+|+++.+|.. ||||.+.... ..+..+.+.+|+.+|.++ +|||||++++++.+ ..
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~ 84 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RG 84 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TT
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CC
Confidence 457999999999999999999999988875 6777765432 334456788999999999 79999999999987 56
Q ss_pred eeEEEEeeccCChhhhhhC----------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCC
Q 011041 193 SLYLVFKYMEHDLAGLAAS----------------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG 256 (495)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~----------------~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~ 256 (495)
.+|+||||++++.+..++. ....+++.++..++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 8999999999766555442 235799999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHH
Q 011041 257 ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFK 335 (495)
Q Consensus 257 ~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~~~i~~ 335 (495)
.+||+|||+++....... .....||+.|+|||.+.+ ..|+.++||||||||+|||++| .+||.+.+..+.+..+.+
T Consensus 165 ~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp CEEECCTTCEESSCEECC--C----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred ceEEcccccccccccccc--ccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 999999999986543322 234568999999999876 5689999999999999999996 568888888887766643
Q ss_pred hcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 336 LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 336 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.. . ......+|+++.+||.+||..||++|||+.++|+|
T Consensus 242 ~~--~--------------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 242 GY--R--------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TC--C--------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cC--C--------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11 0 11123567889999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-49 Score=388.28 Aligned_cols=261 Identities=19% Similarity=0.229 Sum_probs=205.8
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeece-eeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGL-VTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~-~~~~~~~~~~ 195 (495)
.++|++++.||+|+||.||+|++..+|+.||||++...... ..+.+|+++++.++|+|++.++.. +.+ ....+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~--~~~~~ 79 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE--GDYNV 79 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEE--TTEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEec--CCEEE
Confidence 36799999999999999999999999999999998865432 236789999999987776555444 444 56789
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC---CCcEEEeecccccccCCC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASFFDPN 272 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~---~~~vkL~DFG~a~~~~~~ 272 (495)
+||||+++++..........+++..+..++.||+.||+|||++|||||||||+|||++. +..+||+|||+|+.+...
T Consensus 80 ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 80 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 99999999988887777778999999999999999999999999999999999999864 457999999999887543
Q ss_pred CC------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 011041 273 HK------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (495)
Q Consensus 273 ~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (495)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.........+.......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~------ 232 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK------ 232 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH------
T ss_pred ccccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc------
Confidence 22 12345689999999999886 568999999999999999999999998876655444332211000
Q ss_pred hCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHH---HHHhCCCCC
Q 011041 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT---AALRSEFFT 405 (495)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~---elL~hp~f~ 405 (495)
...........+|+++.+||..||..||.+||++. ++|+|+|.+
T Consensus 233 ---------------~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 233 ---------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ---------------HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---------------CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 00002223456888999999999999999999986 557777654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=390.50 Aligned_cols=253 Identities=20% Similarity=0.279 Sum_probs=209.7
Q ss_pred CCCeeeeeeecccCceEEEEEEEC-----CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeccC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 190 (495)
.++|++++.||+|+||.||+|++. .+++.||||++.... .......+.+|+.++..+ +|||||++++++.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-- 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence 378999999999999999999863 567899999997654 345556788999999999 69999999999987
Q ss_pred CceeEEEEeeccCChhhhhhC------------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeee
Q 011041 191 SCSLYLVFKYMEHDLAGLAAS------------------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (495)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~------------------~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl 252 (495)
...+|||||||+++.+..++. ....+++..+..|+.||+.||.|||++|||||||||+||||
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 456999999999875554432 12358999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011041 253 DNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (495)
Q Consensus 253 ~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~ 330 (495)
+.++.+||+|||+++....... ......+||+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+..+.+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999987654332 22344678999999999875 578999999999999999998 78888888777777
Q ss_pred HHHHHhcCCCChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
.++......+ .....+|+++.+||.+||+.||.+|||+.++|+
T Consensus 258 ~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 258 YKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6665432111 112346788999999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=387.17 Aligned_cols=252 Identities=16% Similarity=0.230 Sum_probs=209.9
Q ss_pred CCCeeeeeeecccCceEEEEEEEC-----CCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 191 (495)
.++|++++.||+|+||.||+|.++ .++..||||+++... .......+.+|+.++++++|||||++++++.. .
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--S
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec--C
Confidence 489999999999999999999875 345789999997543 44555678899999999999999999999976 4
Q ss_pred ceeEEEEeeccCChhhhhhC----------CCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEe
Q 011041 192 CSLYLVFKYMEHDLAGLAAS----------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIA 261 (495)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~----------~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~ 261 (495)
..+++||||+.++.+..+.. ....+++..+..++.||+.||.|||+++|+||||||+||||+.++++||+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence 57999999999765544321 22357899999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCC-CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCC
Q 011041 262 DFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGS 339 (495)
Q Consensus 262 DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~~~i~~~~g~ 339 (495)
|||+++....... ......+||+.|+|||.+.+ ..++.++|||||||++|||++| .+||.+.+..+.+..+.+...
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~- 253 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL- 253 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC-
Confidence 9999986643322 12234478999999999876 5689999999999999999998 589999988888887754211
Q ss_pred CChhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
......+|+.+.+||.+||+.||.+|||+.++++
T Consensus 254 ---------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 254 ---------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1112357788999999999999999999999998
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-47 Score=388.29 Aligned_cols=283 Identities=25% Similarity=0.375 Sum_probs=217.0
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-----------CCCeeeeecee
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-----------HPNVVKLEGLV 186 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~~~~ 186 (495)
++|+++++||+|+||+||+|+++.+|+.||||+++++ ....+.+.+|+.+|+.++ |+|||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4699999999999999999999999999999999754 234456788999998875 57899999998
Q ss_pred eccCCceeEEEEeeccCCh---hhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceeccCCCCCeeeCCCC------
Q 011041 187 TSRMSCSLYLVFKYMEHDL---AGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEG------ 256 (495)
Q Consensus 187 ~~~~~~~~~lv~e~~~~~l---~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~-~givHrDlKp~NILl~~~~------ 256 (495)
........+++|+++.... ..........+++..++.++.||+.||.|||+ .||+||||||+||||+.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 7655667777777765432 22334455679999999999999999999997 8999999999999998765
Q ss_pred cEEEeecccccccCCCCCCCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------hHHHH
Q 011041 257 ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT------EVEQL 330 (495)
Q Consensus 257 ~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~------~~~~~ 330 (495)
.+||+|||.+..... .....+||+.|+|||++.+ ..|+.++|||||||++++|++|++||.+.+ ..+.+
T Consensus 170 ~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeeccccccccc----ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 399999999986542 2345689999999999886 568999999999999999999999997543 45677
Q ss_pred HHHHHhcCCCChhhhhhCCCCC----------CccCCCCccccccccc---ccCCCCCCcHHHHHHhccCCCCCccCHHH
Q 011041 331 HKIFKLCGSPSEEYWKKSKLPH----------ATIFKPQQSYKRCIAE---TFKDFPPSSLPLIETLLAIDPAERQTATA 397 (495)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~---~~~~~s~~~~~Li~~~L~~dP~~R~ta~e 397 (495)
..++..+|.++...+....... ................ .....++++.|||.+||.+||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 7888888988877664432110 0000000111111111 11234567899999999999999999999
Q ss_pred HHhCCCCCCCC
Q 011041 398 ALRSEFFTTKP 408 (495)
Q Consensus 398 lL~hp~f~~~~ 408 (495)
+|+||||+..+
T Consensus 325 ~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 325 LVNHPWLKDTL 335 (362)
T ss_dssp HHTCGGGTTCT
T ss_pred HhcCcccCCCC
Confidence 99999999643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.4e-47 Score=375.46 Aligned_cols=253 Identities=18% Similarity=0.207 Sum_probs=207.4
Q ss_pred CCCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCC-CCeeeeeceeeccCCceeE
Q 011041 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH-PNVVKLEGLVTSRMSCSLY 195 (495)
Q Consensus 117 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~~~ 195 (495)
.++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.|.| +||+.+++++.. ....|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 77 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNV 77 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccE
Confidence 36899999999999999999999999999999998754322 346689999999965 899999999877 67899
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCC-----CCcEEEeecccccccC
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-----EGILTIADFGLASFFD 270 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~-----~~~vkL~DFG~a~~~~ 270 (495)
+||||+++++...+......+++..+..++.||+.||+|||++|||||||||+||||+. ++.+||+|||+|+.+.
T Consensus 78 ~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 78 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999998888877777778999999999999999999999999999999999999974 5789999999998764
Q ss_pred CCCC------CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCC
Q 011041 271 PNHK------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---VEQLHKIFKLCGSPS 341 (495)
Q Consensus 271 ~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~g~~~ 341 (495)
.... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+. .....++......++
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 3321 12345689999999999886 5789999999999999999999999987543 333333332211111
Q ss_pred hhhhhhCCCCCCccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
..+..+++|+++.+||..|+..+|.+||+.+.+.+
T Consensus 237 ------------------------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 ------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp ------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------------------------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 22334568889999999999999999998766543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=380.37 Aligned_cols=250 Identities=19% Similarity=0.220 Sum_probs=198.4
Q ss_pred eeeeeecccCceEEEEEEECCCC---eEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCCceeEEE
Q 011041 121 EKLDKIGQGTYSNVYKARDTLTG---QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (495)
Q Consensus 121 ~~~~~LG~G~~g~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~lv 197 (495)
.+.++||+|+||+||+|++..++ ..||||+++.. ........+.+|+.+|++++|||||++++++... +..+++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEE
Confidence 34678999999999999986643 36899998753 3556667899999999999999999999997653 4578999
Q ss_pred EeeccCChhhh-hhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeecccccccCCCCC--
Q 011041 198 FKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-- 274 (495)
Q Consensus 198 ~e~~~~~l~~~-~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~-- 274 (495)
|||++++.+.. +......+++..+..++.||+.||.|||++||+||||||+||||++++.+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999876654 445556788999999999999999999999999999999999999999999999999987644322
Q ss_pred -CCCccccccCCCCCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCChhhhhhCCCCC
Q 011041 275 -QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG-RTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (495)
Q Consensus 275 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwSlGvil~elltG~~pf~~-~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (495)
.......||+.|+|||++.+ ..++.++|||||||++|||++|..||.. .+..+....+.... ..
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~--~~----------- 253 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RL----------- 253 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC--CC-----------
T ss_pred ceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--CC-----------
Confidence 22234578999999998875 5689999999999999999997666654 34444444443211 00
Q ss_pred CccCCCCcccccccccccCCCCCCcHHHHHHhccCCCCCccCHHHHHhC
Q 011041 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (495)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ta~elL~h 401 (495)
.....+++++.+||.+||..||.+|||+.|+++|
T Consensus 254 ---------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 254 ---------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1113467789999999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=374.03 Aligned_cols=268 Identities=24% Similarity=0.254 Sum_probs=188.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeccCC--ceeE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS--CSLY 195 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--~~~~ 195 (495)
.+|.+.+.||+|+||.||+|+. +|+.||||++.... ......+.|+..+..++|||||++++++.+... ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 5799999999999999999975 68999999986432 222233456666667899999999999876432 3689
Q ss_pred EEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh--------CCceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN--------QHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~--------~givHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
+||||+.++.+..++... .+++..+..++.|++.||.|||+ +|||||||||+||||+.++.+||+|||++.
T Consensus 78 lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999987666555433 68999999999999999999996 699999999999999999999999999998
Q ss_pred ccCCCCC---CCCccccccCCCCCcccccCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 011041 268 FFDPNHK---QPMTSRVVTLWYRPPELLLGAT-----DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS 339 (495)
Q Consensus 268 ~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~ 339 (495)
.+..... ......+||+.|+|||++.+.. .++.++|||||||+||||+||.+||............ .....
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~~~~ 235 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVPSD 235 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TSCSS
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-ccccc
Confidence 7754322 1234568999999999986532 2577899999999999999999887543211000000 00000
Q ss_pred CChhhhhhCCCCCCccCCCCccccccccccc--CCCCCCcHHHHHHhccCCCCCccCHHHHHh
Q 011041 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETF--KDFPPSSLPLIETLLAIDPAERQTATAALR 400 (495)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~Li~~~L~~dP~~R~ta~elL~ 400 (495)
+.......... ...+.+. +.... ...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~--~~~~~p~------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 236 PSVEEMRKVVC--EQKLRPN------IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCHHHHHHHHT--TSCCCCC------CCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHh--ccccCCC------CCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 00000000000 0000000 00000 011234778999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.1e-26 Score=212.66 Aligned_cols=166 Identities=15% Similarity=0.113 Sum_probs=122.6
Q ss_pred eeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCC----------------hHHHHHHHHHHHHHHhCCCCCeeeee
Q 011041 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE----------------PESVRFMAREILILRRLDHPNVVKLE 183 (495)
Q Consensus 120 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~----------------~~~~~~~~~Ei~il~~l~HpnIv~l~ 183 (495)
|.+.++||+|+||+||+|++. +|+.||||+++..... ........+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 457899999999999999985 6899999987642110 11223456789999999999999887
Q ss_pred ceeeccCCceeEEEEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhhCCceeccCCCCCeeeCCCCcEEEeec
Q 011041 184 GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADF 263 (495)
Q Consensus 184 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~~givHrDlKp~NILl~~~~~vkL~DF 263 (495)
++.. .+++|||+++..... +++..+..++.||+.+|.|||++||+||||||+||||++++ ++|+||
T Consensus 81 ~~~~------~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDF 146 (191)
T d1zara2 81 AWEG------NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDF 146 (191)
T ss_dssp EEET------TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCC
T ss_pred EecC------CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEEC
Confidence 6532 379999999865432 44556778999999999999999999999999999999654 899999
Q ss_pred ccccccCCCCCCCCccccccCCCCC------cccccCCCCCCchhhHHHHHHHH
Q 011041 264 GLASFFDPNHKQPMTSRVVTLWYRP------PELLLGATDYGVGVDLWSAGCIL 311 (495)
Q Consensus 264 G~a~~~~~~~~~~~~~~~gt~~y~a------PE~l~~~~~~~~~~DvwSlGvil 311 (495)
|+|......... .|.. .+.+. ..|+.++|+||+.--+
T Consensus 147 G~a~~~~~~~~~---------~~l~rd~~~~~~~f~--r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR---------EILERDVRNIITYFS--RTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH---------HHHHHHHHHHHHHHH--HHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH---------HHHHHHHHHHHHHHc--CCCCCcccHHHHHHHH
Confidence 999765422110 1111 12121 4578899999986443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.47 E-value=1.8e-07 Score=87.02 Aligned_cols=139 Identities=14% Similarity=0.102 Sum_probs=89.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeccCCceeEE
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYL 196 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~l 196 (495)
..|+..+..+.++.+.||+.. .++..+.||+...... .....+.+|+..++.|. +--+.+++.+..+ ++..|+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~l 87 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNL 87 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceEE
Confidence 456766666666668999885 4556678888754322 11234667888888773 4345677776665 467899
Q ss_pred EEeeccCChhhhhhCCCCCCCHHHHHHHHHHHHHHHHHhhh---------------------------------------
Q 011041 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN--------------------------------------- 237 (495)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~l~e~~~~~i~~qil~~L~~LH~--------------------------------------- 237 (495)
||++++|..+....... .....++.++...|..||+
T Consensus 88 v~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred EEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 99999986554322111 1112233334444444442
Q ss_pred --------------------CCceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 238 --------------------QHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 238 --------------------~givHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
..++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 138999999999999987666799999774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.16 E-value=5.8e-06 Score=76.06 Aligned_cols=72 Identities=13% Similarity=0.089 Sum_probs=47.9
Q ss_pred eecccC-ceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCC--CCeeeeeceeeccCCceeEEEEeec
Q 011041 125 KIGQGT-YSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH--PNVVKLEGLVTSRMSCSLYLVFKYM 201 (495)
Q Consensus 125 ~LG~G~-~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~~~lv~e~~ 201 (495)
.+..|. .+.||+... ..+..+.+|...... ...+.+|+..|+.|.. -.+++++.+..+ .+..|+||+++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEEee
Confidence 344554 468998863 456678889765432 2246678888887743 335667776665 45789999999
Q ss_pred cCC
Q 011041 202 EHD 204 (495)
Q Consensus 202 ~~~ 204 (495)
+|.
T Consensus 89 ~G~ 91 (255)
T d1nd4a_ 89 PGQ 91 (255)
T ss_dssp SSE
T ss_pred ecc
Confidence 874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.06 E-value=4.9e-06 Score=82.31 Aligned_cols=77 Identities=19% Similarity=0.132 Sum_probs=47.9
Q ss_pred eeeecccCceEEEEEEECCCCeEEEeEEEecC-----CCChHHHHHHHHHHHHHHhCC-C--CCeeeeeceeeccCCcee
Q 011041 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFD-----NLEPESVRFMAREILILRRLD-H--PNVVKLEGLVTSRMSCSL 194 (495)
Q Consensus 123 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~i~~~-----~~~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~~~~~~~ 194 (495)
.+.||.|....||++.+..+++.|++|.-... ...+....+...|+..|+.+. + ..+++++.+.. ...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~----~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT----EMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET----TTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC----CCC
Confidence 56799999999999998877888999965321 001112334557888887762 2 34566654432 235
Q ss_pred EEEEeeccC
Q 011041 195 YLVFKYMEH 203 (495)
Q Consensus 195 ~lv~e~~~~ 203 (495)
++|||++++
T Consensus 107 ~lvmE~L~~ 115 (392)
T d2pula1 107 VTVMEDLSH 115 (392)
T ss_dssp EEEECCCTT
T ss_pred EEEEeccCC
Confidence 789999975
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.31 E-value=0.00044 Score=65.85 Aligned_cols=69 Identities=16% Similarity=0.128 Sum_probs=42.3
Q ss_pred ceEEEEEEECCCCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCCCCCee-----eeeceeeccCCceeEEEEeeccC
Q 011041 131 YSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV-----KLEGLVTSRMSCSLYLVFKYMEH 203 (495)
Q Consensus 131 ~g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-----~l~~~~~~~~~~~~~lv~e~~~~ 203 (495)
--.||+++. .+|..|++|+.+...... +.+..|+..|..|...+|. ..-+-.........+.+++++.|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 358999974 578889999987654333 4466788888887422221 11111100124567889998876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.27 E-value=0.0005 Score=67.36 Aligned_cols=76 Identities=17% Similarity=0.188 Sum_probs=50.3
Q ss_pred CCeeeeeeecccCceEEEEEEECC-------CCeEEEeEEEecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeecc
Q 011041 118 DTFEKLDKIGQGTYSNVYKARDTL-------TGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSR 189 (495)
Q Consensus 118 ~~y~~~~~LG~G~~g~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 189 (495)
+.++ ++.|+.|-.-.+|++.... ..+.|.+++.-. . .......+|..+++.+. +.-.+++++++.+
T Consensus 43 ~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 43 EHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P---ETESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred cceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c---chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 4444 4678999999999997653 235577776542 1 12234668999999884 4334577777643
Q ss_pred CCceeEEEEeeccCC
Q 011041 190 MSCSLYLVFKYMEHD 204 (495)
Q Consensus 190 ~~~~~~lv~e~~~~~ 204 (495)
.+|+||++|.
T Consensus 117 -----g~I~efi~g~ 126 (395)
T d1nw1a_ 117 -----GRLEEYIPSR 126 (395)
T ss_dssp -----EEEECCCCEE
T ss_pred -----ceEEEEeccc
Confidence 6789999863
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.89 E-value=0.00051 Score=64.86 Aligned_cols=30 Identities=23% Similarity=0.383 Sum_probs=27.2
Q ss_pred CCceeccCCCCCeeeCCCCcEEEeeccccc
Q 011041 238 QHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (495)
Q Consensus 238 ~givHrDlKp~NILl~~~~~vkL~DFG~a~ 267 (495)
.||||+|+.++|||++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 579999999999999998878899999874
|